Citrus Sinensis ID: 039318
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 717 | 2.2.26 [Sep-21-2011] | |||||||
| O81832 | 783 | G-type lectin S-receptor- | yes | no | 0.994 | 0.910 | 0.509 | 0.0 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.981 | 0.863 | 0.479 | 0.0 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.991 | 0.853 | 0.435 | 0.0 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.991 | 0.829 | 0.426 | 1e-180 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.994 | 0.838 | 0.436 | 1e-179 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.965 | 0.821 | 0.402 | 1e-173 | |
| Q9SXB5 | 820 | G-type lectin S-receptor- | no | no | 0.976 | 0.853 | 0.418 | 1e-170 | |
| Q9LPZ9 | 830 | G-type lectin S-receptor- | no | no | 0.973 | 0.840 | 0.425 | 1e-170 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.973 | 0.851 | 0.415 | 1e-169 | |
| O64780 | 814 | G-type lectin S-receptor- | no | no | 0.973 | 0.857 | 0.415 | 1e-158 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function desciption |
|---|
Score = 752 bits (1942), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/756 (50%), Positives = 519/756 (68%), Gaps = 43/756 (5%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
+L DG T+VS+ GSFE+GFFSPG S+NRY+GIWYK + ++TVVWVANR +P+ D SG L
Sbjct: 32 TLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVANRDSPLYDLSGTLK 91
Query: 61 VNKTGNLVLTSQNKSVVWSANL-----SKEVRTPVVLQLLDSGNLVLRGERDGDSETYLW 115
V++ G+L L + ++WS++ +R P+V Q+LD+GNLV+R GD + Y+W
Sbjct: 92 VSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIV-QILDTGNLVVRNS--GDDQDYIW 148
Query: 116 QSFDYPSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGS 175
QS DYP D LPGMK G +F TGL R +TSW++ DDPS G++ K++ P+ + K S
Sbjct: 149 QSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNS 208
Query: 176 RKFYRTGPWNGLIFSA-SSLRLNPIFKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSL 234
+RTGPWNGL F+ +L+ NPI++Y +VF E+E+YYT+ L + V++R +N +L
Sbjct: 209 VVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTYKLENPSVLTRMQLNPNGAL 268
Query: 235 RQRFIWRKANQSWELYSNLPKDQCDTYGLCGAYGICIISQSPICQCLEGF---HPKSGGY 291
QR+ W QSW Y + D CD Y LCG+YG C I++SP C+CL+GF P++
Sbjct: 269 -QRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINESPACRCLKGFVAKTPQAWVA 327
Query: 292 VDWSQGCVHNKPLNYSR-KDGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAY 350
DWS+GCV L+ + +DGF+K S+LKLPD+ +SW K+M+L EC++ CL N +C AY
Sbjct: 328 GDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCLRNCTCSAY 387
Query: 351 TNSDITRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASELGGNNRRTDQ--ENEDQNED 408
+ DI GG GC++WFGDLID+R + + GQDLY+R+++SE+ R + + + + ED
Sbjct: 388 SPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLASSEIETLQRESSRVSSRKQEEED 447
Query: 409 LELPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA---------------- 452
LELP +L T++ AT FS KLG+GGFGPVYKGTLA GQE+A
Sbjct: 448 LELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFK 507
Query: 453 ----------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCI 502
HRNLVK+LG C+ EE++LIYE+ PN+SLDSFIFD+ +R+ LDW KR I
Sbjct: 508 NEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEI 567
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV 562
I G ARG+LYLH DSRLRIIHRDLKASNVLLD +MN KISDFGLART GDE E +T RV
Sbjct: 568 IKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRV 627
Query: 563 VGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWN 622
VGTYGYM+PEY DG FS+KSDVFSFG+L+LEIVSG++NRGF + + LNL+GHAW+ +
Sbjct: 628 VGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFL 687
Query: 623 NGMPSQLIDAYYQESC-NLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPK 681
++ID ESC +++EV+R IH+GLLCVQ P+DRP M V+LML SE++L P+
Sbjct: 688 EDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLDPR 747
Query: 682 QPGFLADRKSTGPNSSSSMLESSSTNTITISTLEGR 717
QPGF +R ++ S LE S N T+S ++ R
Sbjct: 748 QPGFFNERNLLFSDTVSINLEIPSNNFQTMSVIDPR 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 673 bits (1737), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/794 (47%), Positives = 494/794 (62%), Gaps = 90/794 (11%)
Query: 2 LSDGRTLVSKEGSFELGFFS---PGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGV 58
L DG TL S + F+LGFFS ++R++G+WY M VVWVANR NP+ +SG
Sbjct: 34 LKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWY--MEPFAVVWVANRNNPLYGTSGF 91
Query: 59 LVVNKTGNLVLTSQNKSVVWSANLSKEVRTPV----VLQLLDSGNLVLRGERDGDSETYL 114
L ++ G+L L +WS++ S + +L++ SGNL+ DG+ E L
Sbjct: 92 LNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNLI---SSDGE-EAVL 147
Query: 115 WQSFDYPSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKG 174
WQSFDYP +T+L GMKLG +FKT +E ++SWK+ DPSPGDF ++ + P+L++ K
Sbjct: 148 WQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTRGLPQLILRKN 207
Query: 175 --SRKFYRTGPWNGLIFSASSL--RLNPIFKYRFVFNEDELYYTFYLTDKDVISRTVMNQ 230
S YR G WNGL F+ + R N +F Y+F + E+ Y++ + ++SR V+N
Sbjct: 208 GDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSWTPRHR-IVSRLVLNN 266
Query: 231 TVSLRQRFIWRKANQSWELYSNLPKDQCDTYGLCGAYGICIIS--QSPICQCLEGFHPKS 288
T L RFI K NQ W L + P+D+CD Y +CGAY +C I+ +P C CL+GF PKS
Sbjct: 267 TGKL-HRFIQSKQNQ-WILANTAPEDECDYYSICGAYAVCGINSKNTPSCSCLQGFKPKS 324
Query: 289 GGYVDWSQG---CVHNKPLNYSRKDGFIKFSELKLPDSTSSW--VSKSMNLKECREKCLE 343
G + S+G CVH P N +KD F+KF LKLPD++ SW M L++C+ KC
Sbjct: 325 GRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKIKCSS 384
Query: 344 NSSCMAYTNSDITRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASELGGNNR------- 396
N SC AY N+DI GG GC++WFGDL+DMR + GQD+YIRM +++ R
Sbjct: 385 NCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVYIRMGFAKIEFKGREVVGMVV 444
Query: 397 -----------------------RTDQENED---QNEDLELPLFELATIANATDNFSINK 430
R EN + EDL+LP+F+ TI+ ATD+FS
Sbjct: 445 GSVVAIAVVLVVVFACFRKKIMKRYRGENFRKGIEEEDLDLPIFDRKTISIATDDFSYVN 504
Query: 431 KLGEGGFGPVYKGTLADGQEIA--------------------------HRNLVKLLGCCI 464
LG GGFGPVYKG L DGQEIA HRNLV+LLGCCI
Sbjct: 505 FLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCI 564
Query: 465 QGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHR 524
QGEE +LIYE+MPN+SLD FIFD+ + LDW KR II G ARG+LYLH DSRLRIIHR
Sbjct: 565 QGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHR 624
Query: 525 DLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSD 584
DLKA NVLLD++MNPKISDFGLA++F GD+ E ST RVVGTYGYM PEYA DG FSVKSD
Sbjct: 625 DLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSD 684
Query: 585 VFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLW-NNGMPSQLIDAYYQESCNLAEV 643
VFSFG+L+LEI++GK NRGF H+D +LNL+GH WK+W + + + +E+ + EV
Sbjct: 685 VFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEV 744
Query: 644 IRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQPGFLADRKSTGPNSSSSMLES 703
+RCIHV LLCVQ PEDRP M SV+LM GS+ LP P QPGF +R P+ SSS L
Sbjct: 745 LRCIHVALLCVQQKPEDRPTMASVVLMFGSDSSLPHPTQPGFFTNRNV--PDISSS-LSL 801
Query: 704 SSTNTITISTLEGR 717
S N ++I+ L+GR
Sbjct: 802 RSQNEVSITMLQGR 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 647 bits (1670), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/813 (43%), Positives = 489/813 (60%), Gaps = 102/813 (12%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
SL DG ++S F GFFS G S+ RYVGIWY + +T+VWVANR +PIND+SG++
Sbjct: 27 SLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDHPINDTSGMVK 86
Query: 61 VNKTGNL-VLTSQNKS-VVWSANLSKEVRTP-VVLQLLDSGNLVLRGERDGDSETYLWQS 117
+ GNL V S N++ ++WS N+S + P +V L D GNLVL G S W+S
Sbjct: 87 FSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVTGRS---FWES 143
Query: 118 FDYPSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRK 177
FD+P+DT LP M+LG+ K GL+R +TSWKS DP GD I ++ER+ +P+L+++KG
Sbjct: 144 FDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLILYKGVTP 203
Query: 178 FYRTGPWNGLIFSA-SSLRLNPIFKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSLRQ 236
++R G W G +S + + IF FV NEDE+ +T+ +TD VI+RT++N+T ++
Sbjct: 204 WWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMVNETGTM-H 262
Query: 237 RFIWRKANQSWELYSNLPKDQCDTYGLCGAYGICIISQSPI--CQCLEGFHPKSGGY--- 291
RF W ++ W + ++PK+QCD Y CG G C S C CL GF PK +
Sbjct: 263 RFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFPRHWFL 322
Query: 292 VDWSQGCVHNKPLNY-SRKDGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAY 350
D S GC K + S KDGF+K +K+PD++ + V ++ LKEC+++CL+N SC+AY
Sbjct: 323 RDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQRCLKNCSCVAY 382
Query: 351 TNS--DITRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASELG---------------- 392
++ + RG GC+ W G ++D R + + GQD YIR+ EL
Sbjct: 383 ASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARWNRNGLSGKRRVLLI 442
Query: 393 ------------------------GNNRRTDQEN---------------EDQNEDLELPL 413
N R+ N +D+ + ELPL
Sbjct: 443 LISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFRFEQDKARNRELPL 502
Query: 414 FELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA--------------------- 452
F+L TI AT+NFS KLG GGFGPVYKG L + EIA
Sbjct: 503 FDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKNEVKL 562
Query: 453 -----HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTA 507
HRNLV++LGCC++ EEK+L+YE++PN+SLD FIF + +R LDW KR I+ G A
Sbjct: 563 ISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIVRGIA 622
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
RG+LYLH DSRLRIIHRDLKASN+LLD EM PKISDFG+AR F G+++EG T RVVGT+G
Sbjct: 623 RGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVVGTFG 682
Query: 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627
YMAPEYA +G FS+KSDV+SFG+L+LEI++GKKN F+ +++ NL+GH W LW NG +
Sbjct: 683 YMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFH--EESSNLVGHIWDLWENGEAT 740
Query: 628 QLIDAYY-QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM-LPQPKQPGF 685
++ID QE+ + EV++CI +GLLCVQ + DR M SV++MLG LP PK P F
Sbjct: 741 EIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGHNATNLPNPKHPAF 800
Query: 686 LADRKSTGPNSSSSMLESS-STNTITISTLEGR 717
+ R+ G N + ++ S N +T S ++GR
Sbjct: 801 TSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 631 bits (1628), Expect = e-180, Method: Compositional matrix adjust.
Identities = 350/821 (42%), Positives = 488/821 (59%), Gaps = 110/821 (13%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
++S +TLVS FE+GFF S Y+G+WYK + +T VWVANR NP++++ G L
Sbjct: 43 TISSNKTLVSPGSIFEVGFFRTNS--RWYLGMWYKKVSDRTYVWVANRDNPLSNAIGTLK 100
Query: 61 VNKTGNLVLTSQNKSVVWSANLSK-EVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFD 119
++ NLVL + VW NL++ R+PVV +LL +GN V+R + D+ YLWQSFD
Sbjct: 101 ISG-NNLVLLDHSNKPVWWTNLTRGNERSPVVAELLANGNFVMRDSSNNDASEYLWQSFD 159
Query: 120 YPSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFY 179
YP+DTLLP MKLG++ KTGL R +TSW+SSDDPS G+F +K+E Q PE + + + +
Sbjct: 160 YPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKLETQSLPEFYLSRENFPMH 219
Query: 180 RTGPWNGLIFSA--SSLRLNPIFKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSLRQR 237
R+GPWNG+ FS +L+ + Y F+ N +E+ YTF +T+ SR + + QR
Sbjct: 220 RSGPWNGIRFSGIPEDQKLSYMV-YNFIENNEEVAYTFRMTNNSFYSRLTL-ISEGYFQR 277
Query: 238 FIWRKANQSWELYSNLPKD-QCDTYGLCGAYGICIISQSPICQCLEGFHPKSGGYVD--- 293
W + + W + + P D QCDTY +CG Y C ++ SP+C C++GF+P++ D
Sbjct: 278 LTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAYCDVNTSPVCNCIQGFNPRNIQQWDQRV 337
Query: 294 WSQGCVHNKPLNYSRKDGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAYTNS 353
W+ GC+ L+ S DGF + ++KLP++T + V +S+ +KEC+++C+ + +C A+ N+
Sbjct: 338 WAGGCIRRTQLSCS-GDGFTRMKKMKLPETTMATVDRSIGVKECKKRCISDCNCTAFANA 396
Query: 354 DITRGGSGCVMWFGDLIDMRNFQDG---GQDLYIRMS----------------------- 387
DI GGSGCV+W L D+RN+ GQDLY+R++
Sbjct: 397 DIRNGGSGCVIWTERLEDIRNYATDAIDGQDLYVRLAAADIAKKRNASGKIISLTVGVSV 456
Query: 388 ------------------ASELGGNNRRTDQ---------------ENEDQNEDLELPLF 414
AS + N + +Q E + E+LELPL
Sbjct: 457 LLLLIMFCLWKRKQKRAKASAISIANTQRNQNLPMNEMVLSSKREFSGEYKFEELELPLI 516
Query: 415 ELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA---------------------- 452
E+ T+ AT+NFS KLG+GGFG VYKG L DG+EIA
Sbjct: 517 EMETVVKATENFSSCNKLGQGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLI 576
Query: 453 ----HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTAR 508
H NLV++LGCCI+G+EK+LIYE++ N SLDS++F +T+R L+W++RF I G AR
Sbjct: 577 ARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVAR 636
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
GLLYLH DSR RIIHRDLK SN+LLD M PKISDFG+AR F DE E +T +VVGTYGY
Sbjct: 637 GLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGY 696
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628
M+PEYA G+FS KSDVFSFG+++LEIVSGKKNRGFY+ D +L+ + W W G +
Sbjct: 697 MSPEYAMYGIFSEKSDVFSFGVIVLEIVSGKKNRGFYNLDYENDLLSYVWSRWKEGRALE 756
Query: 629 LIDAYYQESCNL-------AEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM-LPQP 680
++D +S + EV++CI +GLLCVQ E RP M SV+ M GSE +PQP
Sbjct: 757 IVDPVIVDSLSSQPSIFQPQEVLKCIQIGLLCVQELAEHRPAMSSVVWMFGSEATEIPQP 816
Query: 681 KQPGFLADRKSTGPNSSSSML----ESSSTNTITISTLEGR 717
K PG+ R + SSS ES + N T S ++ R
Sbjct: 817 KPPGYCVRRSPYELDPSSSWQCDENESWTVNQYTCSVIDAR 857
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 628 bits (1619), Expect = e-179, Method: Compositional matrix adjust.
Identities = 356/816 (43%), Positives = 481/816 (58%), Gaps = 103/816 (12%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
++S T+VS FELGFF PG Y+GIWYK + +T VWVANR P++ S G L
Sbjct: 39 TISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANRDTPLSSSIGTLK 98
Query: 61 VNKTGNLVLTSQNKSVVWSANLSK-EVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFD 119
++ + NLV+ Q+ + VWS NL+ +VR+P+V +LLD+GN VLR ++ + LWQSFD
Sbjct: 99 ISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDSKNSAPDGVLWQSFD 157
Query: 120 YPSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFY 179
+P+DTLLP MKLGWD KTG R I SWKS DDPS GDF +K+E + +PE+ +W + Y
Sbjct: 158 FPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWNRESRMY 217
Query: 180 RTGPWNGLIFSASSLRLNPI--FKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSLRQR 237
R+GPWNG+ FS + P + F +++E+ Y+F +T DV SR ++ + L QR
Sbjct: 218 RSGPWNGIRFSGVP-EMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSISSS-GLLQR 275
Query: 238 FIWRKANQSWELYSNLPKDQCDTYGLCGAYGICIISQSPICQCLEGFHPKSG---GYVDW 294
F W + Q+W + PKDQCD Y CG YG C + SP+C C++GF P++ G D
Sbjct: 276 FTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFKPRNPQVWGLRDG 335
Query: 295 SQGCVHNKPLNYSRKDGFIKFSELKLPDSTSSWVSKSMN--------LKECREKCLEN-- 344
S GCV L+ DGF++ ++KLPD+T++ V + + L++C N
Sbjct: 336 SDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTD 395
Query: 345 -----SSCMAYTNS-----DITRGGSGCVMWFG--DLIDMRNFQDG------GQDLYIRM 386
S C+ +T + +GG + DL D RN G + + +
Sbjct: 396 IRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNRSAKIIGSSIGVSVLLLL 455
Query: 387 S--------------------------------ASELGGNNRRTDQENEDQNEDLELPLF 414
S +E+ ++RR E+ +DLELPL
Sbjct: 456 SFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRR-HISRENNTDDLELPLM 514
Query: 415 ELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA---------------------- 452
E +A AT+NFS KLG+GGFG VYKG L DGQE+A
Sbjct: 515 EFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLI 574
Query: 453 ----HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTAR 508
H NLV+LL CC+ EK+LIYE++ N SLDS +FD+++ L+W RF II G AR
Sbjct: 575 ARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIAR 634
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
GLLYLH DSR RIIHRDLKASN+LLD M PKISDFG+AR F DE E +T++VVGTYGY
Sbjct: 635 GLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGY 694
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628
M+PEYA DG+FS+KSDVFSFG+LLLEI+S K+N+GFY+SD++LNL+G W+ W G +
Sbjct: 695 MSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLE 754
Query: 629 LIDAYYQESCNL---AEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE-IMLPQPKQPG 684
+ID +S + E++RCI +GLLCVQ EDRP M VILMLGSE +PQPK PG
Sbjct: 755 IIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPG 814
Query: 685 FLADRKSTGPNSSSSML---ESSSTNTITISTLEGR 717
+ +R +SSSS ES + N IT+S L+ R
Sbjct: 815 YCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 608 bits (1568), Expect = e-173, Method: Compositional matrix adjust.
Identities = 332/824 (40%), Positives = 469/824 (56%), Gaps = 132/824 (16%)
Query: 3 SDGRTLVSKEGSFELGFFSP--GSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
S+ TL+ K G F GFF+P +++ RYVGIWY+ +P++TVVWVAN+ +PIND+SGV+
Sbjct: 42 SESETLLCKSGIFRFGFFTPVNSTTRLRYVGIWYEKIPIQTVVWVANKDSPINDTSGVIS 101
Query: 61 VNKTGNLVLTSQNKSVVWSANLSKEVRTPVV-LQLLDSGNLVLRGERDGDSETYLWQSFD 119
+ + GNL +T +VWS N+S V +QL+DSGNL+L+ R+ LW+SF
Sbjct: 102 IYQDGNLAVTDGRNRLVWSTNVSVPVAPNATWVQLMDSGNLMLQDNRNNGE--ILWESFK 159
Query: 120 YPSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFY 179
+P D+ +P M LG D +TG ++TSW S DDPS G++ I +PEL++WK + +
Sbjct: 160 HPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGNYTAGIAPFTFPELLIWKNNVPTW 219
Query: 180 RTGPWNGLIFSASSLRLNPIFKYRFVFNED------------ELYYTFYLTDKDVISRTV 227
R+GPWNG +F + +F F N D Y F L + +I +
Sbjct: 220 RSGPWNGQVFIGLPNMDSLLFLDGFNLNSDNQGTISMSYANDSFMYHFNLDPEGIIYQK- 278
Query: 228 MNQTVSLRQRFIWRKANQSWELYSNLPKDQCDTYGLCGAYGICIISQSPICQCLEGFHPK 287
W + ++W + P CD YG CG +G C ++P C+C++GF PK
Sbjct: 279 -----------DWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAGENPPCKCVKGFVPK 327
Query: 288 S-----GGYVDWSQGCVHNKPLNYSRK------------DGFIKFSELKLPDSTSSWVSK 330
+ GG +WS GC+ PL R+ DGF+K ++K+P S
Sbjct: 328 NNTEWNGG--NWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKMKVPISAER---S 382
Query: 331 SMNLKECREKCLENSSCMAYTNSDITRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASE 390
+ + C + CL+N SC AY G GC++W GDL+DM++F G DL+IR++ SE
Sbjct: 383 EASEQVCPKVCLDNCSCTAYAYDR----GIGCMLWSGDLVDMQSFLGSGIDLFIRVAHSE 438
Query: 391 LGGNN----------------------------RRTDQENEDQNEDL------------- 409
L ++ ++ +D++ +L
Sbjct: 439 LKTHSNLAVMIAAPVIGVMLIAAVCVLLACRKYKKRPAPAKDRSAELMFKRMEALTSDNE 498
Query: 410 ---------ELPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA-------- 452
ELPLFE +A +TD+FS+ KLG+GGFGPVYKG L +GQEIA
Sbjct: 499 SASNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKS 558
Query: 453 ------------------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLL 494
HRNLVKLLGCCI+GEE++L+YE+MP +SLD+++FD K+K+L
Sbjct: 559 GQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKIL 618
Query: 495 DWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554
DW RF I+ G RGLLYLH DSRL+IIHRDLKASN+LLD +NPKISDFGLAR F +E
Sbjct: 619 DWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANE 678
Query: 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLI 614
E +T+RVVGTYGYM+PEYA +G FS KSDVFS G++ LEI+SG++N + + NLNL+
Sbjct: 679 DEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLL 738
Query: 615 GHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674
+AWKLWN+G + L D + C E+ +C+H+GLLCVQ DRP + +VI ML +E
Sbjct: 739 AYAWKLWNDGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQEVANDRPNVSNVIWMLTTE 798
Query: 675 IM-LPQPKQPGFLADRKSTGPNSSSSMLESSSTNTITISTLEGR 717
M L PKQP F+ R ++ SS + S N ++++ + GR
Sbjct: 799 NMSLADPKQPAFIVRRGASEAESSDQSSQKVSINDVSLTAVTGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB5|Y1135_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11305 OS=Arabidopsis thaliana GN=At1g11305 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 600 bits (1546), Expect = e-170, Method: Compositional matrix adjust.
Identities = 336/803 (41%), Positives = 453/803 (56%), Gaps = 103/803 (12%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
+L+D T+VS +F GFFSP +S NRY GIWY ++PV+TV+WVAN+ PINDSSGV+
Sbjct: 35 TLNDSETIVSSFRTFRFGFFSPVNSTNRYAGIWYNSIPVQTVIWVANKDTPINDSSGVIS 94
Query: 61 VNKTGNLVLTSQNKSVVWSANLSKEVRT-PVVLQLLDSGNLVLRGERDGDSETYLWQSFD 119
+++ GNLV+T + V+WS N+S V +LL+SGNLVL+ D +++ YLW+SF
Sbjct: 95 ISEDGNLVVTDGQRRVLWSTNVSTRASANSTVAELLESGNLVLK---DANTDAYLWESFK 151
Query: 120 YPSDTLLPGMKLGWDFKTGLER-RITSWKSSDDPSPGDFIWKIERQFYPELVMWKGS--- 175
YP+D+ LP M +G + +TG ITSW + DPSPG + + YPEL ++ +
Sbjct: 152 YPTDSWLPNMLVGTNARTGGGNITITSWTNPSDPSPGSYTAALVLAPYPELFIFNNNDNN 211
Query: 176 RKFYRTGPWNGLIFSASSLRLNPIFKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSLR 235
+R+GPWNGL+F+ +F YRF N+D D R +
Sbjct: 212 ATVWRSGPWNGLMFNGLPDVYPGLFLYRFKVNDDTNGSATMSYANDSTLRHLYLDYRGFA 271
Query: 236 QRFIWRKANQSWELYSNLPKDQCDTYGLCGAYGICIISQSPICQCLEGFHPKS---GGYV 292
R W +A ++W L S +P +CD Y CG Y C ++P C C++GF P++
Sbjct: 272 IRRDWSEARRNWTLGSQVPATECDIYSRCGQYTTCNPRKNPHCSCIKGFRPRNLIEWNNG 331
Query: 293 DWSQGCVHNKPLNYSRK------DGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSS 346
+WS GC+ PL R+ D F+K +K+PD + EC CL++ S
Sbjct: 332 NWSGGCIRKLPLQCERQNNKGSADRFLKLQRMKMPDFARR---SEASEPECFMTCLQSCS 388
Query: 347 CMAYTNSDITRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASELGGNNRR--------- 397
C+A+ + G GC++W L+D + G DL IR++ SE +RR
Sbjct: 389 CIAFAHGL----GYGCMIWNRSLVDSQVLSASGMDLSIRLAHSEFKTQDRRPILIGTSLA 444
Query: 398 --------------------------TDQEN---------EDQNEDL-ELPLFELATIAN 421
TD E E L ELPLFE +A
Sbjct: 445 GGIFVVATCVLLARRIVMKKRAKKKGTDAEQIFKRVEALAGGSREKLKELPLFEFQVLAT 504
Query: 422 ATDNFSINKKLGEGGFGPVYKGTLADGQEIA--------------------------HRN 455
ATDNFS++ KLG+GGFGPVYKG L +GQEIA HRN
Sbjct: 505 ATDNFSLSNKLGQGGFGPVYKGMLLEGQEIAVKRLSQASGQGLEELVTEVVVISKLQHRN 564
Query: 456 LVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHH 515
LVKL GCCI GEE++L+YEFMP +SLD +IFD + KLLDW+ RF II G RGLLYLH
Sbjct: 565 LVKLFGCCIAGEERMLVYEFMPKKSLDFYIFDPREAKLLDWNTRFEIINGICRGLLYLHR 624
Query: 516 DSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYAS 575
DSRLRIIHRDLKASN+LLD + PKISDFGLAR F G+E E +T+RVVGTYGYMAPEYA
Sbjct: 625 DSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNEDEANTRRVVGTYGYMAPEYAM 684
Query: 576 DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635
GLFS KSDVFS G++LLEI+SG++N HS L+ H W +WN G + ++D
Sbjct: 685 GGLFSEKSDVFSLGVILLEIISGRRNS---HS----TLLAHVWSIWNEGEINGMVDPEIF 737
Query: 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM-LPQPKQPGFLADRKSTGP 694
+ E+ +C+H+ LLCVQ DRP + +V +ML SE+ +P+PKQP F+
Sbjct: 738 DQLFEKEIRKCVHIALLCVQDAANDRPSVSTVCMMLSSEVADIPEPKQPAFMPRNVGLEA 797
Query: 695 NSSSSMLESSSTNTITISTLEGR 717
S S+ +S N +TI+ + GR
Sbjct: 798 EFSESIALKASINNVTITDVSGR 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ9|SD113_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-13 OS=Arabidopsis thaliana GN=SD113 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 599 bits (1544), Expect = e-170, Method: Compositional matrix adjust.
Identities = 346/814 (42%), Positives = 455/814 (55%), Gaps = 116/814 (14%)
Query: 4 DGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNK 63
D T+VS +F GFFSP +S RY GIW+ N+PV+TVVWVAN +PINDSSG++ ++K
Sbjct: 33 DSETVVSNHSTFRFGFFSPVNSTGRYAGIWFNNIPVQTVVWVANSNSPINDSSGMVSISK 92
Query: 64 TGNLVLTSQNKSVVWSANLSKEVRTPVVL-QLLDSGNLVLRGERDGDSETYLWQSFDYPS 122
GNLV+ V WS N+ V +LL++GNLVL G + E LW+SF++P
Sbjct: 93 EGNLVVMDGRGQVHWSTNVLVPVAANTFYARLLNTGNLVLLGTTNTGDEI-LWESFEHPQ 151
Query: 123 DTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYRTG 182
+ LP M L D KTG ++ SWKS DPSPG + + +PELV+WK +R+G
Sbjct: 152 NIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLIPLPFPELVVWKDDLLMWRSG 211
Query: 183 PWNGLIFSASSLRLNPIFKYRFVFNEDELY------YTFYLTDKDVISRTVMNQTVSLRQ 236
PWNG F P YR E L + ++ +++ S+ Q
Sbjct: 212 PWNGQYFIGL-----PNMDYRINLFELTLSSDNRGSVSMSYAGNTLLYHFLLDSEGSVFQ 266
Query: 237 RFIWRKANQSWELYSNLPKDQCDTYGLCGAYGICIIS--QSPICQCLEGFHPKSGGYVDW 294
R W A Q W+ + +P +CDTY CG + C + +P C C+ GF P+S Y +W
Sbjct: 267 R-DWNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFNPGSTPPCMCIRGFKPQS--YAEW 323
Query: 295 -----SQGCVHNKPL--------NYSRK-DGFIKFSELKLPDSTSSWVSKSMNLKECREK 340
+QGCV PL + SRK DGF++ ++K+P + N ++C E
Sbjct: 324 NNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMKVPHNPQR---SGANEQDCPES 380
Query: 341 CLENSSCMAYTNSDITRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASELGG------- 393
CL+N SC AY+ G GC++W G+L+DM+ F G YIR++ SE
Sbjct: 381 CLKNCSCTAYSFDR----GIGCLLWSGNLMDMQEFSGTGVVFYIRLADSEFKKRTNRSIV 436
Query: 394 ----------------------------NNRRTDQENE---------------DQNEDLE 410
NR T NE +Q + E
Sbjct: 437 ITVTLLVGAFLFAGTVVLALWKIAKHREKNRNTRLLNERMEALSSNDVGAILVNQYKLKE 496
Query: 411 LPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA------------------ 452
LPLFE +A AT+NFSI KLG+GGFG VYKG L +G +IA
Sbjct: 497 LPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVNE 556
Query: 453 --------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIIC 504
HRNLV+LLG CI+GEE++L+YEFMP LD+++FD K++LLDW RF II
Sbjct: 557 VVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNIID 616
Query: 505 GTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVG 564
G RGL+YLH DSRL+IIHRDLKASN+LLD +NPKISDFGLAR F G+E E ST RVVG
Sbjct: 617 GICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVVG 676
Query: 565 TYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG 624
TYGYMAPEYA GLFS KSDVFS G++LLEIVSG++N FY+ +N NL +AWKLWN G
Sbjct: 677 TYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWKLWNTG 736
Query: 625 MPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE-IMLPQPKQP 683
L+D E C E+ RC+HVGLLCVQ H DRP + +VI ML SE LP+PKQP
Sbjct: 737 EDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNLPEPKQP 796
Query: 684 GFLADRKSTGPNSSSSMLESSSTNTITISTLEGR 717
F+ R ++ SS +S N ++++ + GR
Sbjct: 797 AFIPRRGTSEVESSGQSDPRASINNVSLTKITGR 830
|
Receptor-like serine/threonine-protein kinase that represses the disease resistance signaling pathway triggered in response to bacterial pathogen such as Pseudomonas syringae pv. tomato. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 595 bits (1534), Expect = e-169, Method: Compositional matrix adjust.
Identities = 334/803 (41%), Positives = 452/803 (56%), Gaps = 105/803 (13%)
Query: 2 LSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVV 61
L+D T+VS +F GFFSP +S +RY GIWY ++ V+TV+WVAN+ PINDSSGV+ V
Sbjct: 36 LNDSETIVSSFRTFRFGFFSPVNSTSRYAGIWYNSVSVQTVIWVANKDKPINDSSGVISV 95
Query: 62 NKTGNLVLTSQNKSVVWSANLSKEVRT-PVVLQLLDSGNLVLRGERDGDSETYLWQSFDY 120
++ GNLV+T + V+WS N+S + V +LLDSGNLVL+ + S+ YLW+SF Y
Sbjct: 96 SQDGNLVVTDGQRRVLWSTNVSTQASANSTVAELLDSGNLVLK---EASSDAYLWESFKY 152
Query: 121 PSDTLLPGMKLGWDFKTGL-ERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSR--- 176
P+D+ LP M +G + + G ITSWKS DPSPG + + YPEL + +
Sbjct: 153 PTDSWLPNMLVGTNARIGGGNVTITSWKSPSDPSPGSYTAALVLAAYPELFIMNNNNNNS 212
Query: 177 KFYRTGPWNGLIFSASSLRLNPIFKYRFVFNED-ELYYTFYLTDKDVISRTVMNQTVSLR 235
+R+GPWNG +F+ +F YRF+ N+D T + + M+ S+
Sbjct: 213 TVWRSGPWNGQMFNGLPDVYAGVFLYRFIVNDDTNGSVTMSYANDSTLRYFYMDYRGSVI 272
Query: 236 QRFIWRKANQSWELYSNLPKDQCDTYGLCGAYGICIISQSPICQCLEGFHPKS---GGYV 292
+R W + ++W + +P +CD Y CG + C ++P+C C+ GF P++
Sbjct: 273 RR-DWSETRRNWTVGLQVPATECDNYRRCGEFATCNPRKNPLCSCIRGFRPRNLIEWNNG 331
Query: 293 DWSQGCVHNKPLNYSRK------DGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSS 346
+WS GC PL R+ DGF++ +KLPD + EC CL+ S
Sbjct: 332 NWSGGCTRRVPLQCERQNNNGSADGFLRLRRMKLPDFARR---SEASEPECLRTCLQTCS 388
Query: 347 CMAYTNSDITRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASEL--------------- 391
C+A + G GC++W G L+D + G DLYIR++ SE+
Sbjct: 389 CIAAAHGL----GYGCMIWNGSLVDSQELSASGLDLYIRLAHSEIKTKDKRPILIGTILA 444
Query: 392 GG---------------NNRRTDQENEDQNEDLE---------------LPLFELATIAN 421
GG +R ++ D + E LPLFE +A
Sbjct: 445 GGIFVVAACVLLARRIVMKKRAKKKGRDAEQIFERVEALAGGNKGKLKELPLFEFQVLAA 504
Query: 422 ATDNFSINKKLGEGGFGPVYKGTLADGQEIA--------------------------HRN 455
AT+NFS+ KLG+GGFGPVYKG L +GQEIA HRN
Sbjct: 505 ATNNFSLRNKLGQGGFGPVYKGKLQEGQEIAVKRLSRASGQGLEELVNEVVVISKLQHRN 564
Query: 456 LVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHH 515
LVKLLGCCI GEE++L+YEFMP +SLD ++FD + KLLDW RF II G RGLLYLH
Sbjct: 565 LVKLLGCCIAGEERMLVYEFMPKKSLDYYLFDSRRAKLLDWKTRFNIINGICRGLLYLHR 624
Query: 516 DSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYAS 575
DSRLRIIHRDLKASN+LLD + PKISDFGLAR F G+E E +T+RVVGTYGYMAPEYA
Sbjct: 625 DSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNEDEANTRRVVGTYGYMAPEYAM 684
Query: 576 DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635
GLFS KSDVFS G++LLEI+SG++N N L+ + W +WN G + L+D
Sbjct: 685 GGLFSEKSDVFSLGVILLEIISGRRN-------SNSTLLAYVWSIWNEGEINSLVDPEIF 737
Query: 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM-LPQPKQPGFLADRKSTGP 694
+ E+ +CIH+GLLCVQ DRP + +V ML SEI +P+PKQP F++
Sbjct: 738 DLLFEKEIHKCIHIGLLCVQEAANDRPSVSTVCSMLSSEIADIPEPKQPAFISRNNVPEA 797
Query: 695 NSSSSMLESSSTNTITISTLEGR 717
SS + S N +TI+ + GR
Sbjct: 798 ESSENSDLKDSINNVTITDVTGR 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64780|Y1614_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61400 OS=Arabidopsis thaliana GN=At1g61400 PE=2 SV=4 | Back alignment and function description |
|---|
Score = 559 bits (1441), Expect = e-158, Method: Compositional matrix adjust.
Identities = 329/791 (41%), Positives = 450/791 (56%), Gaps = 93/791 (11%)
Query: 2 LSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVV 61
LS G+TL S G +ELGFFS +S+N+YVGI +K + + VVWVANR P+ DS+ LV+
Sbjct: 42 LSIGQTLSSSNGVYELGFFSFNNSQNQYVGISFKGIIPRVVVWVANREKPVTDSAANLVI 101
Query: 62 NKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYP 121
+ G+L L + VVWS+ + V +LLDSGNLV+ + G + LW+SF++
Sbjct: 102 SSNGSLQLFNGKHGVVWSSGKALASNGSRV-ELLDSGNLVVIEKVSGRT---LWESFEHL 157
Query: 122 SDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYRT 181
DTLLP + ++ TG +R +TSWKS DPSPGDF+ I Q + + +GS ++R+
Sbjct: 158 GDTLLPHSTIMYNVHTGEKRGLTSWKSYTDPSPGDFVVLITPQVPSQGFLMRGSTPYFRS 217
Query: 182 GPWNGLIFSASSLRLNPIFKYRFVFNED---ELYYTFYLTDKDVISRTVMNQTVSLRQRF 238
GPW F+ +++ + F +D YY+++ D SR + S++
Sbjct: 218 GPWAKTKFTGLP-QMDESYTSPFSLTQDVNGSGYYSYFDRDNKR-SRIRLTPDGSMKA-- 273
Query: 239 IWRKANQSWELYSNLPKDQCDTYGLCGAYGICIISQSPICQCLEGFHPKS---GGYVDWS 295
R W+ P + CD YG+CG +G C+IS P C+C +GF PKS +W+
Sbjct: 274 -LRYNGMDWDTTYEGPANSCDIYGVCGPFGFCVISVPPKCKCFKGFIPKSIEEWKTGNWT 332
Query: 296 QGCVHNKPL----NYSRKDG--FIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMA 349
GCV L N + KD F +K PD + S++ +EC++ CL N SC+A
Sbjct: 333 SGCVRRSELHCQGNSTGKDANVFHTVPNIKPPDFYE--YADSVDAEECQQNCLNNCSCLA 390
Query: 350 YTNSDITRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASELGGNNR------------- 396
+ G GC+MW DL+D F GG+ L IR++ SEL N R
Sbjct: 391 FAYIP----GIGCLMWSKDLMDTVQFAAGGELLSIRLARSELDVNKRKKTIIAITVSLTL 446
Query: 397 --------------RTDQ---------ENEDQNEDLE-LPLFELATIANATDNFSINKKL 432
R +Q N+ Q +D+ L FE+ TI AT+NFS++ KL
Sbjct: 447 FVILGFTAFGFWRRRVEQNALISEDAWRNDLQTQDVPGLEYFEMNTIQTATNNFSLSNKL 506
Query: 433 GEGGFGPVYKGTLADGQEIA--------------------------HRNLVKLLGCCIQG 466
G GGFG VYKG L DG+EIA HRNLV++LGCC++G
Sbjct: 507 GHGGFGSVYKGKLQDGREIAVKRLSSSSEQGKQEFMNEIVLISKLQHRNLVRVLGCCVEG 566
Query: 467 EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDL 526
EKLLIYEFM N+SLD+F+FD KR +DW KRF II G ARGLLYLH DSRLRIIHRDL
Sbjct: 567 TEKLLIYEFMKNKSLDTFVFDSKKRLEIDWPKRFDIIQGIARGLLYLHRDSRLRIIHRDL 626
Query: 527 KASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVF 586
K SN+LLD +MNPKISDFGLAR F G E + T+RVVGT GYM+PEYA G+FS KSD++
Sbjct: 627 KVSNILLDEKMNPKISDFGLARMFHGTEYQDKTRRVVGTLGYMSPEYAWAGVFSEKSDIY 686
Query: 587 SFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRC 646
SFG+LLLEI+SG+K F + ++ L+ +AW+ W L+D +SC+ EV RC
Sbjct: 687 SFGVLLLEIISGEKISRFSYGEEGKTLLAYAWECWCGARGVNLLDQALGDSCHPYEVGRC 746
Query: 647 IHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQPGFLADRKSTGPNSSSSMLESSST 706
+ +GLLCVQ+ P DRP ++ ML + LP PKQP F+ + S+ SM+ +
Sbjct: 747 VQIGLLCVQYQPADRPNTLELLSMLTTTSDLPLPKQPTFVVHTRDGKSPSNDSMI---TV 803
Query: 707 NTITISTLEGR 717
N +T S + GR
Sbjct: 804 NEMTESVIHGR 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 717 | ||||||
| 224124250 | 820 | predicted protein [Populus trichocarpa] | 0.997 | 0.871 | 0.616 | 0.0 | |
| 224113157 | 786 | predicted protein [Populus trichocarpa] | 0.998 | 0.910 | 0.633 | 0.0 | |
| 224113153 | 785 | predicted protein [Populus trichocarpa] | 0.997 | 0.910 | 0.631 | 0.0 | |
| 224113149 | 820 | predicted protein [Populus trichocarpa] | 0.953 | 0.834 | 0.618 | 0.0 | |
| 356546914 | 788 | PREDICTED: G-type lectin S-receptor-like | 0.995 | 0.906 | 0.580 | 0.0 | |
| 224115136 | 843 | predicted protein [Populus trichocarpa] | 0.990 | 0.842 | 0.567 | 0.0 | |
| 356514935 | 834 | PREDICTED: G-type lectin S-receptor-like | 0.994 | 0.854 | 0.571 | 0.0 | |
| 449458261 | 814 | PREDICTED: receptor-like serine/threonin | 0.994 | 0.875 | 0.564 | 0.0 | |
| 356514907 | 778 | PREDICTED: G-type lectin S-receptor-like | 0.990 | 0.912 | 0.570 | 0.0 | |
| 356545219 | 855 | PREDICTED: G-type lectin S-receptor-like | 0.948 | 0.795 | 0.603 | 0.0 |
| >gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 975 bits (2520), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/790 (61%), Positives = 582/790 (73%), Gaps = 75/790 (9%)
Query: 1 SLSDG--RTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGV 58
S+ DG RTLVSK+GSFELGFFSPGSS+NRYVGIWYKN+PV+TVVWVANR NPINDSSG
Sbjct: 33 SIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWVANRNNPINDSSGF 92
Query: 59 LVVNKTGNLVLTSQNKS-VVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQS 117
L+++ TGN VL S N S VVWS+N SK+ + +L DSGNLVLR E+D +S YLWQS
Sbjct: 93 LMLDNTGNFVLVSNNNSTVVWSSN-SKKAAQSAMGELQDSGNLVLRDEKDDNSGIYLWQS 151
Query: 118 FDYPSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRK 177
FDYPSDTLLPGMKLGWD + GL+RR+++WKS DDPS GDF W + Q PELVMWKGS+K
Sbjct: 152 FDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPELVMWKGSKK 211
Query: 178 FYRTGPWNGLIFSAS-SLRLNPIFKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSLRQ 236
+YR+GPWNG+ FS +LR+NP+F + FV + +E+YYT+ L +K +I+R VMNQT RQ
Sbjct: 212 YYRSGPWNGIGFSGGLALRINPVFYFDFVDDGEEVYYTYNLKNKSLITRIVMNQTTYFRQ 271
Query: 237 RFIWRKANQSWELYSNLPKDQCDTYGLCGAYGICIISQSPICQCLEGFHPKSG---GYVD 293
R+ W + NQ+W LY+ +P+D CDTY LCGAYG CI+SQSP+CQCLE F P+S +D
Sbjct: 272 RYTWNEINQTWVLYATVPRDYCDTYNLCGAYGNCIMSQSPVCQCLEKFTPRSPESWNSMD 331
Query: 294 WSQGCVHNKPLNYSRKDGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAYTNS 353
WS+GCV NKPL+ + DGF+K+ LKLPD+T+SWV+K+MNLKECR KCL+N SCMAYT +
Sbjct: 332 WSKGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSKCLQNCSCMAYTAT 391
Query: 354 DITRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASE----------------------- 390
+I + SGC +WFGDLID+R F GQ++YIR++ASE
Sbjct: 392 NI-KERSGCAVWFGDLIDIRQFSAAGQEIYIRLNASESRAKAASKIKMTVGSALSIFVAC 450
Query: 391 ----------------LGGNNRRTDQENEDQNEDLELPLFELATIANATDNFSINKKLGE 434
+GGN DQ + EDLELPLF+ TIA AT+ FS N KLGE
Sbjct: 451 GILLVAYYIFKRKAKHIGGNREENDQIDSGPKEDLELPLFQFTTIAKATNGFSFNNKLGE 510
Query: 435 GGFGPVYKGTLADGQEIA--------------------------HRNLVKLLGCCIQGEE 468
GGFGPVYKGTL DGQEIA HRNLVKLLGCCIQGEE
Sbjct: 511 GGFGPVYKGTLEDGQEIAAKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEE 570
Query: 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKA 528
K+L+YE+MPN+SLDSFIFDQT+ KLLDWSKRF IICG ARGLLYLH DSRLRI+HRDLKA
Sbjct: 571 KILVYEYMPNKSLDSFIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKA 630
Query: 529 SNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSF 588
SNVLLD +MNPKISDFGLAR F GD+ EG+T RVVGTYGYMAPEYA+DGLFSVKSDVFSF
Sbjct: 631 SNVLLDKDMNPKISDFGLARMFGGDQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSF 690
Query: 589 GILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVI-RCI 647
GIL+LEI+SGKK+RGF H D +L+LIGHAW+LW +G P LI+A+ ESCNL+EVI RCI
Sbjct: 691 GILMLEIISGKKSRGFCHPDHSLSLIGHAWRLWKDGKPLGLIEAFPGESCNLSEVIMRCI 750
Query: 648 HVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQPGFLADRKSTGPNSSSSMLESSSTN 707
++ LLCVQ HP+DRP M +V+ MLG E LPQPK+PGF P+SSS E S N
Sbjct: 751 NISLLCVQQHPDDRPSMATVVWMLGGENTLPQPKEPGFFKGSGPFRPSSSSKNTELFSNN 810
Query: 708 TITISTLEGR 717
IT S L R
Sbjct: 811 EITSSLLYPR 820
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113157|ref|XP_002332644.1| predicted protein [Populus trichocarpa] gi|222832839|gb|EEE71316.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 971 bits (2511), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 473/747 (63%), Positives = 577/747 (77%), Gaps = 31/747 (4%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
SL DG+TLVS+EGSFELGFFSPG SKNRY+GIWYKN+PV+TV+WVANR NPI DSSG L
Sbjct: 41 SLIDGKTLVSREGSFELGFFSPGISKNRYLGIWYKNIPVRTVLWVANRRNPIEDSSGFLT 100
Query: 61 VNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDY 120
++ T NL+L S VVWS+N + ++P+VLQLLDSGNLVLR E+ DS YLWQSFD+
Sbjct: 101 IDNTANLLLVSNRNVVVWSSNSTIVAKSPIVLQLLDSGNLVLRDEK-SDSGRYLWQSFDH 159
Query: 121 PSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYR 180
PSDTL+PGMKLGWD +TGLERR++SW+SSDDPSPGD W I+ Q PE ++W+GS++++R
Sbjct: 160 PSDTLIPGMKLGWDLRTGLERRLSSWRSSDDPSPGDLTWGIKLQNNPETIIWRGSQQYFR 219
Query: 181 TGPWNGLIFS-ASSLRLNPIFKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSLRQRFI 239
+GPW G+ F+ A L NP+FK FV +EDE+Y ++ L + SR V+NQT + R+ +
Sbjct: 220 SGPWTGIAFTGAPELVQNPVFKLNFVSSEDEVYLSYNLKNISAFSRIVVNQTTNYREAYT 279
Query: 240 WRKANQSWELYSNLPKDQCDTYGLCGAYGICIISQSPICQCLEGFHPKSG---GYVDWSQ 296
W +A Q+W LY+++P+D CD Y CGA G CII+ PIC+CL+ F PKS +DWS
Sbjct: 280 WNEATQTWVLYASVPRDSCDNYASCGANGNCIINDLPICRCLKKFKPKSPEKWNLMDWSD 339
Query: 297 GCVHNKPLNYSRKDGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAYTNSDIT 356
GCV NKPLN + DGF+K+ LK PD+T SW++KSMNL ECR KCL+N SCMAY+NSD+
Sbjct: 340 GCVRNKPLNCQKGDGFVKYLGLKWPDATHSWLNKSMNLNECRAKCLQNCSCMAYSNSDVR 399
Query: 357 RGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASELGGNNRRTDQENEDQNEDLELPLFEL 416
GGSGC++W+GDLID+R F GGQ+LYIRM+ SE +++ DQ + +NEDLELP FE
Sbjct: 400 GGGSGCIIWYGDLIDIRQFPAGGQELYIRMNPSESAEMDQQNDQITDGENEDLELPQFEF 459
Query: 417 ATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA------------------------ 452
A I NAT+NFSI KLG+GGFGPVYKGTL DGQEIA
Sbjct: 460 AKIVNATNNFSIKNKLGQGGFGPVYKGTLEDGQEIAVKRLSMSSRQGSKEFKNEVILINK 519
Query: 453 --HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGL 510
HRNLVKLLGC IQ EE+LL+YE+MPN+SLDSF+FDQTK KLLDWSKRF IICG ARGL
Sbjct: 520 LQHRNLVKLLGCSIQREERLLVYEYMPNKSLDSFLFDQTKSKLLDWSKRFNIICGIARGL 579
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMA 570
LYLH DSRLRIIHRDLK+SNVLLD +MNPKISDFGLARTF GD+ EG+T RVVGTYGYMA
Sbjct: 580 LYLHQDSRLRIIHRDLKSSNVLLDKDMNPKISDFGLARTFGGDQTEGNTSRVVGTYGYMA 639
Query: 571 PEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630
PEYA+DGLFSVKSDVFSFGI+LLEIV+GKK+RGFYH D +L+LIG+AW+LW G P +L+
Sbjct: 640 PEYATDGLFSVKSDVFSFGIMLLEIVTGKKSRGFYHPDNSLSLIGYAWRLWKEGKPLELV 699
Query: 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQPGFLADRK 690
D +ES NL+EV++CIH+ LLCVQ +PEDRP M SV+LMLG E LP+PK+PGF DR
Sbjct: 700 DGLAEESWNLSEVMKCIHISLLCVQQYPEDRPSMASVVLMLGGERTLPKPKEPGFFKDRG 759
Query: 691 STGPNSSSSMLESSSTNTITISTLEGR 717
SSSS +ESSSTN I+ S LE R
Sbjct: 760 PVEAYSSSSKVESSSTNEISTSVLEPR 786
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113153|ref|XP_002332643.1| predicted protein [Populus trichocarpa] gi|222832838|gb|EEE71315.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 966 bits (2498), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 472/747 (63%), Positives = 578/747 (77%), Gaps = 32/747 (4%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
SLSDG+TLVS+EGSFELGFFSPG SKNRY+GIWYKN+P++TV+WVANR NPI DSSG+L
Sbjct: 41 SLSDGKTLVSREGSFELGFFSPGISKNRYLGIWYKNIPLRTVLWVANRRNPIEDSSGLLT 100
Query: 61 VNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDY 120
++ T NL+L S VVWS+N + ++P+VLQLLDSGNLVLR E+ DS YLWQSFD+
Sbjct: 101 IDNTANLLLVSNRNVVVWSSNSTIVAKSPIVLQLLDSGNLVLRDEK-SDSGRYLWQSFDH 159
Query: 121 PSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYR 180
PSDTL+PGMKLGWD +TGLERR++SW+SSDDPSPGD W I+ Q PE ++W+GS++++R
Sbjct: 160 PSDTLIPGMKLGWDLRTGLERRLSSWRSSDDPSPGDLTWGIKLQNNPETIIWRGSQQYFR 219
Query: 181 TGPWNGLIFS-ASSLRLNPIFKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSLRQRFI 239
+GPW G+ F+ A L NP+FK FV +EDE+Y ++ L + SR V+NQT + R+ +
Sbjct: 220 SGPWTGIAFTGAPELVQNPVFKLNFVSSEDEVYLSYNLKNISAFSRIVVNQTTNYREAYT 279
Query: 240 WRKANQSWELYSNLPKDQCDTYGLCGAYGICIISQSPICQCLEGFHPKSG---GYVDWSQ 296
W +A Q+W LY+++P+D CD Y CGA G CII+ PIC+CL+ F PKS +DWS
Sbjct: 280 WNEATQTWVLYASVPRDSCDNYASCGANGNCIINDLPICRCLKKFKPKSPEKWNLMDWSD 339
Query: 297 GCVHNKPLNYSRKDGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAYTNSDIT 356
GCV NKPLN + DGF+K+ LK PD+T SW++KSMNL ECR KCL+N SCMAY+NSD+
Sbjct: 340 GCVRNKPLNCQKGDGFVKYLGLKWPDATHSWLNKSMNLNECRAKCLQNCSCMAYSNSDVR 399
Query: 357 RGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASELGGNNRRTDQENEDQNEDLELPLFEL 416
GGSGC++W+G LID+R F GGQ+LYIRM+ SE +++ DQ + +NEDLELP FE
Sbjct: 400 GGGSGCIIWYGGLIDIRQFPAGGQELYIRMNPSE-SEMDQQNDQITDGENEDLELPQFEF 458
Query: 417 ATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA------------------------ 452
A I NAT+NFSI KLG+GGFGPVYKGTL DGQEIA
Sbjct: 459 AKIVNATNNFSIENKLGQGGFGPVYKGTLEDGQEIAVKRLSMSSGQGSKEFKNEVILINK 518
Query: 453 --HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGL 510
HRNLVKLLGC IQ EE+LL+YE+MPN+SLDSF+FDQTK KLLDWSKRF IICG ARGL
Sbjct: 519 LQHRNLVKLLGCSIQREERLLVYEYMPNKSLDSFLFDQTKSKLLDWSKRFNIICGIARGL 578
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMA 570
LYLH DSRLRIIHRDLK+SNVLLD +MNPKISDFGLARTF GD+ EG+T RVVGTYGYMA
Sbjct: 579 LYLHQDSRLRIIHRDLKSSNVLLDKDMNPKISDFGLARTFGGDQTEGNTSRVVGTYGYMA 638
Query: 571 PEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630
PEYA+DGLFSVKSDVFSFGI+LLEIV+GKK+RGFYH D +L+LIG+AW+LW G P +L+
Sbjct: 639 PEYATDGLFSVKSDVFSFGIMLLEIVTGKKSRGFYHPDNSLSLIGYAWRLWKEGKPLELV 698
Query: 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQPGFLADRK 690
D +ES NL+EV++CIH+ LLCVQ +PEDRP M SV+LMLG E LP+PK+PGF DR
Sbjct: 699 DGLAEESWNLSEVMKCIHISLLCVQQYPEDRPSMASVVLMLGGERTLPKPKEPGFFKDRG 758
Query: 691 STGPNSSSSMLESSSTNTITISTLEGR 717
SSSS +ESSSTN I+ S LE R
Sbjct: 759 PVEAYSSSSKVESSSTNEISTSVLEPR 785
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113149|ref|XP_002332642.1| predicted protein [Populus trichocarpa] gi|222832837|gb|EEE71314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 951 bits (2458), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 473/765 (61%), Positives = 564/765 (73%), Gaps = 81/765 (10%)
Query: 1 SLSDG--RTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGV 58
S+ DG RTLVSK+GSFELGFFSPGSS+NRYVGIWYKN+PV+TVVWVANR NPINDSSG
Sbjct: 27 SVCDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWVANRNNPINDSSGF 86
Query: 59 LVVNKTGNLVLTSQNKS-VVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQS 117
L+++ TGNLVL S N S VVWS+N SK+ + +LLDSGNLVLR E+D +S YLWQS
Sbjct: 87 LMLDNTGNLVLVSNNNSTVVWSSN-SKKAAQSAMGELLDSGNLVLRDEKDANSGIYLWQS 145
Query: 118 FDYPSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRK 177
FDYPSDTLLPGMKLGWD + GL+RR+++WKS DDPS GDF W + Q PELVMWKGS++
Sbjct: 146 FDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPELVMWKGSKE 205
Query: 178 FYRTGPWNGLIFSAS-SLRLNPIFKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSLRQ 236
+YR+GPWNG+ FS LR+NP+F + FV + +E+YYT+ L +K +I+R VMNQ+ RQ
Sbjct: 206 YYRSGPWNGIGFSGGPELRINPVFYFDFVDDGEEVYYTYNLKNKSLITRIVMNQSTYFRQ 265
Query: 237 RFIWRKANQSWELYSNLPKDQCDTYGLCGAYGICIISQSPICQCLEGFHPKSG---GYVD 293
R+ W + NQ+W LY+N+P+D CDTY LCGAYG CIISQSP+C+CLE F PKS +D
Sbjct: 266 RYTWNEINQTWVLYANVPRDYCDTYSLCGAYGNCIISQSPVCECLEKFTPKSPESWNSMD 325
Query: 294 WSQGCVHNKPLNYSRKDGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAYTNS 353
WSQGCV NKPL+ + DGF+K+ LKLPD+T+SWV+K+MNLKECR CLEN SCMAYT +
Sbjct: 326 WSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSICLENCSCMAYTAT 385
Query: 354 DITRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASELG--------------------- 392
+I + SGC +WFGDLID+ GQ++YIRM+ASE
Sbjct: 386 NI-KERSGCAIWFGDLIDITQLPAAGQEIYIRMNASESSECLSLVLMAVGIALSIFVACG 444
Query: 393 ------------------------GNNRRTDQENEDQNEDLELPLFELATIANATDNFSI 428
N DQ + EDLELPLF+ TIA AT+ FS
Sbjct: 445 ILLVAYYIFKRKAKLIGKVTLTAFSNREENDQIDSGPKEDLELPLFQFTTIAKATNGFSF 504
Query: 429 NKKLGEGGFGPVYKGTLADGQEIA--------------------------HRNLVKLLGC 462
N KLGEGGFGPVYKGTL DGQEIA HRNLVKLLGC
Sbjct: 505 NNKLGEGGFGPVYKGTLEDGQEIAAKTHSRSSGQGINEFKNEVILITKLQHRNLVKLLGC 564
Query: 463 CIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRII 522
CIQGEEK+L+YE+MPN+SLDSFIFDQT+ +LLDWSKRF IICG ARGLLYLH DSRLRI+
Sbjct: 565 CIQGEEKILVYEYMPNKSLDSFIFDQTRGELLDWSKRFSIICGIARGLLYLHQDSRLRIV 624
Query: 523 HRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVK 582
HRDLKASNVLLD +MNPKISDFGLAR F GD+ EG+T RVVGTYGYMAPEYA+DGLFSVK
Sbjct: 625 HRDLKASNVLLDKDMNPKISDFGLARMFGGDQTEGNTTRVVGTYGYMAPEYATDGLFSVK 684
Query: 583 SDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAE 642
SDVFSFGIL+LEI+SGKK+RGFYH D +L+LIGHAW+LW +G P LI+A+ ES NL+E
Sbjct: 685 SDVFSFGILMLEIISGKKSRGFYHPDHSLSLIGHAWRLWKDGKPLDLIEAFPGESRNLSE 744
Query: 643 VI-RCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQPGFL 686
VI RCI++ LLCVQ HP+DRP M +V+ MLG E LPQP +PGF
Sbjct: 745 VIMRCINISLLCVQQHPDDRPSMATVVWMLGCENTLPQPNEPGFF 789
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546914|ref|XP_003541865.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 900 bits (2327), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/755 (58%), Positives = 568/755 (75%), Gaps = 41/755 (5%)
Query: 1 SLSD---GRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSG 57
SLSD TLVSK+G+FELGFF+PG+S+ RY+GIWY+ +P++TVVWVANR+NPINDSSG
Sbjct: 37 SLSDDGKNTTLVSKDGTFELGFFTPGNSQKRYLGIWYRKIPIQTVVWVANRLNPINDSSG 96
Query: 58 VLVVN-KTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQ 116
+L +N TG LVLT N +V+WS + +PV L LL+SGNLV+R E+D +SE YLW+
Sbjct: 97 ILRMNPSTGTLVLT-HNGTVIWSTASIRRPESPVAL-LLNSGNLVIRDEKDANSEDYLWE 154
Query: 117 SFDYPSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSR 176
SF+YP+DT LP MK GWD +TGL R++ +WKS DDPSP DF + + YPE M KG +
Sbjct: 155 SFNYPTDTFLPEMKFGWDLRTGLNRKLIAWKSPDDPSPSDFSFGMVLNNYPEAYMMKGDQ 214
Query: 177 KFYRTGPWNGLIFSAS-SLRLNPIFKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSLR 235
KFYR+GPWNGL S S ++ NPI+ ++FV N+DELYYT+ L + +ISR V+N T +R
Sbjct: 215 KFYRSGPWNGLHSSGSPQVKANPIYDFKFVSNKDELYYTYSLKNSSMISRLVLNATSYVR 274
Query: 236 QRFIWRKANQSWELYSNLPKDQCDTYGLCGAYGICIISQSPICQCLEGFHPK---SGGYV 292
+R++W ++ Q WE+Y+++P D CD+Y LCGA C+IS SP+CQCL+GF PK + +
Sbjct: 275 KRYVWIESKQRWEVYTSVPLDLCDSYSLCGANANCVISDSPVCQCLQGFKPKLPEAWSSM 334
Query: 293 DWSQGCVHNKPLNYSRK--DGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAY 350
DWS GC+ NK L+ K DGF K + LK PD+T SW+ +++ L+EC+ KCL+N SCMAY
Sbjct: 335 DWSHGCIRNKELSCENKNKDGFNKLTLLKTPDTTHSWLDQTIGLEECKAKCLDNCSCMAY 394
Query: 351 TNSDITRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASELGGNNR--RTDQENEDQNED 408
NSDI+ GSGC MWFGDLID+R F GGQD+Y+R+ ASEL ++ +++Q + Q +D
Sbjct: 395 ANSDISGQGSGCAMWFGDLIDIRQFAAGGQDVYVRIDASELERSDFSIKSNQNSGMQVDD 454
Query: 409 LELPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA---------------- 452
++LP+F+L+TIA AT NF++ K+GEGGFGPVY+G+L DGQEIA
Sbjct: 455 MDLPVFDLSTIAKATSNFTVKNKIGEGGFGPVYRGSLTDGQEIAVKRLSASSGQGLTEFK 514
Query: 453 ----------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCI 502
HRNLVKLLGCC++GEEK+L+YE+M N SLDSFIFD+ + LDWSKRF I
Sbjct: 515 NEVKLIAKLQHRNLVKLLGCCLEGEEKMLVYEYMLNGSLDSFIFDEQRSGSLDWSKRFNI 574
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV 562
ICG A+GLLYLH DSRLRIIHRDLKASNVLLD E+NPKISDFG+AR F D+ EG+TKR+
Sbjct: 575 ICGIAKGLLYLHQDSRLRIIHRDLKASNVLLDSELNPKISDFGMARIFGVDQQEGNTKRI 634
Query: 563 VGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWN 622
VGTYGYMAPEYA+DGLFSVKSDVFSFG+LLLEI+SGK++RG+Y+ + + NLIGHAWKLW
Sbjct: 635 VGTYGYMAPEYATDGLFSVKSDVFSFGVLLLEIISGKRSRGYYNQNHSQNLIGHAWKLWK 694
Query: 623 NGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQ 682
G P +LID ++S +L++++ CIHV LLCVQ +PEDRP M SV+LML SE+ LP+PKQ
Sbjct: 695 EGRPLELIDKSIEDSSSLSQMLHCIHVSLLCVQQNPEDRPGMSSVLLMLVSELELPEPKQ 754
Query: 683 PGFLADRKSTGPNSSSSMLESSSTNTITISTLEGR 717
PGF + S +SS+S + SSTN ITI+ LE R
Sbjct: 755 PGFFG-KYSGEADSSTSKQQLSSTNEITITLLEAR 788
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115136|ref|XP_002316951.1| predicted protein [Populus trichocarpa] gi|222860016|gb|EEE97563.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 887 bits (2292), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 462/814 (56%), Positives = 555/814 (68%), Gaps = 104/814 (12%)
Query: 4 DGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNK 63
DG+TLVS++G+FELGFFSPG SK Y+GIWYKN+PV+T+VWVANR NPINDSSG+L V+
Sbjct: 34 DGKTLVSEKGTFELGFFSPGISKKSYLGIWYKNIPVRTIVWVANRRNPINDSSGLLKVDN 93
Query: 64 TGNLVLTSQN-KSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPS 122
++VL S N +VVWS+N +K+ +P+ LQLLDSGNLVLR + DG S LWQSFDYP
Sbjct: 94 CSDIVLLSNNTNTVVWSSNSTKKASSPI-LQLLDSGNLVLRDKNDGRS-GLLWQSFDYPC 151
Query: 123 DTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYRTG 182
DT+LPGMK+GWD + G + R++SWKSSDDPSPGDF IER+ PE+V WKGS+K YR+G
Sbjct: 152 DTMLPGMKIGWDLRAGFDWRLSSWKSSDDPSPGDFTMGIERESNPEVVAWKGSKKHYRSG 211
Query: 183 PWNGLIFSASS-LRLNPIFKYRFVFNEDELYYTFYL-TDKDVISRTVMNQTVSLRQRFIW 240
PWNG+ FS S+ ++ NP+F + FV N E+YY F L ++ VI+R V+N T S RQ + W
Sbjct: 212 PWNGVGFSGSTEVKPNPVFYFTFVSNNIEVYYIFNLKSESTVITRLVLNHTTSDRQCYTW 271
Query: 241 RKANQSWELYSNLPKDQCDTYGLCGAYGICIISQSPICQCLEGFHPKSG---GYVDWSQG 297
+ Q+W L ++P+D CD YGLCGA CI + P+CQCLE F PKS +DWSQG
Sbjct: 272 NEETQTWVLQVSVPRDHCDNYGLCGANANCIFNAIPVCQCLEKFKPKSPEEWNKMDWSQG 331
Query: 298 CVHNKPLNYSRKDGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAYTNSDITR 357
CV NK L+ + DGFIKF LKLPD+T SWV+K MNLKEC+ KCL N SCMAY+N DI
Sbjct: 332 CVRNKELDCQKGDGFIKFDGLKLPDATHSWVNKDMNLKECKAKCLGNCSCMAYSNLDIRG 391
Query: 358 GGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASELGG------------------------ 393
GGSGC WFGDL+D+R GGQ+LYIRM ASE+G
Sbjct: 392 GGSGCANWFGDLMDIRLVPGGGQELYIRMHASEIGDREAKANMKIAAIATAVVGLILGTL 451
Query: 394 -----------------------NNRRTDQENEDQNEDLELPLFELATIANATDNFSINK 430
N+ + D N Q ED+ELPLF + IA+AT+NFS+N
Sbjct: 452 TISYHVSKEKAKSAENTSSERTENDWKNDTNNGGQKEDMELPLFAFSAIADATNNFSVNN 511
Query: 431 KLGEGGFGPVYKGTLADGQEIA--------------------------HRNLVKLLGCCI 464
KLGEGGFGPVY+G L DG EIA HRNLVKLLGCC
Sbjct: 512 KLGEGGFGPVYRGKLEDGLEIAVKRLSRCSGQGFSEFKNEVILINKLQHRNLVKLLGCCS 571
Query: 465 QGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHR 524
Q EEK+LIYE+MPNRSLD FIFD+TK +LLDWS+RF II G ARGLLYLH DSRLRIIHR
Sbjct: 572 QREEKMLIYEYMPNRSLDFFIFDETKGRLLDWSRRFNIISGIARGLLYLHQDSRLRIIHR 631
Query: 525 DLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV---------------------V 563
DLKASNVLLD MNPKISDFGLAR FV D+ EG T RV
Sbjct: 632 DLKASNVLLDDHMNPKISDFGLARMFVADQTEGDTSRVTSDSLASSNIPILPLCILTLNA 691
Query: 564 GTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNN 623
GYMAPEYA+DGLFSVKSDVFSFG+LLLEI+SGKK++GFYH D +LIGH W+LWN
Sbjct: 692 SCSGYMAPEYATDGLFSVKSDVFSFGVLLLEIISGKKSKGFYHPDH--SLIGHTWRLWNE 749
Query: 624 GMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQP 683
G S+LIDA ESCN +EV+RC+H+ LLCVQHHP+DRP M SV+ MLG + LP+PK+P
Sbjct: 750 GKASELIDALGDESCNPSEVLRCVHISLLCVQHHPDDRPSMASVVWMLGGDSALPKPKEP 809
Query: 684 GFLADRKSTGPNSSSSMLESSSTNTITISTLEGR 717
FL R +SSSS + SSSTN IT+S E R
Sbjct: 810 AFLNYRAPGESSSSSSKVGSSSTNEITVSVFEPR 843
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514935|ref|XP_003526157.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 882 bits (2280), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/789 (57%), Positives = 558/789 (70%), Gaps = 76/789 (9%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
S+ DG TLVSK FELGFFSPGSS+ RY+GIWYKN+P++TVVWVANR NPINDSSG+L
Sbjct: 50 SMRDGDTLVSKTRKFELGFFSPGSSQKRYLGIWYKNIPIQTVVWVANRENPINDSSGILT 109
Query: 61 VNKTGNLVLTSQNKSVVWSANLS-KEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFD 119
+N TGN VL +QN+S+VW N S K+ + PV + LLDSGNLV+R + + + E YLWQSFD
Sbjct: 110 LNNTGNFVL-AQNESLVWYTNNSHKQAQNPVAV-LLDSGNLVIRNDGETNPEAYLWQSFD 167
Query: 120 YPSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFY 179
YPSDTLLPGMKLGWD +TGL+RR+T+WKS DDPSPGD +E YPE + KG++K Y
Sbjct: 168 YPSDTLLPGMKLGWDLRTGLDRRLTAWKSPDDPSPGDVYRDLELYSYPEFYIMKGTKKVY 227
Query: 180 RTGPWNGLIFS-ASSLRLNPIFKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSLRQRF 238
R GPWNGL FS LR N IF + F N++E YY F T+ DV+SR VMN++ ++ R+
Sbjct: 228 RFGPWNGLYFSGVPDLRNNTIFGFNFFSNKEESYYIFSPTN-DVMSRIVMNESTTI-YRY 285
Query: 239 IWRKANQSWELYSNLPKDQCDTYGLCGAYGICIISQSPICQCLEGFHPKS-GGYVD--WS 295
+W + +Q+W +Y++LPKD CDTYGLCG YG C+ +Q+ +CQCL+GF PKS +V WS
Sbjct: 286 VWVEDDQNWRIYTSLPKDFCDTYGLCGVYGNCMTTQTQVCQCLKGFSPKSPEAWVSSGWS 345
Query: 296 QGCVHNKPLNYSRK--DGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAYTNS 353
QGCV NKPL+ K DGF+K+ LK+PD+ +W+ +S+ L+EC+ KCL N SCMAYTNS
Sbjct: 346 QGCVRNKPLSCKDKLTDGFVKYEGLKVPDTRHTWLDESIGLEECKVKCLNNCSCMAYTNS 405
Query: 354 DITRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASELGGNNRR---------------- 397
DI GSGCVMWFGDLID++ Q GQDLYIRM ASEL R
Sbjct: 406 DIRGAGSGCVMWFGDLIDIKQLQTAGQDLYIRMPASELESVYRHKKKTTTIAASTTAAIC 465
Query: 398 ----------------------TDQENEDQNEDLELPLFELATIANATDNFSINKKLGEG 435
T+ ++E +DL++ LF+L TI AT++FS+ K+GEG
Sbjct: 466 GVLLLSSYFICRIRRNNAGKSLTEYDSEKDMDDLDIQLFDLPTITTATNDFSMENKIGEG 525
Query: 436 GFGPVYKGTLADGQEIA--------------------------HRNLVKLLGCCIQGEEK 469
GFGPVYKG L DGQEIA HRNLVKLLGCCIQG+EK
Sbjct: 526 GFGPVYKGILVDGQEIAVKTLSRSSWQGVTEFINEVKLIAKLQHRNLVKLLGCCIQGQEK 585
Query: 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKAS 529
+LIYE+M N SLDSFIFD KRKLL W ++F IICG ARGL+YLH DSRLRIIHRDLKAS
Sbjct: 586 MLIYEYMANGSLDSFIFDDKKRKLLKWPQQFHIICGIARGLMYLHQDSRLRIIHRDLKAS 645
Query: 530 NVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFG 589
NVLLD +PKISDFG+ARTF GD+ EG+T RVVGT GYMAPEYA DG FSVKSDVFSFG
Sbjct: 646 NVLLDENSSPKISDFGMARTFGGDQFEGNTSRVVGTCGYMAPEYAVDGSFSVKSDVFSFG 705
Query: 590 ILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI-DAYYQESCNLAEVIRCIH 648
IL+LEIV GK+N+G Y +DK+LNL+GHAW LW G LI D+ +ESC ++EV+RCIH
Sbjct: 706 ILVLEIVCGKRNKGLYQTDKSLNLVGHAWTLWKEGRALDLIDDSNMKESCVISEVLRCIH 765
Query: 649 VGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQPGFLADRKSTGPNSSSSMLESSSTNT 708
VGLLCVQ +PEDRP M SVILML S + L +PK+ GF++ + S+ ++SS+N
Sbjct: 766 VGLLCVQQYPEDRPTMASVILMLESHMELVEPKEHGFISRNFLGEGDLRSNRKDTSSSND 825
Query: 709 ITISTLEGR 717
+TI+ LE R
Sbjct: 826 VTITLLEAR 834
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458261|ref|XP_004146866.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 882 bits (2278), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/785 (56%), Positives = 548/785 (69%), Gaps = 72/785 (9%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
+L+ G TLVS +G FELGFF+PG+S NRY+GIWYK +PV+T+VWVANR NPI +SS V V
Sbjct: 34 NLTYGDTLVSTKGFFELGFFTPGNSTNRYLGIWYKIIPVRTIVWVANRENPIRNSSAVAV 93
Query: 61 --VNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSF 118
+N T + + +N +VVW K +TP LQLLD+GNL+L+ D +SE WQSF
Sbjct: 94 LKINSTSSDLFLFENDAVVWFGKSLKPAKTPK-LQLLDNGNLLLK---DAESEETSWQSF 149
Query: 119 DYPSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKF 178
DYP+DTLLPGMKLGWDFK G++RR+++WK+SDDPSPG ++ YPE VMW GS ++
Sbjct: 150 DYPTDTLLPGMKLGWDFKNGIQRRLSAWKTSDDPSPGSLTMEMMNTSYPEPVMWNGSSEY 209
Query: 179 YRTGPWNGLIFSASSLRLNPIFKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSLRQRF 238
R+GPWNGL FSA PI Y +V N+ EL Y++ L + +I R V+NQT+ R+
Sbjct: 210 MRSGPWNGLQFSAKPTSALPILVYSYVNNKSELSYSYELINSSLIGRMVLNQTILRREAL 269
Query: 239 IWRKANQSWELYSNLPKDQCDTYGLCGAYGICIISQSPICQCLEGFHP---KSGGYVDWS 295
+W + ++W+ Y+ +P+D CDTY +CGA+G C I Q P CQCL GFHP + +D++
Sbjct: 270 LWSEPEKNWKPYAAMPRDYCDTYSVCGAFGSCDIEQVPACQCLFGFHPNVQEKWNLMDYT 329
Query: 296 QGCVHNKPLNYSRKDGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAYTNSDI 355
+GCV NKPLN S K GF K LKLPD+ SWV++SM+L ECREKCL N SC+A+ N+DI
Sbjct: 330 EGCVRNKPLNCSDKTGFAKLPGLKLPDTKQSWVNESMSLNECREKCLRNCSCVAFANTDI 389
Query: 356 TRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASELGG---------------------- 393
GSGC +WFG+L+D++ + GGQDLY+RM ASEL
Sbjct: 390 RGSGSGCAIWFGELVDIKVVRRGGQDLYVRMLASELETKKTSSVAVGVIVGAAALLILGL 449
Query: 394 ---------NNRR------TDQENEDQNEDLELPLFELATIANATDNFSINKKLGEGGFG 438
+ RR ++ E Q +DLELPLF LATI+NATDNFS KLGEGGFG
Sbjct: 450 LLIGFYVIRSKRRKLEATGAGKDLEGQEDDLELPLFNLATISNATDNFSNFNKLGEGGFG 509
Query: 439 PVYKGTLADGQEIA--------------------------HRNLVKLLGCCIQGEEKLLI 472
V++G L DG+EIA HRNLVKLLGCCIQGEEK+LI
Sbjct: 510 AVFRGRLTDGKEIAVKRLSSYSRQGTDEFKNEVILIAKLQHRNLVKLLGCCIQGEEKMLI 569
Query: 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVL 532
YE+MPN+SLDSFIFD ++KLLDWSKRF IICG ARG+LYLH DSRLRIIHRDLKASNVL
Sbjct: 570 YEYMPNKSLDSFIFDSARKKLLDWSKRFNIICGVARGILYLHQDSRLRIIHRDLKASNVL 629
Query: 533 LDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILL 592
LD ++NPKISDFG+ARTF GD+ EG+T+RVVGTYGYMAPEYA DG FS+KSDVFSFGIL+
Sbjct: 630 LDIDLNPKISDFGMARTFGGDQTEGNTRRVVGTYGYMAPEYAIDGQFSIKSDVFSFGILM 689
Query: 593 LEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLL 652
LEI+SG+KNRGF+ + LNLIGHAWKLWN G P +LIDA ES L+EV+RCIHV LL
Sbjct: 690 LEIISGEKNRGFFRPNHALNLIGHAWKLWNEGKPLELIDASIGESYALSEVLRCIHVSLL 749
Query: 653 CVQHHPEDRPCMPSVILMLGSEIMLPQPKQPGFLADRKSTGPNSSSSMLESSSTNTITIS 712
C+Q PEDRP M +V+LML SE L QPKQPGF +R S S S ESS TN +TI+
Sbjct: 750 CLQQLPEDRPTMSNVVLMLSSEGSLAQPKQPGFYMERDSLEVFSVSGKNESSITNELTIT 809
Query: 713 TLEGR 717
LE R
Sbjct: 810 LLEAR 814
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514907|ref|XP_003526143.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 880 bits (2273), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/752 (57%), Positives = 548/752 (72%), Gaps = 42/752 (5%)
Query: 2 LSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVV 61
L DG TLVSKEG+FELGFF+PG+S N YVGIW+KN+P++TVVWVANR NP D S +L +
Sbjct: 33 LLDGSTLVSKEGTFELGFFTPGNSPNHYVGIWFKNIPMRTVVWVANRDNPAKDKSNMLSL 92
Query: 62 NKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGD---SETYLWQSF 118
+K GNL+L +N+S++WS N + V PVV QLLD+GNLV+R E+D + E ++WQSF
Sbjct: 93 SKDGNLILLGKNRSLIWSTNATIAVSNPVV-QLLDNGNLVIREEKDDNMDNEENFVWQSF 151
Query: 119 DYPSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKF 178
DYP DT L GMKLGW+ KTGL R +T+WK+ +DPS GDF ++ PELV+ KGS ++
Sbjct: 152 DYPCDTQLQGMKLGWNLKTGLNRYLTAWKNWEDPSSGDFTSGLKLGTNPELVISKGSNEY 211
Query: 179 YRTGPWNGLIFSASSLRL--NPIFKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSLRQ 236
YR+GPWNG IFS+ NP+F+Y++V NEDE+Y + L + VIS V+NQT+ LRQ
Sbjct: 212 YRSGPWNG-IFSSGVFGFSPNPLFEYKYVQNEDEVYVRYTLKNSSVISIIVLNQTLFLRQ 270
Query: 237 RFIWRKANQSWELYSNLPKDQCDTYGLCGAYGICIISQSPICQCLEGFHPKSG---GYVD 293
R W ++W +Y +LP+D CD Y +CGAYG C+I+ SP+CQCLEGF PKS +D
Sbjct: 271 RITWIPHTRTWSVYQSLPQDSCDVYNVCGAYGNCMINASPVCQCLEGFKPKSPQDWNQMD 330
Query: 294 WSQGCVHNKP--LNYSRKDGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAYT 351
W++GCV ++P KDGF + +K+PD+T SW+++SM L++C+ KCL+N SC A+
Sbjct: 331 WTKGCVRSEPWSCGVKNKDGFRLIAGMKMPDTTHSWINRSMTLEDCKAKCLKNCSCTAFA 390
Query: 352 NSDITRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASELGGNNRRTDQENEDQNEDLEL 411
N D GGSGC +WFGDL+D+R + GQDLY+RM+ SE N T+++++ E+LEL
Sbjct: 391 NMDTGGGGSGCSIWFGDLVDLR-ISESGQDLYVRMAISE---NGTWTEEKDDGGQENLEL 446
Query: 412 PLFELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA------------------- 452
P F+LATI NAT+NFSI+ KLGEGGFGPVYKGT+ DG EIA
Sbjct: 447 PFFDLATIINATNNFSIDNKLGEGGFGPVYKGTMLDGHEIAVKRLSKSSGQGLKEFKNEV 506
Query: 453 -------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICG 505
HRNLVK+LGCC++GEEK+L+YE+MPNRSLDSFIFD + KLLDW RF I+C
Sbjct: 507 ILCAKLQHRNLVKVLGCCVEGEEKMLLYEYMPNRSLDSFIFDPAQSKLLDWPTRFNILCA 566
Query: 506 TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT 565
ARGLLYLH DSRLRIIHRDLKASN+LLD+ MNPKISDFGLA+ GD++EG+T R+VGT
Sbjct: 567 IARGLLYLHQDSRLRIIHRDLKASNILLDNNMNPKISDFGLAKMCGGDQVEGNTNRIVGT 626
Query: 566 YGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM 625
YGYMAPEYA DGLFS+KSDVFSFG+LLLEI+SGKKNR + + + NLIGHAW+LW G+
Sbjct: 627 YGYMAPEYAIDGLFSIKSDVFSFGVLLLEIISGKKNRTVTYEEHSDNLIGHAWRLWKEGI 686
Query: 626 PSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQPGF 685
P QLIDA +SCN++E++RCI VGLLC+QHHPEDRP M +V++ML SE L QPK PGF
Sbjct: 687 PEQLIDASLVDSCNISELVRCIQVGLLCLQHHPEDRPNMTTVVVMLSSENSLSQPKVPGF 746
Query: 686 LADRKSTGPNSSSSMLESSSTNTITISTLEGR 717
L S ES STN +T+S L R
Sbjct: 747 LIKNISIEGEQPCGRQESCSTNEVTVSLLNAR 778
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545219|ref|XP_003541042.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 879 bits (2270), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/717 (60%), Positives = 530/717 (73%), Gaps = 37/717 (5%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
S+SDG TLVS+ +FELGFFSP +S RY+GIWYKN+P +TVVWV+NR INDSSG+L
Sbjct: 32 SISDGMTLVSRGETFELGFFSPENSNKRYLGIWYKNIP-QTVVWVSNR--AINDSSGILT 88
Query: 61 VNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDY 120
VN TGNLVL +K VVW K+ + PV QLLDSGNLV+R E + DSE YLWQSFDY
Sbjct: 89 VNSTGNLVLRQHDK-VVWYTTSEKQAQNPVA-QLLDSGNLVVRDEGEADSEGYLWQSFDY 146
Query: 121 PSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYR 180
PSDT+LPGMKLG + +TG+E R+TSWK+ +DPSPGDF W + YPE + G+ KF R
Sbjct: 147 PSDTILPGMKLGLNLRTGIEWRMTSWKNPNDPSPGDFYWGLLLYNYPEFYLMMGTEKFVR 206
Query: 181 TGPWNGLIFSA-SSLRLNPIFKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSLRQRFI 239
GPWNGL FS + NPI+ + ++ N+DE YYT+ L + VISR VMNQT S+ R++
Sbjct: 207 VGPWNGLHFSGIPDQKPNPIYAFNYISNKDEKYYTYSLQNAAVISRLVMNQTSSMSIRYV 266
Query: 240 WRKANQSWELYSNLPKDQCDTYGLCGAYGICIISQSPICQCLEGFHPKSG---GYVDWSQ 296
W + Q W++Y +LPKD CD YG CGAYG C+I+ S ICQCL GF PKS DW+Q
Sbjct: 267 WMENEQYWKVYKSLPKDNCDYYGTCGAYGTCLITGSQICQCLAGFSPKSPQAWNSSDWTQ 326
Query: 297 GCVHNKPLNYSRK--DGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAYTNSD 354
GC N+PLN + K DGF+K +K+PD+T +W+ +++ L ECR KCL N SCMAYTNSD
Sbjct: 327 GCTRNQPLNCTNKLNDGFMKVEGVKVPDTTHTWLDETIGLGECRMKCLNNCSCMAYTNSD 386
Query: 355 ITRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASELGGNNRRTDQENEDQNEDLELPLF 414
I GSGCVMWFGDLID+R F++ GQDLYIRM +SEL ++ DQ E+++LPL
Sbjct: 387 IRGEGSGCVMWFGDLIDIRQFENDGQDLYIRMDSSELEYSDIVRDQNRGGSEENIDLPLL 446
Query: 415 ELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA---------------------- 452
+L+TI ATDNFSIN K+GEGGFGPVYKG L GQEIA
Sbjct: 447 DLSTIVIATDNFSINNKIGEGGFGPVYKGRLVSGQEIAVKRLSRGSGQGMTEFKNEVKLI 506
Query: 453 ----HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTAR 508
HRNLVKLLGCC+Q ++++L+YE+M NRSLD IFD TK KLLDW KRF IICG AR
Sbjct: 507 AKLQHRNLVKLLGCCVQEQDRMLVYEYMTNRSLDWLIFDDTKSKLLDWPKRFNIICGIAR 566
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
GLLYLH DSRLRIIHRDLKASNVLLD +M PKISDFG+AR F G++ EG+T RVVGTYGY
Sbjct: 567 GLLYLHQDSRLRIIHRDLKASNVLLDDQMIPKISDFGIARIFGGEQTEGNTNRVVGTYGY 626
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628
MAPEYA+DG+FSVK+DVFSFGILLLEI+SGK+NRGFY +++ NL+ HAW LW G +
Sbjct: 627 MAPEYAADGIFSVKTDVFSFGILLLEILSGKRNRGFYLENQSANLVTHAWNLWKGGRAIE 686
Query: 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQPGF 685
++D+ ++SC L+EV+RCIHV LLCVQ H EDRP MPSV+LMLGSE L +PK+PGF
Sbjct: 687 MVDSNIEDSCVLSEVLRCIHVCLLCVQQHAEDRPLMPSVVLMLGSESELAEPKEPGF 743
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 717 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.630 | 0.577 | 0.461 | 3.2e-197 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.548 | 0.462 | 0.445 | 2e-186 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.535 | 0.455 | 0.420 | 1.6e-182 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.541 | 0.458 | 0.420 | 1.6e-180 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.334 | 0.294 | 0.655 | 5.5e-180 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.365 | 0.308 | 0.582 | 2e-161 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.334 | 0.289 | 0.626 | 4.2e-159 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.329 | 0.293 | 0.593 | 4.3e-149 | |
| TAIR|locus:2197664 | 804 | AT1G61490 [Arabidopsis thalian | 0.330 | 0.294 | 0.565 | 5.5e-147 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.326 | 0.275 | 0.587 | 4.9e-146 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1121 (399.7 bits), Expect = 3.2e-197, Sum P(2) = 3.2e-197
Identities = 216/468 (46%), Positives = 304/468 (64%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
+L DG T+VS+ GSFE+GFFSPG S+NRY+GIWYK + ++TVVWVANR +P+ D SG L
Sbjct: 32 TLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVANRDSPLYDLSGTLK 91
Query: 61 VNKTGNLVLTSQNKSVVWSANLSKE-----VRTPVVLQLLDSGNLVLRGERDGDSETYLW 115
V++ G+L L + ++WS++ S +R P+V Q+LD+GNLV+R GD + Y+W
Sbjct: 92 VSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIV-QILDTGNLVVRNS--GDDQDYIW 148
Query: 116 QSFDYPSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGS 175
QS DYP D LPGMK G +F TGL R +TSW++ DDPS G++ K++ P+ + K S
Sbjct: 149 QSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNS 208
Query: 176 RKFYRTGPWNGLIFSAS-SLRLNPIFKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSL 234
+RTGPWNGL F+ +L+ NPI++Y +VF E+E+YYT+ L + V++R +N +L
Sbjct: 209 VVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTYKLENPSVLTRMQLNPNGAL 268
Query: 235 RQRFIWRKANQSWELYSNLPKDQCDTYGLCGAYGXXXXXXXXXXXXLEGFHPKSG-GYV- 292
QR+ W QSW Y + D CD Y LCG+YG L+GF K+ +V
Sbjct: 269 -QRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINESPACRCLKGFVAKTPQAWVA 327
Query: 293 -DWSQGCVHNKPLNYSR-KDGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAY 350
DWS+GCV L+ + +DGF+K S+LKLPD+ +SW K+M+L EC++ CL N +C AY
Sbjct: 328 GDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCLRNCTCSAY 387
Query: 351 TNSDITRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASELGGNNRRTXXXXXXXXXXXX 410
+ DI GG GC++WFGDLID+R + + GQDLY+R+++SE+ R +
Sbjct: 388 SPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLASSEIETLQRESSRVSSRKQEEED 447
Query: 411 X--PLFELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIAHRNL 456
P +L T++ AT FS KLG+GGFGPVYKGTLA GQE+A + L
Sbjct: 448 LELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRL 495
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 940 (336.0 bits), Expect = 2.0e-186, Sum P(3) = 2.0e-186
Identities = 181/406 (44%), Positives = 257/406 (63%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
++S T+VS FELGFF PG Y+GIWYK + +T VWVANR P++ S G L
Sbjct: 39 TISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANRDTPLSSSIGTLK 98
Query: 61 VNKTGNLVLTSQNKSVVWSANLSK-EVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFD 119
++ + NLV+ Q+ + VWS NL+ +VR+P+V +LLD+GN VLR ++ + LWQSFD
Sbjct: 99 ISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDSKNSAPDGVLWQSFD 157
Query: 120 YPSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFY 179
+P+DTLLP MKLGWD KTG R I SWKS DDPS GDF +K+E + +PE+ +W + Y
Sbjct: 158 FPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWNRESRMY 217
Query: 180 RTGPWNGLIFSASSLRLNPIFKYRFVFN----EDELYYTFYLTDKDVISRTVMNQTVSLR 235
R+GPWNG+ FS + P F+Y VFN ++E+ Y+F +T DV SR ++ + L
Sbjct: 218 RSGPWNGIRFSGVP-EMQP-FEY-MVFNFTTSKEEVTYSFRITKSDVYSRLSISSS-GLL 273
Query: 236 QRFIWRKANQSWELYSNLPKDQCDTYGLCGAYGXXXXXXXXXXXXLEGFHPKSG---GYV 292
QRF W + Q+W + PKDQCD Y CG YG ++GF P++ G
Sbjct: 274 QRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFKPRNPQVWGLR 333
Query: 293 DWSQGCVHNKPLNYSRKDGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAYTN 352
D S GCV L+ DGF++ ++KLPD+T++ V + + +KEC +KCL + +C A+ N
Sbjct: 334 DGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFAN 393
Query: 353 SDITRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASELGGNNRRT 398
+DI GSGCV W G+L D+RN+ GGQDLY+R++A++L R+
Sbjct: 394 TDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNRS 439
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 877 (313.8 bits), Expect = 1.6e-182, Sum P(3) = 1.6e-182
Identities = 167/397 (42%), Positives = 255/397 (64%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
++S +T++S FELGFF+P SS Y+GIWYK +P++T VWVANR NP++ S+G L
Sbjct: 37 TISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSNGTLK 96
Query: 61 VNKTGNLVLTSQNKSVVWSANLSK-EVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFD 119
++ NLV+ Q+ VWS N++ +VR+PV +LLD+GN +LR D ++ LWQSFD
Sbjct: 97 ISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLR---DSNNRL-LWQSFD 151
Query: 120 YPSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFY 179
+P+DTLL MKLGWD KTG R + SWK++DDPS G+F K+E +PE + Y
Sbjct: 152 FPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICSKESILY 211
Query: 180 RTGPWNGLIFSA--SSLRLNPIFKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSLRQR 237
R+GPWNG+ FS+ +++++ + Y F +++E+ Y++ + ++ SR +N + L QR
Sbjct: 212 RSGPWNGMRFSSVPGTIQVDYMV-YNFTASKEEVTYSYRINKTNLYSRLYLN-SAGLLQR 269
Query: 238 FIWRKANQSWELYSNLPKDQCDTYGLCGAYGXXXXXXXXXXXXLEGFHP---KSGGYVDW 294
W + QSW+ PKD CD Y +CG +G ++GF P ++ D
Sbjct: 270 LTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNEQAWDLRDG 329
Query: 295 SQGCVHNKPLNYSRKDGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAYTNSD 354
S GC+ L+ +DGF + +KLPD+T++ V + + LK C+E+CLE+ +C A+ N+D
Sbjct: 330 SAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCTAFANAD 389
Query: 355 ITRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASEL 391
I GGSGCV+W +++DMRN+ GGQDLY+R++A+EL
Sbjct: 390 IRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAEL 426
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 861 (308.1 bits), Expect = 1.6e-180, Sum P(3) = 1.6e-180
Identities = 167/397 (42%), Positives = 242/397 (60%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
++S +T++S FELGFF+P SS Y+GIWYK +P++T VWVANR NP++ S+G L
Sbjct: 37 TISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSNGTLK 96
Query: 61 VNKTGNLVLTSQNKSVVWSANLSK-EVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFD 119
++ NLV+ Q+ VWS N++ +VR+PV +LLD GN VLR ++ +LWQSFD
Sbjct: 97 ISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRDSKNNKPSGFLWQSFD 155
Query: 120 YPSDTLLPGMKLGWDFKTG-LERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKF 178
+P+DTLL MK+GWD K+G R + SWK++DDPS GDF K+ +PE ++
Sbjct: 156 FPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYIYNKESIT 215
Query: 179 YRTGPWNGLIFSASSLRLNPI--FKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSLRQ 236
YR+GPW G FS S + P+ F N ++ Y++ + ++ S ++ T L Q
Sbjct: 216 YRSGPWLGNRFS-SVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSST-GLLQ 273
Query: 237 RFIWRKANQSWELYSNLPKDQCDTYGLCGAYGXXXXXXXXXXXXLEGFHP--KSGGYVDW 294
R W +A QSW+ PKD CD Y CG YG ++GF P + D
Sbjct: 274 RLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEPMNEQAALRDD 333
Query: 295 SQGCVHNKPLNYSRKDGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAYTNSD 354
S GCV L+ +DGF++ +++LPD+T + V K + LKEC E+CL+ +C A+ N+D
Sbjct: 334 SVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTAFANTD 393
Query: 355 ITRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASEL 391
I GGSGCV+W G L D+RN+ GGQDLY+R++A +L
Sbjct: 394 IRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDL 430
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 849 (303.9 bits), Expect = 5.5e-180, Sum P(3) = 5.5e-180
Identities = 158/241 (65%), Positives = 191/241 (79%)
Query: 450 EIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARG 509
++ HRNLV+LLGCCIQGEE +LIYE+MPN+SLD FIFD+ + LDW KR II G ARG
Sbjct: 550 KLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARG 609
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
+LYLH DSRLRIIHRDLKA NVLLD++MNPKISDFGLA++F GD+ E ST RVVGTYGYM
Sbjct: 610 ILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYM 669
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629
PEYA DG FSVKSDVFSFG+L+LEI++GK NRGF H+D +LNL+GH WK+W ++
Sbjct: 670 PPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWVEDREIEV 729
Query: 630 IDA-YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQPGFLAD 688
+ + +E+ + EV+RCIHV LLCVQ PEDRP M SV+LM GS+ LP P QPGF +
Sbjct: 730 PEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDSSLPHPTQPGFFTN 789
Query: 689 R 689
R
Sbjct: 790 R 790
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 790 (283.2 bits), Expect = 2.0e-161, Sum P(3) = 2.0e-161
Identities = 155/266 (58%), Positives = 200/266 (75%)
Query: 430 KKL-GEGGFG-PVYKGTLADGQEIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFD 487
K+L G+ G G +K + ++ HRNLV+LLGCC +GEEK+L+YE+MPN+SLD F+FD
Sbjct: 557 KRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFD 616
Query: 488 QTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547
+TK+ L+DW RF II G ARGLLYLH DSRLRIIHRDLK SNVLLD EMNPKISDFG+A
Sbjct: 617 ETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMA 676
Query: 548 RTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHS 607
R F G++ E +T RVVGTYGYM+PEYA +GLFSVKSDV+SFG+LLLEIVSGK+N S
Sbjct: 677 RIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSS 736
Query: 608 DKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSV 667
+ +LIG+AW L+ +G +L+D + +C+ E +RCIHV +LCVQ +RP M SV
Sbjct: 737 EHG-SLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASV 795
Query: 668 ILMLGSEIM-LPQPKQPGFLADRKST 692
+LML S+ L P+QP F + R+++
Sbjct: 796 LLMLESDTATLAAPRQPTFTSTRRNS 821
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 796 (285.3 bits), Expect = 4.2e-159, Sum P(3) = 4.2e-159
Identities = 151/241 (62%), Positives = 182/241 (75%)
Query: 450 EIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARG 509
++ HRNLV+LLG CI+GEE++L+YEFMP LD+++FD K++LLDW RF II G RG
Sbjct: 562 KLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNIIDGICRG 621
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
L+YLH DSRL+IIHRDLKASN+LLD +NPKISDFGLAR F G+E E ST RVVGTYGYM
Sbjct: 622 LMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVVGTYGYM 681
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629
APEYA GLFS KSDVFS G++LLEIVSG++N FY+ +N NL +AWKLWN G L
Sbjct: 682 APEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWKLWNTGEDIAL 741
Query: 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM-LPQPKQPGFLAD 688
+D E C E+ RC+HVGLLCVQ H DRP + +VI ML SE LP+PKQP F+
Sbjct: 742 VDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNLPEPKQPAFIPR 801
Query: 689 R 689
R
Sbjct: 802 R 802
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 740 (265.6 bits), Expect = 4.3e-149, Sum P(3) = 4.3e-149
Identities = 140/236 (59%), Positives = 176/236 (74%)
Query: 450 EIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARG 509
++ HRNLV++LGCCI+ EEKLLIYEFM N+SLD+F+FD KR +DW KRF II G ARG
Sbjct: 541 KLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQGIARG 600
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
LLYLHHDSRLR+IHRDLK SN+LLD +MNPKISDFGLAR + G E + +T+RVVGT GYM
Sbjct: 601 LLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVGTLGYM 660
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629
+PEYA G+FS KSD++SFG+L+LEI+SG+K F + + LI +AW+ W+ L
Sbjct: 661 SPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEGKTLIAYAWESWSEYRGIDL 720
Query: 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQPGF 685
+D +SC+ EV RCI +GLLCVQH P DRP ++ ML + LP PKQP F
Sbjct: 721 LDQDLADSCHPLEVGRCIQIGLLCVQHQPADRPNTLELLAMLTTTSDLPSPKQPTF 776
|
|
| TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 724 (259.9 bits), Expect = 5.5e-147, Sum P(3) = 5.5e-147
Identities = 134/237 (56%), Positives = 174/237 (73%)
Query: 450 EIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARG 509
++ HRNLV++LGCCI+GEEKLLIYEFM N+SLD+F+FD K+ +DW KRF I+ G ARG
Sbjct: 540 KLQHRNLVRVLGCCIEGEEKLLIYEFMLNKSLDTFVFDARKKLEVDWPKRFDIVQGIARG 599
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
LLYLH DSRL++IHRDLK SN+LLD +MNPKISDFGLAR + G + + T+RVVGT GYM
Sbjct: 600 LLYLHRDSRLKVIHRDLKVSNILLDEKMNPKISDFGLARMYEGTQCQDKTRRVVGTLGYM 659
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629
+PEYA G+FS KSD++SFG+LLLEI+ G+K F + ++ L+ +AW+ W L
Sbjct: 660 SPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSYGEEGKTLLAYAWESWGETKGIDL 719
Query: 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQPGFL 686
+D +SC EV RC+ +GLLCVQH P DRP ++ ML + LP PKQP F+
Sbjct: 720 LDQDLADSCRPLEVGRCVQIGLLCVQHQPADRPNTLELLAMLTTTSDLPSPKQPTFV 776
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 779 (279.3 bits), Expect = 4.9e-146, Sum P(3) = 4.9e-146
Identities = 138/235 (58%), Positives = 189/235 (80%)
Query: 450 EIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARG 509
++ HRNLV+LLGCCI EEK+L+YE+MPN+SLD+F+F+ K++LLDW KRF II G ARG
Sbjct: 580 KLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDIIEGIARG 639
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
LLYLH DSRLR++HRDLKASN+LLD +M PKISDFG+AR F GD+ + +T RVVGT+GYM
Sbjct: 640 LLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVVGTFGYM 699
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629
+PEYA +G+FSVKSDV+ FG+L+LEI++GK+ F+ + +LN+ G+AW+ WN ++L
Sbjct: 700 SPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNEDNAAEL 759
Query: 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM-LPQPKQP 683
ID + SC++ +V+RCIH+ LLCVQ H ++RP +P+VILML ++ LP P+ P
Sbjct: 760 IDPVIRASCSVRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPRPP 814
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81832 | Y4729_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5092 | 0.9944 | 0.9106 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_XIII000369 | hypothetical protein (820 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 717 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-45 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-41 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 1e-38 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-38 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 7e-38 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-38 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 5e-37 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-36 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 5e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-25 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 1e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-23 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 1e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-13 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-12 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-07 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 6e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| pfam08277 | 71 | pfam08277, PAN_3, PAN-like domain | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| smart00605 | 94 | smart00605, CW, CW domain | 0.003 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.003 | |
| cd00129 | 80 | cd00129, PAN_APPLE, PAN/APPLE-like domain; present | 0.003 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.004 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 85/286 (29%), Positives = 118/286 (41%), Gaps = 69/286 (24%)
Query: 430 KKLGEGGFGPVYKGTL------------------ADGQEIA-------------HRNLVK 458
KKLGEG FG VYKG L A +E H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFI------FDQTKRKLLDWSKRFCIICGTARGLLY 512
LLG C + E L+ E+M L ++ F ++ L A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR-TFVGDEIEGSTKRVVGTYGYMAP 571
L + +HRDL A N L+ ++ KISDFGL+R + D T + +MAP
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 572 EYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630
E DG+F+ KSDV+SFG+LL EI + G Y N ++ + L
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATP---YPGLSNEEVLEY------------LR 221
Query: 631 DAYYQ---ESCN--LAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
Y E C L E++ C Q PEDRP ++ L
Sbjct: 222 KGYRLPKPEYCPDELYELMLS------CWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 5e-45
Identities = 88/283 (31%), Positives = 122/283 (43%), Gaps = 65/283 (22%)
Query: 427 SINKKLGEGGFGPVYKGTL-------------------ADGQEIA-------------HR 454
++ KKLGEG FG VYKG L A Q+I H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 455 NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH 514
N+VKLLG C + E ++ E+M L S++ + R L S ARG+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 515 HDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT---YGYMAP 571
IHRDL A N L+ + KISDFGL+R D + R G +MAP
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAP 172
Query: 572 EYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630
E +G F+ KSDV+SFG+LL EI + G++ Y N ++ + L N Q
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEQ---PYPGMSNEEVLEY---LKNGYRLPQ-- 224
Query: 631 DAYYQESC--NLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
+C L +++ C PEDRP ++ +L
Sbjct: 225 ----PPNCPPELYDLMLQ------CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 9e-45
Identities = 86/274 (31%), Positives = 122/274 (44%), Gaps = 60/274 (21%)
Query: 427 SINKKLGEGGFGPVYKGTL-------------------ADGQEIA-------------HR 454
++ KKLGEG FG VYKGTL A Q+I H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 455 NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH 514
N+VKLLG C + E +++ E+MP L ++ + K L S ARG+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120
Query: 515 HDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR-TFVGDEIEGSTKRVVGTYGYMAPEY 573
IHRDL A N L+ + KISDFGL+R + D + ++ +MAPE
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPES 175
Query: 574 ASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632
+G F+ KSDV+SFG+LL EI + G++ Y N ++ + K +P
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEE---PYPGMSNAEVLEYLKK--GYRLPK----- 225
Query: 633 YYQESC--NLAEVIRCIHVGLLCVQHHPEDRPCM 664
+C L +++ L C PEDRP
Sbjct: 226 --PPNCPPELYKLM------LQCWAEDPEDRPTF 251
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 71/208 (34%), Positives = 94/208 (45%), Gaps = 43/208 (20%)
Query: 426 FSINKKLGEGGFGPVYKGTL-------------------ADGQEIA-------------H 453
+ KKLGEG FG VYKGTL A +E H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 454 RNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYL 513
N+V+LLG C QGE ++ E+MP L F+ + + L + A+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG---YMA 570
+HRDL A N L+ + KISDFGL+R D+ G +MA
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG---GGKLPIKWMA 172
Query: 571 PEYASDGLFSVKSDVFSFGILLLEIVSG 598
PE DG F+ KSDV+SFG+LL EI +
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 47/111 (42%), Positives = 70/111 (63%), Gaps = 2/111 (1%)
Query: 179 YRTGPWNGLIFSASS-LRLNPIFKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSLRQR 237
+R+GPWNG+ FS ++ + Y F N +E+YYT+ +T+ + SR ++ SL +R
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSL-ER 59
Query: 238 FIWRKANQSWELYSNLPKDQCDTYGLCGAYGICIISQSPICQCLEGFHPKS 288
F W +Q W L+ + PKDQCD YG CG YG C ++ SP C C++GF PK+
Sbjct: 60 FTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 62/194 (31%), Positives = 86/194 (44%), Gaps = 37/194 (19%)
Query: 432 LGEGGFGPVYKGT-LADGQEIA---------------------------HRNLVKLLGCC 463
LGEGGFG VY G+++A H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 464 IQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIH 523
L+ E+ SL + + + L + I+ GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 524 RDLKASNVLLDH-EMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE-YASDGLFSV 581
RDLK N+LLD K++DFGL++ + K +VGT YMAPE G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 582 KSDVFSFGILLLEI 595
KSD++S G++L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 7e-38
Identities = 61/116 (52%), Positives = 74/116 (63%), Gaps = 8/116 (6%)
Query: 39 VKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSG 98
+TVVWVANR+NP+ DSS L++ GNLVL N VVWS+N S + + V L D G
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKG-SGCVAVLQDDG 59
Query: 99 NLVLRGERDGDSETYLWQSFDYPSDTLLPGMKLGWDFKT-GLERRITSWKSSDDPS 153
NLVL +S LWQSFD+P+DTLLPG K G G RR+TSWKS+ DPS
Sbjct: 60 NLVLY----DNSGKVLWQSFDHPTDTLLPGQKDG--NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 9e-38
Identities = 62/204 (30%), Positives = 89/204 (43%), Gaps = 38/204 (18%)
Query: 426 FSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------HRNL 456
+ + +KLG G FG VYK G+ +A H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 457 VKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD 516
V+L+ + L+ E+ L ++ ++ L + I RGL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH-- 115
Query: 517 SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE-YAS 575
IIHRDLK N+LLD KI+DFGLA+ + S VGT YMAPE
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLG 172
Query: 576 DGLFSVKSDVFSFGILLLEIVSGK 599
+ K DV+S G++L E+++GK
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 5e-37
Identities = 57/121 (47%), Positives = 68/121 (56%), Gaps = 7/121 (5%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
LS G+TLVS FELGFF Y I YK +TVVWVANR NP + SS L
Sbjct: 3 PLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNP-SGSSCTLT 60
Query: 61 VNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDY 120
+ GNLV+ + +VVWS+N ++ VL LLD GNLVL +LWQSFDY
Sbjct: 61 LQSDGNLVIYDGSGTVVWSSNTTRVNG-NYVLVLLDDGNLVLY----DSDGNFLWQSFDY 115
Query: 121 P 121
P
Sbjct: 116 P 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 69/265 (26%), Positives = 104/265 (39%), Gaps = 50/265 (18%)
Query: 426 FSINKKLGEGGFGPVYKGT-LADGQEIA---------------------------HRNLV 457
+ I +KLGEG FG VY G+ +A H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS 517
+L ++ L+ E+ L + + + +L + RF + L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLH--- 114
Query: 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDG 577
I+HRDLK N+LLD + + K++DFGLAR E VGT YMAPE
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGK 171
Query: 578 LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637
+ D++S G++L E+++GK + D L + P D S
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKP---PFPGDDQLLELFKKIGKPKPPFPPPEWDI----S 224
Query: 638 CNLAEVIRCIHVGLLCVQHHPEDRP 662
++IR + PE R
Sbjct: 225 PEAKDLIRK------LLVKDPEKRL 243
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 5e-33
Identities = 57/119 (47%), Positives = 69/119 (57%), Gaps = 8/119 (6%)
Query: 2 LSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVV 61
LS G+TLVS FELGFF+ N Y I YK+ +TVVWVANR NP++D S L +
Sbjct: 4 LSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSD-SCTLTL 60
Query: 62 NKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDY 120
GNLVL + VVWS+N + VL LLD GNLV+ +LWQSFDY
Sbjct: 61 QSDGNLVLYDGDGRVVWSSNTT-GANGNYVLVLLDDGNLVIY----DSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 75/265 (28%), Positives = 113/265 (42%), Gaps = 49/265 (18%)
Query: 426 FSINKKLGEGGFGPVYKGT-LADGQEIA--------------------------HRNLVK 458
F I +K+G+GGFG VYK G+E+A H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
G ++ +E ++ EF SL + T + L S+ + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTL-TESQIAYVCKELLKGLEYLH---S 116
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL 578
IIHRD+KA+N+LL + K+ DFGL+ + +VGT +MAPE +
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKP 173
Query: 579 FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638
+ K+D++S GI +E+ GK K L I NG P + S
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT------NGPPGLRNPEKW--SD 225
Query: 639 NLAEVIRCIHVGLLCVQHHPEDRPC 663
+ ++ C+Q +PE RP
Sbjct: 226 EFKDFLK------KCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 49/212 (23%)
Query: 425 NFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------------HRN 455
++ + LG G FG VY D G+ +A H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 456 LVKLLGCCIQGEEK-LLIY-EFMPNRSLDSFI--F----DQTKRKLLDWSKRFCIICGTA 507
+V+ G E+ L I+ E++ SL S + F + RK I+
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYT-----RQILE--- 112
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
GL YLH I+HRD+K +N+L+D + K++DFG A+ E T V GT
Sbjct: 113 -GLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168
Query: 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+MAPE + +D++S G ++E+ +GK
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 71/205 (34%), Positives = 95/205 (46%), Gaps = 46/205 (22%)
Query: 426 FSINKKLGEGGFGPVYKG-----------TLADG--------QEIA------HRNLVKLL 460
+ +KLG G FG V+ G TL G QE H LV+L
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLY 67
Query: 461 GCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRK-----LLDWSKRFCIICGTARGLLYLHH 515
C + E ++ E+M SL F+ +K L+D + A G+ YL
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA------AQIAEGMAYLE- 120
Query: 516 DSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI---EGSTKRVVGTYGYMAPE 572
IHRDL A N+L+ + KI+DFGLAR DE EG+ + T APE
Sbjct: 121 --SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APE 174
Query: 573 YASDGLFSVKSDVFSFGILLLEIVS 597
A+ G F++KSDV+SFGILL EIV+
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 82/268 (30%), Positives = 118/268 (44%), Gaps = 55/268 (20%)
Query: 426 FSINKKLGEGGFGPVYKGTLADGQEIA--------------------------HRNLVKL 459
F++ +KLG G FG V++G + +A H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 460 LGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRL 519
C GE +I E M SL +F+ + ++L + + C A G+ YL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 520 RIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLF 579
IHRDL A N+L+ ++ K++DFGLAR D S K++ Y + APE AS G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 580 SVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCN 639
S KSDV+SFGILL E+ + G + NN I A Y+ C
Sbjct: 182 STKSDVWSFGILLYEMFT----YG-----------QVPYPGMNNHEVYDQITAGYRMPCP 226
Query: 640 LAEVIRC---IHVGLL-CVQHHPEDRPC 663
+C I+ +L C PEDRP
Sbjct: 227 A----KCPQEIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 35/219 (15%)
Query: 407 EDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA------------- 452
E+L+ L ++ + + + + +K+GEG G VYK T A G+E+A
Sbjct: 2 EELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL 61
Query: 453 ------------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRF 500
H N+V + G+E ++ E+M SL I Q ++ + +
Sbjct: 62 IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNE--PQI 118
Query: 501 CIICG-TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559
+C +GL YLH +IHRD+K+ N+LL + + K++DFG A + +
Sbjct: 119 AYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQ--LTKEKSKR 173
Query: 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSG 598
VVGT +MAPE + K D++S GI+ +E+ G
Sbjct: 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 45/209 (21%)
Query: 424 DNFSINKKLGEGGFGPVYKGTL-ADGQEIA---------------------------HRN 455
+ K LG+G G VYK G+ A
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 456 LVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFC--IICGTARGLLYL 513
+VK G + E ++ E+M SL + +K+ + I +GL YL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYL 115
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV---VGTYGYMA 570
H IIHRD+K SN+L++ + KI+DFG+++ +E + + VGT YM+
Sbjct: 116 HTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKV-----LENTLDQCNTFVGTVTYMS 168
Query: 571 PEYASDGLFSVKSDVFSFGILLLEIVSGK 599
PE +S +D++S G+ LLE GK
Sbjct: 169 PERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 1e-25
Identities = 34/65 (52%), Positives = 49/65 (75%), Gaps = 1/65 (1%)
Query: 308 RKDGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAYTNSDITRGGSGCVMWFG 367
DGF++ +KLPD+T++ V +S+ LKEC ++CL N SC AY +DI RGGSGC++W G
Sbjct: 3 GGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADI-RGGSGCLIWTG 61
Query: 368 DLIDM 372
+L+DM
Sbjct: 62 ELVDM 66
|
Length = 66 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 3e-25
Identities = 56/164 (34%), Positives = 80/164 (48%), Gaps = 12/164 (7%)
Query: 449 QEIAHRNLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTA 507
I H +VKL Q EEKL L+ E+ P L S + + + + RF
Sbjct: 48 SRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARF-YAAEIV 103
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
L YLH L II+RDLK N+LLD + + K++DFGLA+ + +T GT
Sbjct: 104 LALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPE 158
Query: 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNL 611
Y+APE + D +S G+LL E+++GK FY D+
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK--PPFYAEDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 40/200 (20%)
Query: 430 KKLGEGGFGPVYKGTLADGQEIA---------------------------HRNLVKLLGC 462
+K+G+G FG VYKG L E+A H N+VKL+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 463 CIQGEEKLLIYEFMPNRSLDSFIFDQ----TKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
C+Q + ++ E +P SL +F+ + T +KLL + + A G+ YL +S+
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL----QMSL--DAAAGMEYL--ESK 112
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL 578
IHRDL A N L+ KISDFG++R G S + APE + G
Sbjct: 113 -NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 579 FSVKSDVFSFGILLLEIVSG 598
++ +SDV+S+GILL E S
Sbjct: 172 YTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 104 bits (259), Expect = 6e-24
Identities = 77/329 (23%), Positives = 117/329 (35%), Gaps = 51/329 (15%)
Query: 425 NFSINKKLGEGGFGPVYKGTLADGQEIA------------------------------HR 454
++ I +KLGEG FG VY D + +A
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 455 NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH 514
N+VKL L+ E++ SL+ + ++ L S+ I+ L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 515 HDSRLRIIHRDLKASNVLLDHEMN-PKISDFGLARTFVGD----EIEGSTKRVVGTYGYM 569
IIHRD+K N+LLD + K+ DFGLA+ I VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 570 APEYASDGLF---SVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626
APE S SD++S GI L E+++G + + + P
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK--IILELPTP 233
Query: 627 SQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQPGFL 686
S +++ + LL P++R S + S +L K
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLL--AKDPKNRLSSSSDL----SHDLLAHLKLKESD 287
Query: 687 ADRKSTGPNSSSSMLESSSTNTITISTLE 715
+S+ L + IS+L
Sbjct: 288 LSDLLKPDDSAPLRLSLPPSLEALISSLN 316
|
Length = 384 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-23
Identities = 81/272 (29%), Positives = 121/272 (44%), Gaps = 62/272 (22%)
Query: 424 DNFSINKKLGEGGFGPVYKG-----------TLADG--------------QEIAHRNLVK 458
+ + KKLG G FG V+ G +L G +++ H LV+
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVR 65
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFI-----FDQTKRKLLDWSKRFCIICGTARGLLYL 513
L Q E +I E+M N SL F+ T KL+D + + A G+ ++
Sbjct: 66 LYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ------IAEGMAFI 118
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI---EGSTKRVVGTYGYMA 570
R IHRDL+A+N+L+ + KI+DFGLAR +E EG+ + T A
Sbjct: 119 E---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----A 171
Query: 571 PEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630
PE + G F++KSDV+SFGILL EIV+ R Y N +I + + + P
Sbjct: 172 PEAINYGTFTIKSDVWSFGILLTEIVT--YGRIPYPGMTNPEVIQNLERGYRMPRPDNCP 229
Query: 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
+ Y+ + LC + PE+RP
Sbjct: 230 EELYE-------------LMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 64/198 (32%), Positives = 90/198 (45%), Gaps = 49/198 (24%)
Query: 432 LGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQG 466
+G+G FG V G GQ++A H NLV+LLG +QG
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 467 EEKLLIYEFMPNRSLDSFIFDQ-----TKRKLLDWSKRFCIICGTARGLLYLHHDSRLRI 521
++ E+M SL ++ + T + L ++ C G+ YL
Sbjct: 73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVC------EGMEYLEEK---NF 123
Query: 522 IHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY--GYMAPEYASDGLF 579
+HRDL A NVL+ ++ K+SDFGLA+ E S + G + APE + F
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKF 176
Query: 580 SVKSDVFSFGILLLEIVS 597
S KSDV+SFGILL EI S
Sbjct: 177 STKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 65/208 (31%), Positives = 88/208 (42%), Gaps = 50/208 (24%)
Query: 430 KKLGEGGFGPVYKGT---LADGQ-----------------------EIA------HRNLV 457
K+LGEG FG V L D EI H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 458 KLLGCC--IQGEEKLLIYEFMPNRSLDSFIFDQTKR----KLLDWSKRFCIICGTARGLL 511
K G C G LI E++P+ SL ++ + +LL +S + C +G+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQIC------KGMD 123
Query: 512 YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE--IEGSTKRVVGTYGYM 569
YL R IHRDL A N+L++ E KISDFGLA+ D+ + Y
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVS 597
APE FS SDV+SFG+ L E+ +
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 32/199 (16%)
Query: 426 FSINKKLGEGGFGPVYKGT-LADGQEIA------------------------HRNLVKLL 460
F I +KLGEG +G VYK GQ +A +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYY 64
Query: 461 GCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLR 520
G + + ++ E+ S+ + + K L + I+ T +GL YLH +
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLH---SNK 119
Query: 521 IIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFS 580
IHRD+KA N+LL+ E K++DFG++ V+GT +MAPE + ++
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 581 VKSDVFSFGILLLEIVSGK 599
K+D++S GI +E+ GK
Sbjct: 178 NKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 8e-23
Identities = 63/214 (29%), Positives = 91/214 (42%), Gaps = 57/214 (26%)
Query: 425 NFSINKKLGEGGFGPVYKG-TLADGQ----------------------EIA------HRN 455
N+ + +G G FG VYKG L G EI H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 456 LVKLLGCCIQGEEKLLIY-EFMPNRSLDSFIFDQTKRKLLDWSKRF---------CIICG 505
+VK +G I+ + L I E+ N SL I K+F +
Sbjct: 61 IVKYIGS-IETSDSLYIILEYAENGSLRQII------------KKFGPFPESLVAVYVYQ 107
Query: 506 TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT 565
+GL YLH +IHRD+KA+N+L + K++DFG+A T + D VVGT
Sbjct: 108 VLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVA-TKLNDV-SKDDASVVGT 162
Query: 566 YGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+MAPE S SD++S G ++E+++G
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 9e-23
Identities = 61/230 (26%), Positives = 92/230 (40%), Gaps = 65/230 (28%)
Query: 424 DNFSINKKLGEGGFGPVYKGTL-ADGQEIA------------------------------ 452
D+F K +GEG F V +E A
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 453 HRNLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLD--WSKRFC--IICGTA 507
H ++KL Q EE L + E+ PN L +I K LD ++ + I+
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLA-- 114
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV----- 562
L YLH IIHRDLK N+LLD +M+ KI+DFG A+ + S K
Sbjct: 115 --LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 563 -------------VGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
VGT Y++PE ++ SD+++ G ++ ++++GK
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-22
Identities = 35/86 (40%), Positives = 52/86 (60%), Gaps = 8/86 (9%)
Query: 303 PLNYSRK---DGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAYTNSDITRGG 359
PLN DGF+K ++KLPD+ + +++L+ECRE CL N SC AY ++ G
Sbjct: 2 PLNCGGDGSTDGFLKLPDVKLPDN--ASAITAISLEECREACLSNCSCTAYAYNN---GS 56
Query: 360 SGCVMWFGDLIDMRNFQDGGQDLYIR 385
GC++W G L ++R+ GG LY+R
Sbjct: 57 GGCLLWNGLLNNLRSLSSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 65/201 (32%), Positives = 89/201 (44%), Gaps = 46/201 (22%)
Query: 430 KKLGEGGFGPVYKG-----------TLADG--------------QEIAHRNLVKLLGCCI 464
+KLG G FG V++G TL G +++ H L++L C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 465 QGEEKLLIYEFMPNRSLDSFIFDQTKRK-----LLDWSKRFCIICGTARGLLYLHHDSRL 519
E ++ E M SL ++ R L+D + + A G+ YL +
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQ------VASGMAYLEAQN-- 123
Query: 520 RIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT---YGYMAPEYASD 576
IHRDL A NVL+ K++DFGLAR D E G + APE A
Sbjct: 124 -YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALY 178
Query: 577 GLFSVKSDVFSFGILLLEIVS 597
FS+KSDV+SFGILL EIV+
Sbjct: 179 NRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 48/211 (22%)
Query: 424 DNFSINKKLGEGGFGPVYKGTL-------------------ADGQEI------------A 452
+I K +G G FG V +G L +D Q +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLY 512
H N+++L G + ++I E+M N SLD F+ + + ++ G A G+ Y
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKY 121
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG----- 567
L S + +HRDL A N+L++ + K+SDFGL+R ++ T G
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR------RLEDSEATYTTKGGKIPI 172
Query: 568 -YMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+ APE + F+ SDV+SFGI++ E++S
Sbjct: 173 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 49/154 (31%), Positives = 75/154 (48%), Gaps = 12/154 (7%)
Query: 450 EIAHR----NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICG 505
+I H+ +V G + + E+M SLD + + R + I
Sbjct: 51 DILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVA 108
Query: 506 TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT 565
+GL YLH +IIHRD+K SN+L++ K+ DFG++ V K VGT
Sbjct: 109 VLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS----LAKTFVGT 162
Query: 566 YGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
YMAPE +SVKSD++S G+ L+E+ +G+
Sbjct: 163 SSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (239), Expect = 6e-22
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 47/212 (22%)
Query: 425 NFSINKKLGEGGFGPVYKGT-LADG----------------------QEIA------HRN 455
+ I K++G+G FG VY +DG E+ H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 456 LVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKR-------KLLDWSKRFCIICGTAR 508
++K + + ++ E+ L I Q K ++LDW F +C
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW---FVQLC---L 114
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
L YLH SR +I+HRD+K N+ L K+ DFG+++ T VVGT Y
Sbjct: 115 ALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYY 169
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVSGKK 600
++PE + ++ KSD++S G +L E+ + K
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 47/208 (22%)
Query: 430 KKLGEGGFGPVYKG----------------TLADG------QEI----------AHRNLV 457
K LG G FG VYKG L + +EI H ++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKR----KLLDWSKRFCIICGTARGLLYL 513
+LLG C+ + LI + MP L ++ + LL+W + A+G+ YL
Sbjct: 73 RLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYL 125
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEY 573
R++HRDL A NVL+ + KI+DFGLA+ DE E + +MA E
Sbjct: 126 ---EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 574 ASDGLFSVKSDVFSFGILLLEIVS-GKK 600
+++ KSDV+S+G+ + E+++ G K
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 8e-21
Identities = 66/227 (29%), Positives = 98/227 (43%), Gaps = 62/227 (27%)
Query: 424 DNFSINKKLGEGGFGPVYKGTL--------------------ADGQEIA----------- 452
D ++ K LGEG FG V K A ++++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 453 ---HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKR-KLLDWSKRFCIICG--- 505
H+N++ LLG C Q ++ E+ + +L F+ + +R S
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL--RARRPPGEYASPDDPRPPEETL 129
Query: 506 -----------TARGLLYLHHDSRLRIIHRDLKASNVLL--DHEMNPKISDFGLARTFVG 552
ARG+ +L S+ + IHRDL A NVL+ DH M KI+DFGLAR
Sbjct: 130 TQKDLVSFAYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVM--KIADFGLARDI-- 182
Query: 553 DEIEGSTKRVVG--TYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
I+ K G +MAPE D +++ +SDV+SFG+LL EI +
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 57/221 (25%)
Query: 424 DNFSINKKLGEGGFGPVYKG-----------------TLADGQEIAHR------------ 454
+ ++ ++LG+G FG VY+G T+ + + R
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 455 ----NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQ-------------TKRKLLDWS 497
++V+LLG G+ L++ E M L S++ + T +K + +
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 498 KRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR-TFVGDEIE 556
A G+ YL + +HRDL A N ++ ++ KI DFG+ R + D
Sbjct: 126 AEI------ADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176
Query: 557 GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
K ++ +MAPE DG+F+ KSDV+SFG++L E+ +
Sbjct: 177 KGGKGLLPVR-WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (231), Expect = 1e-20
Identities = 67/209 (32%), Positives = 96/209 (45%), Gaps = 48/209 (22%)
Query: 426 FSINKKLGEGGFGPVYKGT-LADGQ----------------------EIA------HRNL 456
+ +KLGEG +G VYK G+ EI+ H N+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 457 VKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHH 515
VKLL I E KL L++E+ + L ++ + L + I+ RGL Y H
Sbjct: 61 VKLL-DVIHTERKLYLVFEYC-DMDLKKYL--DKRPGPLSPNLIKSIMYQLLRGLAYCH- 115
Query: 516 DSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYAS 575
S RI+HRDLK N+L++ + K++DFGLAR F G + T VV T Y APE
Sbjct: 116 -SH-RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEI-- 169
Query: 576 DGLFSVKS-----DVFSFGILLLEIVSGK 599
L K D++S G + E+++GK
Sbjct: 170 --LLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 66/211 (31%), Positives = 92/211 (43%), Gaps = 44/211 (20%)
Query: 424 DNFSINKKLGEGGFGPVYKGTL--------------------ADGQEI------------ 451
+N S K LG G FG V + T A E
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 452 --AHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARG 509
H N+V LLG C G L+I E+ L +F+ + + L A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE---IEGSTKRVVGTY 566
+ +L + IHRDL A NVLL H KI DFGLAR + D ++G+ + V
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-- 208
Query: 567 GYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+MAPE + +++ +SDV+S+GILL EI S
Sbjct: 209 -WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 70/212 (33%), Positives = 94/212 (44%), Gaps = 52/212 (24%)
Query: 432 LGEGGFGPVYKGTLAD---------------------GQEIA-------------HRNLV 457
LG G FG VY+GT D QE H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRK----LLDWSKRFCIICGTARGLLYL 513
KLLG C+ E + +I E M L S++ D + LL + I A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 514 HHDSRLRIIHRDLKASNVLL-----DHEMNPKISDFGLARTFVGDE---IEGSTKRVVGT 565
++ IHRDL A N L+ D + KI DFGLAR + EG V
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 566 YGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+MAPE DG F+ +SDV+SFG+L+ EI++
Sbjct: 179 --WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 66/217 (30%), Positives = 97/217 (44%), Gaps = 55/217 (25%)
Query: 430 KKLGEGGFGPVYKG-----------------TLADGQEIA----------------HRNL 456
++LGEG FG VYKG TL + E H N+
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 457 VKLLGCCIQGEEKLLIYEFMPNRSLDSFIF-------------DQTKRKLLDWSKRFCII 503
V LLG C + + +++E++ + L F+ D+T + LD S I
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 504 CGTARGLLYL--HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR-TFVGDEIEGSTK 560
A G+ YL HH +HRDL A N L+ + KISDFGL+R + D +K
Sbjct: 131 IQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 561 RVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
++ +M PE G F+ +SD++SFG++L EI S
Sbjct: 186 SLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 57/232 (24%), Positives = 96/232 (41%), Gaps = 53/232 (22%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQE--------------------------------- 450
D + ++LGEG FG V+ G +
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64
Query: 451 IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSF-----------IFDQTKRKLLDWSKR 499
H N+VK G C +G+ ++++E+M + L+ F + L S+
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 500 FCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR-TFVGD--EIE 556
I A G++YL + +HRDL N L+ +++ KI DFG++R + D +
Sbjct: 125 LQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVG 181
Query: 557 GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSD 608
G T + +M PE F+ +SDV+SFG++L EI + K + S+
Sbjct: 182 GHTMLPI---RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 70/262 (26%), Positives = 105/262 (40%), Gaps = 54/262 (20%)
Query: 430 KKLGEGGFGPVYKG-----------TLADG--------------QEIAHRNLVKLLGCCI 464
K+LG G FG V+ G + +G +++H NLV+L G C
Sbjct: 10 KELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 465 QGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCI-ICGTARGLLYLHHDSRLRIIH 523
+ ++ E+M N L +++ ++ + +W C +C + YL + IH
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVC---EAMEYLESNG---FIH 123
Query: 524 RDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT---YGYMAPEYASDGLFS 580
RDL A N L+ + K+SDFGLAR + D+ S GT + PE FS
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFS 179
Query: 581 VKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNL 640
KSDV+SFG+L+ E+ S K Y N ++ + P Y
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMP--YERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMY-- 235
Query: 641 AEVIRCIHVGLLCVQHHPEDRP 662
C PEDRP
Sbjct: 236 -----------SCWHEKPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 48/215 (22%)
Query: 426 FSINKKLGEGGFGPVYKGTLA--DG------------------------------QEIAH 453
+ K LGEG FG V +G L+ DG ++ H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 454 RNLVKLLGCCIQGEEK------LLIYEFMPNRSLDSFIF-----DQTKRKLLDWSKRFCI 502
N++KL+G C + ++I FM + L SF+ ++ L +F +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV 562
A G+ YL S IHRDL A N +L +M ++DFGL++ + +
Sbjct: 121 --DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 563 VGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
++A E +D +++ KSDV++FG+ + EI +
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 70/207 (33%), Positives = 99/207 (47%), Gaps = 46/207 (22%)
Query: 424 DNFSINKKLGEGGFGPVYKG-----------TLADG--------------QEIAHRNLVK 458
++ + KKLG G FG V+ G TL G + + H LV+
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVR 65
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKR-----KLLDWSKRFCIICGTARGLLYL 513
L + E +I E+M SL F+ KL+D+S + A G+ Y+
Sbjct: 66 LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI------AEGMAYI 119
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI---EGSTKRVVGTYGYMA 570
R IHRDL+A+NVL+ + KI+DFGLAR +E EG+ + T A
Sbjct: 120 E---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT----A 172
Query: 571 PEYASDGLFSVKSDVFSFGILLLEIVS 597
PE + G F++KSDV+SFGILL EIV+
Sbjct: 173 PEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 65/235 (27%), Positives = 101/235 (42%), Gaps = 73/235 (31%)
Query: 425 NFSINKKLGEGGFGPVYKGT-----------------LADG----------------QEI 451
N + K LGEG FG V K T L + +++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 452 AHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTK--------------------- 490
H +++KL G C Q LLI E+ SL SF+ + K
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 491 ------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDF 544
L+ ++ + RG+ YL + ++++HRDL A NVL+ KISDF
Sbjct: 121 ERALTMGDLISFAWQIS------RGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDF 171
Query: 545 GLARTFVGDE--IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
GL+R ++ ++ S R+ +MA E D +++ +SDV+SFG+LL EIV+
Sbjct: 172 GLSRDVYEEDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 41/207 (19%)
Query: 425 NFSINKKLGEGGFGPVYKGTL-ADGQ----------------------------EIAHRN 455
+F I K+G+G FG V+K AD + ++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 456 LVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLD---WSKRFCIICGTARGLLY 512
+++ + + ++ E+ N L + Q R L + W RF I GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW--RFFI--QILLGLAH 116
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE 572
LH +I+HRD+K+ N+ LD N KI D G+A+ + +T +VGT Y++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 573 YASDGLFSVKSDVFSFGILLLEIVSGK 599
D ++ KSDV++ G++L E +GK
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 8e-19
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 37/205 (18%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVK 458
++ +++G G FG V+ G + +++A H LV+
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQ 63
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
L G C + L++EFM + L ++ + +R + G+ YL +
Sbjct: 64 LYGVCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN- 120
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT---YGYMAPEYAS 575
+IHRDL A N L+ K+SDFG+ R + D+ ST GT + +PE S
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFS 174
Query: 576 DGLFSVKSDVFSFGILLLEIVSGKK 600
+S KSDV+SFG+L+ E+ S K
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 9e-19
Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 63/218 (28%)
Query: 426 FSINKKLGEGGFGPVYKG-----------------TLADG------------QEIAHRNL 456
+ ++GEG +G VYK +G Q++ H N+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 457 VKLLGCCIQGEEK--LLIYEFMPNRSLDSFI------FDQTKRKLLDWSKRFCIICGTAR 508
V+L + +++E+M + L + F +++ K C +
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIK--------CYMKQLLE 111
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
GL YLH + I+HRD+K SN+L++++ K++DFGLAR + T RV+ T Y
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWY 167
Query: 569 MAPE-------YASDGLFSVKSDVFSFGILLLEIVSGK 599
PE Y + D++S G +L E+ GK
Sbjct: 168 RPPELLLGATRYGP------EVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 9e-19
Identities = 69/234 (29%), Positives = 107/234 (45%), Gaps = 48/234 (20%)
Query: 453 HRNLVKLLGCCIQ-GEEKL-LIYEFMPNRSLDSFIFDQTKR----KLLDWSKRFCIICGT 506
H N+VK G C G L L+ E++P SL ++ +R KLL ++ + C
Sbjct: 64 HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQIC----- 118
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVG-- 564
+G+ YL R +HRDL N+L++ E KI DFGL + D+ E R G
Sbjct: 119 -KGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGES 173
Query: 565 -TYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNN 623
+ Y APE ++ FSV SDV+SFG++L E+ F +SDK+ + ++ N
Sbjct: 174 PIFWY-APESLTESKFSVASDVWSFGVVLYEL--------FTYSDKSCSPPAEFMRMMGN 224
Query: 624 GMPSQLIDAYYQESCNLAEVIR----------C---IH-VGLLCVQHHPEDRPC 663
Q+I +L E+++ C I+ + C + P RP
Sbjct: 225 DKQGQMI------VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 40/208 (19%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEI----------------------------AHRN 455
+ +LGEG G V K L + I
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 456 LVKLLGCCIQGEEKLL--IYEFMPNRSLDSFIFDQTKRKLLDWSKRFC--IICGTARGLL 511
+VK G + + E+ SLDS I+ + K++ ++ I +GL
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 512 YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAP 571
YLH SR +IIHRD+K SN+LL + K+ DFG++ G+ + GT YMAP
Sbjct: 120 YLH--SR-KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFYMAP 172
Query: 572 EYASDGLFSVKSDVFSFGILLLEIVSGK 599
E +S+ SDV+S G+ LLE+ +
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 63/208 (30%), Positives = 88/208 (42%), Gaps = 55/208 (26%)
Query: 430 KKLGEGGFGPVYKG---------------TLADGQEIA----------------HRNLVK 458
K+LG G FG V KG TL A H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQ---TKRKLLDWSKRFCIICGTARGLLYLHH 515
L+G C +GE +L+ E P L ++ + L + + + A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113
Query: 516 DSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF-VGDEIEGSTKRVVGTYG-----YM 569
+HRDL A NVLL + KISDFG++R G + +T T G +
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT-----TAGRWPLKWY 165
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVS 597
APE + G FS KSDV+S+G+ L E S
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 78/275 (28%), Positives = 116/275 (42%), Gaps = 57/275 (20%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------- 452
NF I KK+G+G F VYK L DG+ +A
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFI-FDQTKRKLLD----WSKRFCIICGTA 507
H N++K L I+ E ++ E L I + +++L+ W K F +C
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW-KYFVQLC--- 116
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
L ++H S+ RI+HRD+K +NV + K+ D GL R F + VGT
Sbjct: 117 SALEHMH--SK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPY 171
Query: 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627
YM+PE + ++ KSD++S G LL E+ + + FY DK +NL K+ P
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FY-GDK-MNLYSLCKKIEKCDYPP 227
Query: 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
D Y +E +L C+ PE RP
Sbjct: 228 LPADHYSEELRDLVSR---------CINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 49/152 (32%), Positives = 76/152 (50%), Gaps = 6/152 (3%)
Query: 451 IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGL 510
H N+VK + G+E L+ ++ SL + R LD + ++ +GL
Sbjct: 56 CNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGL 115
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV--GDEIEGSTKRVVGTYGY 568
YLH IHRD+KA N+LL + + KI+DFG++ + GD K VGT +
Sbjct: 116 EYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172
Query: 569 MAPEYASDGL-FSVKSDVFSFGILLLEIVSGK 599
MAPE + K+D++SFGI +E+ +G
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 72/271 (26%), Positives = 121/271 (44%), Gaps = 60/271 (22%)
Query: 424 DNFSINKKLGEGGFGPVYKGT----------------------LADGQ---EIAHRNLVK 458
++ + KLG+G FG V+ GT L + Q ++ H LV+
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 65
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKR-----KLLDWSKRFCIICGTARGLLYL 513
L + E ++ E+M SL F+ + + +L+D + + A G+ Y+
Sbjct: 66 LYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI------ASGMAYV 118
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY--GYMAP 571
R+ +HRDL+A+N+L+ + K++DFGLAR +E T R + + AP
Sbjct: 119 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAP 172
Query: 572 EYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631
E A G F++KSDV+SFGILL E+ + K R Y N ++ + + P + +
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPE 230
Query: 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
+ + C C + PE+RP
Sbjct: 231 SLHDLMCQ-------------CWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 31/197 (15%)
Query: 427 SINKKLGEGGFGPVYKG------------TL--------------ADGQEIAHRNLVKLL 460
++ KLG G +G VY+G TL A +EI H NLV+LL
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 461 GCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLR 520
G C + +I EFM +L ++ + R+ ++ + + + YL +
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN--- 124
Query: 521 IIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFS 580
IHRDL A N L+ K++DFGL+R + + + + APE + FS
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 581 VKSDVFSFGILLLEIVS 597
+KSDV++FG+LL EI +
Sbjct: 184 IKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 70/273 (25%), Positives = 115/273 (42%), Gaps = 78/273 (28%)
Query: 432 LGEGGFGPVYKGT---------------------LADGQ-EIA---------HRNLVKLL 460
+G G +G VY+G ++D Q E+A N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 461 GCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSK---RFC--IICGTARGLLYLHH 515
G ++G +I E+ S+ R L+ ++ II L Y+H
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV---------RTLMKAGPIAEKYISVIIREVLVALKYIHK 119
Query: 516 DSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV--VGTYGYMAPEY 573
+IHRD+KA+N+L+ + N K+ DFG+A + S+KR VGT +MAPE
Sbjct: 120 VG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN----QNSSKRSTFVGTPYWMAPEV 172
Query: 574 ASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSD----KNLNLIGHAWKLWNNGMPSQ 628
++G + K+D++S GI + E+ +G +SD + + LI + P +
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPP----YSDVDAFRAMMLIPKS-------KPPR 221
Query: 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDR 661
L D Y S L E + C+ P++R
Sbjct: 222 LEDNGY--SKLLREFV------AACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-18
Identities = 78/273 (28%), Positives = 120/273 (43%), Gaps = 60/273 (21%)
Query: 422 ATDNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNL 456
++ + KKLG G FG V+ GT ++A H L
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63
Query: 457 VKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKR-----KLLDWSKRFCIICGTARGLL 511
V+L + E ++ E+M SL F+ D R L+D + + A G+
Sbjct: 64 VQLYAV-VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQ------VAAGMA 116
Query: 512 YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY--GYM 569
Y+ R+ IHRDL+++N+L+ + KI+DFGLAR +E T R + +
Sbjct: 117 YIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWT 170
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629
APE A G F++KSDV+SFGILL E+V+ K R Y N ++ +
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVT--KGRVPYPGMNNREVL-------------EQ 215
Query: 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
++ Y+ C I + L C + PE+RP
Sbjct: 216 VERGYRMPCPQDCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-18
Identities = 76/274 (27%), Positives = 124/274 (45%), Gaps = 66/274 (24%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVK 458
++ + KKLG G FG V+ T ++A H LVK
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK 65
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFI-FDQTKR----KLLDWSKRFCIICGTARGLLYL 513
L + E +I EFM SL F+ D+ + KL+D+S + A G+ ++
Sbjct: 66 L-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAFI 118
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI---EGSTKRVVGTYGYMA 570
+ IHRDL+A+N+L+ + KI+DFGLAR +E EG+ + T A
Sbjct: 119 E---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT----A 171
Query: 571 PEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLW-NNGMPSQ 628
PE + G F++KSDV+SFGILL+EIV+ G+ + + + + +++ P +
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEE 231
Query: 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
L + + + C ++ PE+RP
Sbjct: 232 LYN-----------------IMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 7e-18
Identities = 74/262 (28%), Positives = 109/262 (41%), Gaps = 56/262 (21%)
Query: 432 LGEGGFGPVYKGTLADGQEIA---------------------------HRNLVKLLGCCI 464
LG+G FG V+KGTL D +A H N+VKL+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 465 QGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHR 524
Q + ++ E +P SF+ + K+ L + A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 525 DLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSD 584
DL A N L+ KISDFG++R D I S+ + APE + G +S +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 585 VFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVI 644
V+S+GILL E S L + + GM +Q ++ ++
Sbjct: 177 VWSYGILLWETFS-------------LGVCPYP------GMTNQQAREQVEKGYRMSCPQ 217
Query: 645 RC----IHVGLLCVQHHPEDRP 662
+C V C + PE+RP
Sbjct: 218 KCPDDVYKVMQRCWDYKPENRP 239
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 7e-18
Identities = 70/267 (26%), Positives = 110/267 (41%), Gaps = 56/267 (20%)
Query: 426 FSINKKLGEGGFGPVYKGT-LADGQEIAHR---------------------------NLV 457
F++ + +G+G FG VYK Q +A + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS 517
K G ++G + +I E+ S D K LD + I+ GL YLH +
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR--VVGTYGYMAPEYAS 575
IHRD+KA+N+LL E + K++DFG++ G +KR VGT +MAPE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 576 DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635
+ K+D++S GI +E+ G+ H + L LI NN P L +
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK-----NN--PPSLEGNKF- 223
Query: 636 ESCNLAEVIRCIHVGLLCVQHHPEDRP 662
S + + C+ P++RP
Sbjct: 224 -SKPFKDFVSL------CLNKDPKERP 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 62/238 (26%), Positives = 93/238 (39%), Gaps = 54/238 (22%)
Query: 421 NATDNFSINKKLGEGGFGPVYKGTLADGQEIA---------------------------H 453
+ T F + + +GEG +G VYK ++ H
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNH 62
Query: 454 RNLVKLLGCCIQ-----GEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF---CI-- 502
N+ G I+ +++L L+ E S+ + + L KR I
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIAY 117
Query: 503 IC-GTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561
I T RGL YLH ++IHRD+K N+LL K+ DFG++ D G
Sbjct: 118 ILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNT 172
Query: 562 VVGTYGYMAPE-----YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLI 614
+GT +MAPE D + +SDV+S GI +E+ GK H + L I
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 47/211 (22%)
Query: 421 NATDNFSINKKLGEGGFGPVYK------GTLADGQ---------------------EIAH 453
N D + I +LG+G FG VYK G A + E H
Sbjct: 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61
Query: 454 RNLVKLLGCCIQGEEKLLIY-EFMPNRSLDSFIFDQTKRKLLDWSKRFCIIC-GTARGLL 511
N+V L E KL I EF +LDS I + +R L + R+ +C L
Sbjct: 62 PNIVGLYEAYFY-ENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY--VCRQMLEALN 117
Query: 512 YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR--VVGTYGYM 569
+LH ++IHRDLKA N+LL + + K++DFG++ ++ KR +GT +M
Sbjct: 118 FLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVS-AKNKSTLQ---KRDTFIGTPYWM 170
Query: 570 APEYA-----SDGLFSVKSDVFSFGILLLEI 595
APE D + K+D++S GI L+E+
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 63/229 (27%), Positives = 94/229 (41%), Gaps = 52/229 (22%)
Query: 422 ATDNFSINKKLGEGGFGPVYKGTL----ADGQEIA------------------------- 452
D+ ++ + LG G FG VY+G D E+
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 453 ----HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRK----LLDWSKRFCIIC 504
H+N+V+L+G + + ++ E M L SF+ + R L
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 505 GTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP----KISDFGLARTFVGDEIEGSTK 560
A+G YL + IHRD+ A N LL + P KI+DFG+AR
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 561 RVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-------GKKNR 602
R + +M PE DG+F+ K+DV+SFG+LL EI S G+ N+
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 5e-17
Identities = 58/239 (24%), Positives = 108/239 (45%), Gaps = 30/239 (12%)
Query: 380 QDLYIRMSASELGGNNRRTDQENEDQNEDLELPLFELATIANATDNFSINKKLGEGGFGP 439
+DLY +S +L ++ + E++D ++D +P + A A+ +++ K L G G
Sbjct: 22 EDLYSDISDGDLEYSDDDSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGR 81
Query: 440 VY-----------------KG-TLADG---QEIAHRNLVKLLGCCIQGEEKLLIYEFMPN 478
V+ KG TL + Q + H +++++ + G ++ +P+
Sbjct: 82 VFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPH 138
Query: 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN 538
S D + + + + L + I GL YLH RIIHRD+K N+ ++
Sbjct: 139 YSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQ 195
Query: 539 PKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
I D G A+ V + GT APE + ++ K+D++S GI+L E+++
Sbjct: 196 VCIGDLGAAQFPVVAPAFLG---LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 46/128 (35%), Positives = 65/128 (50%), Gaps = 13/128 (10%)
Query: 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFC--IICGTARGLLYLHHDSRLRIIHRDLKASNV 531
EFM SLD +K I GL YL++ RI+HRD+K SN+
Sbjct: 83 EFMDCGSLDRIY-----KKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNI 135
Query: 532 LLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGIL 591
L++ K+ DFG++ G+ I VGT YM+PE G ++VKSDV+S GI
Sbjct: 136 LVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGIS 191
Query: 592 LLEIVSGK 599
++E+ GK
Sbjct: 192 IIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-17
Identities = 41/98 (41%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 502 IICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561
IICG L +LH + RI++RDLK NVLLD N +ISD GLA G + K
Sbjct: 104 IICG----LEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153
Query: 562 VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
GT GYMAPE ++ D F+ G L E+++G+
Sbjct: 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 39/200 (19%)
Query: 432 LGEGGFGPVYKGTLADGQ---------------------EIA------HRNLVKLLGCCI 464
LG+G +G VY Q EIA HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 465 QGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTA--RGLLYLHHDSRLRII 522
+ + E +P SL + + ++K L +++ I GL YLH +I+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIV 130
Query: 523 HRDLKASNVLLD-HEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL--F 579
HRD+K NVL++ + KISDFG ++ G I T+ GT YMAPE G +
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRGY 188
Query: 580 SVKSDVFSFGILLLEIVSGK 599
+D++S G ++E+ +GK
Sbjct: 189 GAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 55/154 (35%), Positives = 77/154 (50%), Gaps = 22/154 (14%)
Query: 453 HRNLVKLLGCCIQGEEK--LLIYEFMPNRSLDSFI--FDQTKRKLLDWSKRFCIICGTAR 508
H N+VK GCC + K LI E++P SL ++ +LL ++++ C
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQIC------E 118
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG- 567
G+ YLH IHRDL A NVLLD++ KI DFGLA+ EG V G
Sbjct: 119 GMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRVREDGD 171
Query: 568 ----YMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+ A E + FS SDV+SFG+ L E+++
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 37/205 (18%)
Query: 425 NFSINKKLGEGGFGPVYK-GTLADGQEIA----------------------------HRN 455
+F + KKLG+G +G VYK L+D Q A H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 456 LVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFD-QTKRKLLDWSKRFCIICGTARGLLYLH 514
++ + G + ++ E+ P L I + KRKL+ + + I RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 515 HDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYA 574
+I+HRDLK++N+LL KI D G+++ K +GT YMAPE
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPEVW 173
Query: 575 SDGLFSVKSDVFSFGILLLEIVSGK 599
+S KSD++S G LL E+ +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 75/273 (27%), Positives = 111/273 (40%), Gaps = 57/273 (20%)
Query: 425 NFSINKKLGEGGFGPVYKGT-LADGQEIA-----------------------------HR 454
NF I KK+G G F VY+ T L DG +A H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 455 NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFI--FDQTKRKLLD---WSKRFCIICGTARG 509
N++K I+ E ++ E L I F + KR + + W K F +C
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW-KYFVQLCSA--- 118
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
L H R++HRD+K +NV + K+ D GL R F + +VGT YM
Sbjct: 119 ---LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629
+PE + ++ KSD++S G LL E+ + + ++ DK +NL K+ P
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDK-MNLYSLCKKIEQCDYPPLP 229
Query: 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
D Y +E L +C+ PE RP
Sbjct: 230 SDHYSEELRQLVN---------MCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 37/197 (18%)
Query: 426 FSINKKLGEGGFGPVYKGTLADGQEIA------------------------HRNLVKLLG 461
++ + +GEG FG V +G GQ++A H+NLV+LLG
Sbjct: 8 LTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLG 66
Query: 462 CCIQGEEKLLIYEFMPNRSLDSFIFDQTK-RKLLDWSKRFCIICGTARGLLYLHHDSRLR 520
I ++ E M +L +F+ +T+ R L+ + A G+ YL +
Sbjct: 67 V-ILHNGLYIVMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK---K 120
Query: 521 IIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFS 580
++HRDL A N+L+ + K+SDFGLAR VG ++K V + APE FS
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLAR--VGSMGVDNSKLPV---KWTAPEALKHKKFS 175
Query: 581 VKSDVFSFGILLLEIVS 597
KSDV+S+G+LL E+ S
Sbjct: 176 SKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 43/203 (21%)
Query: 430 KKLGEGGFGPVYKG---------------TLADGQ----------------EIAHRNLVK 458
K +G G FG V++G TL G + +H N+++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWS--KRFCIICGTARGLLYLHHD 516
L G + + ++I E+M N +LD ++ D ++S + ++ G A G+ YL
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYL--- 123
Query: 517 SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG--YMAPEYA 574
S + +HRDL A N+L++ + K+SDFGL+R + D+ EG+ G + APE
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-LEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 575 SDGLFSVKSDVFSFGILLLEIVS 597
+ F+ SDV+SFGI++ E++S
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 45/212 (21%)
Query: 430 KKLGEGGFGPVYKG-TLADGQ----------------------------EIAHRNLVKLL 460
+K+GEG +G VYKG GQ E+ H N+V L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 461 GCCIQGEEKLLIYEFMP---NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS 517
+Q LI+EF+ + LDS Q L S + I+ +G+L+ H
Sbjct: 66 DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCH--- 118
Query: 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDG 577
R++HRDLK N+L+D++ K++DFGLAR F G + T VV T Y APE
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLGS 176
Query: 578 -LFSVKSDVFSFGILLLEIVSGKKNRGFYHSD 608
+S D++S G + E+ + + +H D
Sbjct: 177 PRYSTPVDIWSIGTIFAEMAT---KKPLFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 55/205 (26%), Positives = 80/205 (39%), Gaps = 47/205 (22%)
Query: 430 KKLGEGGFGPVYKGT---------------LADG----------QEIA------HRNLVK 458
KKLG+G FG V +G L +E A H NL++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKR-----KLLDWSKRFCIICGTARGLLYL 513
L G + + + E P SL + L D++ + G+ YL
Sbjct: 61 LYGVVLTHPLMM-VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA------NGMRYL 113
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF-VGDEIEGSTKRVVGTYGYMAPE 572
R IHRDL A N+LL + KI DFGL R ++ + + + + APE
Sbjct: 114 ESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170
Query: 573 YASDGLFSVKSDVFSFGILLLEIVS 597
FS SDV+ FG+ L E+ +
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 5e-16
Identities = 53/154 (34%), Positives = 80/154 (51%), Gaps = 20/154 (12%)
Query: 451 IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKR----KLLDWSKRFCIICGT 506
++H LV+L G C + ++ E+M N L +++ + KR +LL+ K C
Sbjct: 56 LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVC----- 110
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT- 565
G+ YL + IHRDL A N L+D + K+SDFGL+R + DE S VG+
Sbjct: 111 -EGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSK 162
Query: 566 --YGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+ PE FS KSDV++FG+L+ E+ S
Sbjct: 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-16
Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 36/221 (16%)
Query: 406 NEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADGQEIAHR---------- 454
+E++ L + +I + ++ +K+G+G G V+ +A GQE+A +
Sbjct: 1 DEEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK 60
Query: 455 ----------------NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSK 498
N+V L + G+E ++ E++ SL D +D ++
Sbjct: 61 ELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQ 116
Query: 499 RFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558
+ + L +LH + ++IHRD+K+ NVLL + + K++DFG ++ + S
Sbjct: 117 IAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173
Query: 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
T +VGT +MAPE + + K D++S GI+ +E+V G+
Sbjct: 174 T--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 57/158 (36%), Positives = 80/158 (50%), Gaps = 16/158 (10%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFI-----------FDQTK--RKLLDWSKR 499
H+N++ LLG C Q +I E+ +L F+ FD TK + L +
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 500 FCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559
ARG+ YL +SR R IHRDL A NVL+ + KI+DFGLAR + T
Sbjct: 137 VSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+MAPE D +++ +SDV+SFGIL+ EI +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 74/273 (27%), Positives = 116/273 (42%), Gaps = 57/273 (20%)
Query: 425 NFSINKKLGEGGFGPVYKGT-LADGQEIA-----------------------------HR 454
NF I KK+G G F VY+ T L D + +A H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 455 NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFI--FDQTKRKLLD---WSKRFCIICGTARG 509
N++K L I+ E ++ E L I F + KR + + W K F +C
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW-KYFVQLCSAVE- 120
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
H SR R++HRD+K +NV + K+ D GL R F + +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629
+PE + ++ KSD++S G LL E+ + + ++ DK +NL K+ P
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDK-MNLFSLCQKIEQCDYPPLP 229
Query: 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
+ Y ++ L E++ +C+ P+ RP
Sbjct: 230 TEHYSEK---LRELVS------MCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 47/136 (34%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 502 IICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561
IC L YLH IIHRD+K N+LLD + + I+DF +A D + ST
Sbjct: 105 WICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST-- 159
Query: 562 VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGF-YHSDKNLNLIGHAWK- 619
GT GYMAPE +SV D +S G+ E + GK R + HS + I +
Sbjct: 160 -SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK--RPYRGHSRTIRDQIRAKQET 216
Query: 620 ---LWNNGMPSQLIDA 632
L+ ++ IDA
Sbjct: 217 ADVLYPATWSTEAIDA 232
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-16
Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 24/168 (14%)
Query: 450 EIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKL---------------- 493
E H N+VKLLG C G+ L++E+M L+ F+ ++ R
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 494 ---LDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART- 549
L +++ CI A G+ YL S + +HRDL N L+ M KI+DFGL+R
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 550 FVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+ D + S + +M PE ++ +SDV+++G++L EI S
Sbjct: 181 YSADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 7e-16
Identities = 78/272 (28%), Positives = 124/272 (45%), Gaps = 62/272 (22%)
Query: 424 DNFSINKKLGEGGFGPVYKGT----------------------LADGQ---EIAHRNLVK 458
++ ++ KLG+G FG V+ GT L + Q ++ H LV
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVP 65
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
L + E ++ EFM SL F+ + K L + + A G+ Y+ R
Sbjct: 66 LYAV-VSEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---R 120
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY--GYMAPEYASD 576
+ IHRDL+A+N+L+ + KI+DFGLAR +E T R + + APE A
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALY 177
Query: 577 GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636
G F++KSDV+SFGILL E+V+ K R Y N ++ + ++ Y+
Sbjct: 178 GRFTIKSDVWSFGILLTELVT--KGRVPYPGMVNREVL-------------EQVERGYRM 222
Query: 637 SC------NLAEVIRCIHVGLLCVQHHPEDRP 662
C +L E+++ LC + P++RP
Sbjct: 223 PCPQGCPESLHELMK------LCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 58/200 (29%), Positives = 89/200 (44%), Gaps = 38/200 (19%)
Query: 430 KKLGEGGFGPVYKG-TLADGQEIA----------------------------HRNLVKLL 460
K+GEG +G VYK G+ +A H N++KLL
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 461 GCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLR 520
+ L++EFM + L I + +++ L S + +GL + H
Sbjct: 65 DVFRHKGDLYLVFEFM-DTDLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118
Query: 521 IIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE-YASDGLF 579
I+HRDLK N+L++ E K++DFGLAR+F T VV T Y APE D +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGDKGY 176
Query: 580 SVKSDVFSFGILLLEIVSGK 599
S D++S G + E++S +
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 51/149 (34%), Positives = 75/149 (50%), Gaps = 10/149 (6%)
Query: 450 EIAHRNLVKLLGCCIQGEEKLLIY-EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTAR 508
++ H NLV+LLG ++ + L I E+M SL ++ + R +L
Sbjct: 55 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCE 113
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
+ YL ++ +HRDL A NVL+ + K+SDFGL + + + K V +
Sbjct: 114 AMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVK---W 165
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVS 597
APE + FS KSDV+SFGILL EI S
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 59/210 (28%), Positives = 89/210 (42%), Gaps = 59/210 (28%)
Query: 431 KLGEGGFGPVYKG-TLADGQEIA----------------------------HRNLVKLLG 461
K+GEG +G VYK G+ +A H N+V+LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 462 CCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCI-----------ICGTARGL 510
+ L++EF+ D +K +D S + + +G+
Sbjct: 66 VVHSENKLYLVFEFL----------DLDLKKYMDSSPLTGLDPPLIKSYLYQLL---QGI 112
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMA 570
Y H S R++HRDLK N+L+D E K++DFGLAR F G + T VV T Y A
Sbjct: 113 AYCH--SH-RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRA 167
Query: 571 PEYASDG-LFSVKSDVFSFGILLLEIVSGK 599
PE +S D++S G + E+V+ +
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 64/207 (30%), Positives = 89/207 (42%), Gaps = 49/207 (23%)
Query: 430 KKLGEGGFGPVYKGT--------------------LADG------------QEIAHRNLV 457
KKLGEG + VYK DG QE+ H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS 517
LL L++EFM L+ I D K +L + + T RGL YLH
Sbjct: 66 GLLDVFGHKSNINLVFEFMET-DLEKVIKD--KSIVLTPADIKSYMLMTLRGLEYLH--- 119
Query: 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDG 577
I+HRDLK +N+L+ + K++DFGLAR+F G T +VV T Y APE
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVV-TRWYRAPEL---- 173
Query: 578 LFSVKS-----DVFSFGILLLEIVSGK 599
LF + D++S G + E++
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 46/204 (22%)
Query: 430 KKLGEGGFGPVYKGT-LADGQEIA-------------------------------HRNLV 457
K LG G FG VYKG + +G+ + H +LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQT----KRKLLDWSKRFCIICGTARGLLYL 513
+LLG C+ +L + + MP+ L ++ + + LL+W C+ A+G++YL
Sbjct: 73 RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW----CV--QIAKGMMYL 125
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEY 573
R++HRDL A NVL+ + KI+DFGLAR GDE E + +MA E
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 574 ASDGLFSVKSDVFSFGILLLEIVS 597
F+ +SDV+S+G+ + E+++
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 46/160 (28%), Positives = 88/160 (55%), Gaps = 20/160 (12%)
Query: 449 QEIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFI-----FDQTKRKLLDWSKRFCII 503
+E+ H N+V+ LG + + + E++P S+ + + F++T + F +
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEET------LVRNF--V 112
Query: 504 CGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR-- 561
+GL YLH+ IIHRD+K +N+L+D++ KISDFG+++ + + T
Sbjct: 113 RQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR 169
Query: 562 --VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+ G+ +MAPE ++ K+D++S G L++E+++GK
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 48/215 (22%)
Query: 431 KLGEGGFGPVYKG-----------------TLADGQEIA---------------HRNLVK 458
+LGEG FG V+ L + E A H+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSF---------IFDQTKRKL---LDWSKRFCIICGT 506
G C +G L+++E+M + L+ F I + L + I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
A G++YL + L +HRDL N L+ + KI DFG++R + R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 567 GYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKK 600
+M PE F+ +SD++SFG++L EI + GK+
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 73/279 (26%), Positives = 110/279 (39%), Gaps = 87/279 (31%)
Query: 432 LGEGGFGPVYKG-TLADG-------------------------QEIA------HRNLVKL 459
LG G FG VY+G L DG QEIA H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 460 LGCCIQGEEKLLIY-EFMPNRSLDSFI-----FDQT-----KRKLLDWSKRFCIICGTAR 508
LG + E+ L I+ E +P SL + F + R++L
Sbjct: 68 LGT-EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL------------- 113
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
GL YLH +HRD+K +N+L+D K++DFG+A+ V K G+ +
Sbjct: 114 GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE---FSFAKSFKGSPYW 167
Query: 569 MAPEY-ASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG--- 624
MAPE A G + + +D++S G +LE+ +GK + +K+ +
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELP 221
Query: 625 -MPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
+P L S + I C+Q P RP
Sbjct: 222 PIPDHL-------SDEAKDFIL------KCLQRDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 39/103 (37%), Positives = 59/103 (57%), Gaps = 11/103 (10%)
Query: 502 IICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561
I + L YLH S+L +IHRD+K SNVL++ K+ DFG++ G ++ K
Sbjct: 108 IAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKT 161
Query: 562 V-VGTYGYMAPEYASDGL----FSVKSDVFSFGILLLEIVSGK 599
+ G YMAPE + L + VKSDV+S GI ++E+ +G+
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 6e-15
Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 28/157 (17%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIIC------GT 506
H N++ L G + + +++ E+M N SLD+F+ RK +F +I G
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL-----RK---HDGQFTVIQLVGMLRGI 115
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
A G+ YL S + +HRDL A N+L++ + K+SDFGL+R +E + T
Sbjct: 116 ASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-----LEDDPEAAYTTR 167
Query: 567 G------YMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
G + APE + F+ SDV+S+GI++ E++S
Sbjct: 168 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 50/162 (30%), Positives = 86/162 (53%), Gaps = 24/162 (14%)
Query: 449 QEIAHRNLVKLLGCCIQGEEKLLIY-EFMPNRSLDSFI-----FDQTKRKLLDWSKRFCI 502
+++ H N+V+ LG EE L I+ E++P S+ S + F++ +
Sbjct: 63 KDLDHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ----- 116
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS--TK 560
GL YLH I+HRDLKA N+L+D + KISDFG+++ D+I +
Sbjct: 117 ---VLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNM 168
Query: 561 RVVGTYGYMAPE--YASDGLFSVKSDVFSFGILLLEIVSGKK 600
+ G+ +MAPE ++ +S K D++S G ++LE+ +G++
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 52/157 (33%), Positives = 80/157 (50%), Gaps = 18/157 (11%)
Query: 450 EIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQ----TKRKLLDWSKRFCIICG 505
+++H LV+L G C Q + ++ EFM N L +++ + +K LL + C
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVC---- 110
Query: 506 TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST--KRVV 563
G+ YL +S IHRDL A N L+ K+SDFG+ R + DE S+ K V
Sbjct: 111 --EGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPV 165
Query: 564 GTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKK 600
+ PE + +S KSDV+SFG+L+ E+ + K
Sbjct: 166 ---KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 56/221 (25%), Positives = 105/221 (47%), Gaps = 36/221 (16%)
Query: 406 NEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA------------ 452
+E++ L + ++ + ++ +K+G+G G VY +A GQE+A
Sbjct: 1 DEEILEKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK 60
Query: 453 --------------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSK 498
H N+V L + G+E ++ E++ SL D +D +
Sbjct: 61 ELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQ 116
Query: 499 RFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558
+ + L +LH + ++IHRD+K+ N+LL + + K++DFG ++ + S
Sbjct: 117 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173
Query: 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
T +VGT +MAPE + + K D++S GI+ +E+V G+
Sbjct: 174 T--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 426 FSINKKLGEGGFGPVYKGTLADGQEIAHRNLVKL-------------------------- 459
F+ +++G+G FG VYKG +E+ ++ L
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 460 --LGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS 517
G ++G + +I E++ S D K L+ + I+ +GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDG 577
R IHRD+KA+NVLL + + K++DFG+A +I+ +T VGT +MAPE
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176
Query: 578 LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLI 614
+ K+D++S GI +E+ G+ H + L LI
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 42/149 (28%), Positives = 78/149 (52%), Gaps = 13/149 (8%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLY 512
H N+V++ + G+E ++ EF+ +L I T+ ++ + + + L +
Sbjct: 75 HPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTR---MNEEQIATVCLAVLKALSF 130
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR--VVGTYGYMA 570
LH +IHRD+K+ ++LL + K+SDFG F + +R +VGT +MA
Sbjct: 131 LHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMA 183
Query: 571 PEYASDGLFSVKSDVFSFGILLLEIVSGK 599
PE S + + D++S GI+++E+V G+
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 69/286 (24%), Positives = 111/286 (38%), Gaps = 76/286 (26%)
Query: 427 SINKKLGEGGFGPVYKGTLADG-------------------------------QEIAHRN 455
++ K LGEG FG V +G L +E H N
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 456 LVKLLGCCIQGEEK------LLIYEFMPNRSLDSFIF-----DQTKRKLLDWSKRFCIIC 504
+++L+G C+Q E ++I FM + L SF+ D + +F +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF--MT 119
Query: 505 GTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVG 564
A G+ YL S IHRDL A N +L+ MN ++DFGL++ + +
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 565 TYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-------GKKNRGFYHSDKNLNLIGHA 617
++A E +D +++ KSDV+SFG+ + EI + G +N Y + N +
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ- 235
Query: 618 WKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPC 663
P +D Y + C +P+DRP
Sbjct: 236 --------PPDCLDGLYSLMSS-------------CWLLNPKDRPS 260
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 58/200 (29%), Positives = 87/200 (43%), Gaps = 44/200 (22%)
Query: 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL 533
EFM SLD ++ + +L I +GL YL L+I+HRD+K SN+L+
Sbjct: 79 EFMDGGSLD--VYRKIPEHVLGR-----IAVAVVKGLTYLW---SLKILHRDVKPSNMLV 128
Query: 534 DHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLL 593
+ K+ DFG++ V K VGT YMAPE S + + SDV+S GI +
Sbjct: 129 NTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFM 184
Query: 594 EIVSGK-------KNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEV--- 643
E+ G+ KN+G MP QL+ E + V
Sbjct: 185 ELALGRFPYPQIQKNQGSL-------------------MPLQLLQCIVDEDPPVLPVGQF 225
Query: 644 -IRCIHVGLLCVQHHPEDRP 662
+ +H C++ P++RP
Sbjct: 226 SEKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 43/216 (19%)
Query: 422 ATDNFSINKKLGEGGFGPVYKG-----------------TLADGQEIAHR---------- 454
A + +++++LG+G FG VY+G T+ + + R
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 455 ------NLVKLLGCCIQGEEKLLIYEFMPN-------RSLDSFIFDQTKRKLLDWSKRFC 501
++V+LLG QG+ L+I E M RSL + + + K
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 502 IICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561
+ A G+ YL+ + + +HRDL A N ++ + KI DFG+ R + +
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 562 VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+ +M+PE DG+F+ SDV+SFG++L EI +
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 62/214 (28%)
Query: 432 LGEGGFGPVYKGTLADGQEIA--------------------------------HRNLVKL 459
LG+G +G VY G GQ IA H N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 460 LGCCIQGEEKLLIYEFMPNRSLDSFI----------FDQTKRKLLDWSKRFCIICGTARG 509
LG C+ + EF+P S+ S + F + +++LD G
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-------------G 114
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS----TKRVVGT 565
+ YLH++ ++HRD+K +NV+L K+ DFG AR + G+ K + GT
Sbjct: 115 VAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGT 171
Query: 566 YGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+MAPE ++ + KSD++S G + E+ +GK
Sbjct: 172 PYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 449 QEIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIIC-GTA 507
Q++ H N ++ GC ++ L+ E+ + D I + K+ L + IC G
Sbjct: 70 QQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQE--VEIAAICHGAL 125
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
+GL YLH R IHRD+KA N+LL K++DFG A + VGT
Sbjct: 126 QGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPY 176
Query: 568 YMAPE--YASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG 624
+MAPE A D G + K DV+S GI +E+ +K F N+N + + + N
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLF-----NMNAMSALYHIAQND 230
Query: 625 MPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
P+ + + N + C+Q P+DRP
Sbjct: 231 SPTLSSNDWSDYFRNFVD---------SCLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 48/151 (31%), Positives = 84/151 (55%), Gaps = 8/151 (5%)
Query: 451 IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGL 510
++H N+++ ++ + +++ E+ P +L +I + LLD I+ + L
Sbjct: 56 LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDT---ILHFFVQIL 111
Query: 511 LYLHHDSRLRIIHRDLKASNVLLD-HEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
L LHH I+HRDLK N+LLD H+M KI DFG+++ + + + T VVGT Y+
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI-LSSKSKAYT--VVGTPCYI 168
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGKK 600
+PE ++ KSD+++ G +L E+ S K+
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 45/98 (45%), Positives = 59/98 (60%), Gaps = 10/98 (10%)
Query: 506 TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT 565
T + L YL + L+IIHRD+K SN+LLD N K+ DFG++ V D I + R G
Sbjct: 116 TVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSIAKT--RDAGC 170
Query: 566 YGYMAPE----YASDGLFSVKSDVFSFGILLLEIVSGK 599
YMAPE A DG + V+SDV+S GI L E+ +GK
Sbjct: 171 RPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 51/154 (33%), Positives = 73/154 (47%), Gaps = 24/154 (15%)
Query: 457 VKLLGCCIQGEEKL-LIYEFMPNRSLDSFI-----FDQTKRKLLDWSKRFCIICGTARGL 510
VKL QG++ L L+ E++P L S + D+ ++ I L
Sbjct: 56 VKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI--------YIAEIVLAL 106
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART-FVGDEI-----EGSTKRVVG 564
YLH IIHRDLK N+L+D + K++DFGL++ V +I E KR+VG
Sbjct: 107 EYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163
Query: 565 TYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSG 598
T Y+APE S D +S G +L E + G
Sbjct: 164 TPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 44/153 (28%), Positives = 76/153 (49%), Gaps = 10/153 (6%)
Query: 451 IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFI------FDQTKRKLLDWSKRFCIIC 504
++H+N+V+LLG C + E +I E+ L F+ ++ K L ++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 505 GTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVG 564
A G+ +L S R +HRDL A N L+ + K+S L++ E ++
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI- 180
Query: 565 TYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
++APE + FS KSDV+SFG+L+ E+ +
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 45/210 (21%)
Query: 421 NATDNFSINKKLGEGGFGPVYK------GTLADGQEIA---------------------H 453
+ + + I +LG+G FG VYK G LA + I H
Sbjct: 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNH 68
Query: 454 RNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTA-RGLLY 512
+VKLLG + ++ EF P ++D+ + + R L + + +IC L Y
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIML-ELDRGLTEPQIQ--VICRQMLEALQY 125
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR--VVGTYGYMA 570
LH ++IIHRDLKA NVLL + + K++DFG++ ++ +R +GT +MA
Sbjct: 126 LH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYWMA 178
Query: 571 PEYA-----SDGLFSVKSDVFSFGILLLEI 595
PE D + K+D++S GI L+E+
Sbjct: 179 PEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 51/213 (23%)
Query: 424 DNFSINKKLGEGGFGPVYK------GTLA--------DG-------QEIA------HRNL 456
+++ + +++G G +G VYK G L G QEI+ H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 457 VKLLGCCIQGEEKLLI-YEFMPNRSLDSFIFDQTKRKLLDWSKRFCI--IC-GTARGLLY 512
V G +KL I E+ SL I+ T+ L I +C T +GL Y
Sbjct: 63 VAYFGS-YLRRDKLWIVMEYCGGGSLQD-IYQVTRGPL----SELQIAYVCRETLKGLAY 116
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS-TKR--VVGTYGYM 569
LH IHRD+K +N+LL + + K++DFG V ++ + KR +GT +M
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFG-----VSAQLTATIAKRKSFIGTPYWM 168
Query: 570 APEYA---SDGLFSVKSDVFSFGILLLEIVSGK 599
APE A G + K D+++ GI +E+ +
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 39/200 (19%)
Query: 432 LGEGGFGPVYKGTL--ADGQEI-----------------------------AHRNLVKLL 460
+G+G FG VY GTL +DGQ+I +H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 461 GCCIQGE-EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRL 519
G C+ E L++ +M + L +FI +T + F + A+G+ YL +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYL---ASK 117
Query: 520 RIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY--GYMAPEYASDG 577
+ +HRDL A N +LD K++DFGLAR E +MA E
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 578 LFSVKSDVFSFGILLLEIVS 597
F+ KSDV+SFG+LL E+++
Sbjct: 178 KFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 4e-14
Identities = 55/221 (24%), Positives = 105/221 (47%), Gaps = 36/221 (16%)
Query: 406 NEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKG-TLADGQEIAHR---------- 454
+E++ L + ++ + ++ +K+G+G G VY +A GQE+A +
Sbjct: 1 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK 60
Query: 455 ----------------NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSK 498
N+V L + G+E ++ E++ SL D +D +
Sbjct: 61 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQ 116
Query: 499 RFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558
+ + L +LH + ++IHRD+K+ N+LL + + K++DFG ++ + S
Sbjct: 117 IAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173
Query: 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
T +VGT +MAPE + + K D++S GI+ +E+V G+
Sbjct: 174 T--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 60/214 (28%), Positives = 90/214 (42%), Gaps = 49/214 (22%)
Query: 430 KKLGEGGFGPVYKG----------------TLADGQ----------------EIAHRNLV 457
++LGE FG +YKG TL D E+ H N+V
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIF--------------DQTKRKLLDWSKRFCII 503
LLG Q + +++E++ L F+ D T + LD I
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 504 CGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVV 563
A G+ YL S +H+DL A N+L+ +++ KISD GL+R + + +
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 564 GTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+M PE G FS SD++SFG++L EI S
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 51/158 (32%), Positives = 78/158 (49%), Gaps = 16/158 (10%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFI-----------FDQTKRKLLDWSKRFC 501
H+N++ LLG C Q ++ E+ +L ++ FD K + +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 502 IICG--TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559
+ C ARG+ YL + + IHRDL A NVL+ + KI+DFGLAR + T
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+MAPE D +++ +SDV+SFG+LL EI +
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 53/216 (24%)
Query: 430 KKLGEGGFGPVYKG-----------------TLADGQEIA----------------HRNL 456
++LGE FG VYKG TL D E H N+
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 457 VKLLGCCIQGEEKLLIYEFMPNRSLDSFIF-------------DQTKRKLLDWSKRFCII 503
V LLG + + +I+ + + L F+ D+T + L+ + I+
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 504 CGTARGLLYL--HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561
A G+ +L HH ++H+DL NVL+ ++N KISD GL R +
Sbjct: 131 TQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 562 VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+ +M+PE G FS+ SD++S+G++L E+ S
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 5e-14
Identities = 69/218 (31%), Positives = 100/218 (45%), Gaps = 60/218 (27%)
Query: 426 FSINKKLGEGGFGPVYKG-------TLA------------DGQ----EIA-------HRN 455
+ I +KLG+G +G V+K +A D Q EI H N
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPN 68
Query: 456 LVKLLGCCIQGEEKLLIY---EFMPNRSLDSFIFDQTKRKLL-DWSKRFCIICGTARGLL 511
+VKLL I+ E IY E+M L + I + +L D KR+ I+ + L
Sbjct: 69 IVKLLNV-IKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRY-IMYQLLKALK 121
Query: 512 YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR-----VVGTY 566
Y+H S +IHRDLK SN+LL+ + K++DFGLAR+ E+E + + V T
Sbjct: 122 YIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLTDYVATR 176
Query: 567 GYMAPEYASDGLFSVKS-----DVFSFGILLLEIVSGK 599
Y APE L D++S G +L E++ GK
Sbjct: 177 WYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 62/223 (27%), Positives = 96/223 (43%), Gaps = 69/223 (30%)
Query: 425 NFSINKKLGEGGFGPVYKGTLAD-GQEIA------------------------------- 452
N+ K LG+G FG VY D G+E+A
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 453 HRNLVKLLGCCIQGEEKLLIY-EFMPNRSLDSFIFDQTK--------------RKLLDWS 497
H +V+ G C++ +E L I+ E+MP S + DQ K R++L+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGS----VKDQLKAYGALTETVTRKYTRQILE-- 115
Query: 498 KRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557
G+ YLH I+HRD+K +N+L D N K+ DFG ++ G
Sbjct: 116 -----------GVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161
Query: 558 S-TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+ K V GT +M+PE S + K+DV+S G ++E+++ K
Sbjct: 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 39/206 (18%)
Query: 425 NFSINKKLGEGGFGPVYKG-----------------TLADG------------QEIAHRN 455
NF +K+GEG +G VYK T +G +E+ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 456 LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH 514
+VKLL I E KL L++EF+ ++ L F+ D + + + +GL + H
Sbjct: 61 IVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 515 HDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE-Y 573
R++HRDLK N+L++ E K++DFGLAR F G + T VV T Y APE
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 172
Query: 574 ASDGLFSVKSDVFSFGILLLEIVSGK 599
+S D++S G + E+V+ +
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 54/188 (28%), Positives = 74/188 (39%), Gaps = 58/188 (30%)
Query: 425 NFSINKKLGEGGFGPVYK-----------------GTLADG------------QEIAHRN 455
+ I ++GEG G V+K L G Q H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 456 LVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFD--------QTK---RKLLDWSKRFCIIC 504
+VKLL G +L+ E+MP L + D Q K R LL
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLK--------- 110
Query: 505 GTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVG 564
G+ Y+H I+HRDLK +N+L+ + KI+DFGLAR F +E + + V
Sbjct: 111 ----GVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VA 162
Query: 565 TYGYMAPE 572
T Y APE
Sbjct: 163 TRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 66/216 (30%), Positives = 94/216 (43%), Gaps = 70/216 (32%)
Query: 431 KLGEGGFGPVYKG-------TLA----------DG------------QEIAHRNLVKLLG 461
++GEG +G VY+ +A DG + H N+V+L
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK- 72
Query: 462 CCIQGEEKLLIYEFMPNRSLDSFIF------DQTKRKLLDWSKR-F------CIICGTAR 508
E + + LDS IF +Q LLD F C++ R
Sbjct: 73 ------------EVVVGKHLDS-IFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLR 119
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
GL YLH + IIHRDLK SN+LL + KI+DFGLART+ G + T +VV T Y
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWY 174
Query: 569 MAPEYASDGLFSVKS-----DVFSFGILLLEIVSGK 599
APE L + D+++ G +L E+++ K
Sbjct: 175 RAPEL----LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 55/163 (33%), Positives = 82/163 (50%), Gaps = 29/163 (17%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTA----- 507
H N++ LLG C L E+ P+ +L F+ K ++L+ F I TA
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSS 123
Query: 508 -----------RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556
RG+ YL S+ + IHRDL A N+L+ KI+DFGL+R G E+
Sbjct: 124 QQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEV- 176
Query: 557 GSTKRVVGTYG--YMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
K+ +G +MA E + +++ SDV+S+G+LL EIVS
Sbjct: 177 -YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 10/155 (6%)
Query: 451 IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGL 510
+ + N+++LLG C+ + +I E+M N L+ F+ + + I + L
Sbjct: 74 LKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN--IPSVSIANL 131
Query: 511 LYL--------HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV 562
LY+ + + L +HRDL N L+ + KI+DFG++R + R
Sbjct: 132 LYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRA 191
Query: 563 VGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
V +MA E G F+ SDV++FG+ L E+ +
Sbjct: 192 VLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 51/158 (32%), Positives = 79/158 (50%), Gaps = 16/158 (10%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFI-----------FDQTKRKLLDWSKRFC 501
H+N++ LLG C Q +I E+ +L ++ ++ T+ S +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 502 IICG--TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559
+ C ARG+ YL + + IHRDL A NVL+ + KI+DFGLAR + T
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+MAPE D +++ +SDV+SFG+LL EI +
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 9/141 (6%)
Query: 460 LGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
L C Q +++L + E++ L I Q + + RF GL +LH
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARFYAAE-IVLGLQFLHERG- 116
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL 578
II+RDLK NVLLD E + KI+DFG+ + + + +T GT Y+APE S
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAPEILSYQP 172
Query: 579 FSVKSDVFSFGILLLEIVSGK 599
+ D ++ G+LL E+++G+
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 54/221 (24%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 406 NEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADGQEIAHR---------- 454
+E++ L + ++ + ++ +K+G+G G VY +A GQE+A R
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 455 ----------------NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSK 498
N+V L + G+E ++ E++ SL D +D +
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQ 117
Query: 499 RFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558
+ + L +LH + ++IHRD+K+ N+LL + + K++DFG ++ + S
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174
Query: 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+VGT +MAPE + + K D++S GI+ +E++ G+
Sbjct: 175 --TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 61/212 (28%)
Query: 434 EGGFGPVYKG----------------TLADG----------------QEIAHRNLVKLLG 461
EG FG ++ G T+ D ++H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 462 CCIQGEEK-LLIYEFMPNRSLDSFIFDQTKRKLLDW------SKRFCIICGT--ARGLLY 512
CI+ E ++Y +M +L F+ + +L + S + + A G+ Y
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFL---QQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF-------VGDEIEGSTKRVVGT 565
LH + +IH+D+ A N ++D E+ KI+D L+R +GD K
Sbjct: 133 LH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK----- 184
Query: 566 YGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+MA E + +S SDV+SFG+LL E+++
Sbjct: 185 --WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 35/95 (36%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 510 LLYLHH-----DSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVG 564
LL L+ D ++HRDLK +N+ LD N K+ DFGLA+ D T VG
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVG 172
Query: 565 TYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
T YM+PE + + KSD++S G L+ E+ +
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 54/160 (33%), Positives = 82/160 (51%), Gaps = 23/160 (14%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTA----- 507
H N++ LLG C L E+ P+ +L F+ K ++L+ F I TA
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSS 111
Query: 508 RGLLYLHHD--------SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559
+ LL+ D S+ + IHRDL A N+L+ KI+DFGL+R G E+
Sbjct: 112 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEV--YV 166
Query: 560 KRVVGTYG--YMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
K+ +G +MA E + +++ SDV+S+G+LL EIVS
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 61/220 (27%), Positives = 105/220 (47%), Gaps = 35/220 (15%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRK---LLDWSKRFCIICGTARG 509
H +++++LG + L E+M S+ + K +++++++ RG
Sbjct: 62 HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL------RG 115
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHE-MNPKISDFG----LARTFVG-DEIEGSTKRVV 563
L YLH + +IIHRD+K +N+L+D +I+DFG LA G E +G +++
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLL 169
Query: 564 GTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWN- 622
GT +MAPE + DV+S G +++E+ + K +L LI +K+ +
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKIASA 226
Query: 623 NGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
PS E L+ +R V L C++ PEDRP
Sbjct: 227 TTAPS------IPEH--LSPGLR--DVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 20/154 (12%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIIC------GT 506
H N++ L G + ++I EFM N +LDSF+ + D +F +I G
Sbjct: 64 HPNIIHLEGVVTKSRPVMIITEFMENGALDSFL------RQND--GQFTVIQLVGMLRGI 115
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVG-- 564
A G+ YL S + +HRDL A N+L++ + K+SDFGL+R D + + +G
Sbjct: 116 AAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172
Query: 565 -TYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+ APE + F+ SDV+S+GI++ E++S
Sbjct: 173 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 55/160 (34%), Positives = 83/160 (51%), Gaps = 23/160 (14%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTA----- 507
H N++ LLG C + E+ P +L F+ K ++L+ F GTA
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTS 118
Query: 508 RGLLY--------LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559
+ LL + + S + IHRDL A NVL+ + KI+DFGL+R G+E+
Sbjct: 119 QQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEV--YV 173
Query: 560 KRVVGTYG--YMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
K+ +G +MA E + +++ KSDV+SFG+LL EIVS
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 49/158 (31%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFI-----------FDQTKRKLLDWSKRFC 501
H+N++ LLG C Q +I E+ +L ++ +D + + +
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 502 IICG--TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559
+ C ARG+ YL + + IHRDL A NVL+ KI+DFGLAR + T
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+MAPE D +++ +SDV+SFG+L+ EI +
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 41/200 (20%)
Query: 430 KKLGEGGFGPVYKGTL-ADGQEIA---------------------------HRNLVKLLG 461
+++G G FG V+ G L AD +A H N+V+L+G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 462 CCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRI 521
C Q + ++ E + +F+ +T+ L + ++ A G+ YL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 522 IHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT----YGYMAPEYASDG 577
IHRDL A N L+ + KISDFG++R +E +G G + APE + G
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 578 LFSVKSDVFSFGILLLEIVS 597
+S +SDV+SFGILL E S
Sbjct: 172 RYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-13
Identities = 30/81 (37%), Positives = 39/81 (48%), Gaps = 6/81 (7%)
Query: 307 SRKDGFIKFSELKLPDSTSSWVSKSMNLKECREKCLE-NSSCMAYTNSDITRGGSGCVMW 365
D F++ KLP S V +L+EC KCL N SC ++T G GC++W
Sbjct: 1 KSDDCFVRLPNTKLPG-FSRIVISVASLEECASKCLNSNCSCRSFTY---NNGTKGCLLW 56
Query: 366 -FGDLIDMRNFQDGGQDLYIR 385
L D R F GG DLY +
Sbjct: 57 SESSLGDARLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 506 TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT 565
TA+ + L H + RII+RDLK NVLLD++ N +ISD GLA + + TK GT
Sbjct: 103 TAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELK--DGQSKTKGYAGT 160
Query: 566 YGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
G+MAPE + D F+ G+ L E+++ +
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 59/208 (28%)
Query: 432 LGEGGFGPVYKGT-LADGQ----------------------EIA---------HRNLVKL 459
+GEG +G VYK L G+ EIA H N+V+L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 460 LGCC--IQGEEKL---LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH 514
L C + + +L L++E + ++ L +++ K L + + ++ RG+ +LH
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKD-LMRQLLRGVDFLH 124
Query: 515 -HDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE- 572
H RI+HRDLK N+L+ + KI+DFGLAR + E + VV T Y APE
Sbjct: 125 SH----RIVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMALTSVVVTLWYRAPEV 177
Query: 573 -----YASDGLFSVKSDVFSFGILLLEI 595
YA+ V D++S G + E+
Sbjct: 178 LLQSSYAT----PV--DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 43/216 (19%)
Query: 422 ATDNFSINKKLGEGGFGPVYKG-----------------TLADGQEIAHR---------- 454
+ + ++ ++LG+G FG VY+G T+ + + R
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63
Query: 455 ------NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIF-------DQTKRKLLDWSKRFC 501
++V+LLG +G+ L++ E M + L S++ + R +
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 502 IICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561
+ A G+ YL+ + +HRDL A N ++ H+ KI DFG+ R + +
Sbjct: 124 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 562 VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+ +MAPE DG+F+ SD++SFG++L EI S
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 46/148 (31%), Positives = 80/148 (54%), Gaps = 11/148 (7%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTA-RGLL 511
H+N+V++ + GEE ++ EF+ +L I QT+ ++ +C + + L
Sbjct: 77 HQNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQTRLN----EEQIATVCESVLQALC 131
Query: 512 YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAP 571
YLH +IHRD+K+ ++LL + K+SDFG D + K +VGT +MAP
Sbjct: 132 YLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAP 186
Query: 572 EYASDGLFSVKSDVFSFGILLLEIVSGK 599
E S + + D++S GI+++E+V G+
Sbjct: 187 EVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 37/217 (17%)
Query: 426 FSINKKLGEGGFGPVYKGTLADGQEIAHRNLV---------------------------- 457
F+ +K+G+G FG V+KG Q++ ++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS 517
K G ++ + +I E++ S D + LD ++ I+ +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDG 577
+ IHRD+KA+NVLL K++DFG+A +I+ VGT +MAPE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQS 176
Query: 578 LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLI 614
+ K+D++S GI +E+ G+ H K L LI
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 42/95 (44%), Positives = 55/95 (57%), Gaps = 14/95 (14%)
Query: 522 IHRDLKASNVLLDHEMNPKISDFGLARTFVGDE---IEGSTKRVVGTYGYMAPEYASDGL 578
IHRD+ A NVLL KI DFGLAR + D ++G+ + V +MAPE D +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV---KWMAPESIFDCV 290
Query: 579 FSVKSDVFSFGILLLEIVS-GKK-------NRGFY 605
++V+SDV+S+GILL EI S GK N FY
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY 325
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 23/155 (14%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLD-SFIFDQTKRKLLDWSKRFCIICGTARGLL 511
H N+VK E ++ EFM SL+ + I D+ + L D +++ I+ G A
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADE--QFLADVARQ--ILSGIA---- 182
Query: 512 YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG--DEIEGSTKRVVGTYGYM 569
YLH R I+HRD+K SN+L++ N KI+DFG++R D S VGT YM
Sbjct: 183 YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS----VGTIAYM 235
Query: 570 APEYA----SDGLFS-VKSDVFSFGILLLEIVSGK 599
+PE + G + D++S G+ +LE G+
Sbjct: 236 SPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 48/147 (32%), Positives = 75/147 (51%), Gaps = 10/147 (6%)
Query: 453 HRNLVKLLGCCIQGEEKLL-IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLL 511
H L +L CC Q ++L + EF+ L +F K + D ++ L+
Sbjct: 55 HPFLTQLY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALM 110
Query: 512 YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAP 571
+LH II+RDLK NVLLDHE + K++DFG+ + + + ST GT Y+AP
Sbjct: 111 FLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST--FCGTPDYIAP 165
Query: 572 EYASDGLFSVKSDVFSFGILLLEIVSG 598
E + L+ D ++ G+LL E++ G
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 37/217 (17%)
Query: 426 FSINKKLGEGGFGPVYKGTLADGQEIAHRNLV---------------------------- 457
F+ +++G+G FG V+KG Q++ ++
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS 517
K G ++G + +I E++ S D + D + ++ +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDG 577
+ IHRD+KA+NVLL + + K++DFG+A +I+ +T VGT +MAPE
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 176
Query: 578 LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLI 614
+ K+D++S GI +E+ G+ H + L LI
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 45/121 (37%), Positives = 66/121 (54%), Gaps = 10/121 (8%)
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMA 570
L L H L II+RDLK N+LLD E + K++DFGL++ + E GT YMA
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVEYMA 166
Query: 571 PEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKN--LNLIGHAWKLWNNGMPSQ 628
PE + + +D +SFG+L+ E+++G + F D+ + +I A KL GMP
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTG--SLPFQGKDRKETMTMILKA-KL---GMPQF 220
Query: 629 L 629
L
Sbjct: 221 L 221
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 38/204 (18%)
Query: 426 FSINKKLGEGGFGPVYKGT-LADGQEIA-------------------------------H 453
F K LG G FG VYKG + +G+++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 454 RNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYL 513
++ +LLG C+ +L I + MP L ++ + + +C+ A+G+ YL
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV--QIAKGMNYL 125
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEY 573
R++HRDL A NVL+ + KI+DFGLA+ DE E + +MA E
Sbjct: 126 EER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 574 ASDGLFSVKSDVFSFGILLLEIVS 597
+++ +SDV+S+G+ + E+++
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 52/202 (25%), Positives = 78/202 (38%), Gaps = 62/202 (30%)
Query: 422 ATDNFSINKKLGEGGFGPVYKG-TLADGQEIA---------------------------- 452
++ I KLGEG FG VYK + G+ +A
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 453 HRNLVKLLGCCI-----QGEEKLLIYEFMPNRSLD--------SFIFDQTKRKLLDWSKR 499
H N+V L+ + ++ +Y P D S +++ K
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK------- 118
Query: 500 FCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD-----E 554
C + G+ YLH I+HRD+KA+N+L+D++ KI+DFGLAR + G
Sbjct: 119 -CYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 555 IEGSTKR----VVGTYGYMAPE 572
G R +V T Y PE
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 46/204 (22%)
Query: 430 KKLGEGGFGPVYKGTLA-DGQEI----------------AHRNLV--------------- 457
K LG G FG VYKG DG+ + A++ ++
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKR----KLLDWSKRFCIICGTARGLLYL 513
+LLG C+ +L + + MP L ++ + R LL+W C+ A+G+ YL
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW----CV--QIAKGMSYL 125
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEY 573
+R++HRDL A NVL+ + KI+DFGLAR DE E +MA E
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 574 ASDGLFSVKSDVFSFGILLLEIVS 597
F+ +SDV+S+G+ + E+++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 34/92 (36%), Positives = 55/92 (59%), Gaps = 6/92 (6%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
RGL YL + +I+HRD+K SN+L++ K+ DFG++ G I+ VGT
Sbjct: 110 RGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRS 163
Query: 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
YM+PE ++V+SD++S G+ L+E+ G+
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 51/144 (35%), Positives = 75/144 (52%), Gaps = 15/144 (10%)
Query: 460 LGCCIQGEEKLL-IYEFMPNRSLDSFIFDQTKRKLLDWSKRFC---IICGTARGLLYLHH 515
L C Q +E L + E++ L I Q+ + + RF IICG L +LH
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIICG----LQFLHK 114
Query: 516 DSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYAS 575
II+RDLK NVLLD + + KI+DFG+ + + E + ST GT Y+APE
Sbjct: 115 KG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILK 169
Query: 576 DGLFSVKSDVFSFGILLLEIVSGK 599
++ D +SFG+LL E++ G+
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 1e-12
Identities = 55/203 (27%), Positives = 84/203 (41%), Gaps = 44/203 (21%)
Query: 430 KKLGEGGFGPVYKGTLADGQEI-----------------------------AHRNLVKLL 460
K+LG+G FG VY + E+ H N+VKL
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 461 GCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLR 520
+ +E ++E+M +L + D+ K K S II +GL ++H +
Sbjct: 65 EVFRENDELYFVFEYM-EGNLYQLMKDR-KGKPFSESVIRSIIYQILQGLAHIH---KHG 119
Query: 521 IIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS---TKRVVGTYGYMAPE-YASD 576
HRDLK N+L+ KI+DFGLAR EI T V T Y APE
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTD-YVSTRWYRAPEILLRS 173
Query: 577 GLFSVKSDVFSFGILLLEIVSGK 599
+S D+++ G ++ E+ + +
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 51/209 (24%)
Query: 426 FSINKKLGEGGFGPVY--KGTLADGQE------------------------------IAH 453
+ + ++LG+G FG VY K A +E + H
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 454 RNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFI--FDQTKRKL-----LDWSKRFCIICGT 506
+VK ++ + +I E+ R LD + T + L +W
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW------FIQL 115
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
G+ Y+H RI+HRDLKA N+ L + + KI DFG++R +G +T GT
Sbjct: 116 LLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTP 169
Query: 567 GYMAPEYASDGLFSVKSDVFSFGILLLEI 595
YM+PE + KSD++S G +L E+
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 37/205 (18%)
Query: 425 NFSINKKLGEGGFGPVYKG----------------------------TLADGQEIAHRNL 456
NF +KLGEG + VYKG ++ +E+ H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 457 VKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHH 515
V+L I E KL L++E+M L ++ R LD + +G+ + H
Sbjct: 61 VRLHDV-IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 516 DSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE-YA 574
+ R++HRDLK N+L++ K++DFGLAR F G + + VV T Y AP+
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAF-GIPVNTFSNEVV-TLWYRAPDVLL 173
Query: 575 SDGLFSVKSDVFSFGILLLEIVSGK 599
+S D++S G ++ E+++G+
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 51/165 (30%), Positives = 78/165 (47%), Gaps = 31/165 (18%)
Query: 455 NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLD------------------- 495
N+++LLG C+ + +I E+M N L+ F+ + L D
Sbjct: 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPPAHCLPAIS 136
Query: 496 WSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART-FVGD- 553
+S + A G+ YL S L +HRDL N L+ + KI+DFG++R + GD
Sbjct: 137 YSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY 193
Query: 554 -EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
I+G R V +MA E G F+ SDV++FG+ L EI+
Sbjct: 194 YRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 16/156 (10%)
Query: 449 QEIAHRNLVKLLGCCIQGEEK--LLIYEFMPNRSLDSFIFDQTK----RKLLDWSKRFCI 502
+ + H N+VK G C + LI EF+P+ SL ++ ++ L ++ + C
Sbjct: 61 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQIC- 119
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV 562
+G+ YL SR + +HRDL A NVL++ E KI DFGL + D+ + K
Sbjct: 120 -----KGMDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD 171
Query: 563 VGT-YGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+ + + APE F + SDV+SFG+ L E+++
Sbjct: 172 LDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 45/148 (30%), Positives = 78/148 (52%), Gaps = 11/148 (7%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIIC-GTARGLL 511
H N+V++ + G+E ++ EF+ +L I T+ ++ +C + L
Sbjct: 76 HENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMN----EEQIAAVCLAVLKALS 130
Query: 512 YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAP 571
LH +IHRD+K+ ++LL H+ K+SDFG V E+ K +VGT +MAP
Sbjct: 131 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ-VSKEVP-RRKSLVGTPYWMAP 185
Query: 572 EYASDGLFSVKSDVFSFGILLLEIVSGK 599
E S + + D++S GI+++E+V G+
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 425 NFSINKKLGEGGFGPVYKG-----------------TLADGQE---------------IA 452
N + ++LGEG FG V+ TL D + +
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKL----------LDWSKRFCI 502
H ++VK G C++G+ ++++E+M + L+ F+ + L S+ I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV 562
A G++YL + +HRDL N L+ + KI DFG++R +
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 563 VGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKK 600
+ +M PE F+ +SDV+S G++L EI + GK+
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 52/170 (30%), Positives = 76/170 (44%), Gaps = 25/170 (14%)
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE--IEGSTKRVVG 564
ARG+ +L SR + IHRDL A N+LL KI DFGLAR D + R+
Sbjct: 183 ARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 237
Query: 565 TYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS--GKKNRGFYHSDKNLNLIGHAWKLWN 622
+MAPE D +++ +SDV+SFG+LL EI S G ++ + ++
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-- 295
Query: 623 NGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672
P Y + C ++PEDRP ++ +LG
Sbjct: 296 -RAPEYATPEIYSIMLD-------------CWHNNPEDRPTFSELVEILG 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 52/214 (24%)
Query: 424 DNFSINKKLGEGGFGPVYKG-------TLA----------DG------------QEIAHR 454
D + +K+GEG +G VYK T+A +G +E+ H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 455 NLVKLLGCCIQGEEKL-LIYEFMP---NRSLDS---FIFDQTKRKLLDWSKRFCIICGTA 507
N+V+L + E++L L++E++ + +DS F + K +
Sbjct: 62 NIVRLQDV-VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ--------IL 112
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP-KISDFGLARTFVGDEIEGSTKRVVGTY 566
RG+ Y H S R++HRDLK N+L+D N K++DFGLAR F G + T VV T
Sbjct: 113 RGIAYCH--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TL 167
Query: 567 GYMAPE-YASDGLFSVKSDVFSFGILLLEIVSGK 599
Y APE +S D++S G + E+V+ K
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 2e-12
Identities = 55/164 (33%), Positives = 76/164 (46%), Gaps = 39/164 (23%)
Query: 449 QEIAHRNLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTA 507
Q I H LV L G Q + L L+ E++P L F L S RF A
Sbjct: 56 QSIRHPFLVNLYGS-FQDDSNLYLVMEYVPGGEL----FS-----HLRKSGRFPE--PVA 103
Query: 508 R--------GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559
R L YLH L I++RDLK N+LLD + KI+DFG A+ ++G T
Sbjct: 104 RFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRT 155
Query: 560 KRVVGTYGYMAPEYASDGLFSVK-----SDVFSFGILLLEIVSG 598
+ GT Y+APE + K D ++ GIL+ E+++G
Sbjct: 156 YTLCGTPEYLAPE-----IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 46/227 (20%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLAD--GQEIA----------------------------- 452
++ ++ + +GEG FG VY+G ++IA
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSK--RFCIICGTARGL 510
H ++VKL+G + ++ E P L S++ Q + LD + + TA L
Sbjct: 66 HPHIVKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTA--L 120
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMA 570
YL R +HRD+ A NVL+ K+ DFGL+R ++ DE + +MA
Sbjct: 121 AYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMA 176
Query: 571 PEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGH 616
PE + F+ SDV+ FG+ + EI+ G K + KN ++IG
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKP---FQGVKNNDVIGR 220
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 44/160 (27%), Positives = 77/160 (48%), Gaps = 21/160 (13%)
Query: 512 YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAP 571
Y+H I+HRD+K N+ L K+ DFG+++ +G E + + VVGT YM+P
Sbjct: 116 YIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI-LGSEYSMA-ETVVGTPYYMSP 170
Query: 572 EYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631
E ++ KSD+++ G +L E+++ K+ + + LNL+ K+ G + ++
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRT---FDATNPLNLV---VKIV-QGNYTPVVS 223
Query: 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
Y E L ++ +Q PE RP V+
Sbjct: 224 VYSSE---LISLVHS------LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 39/92 (42%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV-GDEIEGSTKRVVGTYG 567
GL LH R RI++RDLK N+LLD + +ISD GLA G+ I G VGT G
Sbjct: 114 GLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVG 166
Query: 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
YMAPE + ++ D + G L+ E++ GK
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 52/199 (26%), Positives = 82/199 (41%), Gaps = 41/199 (20%)
Query: 432 LGEGGFGPVYKGTLADG------------------------------QEIAHRNLVKLLG 461
LG GGFG V + +E H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 462 CCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLR 520
+ ++ + ++ E+ L + + D + +++ RF I C YLH+
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARFYIACVV-LAFEYLHN---RG 113
Query: 521 IIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFS 580
II+RDLK N+LLD K+ DFG A+ + T GT Y+APE + +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYD 170
Query: 581 VKSDVFSFGILLLEIVSGK 599
D +S GILL E+++G+
Sbjct: 171 FSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 48/166 (28%), Positives = 84/166 (50%), Gaps = 28/166 (16%)
Query: 449 QEIAHRNLVKLLGCCIQGEEK------LLIYEFMPNRSLDSFI---------FDQTKRKL 493
+E H N++KL+G ++ K ++I FM + L +F+ F + L
Sbjct: 56 KEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTL 115
Query: 494 LDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART-FVG 552
+ RF I A G+ YL S IHRDL A N +L+ M ++DFGL++ + G
Sbjct: 116 V----RFMI--DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG 166
Query: 553 DEI-EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
D +G ++ ++A E +D +++ SDV++FG+ + EI++
Sbjct: 167 DYYRQGCASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 449 QEIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTAR 508
Q I H N ++ GC ++ L+ E+ + D + +K L + I G +
Sbjct: 80 QRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQ 136
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
GL YLH + +IHRD+KA N+LL K++DFG A I VGT +
Sbjct: 137 GLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYW 187
Query: 569 MAPEY---ASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM 625
MAPE +G + K DV+S GI +E+ +K F N+N + + + N
Sbjct: 188 MAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLF-----NMNAMSALYHIAQNES 241
Query: 626 PSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
P+ + + N + C+Q P+DRP
Sbjct: 242 PTLQSNEWSDYFRNFVDS---------CLQKIPQDRP 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-12
Identities = 57/231 (24%), Positives = 107/231 (46%), Gaps = 16/231 (6%)
Query: 445 LADGQEIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIIC 504
+AD ++ H N+VKL+G C + LI+E++ ++L + + L W +R I
Sbjct: 734 IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAI 787
Query: 505 GTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVG 564
G A+ L +LH ++ +L +++D + P + L D TK +
Sbjct: 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFIS 841
Query: 565 TYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG 624
+ Y+APE + KSD++ FG++L+E+++G K+ + +++ A +++
Sbjct: 842 S-AYVAPETRETKDITEKSDIYGFGLILIELLTG-KSPADAEFGVHGSIVEWARYCYSDC 899
Query: 625 MPSQLIDA--YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673
ID S N E++ +++ L C P RPC V+ L S
Sbjct: 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 45/148 (30%), Positives = 78/148 (52%), Gaps = 11/148 (7%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIIC-GTARGLL 511
H N+V + + G+E ++ EF+ +L I T+ ++ +C R L
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMN----EEQIATVCLSVLRALS 132
Query: 512 YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAP 571
YLH+ +IHRD+K+ ++LL + K+SDFG V E+ K +VGT +MAP
Sbjct: 133 YLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQ-VSKEVP-KRKSLVGTPYWMAP 187
Query: 572 EYASDGLFSVKSDVFSFGILLLEIVSGK 599
E S + + D++S GI+++E++ G+
Sbjct: 188 EVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 10/147 (6%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLY 512
H N+V+L G +G +++ E+M N +LDSF+ + L + ++ G A G+ Y
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKY 122
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG--STKRVVGTYGYMA 570
L S + +H+ L A VL++ ++ KIS F + D+ E +T + A
Sbjct: 123 L---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE---DKSEAIYTTMSGKSPVLWAA 176
Query: 571 PEYASDGLFSVKSDVFSFGILLLEIVS 597
PE FS SDV+SFGI++ E++S
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 16/167 (9%)
Query: 451 IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSF----------IFDQTKRKL---LDWS 497
+ H ++VK G C G+ ++++E+M + L+ F + D R+ L S
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 498 KRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557
+ I A G++YL + +HRDL N L+ + KI DFG++R +
Sbjct: 124 QMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 180
Query: 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGF 604
+ +M PE F+ +SDV+SFG++L EI + K F
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 43/221 (19%)
Query: 416 LATIANATDNFSINKKLGEGGFGPVYK------GTLAD----------GQEIA------- 452
L ++ + TD + I + +G+G +G VYK G+LA +EI
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQ 73
Query: 453 ----HRNLVKLLGCCIQ-----GEEKLLIYEFMPNRSLDSFIFDQTKR-KLLDWSKRFCI 502
H N+VK G + G + L+ E S+ + + LD + I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV 562
+ G GL +LH++ RIIHRD+K +N+LL E K+ DFG++ + +T
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-- 188
Query: 563 VGTYGYMAPEYAS-----DGLFSVKSDVFSFGILLLEIVSG 598
VGT +MAPE + D + + DV+S GI +E+ G
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 73/281 (25%), Positives = 111/281 (39%), Gaps = 81/281 (28%)
Query: 430 KKLGEGGFGPVYK------GTLADGQEIA-----------------------HRNLVKLL 460
K+G G FG VY G L +EI H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 461 GCCIQGEEKLLIYEFMPNRSLDSF-----IFDQ--TKR---KLLDWSKRFCIICGTARGL 510
G + E+ + E+ +L+ I D+ + +LL GL
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLL-------------EGL 112
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR------TFVGDEIEGSTKRVVG 564
YLH I+HRD+K +N+ LDH K+ DFG A T +G+E++ + G
Sbjct: 113 AYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS----LAG 165
Query: 565 TYGYMAPEYASDGLFSVK---SDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLW 621
T YMAPE + G +D++S G ++LE+ +GK R + D ++ H
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK--RPWSELDNEFQIMFHV---- 219
Query: 622 NNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
G + D+ Q S E + C++ P+ RP
Sbjct: 220 GAGHKPPIPDS-LQLS---PEGKDFLD---RCLESDPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 4e-12
Identities = 41/99 (41%), Positives = 53/99 (53%), Gaps = 15/99 (15%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS--TKRVVGT 565
RGL YLH +IHRDLK SN+L++ + KI DFGLAR DE E T+ VV T
Sbjct: 114 RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-T 169
Query: 566 YGYMAPEYASDGLFSVKS-----DVFSFGILLLEIVSGK 599
Y APE L S D++S G + E+++ K
Sbjct: 170 RWYRAPEL----LLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 49/212 (23%)
Query: 421 NATDNFSINKKLGEGGFGPVYK------GTLADGQEI---------------------AH 453
N + + I +LG+G FG VYK G LA + I H
Sbjct: 2 NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH 61
Query: 454 RNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICG-TARGLLY 512
N+VKLL ++ EF ++D+ + + +R L + R ++C T L Y
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTEPQIR--VVCKQTLEALNY 118
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA----RTFVGDEIEGSTKRVVGTYGY 568
LH + +IIHRDLKA N+L + + K++DFG++ RT +GT +
Sbjct: 119 LHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI------QRRDSFIGTPYW 169
Query: 569 MAPEY-----ASDGLFSVKSDVFSFGILLLEI 595
MAPE + D + K+DV+S GI L+E+
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 55/217 (25%)
Query: 425 NFSINKKLGEGGFGPVYKGTLAD-GQEIA------------------------------- 452
N+ + K LG+G FG VY AD G+E+A
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 453 HRNLVKLLGCCIQGEEKLL--IYEFMPNRSLDSFIFDQ-------TKRKLLDWSKRFCII 503
H +V+ GC E+ L E MP S I DQ T+ ++++
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQIL-- 116
Query: 504 CGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS-TKRV 562
G+ YLH + I+HRD+K +N+L D N K+ DFG ++ + G+ K V
Sbjct: 117 ----EGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV 169
Query: 563 VGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
GT +M+PE S + K+D++S G ++E+++ K
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 6/92 (6%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
RGL YL + +I+HRD+K SN+L++ K+ DFG++ G I+ VGT
Sbjct: 114 RGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRS 167
Query: 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
YM+PE +SV+SD++S G+ L+E+ G+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 48/158 (30%), Positives = 74/158 (46%), Gaps = 17/158 (10%)
Query: 451 IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFI--------FDQTKRKLLDWSKRFCI 502
++ N+ +LLG C +I E+M N L+ F+ K L +S +
Sbjct: 76 LSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYM 135
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART-FVGD--EIEGST 559
A G+ YL L +HRDL N L+ KI+DFG++R + D ++G
Sbjct: 136 ATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQG-- 190
Query: 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
R +MA E G F+ KSDV++FG+ L EI++
Sbjct: 191 -RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 449 QEIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTAR 508
Q++ H N ++ GC ++ L+ E+ + D + +K L + + G +
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQ 126
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
GL YLH + +IHRD+KA N+LL K+ DFG A I VGT +
Sbjct: 127 GLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYW 177
Query: 569 MAPEY---ASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM 625
MAPE +G + K DV+S GI +E+ ++ + N+N + + + N
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLF----NMNAMSALYHIAQNES 231
Query: 626 PSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
P+ + + N + C+Q P+DRP
Sbjct: 232 PALQSGHWSEYFRNFVDS---------CLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 40/203 (19%)
Query: 431 KLGEGGFGPVYKGT--------------LADGQEIAHRN----------------LVKLL 460
+LG G FG V KG L + E + R+ +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 461 GCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLR 520
G C + E +L+ E L+ F+ K+ + S ++ + G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 521 IIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY--GYMAPEYASDGL 578
+HRDL A NVLL ++ KISDFGL++ D+ R G + + APE +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECINFRK 174
Query: 579 FSVKSDVFSFGILLLEIVS-GKK 600
FS +SDV+S+GI + E S G+K
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 39/92 (42%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST-KRVVGTYG 567
GL LH + RI++RDLK N+LLD + +ISD GLA EG T K VGT G
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP----EGQTIKGRVGTVG 166
Query: 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
YMAPE + ++ D ++ G LL E+++G+
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 35/93 (37%), Positives = 55/93 (59%), Gaps = 5/93 (5%)
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
A GL +LH II+RDLK NV+LD E + KI+DFG+ + + +T+ GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTP 165
Query: 567 GYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
Y+APE + + D ++FG+LL E+++G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 40/91 (43%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
ARG+ +L + +HRDL A NVLL KI DFGLAR + D S
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 567 GYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+MAPE D L++ SDV+S+GILL EI S
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 425 NFSINKKLGEGGFGPVYKGTLAD-GQEIA------------------------------- 452
N+ + K LG G FG VY AD G+E+A
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 453 HRNLVKLLGCCIQGEEKLL--IYEFMPNRSLDSFIFDQTKRK---LLDWSKRFCIICGTA 507
H +V+ GC EEK L E+MP S I DQ K + ++R+
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTR--QIL 116
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS-TKRVVGTY 566
+G+ YLH + I+HRD+K +N+L D N K+ DFG ++ + G+ K V GT
Sbjct: 117 QGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 567 GYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+M+PE S + K+DV+S ++E+++ K
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 37/93 (39%), Positives = 57/93 (61%), Gaps = 5/93 (5%)
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
A GL +LH II+RDLK NV+LD E + KI+DFG+ + + D + +TK GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTP 165
Query: 567 GYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
Y+APE + + D ++FG+LL E+++G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 48/154 (31%), Positives = 77/154 (50%), Gaps = 17/154 (11%)
Query: 455 NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFI--------FDQTKRKLLDWSKRFCIICGT 506
N+++LL CI + +I E+M N L+ F+ ++ + +S +
Sbjct: 80 NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQI 139
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART-FVGD--EIEGSTKRVV 563
A G+ YL S L +HRDL N L+ KI+DFG++R + GD I+G R V
Sbjct: 140 ASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG---RAV 193
Query: 564 GTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+M+ E G F+ SDV++FG+ L EI++
Sbjct: 194 LPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 34/91 (37%), Positives = 53/91 (58%), Gaps = 6/91 (6%)
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
G+L+LH + I++RD+K NVLLD + N ++SD GLA + + + GT GY
Sbjct: 107 GILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGY 160
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
MAPE + +S D F+ G + E+V+G+
Sbjct: 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 61/224 (27%), Positives = 93/224 (41%), Gaps = 48/224 (21%)
Query: 415 ELATIANATDNFSINKKLGEGGFGPVYKG----------------TLADGQEIA------ 452
+L+ + + F + + +G G +G VYKG T + +EI
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66
Query: 453 -----HRNLVKLLGCCI------QGEEKLLIYEFMPNRSLDSFIFDQTKRKLL--DWSKR 499
HRN+ G I ++ L+ EF S+ + TK L DW
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV-KNTKGNALKEDWIAY 125
Query: 500 FCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559
C RGL +LH ++IHRD+K NVLL K+ DFG++ D G
Sbjct: 126 ICR--EILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRR 178
Query: 560 KRVVGTYGYMAPEYAS-----DGLFSVKSDVFSFGILLLEIVSG 598
+GT +MAPE + D + +SD++S GI +E+ G
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 30/217 (13%)
Query: 449 QEIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTAR 508
Q++ H N ++ GC ++ L+ E+ + D + +K L + I G +
Sbjct: 76 QQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQ 132
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
GL YLH + +IHRD+KA N+LL K++DFG A VGT +
Sbjct: 133 GLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYW 183
Query: 569 MAPEY---ASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM 625
MAPE +G + K DV+S GI +E+ +K F N+N + + + N
Sbjct: 184 MAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLF-----NMNAMSALYHIAQNDS 237
Query: 626 PSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
P+ + + + C+Q P++RP
Sbjct: 238 PTLQSNEWTDSFRGFVD---------YCLQKIPQERP 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 41/93 (44%), Positives = 55/93 (59%), Gaps = 7/93 (7%)
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE--IEGSTKRVVG 564
ARG+ +L SR + IHRDL A N+LL KI DFGLAR D + + R+
Sbjct: 184 ARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL-- 238
Query: 565 TYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+MAPE D +++ +SDV+SFG+LL EI S
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 35/91 (38%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
+L L H +L II+RD+K N+LLD E + ++DFGL++ F+ +E E GT YM
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 570 APEY--ASDGLFSVKSDVFSFGILLLEIVSG 598
APE G D +S G+L E+++G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 63/229 (27%), Positives = 92/229 (40%), Gaps = 48/229 (20%)
Query: 426 FSINKKLGEGGFGPVYKGTLADGQEIA---------------------------HRNLVK 458
F + + +G G +G VYKG ++A HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 459 LLGCCIQ------GEEKLLIYEFMPNRSLDSFIFDQTKRKLL--DWSKRFCIICGTARGL 510
G I+ ++ L+ EF S+ I TK L +W C RGL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICR--EILRGL 124
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMA 570
+LH ++IHRD+K NVLL K+ DFG++ D G +GT +MA
Sbjct: 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMA 179
Query: 571 PEYAS-----DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLI 614
PE + D + KSD++S GI +E+ G H + L LI
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 36/90 (40%), Positives = 54/90 (60%), Gaps = 2/90 (2%)
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
+L L H +L I++RD+K N+LLD E + ++DFGL++ F+ +E E T GT YM
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYM 173
Query: 570 APEYA-SDGLFSVKSDVFSFGILLLEIVSG 598
APE G D +S GIL+ E+++G
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 38/103 (36%), Positives = 56/103 (54%), Gaps = 6/103 (5%)
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
+L L H +++RDLK +N+LLD + +ISD GLA F + S VGT+GYM
Sbjct: 107 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYM 162
Query: 570 APEYASDGL-FSVKSDVFSFGILLLEIVSGKK-NRGFYHSDKN 610
APE G+ + +D FS G +L +++ G R DK+
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 50/175 (28%), Positives = 85/175 (48%), Gaps = 15/175 (8%)
Query: 427 SINKKLGEGGFGPVYKGTLADGQEIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIF 486
+I + G F + LA G + H +V+LLG C G L+ + P SL +
Sbjct: 43 TIQDRSGRQTFQEITDHMLAMGS-LDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVR 100
Query: 487 DQ----TKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKIS 542
++LL+W C+ A+G+ YL R++HR+L A N+LL + +I+
Sbjct: 101 QHRDSLDPQRLLNW----CV--QIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIA 151
Query: 543 DFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
DFG+A D+ + +MA E G ++ +SDV+S+G+ + E++S
Sbjct: 152 DFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 58/207 (28%), Positives = 82/207 (39%), Gaps = 49/207 (23%)
Query: 426 FSINKKLGEGGFGPVY-----------------KGTLADGQEIAH-------------RN 455
F I ++G+GG+G V+ K L E+ H
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 456 LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCI---ICGTARGLL 511
LVKLL Q +E L L E++P + + L + RF +
Sbjct: 63 LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDA--- 116
Query: 512 YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAP 571
LH L IHRDLK N L+D + K++DFGL++ V S VVG+ YMAP
Sbjct: 117 -LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV--TYANS---VVGSPDYMAP 167
Query: 572 EYASDGLFSVKSDVFSFGILLLEIVSG 598
E + D +S G +L E + G
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 35/91 (38%), Positives = 54/91 (59%), Gaps = 3/91 (3%)
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
+L L H +L II+RD+K N+LLD + ++DFGL++ F DE+E + GT YM
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYM 173
Query: 570 APEY--ASDGLFSVKSDVFSFGILLLEIVSG 598
AP+ DG D +S G+L+ E+++G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 54/179 (30%), Positives = 86/179 (48%), Gaps = 27/179 (15%)
Query: 490 KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549
+ ++++W F I A L YLH I+HRDLK NV L K+ D G+AR
Sbjct: 101 ENQVVEW---FVQI---AMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARV 151
Query: 550 FVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDK 609
ST ++GT YM+PE S+ ++ KSDV++ G + E+ + K F D
Sbjct: 152 LENQCDMAST--LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK--HAFNAKDM 207
Query: 610 NLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVI 668
N +L+ +++ +P + Y E L E+I +L + PE RP + S++
Sbjct: 208 N-SLV---YRIIEGKLP-PMPKDYSPE---LGELIA----TMLSKR--PEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 43/109 (39%), Positives = 60/109 (55%), Gaps = 7/109 (6%)
Query: 491 RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550
+K+L C A+G+ +L SR + IHRDL A N+LL KI DFGLAR
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDI 229
Query: 551 VGDE--IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
D + R+ +MAPE D +++++SDV+SFG+LL EI S
Sbjct: 230 YKDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 36/93 (38%), Positives = 54/93 (58%), Gaps = 6/93 (6%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
G+ +LH + I+HRDLK SN+LL++ KI DFGLAR + G ++ T+ VV T
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVV-TLW 171
Query: 568 YMAPE-YASDGLFSVKSDVFSFGILLLEIVSGK 599
Y APE +S D++S G + E+++ K
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 34/92 (36%), Positives = 55/92 (59%), Gaps = 6/92 (6%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
+GL YL + +I+HRD+K SN+L++ K+ DFG++ G I+ VGT
Sbjct: 114 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRS 167
Query: 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
YM+PE +SV+SD++S G+ L+E+ G+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 53/228 (23%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 449 QEIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSL-DSFIFDQTKRKLLDWSKRFCIICGTA 507
+++ H N+V+ ++ + ++ + + L + F + K++ + + I
Sbjct: 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
L YLH + R I+HRDL +N++L + I+DFGLA+ + E VVGT
Sbjct: 124 LALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQ---KQPESKLTSVVGTIL 178
Query: 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627
Y PE + + K+DV++FG +L ++ + FY + N++ + +
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYST----NML---------SLAT 223
Query: 628 QLIDAYYQESCNLAEVIRCIHVGLL---CVQHHPEDRPCMPSVILMLG 672
++++A Y+ L E + V + C+ E RP + V M+
Sbjct: 224 KIVEAVYEP---LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 38/172 (22%)
Query: 450 EIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRF------CII 503
EI H N++ L+ ++G+ L+ + M +K++D R CI+
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIM----------ASDLKKVVDRKIRLTESQVKCIL 125
Query: 504 CGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS----- 558
GL LH +HRDL +N+ ++ + KI+DFGLAR + +
Sbjct: 126 LQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 559 --------TKRVVGTYGYMAPEY---ASDGLFSVKSDVFSFGILLLEIVSGK 599
T +VV T Y APE A F+V D++S G + E+++GK
Sbjct: 183 TMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 52/157 (33%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 449 QEIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTAR 508
Q++ + +V+++G C + E +L+ E L+ F+ K K + ++ +
Sbjct: 51 QQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSM 106
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE----IEGSTKRVVG 564
G+ YL + +HRDL A NVLL + KISDFGL++ DE + K V
Sbjct: 107 GMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK 163
Query: 565 TYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKK 600
Y APE + FS KSDV+SFG+L+ E S G+K
Sbjct: 164 WY---APECMNYYKFSSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 36/99 (36%), Positives = 54/99 (54%), Gaps = 12/99 (12%)
Query: 502 IICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA-RTFVGDEIEGSTK 560
I+CG L R ++RDLK N+LLD + +ISD GLA + G+ I G
Sbjct: 111 ILCG-------LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR-- 161
Query: 561 RVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
VGT GYMAPE ++ +++ D + G L+ E++ G+
Sbjct: 162 --VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 9e-11
Identities = 36/79 (45%), Positives = 49/79 (62%), Gaps = 6/79 (7%)
Query: 522 IHRDLKASNVLLDHEMNPKISDFGLARTFVGDE---IEGSTKRVVGTYGYMAPEYASDGL 578
IHRDL A N+LL H KI DFGLAR D ++G+ + V +MAPE + +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV---KWMAPESIFNCV 292
Query: 579 FSVKSDVFSFGILLLEIVS 597
++ +SDV+S+GILL EI S
Sbjct: 293 YTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 37/99 (37%), Positives = 50/99 (50%), Gaps = 17/99 (17%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
RGL YLH I+HRD+K N+L++ KI DFGLAR DE + T+ VV Y
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 568 YMAPE-------YASDGLFSVKSDVFSFGILLLEIVSGK 599
Y APE Y S D++S G + E++ +
Sbjct: 170 YRAPEILMGSRHYTS------AVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 37/227 (16%)
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
LL +HH +IHRD+K++N+LL K+ DFG ++ + + + GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629
APE +S K+D+FS G+LL E+++ K R F +N+ + M L
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLK--RPF--DGENMEEV----------MHKTL 258
Query: 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPC------MPSVILMLGSEIMLPQPKQP 683
Y +++ ++ I LL P+ RP MP L + + + Q QP
Sbjct: 259 AGRYDPLPPSISPEMQEIVTALLSSD--PKRRPSSSKLLNMPICKLFISGLLEIVQ-TQP 315
Query: 684 GFLADRKSTGPN--------------SSSSMLESSSTNTITISTLEG 716
GF + T +E S + + + LEG
Sbjct: 316 GFSGPLRDTISRQIQQTKQLLQVERRRIVRQMEESLSTAASTTILEG 362
|
Length = 496 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 29/164 (17%)
Query: 449 QEIAHRNLVKLLGCCI-QGEEKLLIY-EFMPNRS----------LDSFIFDQTKRKLLDW 496
+ + H +V+ GC + E+ L I+ E+MP S L + + R++L+
Sbjct: 59 KNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE- 117
Query: 497 SKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556
G+ YLH + I+HRD+K +N+L D N K+ DFG ++ +
Sbjct: 118 ------------GMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162
Query: 557 GSTKR-VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
G+ R V GT +M+PE S + K+DV+S G ++E+++ K
Sbjct: 163 GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 31/83 (37%), Positives = 49/83 (59%), Gaps = 7/83 (8%)
Query: 521 IIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEY----ASD 576
+IHRD+K SN+LLD N K+ DFG++ V + + R G YMAPE +
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK---AKTRSAGCAAYMAPERIDPPDPN 192
Query: 577 GLFSVKSDVFSFGILLLEIVSGK 599
+ +++DV+S GI L+E+ +G+
Sbjct: 193 PKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 35/93 (37%), Positives = 58/93 (62%), Gaps = 5/93 (5%)
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
+ GL +LH R II+RDLK NV+LD E + KI+DFG+ + + D + +T+ GT
Sbjct: 111 SVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTP 165
Query: 567 GYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
Y+APE + + D +++G+LL E+++G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 29/67 (43%), Positives = 40/67 (59%), Gaps = 7/67 (10%)
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS---TKRVVGT 565
GL Y+H R +I+HRD+KA+N+L+ + K++DFGLAR F + T RVV T
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186
Query: 566 YGYMAPE 572
Y PE
Sbjct: 187 LWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
+L L H +++RDLK +N+LLD + +ISD GLA F + S VGT+GYM
Sbjct: 107 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYM 162
Query: 570 APEYASDGL-FSVKSDVFSFGILLLEIVSG 598
APE G + +D FS G +L +++ G
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 43/156 (27%), Positives = 68/156 (43%), Gaps = 14/156 (8%)
Query: 450 EIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFC--IICGTA 507
E+ H N+++ LG CI+ LL+ EF P L +++ K + C A
Sbjct: 51 ELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVA 110
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART-FVGDEIEGSTKRVVGTY 566
GLL+LH + IH DL N L +++ KI D+GLA + D V
Sbjct: 111 SGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PL 166
Query: 567 GYMAPEYAS---DGLFSVK----SDVFSFGILLLEI 595
++APE L S+++S G+ + E+
Sbjct: 167 RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 49/143 (34%), Positives = 73/143 (51%), Gaps = 13/143 (9%)
Query: 460 LGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
L C Q E +L + EF+ L Q +RKL + RF +A L L+
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFY----SAEISLALNFLHE 114
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEY--ASD 576
II+RDLK NVLLD E + K++D+G+ + + ST GT Y+APE D
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST--FCGTPNYIAPEILRGED 172
Query: 577 GLFSVKSDVFSFGILLLEIVSGK 599
FSV D ++ G+L+ E+++G+
Sbjct: 173 YGFSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 40/107 (37%), Positives = 59/107 (55%), Gaps = 12/107 (11%)
Query: 502 IICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561
I+CG L +LH II+RDLK NV+LD + + KI+DFG+ + V + ST
Sbjct: 105 IVCG----LQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-- 155
Query: 562 VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSD 608
GT Y+APE ++ D +SFG+LL E++ G+ +H D
Sbjct: 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP---FHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 35/83 (42%), Positives = 49/83 (59%), Gaps = 5/83 (6%)
Query: 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR-VVGTYGYMAPEYASD 576
R RI++RDLK N+LLD + +ISD GLA EG T R VGT GYMAPE ++
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQIP----EGETVRGRVGTVGYMAPEVINN 175
Query: 577 GLFSVKSDVFSFGILLLEIVSGK 599
++ D + G L+ E++ G+
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 44/129 (34%), Positives = 65/129 (50%), Gaps = 14/129 (10%)
Query: 471 LIYEFMPNRSLDSFIFDQTKRKL-LDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKAS 529
L+ E++ S I +T L DW+K++ I G+ LH IIHRD+K
Sbjct: 74 LVMEYLNGGDCASLI--KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---IIHRDIKPE 126
Query: 530 NVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFG 589
N+L+D + K++DFGL+R G E K+ VGT Y+APE SD +S G
Sbjct: 127 NLLIDQTGHLKLTDFGLSR--NGLE----NKKFVGTPDYLAPETILGVGDDKMSDWWSLG 180
Query: 590 ILLLEIVSG 598
++ E + G
Sbjct: 181 CVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 43/155 (27%), Positives = 79/155 (50%), Gaps = 21/155 (13%)
Query: 450 EIAHRNLVKLLGCCIQGEEKLL--IYEFMPNRSLDSFIFDQTKRKLLDWSKRFC---IIC 504
E++H +++L + +++ L + E++P L S++ + + + + F I+C
Sbjct: 57 EVSHPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVC 112
Query: 505 GTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVG 564
L YLH I++RDLK N+LLD E + K++DFG A+ ++ T + G
Sbjct: 113 A----LEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCG 160
Query: 565 TYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
T Y+APE + D ++ GIL+ E++ G
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 40/132 (30%), Positives = 64/132 (48%), Gaps = 12/132 (9%)
Query: 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL 533
E+M SLD + + I +GL +L + IIHRD+K +NVL+
Sbjct: 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLV 136
Query: 534 DHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDG------LFSVKSDVFS 587
+ K+ DFG++ G+ + K +G YMAPE G ++V+SDV+S
Sbjct: 137 NGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWS 192
Query: 588 FGILLLEIVSGK 599
G+ +LE+ G+
Sbjct: 193 LGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 24/181 (13%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSF------IFDQTKRKLLDWSKRFCIICGT 506
H NLV L+ + + L++EF+ + LD + + RK L F I+
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL-----FQIL--- 110
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
RG+ + H + IIHRD+K N+L+ K+ DFG ART E T V T
Sbjct: 111 -RGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD-YVATR 164
Query: 567 GYMAPEY-ASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM 625
Y APE D + D+++ G L+ E+++G+ + D +++ + H K N +
Sbjct: 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP---LFPGDSDIDQLYHIIKCLGNLI 221
Query: 626 P 626
P
Sbjct: 222 P 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
RGL Y+H + ++HRDLK SN+LL+ + KI DFGLART E V T
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVTRW 173
Query: 568 YMAPEY---ASDGLFSVKSDVFSFGILLLEIVSGK 599
Y APE S+ ++ DV+S G + E++ K
Sbjct: 174 YRAPELLLNCSE--YTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 55/220 (25%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-----------------------------HR 454
D F I ++GEG +G VYK D E+ HR
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66
Query: 455 NLVKLLGCCIQGEEKL----------LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIIC 504
N+V L ++ L L++E+M D + + L+ +S+ I
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDH--IK 119
Query: 505 GTAR----GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTK 560
+ GL Y H + L HRD+K SN+LL+++ K++DFGLAR + +E T
Sbjct: 120 SFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176
Query: 561 RVVGTYGYMAPE-YASDGLFSVKSDVFSFGILLLEIVSGK 599
+V+ T Y PE + + DV+S G +L E+ + K
Sbjct: 177 KVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST-KRVVGTY 566
RGL Y+H + ++HRDLK SN+LL+ + KI DFGLAR + V T
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 567 GYMAPEYA-SDGLFSVKSDVFSFGILLLEIVSGK 599
Y APE + ++ D++S G +L E++S +
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 38/99 (38%), Positives = 56/99 (56%), Gaps = 11/99 (11%)
Query: 502 IICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR-TFVGDEIEGSTK 560
IICG L +LH I++RDLK N+LLD + + KI+DFG+ + +GD T
Sbjct: 105 IICG----LQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTC 154
Query: 561 RVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
GT Y+APE ++ D +SFG+LL E++ G+
Sbjct: 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 49/166 (29%), Positives = 75/166 (45%), Gaps = 40/166 (24%)
Query: 451 IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSF--------IFD----QTKRKLLDWSK 498
+ H+N++ LL F P +SL+ F + D Q + LD +
Sbjct: 72 VNHKNIIGLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD-HE 118
Query: 499 R-----FCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553
R + ++CG + +LH IIHRDLK SN+++ + KI DFGLART
Sbjct: 119 RMSYLLYQMLCG----IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171
Query: 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+ T VV Y Y APE + D++S G ++ E++ G
Sbjct: 172 FM--MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 41/110 (37%), Positives = 62/110 (56%), Gaps = 10/110 (9%)
Query: 491 RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550
+KL D +F +I RGL Y+H IIHRDLK SN+ ++ + KI DFGLAR
Sbjct: 115 QKLTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-H 169
Query: 551 VGDEIEGSTKRVVGTYGYMAPEYASDGL-FSVKSDVFSFGILLLEIVSGK 599
DE+ G V T Y APE + + ++ D++S G ++ E+++G+
Sbjct: 170 TDDEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 44/141 (31%), Positives = 76/141 (53%), Gaps = 9/141 (6%)
Query: 460 LGCCIQGEEKLL-IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
L CC Q +++L + E++ L I Q RK + RF T L++LH R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTL-ALMFLH---R 114
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL 578
+I+RDLK N+LLD E + K++DFG+ + + + + +T GT Y+APE +
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT--FCGTPDYIAPEILQELE 172
Query: 579 FSVKSDVFSFGILLLEIVSGK 599
+ D ++ G+L+ E+++G+
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 34/204 (16%)
Query: 425 NFSINKKLGEGGFGPVYKGTLADGQEIAHRNLVK---LLGCCIQGEE----KLLIYEFMP 477
+ I KK+GEG FG +Y LA + + ++K L ++ +E ++++ M
Sbjct: 1 RYEIIKKIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK 57
Query: 478 NRSLDSFI--FDQTKRKLL--------DWSKRFC-----------IICGTARGLLYLHHD 516
+ ++ +F F + R + D KR I+ + L L H
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI 117
Query: 517 SRLRIIHRDLKASNVLLDHE-MNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYAS 575
+I+HRD+K+ N+ L M K+ DFG+AR + D +E + VGT Y++PE
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDSMELA-YTCVGTPYYLSPEICQ 175
Query: 576 DGLFSVKSDVFSFGILLLEIVSGK 599
+ ++ K+D++S G +L E+ + K
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 34/76 (44%), Positives = 43/76 (56%)
Query: 522 IHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSV 581
+HRDL A NVL+ KI DFGLAR + D S +MAPE + L++
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 582 KSDVFSFGILLLEIVS 597
SDV+SFGILL EI +
Sbjct: 321 LSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 45/141 (31%), Positives = 70/141 (49%), Gaps = 9/141 (6%)
Query: 460 LGCCIQGEEKLL-IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
L C Q E +L + E++ D Q +RKL + RF + L YLH
Sbjct: 61 LHSCFQTESRLFFVIEYV--NGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLHERG- 116
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL 578
II+RDLK NVLLD E + K++D+G+ + G +T GT Y+APE
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 579 FSVKSDVFSFGILLLEIVSGK 599
+ D ++ G+L+ E+++G+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 19/146 (13%)
Query: 460 LGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF-----CIICGTARGLLYL 513
L C Q +L L+ E++ D Q +RKL + RF CI L +L
Sbjct: 61 LHSCFQTTSRLFLVIEYV--NGGDLMFHMQRQRKLPEEHARFYAAEICI------ALNFL 112
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEY 573
H II+RDLK NVLLD + + K++D+G+ + +G +T GT Y+APE
Sbjct: 113 HERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNYIAPEI 167
Query: 574 ASDGLFSVKSDVFSFGILLLEIVSGK 599
+ D ++ G+L+ E+++G+
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 46/212 (21%), Positives = 75/212 (35%), Gaps = 93/212 (43%)
Query: 426 FSINKKLGEGGFGPVYKGTLADGQ--------------------------------EIAH 453
+ I +G G +G VYK +G+ E+ H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 454 RNLVKLLGCCIQGEEKL--LIYEF-------------------MPNRSLDSFIFDQTKRK 492
N+V L+ ++ +K L++++ +P + S ++ +
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW-----Q 116
Query: 493 LLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP----KISDFGLAR 548
+L+ G+ YLH + ++HRDLK +N+L+ E KI D GLAR
Sbjct: 117 ILN-------------GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
Query: 549 TFV--------GDEIEGSTKRVVGTYGYMAPE 572
F D VV T Y APE
Sbjct: 161 LFNAPLKPLADLD-------PVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 12/115 (10%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF--VGDEIEGSTKRVVGT 565
GL Y+H + ++HRDLK N+L++ + KI DFGLAR F E G V T
Sbjct: 116 CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 566 YGYMAPEYA-SDGLFSVKSDVFSFGILLLEIVSGK---KNRGFYHSDKNLNLIGH 616
Y APE S ++ DV+S G +L E++ K K + + LN I
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQ 224
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 34/90 (37%), Positives = 53/90 (58%), Gaps = 5/90 (5%)
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
GL YLH + +I++RDLK N+LLD E KI+DFGL + +G ST GT +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST--FCGTPEF 167
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVSG 598
+APE ++ ++ D + G+L+ E++ G
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 38/151 (25%), Positives = 62/151 (41%), Gaps = 8/151 (5%)
Query: 449 QEIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTAR 508
+++ H N+V L + L++E++ L+ + L I +
Sbjct: 55 RQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQ 111
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
+ Y H IIHRD+K N+L+ K+ DFG AR T V T Y
Sbjct: 112 AIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWY 167
Query: 569 MAPE-YASDGLFSVKSDVFSFGILLLEIVSG 598
APE D + DV++ G ++ E++ G
Sbjct: 168 RAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 8e-09
Identities = 35/110 (31%), Positives = 61/110 (55%), Gaps = 11/110 (10%)
Query: 490 KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549
+ ++LDW F IC L L H +I+HRD+K+ N+ L + K+ DFG+AR
Sbjct: 100 EDQILDW---FVQIC------LALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARV 150
Query: 550 FVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+ +E + +GT Y++PE + ++ KSD+++ G +L E+ + K
Sbjct: 151 -LNSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 7/99 (7%)
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
L YLH +++RD+K N++LD + + KI+DFGL + + D + K GT Y+
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYL 162
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSD 608
APE D + D + G+++ E++ G+ FY+ D
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 36/101 (35%), Positives = 57/101 (56%), Gaps = 8/101 (7%)
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST-KRVVGTYG 567
L YLH S +++RDLK N++LD + + KI+DFGL + + D G+T K GT
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD---GATMKTFCGTPE 161
Query: 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSD 608
Y+APE D + D + G+++ E++ G+ FY+ D
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS-TKRVVGTYGY 568
L L H + II+RDLK N+LLD + + K++DFGL + + EG+ T GT Y
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI---HEGTVTHTFCGTIEY 166
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVSG 598
MAPE D +S G L+ ++++G
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 75/238 (31%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQEIAH----RN------- 455
D+F + K +G G FG V+ K + +IAH R+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 456 --LVKLLGCCIQGEEKL-LIYEFMPNRSL-----DSFIFDQTKRKLLDWSKRFCIICGTA 507
+VKL Q EE L L+ E+MP L +F + + ++ + A
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETARFY-----IA 108
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA--------RTFVGDEIEGST 559
+L L +L IHRD+K N+L+D + + K++DFGL R + ++
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 560 KR-------------------VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSG 598
R VGT Y+APE + ++ D +S G++L E++ G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 7/101 (6%)
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
L YLH +++RDLK N++LD + + KI+DFGL + + D + K GT Y+
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYL 162
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKN 610
APE D + D + G+++ E++ G+ FY+ D
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 40/115 (34%), Positives = 57/115 (49%), Gaps = 6/115 (5%)
Query: 484 FIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISD 543
F Q +R L+ RF A + YLH L II+RDLK N+LLD + + ++D
Sbjct: 84 FFHLQRERCFLEPRARF-YAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTD 139
Query: 544 FGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSG 598
FGL + G E E +T GT Y+APE + D + G +L E++ G
Sbjct: 140 FGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 34/100 (34%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
L YLH +I++RDLK N++LD + + KI+DFGL + + D + K GT Y
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGTPEY 161
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSD 608
+APE D + D + G+++ E++ G+ FY+ D
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
RGL Y+H IIHRDLK SNV ++ + +I DFGLAR DE+ G V T
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRW 180
Query: 568 YMAPEYASDGL-FSVKSDVFSFGILLLEIVSGK 599
Y APE + + ++ D++S G ++ E++ GK
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
RGL Y+H ++HRDLK SN+L++ + KI DFGLAR + V T
Sbjct: 119 RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRY 170
Query: 568 YMAPEYA-SDGLFSVKSDVFSFGILLLEIVSGK 599
Y APE + + V+ D++S G + E++ GK
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 34/121 (28%), Positives = 60/121 (49%), Gaps = 11/121 (9%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
RGL +LH R++HRDLK N+L+ K++DFGLAR + + + VV T
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLW 174
Query: 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627
Y APE ++ D++S G + E+ + + + +++ +G + G+P
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSSDVDQLGKILDVI--GLPG 229
Query: 628 Q 628
+
Sbjct: 230 E 230
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 2/93 (2%)
Query: 506 TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT 565
TA L L + + +I+RDLK N+LLD++ + + DFGL + + D + T GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGT 156
Query: 566 YGYMAPEYASDGLFSVKSDVFSFGILLLEIVSG 598
Y+APE ++ D ++ G+LL E+++G
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 45/203 (22%)
Query: 430 KKLGEGGFGPVYKG-TLADGQEIA---------------------------HRNLVKLLG 461
+KLGEG + VYKG + +GQ +A H N+V LL
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLH 69
Query: 462 CCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLR 520
I +E L ++E+M + L ++ Q L ++ R + RGL Y+H
Sbjct: 70 DIIHTKETLTFVFEYM-HTDLAQYMI-QHPGGLHPYNVRLFMF-QLLRGLAYIHGQ---H 123
Query: 521 IIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST-KRVVGTYGYMAPEY---ASD 576
I+HRDLK N+L+ + K++DFGLAR I T V T Y P+ A+D
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARA---KSIPSQTYSSEVVTLWYRPPDVLLGATD 180
Query: 577 GLFSVKSDVFSFGILLLEIVSGK 599
+S D++ G + +E++ G+
Sbjct: 181 --YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 39/229 (17%)
Query: 450 EIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARG 509
+++H++LV G C+ G+E +++ E++ SLD+++ + W A+
Sbjct: 55 QLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLE------VAKQ 108
Query: 510 LLY-LHHDSRLRIIHRDLKASNVLLDHEM-----NP---KISDFGLARTFVGDEIEGSTK 560
L + LH + H ++ A NVLL E NP K+SD G++ T + EI +
Sbjct: 109 LAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI--LLE 166
Query: 561 RVVGTYGYMAPEYASDGL-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWK 619
R+ ++ PE + S+ +D +SFG L EI SG DK L+ + K
Sbjct: 167 RI----PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG--------GDKPLSALDSQKK 214
Query: 620 LWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVI 668
L QL + E LA +I C+ + P+ RP ++I
Sbjct: 215 LQFYEDRHQLPAPKWTE---LANLINQ------CMDYEPDFRPSFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 38/205 (18%)
Query: 421 NATDNFSINKKLGEGGFGPVYKGTLADGQEIA---------------------------H 453
N ++F + +++G G +G VYK + E+A H
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 454 RNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYL 513
N+V G ++ ++ + EF SL I+ T L S+ + T +GL YL
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQGLYYL 122
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEY 573
H + +HRD+K +N+LL + K++DFG++ K +GT +MAPE
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEV 177
Query: 574 AS---DGLFSVKSDVFSFGILLLEI 595
A+ G ++ D+++ GI +E+
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 34/92 (36%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
A L YLH L II+RDLK N+LLD + + ++DFGL + G E +T GT
Sbjct: 106 ASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTP 160
Query: 567 GYMAPEYASDGLFSVKSDVFSFGILLLEIVSG 598
Y+APE + D + G +L E++ G
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 40/206 (19%)
Query: 421 NATDNFSINKKLGEGGFGPVYK------GTLAD---------------GQEI------AH 453
N ++ + +++G G +G VYK G LA QEI H
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKH 65
Query: 454 RNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIIC-GTARGLLY 512
N+V G + E+ + E+ SL L + +C T +GL Y
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL----QIAYVCRETLQGLAY 121
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE 572
LH ++ HRD+K +N+LL + K++DFG+A K +GT +MAPE
Sbjct: 122 LHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMAPE 176
Query: 573 YAS---DGLFSVKSDVFSFGILLLEI 595
A+ +G ++ D+++ GI +E+
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 31/87 (35%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 512 YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAP 571
YLH II+RDLK N+LLD++ + K++DFG A+ ++ T + GT Y+AP
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184
Query: 572 EYASDGLFSVKSDVFSFGILLLEIVSG 598
E D ++ G+LL E ++G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 19/159 (11%)
Query: 452 AHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSF--------IFD----QTKRKLLDWSKR 499
A+R LV LL C L+ F P +SL+ F + D Q LD +
Sbjct: 67 AYRELV-LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERM 125
Query: 500 FCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559
++ G+ +LH IIHRDLK SN+++ + KI DFGLART + + T
Sbjct: 126 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MT 180
Query: 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSG 598
VV Y Y APE + D++S G ++ E+V G
Sbjct: 181 PYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 53/207 (25%), Positives = 85/207 (41%), Gaps = 56/207 (27%)
Query: 431 KLGEGGFGPVYKGTLADGQEIA-----------------------------HRNLVKLLG 461
K+GEG +G V+K + EI H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 462 CCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTA--------RGLLY 512
+ ++KL L++E+ DQ +K D S I +GL +
Sbjct: 67 V-LHSDKKLTLVFEYC----------DQDLKKYFD-SCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE 572
H ++HRDLK N+L++ K++DFGLAR F G + + VV T Y P+
Sbjct: 115 CHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPD 169
Query: 573 YASDG-LFSVKSDVFSFGILLLEIVSG 598
L+S D++S G + E+ +
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST--KRVVGT 565
RGL Y+H + +IHRDLK SN+L++ + +I DFG+AR E V T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 566 YGYMAPEYA-SDGLFSVKSDVFSFGILLLEIV 596
Y APE S ++ D++S G + E++
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 33/111 (29%), Positives = 52/111 (46%), Gaps = 11/111 (9%)
Query: 489 TKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548
+ +L W + C L + H R++HRD+K+ N+ L K+ DFG AR
Sbjct: 98 PEDTILQWFVQMC---------LGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148
Query: 549 TFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
T VGT Y+ PE + ++ KSD++S G +L E+ + K
Sbjct: 149 LLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 7e-08
Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 9/93 (9%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
RGL Y+H IIHRDLK SN+ ++ + KI DFGLAR DE+ G V T
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTG----YVATRW 180
Query: 568 YMAPEYASDGLFSVKS-DVFSFGILLLEIVSGK 599
Y APE + + ++ D++S G ++ E+++GK
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 29/213 (13%)
Query: 414 FELATIANAT-DNFSINKKLGEGGFGPVYKGTLADGQEIAHRNLVKLLGCCIQGEEKLLI 472
F A I N T ++ I K G+ G G + + + I H ++++L G + LI
Sbjct: 107 FAFACIDNKTCEHVVI--KAGQRG-GTATEAHIL--RAINHPSIIQLKGTFTYNKFTCLI 161
Query: 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLL----YLHHDSRLRIIHRDLKA 528
+P D + + KR + C I R +L YLH + RIIHRD+KA
Sbjct: 162 ---LPRYKTDLYCYLAAKRNI-----AICDILAIERSVLRAIQYLHEN---RIIHRDIKA 210
Query: 529 SNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSF 588
N+ ++H + + DFG A F D GT APE + + D++S
Sbjct: 211 ENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSA 269
Query: 589 GILLLEIVSGKKN-------RGFYHSDKNLNLI 614
GI+L E+ + + G SD+ + LI
Sbjct: 270 GIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLI 302
|
Length = 391 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 55/219 (25%)
Query: 424 DNFSINKKLGEGGFGPVYKG-TLADGQEIAHRN--------------------------- 455
D + +K+GEG +G VYK G+ +A +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 456 --LVKLLGCCIQGEEKL------LIYEFMPNRSLDSFIFDQTKRKL---LDWS--KRFCI 502
+V+LL EEK L++E++ + L F+ D R L K F
Sbjct: 61 IYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMY 117
Query: 503 -ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP-KISDFGLARTFVGDEIEGSTK 560
+ +G+ + H + ++HRDLK N+L+D + KI+D GL R F ++ T
Sbjct: 118 QLL---KGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTH 170
Query: 561 RVVGTYGYMAPEYASDGL-FSVKSDVFSFGILLLEIVSG 598
+V T Y APE +S D++S G + E+
Sbjct: 171 EIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 43/166 (25%), Positives = 73/166 (43%), Gaps = 35/166 (21%)
Query: 453 HRNLVKLLGCCIQGEEKLL-IYEFMPNRSLDSFIFDQ-------TKR---KLLDWSKRFC 501
H N+V LL L ++E++P R+L + T R ++LD
Sbjct: 37 HPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLD-----A 91
Query: 502 IICGTARGLLYLHHDSRLRIIHRDLKASNVLL---DHEMNPKISDFGLARTF--VGDEIE 556
+ C +G I+HRDLK N+++ + K+ DFG+ V D
Sbjct: 92 LACAHNQG-----------IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADV 140
Query: 557 GSTKR---VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+ R V+GT Y APE + SD++++G++ LE ++G+
Sbjct: 141 ATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 41/215 (19%)
Query: 421 NATDNFSINKKLGEGGFGPVYK-GTLADGQEIA--------------------------H 453
+ +D + I + +G+G +G V+K +G + A H
Sbjct: 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDH 74
Query: 454 RNLVKLLGC-----CIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTAR 508
N+VK G G++ L+ E S+ + KR + + I
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG--ERMEEPIIAYILHE 132
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
L+ L H + IHRD+K +N+LL E K+ DFG++ + +T VGT +
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 190
Query: 569 MAPEYAS-----DGLFSVKSDVFSFGILLLEIVSG 598
MAPE + D + + DV+S GI +E+ G
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
RGL +LH + I+HRDLK N+L+ K++DFGLAR + + + VV T
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLW 172
Query: 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
Y APE ++ D++S G + E+ K
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 38/111 (34%), Positives = 56/111 (50%), Gaps = 6/111 (5%)
Query: 488 QTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547
Q +R L+ RF A L YLH L I++RDLK N+LLD + + ++DFGL
Sbjct: 88 QRERCFLEPRARF-YAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLC 143
Query: 548 RTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSG 598
+ + E G+T GT Y+APE + D + G +L E++ G
Sbjct: 144 KENI--EHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 44/148 (29%), Positives = 75/148 (50%), Gaps = 21/148 (14%)
Query: 460 LGCCIQGEEKL-LIYEFMPNRSLDSFI--FDQTKRKLLDWSKRFCIICGTARGLLYLHHD 516
L C Q ++ L ++ E+MP L + + +D ++ W+K + TA +L L
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY-----TAEVVLALDAI 158
Query: 517 SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTK--RVVGTYGYMAPEY- 573
+ +IHRD+K N+LLD + K++DFG T + + G + VGT Y++PE
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFG---TCMKMDETGMVRCDTAVGTPDYISPEVL 215
Query: 574 ---ASDGLFSVKSDVFSFGILLLEIVSG 598
DG + + D +S G+ L E++ G
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 43/199 (21%), Positives = 84/199 (42%), Gaps = 27/199 (13%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFC-------IICG 505
H N+++ LG C++ LL++E+ L S++ + W +R + C
Sbjct: 54 HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACE 107
Query: 506 TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART-FVGDEIEGSTKRVVG 564
A G+ ++H + +H DL N L ++ K+ D+G+ + + D IE + V
Sbjct: 108 IAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV- 163
Query: 565 TYGYMAPEYAS---DGLFSVK----SDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHA 617
++APE GL + + S+V++ G+ L E+ Y + ++ H
Sbjct: 164 PLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP--YSHLSDREVLNHV 221
Query: 618 WKLWNNGMPSQLIDAYYQE 636
K + ++ Y E
Sbjct: 222 IKDQQVKLFKPQLELPYSE 240
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
+GL Y+H IIHRDLK N+ ++ + KI DFGLAR E+ G V T
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-TDSEMTG----YVVTRW 180
Query: 568 YMAPEYASDGL-FSVKSDVFSFGILLLEIVSGK 599
Y APE + + ++ D++S G ++ E+++GK
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 51/160 (31%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 452 AHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSF--------IFD----QTKRKLLDWSKR 499
A+R LV L+ C L+ F P +SL+ F + D Q + LD +
Sbjct: 70 AYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 500 FCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559
++ G+ +LH IIHRDLK SN+++ + KI DFGLART G T
Sbjct: 129 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFM-MT 183
Query: 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
VV Y Y APE + D++S G ++ E++ G
Sbjct: 184 PYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 42/135 (31%), Positives = 63/135 (46%), Gaps = 9/135 (6%)
Query: 465 QGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIH 523
Q EKL + +F+ L F Q +R + RF A L YLH + I++
Sbjct: 66 QTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARF-YAAEIASALGYLH---SINIVY 119
Query: 524 RDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKS 583
RDLK N+LLD + + ++DFGL + G +T GT Y+APE +
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177
Query: 584 DVFSFGILLLEIVSG 598
D + G +L E++ G
Sbjct: 178 DWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 19/155 (12%)
Query: 449 QEIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTAR 508
++++H+++V L G C++ E +++ EF+ LD F+ ++ W +F + A
Sbjct: 59 RQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLAS 116
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLL-----DHEMNP--KISDFGLARTFVGDEIEGSTKR 561
L YL D L +H ++ N+LL D E P K+SD G+ T + S +
Sbjct: 117 ALSYL-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVL------SRQE 167
Query: 562 VVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEI 595
V ++APE D S+ +D +SFG L EI
Sbjct: 168 CVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 6e-07
Identities = 19/43 (44%), Positives = 26/43 (60%), Gaps = 2/43 (4%)
Query: 677 LPQPKQPGFLADRKSTGPNSSSS--MLESSSTNTITISTLEGR 717
+PQPKQPGF R +SSSS ES + N +T+S ++ R
Sbjct: 6 IPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 3/93 (3%)
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
A +L L H + I++RDLK N+LLD + + DFGL++ + D +T GT
Sbjct: 103 AELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTTNTFCGTT 160
Query: 567 GYMAPE-YASDGLFSVKSDVFSFGILLLEIVSG 598
Y+APE + ++ D +S G+L+ E+ G
Sbjct: 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 36/100 (36%), Positives = 48/100 (48%), Gaps = 16/100 (16%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTK----RVV 563
R L Y+H + + HRDLK N+L + + KI DFGLAR D T V
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFND---TPTAIFWTDYV 167
Query: 564 GTYGYMAPEYASDGLFSVKS----DVFSFGILLLEIVSGK 599
T Y APE G F K D++S G + E+++GK
Sbjct: 168 ATRWYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 45/202 (22%)
Query: 431 KLGEGGFGPVYKG--TLADG--------------------------QEIAHRNLVKLLGC 462
KLGEG + VYKG L D +++ H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 463 CIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRI 521
I E+ L L++E++ ++ L ++ D + K F + RGL Y H R ++
Sbjct: 73 -IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRKV 125
Query: 522 IHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST-KRVVGTYGYMAPEY---ASDG 577
+HRDLK N+L++ K++DFGLAR I T V T Y P+ ++D
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGSTD- 181
Query: 578 LFSVKSDVFSFGILLLEIVSGK 599
+S + D++ G + E+ +G+
Sbjct: 182 -YSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 39/148 (26%), Positives = 59/148 (39%), Gaps = 38/148 (25%)
Query: 431 KLGEGGFGPVYKGTLADGQEIAHRNLVKLLGCCIQGEE----------KLL--------- 471
KLGEG + VYKG + LV L ++ EE LL
Sbjct: 12 KLGEGSYATVYKG-----RSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV 66
Query: 472 -IYEFMPNRSLDSFIFDQTKRKL---LDWSKRF-------CIICGTARGLLYLHHDSRLR 520
+++ + + + +F+ L +D + RGL Y H R
Sbjct: 67 TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---R 123
Query: 521 IIHRDLKASNVLLDHEMNPKISDFGLAR 548
++HRDLK N+L+ K++DFGLAR
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 52/160 (32%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 452 AHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSF--------IFD----QTKRKLLDWSKR 499
A+R LV L+ C L+ F P +SL+ F + D Q + LD +
Sbjct: 63 AYRELV-LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERM 121
Query: 500 FCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559
++ G+ +LH IIHRDLK SN+++ + KI DFGLART G T
Sbjct: 122 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFM-MT 176
Query: 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
VV Y Y APE + D++S G ++ E+V K
Sbjct: 177 PYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 39/200 (19%)
Query: 430 KKLGEGGFGPVYKG--TLADG--------------------------QEIAHRNLVKLLG 461
+KLGEG + V+KG L + +++ H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 462 CCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRI 521
+ L++E++ ++ L ++ D + K F + RGL Y H R ++
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRKV 125
Query: 522 IHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST-KRVVGTYGYMAPE-YASDGLF 579
+HRDLK N+L++ K++DFGLAR + T V T Y P+ +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 580 SVKSDVFSFGILLLEIVSGK 599
S + D++ G + E+ SG+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 506 TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT 565
GL Y+H IIHRDLK N+ ++ + KI DFGLAR E+ G V T
Sbjct: 126 MLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARH-ADAEMTG----YVVT 177
Query: 566 YGYMAPEYASDGLFSVKS-DVFSFGILLLEIVSGK 599
Y APE + + ++ D++S G ++ E+++GK
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 12/170 (7%)
Query: 451 IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFC--IICGTAR 508
+ H NL++ LG C + LL+ EF P L ++ K +L+ + C A
Sbjct: 52 LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
GLL+LH ++ IH DL N LL ++ KI D+GL+ ++ + ++ +
Sbjct: 112 GLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168
Query: 569 MAPEYASD---GLFSV----KSDVFSFGILLLEIVSGKKNRGFYHSDKNL 611
+APE + L V +S+V+S G+ + E+ + SD+ +
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV 218
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 49/198 (24%), Positives = 85/198 (42%), Gaps = 38/198 (19%)
Query: 431 KLGEGGFGPVYKGTLAD-GQEIA----------------------------HRNLVKLLG 461
K+GEG +G V+K + GQ +A H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 462 CCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRI 521
+ + L++E+ + L+ ++ R + + + II T + + + H +
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIK-KIIWQTLQAVNFCH---KHNC 121
Query: 522 IHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEY-ASDGLFS 580
IHRD+K N+L+ + K+ DFG AR G + + V T Y APE D +
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD--YVATRWYRAPELLVGDTQYG 179
Query: 581 VKSDVFSFGILLLEIVSG 598
DV++ G + E+++G
Sbjct: 180 PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
A+ +L + L I++RDLK N+LLD + K++DFG A+ ++ T + GT
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTP 192
Query: 567 GYMAPEYASDGLFSVKSDVFSFGILLLEIVSG 598
Y+APE + +D ++ GI + EI+ G
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 36/156 (23%), Positives = 66/156 (42%), Gaps = 17/156 (10%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLY 512
H N++ + I E ++ M S + + L + + F I+ L Y
Sbjct: 58 HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-ILKDVLNALDY 116
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG----- 567
+H IHR +KAS++LL + +S + + + G +RVV +
Sbjct: 117 IHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK---HGKRQRVVHDFPKSSVK 170
Query: 568 ---YMAPEYASDGL--FSVKSDVFSFGILLLEIVSG 598
+++PE L ++ KSD++S GI E+ +G
Sbjct: 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHE-MNPKISDFGLARTFVGD-EIEGSTKRVVGT 565
RGL Y+H + ++HRDLK +NV ++ E + KI DFGLAR +G + T
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 566 YGYMAPEYA-SDGLFSVKSDVFSFGILLLEIVSGK 599
Y +P S ++ D+++ G + E+++GK
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 7e-06
Identities = 47/196 (23%), Positives = 79/196 (40%), Gaps = 36/196 (18%)
Query: 431 KLGEGGFGPVYKG-TLADGQEIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDS------ 483
K+GEG F V K + G+ A + + K E+ + E R L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKK---HFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 484 ---FIFDQTKRK------LLDWS-------KRFCIICGTARGLLY-----LHHDSRLRII 522
+FD+ + L+D + ++ + + +Y L H R I
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIF 122
Query: 523 HRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE-YASDGLFSV 581
HRD+K N+L+ + K++DFG R + + T Y APE +DG +
Sbjct: 123 HRDIKPENILIKDD-ILKLADFGSCRGIYS---KPPYTEYISTRWYRAPECLLTDGYYGP 178
Query: 582 KSDVFSFGILLLEIVS 597
K D+++ G + EI+S
Sbjct: 179 KMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 8e-06
Identities = 33/114 (28%), Positives = 52/114 (45%), Gaps = 22/114 (19%)
Query: 500 FCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE----- 554
F IC T Y+H S+ ++HRDLK N+LL I D+G A +E
Sbjct: 119 FHKICATIE---YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 555 ----IEGS-----TK--RVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
T ++VGT YMAPE S +D+++ G++L ++++
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMA 570
L +H ++ +HRD+K NVL+D + K++DFG A +++ S K VGT Y+A
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS-KLPVGTPDYIA 171
Query: 571 PEY------ASDGLFSVKSDVFSFGILLLEIVSGK 599
PE G + V+ D +S G++ E++ G+
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 24/78 (30%), Positives = 44/78 (56%)
Query: 520 RIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLF 579
+++HRDLK++N+ L K+ DFG ++ + GT Y+APE +
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 580 SVKSDVFSFGILLLEIVS 597
S K+D++S G++L E+++
Sbjct: 249 SKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 40/136 (29%), Positives = 68/136 (50%), Gaps = 20/136 (14%)
Query: 471 LIYEFMPNRSLDSFI--FDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKA 528
++ E+MP L + + +D ++ W++ + TA +L L + IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEK----WARFY-----TAEVVLALDAIHSMGFIHRDVKP 170
Query: 529 SNVLLDHEMNPKISDFGLARTFVGDEIEGSTK--RVVGTYGYMAPEY----ASDGLFSVK 582
N+LLD + K++DFG T + EG + VGT Y++PE DG + +
Sbjct: 171 DNMLLDKSGHLKLADFG---TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 583 SDVFSFGILLLEIVSG 598
D +S G+ L E++ G
Sbjct: 228 CDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 19/157 (12%)
Query: 451 IAHRN--LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTA 507
+AH N + L Q ++ L ++ E+MP L + + + + W++ + TA
Sbjct: 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE--KWARFY-----TA 149
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTK--RVVGT 565
+L L + IHRD+K N+LLD + K++DFG T + + G + VGT
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG---TCMKMDANGMVRCDTAVGT 206
Query: 566 YGYMAPEY----ASDGLFSVKSDVFSFGILLLEIVSG 598
Y++PE DG + + D +S G+ L E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 25/160 (15%)
Query: 449 QEIAHRNLVKLLGCCIQGEEKLLIYE---FMPNRSLD----SFIFD---QTKRKLLDWSK 498
+ H N++K+ E++L E +M + D SF++D K + L
Sbjct: 218 GRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQT 269
Query: 499 RFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558
R I+ + Y+H ++IHRD+K N+ L+ + + DFG A F E E
Sbjct: 270 R-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKEREAF 324
Query: 559 TKRVVGTYGYMAPE-YASDGLFSVKSDVFSFGILLLEIVS 597
VGT +PE A DG + +D++S G++LL+++S
Sbjct: 325 DYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST-KRVVGTY 566
RGL Y H +I+HRDLK N+L++ + K++DFGLAR + T V T
Sbjct: 114 RGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTL 167
Query: 567 GYMAPE-YASDGLFSVKSDVFSFGILLLEIVSGK 599
Y P+ +S D++ G +L E+ +G+
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 6/98 (6%)
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
A +L +H +L +HRD+K NVLLD + +++DFG D S+ VGT
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV-AVGTP 167
Query: 567 GYMAPEY---ASDGL--FSVKSDVFSFGILLLEIVSGK 599
Y++PE DG+ + + D +S G+ + E++ G+
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 19/154 (12%)
Query: 450 EIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARG 509
+++H +L + G C++G E +++ EF+ + LD + + R + W + + A
Sbjct: 72 QVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLASA 129
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHE-----MNP--KISDFGLARTFVGDEIEGSTKRV 562
L YL + ++H ++ A N+LL +P K+SD G++ T + S +
Sbjct: 130 LSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTAL------SREER 180
Query: 563 VGTYGYMAPEYASDGL-FSVKSDVFSFGILLLEI 595
V ++APE G S +D +SFG LLEI
Sbjct: 181 VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 35/108 (32%), Positives = 52/108 (48%), Gaps = 20/108 (18%)
Query: 506 TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG------------- 552
T L YLH+ I+HRDLK N+L+ + K++DFGL++ +G
Sbjct: 110 TVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSK--IGLMSLTTNLYEGHI 164
Query: 553 --DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSG 598
D E K+V GT Y+APE + D ++ GI+L E + G
Sbjct: 165 EKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 6e-05
Identities = 49/192 (25%), Positives = 77/192 (40%), Gaps = 59/192 (30%)
Query: 452 AHRNLVKLLGCCIQGEEKL-LIYEFMPNRSL-------DSFIFDQTKRKLLDWSKRFCII 503
A V L Q E L LI E++P + D+F ++T RF I
Sbjct: 58 ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET---------RFYI- 107
Query: 504 CGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGL----------------- 546
A +L + +L IHRD+K N+LLD + + K+SDFGL
Sbjct: 108 ---AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164
Query: 547 -----------ARTFVGDEIEGSTKR--------VVGTYGYMAPE-YASDGLFSVKSDVF 586
++ + KR VGT Y+APE + G ++ + D +
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWW 223
Query: 587 SFGILLLEIVSG 598
S G+++ E++ G
Sbjct: 224 SLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 46/161 (28%), Positives = 64/161 (39%), Gaps = 44/161 (27%)
Query: 508 RGLL----YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV- 562
R LL YLH IIHRD+K N+ LD N + DFG A D + +
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKL--DAHPDTPQCYG 246
Query: 563 -VGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLW 621
GT +PE + + K+D++S G++L E+ S KN+ L G
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM-----------SVKNVTLFGKQ---- 291
Query: 622 NNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
SQ L +IRC+ V HP + P
Sbjct: 292 VKSSSSQ-----------LRSIIRCMQV-------HPLEFP 314
|
Length = 392 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 49/211 (23%), Positives = 81/211 (38%), Gaps = 39/211 (18%)
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
A L YLH R IIHRDLK N+L+ +E + K++DFGL++ + E+
Sbjct: 114 ALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELN---------- 160
Query: 567 GYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626
M + + K+D +L ++S + GF + G NNG
Sbjct: 161 --MMDILTTPSMAKPKNDYSRTPGQVLSLIS---SLGFN-TPVGEKDQGSVNSGQNNGTS 214
Query: 627 SQLIDAYYQESCNLAEVIR--CIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQPG 684
S + + +I + + L + E PS + + P
Sbjct: 215 SVR-----TGTSHPLLMINKESLPMSLKLSKSCLETSESSPS---------LPVRSLTPN 260
Query: 685 FLADRKSTGPNSSSSMLESSSTNTITISTLE 715
L RK ++SS + S T ++S+ E
Sbjct: 261 LLKSRKRPEASTSS----THSCMTNSLSSCE 287
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 25/79 (31%), Positives = 40/79 (50%), Gaps = 1/79 (1%)
Query: 521 IIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFS 580
I+HRD+K N+L+ H K+ DFG AR + + + V T Y +PE +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARN-LSEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 581 VKSDVFSFGILLLEIVSGK 599
D++S G +L E+ G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 41/206 (19%)
Query: 424 DNFSINKKLGEGGFGPVYKG-TLADGQEIA---------------------------HRN 455
D++ +KLGEG + VYKG + +G+ +A H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 456 LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH 514
+V LL I +E L L++E++ + L ++ + K F + RGL Y+H
Sbjct: 65 IV-LLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLF--LFQLLRGLSYIH 120
Query: 515 HDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST-KRVVGTYGYMAPE- 572
I+HRDLK N+L+ K++DFGLAR + T V T Y P+
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLWYRPPDV 174
Query: 573 YASDGLFSVKSDVFSFGILLLEIVSG 598
+S D++ G + +E++ G
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 61/232 (26%), Positives = 89/232 (38%), Gaps = 73/232 (31%)
Query: 430 KKLGEGGFGPVY----KGT-------LADGQEIAHRN-------------------LVKL 459
K LG+G G V+ KGT + D +E+ RN L L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 460 LGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFC---IICGTARGLLYLHH 515
Q E L L+ ++ P L + Q + L + RF ++ L YLH
Sbjct: 67 Y-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA----LEYLH- 120
Query: 516 DSRLRIIHRDLKASNVLLDHEMNPKISDFGLART-------------------------- 549
L I++RDLK N+LL + +SDF L++
Sbjct: 121 --LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 550 -FVGDEIEGSTKRVVGTYGYMAPEYAS-DG-LFSVKSDVFSFGILLLEIVSG 598
+E + VGT Y+APE S DG +V D ++ GILL E++ G
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 39/149 (26%), Positives = 71/149 (47%), Gaps = 24/149 (16%)
Query: 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYAS-- 575
+L +HRD+K N+L+D + +++DFG + D S+ VGT Y++PE
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQAM 178
Query: 576 ---DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG----MPSQ 628
G + + D +S G+ + E++ G+ FY +L+ K+ N+ P+Q
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETP--FYAE----SLVETYGKIMNHKERFQFPAQ 232
Query: 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHH 657
+ D S + ++IR L+C + H
Sbjct: 233 VTDV----SEDAKDLIR----RLICSREH 253
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 16/34 (47%), Positives = 20/34 (58%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIAHRNLV 457
D+F + KKLGEG FG VYK +L + Q V
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV 165
|
Length = 566 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 44/161 (27%), Positives = 69/161 (42%), Gaps = 39/161 (24%)
Query: 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASN 530
LI EF+P + + + K L + +F I A +L + +L IHRD+K N
Sbjct: 78 LIMEFLPGGDMMTLLM--KKDTLTEEETQFYI----AETVLAIDSIHQLGFIHRDIKPDN 131
Query: 531 VLLDHEMNPKISDFGLA-------RTFVGDEIEGS-----------TKR----------- 561
+LLD + + K+SDFGL RT + S +KR
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 562 ----VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSG 598
VGT Y+APE ++ D +S G+++ E++ G
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 60/227 (26%), Positives = 91/227 (40%), Gaps = 49/227 (21%)
Query: 431 KLGEGGFGPVYKGTLADGQEIAHRNLVKLLGCCIQ---GEEKLLIYEFM-PNR-SLDSFI 485
K+G G +G VYK DG++ L ++ G I E L+ E PN SL
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 486 FDQTKRK---LLDWS------------------KRFCIICGTARGLLY-----LHHDSRL 519
RK L D++ K + G + LLY +H+
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 520 RIIHRDLKASNVLLDHEMNP-----KISDFGLARTFVGD-EIEGSTKRVVGTYGYMAPEY 573
++HRDLK +N+L+ E P KI+D G AR F + VV T+ Y APE
Sbjct: 128 WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186
Query: 574 ASDGLFSVKS-DVFSFGILLLEIVSGK----------KNRGFYHSDK 609
K+ D+++ G + E+++ + K YH D+
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 30/87 (34%), Positives = 42/87 (48%), Gaps = 20/87 (22%)
Query: 471 LIYEFMPNRSL-------DSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIH 523
LI EF+P L D+F D T RF + A +L + +L IH
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDVT---------RFYM----AECVLAIEAVHKLGFIH 124
Query: 524 RDLKASNVLLDHEMNPKISDFGLARTF 550
RD+K N+L+D + K+SDFGL+ F
Sbjct: 125 RDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 32/108 (29%), Positives = 55/108 (50%), Gaps = 16/108 (14%)
Query: 502 IICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561
I+ G RGL YLH + IHR++KAS++L+ + +S + V + G +
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRN---GQKAK 159
Query: 562 VVGTYG--------YMAPEYASDGL--FSVKSDVFSFGILLLEIVSGK 599
VV + +++PE L ++VKSD++S GI E+ +G+
Sbjct: 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 8e-04
Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 30/170 (17%)
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFD--QTKRKLLDWSKRFC--IICGTAR 508
+ N +KL + +LI +++ + L FD + + KL S+ II
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKL---SEAEVKKIIRQLVE 120
Query: 509 GLLYLH-HDSRLRIIHRDLKASNVLLDHEMNP-KISDFGLARTFVGDEIEGSTKRVVGTY 566
L LH H IIH D+K NVL D + + D+GL + I G+ GT
Sbjct: 121 ALNDLHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCK------IIGTPSCYDGTL 170
Query: 567 GYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK---KNRGFYHSDKNLNL 613
Y +PE + V D ++ G+L E+++GK K D+ L+L
Sbjct: 171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE----DEDEELDL 216
|
Length = 267 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 27/87 (31%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEY---- 573
+L +HRD+K NVLLD + +++DFG + D S VGT Y++PE
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV-AVGTPDYISPEILQAM 178
Query: 574 -ASDGLFSVKSDVFSFGILLLEIVSGK 599
G + + D +S G+ + E++ G+
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 32/99 (32%), Positives = 48/99 (48%), Gaps = 22/99 (22%)
Query: 520 RIIHRDLKASNVLLD-------------HEMN----PKISDFGLARTFVGDEIEGSTKRV 562
R++HRDLK N+ L + +N KI DFGL++ +G IE
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN-IG--IESMAHSC 201
Query: 563 VGTYGYMAPEYA--SDGLFSVKSDVFSFGILLLEIVSGK 599
VGT Y +PE + KSD+++ G ++ E+ SGK
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|219775 pfam08277, PAN_3, PAN-like domain | Back alignment and domain information |
|---|
Score = 37.3 bits (87), Expect = 0.001
Identities = 13/34 (38%), Positives = 25/34 (73%), Gaps = 1/34 (2%)
Query: 322 DSTSSWVSKSMNLKECREKCLENSSCM-AYTNSD 354
DS+++ + S++ ++C KC E+S+C+ AY NS+
Sbjct: 10 DSSNTSSTTSLSWEDCVTKCYEDSTCVLAYFNSE 43
|
Length = 71 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 57/238 (23%), Positives = 92/238 (38%), Gaps = 69/238 (28%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQEIAH----RNL------ 456
D+F K +G G FG V K + + +++AH R++
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 457 ---VKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYL 513
VK+ LI EF+P + + + K L + + +F I A +L +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYI----AETVLAI 114
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA-------RT-------------FVGD 553
+L IHRD+K N+LLD + + K+SDFGL RT F
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 554 EIEGSTK-------------RVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSG 598
+ K VGT Y+APE ++ D +S G+++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|214742 smart00605, CW, CW domain | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.003
Identities = 19/74 (25%), Positives = 41/74 (55%), Gaps = 9/74 (12%)
Query: 321 PDSTSSWVS-KSMNLKECREKCLENSSCM-AYTNSDITRGGSGCVMW-FGDLIDMRNFQ- 376
P ++SS V+ +++ EC +KC E+S+C+ AY NS C ++ +G ++ ++
Sbjct: 10 PTTSSSSVTAATLSWDECIQKCYEDSNCVLAYGNSS-----ETCYLFSYGTVLTVKKLSS 64
Query: 377 DGGQDLYIRMSASE 390
G+ + ++S +
Sbjct: 65 SSGKKVAFKVSTDQ 78
|
Length = 94 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 28/123 (22%), Positives = 48/123 (39%), Gaps = 41/123 (33%)
Query: 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTF-------------------------VG 552
++ IHRD+K N+L+D + + K++DFGL F
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 553 DEIEGSTKRV----------------VGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIV 596
+ K + VGT Y+APE ++ D +S G++L E++
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 597 SGK 599
G+
Sbjct: 239 VGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Score = 36.5 bits (84), Expect = 0.003
Identities = 17/82 (20%), Positives = 29/82 (35%), Gaps = 13/82 (15%)
Query: 308 RKDGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENS---SCMAYTNSDITRGGSGCVM 364
+ LK+ + K+ EC +C +N SC A+ + C+
Sbjct: 7 SAGTTLIKIALKIKTT------KANTADECANRCEKNGLPFSCKAFV---FAKARKQCLW 57
Query: 365 W-FGDLIDMRNFQDGGQDLYIR 385
+ F + +R G DLY
Sbjct: 58 FPFNSMSGVRKEFSHGFDLYEN 79
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.004
Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 39/207 (18%)
Query: 431 KLGEGGFGPVYKGTLADGQEIAHRNLVKLLGCCIQ---GEEKLLIYEFM-PNR-SLDSFI 485
K+G G +G VYK DG++ L ++ G I E L+ E PN +L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 486 FDQTKRK---LLDWS------------------KRFCIICGTARGLLY-----LHHDSRL 519
+ RK L D++ K + + LLY +H+
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 520 RIIHRDLKASNVLLDHEMNP-----KISDFGLARTFVGD-EIEGSTKRVVGTYGYMAPEY 573
++HRDLK +N+L+ E P KI+D G AR F + VV T+ Y APE
Sbjct: 128 WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186
Query: 574 ASDGLFSVKS-DVFSFGILLLEIVSGK 599
K+ D+++ G + E+++ +
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 503 ICGTARGLL----YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558
+ AR LL Y+H + IIHRD+K NVL++ + + DFG A G
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLE 594
+ GT APE + ++ D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 717 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.98 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.98 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.98 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.98 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.98 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.98 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.98 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.98 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.98 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.98 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.98 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.98 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.98 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.98 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.98 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.98 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.98 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.93 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.93 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.9 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.78 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.66 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.65 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.63 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.62 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.62 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.57 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.46 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.46 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.46 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.45 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.41 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.34 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.31 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.28 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.21 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.21 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.12 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.0 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.93 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.91 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.75 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.71 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.62 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.55 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.48 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.45 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.4 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.31 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.25 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.19 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.17 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.15 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.15 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.1 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.09 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.02 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 98.02 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.88 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.71 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.63 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.54 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.49 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.48 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.48 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.41 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.01 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.62 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.52 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.44 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 96.4 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 95.84 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.76 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.57 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.4 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 95.33 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.29 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 94.81 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.63 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 94.57 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 94.56 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 94.17 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.41 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 92.34 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 90.35 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 89.75 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 88.46 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 87.27 | |
| PF00024 | 79 | PAN_1: PAN domain This Prosite entry concerns appl | 86.95 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 86.18 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 86.12 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 85.67 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 84.61 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 84.47 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=416.96 Aligned_cols=263 Identities=43% Similarity=0.745 Sum_probs=231.7
Q ss_pred CCCcccHHHHHHHhcCcccccccccCCccceEeeeeCCchhhh--------------------------hhhhhhhccee
Q 039318 410 ELPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA--------------------------HRNLVKLLGCC 463 (717)
Q Consensus 410 ~~~~~~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va--------------------------h~niv~l~~~~ 463 (717)
....|++.++..+|++|...++||+|+||.||+|.+.+++.|| |||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 5678999999999999999999999999999999987753222 99999999999
Q ss_pred ecCc-eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceec
Q 039318 464 IQGE-EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKIS 542 (717)
Q Consensus 464 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 542 (717)
.+.+ +++||||||++|+|+++++..... .++|.+|++|+.++|+||+|||+.+..+||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999765444 88999999999999999999999988889999999999999999999999
Q ss_pred cccccccccCCcccccccee-cccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHh
Q 039318 543 DFGLARTFVGDEIEGSTKRV-VGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLW 621 (717)
Q Consensus 543 Dfgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 621 (717)
|||+|+...... ...... .||.+|+|||++..+..+.|+|||||||+|+||++|+++.+...+.....+..|++..+
T Consensus 220 DFGLa~~~~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999997643211 111122 89999999999999999999999999999999999999987655555566889999999
Q ss_pred hCCCCccccchhhh-ccCCH-HHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 622 NNGMPSQLIDAYYQ-ESCNL-AEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 622 ~~~~~~~l~d~~~~-~~~~~-~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.++...+++|+.+. +..+. +++.++..++++|++.+|.+||+|.+|+++|+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999999999987 55554 68999999999999999999999999999995544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=343.33 Aligned_cols=226 Identities=28% Similarity=0.385 Sum_probs=182.3
Q ss_pred CcccccccccCCccceEeeeeCCchhh----------------------------hhhhhhhhcceeecCc-eeeEEEec
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQEI----------------------------AHRNLVKLLGCCIQGE-EKLLIYEF 475 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~~v----------------------------ah~niv~l~~~~~~~~-~~~lV~E~ 475 (717)
+.+..+.||+|..|+|||++++.++++ .||+||++||.|.... ...|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 445568999999999999998765332 1999999999999988 59999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhh-cCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHH-DSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|++|+|++++... +.+++...-+|+.+|++||.|||+ ++ ||||||||+||||+..|++||+|||.++.+...
T Consensus 160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999543 568999999999999999999996 55 999999999999999999999999999987543
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
..++++||..|||||.+.+..|+.++||||||+.++|+..|+.|+..... ......... ..+-.+.+..+.+.
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll-~~Iv~~ppP~lP~~-- 305 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELL-CAIVDEPPPRLPEG-- 305 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHH-HHHhcCCCCCCCcc--
Confidence 45679999999999999999999999999999999999999999875411 111111111 11112222222211
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
....++..++..||++||.+||++.++++.
T Consensus 306 ------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 ------EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ------cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 233456788889999999999999999874
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=349.97 Aligned_cols=230 Identities=33% Similarity=0.514 Sum_probs=185.0
Q ss_pred cccccccccCCccceEeeeeCCchh----------------------------hhhhhhhhhcceeecCc-eeeEEEecc
Q 039318 426 FSINKKLGEGGFGPVYKGTLADGQE----------------------------IAHRNLVKLLGCCIQGE-EKLLIYEFM 476 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~~~~----------------------------vah~niv~l~~~~~~~~-~~~lV~E~~ 476 (717)
+.+.+.||+|+||+||+|.++.... +.|||||+++|++.+.. ..+||||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 3444669999999999998764431 23999999999999888 799999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC-CceeccccccccccCCcc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM-NPKISDFGLARTFVGDEI 555 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~ 555 (717)
++|+|.++++.. ....+++..+++++.+||+||.|||+++. ||||||||+||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999664 45679999999999999999999999874 99999999999999997 99999999998754322
Q ss_pred ccccceecccccccCccccc--cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 556 EGSTKRVVGTYGYMAPEYAS--DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
.......||+.|||||++. ...|+.|+||||||+++|||++|+.||+..... ..+...........+.
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------~~~~~v~~~~~Rp~~p--- 268 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------QVASAVVVGGLRPPIP--- 268 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcCCCCCCC---
Confidence 2223378999999999999 569999999999999999999999999854431 1122222222221111
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
......+..++.+||+.||..||++.+++.+|+...
T Consensus 269 ------~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 269 ------KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred ------ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 113445677888899999999999999999998553
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=355.71 Aligned_cols=222 Identities=27% Similarity=0.399 Sum_probs=185.8
Q ss_pred cCcccccccccCCccceEeeee-CCchhhh-----------------------------hhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTL-ADGQEIA-----------------------------HRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~va-----------------------------h~niv~l~~~~~~~~~~~lV~ 473 (717)
.+|...+.||+|||+.||+++. ..++.+| |||||+++++|++.+.+|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999998 4444333 999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
|+|++++|.+++. .++.+++.++..++.||+.||.|||+++ |+|||||..||+|+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999993 6778999999999999999999999998 999999999999999999999999999987543
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
. ....+.+|||.|+|||++....++..+||||+|||+|-||.|++||+-..-.+....+ +...
T Consensus 172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I-------k~~~-------- 234 (592)
T KOG0575|consen 172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI-------KLNE-------- 234 (592)
T ss_pred c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH-------HhcC--------
Confidence 2 3455799999999999999999999999999999999999999999743222221111 1100
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
...+..-..+..+|+..+|+.+|.+|||+++|+..
T Consensus 235 --Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 --YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred --cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00111223356678889999999999999999973
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=338.03 Aligned_cols=178 Identities=30% Similarity=0.513 Sum_probs=157.6
Q ss_pred hcCcccccccccCCccceEeeeeCCch-hh----------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ-EI----------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~v----------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
..+|.+.++||+|+||+||+|+++... .| .|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357899999999999999999986532 22 2999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC------CCceecccccc
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE------MNPKISDFGLA 547 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~------~~~kl~Dfgla 547 (717)
|||.||+|.+||.. ++.+++.....++.||+.||++||+++ ||||||||+||||... -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999954 446899999999999999999999998 9999999999999765 56899999999
Q ss_pred ccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCC
Q 039318 548 RTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDK 609 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~ 609 (717)
+.+.... ...+.+|++.|||||+++...|+.|+|+||+|+|||+|++|+.||......+
T Consensus 163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 9886543 3446899999999999999999999999999999999999999998554443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=318.66 Aligned_cols=233 Identities=28% Similarity=0.399 Sum_probs=185.0
Q ss_pred cCcccccccccCCccceEeeeeC-Cchhhh----------------------------hhhhhhhcc-eeecCce-eeEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLA-DGQEIA----------------------------HRNLVKLLG-CCIQGEE-KLLI 472 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~va----------------------------h~niv~l~~-~~~~~~~-~~lV 472 (717)
.+|+++++||+|+||.|||+... ++..+| |||||++++ .+.++++ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 36889999999999999999753 332222 999999999 5666666 8999
Q ss_pred EeccCCCChhhHhhhc-cccccCChhhHHHHHHHHHHHHHHHhhcC-CCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 473 YEFMPNRSLDSFIFDQ-TKRKLLDWSKRFCIICGTARGLLYLHHDS-RLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
||||..|+|...|... ..++.+++..+++++.|++.||..+|.+- |.-|+||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999654 34567899999999999999999999842 234999999999999999999999999999988
Q ss_pred cCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
...... ....+|||.||+||.+.+.+|+.||||||+||++|||..-++||... ++. ...+.+.++....+.
T Consensus 179 ~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~-~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 179 SSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLL-SLCKKIEQGDYPPLP 249 (375)
T ss_pred cchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHH-HHHHHHHcCCCCCCc
Confidence 655433 34689999999999999999999999999999999999999998743 222 223334444433333
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
+. .....+..|+..|+..||+.||+...+++.+..
T Consensus 250 ~~--------~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 DE--------HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HH--------HhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 22 223455667778999999999996666665543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=336.23 Aligned_cols=226 Identities=25% Similarity=0.326 Sum_probs=179.5
Q ss_pred HhcCcccccccccCCccceEeeeeCC-chhh---------------------------------hhhhhhhhcceeecCc
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLAD-GQEI---------------------------------AHRNLVKLLGCCIQGE 467 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v---------------------------------ah~niv~l~~~~~~~~ 467 (717)
..+.|.+.+.||+|+||.|-+|..+. ++.+ .|||||++.+++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 44678889999999999999987543 2222 2999999999999999
Q ss_pred eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC---CCceeccc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE---MNPKISDF 544 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~---~~~kl~Df 544 (717)
..||||||++||+|.+++.. .+.+.+..-..++.|++.|+.|||++| |+||||||+||||..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999944 455777888889999999999999999 9999999999999766 77999999
Q ss_pred cccccccCCccccccceecccccccCccccccCC---CCccccchhHhHHHHHhhcCCCCCCCCCCCC-chhHHHHHHHH
Q 039318 545 GLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL---FSVKSDVFSFGILLLEIVSGKKNRGFYHSDK-NLNLIGHAWKL 620 (717)
Q Consensus 545 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~elltG~~p~~~~~~~~-~~~~~~~~~~~ 620 (717)
|+|+..... ...++.+||+.|.|||++.+.. +..|+|+||+|||||-+++|.+||.....+. -..++.
T Consensus 324 GlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~----- 395 (475)
T KOG0615|consen 324 GLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL----- 395 (475)
T ss_pred chhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh-----
Confidence 999987532 2355799999999999997654 3348899999999999999999997544332 111111
Q ss_pred hhCCCCccccchhhhccC-CHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 621 WNNGMPSQLIDAYYQESC-NLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 621 ~~~~~~~~l~d~~~~~~~-~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+... -.+. -.+-.++..+++.+||+.||++|||+.|+++.
T Consensus 396 --~G~y~-------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 396 --KGRYA-------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred --cCccc-------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 11100 0111 11233577899999999999999999999873
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=332.03 Aligned_cols=216 Identities=28% Similarity=0.367 Sum_probs=176.3
Q ss_pred hcCcccccccccCCccceEeeeeCCchhh------------------------------hhhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEI------------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~v------------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
.++|++.+.||+|+||+||.++.++.+++ .||+||+++-.|++.+++|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46899999999999999999987765332 299999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
+||+.||.|..+|. +.+.+++..+..++.+|+.||.|||+++ ||||||||+|||||++|+++|+||||++....
T Consensus 104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999994 3445888888889999999999999999 99999999999999999999999999996543
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
. ...+.+++||+.|||||++.+..|+.++|.||||+++|||++|.+||...+...... ++.. ++..
T Consensus 178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~------~I~~-~k~~----- 243 (357)
T KOG0598|consen 178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD------KILK-GKLP----- 243 (357)
T ss_pred C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH------HHhc-CcCC-----
Confidence 3 233456899999999999999999999999999999999999999987543222111 1111 1100
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCC
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP 662 (717)
..+.--..++.+++...|+.+|++|.
T Consensus 244 ----~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 ----LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ----CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 00111223566788889999999996
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=332.29 Aligned_cols=226 Identities=27% Similarity=0.367 Sum_probs=184.5
Q ss_pred HhcCcccccccccCCccceEeeeeCCchh-hh------------------------------hhhhhhhcceeecCceee
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQE-IA------------------------------HRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-va------------------------------h~niv~l~~~~~~~~~~~ 470 (717)
..++|...+.||+|+|++|++|+.++... .| ||.|++|+-.|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 34689999999999999999998765321 11 999999999999999999
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
+|+||+++|+|.++|.+ .+.+++.....++.+|+.||+|||.+| ||||||||+|||||.++++||+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999954 456899999999999999999999999 999999999999999999999999999987
Q ss_pred cCCccc---------ccc--ceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHH
Q 039318 551 VGDEIE---------GST--KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWK 619 (717)
Q Consensus 551 ~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 619 (717)
...... ... ..++||..|.+||++.....+..+|||+||||||+|+.|++||.....- ++ ..+
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----li--Fqk 298 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----LI--FQK 298 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----HH--HHH
Confidence 654322 111 4589999999999999999999999999999999999999998743221 11 111
Q ss_pred HhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 620 LWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 620 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
++. ++-.....++ ..+.+|+.+.|..||.+|+|.+++.+.
T Consensus 299 I~~-------l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 299 IQA-------LDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHH-------hcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 110 0111111112 455688889999999999999999885
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=335.26 Aligned_cols=229 Identities=33% Similarity=0.500 Sum_probs=188.4
Q ss_pred cccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCceeeEEEeccCCCC
Q 039318 426 FSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFMPNRS 480 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~~~gs 480 (717)
+..++.||+|-||.||.|.++....+| |+|||+++++|..++.++||||||+.|+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 455689999999999999987654443 9999999999999889999999999999
Q ss_pred hhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccc
Q 039318 481 LDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTK 560 (717)
Q Consensus 481 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 560 (717)
|.+||.. ..+..+...+.+.++.|||+|++||++++ +|||||.+.||||+++..+||+|||||+....+......
T Consensus 288 Ll~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~- 362 (468)
T KOG0197|consen 288 LLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE- 362 (468)
T ss_pred HHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecC-
Confidence 9999965 34567888999999999999999999998 999999999999999999999999999965555443322
Q ss_pred eecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCC
Q 039318 561 RVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCN 639 (717)
Q Consensus 561 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 639 (717)
...-...|.|||.+..+.|+.|||||||||+|+||+| |+.|+......+... .+ +.-.+-..+
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~-------~l---------e~GyRlp~P 426 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLE-------LL---------ERGYRLPRP 426 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHH-------HH---------hccCcCCCC
Confidence 2334578999999999999999999999999999999 888877544332222 22 222222334
Q ss_pred HHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 640 LAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 640 ~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
......+.+|+..||+.+|++|||.+.+...|+...
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 445567788999999999999999999999887654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=306.60 Aligned_cols=238 Identities=21% Similarity=0.293 Sum_probs=182.7
Q ss_pred cCcccccccccCCccceEeeeeCCchhhh-----------------------------hhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-----------------------------HRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-----------------------------h~niv~l~~~~~~~~~~~lV~E 474 (717)
+.|+.+.++|+|+||+|||++.++..+|. |+|+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999988754432 9999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
||+..-|+++-. ...-++.+.+.+++.|+++|+.|+|+++ +|||||||+||||..++.+||||||+|+.+...
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 999866665542 2234788899999999999999999998 999999999999999999999999999987632
Q ss_pred cccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHH--------HHHHhhCC-
Q 039318 555 IEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGH--------AWKLWNNG- 624 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~~- 624 (717)
....+.++.|+.|+|||++.+ .+|+..+||||+||++.||++|.+-|......+....+.. ..+++...
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 223445789999999999987 6899999999999999999999998875544443322222 11222111
Q ss_pred C-----CccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 625 M-----PSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 625 ~-----~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
. +.+.-++...+..-+.-..-+++++..||+.||++|++-++++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1 11111111111111122235689999999999999999999876
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=325.33 Aligned_cols=231 Identities=23% Similarity=0.274 Sum_probs=184.0
Q ss_pred HHHhcCcccccccccCCccceEeeeeCCchhhh------------------------------hhhhhhhcceeecCcee
Q 039318 420 ANATDNFSINKKLGEGGFGPVYKGTLADGQEIA------------------------------HRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 420 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va------------------------------h~niv~l~~~~~~~~~~ 469 (717)
....++|++++.||+|+||.||+|+-++...|. +|.||+||-.|++.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 345689999999999999999999877654321 78999999999999999
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
||||||+|||++..+|. ....|++..+..++.+++.|+..||+.| +|||||||+|+|||..|++||+||||+.-
T Consensus 217 YLiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999994 4567999999999999999999999999 99999999999999999999999999964
Q ss_pred ccCC----------------------ccc-----c------------------ccceecccccccCccccccCCCCcccc
Q 039318 550 FVGD----------------------EIE-----G------------------STKRVVGTYGYMAPEYASDGLFSVKSD 584 (717)
Q Consensus 550 ~~~~----------------------~~~-----~------------------~~~~~~gt~~y~aPE~~~~~~~~~~sD 584 (717)
+... +.. . .....+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 3210 000 0 011248999999999999999999999
Q ss_pred chhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCC-
Q 039318 585 VFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPC- 663 (717)
Q Consensus 585 vwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs- 663 (717)
+||||||+||||.|.+||....+.+....+..-...+.... ......+..+||.+||- ||++|..
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-------------~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-------------EVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-------------cCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 99999999999999999987666654433322222221111 11112567788999888 9999975
Q ss_pred --hHHHHHH
Q 039318 664 --MPSVILM 670 (717)
Q Consensus 664 --~~evl~~ 670 (717)
++||.++
T Consensus 437 ~G~~EIK~H 445 (550)
T KOG0605|consen 437 KGAEEIKKH 445 (550)
T ss_pred ccHHHHhcC
Confidence 6666653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=318.45 Aligned_cols=229 Identities=29% Similarity=0.412 Sum_probs=177.9
Q ss_pred cCcccccccccCCccceEeeeeCC-chh--------------------------hhhhhhhhhcceeecCc--eeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQE--------------------------IAHRNLVKLLGCCIQGE--EKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~--------------------------vah~niv~l~~~~~~~~--~~~lV~E 474 (717)
.+|...+.||+|+||.||++...+ +.. +.|||||+++|...... ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457788999999999999998764 211 12999999999855444 6899999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC-CCCceeccccccccccC-
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH-EMNPKISDFGLARTFVG- 552 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~Dfgla~~~~~- 552 (717)
|+++|+|.+++.+... .|++..+..+.+||++||+|||+++ ||||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999965433 6899999999999999999999998 999999999999999 79999999999987653
Q ss_pred CccccccceecccccccCccccccCC-CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGL-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
...........||+.|||||++..+. ...++|||||||++.||+||++||... ............+.....+.+
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~ip~ 246 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPEIPD 246 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCCCCc
Confidence 11122234588999999999998643 345999999999999999999998754 111122222222222222211
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHh
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L 671 (717)
.-.....+++.+|++.+|++|||+.++++..
T Consensus 247 ---------~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 247 ---------SLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ---------ccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 1223456788899999999999999999864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=323.66 Aligned_cols=238 Identities=24% Similarity=0.337 Sum_probs=187.9
Q ss_pred HHhcCcccccccccCCccceEeeeeCCc-hhhh----------------------------hhhhhhhcceeecCc-eee
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADG-QEIA----------------------------HRNLVKLLGCCIQGE-EKL 470 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~va----------------------------h~niv~l~~~~~~~~-~~~ 470 (717)
...++|.++++||.|.||.||+|+-... ..|| |||||++.+++.+.+ .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3457899999999999999999986542 2222 999999999999988 999
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
+|||||+. .|.++++++ ++.+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+.+
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999965 899999654 678999999999999999999999999 999999999999998889999999999976
Q ss_pred cCCccccccceecccccccCcccc-ccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYA-SDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
.. ....+.++.|+.|+|||++ +.+.|+.+.|+||+|||++|+.+-++.|......+ .+..+..++........
T Consensus 161 ~S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D---qi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 161 RS---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID---QIYKICEVLGTPDKDSW 234 (538)
T ss_pred cc---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH---HHHHHHHHhCCCccccc
Confidence 43 2345568999999999976 56779999999999999999999999887544333 33333333322221111
Q ss_pred cch-----hhh------ccCCH-----HHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 630 IDA-----YYQ------ESCNL-----AEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 630 ~d~-----~~~------~~~~~-----~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
... .+. ...++ ....++++++.+||+.||.+|||+++++++
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 110 000 01111 134578899999999999999999999996
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=300.93 Aligned_cols=210 Identities=26% Similarity=0.324 Sum_probs=172.3
Q ss_pred cCcccccccccCCccceEeeeeCCch------------------------------hhhhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ------------------------------EIAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~------------------------------~vah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++++.||.|+||.|.+++.+.+. .+.||+++++++.+.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 57889999999999999999876542 122999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||++||.|.+++++ .+.+++..+..++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 99999999999943 456899999999999999999999998 99999999999999999999999999997643
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
.+-+.+|||.|+|||+++..+|..++|.|||||++|||+.|.+||....+.. . ..++. ++++.
T Consensus 197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~---i---Y~KI~-~~~v~------ 259 (355)
T KOG0616|consen 197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ---I---YEKIL-EGKVK------ 259 (355)
T ss_pred ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH---H---HHHHH-hCccc------
Confidence 3457899999999999999999999999999999999999999987544421 1 11111 11110
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCC
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDR 661 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~R 661 (717)
++..-...+.+|+...||.|-.+|
T Consensus 260 ----fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 ----FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----CCcccCHHHHHHHHHHHhhhhHhh
Confidence 111112244567777888888888
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.30 Aligned_cols=235 Identities=30% Similarity=0.464 Sum_probs=180.4
Q ss_pred HhcCcccccccccCCccceEeeeeC------Cchhh----------------------------hhhhhhhhcceeecC-
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLA------DGQEI----------------------------AHRNLVKLLGCCIQG- 466 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~v----------------------------ah~niv~l~~~~~~~- 466 (717)
..++|++.++||+|+||.||+|... .+..+ .||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4578999999999999999999631 11111 299999999988764
Q ss_pred ceeeEEEeccCCCChhhHhhhccc--------------------------------------------------------
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTK-------------------------------------------------------- 490 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 490 (717)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 457899999999999999964321
Q ss_pred ---cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccceeccccc
Q 039318 491 ---RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567 (717)
Q Consensus 491 ---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 567 (717)
...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...............+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134778888999999999999999998 99999999999999999999999999986543322222233456788
Q ss_pred ccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHH
Q 039318 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRC 646 (717)
Q Consensus 568 y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~ 646 (717)
|+|||++.+..++.++|||||||++|||++ |+.||........ .......+..... +......+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTRMRA---------PENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCCCCC---------CCCCCHHH
Confidence 999999999999999999999999999997 9999875432211 1111122211110 11122357
Q ss_pred HHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 647 IHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 647 ~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.+++.+||+.+|++||++.||+++|+..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 7899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.35 Aligned_cols=225 Identities=27% Similarity=0.418 Sum_probs=183.7
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhhh--------------------------hhhhhhhcceeecCceeeEEEec
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEIA--------------------------HRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va--------------------------h~niv~l~~~~~~~~~~~lV~E~ 475 (717)
...|...++||+|+.|.||.++... ++.|| |+|||++++.|..++++++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3467788899999999999997543 22222 99999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
|++|+|.+.+.. ..+++.++..|++++++||+|||.++ |+|||||.+||||..+|.+||+|||++..+..+..
T Consensus 352 m~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999999933 34899999999999999999999999 99999999999999999999999999998876654
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
...+.+||+.|||||+.....|++|+||||||+++.||+.|++||=...+-..+ +.+...+.+ ++-.
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl------yLIa~ng~P-~lk~---- 491 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNGTP-KLKN---- 491 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH------HHHhhcCCC-CcCC----
Confidence 334689999999999999999999999999999999999999997543222222 222222221 1111
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
...-...+.++..+||+.|+++||++.|+|+.
T Consensus 492 ---~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 ---PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ---ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11122356688889999999999999999983
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=314.18 Aligned_cols=242 Identities=25% Similarity=0.352 Sum_probs=183.8
Q ss_pred HhcCcccccccccCCccceEeeeeCCchh-hh----------------------------hhhhhhhcceeecC--ceee
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQE-IA----------------------------HRNLVKLLGCCIQG--EEKL 470 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-va----------------------------h~niv~l~~~~~~~--~~~~ 470 (717)
..+.|+.+++||+|.||.||||+.....+ || ||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 34678889999999999999998754432 22 99999999998876 6899
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
||+|||+. +|.-++.. ..-.+++.++..++.||+.||.|+|.++ |+|||||.+|||||.+|.+||+|||||+++
T Consensus 195 lVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 99999987 77777732 3335889999999999999999999999 999999999999999999999999999987
Q ss_pred cCCccccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHH-----HhhCC
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWK-----LWNNG 624 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~-----~~~~~ 624 (717)
....... .+..+-|..|+|||++.|. .|+.++|+||.||||.||+.|++.|......+....|...-. .|...
T Consensus 269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 6554333 4456789999999999875 599999999999999999999999876555444444332211 12111
Q ss_pred CCc--cccchhhhccCCHHHH-----HHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 625 MPS--QLIDAYYQESCNLAEV-----IRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 625 ~~~--~l~d~~~~~~~~~~~~-----~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
++. ..+.+...-...+.|. ..+++|+..+|..||.+|.|+.++++-
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111 1111111101111111 346788889999999999999998873
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=308.81 Aligned_cols=236 Identities=25% Similarity=0.374 Sum_probs=184.6
Q ss_pred hcCcccccccccCCccceEeeeeCCchh-h---------------------------hhhhhhhhcceeecCceeeEEEe
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQE-I---------------------------AHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-v---------------------------ah~niv~l~~~~~~~~~~~lV~E 474 (717)
.+.|++.+.||.|..++||+|+.....+ | .||||++++..|..+..+++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4689999999999999999998643222 1 19999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
||.+|++.++++.....+ +++..+..|++++++||.|||++| .||||||+.||||+.+|.|||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999997765544 889999999999999999999999 9999999999999999999999999987654432
Q ss_pred ccc-cc-ceecccccccCcccccc--CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 555 IEG-ST-KRVVGTYGYMAPEYASD--GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 555 ~~~-~~-~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
... .. ++++||++|||||+++. ..|+.|+||||||+...||.+|+.||..+.+.... ...+.+..+ .+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL------l~tLqn~pp-~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL------LLTLQNDPP-TLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH------HHHhcCCCC-Ccc
Confidence 111 11 56799999999999543 45999999999999999999999999876654321 122222221 111
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
-..+........-..+.+++-.||+.||.+|||++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111111111122235667777899999999999999987
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.75 Aligned_cols=245 Identities=26% Similarity=0.363 Sum_probs=193.1
Q ss_pred HHHHhcCcccccccccCCccceEeeeeCCchhhh-------------------------------hhhhhhhcceeecCc
Q 039318 419 IANATDNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------------HRNLVKLLGCCIQGE 467 (717)
Q Consensus 419 i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------------h~niv~l~~~~~~~~ 467 (717)
.....++|.+++.||+|.||+|++++++...++. ||.|++++.+|+..+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3445679999999999999999999887543221 999999999999999
Q ss_pred eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla 547 (717)
++|+||||+.||++..++ ....+++..+..+++.|+.||.|||+++ ||+||||.+|||||.+|++||+||||+
T Consensus 443 ~l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred eEEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence 999999999999955444 4456899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 548 RTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
+.-... ...+.+++||+.|||||++.+..|+.++|.|||||+|||||.|+.||...+.++..+-|. .+
T Consensus 516 Ke~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~------~d---- 583 (694)
T KOG0694|consen 516 KEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV------ND---- 583 (694)
T ss_pred cccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh------cC----
Confidence 964422 235668999999999999999999999999999999999999999998655444332221 00
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCCCCCh----HHHHHH---hcCC-------CCCCCCCCCCccccC
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCM----PSVILM---LGSE-------IMLPQPKQPGFLADR 689 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~----~evl~~---L~~~-------~~~~~p~~p~~~~~~ 689 (717)
|. ..+.-...+.+.|+.++|..+|++|..+ .+.+.. +.++ ..+.+|=.|....++
T Consensus 584 ---~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~ 652 (694)
T KOG0694|consen 584 ---EV----RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPE 652 (694)
T ss_pred ---CC----CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChh
Confidence 11 1222334566788889999999999977 444432 2221 234555556665554
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=314.01 Aligned_cols=223 Identities=26% Similarity=0.415 Sum_probs=185.1
Q ss_pred cCcccccccccCCccceEeeeeCCchhhh----------------------------hhhhhhhcceeecCceeeEEEec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA----------------------------HRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~va----------------------------h~niv~l~~~~~~~~~~~lV~E~ 475 (717)
..|+..++||+|+||.||||.+...+++. ++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777789999999999999876543321 89999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
|.+|++.+.+ .....+++..+..|+++++.||.|||.++ .+|||||+.||||..+|.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999999 34445588888889999999999999998 99999999999999999999999999988765443
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
. ..+++||+.|||||++++..|+.|+||||||++.+||.+|.+|+...++.....++. ... .+.++
T Consensus 167 r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-------k~~-----PP~L~ 232 (467)
T KOG0201|consen 167 R--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-------KSA-----PPRLD 232 (467)
T ss_pred c--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-------CCC-----CCccc
Confidence 3 357999999999999998899999999999999999999999998877765544331 111 12222
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+. ....+.+++..||++||+.||++.++++.
T Consensus 233 ~~----~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 GD----FSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cc----cCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 21 12235567777999999999999999873
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=287.56 Aligned_cols=236 Identities=27% Similarity=0.389 Sum_probs=185.5
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh----------------------------hhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------------HRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va----------------------------h~niv~l~~~~~~~~~~~lV~E 474 (717)
++|..+++||+|.||.||+|++.. ++.|| |+||+.++++|-..+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 578888999999999999998653 22222 9999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
||+. +|+..|++ +...++...+..++.++++||+|||++. |+||||||.|+|++++|.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9976 89999954 4457889999999999999999999998 9999999999999999999999999999876544
Q ss_pred cccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc------
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS------ 627 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 627 (717)
.... ..+-|..|+|||++.|. .|+..+|+||.|||+.||+-|.+-|.. +.+.+++..+++.+.-....
T Consensus 156 ~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG---~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 156 RIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG---DSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred cccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC---CchHHHHHHHHHHcCCCCcccCcccc
Confidence 3222 23789999999988775 599999999999999999999876654 44444555555444322211
Q ss_pred cccchhh--------hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 628 QLIDAYY--------QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 628 ~l~d~~~--------~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+.|-.. ....-......+++++..++..||.+|++++|++++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111110 000112233456899999999999999999999886
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=313.46 Aligned_cols=239 Identities=24% Similarity=0.337 Sum_probs=189.4
Q ss_pred cCcccccccccCCccceEeeeeCCch-----------------------------hhhhhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-----------------------------EIAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-----------------------------~vah~niv~l~~~~~~~~~~~lV~E 474 (717)
++|.+.+.||+|+||.||||+-+... .+.|||||.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999754321 1229999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+.| +|..++.. .+.++++.+..++.+++.||.|||++. |+|||+||+||||+..+.+|++|||+|+.+..+.
T Consensus 82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9988 99999943 456899999999999999999999998 9999999999999999999999999999875432
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
.....+.|||.|||||+..+++|+..+|+||||||+|||+.|++||-.. -+.+..+.+..+.+.
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-------si~~Lv~~I~~d~v~------- 218 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-------SITQLVKSILKDPVK------- 218 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------HHHHHHHHHhcCCCC-------
Confidence 2344678999999999999999999999999999999999999998521 111111221111111
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH--hcCCC-CCCCCCCCCcccc
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM--LGSEI-MLPQPKQPGFLAD 688 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~--L~~~~-~~~~p~~p~~~~~ 688 (717)
.+......++.++.-.|++||.+|.+..+++.. .++.. .+..|.+|+...+
T Consensus 219 ---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~sp 272 (808)
T KOG0597|consen 219 ---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSP 272 (808)
T ss_pred ---CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCc
Confidence 122344567788888999999999999999873 34433 3445555554443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.49 Aligned_cols=241 Identities=27% Similarity=0.448 Sum_probs=188.4
Q ss_pred HHHHHHhcCcccccccccCCccceEeeeeCCch--------------------hhh------hhhhhhhcceeecCceee
Q 039318 417 ATIANATDNFSINKKLGEGGFGPVYKGTLADGQ--------------------EIA------HRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 417 ~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~--------------------~va------h~niv~l~~~~~~~~~~~ 470 (717)
.++....+.+.+.++||+|.||+||+|++...- +|+ |-||+-++|+|..... .
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 344444566778899999999999999875321 222 9999999999998877 9
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
||+.+|+|.+|+.+|+.. +..++..+.+.|++||++|+.|||+++ |||||||..||+|.+++.|||.||||+...
T Consensus 464 IiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeee
Confidence 999999999999999543 356888999999999999999999999 999999999999999999999999999865
Q ss_pred cCCccccccceecccccccCcccccc---CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYASD---GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
.............|...|||||+++. .+|++.+||||||+|+|||++|..||.....+.-..++. ......
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG------rG~l~p 612 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG------RGYLMP 612 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec------ccccCc
Confidence 54433444556778999999999863 579999999999999999999999988433332221111 111111
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
++.. .. ......+.+|+..||..++++||...+|+.+|+...
T Consensus 613 d~s~---~~---s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 613 DLSK---IR---SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred cchh---hh---ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 1111 11 122345677888899999999999999999887654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=319.09 Aligned_cols=225 Identities=25% Similarity=0.342 Sum_probs=181.2
Q ss_pred HHhcCcccccccccCCccceEeeeeCCc--------------------------hh------hh-hhhhhhhcceeecCc
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADG--------------------------QE------IA-HRNLVKLLGCCIQGE 467 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~--------------------------~~------va-h~niv~l~~~~~~~~ 467 (717)
...++|.+.+.||+|+||.|+.|..... ++ +. ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999965321 11 12 999999999999999
Q ss_pred eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC-CCceeccccc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE-MNPKISDFGL 546 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~Dfgl 546 (717)
..++||||+.+|+|.+++.+ .+.+.+.....+++|++.|++|+|+++ |+||||||+||||+.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999954 456888999999999999999999998 9999999999999999 9999999999
Q ss_pred cccccCCccccccceecccccccCccccccCC-CC-ccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCC
Q 039318 547 ARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL-FS-VKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG 624 (717)
Q Consensus 547 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 624 (717)
+.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... ...+. .+ +..+
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~---~~~l~---~k-i~~~ 238 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN---VPNLY---RK-IRKG 238 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc---HHHHH---HH-HhcC
Confidence 99863 1123345789999999999999977 86 78999999999999999999998521 11111 11 1111
Q ss_pred CCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 625 MPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 625 ~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.. . + ..... ..++..++.+||+.+|.+|+++.+++.
T Consensus 239 ~~-~-~----p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 239 EF-K-I----PSYLL---SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred Cc-c-C----CCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 10 0 0 00010 456778899999999999999999994
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=319.40 Aligned_cols=228 Identities=25% Similarity=0.351 Sum_probs=184.9
Q ss_pred cCcccccccccCCccceEeeeeCCchhhh------------------------------hhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA------------------------------HRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~va------------------------------h~niv~l~~~~~~~~~~~lV~ 473 (717)
.-|++.+.||.|+-|.|-.|++..+.+.| |||++++|+++.+..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45888999999999999999876543322 999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++|.|.+++ ..++.+++.+..+++.||+.|+.|+|..+ |+||||||+|+|||...++||+|||+|.....+
T Consensus 92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999999 45667899999999999999999999998 999999999999999999999999999875444
Q ss_pred ccccccceecccccccCccccccCCCC-ccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFS-VKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
. ...+.||++.|.|||++.|.+|. .++||||.|||||.||+|+.||+. ++...+ ..+...+.- ++.
T Consensus 166 k---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~L---LlKV~~G~f-~MP-- 232 (786)
T KOG0588|consen 166 K---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVL---LLKVQRGVF-EMP-- 232 (786)
T ss_pred c---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHH---HHHHHcCcc-cCC--
Confidence 3 24568999999999999999985 799999999999999999999982 222211 112222211 110
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH--hcCCCCC
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM--LGSEIML 677 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~--L~~~~~~ 677 (717)
..-..++.+|+.+||..||++|.|++||++. |.+-...
T Consensus 233 -------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 233 -------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred -------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 1112345577888999999999999999984 4444433
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=311.36 Aligned_cols=238 Identities=25% Similarity=0.413 Sum_probs=179.5
Q ss_pred cCcccccccccCCccceEeeeeCCch--------------------------------------------hhhhhhhhhh
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ--------------------------------------------EIAHRNLVKL 459 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~--------------------------------------------~vah~niv~l 459 (717)
++|.+.++||+|+||.||++.+.+.. .+.||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 57889999999999999998643210 1129999999
Q ss_pred cceeecCceeeEEEeccCCCChhhHhhhcc----------------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEe
Q 039318 460 LGCCIQGEEKLLIYEFMPNRSLDSFIFDQT----------------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIH 523 (717)
Q Consensus 460 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH 523 (717)
++++.+.+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999985421 1134677889999999999999999998 999
Q ss_pred ccCCCCceEEcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc--CCCC
Q 039318 524 RDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS--GKKN 601 (717)
Q Consensus 524 rDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--G~~p 601 (717)
|||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543332222233456789999999988899999999999999999987 4556
Q ss_pred CCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 602 RGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
|...... ..+......+......... ..+......+.+++.+||+.+|++|||+.+|+++|++
T Consensus 242 ~~~~~~~---~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDE---QVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHH---HHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 5543222 2222222222111100000 0011122457789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.74 Aligned_cols=235 Identities=28% Similarity=0.427 Sum_probs=186.5
Q ss_pred ccCCCCCcccHHHHHHHhcCcccccccccCCccceEeeeeCCch------------------hhhhhhhhhhcceeecCc
Q 039318 406 NEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADGQ------------------EIAHRNLVKLLGCCIQGE 467 (717)
Q Consensus 406 ~~~~~~~~~~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~------------------~vah~niv~l~~~~~~~~ 467 (717)
++..++|.-.+.++ +-||+|+.|.||+|++++.. .+.||||+.+.|+|....
T Consensus 116 ~e~WeiPFe~IsEL----------eWlGSGaQGAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 116 EELWEIPFEEISEL----------EWLGSGAQGAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hhhccCCHHHhhhh----------hhhccCcccceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCc
Confidence 44556665444444 56999999999999986532 223999999999999999
Q ss_pred eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla 547 (717)
..+||||||+.|-|...|+ ....+.......+..+||.|+.|||.+. |||||||.-||||..+..+||+|||-+
T Consensus 186 cyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred eeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccch
Confidence 9999999999999999993 4456777888899999999999999998 999999999999999999999999999
Q ss_pred ccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 548 RTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
+...... ....++||..|||||+++..+.++|+|||||||||||||||..||....... | +|..-. .
T Consensus 260 ~e~~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----I--IwGVGs--N-- 326 (904)
T KOG4721|consen 260 KELSDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----I--IWGVGS--N-- 326 (904)
T ss_pred Hhhhhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----e--EEeccC--C--
Confidence 9765432 2335899999999999999999999999999999999999999976322111 1 111110 1
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.+.-..+......++-|+.+||+-.|.+||++.+++..|+=.
T Consensus 327 -----sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 327 -----SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred -----cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 111122233344555678889999999999999999999644
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=320.49 Aligned_cols=233 Identities=30% Similarity=0.442 Sum_probs=179.3
Q ss_pred hcCcccccccccCCccceEeeeeC------Cch---------------------h------h-hhhhhhhhcceeecCce
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLA------DGQ---------------------E------I-AHRNLVKLLGCCIQGEE 468 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~---------------------~------v-ah~niv~l~~~~~~~~~ 468 (717)
.++|++.++||+|+||.||+|+.. .+. + + .||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 346888999999999999998531 000 1 1 39999999999999999
Q ss_pred eeEEEeccCCCChhhHhhhccc----------------------------------------------------------
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTK---------------------------------------------------------- 490 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 490 (717)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999854221
Q ss_pred --------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 491 --------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 491 --------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124778889999999999999999998 999999999999999999999999999865433221
Q ss_pred cccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 557 GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.....+.. ..+.+..+.....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~------~~~~~~~~~~~~~------ 338 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK------FYKMIKEGYRMLS------ 338 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH------HHHHHHhCccCCC------
Confidence 12222345678999999999999999999999999999998 8888764332211 1122222211000
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
+.....++.+|+.+||+.||++||++.||+++|+.
T Consensus 339 ---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 339 ---PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 00112357789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=325.80 Aligned_cols=236 Identities=26% Similarity=0.306 Sum_probs=191.3
Q ss_pred HhcCcccccccccCCccceEeeeeCCc-hhhh---------------------------hhhhhhhcce-eec------C
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADG-QEIA---------------------------HRNLVKLLGC-CIQ------G 466 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~va---------------------------h~niv~l~~~-~~~------~ 466 (717)
...++++.+.|.+|||+.||.|++..+ .++| |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345788899999999999999998776 4443 9999999993 221 2
Q ss_pred ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccc
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGL 546 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgl 546 (717)
-+.+|.||||++|.|-+++..+...+ |++.++++|+.++++|+++||... .+|||||||-+||||+.+++.||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 46789999999999999997655544 999999999999999999999985 6899999999999999999999999999
Q ss_pred cccccCCccccc-------cceecccccccCcccc---ccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHH
Q 039318 547 ARTFVGDEIEGS-------TKRVVGTYGYMAPEYA---SDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGH 616 (717)
Q Consensus 547 a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~ 616 (717)
|........... .-...-|+.|+|||++ .+.++++|+|||||||+||-|+....||+...
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg---------- 262 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG---------- 262 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----------
Confidence 975433221110 0113568999999977 57889999999999999999999999997321
Q ss_pred HHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCCCC
Q 039318 617 AWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLP 678 (717)
Q Consensus 617 ~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~ 678 (717)
...+++..+.-+.......++.+||..||+.||++||++-+|+..+......+
T Consensus 263 ---------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 ---------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 22445555555555678888999999999999999999999999887665433
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=320.19 Aligned_cols=234 Identities=30% Similarity=0.455 Sum_probs=179.5
Q ss_pred hcCcccccccccCCccceEeeeeCC------ch---------------------------hh-hhhhhhhhcceeecCce
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD------GQ---------------------------EI-AHRNLVKLLGCCIQGEE 468 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~---------------------------~v-ah~niv~l~~~~~~~~~ 468 (717)
.++|++.+.||+|+||.||+|+... +. .+ .|+|||++++++.+.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 3578999999999999999876311 00 11 29999999999999999
Q ss_pred eeEEEeccCCCChhhHhhhccc----------------------------------------------------------
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTK---------------------------------------------------------- 490 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 490 (717)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999854211
Q ss_pred ---------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccce
Q 039318 491 ---------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561 (717)
Q Consensus 491 ---------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 561 (717)
...+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 124678888999999999999999998 99999999999999999999999999986543322112222
Q ss_pred ecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCH
Q 039318 562 VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNL 640 (717)
Q Consensus 562 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~ 640 (717)
..++..|+|||++.+..++.++|||||||++|||++ |+.||........ .......+..... ..
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~~~~~-----~~---- 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRGYQMSR-----PD---- 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHcccCccC-----CC----
Confidence 345678999999998999999999999999999997 9999865332211 1111111110000 00
Q ss_pred HHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 641 AEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 641 ~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.....+.+++.+||+.+|++||++.+|+++|+..
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0124567888999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=314.15 Aligned_cols=227 Identities=23% Similarity=0.337 Sum_probs=179.6
Q ss_pred cCcccccccccCCccceEeeeeCCc-hhh-----------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QEI-----------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v-----------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.++||+|+||.||+|+.... +.+ .||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4689999999999999999987542 211 1999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999943 345788999999999999999999998 99999999999999999999999999986532
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ..+... .. .+.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i----~~~~~~-~~---~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL----KYWKET-LQ---RPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH----Hhcccc-cc---CCC
Confidence 233467999999999999999999999999999999999999998754322211111 111110 00 000
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.. .........+.+++.+||+.+|.+||++.++++.
T Consensus 222 ~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 0001123456788899999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=288.80 Aligned_cols=252 Identities=23% Similarity=0.286 Sum_probs=185.4
Q ss_pred hcCcccccccccCCccceEeeeeCCchhhh-----------------------------hhhhhhhcceeec--CceeeE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA-----------------------------HRNLVKLLGCCIQ--GEEKLL 471 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-----------------------------h~niv~l~~~~~~--~~~~~l 471 (717)
.++|+.+++|++|+||.||+|+++...+|. |||||.+-.+... -+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 457999999999999999999987654432 9999999887653 457999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
|||||+. +|..++.... +.+...++..+..|+++|++|||.+. |+||||||+|+|+...|.+||+|||+|+.+.
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999976 8888885433 46888999999999999999999998 9999999999999999999999999999875
Q ss_pred CCccccccceecccccccCccccccCC-CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhh---CCCCc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGL-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWN---NGMPS 627 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 627 (717)
... ...+..+-|..|+|||++.+.. |+.+.|+||+|||+.||+.+++.|......+ ++..+++.+. +....
T Consensus 229 sp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d---Ql~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 229 SPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID---QLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred CCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH---HHHHHHHHhCCCccccCC
Confidence 432 2234577899999999998764 9999999999999999999999887554443 3333333321 11111
Q ss_pred cccchh--------------hhccCCHH-HHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCCCCCCCCCCcc
Q 039318 628 QLIDAY--------------YQESCNLA-EVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQPGFL 686 (717)
Q Consensus 628 ~l~d~~--------------~~~~~~~~-~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~p~~p~~~ 686 (717)
.+.+.. +...+... -...-.+|.-..|..||.+|.|++|.++.= --.+.|.|..|.++
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~-~F~e~P~p~~P~~~ 376 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE-YFRETPLPIDPSMF 376 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc-ccccCCCCCChhhc
Confidence 110000 00001100 113446777788999999999999987641 11244445444444
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=276.54 Aligned_cols=223 Identities=26% Similarity=0.348 Sum_probs=184.0
Q ss_pred hcCcccccccccCCccceEeeeeCCchhh------------------------------hhhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEI------------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~v------------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
.++|++.+.||+|-||.||.|+.+...-+ .||||+++|+++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 46899999999999999999987654321 199999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
+||.+.|.|...+... ..+.+++.....++.|+|.||.|+|.++ ||||||||+|+|++.++.+||+|||-+....
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999999543 3456788889999999999999999998 9999999999999999999999999987643
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
.....+.+||..|++||...+..++.++|+|++|++.||++.|.+||+....++....+ .+ - ++.+
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI---~k----~---~~~~- 241 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI---RK----V---DLKF- 241 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH---HH----c---cccC-
Confidence 22344689999999999999999999999999999999999999999854422222111 11 0 1111
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+..-...+.+++.+|+.++|.+|.+..||+..
T Consensus 242 ------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 ------PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ------CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 11222456789999999999999999999863
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=305.92 Aligned_cols=239 Identities=22% Similarity=0.268 Sum_probs=177.5
Q ss_pred cCcccccccccCCccceEeeeeCCchh-----------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQE-----------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~-----------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
++|++.+.||+|+||.||+++.+...+ +.||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 478999999999999999998754221 129999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|++++.+..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999987765542 2345888999999999999999999988 9999999999999999999999999998753322
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHH--------HHh-hCCC
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAW--------KLW-NNGM 625 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~--------~~~-~~~~ 625 (717)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+.... +.+ ....
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 12224578999999999999899999999999999999999999987543222111111100 000 0000
Q ss_pred CccccchhhhccCCH------HHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 626 PSQLIDAYYQESCNL------AEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 626 ~~~l~d~~~~~~~~~------~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
......+........ .....+.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000000 11235789999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=301.69 Aligned_cols=231 Identities=29% Similarity=0.474 Sum_probs=182.6
Q ss_pred cCcccccccccCCccceEeeeeCCch------h---------------------------hhhhhhhhhcceeecCceee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ------E---------------------------IAHRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~------~---------------------------vah~niv~l~~~~~~~~~~~ 470 (717)
++|++.+.||+|+||.||+|...... . +.||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 46888999999999999998753211 0 11999999999999999999
Q ss_pred EEEeccCCCChhhHhhhccc-------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC
Q 039318 471 LIYEFMPNRSLDSFIFDQTK-------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM 537 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~ 537 (717)
++|||+++++|.+++..... ...+++..++.++.|+++||.|||+++ |+|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999965321 145788899999999999999999998 99999999999999999
Q ss_pred CceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHH
Q 039318 538 NPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGH 616 (717)
Q Consensus 538 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~ 616 (717)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999986543322222334566889999999998899999999999999999998 999986433221
Q ss_pred HHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 617 AWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 617 ~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
....+..+..... +.....++.+|+.+||+.+|++||++.||++.|+.
T Consensus 235 ~~~~i~~~~~~~~---------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIRSRQLLPC---------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcCCC---------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1122222221111 11223567789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.47 Aligned_cols=174 Identities=29% Similarity=0.403 Sum_probs=151.2
Q ss_pred hcCcccccccccCCccceEeeeeCCchh----------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQE----------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~----------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
.++|++.+.||+|+||.||+++...... +.||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4689999999999999999998753211 119999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++++|.+++.. ...+++..+..++.|++.||.|||+++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999944 335788999999999999999999853 3999999999999999999999999999865322
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCC
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFY 605 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~ 605 (717)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 123457899999999999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=309.16 Aligned_cols=226 Identities=24% Similarity=0.369 Sum_probs=187.0
Q ss_pred hcCcccccccccCCccceEeeeeCCch-----------------------------hhhhhhhhhhcceeecCce-eeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ-----------------------------EIAHRNLVKLLGCCIQGEE-KLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-----------------------------~vah~niv~l~~~~~~~~~-~~lV 472 (717)
.++|..++.||+|+||.++..+.+... ++.|||||.+.+.+.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367889999999999999988754321 1229999999999999988 9999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|+||+||+|.+.|.++. ...++++.+..++.|++.|+.|||++. |+|||||+.||++..+..|||.|||+|+.+..
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999997654 567899999999999999999999877 99999999999999999999999999998866
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
.. ....+.+||+.||+||++.+.+|..|+|||||||++|||++=+++|...+... ++....+ ..
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki~~----~~------- 222 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKINR----GL------- 222 (426)
T ss_pred ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHHhh----cc-------
Confidence 54 23456899999999999999999999999999999999999999987543222 1111111 11
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
-.+.+.....++..++..||+.+|..||++.+++.+
T Consensus 223 --~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 --YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 112333455567778889999999999999999885
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.04 Aligned_cols=219 Identities=22% Similarity=0.251 Sum_probs=175.8
Q ss_pred cCcccccccccCCccceEeeeeCCc-hh-----------------------------hhhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QE-----------------------------IAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~-----------------------------vah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||.||+|+.... +. +.||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4688999999999999999987532 11 12999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++++|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999944 345888999999999999999999998 999999999999999999999999999865322
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....... .. .........
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~----~~i~~~~~~------ 216 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IY----EKILAGKLE------ 216 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHHhCCcC------
Confidence 224578999999999999999999999999999999999999986432211 11 111111110
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPC-----MPSVILM 670 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----~~evl~~ 670 (717)
... .....+.+++.+||+.||.+||+ ++++++.
T Consensus 217 ~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 FPR----HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCc----cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 001 11235678899999999999995 7887764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=300.89 Aligned_cols=225 Identities=24% Similarity=0.331 Sum_probs=175.8
Q ss_pred CcccccccccCCccceEeeeeCC-chhh-----------------------------hhhhhhhhcceeecCceeeEEEe
Q 039318 425 NFSINKKLGEGGFGPVYKGTLAD-GQEI-----------------------------AHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-----------------------------ah~niv~l~~~~~~~~~~~lV~E 474 (717)
.|+..+.||+|+||.||++.... ++.+ .|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37788999999999999997642 2111 29999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999998885432 335789999999999999999999998 9999999999999999999999999998653222
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
......||..|+|||++.+..++.++|||||||++|||++|+.||...........+ ........ ..
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~~~~~-~~------ 223 (285)
T cd05631 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV---DRRVKEDQ-EE------ 223 (285)
T ss_pred ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH---HHHhhccc-cc------
Confidence 122457899999999999999999999999999999999999998754332211111 11111110 00
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPC-----MPSVIL 669 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----~~evl~ 669 (717)
.+......+.+|+.+||+.||.+||+ ++++++
T Consensus 224 ---~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 224 ---YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ---CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11111235678899999999999997 778776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=296.64 Aligned_cols=236 Identities=24% Similarity=0.308 Sum_probs=178.4
Q ss_pred CcccccccccCCccceEeeeeCCc-hhhh----------------------hhhhhhhcceeecCc-----eeeEEEecc
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG-QEIA----------------------HRNLVKLLGCCIQGE-----EKLLIYEFM 476 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~-~~va----------------------h~niv~l~~~~~~~~-----~~~lV~E~~ 476 (717)
.|...+.+|.|+||.||+|++... +.|| |||||+|.-+|.... ...||||||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 466678999999999999997654 3333 999999998876432 345899999
Q ss_pred CCCChhhHhhhc-cccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC-CCceeccccccccccCCc
Q 039318 477 PNRSLDSFIFDQ-TKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE-MNPKISDFGLARTFVGDE 554 (717)
Q Consensus 477 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~Dfgla~~~~~~~ 554 (717)
|. +|.+.++.. .....++...+.-+..||++||+|||+.+ |+||||||+|||+|.+ |.+||||||.|+.+...+
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 87 888888542 12345777788889999999999999988 9999999999999977 899999999999876554
Q ss_pred cccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccc----
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL---- 629 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l---- 629 (717)
.. ..+..|+.|+|||++.+. .|+.+.||||.|||+.||+-|++-|...... +++..+.+.+.-...+++
T Consensus 181 pn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~---dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 181 PN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV---DQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred Cc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH---HHHHHHHHHhCCCCHHHHhhcC
Confidence 32 457889999999988775 5999999999999999999999998764443 344444443321111111
Q ss_pred -----------cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 630 -----------IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 630 -----------~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.......-.......+.++++.++|+.+|.+|.++.|++..
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11111111122233567899999999999999999999874
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.72 Aligned_cols=219 Identities=22% Similarity=0.268 Sum_probs=175.5
Q ss_pred cCcccccccccCCccceEeeeeCCc-hh-----------------------------hhhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QE-----------------------------IAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~-----------------------------vah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||.||+|+.+.. +. +.||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5789999999999999999987532 11 11999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999954 345788888999999999999999998 999999999999999999999999999865332
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... .....++... +
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~----~~~i~~~~~~-~---- 234 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---FRI----YEKILAGRLK-F---- 234 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---HHH----HHHHhcCCcC-C----
Confidence 2246799999999999999999999999999999999999999863221 111 1111122110 0
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPC-----MPSVILM 670 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----~~evl~~ 670 (717)
... ...++.+++.+||+.||.+||+ +.+++..
T Consensus 235 -p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 235 -PNW----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -CCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 001 1234668899999999999997 6777653
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=298.69 Aligned_cols=229 Identities=27% Similarity=0.391 Sum_probs=178.3
Q ss_pred hcCcccccccccCCccceEeeeeCC----chh---------------------------hhhhhhhhhcceeecCceeeE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD----GQE---------------------------IAHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~---------------------------vah~niv~l~~~~~~~~~~~l 471 (717)
.++|++.+.||+|+||.||+|.++. +.. +.||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 3578899999999999999997531 111 129999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++++|.+++... ...+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999999543 346889999999999999999999998 9999999999999999999999999876532
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
.... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ..+ +...+.....
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~----~~~~~~~~~~-- 228 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVI----KAVEDGFRLP-- 228 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHH----HHHHCCCCCC--
Confidence 2211 11112345678999999999999999999999999999775 99998643221 111 1112221110
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
.+......+.+++.+||+.+|.+||++.++++.|+.
T Consensus 229 -------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 229 -------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 111123457788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=308.74 Aligned_cols=234 Identities=30% Similarity=0.460 Sum_probs=180.2
Q ss_pred hcCcccccccccCCccceEeeeeCCc------hh---------------------------h-hhhhhhhhcceeec-Cc
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG------QE---------------------------I-AHRNLVKLLGCCIQ-GE 467 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~---------------------------v-ah~niv~l~~~~~~-~~ 467 (717)
.++|++.+.||+|+||.||+|...+. +. + .|+||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 46899999999999999999853210 01 1 28999999998764 45
Q ss_pred eeeEEEeccCCCChhhHhhhccc---------------------------------------------------------
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTK--------------------------------------------------------- 490 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 490 (717)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 68899999999999999854221
Q ss_pred -cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccceeccccccc
Q 039318 491 -RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569 (717)
Q Consensus 491 -~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~ 569 (717)
...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 125788999999999999999999988 9999999999999999999999999998764333222233455678899
Q ss_pred CccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHH
Q 039318 570 APEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIH 648 (717)
Q Consensus 570 aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 648 (717)
|||++.+..++.++|||||||++|||++ |+.||......+. ............. +.....++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRMRA---------PEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCCCC---------CccCCHHHHH
Confidence 9999999999999999999999999998 9999864332221 1111111111110 1112345778
Q ss_pred HHhhccccCCCCCCChHHHHHHhcCC
Q 039318 649 VGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 649 l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
++.+||+.+|++||++.||+++|+..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=303.61 Aligned_cols=215 Identities=27% Similarity=0.359 Sum_probs=168.9
Q ss_pred cccccCCccceEeeeeCCch-hh------------------------------hhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLADGQ-EI------------------------------AHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~-~v------------------------------ah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
+.||+|+||.||+|+..... .+ .||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865321 11 299999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999998843 335888999999999999999999998 9999999999999999999999999998643222 22
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... . ...... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~---~-i~~~~~------~~---- 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFD---S-ILNDRP------HF---- 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HHcCCC------CC----
Confidence 33467999999999999999999999999999999999999998643221 1111 1 111110 00
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCChH-HHHH
Q 039318 639 NLAEVIRCIHVGLLCVQHHPEDRPCMP-SVIL 669 (717)
Q Consensus 639 ~~~~~~~~~~l~~~Cl~~dp~~RPs~~-evl~ 669 (717)
+......+.+++.+||+.+|.+||++. ++++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 111123456788899999999999986 4443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=300.72 Aligned_cols=220 Identities=20% Similarity=0.295 Sum_probs=172.3
Q ss_pred cccccCCccceEeeeeCCch----------------------------hhhhhhhhhhcceeec----CceeeEEEeccC
Q 039318 430 KKLGEGGFGPVYKGTLADGQ----------------------------EIAHRNLVKLLGCCIQ----GEEKLLIYEFMP 477 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~----------------------------~vah~niv~l~~~~~~----~~~~~lV~E~~~ 477 (717)
..||+|++|.||+|++.... .+.|||||++++++.+ ....++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 57999999999999874311 0119999999999876 456789999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhc-CCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD-SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
+|+|.+++.. .+.+++.....++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++......
T Consensus 106 ~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 106 RGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 9999999954 34688999999999999999999985 5 8899999999999999999999999998653221
Q ss_pred cccceecccccccCcccccc--CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 557 GSTKRVVGTYGYMAPEYASD--GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..... .........
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~~---i~~~~~~~~------ 242 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYDL---IINKNNSLK------ 242 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHHH---HHhcCCCCC------
Confidence 23568899999999976 67999999999999999999999998743221 11111 111111100
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.+......+.+++.+||+.||++|||+.||++.|+...
T Consensus 243 ---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 243 ---LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ---CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11122345778899999999999999999999997643
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=295.22 Aligned_cols=227 Identities=27% Similarity=0.438 Sum_probs=178.5
Q ss_pred cCcccccccccCCccceEeeeeCCchhh-------------------------hhhhhhhhcceeecCceeeEEEeccCC
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEI-------------------------AHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~v-------------------------ah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
++|++.+.||+|+||.||+++.+++..+ .||||+++++++.+.+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 4688889999999999999987654222 299999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~- 157 (256)
T cd05114 84 GCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS- 157 (256)
T ss_pred CcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec-
Confidence 9999998542 235889999999999999999999998 9999999999999999999999999998653322211
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhcc
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 637 (717)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ...... ..++... ..+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~----i~~~~~~--~~~----- 223 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEM----ISRGFRL--YRP----- 223 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----HHCCCCC--CCC-----
Confidence 112345568999999998899999999999999999999 8999864321 111111 1111110 000
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
......+.+++.+||+.+|++||++.+++++|.
T Consensus 224 --~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 --KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011235788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=296.31 Aligned_cols=230 Identities=30% Similarity=0.445 Sum_probs=181.7
Q ss_pred hcCcccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCceeeEEEeccC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.++|++.++||+|+||.||+|...+++.++ |+||+++++++.+.+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 367999999999999999999875543222 9999999999999999999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 99999998553 2345788899999999999999999988 9999999999999999999999999998754322211
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
.....++..|+|||++.+..++.++||||||+++|+|++ |+.||...... ..... +........
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~~~~~~~~------- 225 (261)
T cd05072 161 -REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSA----LQRGYRMPR------- 225 (261)
T ss_pred -cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHH----HHcCCCCCC-------
Confidence 122345678999999998899999999999999999998 99998643211 11111 111111000
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
.......+.+++.+|++.+|++||++++++++|+.
T Consensus 226 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 --MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00122356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=299.31 Aligned_cols=230 Identities=26% Similarity=0.372 Sum_probs=178.6
Q ss_pred cCcccccccccCCccceEeeeeCC-ch-------------------------------hhhhhhhhhhcceeecCceeeE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQ-------------------------------EIAHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~-------------------------------~vah~niv~l~~~~~~~~~~~l 471 (717)
++|++.+.||+|+||.||+|.+.. ++ .+.||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 468888999999999999997632 11 112999999999875 456789
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+++ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999542 346889999999999999999999988 9999999999999999999999999998654
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||....... + ...+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----~---~~~~~~~~~~~-- 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE----V---PDLLEKGERLA-- 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----H---HHHHHCCCcCC--
Confidence 4332222334567788999999998999999999999999999998 999986432211 1 11111111111
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.+ .. ....+.+++.+|++.+|++||++.|+++.|....
T Consensus 232 ~~---~~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 232 QP---QI----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CC---CC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 00 00 1234567888999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=299.96 Aligned_cols=233 Identities=26% Similarity=0.442 Sum_probs=179.9
Q ss_pred HhcCcccccccccCCccceEeeeeCC------ch---------------------------hhhhhhhhhhcceeecCce
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLAD------GQ---------------------------EIAHRNLVKLLGCCIQGEE 468 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~---------------------------~vah~niv~l~~~~~~~~~ 468 (717)
.+++|++.+.||+|+||.||+|.... +. .+.||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 46789999999999999999876421 00 1129999999999999999
Q ss_pred eeEEEeccCCCChhhHhhhccc-------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCcee
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTK-------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKI 541 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl 541 (717)
.++||||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854321 224577888999999999999999988 999999999999999999999
Q ss_pred ccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHH
Q 039318 542 SDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKL 620 (717)
Q Consensus 542 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 620 (717)
+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||...... ... +.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~----~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVL----RF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HH
Confidence 99999986543322222222355788999999999999999999999999999999 78887643221 111 11
Q ss_pred hhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 621 WNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 621 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
.......... ......+.+++.+||+.+|++||++.|++++|++
T Consensus 234 ~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111111111 1112356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=306.18 Aligned_cols=226 Identities=22% Similarity=0.294 Sum_probs=173.8
Q ss_pred CcccccccccCCccceEeeeeCC----chhh-------------------------------hhhhhhhhcceeecCcee
Q 039318 425 NFSINKKLGEGGFGPVYKGTLAD----GQEI-------------------------------AHRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~----~~~v-------------------------------ah~niv~l~~~~~~~~~~ 469 (717)
+|++.++||+|+||.||+++... ++.+ .||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 48889999999999999886531 1111 189999999999999999
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999854 345889999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCccccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 550 FVGDEIEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 550 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.. ... ...
T Consensus 155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~--~~~-~~~--- 227 (332)
T cd05614 155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR--RIL-KCD--- 227 (332)
T ss_pred ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH--HHh-cCC---
Confidence 533221 122346799999999999865 478999999999999999999999875433222221111 111 110
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP-----CMPSVILM 670 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~~ 670 (717)
+.... .....+.+++.+||+.||++|| +++++++.
T Consensus 228 ---~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 ---PPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---CCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 00111 1123456788999999999999 66677653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=301.77 Aligned_cols=235 Identities=23% Similarity=0.341 Sum_probs=174.1
Q ss_pred cCcccccccccCCccceEeeeeC-C-chhh-------------------------------hhhhhhhhcceee-----c
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLA-D-GQEI-------------------------------AHRNLVKLLGCCI-----Q 465 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~-~-~~~v-------------------------------ah~niv~l~~~~~-----~ 465 (717)
++|++.+.||+|+||.||+|+.. . ++.+ .||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 37899999999999999999763 1 2111 2999999999875 3
Q ss_pred CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 466 GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 466 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
....++||||++ ++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999997 5898888543 2345789999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM 625 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 625 (717)
+++..... .......|++.|+|||++.+..++.++|||||||++|||++|++||......+ .+...........
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~ 229 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPG 229 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCC
Confidence 99865332 12334678999999999998899999999999999999999999987543322 1211111110000
Q ss_pred Ccc------ccchhh--hccCCHH-----HHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 626 PSQ------LIDAYY--QESCNLA-----EVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 626 ~~~------l~d~~~--~~~~~~~-----~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
... +..... ......+ ....+.+++.+||+.+|++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 000000 0000111 1234568999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=306.42 Aligned_cols=230 Identities=26% Similarity=0.411 Sum_probs=177.6
Q ss_pred cCcccccccccCCccceEeeeeCCc-hh----h---------------------------hhhhhhhhcceeecCceeeE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QE----I---------------------------AHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~----v---------------------------ah~niv~l~~~~~~~~~~~l 471 (717)
.+|++.+.||+|+||.||+|++... .. + .||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 5699999999999999999975321 11 1 199999999998764 5789
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
|+||+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999999543 335788899999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
............++..|+|||++.+..++.++||||||+++|||++ |+.||+.....+ + ...........
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~----~---~~~~~~~~~~~-- 231 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----I---SSILEKGERLP-- 231 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----H---HHHHhCCCCCC--
Confidence 4332222222334678999999999999999999999999999997 999986432111 1 11111111100
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.+......+.+++.+||+.+|++||++.+++..|....
T Consensus 232 -------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 232 -------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred -------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00112235678899999999999999999999986553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=322.63 Aligned_cols=234 Identities=29% Similarity=0.456 Sum_probs=190.8
Q ss_pred cCcccccccccCCccceEeeeeCCc------hhh---------------------------hhhhhhhhcceeecCceee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG------QEI---------------------------AHRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~------~~v---------------------------ah~niv~l~~~~~~~~~~~ 470 (717)
.+....+.||+|.||+||+|+.... +.| .|||||+|+|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 3456678999999999999985321 111 1999999999999999999
Q ss_pred EEEeccCCCChhhHhhhccc-----------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCc
Q 039318 471 LIYEFMPNRSLDSFIFDQTK-----------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP 539 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~ 539 (717)
+|+|||..|+|.+||..... ..+|+..+.+.|+.|||.||.||-++. +|||||-..|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 99999999999999965321 234888999999999999999999987 9999999999999999999
Q ss_pred eeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHH
Q 039318 540 KISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAW 618 (717)
Q Consensus 540 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~ 618 (717)
||+||||++.....+.......-.-.++||+||.+..+.||.+||||||||+|+|+++ |+.|+.....++..
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI------- 715 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI------- 715 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH-------
Confidence 9999999997665554433333445689999999999999999999999999999999 99998765544332
Q ss_pred HHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCC
Q 039318 619 KLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM 676 (717)
Q Consensus 619 ~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~ 676 (717)
+.+.++.+ -+.+.....++.+|+..||+.+|.+||+++||-..|+....
T Consensus 716 e~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 716 ECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 23333332 22344455678899999999999999999999999976654
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=301.89 Aligned_cols=235 Identities=23% Similarity=0.314 Sum_probs=174.6
Q ss_pred cCcccccccccCCccceEeeeeCCch-h---------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-E---------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-~---------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
++|++.++||+|+||.||+|+.+... . +.||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999764321 1 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++ +|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 985 888888432 335788899999999999999999998 9999999999999999999999999997643221
Q ss_pred ccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC---Cc----
Q 039318 556 EGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM---PS---- 627 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~---- 627 (717)
.......+++.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+ ........ ..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI---FRLLGTPTEETWPGITS 233 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCChHHhhcccc
Confidence 11223568999999998865 56899999999999999999999998654333222211 11111000 00
Q ss_pred -----cccchhhhccC----CHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 628 -----QLIDAYYQESC----NLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 628 -----~l~d~~~~~~~----~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
....+...... .......+++++.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000000 0011235678999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=293.48 Aligned_cols=222 Identities=23% Similarity=0.402 Sum_probs=184.0
Q ss_pred hcCcccccccccCCccceEeeee-CCchhhh-----------------------------hhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTL-ADGQEIA-----------------------------HRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~va-----------------------------h~niv~l~~~~~~~~~~~lV 472 (717)
..+|++.+.||+|.||.|-+|.. ..|+.|| ||||+.+|.+|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45799999999999999999875 3444433 99999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||..+|.|.+|+ ..++.|++.+...+++||..|+.|+|.+. ++|||||.+|||||.++++||+||||+..+..
T Consensus 132 MEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999999 45667999999999999999999999998 99999999999999999999999999988754
Q ss_pred CccccccceecccccccCccccccCCCC-ccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFS-VKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
.. ...+++|++-|.+||++.+.+|. +.+|-|||||+||.|+.|..||+..+.. .++ +.+..+
T Consensus 206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lv----rQIs~G------- 268 (668)
T KOG0611|consen 206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLV----RQISRG------- 268 (668)
T ss_pred cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHH----HHhhcc-------
Confidence 43 24478999999999999999985 8999999999999999999999854321 111 111111
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHh
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L 671 (717)
.+.++ +......-|+.|||..||++|.|+.+|....
T Consensus 269 -aYrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 269 -AYREP---ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -cccCC---CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11111 1223345678899999999999999999863
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=294.15 Aligned_cols=230 Identities=30% Similarity=0.465 Sum_probs=181.0
Q ss_pred hcCcccccccccCCccceEeeeeCCchhh-------------------------hhhhhhhhcceeecCceeeEEEeccC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEI-------------------------AHRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~v-------------------------ah~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.++|++.++||+|++|.||+|....++.+ .||||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 45789999999999999999986544222 29999999999999999999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++........
T Consensus 85 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05068 85 YGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE- 159 (261)
T ss_pred CCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence 999999995433 345789999999999999999999998 999999999999999999999999999876422111
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
.......+..|+|||++.+..++.++||||||+++|||++ |+.||...... ... .........
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~----~~~~~~~~~--------- 223 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVL----QQVDQGYRM--------- 223 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHHcCCCC---------
Confidence 1111223457999999999999999999999999999999 99998633211 111 111111100
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
..+......+.+++.+|++.+|++||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0111223467789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=294.80 Aligned_cols=230 Identities=32% Similarity=0.536 Sum_probs=183.3
Q ss_pred HhcCcccccccccCCccceEeeeeCCchhh--------------------------hhhhhhhhcceeecCceeeEEEec
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQEI--------------------------AHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~v--------------------------ah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
...+|++.++||+|+||.||+|...++..+ .|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 345789999999999999999987653322 299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++.... ...+++..+..++.||+.||.|||+++ |+|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999996532 346789999999999999999999998 99999999999999999999999999986543221
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ...... ......
T Consensus 160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~----~~~~~~------- 223 (261)
T cd05148 160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQI----TAGYRM------- 223 (261)
T ss_pred c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHH----HhCCcC-------
Confidence 1 113345678999999988899999999999999999998 89998643311 111111 111100
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
..+......+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 --PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1111223456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=290.71 Aligned_cols=246 Identities=22% Similarity=0.254 Sum_probs=191.8
Q ss_pred cCcccccccccCCccceEeeeeCCchh------------------------------hhhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQE------------------------------IAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~------------------------------vah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|+++++||.|.-|+||++++++... ..||.|+.||..++.++..+|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 467788999999999999999876421 11999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC-
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG- 552 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~- 552 (717)
|||+||+|..+++++ ..+.+++..+..++.+|+.||+|||-.| ||.|||||+||||.++|++.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999988664 4557888999999999999999999998 99999999999999999999999999753210
Q ss_pred -----------------------------------------------------CccccccceecccccccCccccccCCC
Q 039318 553 -----------------------------------------------------DEIEGSTKRVVGTYGYMAPEYASDGLF 579 (717)
Q Consensus 553 -----------------------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~ 579 (717)
+......+.++||-.|+|||++.|...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000122345799999999999999999
Q ss_pred CccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCC
Q 039318 580 SVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPE 659 (717)
Q Consensus 580 ~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~ 659 (717)
+.++|+|+|||++||||.|+.||......+...-+ +-+.+.-...+.....+.+||.+.|.+||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI---------------v~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI---------------VGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH---------------hcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 99999999999999999999999866554432211 111111111223345678899999999999
Q ss_pred CCCC----hHHHHH--HhcCCC-----CCCCCCCCCcccc
Q 039318 660 DRPC----MPSVIL--MLGSEI-----MLPQPKQPGFLAD 688 (717)
Q Consensus 660 ~RPs----~~evl~--~L~~~~-----~~~~p~~p~~~~~ 688 (717)
+|.. +.||-+ .+++.. -..+|..|.....
T Consensus 378 kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~ 417 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDG 417 (459)
T ss_pred hhhccccchHHhhcCccccCCChhheeccCCCcCCCcccc
Confidence 9998 888877 345543 1234444555443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=306.43 Aligned_cols=215 Identities=21% Similarity=0.260 Sum_probs=170.3
Q ss_pred cccccCCccceEeeeeCCc-hh-----------------------------hhhhhhhhhcceeecCceeeEEEeccCCC
Q 039318 430 KKLGEGGFGPVYKGTLADG-QE-----------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPNR 479 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~-~~-----------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~g 479 (717)
+.||+|+||.||+++.+.. +. +.||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986532 11 12999999999999999999999999999
Q ss_pred ChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccccc
Q 039318 480 SLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559 (717)
Q Consensus 480 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 559 (717)
+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 99998843 346889999999999999999999998 9999999999999999999999999997532211 122
Q ss_pred ceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCC
Q 039318 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCN 639 (717)
Q Consensus 560 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 639 (717)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ........ . .+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~----~~~~~~~~-~---------~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF----ELILMEEI-R---------FP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHH----HHHHcCCC-C---------CC
Confidence 3467999999999999999999999999999999999999998532211 111 11111111 0 01
Q ss_pred HHHHHHHHHHHhhccccCCCCCC-----ChHHHHH
Q 039318 640 LAEVIRCIHVGLLCVQHHPEDRP-----CMPSVIL 669 (717)
Q Consensus 640 ~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~ 669 (717)
......+.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 11223567889999999999999 7888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=310.07 Aligned_cols=240 Identities=21% Similarity=0.244 Sum_probs=176.5
Q ss_pred HhcCcccccccccCCccceEeeeeCCch-h--------------------hhhhhhhhhcceeecCceeeEEEeccCCCC
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQ-E--------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPNRS 480 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~--------------------vah~niv~l~~~~~~~~~~~lV~E~~~~gs 480 (717)
...+|++.++||+|+||.||++...... . +.|||||++++++......++|||++. ++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~ 168 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TD 168 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CC
Confidence 3468999999999999999999875332 1 229999999999999999999999996 68
Q ss_pred hhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccc
Q 039318 481 LDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTK 560 (717)
Q Consensus 481 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 560 (717)
|..++.. ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++...... .....
T Consensus 169 L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~ 241 (391)
T PHA03212 169 LYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYY 241 (391)
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccccc
Confidence 8888743 345789999999999999999999998 9999999999999999999999999997532211 11223
Q ss_pred eecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCC-C---CchhHHHHHHHHhhCCC---C---cccc
Q 039318 561 RVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHS-D---KNLNLIGHAWKLWNNGM---P---SQLI 630 (717)
Q Consensus 561 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~-~---~~~~~~~~~~~~~~~~~---~---~~l~ 630 (717)
...||+.|+|||++.+..++.++|||||||++|||++|+.|+-.... + .....+........... . ...+
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 46799999999999999999999999999999999999987632211 1 01111111111110000 0 0000
Q ss_pred chhh-----------hccCC----HHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 631 DAYY-----------QESCN----LAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 631 d~~~-----------~~~~~----~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+... ..... ......+.+|+.+||+.||++|||++|+++
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 00000 112346778999999999999999999986
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=309.79 Aligned_cols=227 Identities=21% Similarity=0.265 Sum_probs=170.7
Q ss_pred CcccccccccCCccceEeeeeCCch-h-----------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ-E-----------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~-~-----------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
.|+++++||+|+||.||+|+..... . +.||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999764321 1 119999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999854 335788888899999999999999998 9999999999999999999999999986431100
Q ss_pred c---------------------------------------------ccccceecccccccCccccccCCCCccccchhHh
Q 039318 555 I---------------------------------------------EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFG 589 (717)
Q Consensus 555 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 589 (717)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235799999999999998999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhh--ccccCCCCCCChHHH
Q 039318 590 ILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLL--CVQHHPEDRPCMPSV 667 (717)
Q Consensus 590 ~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~--Cl~~dp~~RPs~~ev 667 (717)
|++|||++|+.||......+.. ...........+. ........+.+++.+ |+..++..||++.++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~------~~i~~~~~~~~~~-------~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQ------LKVINWENTLHIP-------PQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHH------HHHHccccccCCC-------CCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 9999999999998653322111 1111100000000 000111234455655 667777789999999
Q ss_pred HHH
Q 039318 668 ILM 670 (717)
Q Consensus 668 l~~ 670 (717)
+..
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 984
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=296.43 Aligned_cols=231 Identities=27% Similarity=0.450 Sum_probs=181.2
Q ss_pred hcCcccccccccCCccceEeeeeCCc------hh---------------------------hhhhhhhhhcceeecCcee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG------QE---------------------------IAHRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~---------------------------vah~niv~l~~~~~~~~~~ 469 (717)
.++|.+.+.||+|+||.||+|+..+. .. +.|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 35688899999999999999976322 11 1299999999999999999
Q ss_pred eEEEeccCCCChhhHhhhcc-----------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC
Q 039318 470 LLIYEFMPNRSLDSFIFDQT-----------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN 538 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~ 538 (717)
++||||+++++|.+++.... ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999996432 2345788899999999999999999998 999999999999999999
Q ss_pred ceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHH
Q 039318 539 PKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHA 617 (717)
Q Consensus 539 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~ 617 (717)
+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~--- 234 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VI--- 234 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH---
Confidence 99999999986533222222223456788999999999999999999999999999998 999986433221 11
Q ss_pred HHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 618 WKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 618 ~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
.....+...... ......+.+++.+||+.+|++||++.||+++|+
T Consensus 235 -~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 -ECITQGRLLQRP---------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -HHHHcCCcCCCC---------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111122211111 112245678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=309.71 Aligned_cols=225 Identities=25% Similarity=0.345 Sum_probs=178.0
Q ss_pred cCcccccccccCCccceEeeeeCC-chhh-----------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEI-----------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-----------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|.+.+.||+|+||.||+|+... ++.+ .||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 478999999999999999998763 2211 1999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999543 56889999999999999999999988 999999999999999999999999999865432
Q ss_pred c---------------------------cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCC
Q 039318 554 E---------------------------IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYH 606 (717)
Q Consensus 554 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~ 606 (717)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0012234679999999999999999999999999999999999999987543
Q ss_pred CCCchhHHHHHHHHhh--CCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCC-hHHHHHH
Q 039318 607 SDKNLNLIGHAWKLWN--NGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPC-MPSVILM 670 (717)
Q Consensus 607 ~~~~~~~~~~~~~~~~--~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-~~evl~~ 670 (717)
.... ...... .... + . ........+.+++.+||+ +|.+||+ ++++++.
T Consensus 235 ~~~~------~~~i~~~~~~~~--~-----p--~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQET------YNKIINWKESLR--F-----P--PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHH------HHHHhccCCccc--C-----C--CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2111 111111 1100 0 0 000023456678888997 9999999 9999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=312.65 Aligned_cols=234 Identities=30% Similarity=0.420 Sum_probs=180.7
Q ss_pred hcCcccccccccCCccceEeeeeCCc------h---------------------h------h-hhhhhhhhcceeecCce
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG------Q---------------------E------I-AHRNLVKLLGCCIQGEE 468 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~------~---------------------~------v-ah~niv~l~~~~~~~~~ 468 (717)
.++|.+.++||+|+||.||+|+.... . + + .|||||++++++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 45788999999999999999874210 0 0 1 19999999999999999
Q ss_pred eeEEEeccCCCChhhHhhhccc----------------------------------------------------------
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTK---------------------------------------------------------- 490 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 490 (717)
.+||||||++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999999854210
Q ss_pred -----------------------------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC
Q 039318 491 -----------------------------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH 535 (717)
Q Consensus 491 -----------------------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~ 535 (717)
...+++..++.++.||++||+|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124677888999999999999999988 999999999999999
Q ss_pred CCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHH
Q 039318 536 EMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLI 614 (717)
Q Consensus 536 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~ 614 (717)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....+...
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--- 349 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--- 349 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH---
Confidence 99999999999986543322222223456788999999999999999999999999999997 99998643222111
Q ss_pred HHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 615 GHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 615 ~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
......+.... .+......+.+++.+||+.+|++||++.+|+++|+..
T Consensus 350 ---~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 350 ---YNKIKSGYRMA---------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred ---HHHHhcCCCCC---------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 11111111100 0111234577899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=303.45 Aligned_cols=231 Identities=30% Similarity=0.453 Sum_probs=183.8
Q ss_pred ccccCCccceEeeeeCCchh---------------------------hhhhhhhhhcceeecCceeeEEEeccCCCChhh
Q 039318 431 KLGEGGFGPVYKGTLADGQE---------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDS 483 (717)
Q Consensus 431 ~lG~G~fg~Vy~~~~~~~~~---------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~gsL~~ 483 (717)
.||+|.||+||-|++.+.+. +.|+|||+++|.+.+++..-|.||.+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999765431 229999999999999999999999999999999
Q ss_pred HhhhccccccC--ChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC-CCCceeccccccccccCCccccccc
Q 039318 484 FIFDQTKRKLL--DWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH-EMNPKISDFGLARTFVGDEIEGSTK 560 (717)
Q Consensus 484 ~l~~~~~~~~l--~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~ 560 (717)
+++. +.+++ .+.++-.+..||++||.|||++. |||||||-+|+||+. .|.+||+|||-++.+.. ....+.
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence 9953 45566 77888889999999999999998 999999999999974 58899999999997643 334566
Q ss_pred eecccccccCccccccCC--CCccccchhHhHHHHHhhcCCCCCCCCCCC-CchhHHHHHHHHhhCCCCccccchhhhcc
Q 039318 561 RVVGTYGYMAPEYASDGL--FSVKSDVFSFGILLLEIVSGKKNRGFYHSD-KNLNLIGHAWKLWNNGMPSQLIDAYYQES 637 (717)
Q Consensus 561 ~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 637 (717)
++.||..|||||++..++ |+.++|||||||.+.||.||++||-..... ..+..+ +.- .....
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV---------Gmy------KvHP~ 799 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV---------GMY------KVHPP 799 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh---------cce------ecCCC
Confidence 789999999999998765 889999999999999999999998533221 111111 110 01223
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHH--HhcCCCCCCCCCCC
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL--MLGSEIMLPQPKQP 683 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~--~L~~~~~~~~p~~p 683 (717)
.+.+...++..++++|+..+|.+||+++++++ .|.-....+.|+.+
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~ls 847 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKLS 847 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCCCC
Confidence 34455678899999999999999999999998 45443334444444
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=308.64 Aligned_cols=236 Identities=23% Similarity=0.291 Sum_probs=183.9
Q ss_pred cCcccccccccCCccceEeeeeCCch--hh-----------------------------hhhhhhhhcceeecCceeeEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ--EI-----------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~--~v-----------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
++|++.+.||+|+||.||+|+.+... .+ .||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 57999999999999999999754321 11 199999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999954 345888999999999999999999998 99999999999999999999999999986532
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... .........
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~----~~i~~~~~~----- 246 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LIY----QKILEGIIY----- 246 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HHH----HHHhcCCCC-----
Confidence 1 23467999999999999988999999999999999999999998643211 111 111111110
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH--hcCC-------CCCCCCCCCCccc
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRP-----CMPSVILM--LGSE-------IMLPQPKQPGFLA 687 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~~--L~~~-------~~~~~p~~p~~~~ 687 (717)
.... ....+.+++.+||+.+|++|+ +++++++. +.+. ..++.|..|.+..
T Consensus 247 -~p~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~ 310 (340)
T PTZ00426 247 -FPKF----LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKN 310 (340)
T ss_pred -CCCC----CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 0011 113456889999999999995 88888875 2221 1345666666533
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=320.12 Aligned_cols=226 Identities=18% Similarity=0.244 Sum_probs=178.9
Q ss_pred CcccccccccCCccceEeeeeCCc--hhh--------------------------hhhhhhhhcceeecCceeeEEEecc
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG--QEI--------------------------AHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~--~~v--------------------------ah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
.|.+.+.||+|+||.||+|..... +.+ .|||||++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 488999999999999999975432 111 1999999999999999999999999
Q ss_pred CCCChhhHhhhc-cccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 477 PNRSLDSFIFDQ-TKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 477 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
++|+|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988543 23446888899999999999999999998 99999999999999999999999999987644322
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+ ..... +....+
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~---~~~~~-~~~~~~------ 291 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIM---QQVLY-GKYDPF------ 291 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHh-CCCCCC------
Confidence 22234567999999999999999999999999999999999999998642211 111 11111 111100
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+......+.+++.+||+.+|++||++.+++.
T Consensus 292 ---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 ---PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1111235678899999999999999999875
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=293.57 Aligned_cols=230 Identities=29% Similarity=0.446 Sum_probs=180.5
Q ss_pred cCcccccccccCCccceEeeeeCCc----hh---------------------------hhhhhhhhhcceeecCceeeEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG----QE---------------------------IAHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~----~~---------------------------vah~niv~l~~~~~~~~~~~lV 472 (717)
++|++.+.||+|+||.||+|+++.. .. +.||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5789999999999999999976421 00 1199999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999999543 236889999999999999999999988 99999999999999999999999999997642
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
...........++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ..........
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~----~~~~~~~~~~--- 228 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVI----KAVEDGYRLP--- 228 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHH----HHHHcCCCCC---
Confidence 221111222345678999999998899999999999999999998 99997532211 111 1111111100
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.+......+.+++.+|++.+|++||++.+|+++|+..
T Consensus 229 ------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 ------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0111234567899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=305.12 Aligned_cols=215 Identities=26% Similarity=0.334 Sum_probs=171.0
Q ss_pred CcccccccccCCccceEeeeeCCch-hh------------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ-EI------------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~-~v------------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
+|.+.+.||+|+||.||+|+..... .+ .|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999865421 11 1788999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999988843 345888999999999999999999998 999999999999999999999999999754322
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... .......
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~----i~~~~~~------ 219 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQS----IMEHNVA------ 219 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHH----HHhCCCC------
Confidence 1 1223467999999999999999999999999999999999999998743321 11111 1111110
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCCh
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCM 664 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~ 664 (717)
.+.....++.+++.+||+.+|++|++.
T Consensus 220 ----~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 ----YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 011122456789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.38 Aligned_cols=237 Identities=23% Similarity=0.324 Sum_probs=174.1
Q ss_pred hcCcccccccccCCccceEeeeeCC-chh---------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQE---------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~---------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
.++|++.++||+|+||.||+|+... ++. +.||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 4689999999999999999998753 211 129999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|++ ++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 577777743 2345788889999999999999999998 9999999999999999999999999997543221
Q ss_pred cccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc------
Q 039318 555 IEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS------ 627 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 627 (717)
.......+++.|+|||++.+ ..++.++|||||||++|||++|+.||..... ....+......+......
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchh
Confidence 11223568999999998865 4588999999999999999999999875322 111222222111110000
Q ss_pred ---cccchhh--hccCCHH-------HHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 628 ---QLIDAYY--QESCNLA-------EVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 628 ---~l~d~~~--~~~~~~~-------~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
....... ....... ....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000 0000111 1135678899999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=308.14 Aligned_cols=176 Identities=26% Similarity=0.356 Sum_probs=150.8
Q ss_pred cCcccccccccCCccceEeeeeCCc-hhh-----------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QEI-----------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v-----------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||.||+++.... +.+ .||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4789999999999999999976532 111 1999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++|+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999954 346889999999999999999999998 999999999999999999999999999754321
Q ss_pred ccc---------------------------------cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCC
Q 039318 554 EIE---------------------------------GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKK 600 (717)
Q Consensus 554 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~ 600 (717)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCCC
Q 039318 601 NRGFY 605 (717)
Q Consensus 601 p~~~~ 605 (717)
||...
T Consensus 235 Pf~~~ 239 (363)
T cd05628 235 PFCSE 239 (363)
T ss_pred CCCCC
Confidence 98643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=271.36 Aligned_cols=239 Identities=21% Similarity=0.252 Sum_probs=182.4
Q ss_pred HhcCcccccccccCCccceEeeeeCCc---------------------------hhhhhhhhhhhcceeecCc-----ee
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADG---------------------------QEIAHRNLVKLLGCCIQGE-----EK 469 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~---------------------------~~vah~niv~l~~~~~~~~-----~~ 469 (717)
..++|.+.+.||+|||..||.++.-.. +.+.|||+++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 457899999999999999999983211 1122999999998876544 48
Q ss_pred eEEEeccCCCChhhHhhhcccc-ccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKR-KLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
||+++|...|+|.+.+...... ..+++.+++.|+.+|++||++||+.. .++.||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999765444 47999999999999999999999987 479999999999999999999999999997
Q ss_pred cccCCcc-------ccccceecccccccCccccc---cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHH
Q 039318 549 TFVGDEI-------EGSTKRVVGTYGYMAPEYAS---DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAW 618 (717)
Q Consensus 549 ~~~~~~~-------~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~ 618 (717)
...-... ......-..|..|+|||++. +...++++|||||||+||+|+.|..||+..-....
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-------- 249 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-------- 249 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC--------
Confidence 5421110 00112246789999999885 45578999999999999999999999974321110
Q ss_pred HHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 619 KLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 619 ~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.....+....+.-+......+.+.+++.+|||.||.+||++.+++..++.+
T Consensus 250 -----SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 250 -----SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 011111121222222223556788999999999999999999999988654
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.56 Aligned_cols=233 Identities=25% Similarity=0.432 Sum_probs=183.6
Q ss_pred cCcccccccccCCccceEeeeeCC------c--------------------------hhhhhhhhhhhcceeecCceeeE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD------G--------------------------QEIAHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~------~--------------------------~~vah~niv~l~~~~~~~~~~~l 471 (717)
++|.+.+.||+|+||.||+|+... . +.+.|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 468888999999999999986421 0 01129999999999999999999
Q ss_pred EEeccCCCChhhHhhhcc-------------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC
Q 039318 472 IYEFMPNRSLDSFIFDQT-------------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN 538 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~ 538 (717)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999996532 1235789999999999999999999998 999999999999999999
Q ss_pred ceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHH
Q 039318 539 PKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHA 617 (717)
Q Consensus 539 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~ 617 (717)
+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~---- 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---V---- 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H----
Confidence 99999999986543322222233556789999999999999999999999999999998 999976433221 1
Q ss_pred HHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 618 WKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 618 ~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
......+...... ......+.+++.+||+.+|++||++.+|+++|+...
T Consensus 235 ~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 235 IECITQGRVLERP---------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred HHHHhCCCCCCCC---------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1122222221111 112345778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=301.01 Aligned_cols=218 Identities=25% Similarity=0.365 Sum_probs=171.8
Q ss_pred cccccccccCCccceEeeeeCCc-h--------------------------------hhhhhhhhhhcceeecCceeeEE
Q 039318 426 FSINKKLGEGGFGPVYKGTLADG-Q--------------------------------EIAHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~~-~--------------------------------~vah~niv~l~~~~~~~~~~~lV 472 (717)
|++.+.||+|+||.||+|+.... + .+.||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67789999999999999976432 1 01299999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++++|..++. ...+++..+..++.||+.||.|||+++ |+||||||+||||++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988873 245899999999999999999999998 99999999999999999999999999875322
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
.. .......|++.|+|||++.+..++.++|||||||++|||++|+.||......+ ... ... .....
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---~~~---~i~-~~~~~----- 219 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---VFD---SIV-NDEVR----- 219 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---HHH---HHH-hCCCC-----
Confidence 11 12234679999999999999999999999999999999999999986432211 111 111 11110
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRP-----CMPSVIL 669 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~ 669 (717)
... .....+.+++.+||+.||.+|| ++.++++
T Consensus 220 -~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 -YPR----FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -CCC----CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 001 1123456889999999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=291.90 Aligned_cols=230 Identities=29% Similarity=0.470 Sum_probs=179.6
Q ss_pred cCcccccccccCCccceEeeeeCCch--------------------------hhhhhhhhhhcceeecCceeeEEEeccC
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ--------------------------EIAHRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~--------------------------~vah~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.+|.+.++||+|+||.||+|..++.. .+.||||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 45788899999999999999864311 1129999999999999999999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++... ....+++..++.++.|+++||+|||+++ ++||||||+||++++++.+||+|||++..........
T Consensus 86 ~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 86 YGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 99999998543 2345789999999999999999999988 9999999999999999999999999998754322111
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||.....++ ............. ..
T Consensus 162 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~-----~~ 228 (263)
T cd05052 162 -HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKGYRMER-----PE 228 (263)
T ss_pred -cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCCCCC-----CC
Confidence 112234568999999999999999999999999999998 999976432211 1111211111110 11
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.....+.+++.+||+.+|++||++.+++++|+..
T Consensus 229 ----~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 ----GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1124567889999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=302.71 Aligned_cols=211 Identities=22% Similarity=0.272 Sum_probs=167.0
Q ss_pred cccccCCccceEeeeeCCc-hh------------------------------hhhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLADG-QE------------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~-~~------------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
+.||+|+||.||+|+.... +. +.||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999987532 11 1299999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|..++.. .+.+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 999998843 345788899999999999999999998 9999999999999999999999999987532221 12
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... .... .... .+ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~---~~i~-~~~~-~~-----~--- 216 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EMY---DNIL-NKPL-RL-----K--- 216 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH---HHH---HHHH-cCCC-CC-----C---
Confidence 33467999999999999999999999999999999999999998643211 111 1111 1111 00 0
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCChH
Q 039318 639 NLAEVIRCIHVGLLCVQHHPEDRPCMP 665 (717)
Q Consensus 639 ~~~~~~~~~~l~~~Cl~~dp~~RPs~~ 665 (717)
......+.+++.+||+.+|++||++.
T Consensus 217 -~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 -PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11134567889999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.96 Aligned_cols=231 Identities=29% Similarity=0.450 Sum_probs=178.5
Q ss_pred cCcccccccccCCccceEeeeeC-----Cch---------------------------hhhhhhhhhhcceeecCceeeE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLA-----DGQ---------------------------EIAHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~---------------------------~vah~niv~l~~~~~~~~~~~l 471 (717)
++|++.+.||+|+||.||+|... .+. .+.||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 46788899999999999998741 111 1129999999999999999999
Q ss_pred EEeccCCCChhhHhhhccc--------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC
Q 039318 472 IYEFMPNRSLDSFIFDQTK--------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM 537 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~ 537 (717)
||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853221 234788889999999999999999998 99999999999999999
Q ss_pred CceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHH
Q 039318 538 NPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGH 616 (717)
Q Consensus 538 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~ 616 (717)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...... ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~--- 235 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EV--- 235 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH---
Confidence 999999999986543332222233456778999999998899999999999999999998 98887543211 11
Q ss_pred HHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 617 AWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 617 ~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
.+......... .... ...++.+++.+|++.+|++||++.+|+++|..
T Consensus 236 -~~~~~~~~~~~-----~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 -IEMVRKRQLLP-----CSED----CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHcCCcCC-----CCCC----CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111111 0111 12356788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.21 Aligned_cols=232 Identities=29% Similarity=0.461 Sum_probs=178.9
Q ss_pred HhcCcccccccccCCccceEeeeeCC-----c-h---------------------------hhhhhhhhhhcceeecCce
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLAD-----G-Q---------------------------EIAHRNLVKLLGCCIQGEE 468 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~-~---------------------------~vah~niv~l~~~~~~~~~ 468 (717)
.+++|.+.+.||+|+||.||+|.+.. . . .+.|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34679999999999999999998754 1 1 1129999999999999999
Q ss_pred eeEEEeccCCCChhhHhhhccc----cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC---Ccee
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTK----RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM---NPKI 541 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl 541 (717)
.++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999955321 135889999999999999999999998 99999999999998765 5899
Q ss_pred ccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHH
Q 039318 542 SDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKL 620 (717)
Q Consensus 542 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 620 (717)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||......+ .. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~----~~ 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VM----EF 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HH
Confidence 99999987633222221222334568999999999999999999999999999997 999986432221 11 11
Q ss_pred hhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 621 WNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 621 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
........ .+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 234 ~~~~~~~~---------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGGGRLD---------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111000 01112245678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.50 Aligned_cols=174 Identities=28% Similarity=0.406 Sum_probs=150.3
Q ss_pred hcCcccccccccCCccceEeeeeCCchh----------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQE----------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~----------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
.++|++.++||+|+||.||+++...... +.||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4689999999999999999998753211 119999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++++|.+++.. .+.+++..+..++.+++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999943 345788899999999999999999753 3999999999999999999999999999765322
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCC
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFY 605 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~ 605 (717)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 123457899999999999989999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=305.40 Aligned_cols=226 Identities=20% Similarity=0.258 Sum_probs=174.9
Q ss_pred cCcccccccccCCccceEeeeeCCc-hhh-----------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QEI-----------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v-----------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||.||+++.... +.+ .||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4789999999999999999986532 111 1999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999999543 246889999999999999999999998 999999999999999999999999999865433
Q ss_pred ccccccceecccccccCccccc------cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 554 EIEGSTKRVVGTYGYMAPEYAS------DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... . ...........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~---~~~i~~~~~~~ 228 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK---T---YNNIMNFQRFL 228 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH---H---HHHHHcCCCcc
Confidence 221 222357899999999986 4567899999999999999999999986432211 1 11111111110
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
... ........+.+++..||+ +|.+||+++++++
T Consensus 229 ~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 KFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 100 011122345677888998 9999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=302.65 Aligned_cols=215 Identities=22% Similarity=0.255 Sum_probs=168.6
Q ss_pred cccCCccceEeeeeCCch-h-----------------------------hhhhhhhhhcceeecCceeeEEEeccCCCCh
Q 039318 432 LGEGGFGPVYKGTLADGQ-E-----------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSL 481 (717)
Q Consensus 432 lG~G~fg~Vy~~~~~~~~-~-----------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~gsL 481 (717)
||+|+||.||+++..... . +.||||+++++++.+.+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875421 1 1199999999999999999999999999999
Q ss_pred hhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccce
Q 039318 482 DSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561 (717)
Q Consensus 482 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 561 (717)
.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 999854 345889999999999999999999998 9999999999999999999999999998643222 12334
Q ss_pred ecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHH
Q 039318 562 VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLA 641 (717)
Q Consensus 562 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~ 641 (717)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ........ . .+ +..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~---~~---~~~~~~~~-~-~~---------~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN---EM---YRKILQEP-L-RF---------PDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH---HH---HHHHHcCC-C-CC---------CCc
Confidence 67999999999999999999999999999999999999998643211 11 11111111 0 00 011
Q ss_pred HHHHHHHHHhhccccCCCCCCChHHHHHHh
Q 039318 642 EVIRCIHVGLLCVQHHPEDRPCMPSVILML 671 (717)
Q Consensus 642 ~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L 671 (717)
....+.+++.+||+.||.+||+...+.+.|
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 123466888999999999998755444444
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=293.09 Aligned_cols=234 Identities=25% Similarity=0.439 Sum_probs=182.6
Q ss_pred hcCcccccccccCCccceEeeeeCC------ch--------------------------hhhhhhhhhhcceeecCceee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD------GQ--------------------------EIAHRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~--------------------------~vah~niv~l~~~~~~~~~~~ 470 (717)
.++|.+.+.||+|+||.||++.... .. .+.||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 3578899999999999999987421 00 112999999999999999999
Q ss_pred EEEeccCCCChhhHhhhcc----------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCce
Q 039318 471 LIYEFMPNRSLDSFIFDQT----------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPK 540 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~k 540 (717)
+||||+++++|.+++.... ....+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999996432 1234899999999999999999999998 99999999999999999999
Q ss_pred eccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHH
Q 039318 541 ISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWK 619 (717)
Q Consensus 541 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~ 619 (717)
|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||......+ . ..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~----~~ 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---V----IE 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HH
Confidence 999999986543322222223445778999999998899999999999999999998 899875433211 1 11
Q ss_pred HhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 620 LWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 620 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
....+..... ... ....+.+++.+||+.+|.+||++.+|++.|+...
T Consensus 234 ~i~~~~~~~~-----~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 234 CITQGRVLQR-----PRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHHcCCcCCC-----CCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1122221111 111 1235788999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=295.32 Aligned_cols=238 Identities=24% Similarity=0.396 Sum_probs=178.7
Q ss_pred hcCcccccccccCCccceEeeeeCCch------------------------------------------hhhhhhhhhhc
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ------------------------------------------EIAHRNLVKLL 460 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~------------------------------------------~vah~niv~l~ 460 (717)
.++|++.++||+|+||.||+++..... .+.|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 357999999999999999987542110 11299999999
Q ss_pred ceeecCceeeEEEeccCCCChhhHhhhccc---------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCce
Q 039318 461 GCCIQGEEKLLIYEFMPNRSLDSFIFDQTK---------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNV 531 (717)
Q Consensus 461 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NI 531 (717)
+++...+..++||||+++++|.+++..... ...+++..++.++.|+++||+|||+++ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999854321 124678889999999999999999998 99999999999
Q ss_pred EEcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc--CCCCCCCCCCCC
Q 039318 532 LLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS--GKKNRGFYHSDK 609 (717)
Q Consensus 532 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--G~~p~~~~~~~~ 609 (717)
++++++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999986533322222223445778999999998899999999999999999988 556665433222
Q ss_pred chhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 610 NLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
.+....+.+.......... .+......+.+|+.+|++.+|++||++.+|+++|+
T Consensus 241 ---~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 ---VIENTGEFFRNQGRQIYLS------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ---HHHHHHHhhhhccccccCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 2211111111110000000 01112246789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=290.15 Aligned_cols=222 Identities=27% Similarity=0.421 Sum_probs=171.2
Q ss_pred cccccCCccceEeeeeCC-chh---------------------------hhhhhhhhhcceeecCceeeEEEeccCCCCh
Q 039318 430 KKLGEGGFGPVYKGTLAD-GQE---------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSL 481 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~-~~~---------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~gsL 481 (717)
++||+|+||.||+|+... ++. +.||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 479999999999997642 211 1299999999999999999999999999999
Q ss_pred hhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccce
Q 039318 482 DSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561 (717)
Q Consensus 482 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 561 (717)
.+++... ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998432 345789999999999999999999998 99999999999999999999999999876432211111111
Q ss_pred ecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCH
Q 039318 562 VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNL 640 (717)
Q Consensus 562 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~ 640 (717)
...+..|+|||.+.+..++.++||||||+++|||++ |..||....... ............ .+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGVRLP---------CPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCCCC---------Ccc
Confidence 223467999999999999999999999999999997 888876432211 111111111101 111
Q ss_pred HHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 641 AEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 641 ~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
.....+.+++.+||+.+|++||++.+|+++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 12345778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.18 Aligned_cols=227 Identities=28% Similarity=0.446 Sum_probs=178.8
Q ss_pred cCcccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCceeeEEEeccCC
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
++|.+.+.||+|+||.||+|+..++..++ ||||+++++++.+.+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 46888899999999999999865443222 99999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++........ .
T Consensus 84 ~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~ 157 (256)
T cd05113 84 GCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-S 157 (256)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-e
Confidence 9999998543 235889999999999999999999998 999999999999999999999999999865433211 1
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhcc
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 637 (717)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .... .........
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~----~~~~~~~~~-------- 222 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEK----VSQGLRLYR-------- 222 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHH----HhcCCCCCC--------
Confidence 112345678999999998889999999999999999998 999986433211 1111 111111000
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
+......+.+++.+||+.+|.+||++.++++.|+
T Consensus 223 -~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 -PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0012346678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=301.46 Aligned_cols=222 Identities=22% Similarity=0.315 Sum_probs=170.8
Q ss_pred cccccCCccceEeeeeCCchh-h------------------------------hhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLADGQE-I------------------------------AHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~~-v------------------------------ah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
+.||+|+||.||+++.....+ + .||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999998653211 0 299999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 999888843 345889999999999999999999998 9999999999999999999999999997532211 12
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCc--hhHHHHHHHHhhCCCCccccchhhhc
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKN--LNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+..+........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--------- 223 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--------- 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC---------
Confidence 2346799999999999999999999999999999999999999964322211 11111122222111110
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCCh------HHHHH
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCM------PSVIL 669 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~------~evl~ 669 (717)
.+......+.+++.+||+.||++||+. .++++
T Consensus 224 -~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 224 -IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred -CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 111122356788999999999999984 56654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.94 Aligned_cols=232 Identities=26% Similarity=0.455 Sum_probs=182.1
Q ss_pred hcCcccccccccCCccceEeeeeCCch------h---------------------------hhhhhhhhhcceeecCcee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ------E---------------------------IAHRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~------~---------------------------vah~niv~l~~~~~~~~~~ 469 (717)
.++|.+.+.||+|+||.||+|..+... . +.||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 467899999999999999998764211 1 1199999999999999999
Q ss_pred eEEEeccCCCChhhHhhhccc-------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceec
Q 039318 470 LLIYEFMPNRSLDSFIFDQTK-------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKIS 542 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 542 (717)
++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999965322 234688899999999999999999988 9999999999999999999999
Q ss_pred cccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHh
Q 039318 543 DFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLW 621 (717)
Q Consensus 543 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 621 (717)
|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ .. +..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~----~~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VL----KFV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HH----HHH
Confidence 9999986544332222233456789999999988889999999999999999998 999986432211 11 111
Q ss_pred hCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 622 NNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 622 ~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
.......... .....+.+++.+||+.+|++|||+.++++.|+.
T Consensus 235 ~~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHLDLPE---------NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCCCCCC---------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111111111 113467789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=302.51 Aligned_cols=210 Identities=27% Similarity=0.386 Sum_probs=166.9
Q ss_pred cccccCCccceEeeeeCCch-hh------------------------------hhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLADGQ-EI------------------------------AHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~-~v------------------------------ah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
+.||+|+||.||+|+.+... .+ .||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875321 11 199999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 999988843 345889999999999999999999998 9999999999999999999999999987542221 12
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~----~~i~~~~~~------~---- 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LF----EAILNDEVV------Y---- 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HH----HHHhcCCCC------C----
Confidence 234679999999999999999999999999999999999999987433211 11 111111110 0
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCCh
Q 039318 639 NLAEVIRCIHVGLLCVQHHPEDRPCM 664 (717)
Q Consensus 639 ~~~~~~~~~~l~~~Cl~~dp~~RPs~ 664 (717)
+......+.+++.+||+.||++||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 00112356788999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=297.96 Aligned_cols=234 Identities=29% Similarity=0.433 Sum_probs=182.8
Q ss_pred HhcCcccccccccCCccceEeeeeCCc--------------------h-------------hh-hhhhhhhhcceeecCc
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADG--------------------Q-------------EI-AHRNLVKLLGCCIQGE 467 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~--------------------~-------------~v-ah~niv~l~~~~~~~~ 467 (717)
..++|++.+.||+|+||.||++..... + .+ .|+||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 346789999999999999999875321 0 11 3999999999999999
Q ss_pred eeeEEEeccCCCChhhHhhhc-------------cccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQ-------------TKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD 534 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~ 534 (717)
..++||||+++++|.+++... .....+++..++.++.|++.||+|||+++ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999999542 22346889999999999999999999988 99999999999999
Q ss_pred CCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhH
Q 039318 535 HEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNL 613 (717)
Q Consensus 535 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~ 613 (717)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 242 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 242 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----
Confidence 999999999999987644322222222345678999999998899999999999999999997 888875332211
Q ss_pred HHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 614 IGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
..+....+... ..+......+.+++.+|++.+|++|||+.|+++.|+..
T Consensus 243 ---~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 ---LFKLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11111111111 01112234677899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.79 Aligned_cols=237 Identities=28% Similarity=0.420 Sum_probs=183.2
Q ss_pred HhcCcccccccccCCccceEeeeeC--------Cch---------------------------hh-hhhhhhhhcceeec
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLA--------DGQ---------------------------EI-AHRNLVKLLGCCIQ 465 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~---------------------------~v-ah~niv~l~~~~~~ 465 (717)
..++|.+.+.||+|+||.||+|+.. ++. .+ .||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567889999999999999988631 000 11 29999999999999
Q ss_pred CceeeEEEeccCCCChhhHhhhccc-------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceE
Q 039318 466 GEEKLLIYEFMPNRSLDSFIFDQTK-------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVL 532 (717)
Q Consensus 466 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIl 532 (717)
....++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999965321 235788889999999999999999998 999999999999
Q ss_pred EcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCch
Q 039318 533 LDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNL 611 (717)
Q Consensus 533 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~ 611 (717)
++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-- 247 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 247 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--
Confidence 99999999999999987643332222223456678999999998899999999999999999998 788875332111
Q ss_pred hHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCCC
Q 039318 612 NLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIML 677 (717)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~ 677 (717)
............. +......+.+++.+||+.+|++||++.||++.|+....+
T Consensus 248 -----~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 248 -----LFKLLKEGHRMDK---------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -----HHHHHHcCCcCCC---------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1112222211110 111234567889999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.99 Aligned_cols=226 Identities=21% Similarity=0.278 Sum_probs=170.2
Q ss_pred CcccccccccCCccceEeeeeCCch-h-----------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ-E-----------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~-~-----------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
+|++++.||+|+||.||+++..... . +.||||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6899999999999999999865321 1 129999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++|+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999944 345788888899999999999999998 9999999999999999999999999985321000
Q ss_pred -----------------------------------------cccccceecccccccCccccccCCCCccccchhHhHHHH
Q 039318 555 -----------------------------------------IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLL 593 (717)
Q Consensus 555 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ 593 (717)
.........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000011357999999999999999999999999999999
Q ss_pred HhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCC---ChHHHHHH
Q 039318 594 EIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP---CMPSVILM 670 (717)
Q Consensus 594 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP---s~~evl~~ 670 (717)
||++|+.||......+... ....+.... .+.. ... ....+.+++.+|+ .+|.+|+ ++.++++.
T Consensus 236 ell~G~~Pf~~~~~~~~~~----~i~~~~~~~--~~~~---~~~----~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAETQL----KVINWETTL--HIPS---QAK----LSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHHHH----HHhccCccc--cCCC---CCC----CCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999987543221111 011111100 0000 001 1123445666655 4999999 88888874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=301.35 Aligned_cols=174 Identities=24% Similarity=0.369 Sum_probs=147.8
Q ss_pred HHHhcCcccccccccCCccceEeeeeCCch---------------------hhhhhhhhhhcceeecCceeeEEEeccCC
Q 039318 420 ANATDNFSINKKLGEGGFGPVYKGTLADGQ---------------------EIAHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 420 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~---------------------~vah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
.....+|++.+.||+|+||.||+|+..... .+.||||+++++++.+.+..++||||+.
T Consensus 62 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 140 (357)
T PHA03209 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS- 140 (357)
T ss_pred hhhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-
Confidence 344568999999999999999999875432 1239999999999999999999999995
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 141 ~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~ 212 (357)
T PHA03209 141 SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PA 212 (357)
T ss_pred CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC---cc
Confidence 588888743 3346899999999999999999999998 999999999999999999999999999753221 11
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCC
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNR 602 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~ 602 (717)
.....||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 22457899999999999999999999999999999999865543
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=300.56 Aligned_cols=222 Identities=22% Similarity=0.312 Sum_probs=171.3
Q ss_pred cccccCCccceEeeeeCCch-hh------------------------------hhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLADGQ-EI------------------------------AHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~-~v------------------------------ah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
+.||+|+||.||+++..... .+ .||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865321 11 299999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 999988843 345899999999999999999999998 9999999999999999999999999987532111 12
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCC--chhHHHHHHHHhhCCCCccccchhhhc
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDK--NLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .........+........ ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~p~ 226 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------IPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------CCC
Confidence 234679999999999999999999999999999999999999997433222 111111122222221111 011
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCC------hHHHHH
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPC------MPSVIL 669 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs------~~evl~ 669 (717)
. ....+.+++.+||+.||.+||+ ++++++
T Consensus 227 ~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 227 S----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred C----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1 1235678899999999999997 567765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=298.24 Aligned_cols=214 Identities=27% Similarity=0.352 Sum_probs=168.2
Q ss_pred cccccCCccceEeeeeCCch-h------------------------------hhhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLADGQ-E------------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~-~------------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
+.||+|+||.||+|+.+... . ..||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999875321 1 1299999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|..++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 999998844 345788899999999999999999998 9999999999999999999999999987432111 12
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... +....... .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~----~~~~~~~~------~~~~~- 218 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELF----ESIRVDTP------HYPRW- 218 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCC------CCCCC-
Confidence 23467999999999999999999999999999999999999998643221 111 11111110 00111
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCChH-HHH
Q 039318 639 NLAEVIRCIHVGLLCVQHHPEDRPCMP-SVI 668 (717)
Q Consensus 639 ~~~~~~~~~~l~~~Cl~~dp~~RPs~~-evl 668 (717)
....+.+++.+||+.||++||++. +++
T Consensus 219 ---~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ---ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 123466788999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=306.89 Aligned_cols=241 Identities=19% Similarity=0.222 Sum_probs=181.6
Q ss_pred hcCcccccccccCCccceEeeeeCCc---h---------------------hhhhhhhhhhcceeecCceeeEEEeccCC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG---Q---------------------EIAHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~---~---------------------~vah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
..+|.+.+.||+|+||.||++...+. . .+.|||||++++++......++|||++.
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 169 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK- 169 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-
Confidence 45799999999999999999864321 1 1129999999999999999999999996
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..........
T Consensus 170 ~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 170 CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 57888872 3456899999999999999999999998 99999999999999999999999999986544333223
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc-------cccc
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS-------QLID 631 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------~l~d 631 (717)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....+........ .+..
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 323 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK 323 (392)
T ss_pred ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence 334679999999999999999999999999999999999999986554433333332222222111000 0000
Q ss_pred h------hhhccCCH-------HHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 632 A------YYQESCNL-------AEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 632 ~------~~~~~~~~-------~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
. ........ .....+.+++.+||+.+|++||++.|++..
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00000000 012356678899999999999999999986
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=308.38 Aligned_cols=231 Identities=18% Similarity=0.232 Sum_probs=175.4
Q ss_pred HHHHhcCcccccccccCCccceEeeeeCCchh-h-----------------------------hhhhhhhhcceeecCce
Q 039318 419 IANATDNFSINKKLGEGGFGPVYKGTLADGQE-I-----------------------------AHRNLVKLLGCCIQGEE 468 (717)
Q Consensus 419 i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-v-----------------------------ah~niv~l~~~~~~~~~ 468 (717)
+....++|++.+.||+|+||.||+++.....+ + .||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 34456789999999999999999998754211 1 19999999999999999
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
.++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence 9999999999999999843 24788889999999999999999998 9999999999999999999999999998
Q ss_pred cccCCccccccceecccccccCccccccCC----CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCC
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYASDGL----FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG 624 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 624 (717)
....... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... . ........
T Consensus 191 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~---~---~~~i~~~~ 263 (370)
T cd05621 191 KMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG---T---YSKIMDHK 263 (370)
T ss_pred ecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH---H---HHHHHhCC
Confidence 6533221 1223567999999999987543 7899999999999999999999986432211 1 11111111
Q ss_pred CCccccchhhhccCCHHHHHHHHHHHhhccccCCCC--CCChHHHHHH
Q 039318 625 MPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPED--RPCMPSVILM 670 (717)
Q Consensus 625 ~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~--RPs~~evl~~ 670 (717)
....+ .........+.+++..||+.++.+ ||++.|+++.
T Consensus 264 ~~~~~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 264 NSLNF-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cccCC-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 10010 011111234556777888755543 8899999885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=295.53 Aligned_cols=232 Identities=30% Similarity=0.457 Sum_probs=179.5
Q ss_pred CcccccccccCCccceEeeeeCCc---------------------------------hhhhhhhhhhhcceeecCceeeE
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG---------------------------------QEIAHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~---------------------------------~~vah~niv~l~~~~~~~~~~~l 471 (717)
+|++.+.||+|+||.||+|+.... ..+.||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 477889999999999999875210 01129999999999999999999
Q ss_pred EEeccCCCChhhHhhhcc---------------------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCc
Q 039318 472 IYEFMPNRSLDSFIFDQT---------------------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASN 530 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~N 530 (717)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999985321 1235788899999999999999999988 9999999999
Q ss_pred eEEcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCC
Q 039318 531 VLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDK 609 (717)
Q Consensus 531 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~ 609 (717)
|||++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986543322222223455678999999988899999999999999999998 999985432111
Q ss_pred chhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 610 NLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.+.......... .+......+.+++.+||+.+|++||++.++++.|+...
T Consensus 238 -------~~~~~~~~~~~~---------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 -------LFNLLKTGYRME---------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred -------HHHHHhCCCCCC---------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 112221111100 01112245778999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=319.11 Aligned_cols=232 Identities=21% Similarity=0.299 Sum_probs=179.1
Q ss_pred HHHhcCcccccccccCCccceEeeeeCC-chhh----------------------------hhhhhhhhcceeecCc---
Q 039318 420 ANATDNFSINKKLGEGGFGPVYKGTLAD-GQEI----------------------------AHRNLVKLLGCCIQGE--- 467 (717)
Q Consensus 420 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v----------------------------ah~niv~l~~~~~~~~--- 467 (717)
....++|.+.+.||+|+||.||+|+... ++.+ .|+||+++...+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 3445799999999999999999997642 2211 1889998877665432
Q ss_pred -----eeeEEEeccCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCcee
Q 039318 468 -----EKLLIYEFMPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKI 541 (717)
Q Consensus 468 -----~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl 541 (717)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+||||+.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 3679999999999999996532 3356888999999999999999999998 999999999999999999999
Q ss_pred ccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHh
Q 039318 542 SDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLW 621 (717)
Q Consensus 542 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 621 (717)
+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~~~---~~~~ 258 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVM---HKTL 258 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHh
Confidence 9999998764433233334568999999999999999999999999999999999999998643211 111 1111
Q ss_pred hCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 622 NNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 622 ~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+....+ +......+.+++.+||+.+|.+||++.+++.+
T Consensus 259 -~~~~~~~---------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 -AGRYDPL---------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -cCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111111 11122457788999999999999999999864
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=290.08 Aligned_cols=227 Identities=28% Similarity=0.452 Sum_probs=177.4
Q ss_pred cCcccccccccCCccceEeeeeCCchh-------------------------hhhhhhhhhcceeecCceeeEEEeccCC
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQE-------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~-------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
.+|++.+.||+|+||.||+++.+.+.. +.||||+++++++.+.+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 357888999999999999987654321 1299999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~- 157 (256)
T cd05059 84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS- 157 (256)
T ss_pred CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence 9999998543 236889999999999999999999998 9999999999999999999999999998654322111
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhcc
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 637 (717)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .. ......... .
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~~~~~~---------~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VV----ESVSAGYRL---------Y 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HH----HHHHcCCcC---------C
Confidence 111233457999999999999999999999999999998 899986432221 11 111111100 0
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
.+......+.+++.+||+.+|++||++.||+++|.
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 01112345778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.30 Aligned_cols=215 Identities=26% Similarity=0.357 Sum_probs=169.0
Q ss_pred CcccccccccCCccceEeeeeCCch-hhh------------------------------hhhhhhhcceeecCceeeEEE
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ-EIA------------------------------HRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~-~va------------------------------h~niv~l~~~~~~~~~~~lV~ 473 (717)
+|++.+.||+|+||.||+|+..... .+| |++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4888999999999999999865431 111 456888999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999998843 335788999999999999999999998 999999999999999999999999998753221
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... ...... .
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~----i~~~~~-~----- 219 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQS----IMEHNV-S----- 219 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH----HHcCCC-C-----
Confidence 1 1223467999999999999999999999999999999999999998643221 11111 111111 0
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCCh
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCM 664 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~ 664 (717)
... .....+.+++.+||+.+|.+|++.
T Consensus 220 ~~~----~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 YPK----SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCC----CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 001 112356788899999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.36 Aligned_cols=216 Identities=22% Similarity=0.282 Sum_probs=169.8
Q ss_pred cccccCCccceEeeeeCCc-hh-----------------------------hhhhhhhhhcceeecCceeeEEEeccCCC
Q 039318 430 KKLGEGGFGPVYKGTLADG-QE-----------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPNR 479 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~-~~-----------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~g 479 (717)
+.||+|+||.||+++.... +. +.||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986432 11 12999999999999999999999999999
Q ss_pred ChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccccc
Q 039318 480 SLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559 (717)
Q Consensus 480 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 559 (717)
+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 99988843 345889999999999999999999998 9999999999999999999999999987532221 122
Q ss_pred ceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCC
Q 039318 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCN 639 (717)
Q Consensus 560 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 639 (717)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .. ....... . . ...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~---~~~~~~~-~-~-----~p~--- 216 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LF---ELILMED-I-K-----FPR--- 216 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HH---HHhccCC-c-c-----CCC---
Confidence 34679999999999999999999999999999999999999986432211 11 1111110 0 0 011
Q ss_pred HHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 039318 640 LAEVIRCIHVGLLCVQHHPEDRP-----CMPSVILM 670 (717)
Q Consensus 640 ~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~~ 670 (717)
.....+.+++.+||+.||++|| ++.++++.
T Consensus 217 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 -TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1123567888999999999997 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=302.55 Aligned_cols=222 Identities=26% Similarity=0.374 Sum_probs=168.9
Q ss_pred cCcccccccccCCccceEeeeeCC-chh---------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQE---------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~---------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
++|+..++||+|+||.||+|+... ++. +.|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 356677899999999999998652 211 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.... ...+..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999986432 3456777889999999999999998 9999999999999999999999999998653221
Q ss_pred ccccceecccccccCcccccc-----CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 556 EGSTKRVVGTYGYMAPEYASD-----GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||......+........ . ......
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~-~~~~~~-- 295 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---C-MSQPPE-- 295 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---h-ccCCCC--
Confidence 11234579999999998743 23456899999999999999999999743322221111110 0 000000
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
........+.+|+.+||+.||++||++.||++.
T Consensus 296 -------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 -------APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011123457788999999999999999999985
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.11 Aligned_cols=175 Identities=24% Similarity=0.358 Sum_probs=148.3
Q ss_pred CcccccccccCCccceEeeeeCCchh------------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQE------------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~~------------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
+|+++++||+|+||.||+|+.....+ +.|||||++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58899999999999999998643211 119999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
||++|+|.+++.+ .+.+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999854 245788888999999999999999998 9999999999999999999999999975321000
Q ss_pred ---------------------------------------------cccccceecccccccCccccccCCCCccccchhHh
Q 039318 555 ---------------------------------------------IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFG 589 (717)
Q Consensus 555 ---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 589 (717)
.........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00001235799999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCC
Q 039318 590 ILLLEIVSGKKNRGFY 605 (717)
Q Consensus 590 ~il~elltG~~p~~~~ 605 (717)
|++|||++|+.||...
T Consensus 236 vil~elltG~~Pf~~~ 251 (382)
T cd05625 236 VILYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHHHhCCCCCCCC
Confidence 9999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=299.46 Aligned_cols=215 Identities=25% Similarity=0.341 Sum_probs=169.5
Q ss_pred cccccCCccceEeeeeCCch-hh------------------------------hhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLADGQ-EI------------------------------AHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~-~v------------------------------ah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
+.||+|+||.||+|+..... .+ .||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875431 11 299999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
|+|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999999843 345788999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... ...... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~----i~~~~~--~~~------- 216 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQS----IRMDNP--CYP------- 216 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhCCC--CCC-------
Confidence 23467999999999999999999999999999999999999998643221 11111 111110 000
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCChH-HHHH
Q 039318 639 NLAEVIRCIHVGLLCVQHHPEDRPCMP-SVIL 669 (717)
Q Consensus 639 ~~~~~~~~~~l~~~Cl~~dp~~RPs~~-evl~ 669 (717)
......+.+++.+||+.+|++||++. ++.+
T Consensus 217 -~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 -RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 01123467889999999999999997 5554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=294.78 Aligned_cols=230 Identities=27% Similarity=0.400 Sum_probs=177.5
Q ss_pred cCcccccccccCCccceEeeeeCCch------------------------------hh-hhhhhhhhcceeecCceeeEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ------------------------------EI-AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~------------------------------~v-ah~niv~l~~~~~~~~~~~lV 472 (717)
++|++.+.||+|+||.||+|...+.. ++ .||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57889999999999999999764321 01 299999999999999999999
Q ss_pred EeccCCCChhhHhhhcc-------------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCc
Q 039318 473 YEFMPNRSLDSFIFDQT-------------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP 539 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~ 539 (717)
|||+++++|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999995432 1134788899999999999999999988 9999999999999999999
Q ss_pred eeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHH
Q 039318 540 KISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAW 618 (717)
Q Consensus 540 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~ 618 (717)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |+.||......+ . .
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~----~ 228 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---L----Y 228 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----H
Confidence 99999998643211 11111233557999999998899999999999999999997 999986432221 1 1
Q ss_pred HHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 619 KLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 619 ~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.....+.... .+......+.+|+.+||+.+|.+||+++++++.|+...
T Consensus 229 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 229 EKLPQGYRME---------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111111000 01111235678999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.40 Aligned_cols=227 Identities=23% Similarity=0.264 Sum_probs=173.5
Q ss_pred cCcccccccccCCccceEeeeeCCc-hhh-----------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QEI-----------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v-----------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||.||+|+.... +.+ .||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4789999999999999999987532 111 1999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999854 345889999999999999999999998 999999999999999999999999999754321
Q ss_pred cccc------------------------------------ccceecccccccCccccccCCCCccccchhHhHHHHHhhc
Q 039318 554 EIEG------------------------------------STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597 (717)
Q Consensus 554 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt 597 (717)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112469999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCC---hHHHHHH
Q 039318 598 GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPC---MPSVILM 670 (717)
Q Consensus 598 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs---~~evl~~ 670 (717)
|+.||....... .. ...........+.. .. .....+.+++.+|+. +|.+|++ +.++++.
T Consensus 235 G~~Pf~~~~~~~---~~---~~i~~~~~~~~~~~-----~~--~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQE---TY---RKIINWKETLQFPD-----EV--PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHH---HH---HHHHcCCCccCCCC-----CC--CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999986433211 11 11111110000000 00 112345567777886 8999998 8888773
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.26 Aligned_cols=216 Identities=23% Similarity=0.361 Sum_probs=170.4
Q ss_pred cccccCCccceEeeeeCCc-hhh------------------------------hhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLADG-QEI------------------------------AHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~-~~v------------------------------ah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
++||+|+||.||+|+.... +.+ .||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999986532 111 199999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|..++.. ...+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 999988843 335788999999999999999999998 9999999999999999999999999987543222 12
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ........ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~---~i~~~~~~-------~---- 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFE---SILHDDVL-------Y---- 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHH---HHHcCCCC-------C----
Confidence 23467999999999999999999999999999999999999998743321 1111 11111100 0
Q ss_pred CHHHHHHHHHHHhhccccCCCCCC-------ChHHHHHH
Q 039318 639 NLAEVIRCIHVGLLCVQHHPEDRP-------CMPSVILM 670 (717)
Q Consensus 639 ~~~~~~~~~~l~~~Cl~~dp~~RP-------s~~evl~~ 670 (717)
+......+.+++..||+.+|++|| +++++++.
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 001123567888999999999999 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=291.41 Aligned_cols=238 Identities=27% Similarity=0.409 Sum_probs=182.2
Q ss_pred hcCcccccccccCCccceEeeeeCCch--------------------------------------------hhhhhhhhh
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ--------------------------------------------EIAHRNLVK 458 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~--------------------------------------------~vah~niv~ 458 (717)
..+|++.+.||+|+||.||+++..... .+.||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357899999999999999997653210 112999999
Q ss_pred hcceeecCceeeEEEeccCCCChhhHhhhcc--------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCc
Q 039318 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQT--------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASN 530 (717)
Q Consensus 459 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~N 530 (717)
+++++..++..++||||+++++|.+++.... ....+++..++.++.|+++||+|||+++ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999996533 1235889999999999999999999988 9999999999
Q ss_pred eEEcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc--CCCCCCCCCCC
Q 039318 531 VLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS--GKKNRGFYHSD 608 (717)
Q Consensus 531 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--G~~p~~~~~~~ 608 (717)
|+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ +..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999986543332222334556789999999988889999999999999999998 6667653321
Q ss_pred CchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 609 KNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
...+......+.......... .+.....++.+++.+||+.+|++||++.||++.|+
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 222222222221111111111 11112246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.30 Aligned_cols=215 Identities=21% Similarity=0.283 Sum_probs=168.9
Q ss_pred cccccCCccceEeeeeCCc-hhh-----------------------------hhhhhhhhcceeecCceeeEEEeccCCC
Q 039318 430 KKLGEGGFGPVYKGTLADG-QEI-----------------------------AHRNLVKLLGCCIQGEEKLLIYEFMPNR 479 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~-~~v-----------------------------ah~niv~l~~~~~~~~~~~lV~E~~~~g 479 (717)
+.||+|+||.||+++.... +.+ .||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999986432 111 2999999999999999999999999999
Q ss_pred ChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccccc
Q 039318 480 SLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559 (717)
Q Consensus 480 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 559 (717)
+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 99888843 345889999999999999999999998 9999999999999999999999999987532221 112
Q ss_pred ceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCC
Q 039318 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCN 639 (717)
Q Consensus 560 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 639 (717)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ..... .. . ...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~---~~~~~-~~-~-----~p~--- 216 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE---LILME-EI-R-----FPR--- 216 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHhcC-CC-C-----CCC---
Confidence 24679999999999999999999999999999999999999986432211 111 11111 10 0 011
Q ss_pred HHHHHHHHHHHhhccccCCCCCC-----ChHHHHH
Q 039318 640 LAEVIRCIHVGLLCVQHHPEDRP-----CMPSVIL 669 (717)
Q Consensus 640 ~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~ 669 (717)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 -TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1123456888899999999998 7888776
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=292.64 Aligned_cols=233 Identities=27% Similarity=0.386 Sum_probs=179.0
Q ss_pred hcCcccccccccCCccceEeeeeC-Cchh----h---------------------------hhhhhhhhcceeecCceee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLA-DGQE----I---------------------------AHRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~----v---------------------------ah~niv~l~~~~~~~~~~~ 470 (717)
.++|++.++||+|+||.||+|+.. ++.. + .||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 457889999999999999999743 2211 1 19999999999875 4578
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
++|||+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998542 345889999999999999999999998 999999999999999999999999999876
Q ss_pred cCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
.............++..|+|||.+.+..++.++|||||||++|||++ |..||....... .. ..+........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~~~ 232 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IP----DLLEKGERLPQ 232 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHCCCcCCC
Confidence 43322211222345678999999999999999999999999999998 899986432211 11 11111111110
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCCC
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIML 677 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~ 677 (717)
+......+.+++.+||+.||++||++.++++.|+.....
T Consensus 233 ---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 233 ---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 111223567889999999999999999999999766543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=300.08 Aligned_cols=211 Identities=22% Similarity=0.252 Sum_probs=166.2
Q ss_pred cccccCCccceEeeeeCCch-h------------------------------hhhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLADGQ-E------------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~-~------------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
+.||+|+||.||+|+..... . +.||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875321 1 1199999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|..++.. ...+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 999888843 345788888899999999999999988 9999999999999999999999999987532221 12
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... .... .... . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~---~~i~-~~~~-~---------~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQMY---DNIL-HKPL-Q---------L 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HHHH---HHHh-cCCC-C---------C
Confidence 3346799999999999999999999999999999999999999864321 1111 1111 1110 0 1
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCChH
Q 039318 639 NLAEVIRCIHVGLLCVQHHPEDRPCMP 665 (717)
Q Consensus 639 ~~~~~~~~~~l~~~Cl~~dp~~RPs~~ 665 (717)
+......+.+++.+||+.+|.+||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 112234567899999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=308.42 Aligned_cols=228 Identities=18% Similarity=0.232 Sum_probs=176.3
Q ss_pred HhcCcccccccccCCccceEeeeeCCchh------------------------------hhhhhhhhhcceeecCceeeE
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQE------------------------------IAHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~------------------------------vah~niv~l~~~~~~~~~~~l 471 (717)
..++|++.++||+|+||.||+++...... +.||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 45689999999999999999998653211 119999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998843 24778888889999999999999998 9999999999999999999999999998654
Q ss_pred CCccccccceecccccccCccccccC----CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDG----LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... . ...........
T Consensus 194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~---~~~i~~~~~~~ 266 (370)
T cd05596 194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---T---YSKIMDHKNSL 266 (370)
T ss_pred CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH---H---HHHHHcCCCcC
Confidence 3221 122346799999999998653 47899999999999999999999987433211 1 11111111100
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCC--CCChHHHHHH
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPED--RPCMPSVILM 670 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~--RPs~~evl~~ 670 (717)
.+. ........+.+++.+||+.+|.+ ||++.|++..
T Consensus 267 ~~~-------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TFP-------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCC-------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 01112345678889999999987 9999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=298.32 Aligned_cols=217 Identities=22% Similarity=0.342 Sum_probs=169.3
Q ss_pred cccccCCccceEeeeeCCchh-h------------------------------hhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLADGQE-I------------------------------AHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~~-v------------------------------ah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
+.||+|+||.||+++...+.. + .||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999998654311 1 189999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|..++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 999988843 345899999999999999999999998 9999999999999999999999999997532211 12
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||................+........ +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~--------- 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR-I--------- 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC-C---------
Confidence 234679999999999999999999999999999999999999997543332222222222222221110 0
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCCh
Q 039318 639 NLAEVIRCIHVGLLCVQHHPEDRPCM 664 (717)
Q Consensus 639 ~~~~~~~~~~l~~~Cl~~dp~~RPs~ 664 (717)
+......+.+++.+||+.||++||++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11112345688999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.79 Aligned_cols=231 Identities=26% Similarity=0.414 Sum_probs=178.6
Q ss_pred cCcccccccccCCccceEeeeeCCc------hh---------------------------hhhhhhhhhcceeecCceee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG------QE---------------------------IAHRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~------~~---------------------------vah~niv~l~~~~~~~~~~~ 470 (717)
.+|.+.++||+|+||.||+|..... +. +.||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 3577789999999999999975321 11 11999999999999999999
Q ss_pred EEEeccCCCChhhHhhhcc-------------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC
Q 039318 471 LIYEFMPNRSLDSFIFDQT-------------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM 537 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~ 537 (717)
+++||+++++|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999984321 1234788889999999999999999998 99999999999999999
Q ss_pred CceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHH
Q 039318 538 NPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGH 616 (717)
Q Consensus 538 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~ 616 (717)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~---- 234 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---D---- 234 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---H----
Confidence 999999999886543322222233456789999999988899999999999999999998 88887643221 1
Q ss_pred HHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 617 AWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 617 ~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
............. +......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 235 ~~~~i~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNRQVLPC---------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcCCcCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1122222221111 11123346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=291.26 Aligned_cols=229 Identities=25% Similarity=0.317 Sum_probs=175.8
Q ss_pred HHhcCcccccccccCCccceEeeeeCCch-----------------------------------hhh------hhhhhhh
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADGQ-----------------------------------EIA------HRNLVKL 459 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-----------------------------------~va------h~niv~l 459 (717)
...++|++++.||+|.||.|-+|...... +|+ |||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999998753221 111 9999999
Q ss_pred cceeecC--ceeeEEEeccCCCChhhHhhhcccccc-CChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC
Q 039318 460 LGCCIQG--EEKLLIYEFMPNRSLDSFIFDQTKRKL-LDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE 536 (717)
Q Consensus 460 ~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~ 536 (717)
+.+..+. +.+|||+|||..|.+...= ..++ +++.+..+++++++.||+|||.++ ||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 9998764 6789999999998875332 2333 899999999999999999999999 9999999999999999
Q ss_pred CCceeccccccccccCC---ccccccceecccccccCccccccCC----CCccccchhHhHHHHHhhcCCCCCCCCCCCC
Q 039318 537 MNPKISDFGLARTFVGD---EIEGSTKRVVGTYGYMAPEYASDGL----FSVKSDVFSFGILLLEIVSGKKNRGFYHSDK 609 (717)
Q Consensus 537 ~~~kl~Dfgla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltG~~p~~~~~~~~ 609 (717)
|++||+|||.+...... .........+|||.|+|||...++. .+.+.||||+||.||-|+.|+.||-....-
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~- 325 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL- 325 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH-
Confidence 99999999999865221 1112223478999999999987633 357899999999999999999998532111
Q ss_pred chhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHh
Q 039318 610 NLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L 671 (717)
....++. ...+.-....+...++.+|++++|++||++|.++.+|....
T Consensus 326 ------~l~~KIv--------n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 326 ------ELFDKIV--------NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ------HHHHHHh--------cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1111111 11122222334556778999999999999999999998765
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=304.97 Aligned_cols=232 Identities=33% Similarity=0.460 Sum_probs=180.8
Q ss_pred cCcccccccccCCccceEeeeeCCch----h-hh-----------------------------hhhhhhhcceeecCcee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ----E-IA-----------------------------HRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~----~-va-----------------------------h~niv~l~~~~~~~~~~ 469 (717)
++..+.++||+|+||.||+|+++... . || |||||++||++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 44555689999999999999875431 1 33 99999999999999999
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
+||||+|+||+|.+++.+.. +.++..+++.++.+.|.||+|||+++ +|||||-..|+|++.++.+||+||||++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 99999999999999995533 36899999999999999999999998 99999999999999999999999999886
Q ss_pred ccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 550 FVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 550 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
-. ..........-...|+|||.+....|+.++|||||||++||+++ |..||......+ .. .+...++....
T Consensus 312 ~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~---~kI~~~~~r~~ 383 (474)
T KOG0194|consen 312 GS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VK---AKIVKNGYRMP 383 (474)
T ss_pred Cc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HH---HHHHhcCccCC
Confidence 43 11111112234579999999999999999999999999999999 888876443221 11 11112221111
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCCC
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIML 677 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~ 677 (717)
.+......+..+..+|++.+|++||+|.++.+.|+.....
T Consensus 384 ---------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 384 ---------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred ---------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 1112233445566789999999999999999999876543
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=289.79 Aligned_cols=230 Identities=27% Similarity=0.450 Sum_probs=174.3
Q ss_pred cccccccccCCccceEeeeeCCchh-------------------------------hhhhhhhhhcceeecC------ce
Q 039318 426 FSINKKLGEGGFGPVYKGTLADGQE-------------------------------IAHRNLVKLLGCCIQG------EE 468 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~~~~-------------------------------vah~niv~l~~~~~~~------~~ 468 (717)
|.+.+.||+|+||.||+|+...... +.||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999997643221 1299999999987532 25
Q ss_pred eeEEEeccCCCChhhHhhhcc---ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQT---KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
.++||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999884321 2345789999999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCC
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNG 624 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 624 (717)
+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~----~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEI----YDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHH----HHHHHcC
Confidence 9987643322111223346778999999999999999999999999999999 8888754221 111 1112222
Q ss_pred CCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 625 MPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 625 ~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
..... .......+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 231 ~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLKQ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11110 011223467899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=322.68 Aligned_cols=233 Identities=31% Similarity=0.506 Sum_probs=186.2
Q ss_pred cCcccccccccCCccceEeeeeCCc--h--h--h---------------------------hhhhhhhhcceeecCceee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG--Q--E--I---------------------------AHRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~--~--~--v---------------------------ah~niv~l~~~~~~~~~~~ 470 (717)
++.+..+.||+|.||.||+|.+.+- . . | .|||||+++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 4556778999999999999986532 1 0 1 1999999999999999999
Q ss_pred EEEeccCCCChhhHhhhcc----ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQT----KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGL 546 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgl 546 (717)
|++|||++|+|..||++.. ....|.....+.++.+||+|+.||++++ +|||||...|+||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999996642 1346888999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCC
Q 039318 547 ARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGM 625 (717)
Q Consensus 547 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 625 (717)
|+.+...+.-.....-.-...|||||.++.+.|+.|+|||||||++||+++ |..||......+ ++.. ...+++
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---v~~~---~~~ggR 922 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---VLLD---VLEGGR 922 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---HHHH---HHhCCc
Confidence 996554444333323334568999999999999999999999999999999 899986433222 2211 112221
Q ss_pred CccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 626 PSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 626 ~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
+ ..+.....++.+|+..||+.+|++||++..+++.+....
T Consensus 923 L----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 923 L----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred c----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 1 223344567789999999999999999999999876554
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=307.52 Aligned_cols=227 Identities=22% Similarity=0.257 Sum_probs=171.1
Q ss_pred cCcccccccccCCccceEeeeeCCch-h-----------------------------hhhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-E-----------------------------IAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-~-----------------------------vah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|.+.++||+|+||.||+++..... . +.||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999998764321 1 12999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999853 345788889999999999999999998 999999999999999999999999999643210
Q ss_pred ccc---------------------------------------------cccceecccccccCccccccCCCCccccchhH
Q 039318 554 EIE---------------------------------------------GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSF 588 (717)
Q Consensus 554 ~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 588 (717)
... .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 00012469999999999999999999999999
Q ss_pred hHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCC---CChH
Q 039318 589 GILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDR---PCMP 665 (717)
Q Consensus 589 G~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~R---Ps~~ 665 (717)
||++|||++|+.||......+ ... ..........+.+ .......+.+++.+||+ +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~---~~~---~i~~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHE---TYR---KIINWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHH---HHH---HHHccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 999999999999986433211 111 1111000000000 00112345677888887 66665 5898
Q ss_pred HHHHH
Q 039318 666 SVILM 670 (717)
Q Consensus 666 evl~~ 670 (717)
|+++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 88875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=299.34 Aligned_cols=215 Identities=25% Similarity=0.328 Sum_probs=168.9
Q ss_pred cccccCCccceEeeeeCC----chh------------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 430 KKLGEGGFGPVYKGTLAD----GQE------------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~----~~~------------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
++||+|+||.||+++... ++. +.||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 689999999999987531 111 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++.. .+.+.+..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 999999999843 345778888889999999999999998 9999999999999999999999999987543222
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ..... .+.. .+
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~~---~~~~~-~~~~-~~------ 219 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KT---IDKIL-KGKL-NL------ 219 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---HH---HHHHH-cCCC-CC------
Confidence 1223467999999999999989999999999999999999999998643221 11 11111 1111 00
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHH
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRP-----CMPSVIL 669 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~ 669 (717)
+......+.+++.+||+.+|++|| ++.++++
T Consensus 220 ---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 ---PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ---CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111123567889999999999999 7888776
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=311.16 Aligned_cols=239 Identities=19% Similarity=0.269 Sum_probs=173.2
Q ss_pred HhcCcccccccccCCccceEeeeeCCc-hhh----------------------hhhhhhhhcceeecC--------ceee
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADG-QEI----------------------AHRNLVKLLGCCIQG--------EEKL 470 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v----------------------ah~niv~l~~~~~~~--------~~~~ 470 (717)
..++|++.++||+|+||.||+|..... +.+ .|||||++++++... ...+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 456899999999999999999987532 222 299999998876432 2467
Q ss_pred EEEeccCCCChhhHhhhc-cccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC-Cceeccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQ-TKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM-NPKISDFGLAR 548 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~Dfgla~ 548 (717)
+||||+++ +|.+++... .....+++..+..++.||++||+|||+++ |+||||||+||||+.++ .+||+|||+++
T Consensus 144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccch
Confidence 89999986 676666432 23456889999999999999999999998 99999999999999665 69999999998
Q ss_pred cccCCccccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC-
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP- 626 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 626 (717)
.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|++||......+ .+....+.+.....
T Consensus 220 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~---~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 220 NLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD---QLVRIIQVLGTPTED 293 (440)
T ss_pred hccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHH
Confidence 654322 12245789999999988764 68999999999999999999999986543222 12122221111100
Q ss_pred --------------ccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 627 --------------SQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 627 --------------~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
..+....+....+.....++++|+.+||+.+|.+|||+.|+++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000011111111122467899999999999999999999864
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=288.83 Aligned_cols=230 Identities=26% Similarity=0.448 Sum_probs=176.8
Q ss_pred cccccccccCCccceEeeeeCCch----h----------------------------hhhhhhhhhcceeecCce-----
Q 039318 426 FSINKKLGEGGFGPVYKGTLADGQ----E----------------------------IAHRNLVKLLGCCIQGEE----- 468 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~~~----~----------------------------vah~niv~l~~~~~~~~~----- 468 (717)
|.+.+.||+|+||.||+|.+.... . +.||||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567789999999999999764211 1 119999999998876554
Q ss_pred -eeEEEeccCCCChhhHhhhcc---ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccc
Q 039318 469 -KLLIYEFMPNRSLDSFIFDQT---KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDF 544 (717)
Q Consensus 469 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 544 (717)
.++||||+++++|..++.... ....+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999999985532 2346888999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhC
Q 039318 545 GLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNN 623 (717)
Q Consensus 545 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 623 (717)
|+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..... .... .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~----~~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIY----DYLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHH----HHHHc
Confidence 99986543322222222345678999999988899999999999999999999 8888754321 1111 11111
Q ss_pred CCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 624 GMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 624 ~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
+..... +......+.+++.+||+.||++||++.||++.|+..
T Consensus 231 ~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRLKQ---------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCC---------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111 112234678899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=291.09 Aligned_cols=230 Identities=25% Similarity=0.434 Sum_probs=177.3
Q ss_pred cCcccccccccCCccceEeeeeCC------c--------------------------hhhhhhhhhhhcceeecCceeeE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD------G--------------------------QEIAHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~------~--------------------------~~vah~niv~l~~~~~~~~~~~l 471 (717)
++|...++||+|+||.||+++... + ..+.|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 467888999999999999986321 0 01129999999999999999999
Q ss_pred EEeccCCCChhhHhhhccc------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCc
Q 039318 472 IYEFMPNRSLDSFIFDQTK------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP 539 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~ 539 (717)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999965321 134788999999999999999999998 9999999999999999999
Q ss_pred eeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHH
Q 039318 540 KISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAW 618 (717)
Q Consensus 540 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~ 618 (717)
||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+ ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~---- 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AI---- 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HH----
Confidence 9999999976533222122223345688999999999999999999999999999998 899875322211 11
Q ss_pred HHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 619 KLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 619 ~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
.....+...... . .....+.+++.+||+.+|++||++.||++.|+
T Consensus 235 ~~~~~~~~~~~~-----~----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ECITQGRELERP-----R----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHcCccCCCC-----C----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111111111000 0 11234668899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=295.16 Aligned_cols=235 Identities=26% Similarity=0.477 Sum_probs=180.6
Q ss_pred HhcCcccccccccCCccceEeeeeCC------ch---------------------------hhhhhhhhhhcceeecCce
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLAD------GQ---------------------------EIAHRNLVKLLGCCIQGEE 468 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~---------------------------~vah~niv~l~~~~~~~~~ 468 (717)
..++|++.++||+|+||.||+|..++ +. .+.||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999986431 00 0129999999999999999
Q ss_pred eeEEEeccCCCChhhHhhhccc-------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCcee
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTK-------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKI 541 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl 541 (717)
.++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964321 234566788899999999999999998 999999999999999999999
Q ss_pred ccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHH
Q 039318 542 SDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKL 620 (717)
Q Consensus 542 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 620 (717)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ... ..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~----~~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVL----KF 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HH
Confidence 99999986533222222223345678999999999999999999999999999998 78887532211 111 11
Q ss_pred hhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 621 WNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 621 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
...+..... +......+.+++.+||+.+|++||++.++++.|....
T Consensus 234 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111111110 0111246788999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.92 Aligned_cols=216 Identities=21% Similarity=0.269 Sum_probs=169.0
Q ss_pred cccccCCccceEeeeeCCc-hh-----------------------------hhhhhhhhhcceeecCceeeEEEeccCCC
Q 039318 430 KKLGEGGFGPVYKGTLADG-QE-----------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPNR 479 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~-~~-----------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~g 479 (717)
+.||+|+||.||+++.... +. +.||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999876432 11 11999999999999999999999999999
Q ss_pred ChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhh-cCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 480 SLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHH-DSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 480 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 99988843 3468899999999999999999997 66 9999999999999999999999999987533221 11
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.....+.. . ........ . ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~---~----~~i~~~~~-~-----~p~~- 218 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---F----ELILMEEI-R-----FPRT- 218 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH---H----HHHhcCCC-C-----CCCC-
Confidence 2346799999999999999999999999999999999999999864322111 1 11111110 0 0111
Q ss_pred CHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 039318 639 NLAEVIRCIHVGLLCVQHHPEDRP-----CMPSVILM 670 (717)
Q Consensus 639 ~~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~~ 670 (717)
....+.+++.+||+.||++|+ ++.++++.
T Consensus 219 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 ---LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ---CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 123466788999999999997 88988864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=297.08 Aligned_cols=233 Identities=30% Similarity=0.425 Sum_probs=179.7
Q ss_pred hcCcccccccccCCccceEeeeeCC----------------------ch-------h------h-hhhhhhhhcceeecC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD----------------------GQ-------E------I-AHRNLVKLLGCCIQG 466 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~----------------------~~-------~------v-ah~niv~l~~~~~~~ 466 (717)
.++|.+.+.||+|+||.||+++... .. + + .||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3679999999999999999886421 00 0 1 299999999999999
Q ss_pred ceeeEEEeccCCCChhhHhhhccc-------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTK-------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL 533 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll 533 (717)
+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999965321 235788999999999999999999988 9999999999999
Q ss_pred cCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchh
Q 039318 534 DHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLN 612 (717)
Q Consensus 534 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~ 612 (717)
+.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence 9999999999999986533221111222334568999999998899999999999999999998 88887533211
Q ss_pred HHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 613 LIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.............. +......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 250 ---~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 250 ---ELFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred ---HHHHHHHcCCCCCC---------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11111222211111 111224566789999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.66 Aligned_cols=239 Identities=22% Similarity=0.334 Sum_probs=171.4
Q ss_pred CcccccccccCCccceEeeeeCCc-hh----------------------------hhhhhhhhhcceeecC-----ceee
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG-QE----------------------------IAHRNLVKLLGCCIQG-----EEKL 470 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~-~~----------------------------vah~niv~l~~~~~~~-----~~~~ 470 (717)
+|++.++||+|+||.||+|+.... +. +.||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588899999999999999986432 11 1299999999987643 2479
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
+||||++ ++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 588888843 345889999999999999999999998 999999999999999999999999999864
Q ss_pred cCCcc-ccccceecccccccCcccccc--CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHH--------HH
Q 039318 551 VGDEI-EGSTKRVVGTYGYMAPEYASD--GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHA--------WK 619 (717)
Q Consensus 551 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~--------~~ 619 (717)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+... ..
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 111234579999999999876 67899999999999999999999998653322111111000 00
Q ss_pred HhhCCCCccccchhhh-ccCCH-----HHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 620 LWNNGMPSQLIDAYYQ-ESCNL-----AEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 620 ~~~~~~~~~l~d~~~~-~~~~~-----~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+........+..... ..... .....+.+++.+||+.+|++||+++|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000000000 00000 012346789999999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=300.51 Aligned_cols=215 Identities=22% Similarity=0.281 Sum_probs=168.2
Q ss_pred cccccCCccceEeeeeCCchh-------------------------------hhhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLADGQE-------------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~~-------------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
+.||+|+||.||+++...... +.||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999998653211 1299999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|.+++.. ...+.+..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 999999844 334677888889999999999999998 9999999999999999999999999997543221 12
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... ... ... . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~---i~~-~~~-~---------~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDN---ILN-KPL-Q---------L 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHHH---HHh-CCc-C---------C
Confidence 33467999999999999999999999999999999999999998643211 11111 111 110 0 0
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 639 NLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 639 ~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.......+.+++.+||+.+|.+||++.+.+.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 0111234668888999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=287.28 Aligned_cols=229 Identities=28% Similarity=0.456 Sum_probs=178.2
Q ss_pred hcCcccccccccCCccceEeeeeCCchhh-------------------------hhhhhhhhcceeecCceeeEEEeccC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEI-------------------------AHRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~v-------------------------ah~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.++|++.++||+|+||.||+|+..+...+ .||||+++++++. .+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 35799999999999999999986543222 2999999998874 456899999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 99999999543 2345788999999999999999999988 999999999999999999999999999865433211
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ... .........
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~----~~~~~~~~~--------- 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL----DQVERGYRM--------- 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHH----HHHhcCCCC---------
Confidence 1123346678999999988899999999999999999999 88887643211 111 111111100
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
.........+.+++.+|++.+|++||++.+++++|+.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1112233457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=292.68 Aligned_cols=224 Identities=35% Similarity=0.572 Sum_probs=168.5
Q ss_pred cccccccCCccceEeeeeCC-----ch---------------------------hhhhhhhhhhcceeecCceeeEEEec
Q 039318 428 INKKLGEGGFGPVYKGTLAD-----GQ---------------------------EIAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 428 ~~~~lG~G~fg~Vy~~~~~~-----~~---------------------------~vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+.+.||.|.||.||+|++.. +. .+.||||+++++++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 45789999999999998871 11 11299999999999988889999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++|+|.+++... ....+++..+..|+.||++||.|||+++ |+|++|+++||+++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999654 2456899999999999999999999988 99999999999999999999999999987632222
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
............|+|||.+....++.++||||||+++|||++ |+.|+.... ....... +.+......
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~~~----~~~~~~~~~----- 226 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEIIEK----LKQGQRLPI----- 226 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHHHH----HHTTEETTS-----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccc----cccccccee-----
Confidence 222233456789999999999999999999999999999999 788875432 1111111 111111110
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHh
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L 671 (717)
+......+.+++..||+.+|++||++.++++.|
T Consensus 227 ----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 ----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111233466889999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=299.44 Aligned_cols=214 Identities=21% Similarity=0.255 Sum_probs=167.6
Q ss_pred cccccCCccceEeeeeCCc-hh------------------------------hhhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLADG-QE------------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~-~~------------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
+.||+|+||.||+|+.... +. +.||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999976432 11 1199999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|..++.. ...+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 999888843 346889999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... .... ..... +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~---~~~~-~~~~~--~-------- 215 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EMY---DNIL-HKPLV--L-------- 215 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---HHH---HHHH-cCCcc--C--------
Confidence 23467999999999999999999999999999999999999998643211 111 1111 11110 0
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCChHHHH
Q 039318 639 NLAEVIRCIHVGLLCVQHHPEDRPCMPSVI 668 (717)
Q Consensus 639 ~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl 668 (717)
.......+.+++.+||+.+|.+||++.+.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 011223566788999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=282.42 Aligned_cols=241 Identities=25% Similarity=0.323 Sum_probs=179.4
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hhhh----------------------------hhhhhhhcceeec-----Cce
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QEIA----------------------------HRNLVKLLGCCIQ-----GEE 468 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~va----------------------------h~niv~l~~~~~~-----~~~ 468 (717)
...|..++.||+|+||.|..+..+.. ..|| |+||+.+++.+.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 34566678999999999999987543 3332 9999999998865 356
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
+|+|+|+| +.+|...++ ..+.|+...+..++.||++||.|+|+.+ |+||||||.|+|++.+..+||+|||+|+
T Consensus 101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 79999999 558888883 3344888999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCccccccceecccccccCccccc-cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHH-------
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYAS-DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKL------- 620 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~------- 620 (717)
...........+.++.|..|+|||++. ...|+.+.||||+|||+.||++|++.|...+..+...++......
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 875432233345688999999999775 467999999999999999999999998765444333332221110
Q ss_pred -hhCCCCccccchhhh-ccCCHHH-----HHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 621 -WNNGMPSQLIDAYYQ-ESCNLAE-----VIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 621 -~~~~~~~~l~d~~~~-~~~~~~~-----~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+........+..... ...++.. ....++|+.+||+.||.+|+|++|+++.
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 110001111110000 0111111 1356789999999999999999999984
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=305.59 Aligned_cols=175 Identities=23% Similarity=0.327 Sum_probs=149.3
Q ss_pred HhcCcccccccccCCccceEeeeeCCch---------------------hhhhhhhhhhcceeecCceeeEEEeccCCCC
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQ---------------------EIAHRNLVKLLGCCIQGEEKLLIYEFMPNRS 480 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~---------------------~vah~niv~l~~~~~~~~~~~lV~E~~~~gs 480 (717)
....|.+.+.||+|+||.||++...... .+.|+|||++++++..++..++|||++. ++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~ 245 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SD 245 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CC
Confidence 3568999999999999999999876431 1239999999999999999999999995 68
Q ss_pred hhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccc
Q 039318 481 LDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTK 560 (717)
Q Consensus 481 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 560 (717)
|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++............
T Consensus 246 L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 246 LYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 88887432 336899999999999999999999998 9999999999999999999999999998654332222222
Q ss_pred eecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCC
Q 039318 561 RVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNR 602 (717)
Q Consensus 561 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~ 602 (717)
...||+.|+|||++.+..++.++|||||||++|||++|..++
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 457999999999999999999999999999999999987654
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=297.50 Aligned_cols=233 Identities=28% Similarity=0.426 Sum_probs=180.1
Q ss_pred cCcccccccccCCccceEeeeeCC----------------------ch-------------hh-hhhhhhhhcceeecCc
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD----------------------GQ-------------EI-AHRNLVKLLGCCIQGE 467 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~----------------------~~-------------~v-ah~niv~l~~~~~~~~ 467 (717)
.+|++.+.||+|+||.||+++... .. .+ .||||+++++++.+.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468999999999999999986311 00 11 2999999999999999
Q ss_pred eeeEEEeccCCCChhhHhhhcc-------------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQT-------------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD 534 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~ 534 (717)
..++||||+++++|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999996432 1234788899999999999999999998 99999999999999
Q ss_pred CCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhH
Q 039318 535 HEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNL 613 (717)
Q Consensus 535 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~ 613 (717)
.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||.....++
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence 999999999999986543222112222344568999999999999999999999999999998 888875432111
Q ss_pred HHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 614 IGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
............. +......+.+++.+|++.+|++||++.|+++.|+...
T Consensus 245 ---~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 245 ---LFKLLKEGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred ---HHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 1111112111111 1112245678899999999999999999999998665
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=304.91 Aligned_cols=235 Identities=19% Similarity=0.238 Sum_probs=177.6
Q ss_pred HHHHHHHhcCcccccccccCCccceEeeeeCCchh------------------------------hhhhhhhhhcceeec
Q 039318 416 LATIANATDNFSINKKLGEGGFGPVYKGTLADGQE------------------------------IAHRNLVKLLGCCIQ 465 (717)
Q Consensus 416 ~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~------------------------------vah~niv~l~~~~~~ 465 (717)
+.++....++|++.+.||+|+||.||+++.+...+ +.||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 44445566899999999999999999998754321 119999999999999
Q ss_pred CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 466 GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 466 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
.+..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999999843 23788888899999999999999998 9999999999999999999999999
Q ss_pred ccccccCCccccccceecccccccCccccccCC----CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHh
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL----FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLW 621 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 621 (717)
+++....... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... .......
T Consensus 188 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~ 260 (371)
T cd05622 188 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIM 260 (371)
T ss_pred ceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHH
Confidence 9986543221 1223467999999999987543 789999999999999999999998643221 1111111
Q ss_pred hCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCC--CCChHHHHHHh
Q 039318 622 NNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPED--RPCMPSVILML 671 (717)
Q Consensus 622 ~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~--RPs~~evl~~L 671 (717)
.......+.+ .......+.+++.+||+..+.+ ||+++++++..
T Consensus 261 ~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 261 NHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1111111111 1112234567888899844433 78999988853
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=287.49 Aligned_cols=228 Identities=27% Similarity=0.421 Sum_probs=168.2
Q ss_pred cccccCCccceEeeeeCCch------------------------------hhhhhhhhhhcceeecCceeeEEEeccCCC
Q 039318 430 KKLGEGGFGPVYKGTLADGQ------------------------------EIAHRNLVKLLGCCIQGEEKLLIYEFMPNR 479 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~------------------------------~vah~niv~l~~~~~~~~~~~lV~E~~~~g 479 (717)
+.||+|+||.||+|+..++. .+.||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36999999999999753221 012999999999999999999999999999
Q ss_pred ChhhHhhhccc--cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 480 SLDSFIFDQTK--RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 480 sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999965322 234567778889999999999999998 9999999999999999999999999997654333222
Q ss_pred ccceecccccccCccccccC-------CCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 558 STKRVVGTYGYMAPEYASDG-------LFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+ ..... ..+. ...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~---~~~~-~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT---VREQ-QLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH---hhcc-cCCC
Confidence 22335577889999988642 35789999999999999996 999986543221 11111 1111 1111
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
.++..... ....+.+++..|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111111 1223556777888 58999999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=291.20 Aligned_cols=235 Identities=26% Similarity=0.431 Sum_probs=182.9
Q ss_pred HhcCcccccccccCCccceEeeeeCC-----chh---------------------------hhhhhhhhhcceeec-Cce
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLAD-----GQE---------------------------IAHRNLVKLLGCCIQ-GEE 468 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~---------------------------vah~niv~l~~~~~~-~~~ 468 (717)
..++|.+.+.||+|+||.||+|.... +.. +.|+||+++++++.+ ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999998754 211 129999999998766 577
Q ss_pred eeEEEeccCCCChhhHhhhcccc-----ccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKR-----KLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISD 543 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 543 (717)
.++++||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998554322 46889999999999999999999988 99999999999999999999999
Q ss_pred ccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhh
Q 039318 544 FGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWN 622 (717)
Q Consensus 544 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 622 (717)
||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||..... .... ....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~----~~~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMA----AYLK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHH----HHHH
Confidence 999986544332222223456778999999998899999999999999999999 9999864322 1111 1111
Q ss_pred CCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 623 NGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 623 ~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.+.... ........+.+++.+|++.+|++||++.+|+++|+...
T Consensus 234 ~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 234 DGYRLA---------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred cCCCCC---------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111000 00111235678999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=289.36 Aligned_cols=237 Identities=24% Similarity=0.385 Sum_probs=177.7
Q ss_pred cCcccccccccCCccceEeeeeCC------------------------------c--------------hhhhhhhhhhh
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD------------------------------G--------------QEIAHRNLVKL 459 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~------------------------------~--------------~~vah~niv~l 459 (717)
++|++.++||+|+||.||+++... . +.+.|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 579999999999999999874211 0 01229999999
Q ss_pred cceeecCceeeEEEeccCCCChhhHhhhccc--------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCce
Q 039318 460 LGCCIQGEEKLLIYEFMPNRSLDSFIFDQTK--------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNV 531 (717)
Q Consensus 460 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NI 531 (717)
++++...+..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ |+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999965321 124677889999999999999999998 99999999999
Q ss_pred EEcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc--CCCCCCCCCCCC
Q 039318 532 LLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS--GKKNRGFYHSDK 609 (717)
Q Consensus 532 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--G~~p~~~~~~~~ 609 (717)
|++.++.++|+|||+++.+.............++..|+|||...++.++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986543322222223345678999999888899999999999999999998 667775433222
Q ss_pred chhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 610 NLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
. +......+.......... .+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 242 ~---~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 V---IENTGEFFRDQGRQVYLP------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H---HHHHHHHHhhccccccCC------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 111111111111000000 01112245678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=283.06 Aligned_cols=239 Identities=24% Similarity=0.328 Sum_probs=180.6
Q ss_pred hcCcccccccccCCccceEeeeeCCch-h----------------------------hhhhh-hhhhcceeecCc-----
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ-E----------------------------IAHRN-LVKLLGCCIQGE----- 467 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~----------------------------vah~n-iv~l~~~~~~~~----- 467 (717)
...|...++||+|+||+||+|+.+... . +.|+| ||++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345777789999999999999865322 1 22888 999999999887
Q ss_pred -eeeEEEeccCCCChhhHhhhcccc-ccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 468 -EKLLIYEFMPNRSLDSFIFDQTKR-KLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 468 -~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
..++|+||+.. +|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 78999999965 898888543321 34666889999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCccccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCC
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG 624 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 624 (717)
+|+...-.. ......++|..|+|||++.+. .|+...||||+|||+.||++++..|..... ..++..+.+.+.-.
T Consensus 166 lAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 166 LARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTP 240 (323)
T ss_pred hHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCC
Confidence 999654221 113356789999999999887 699999999999999999999888765443 44555555544321
Q ss_pred ---CCccc---cchh--hhc---cCCHHHH-----HHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 625 ---MPSQL---IDAY--YQE---SCNLAEV-----IRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 625 ---~~~~l---~d~~--~~~---~~~~~~~-----~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
....+ .+-. ... ..+.... ....+++.+||+.+|++|.|++.++++
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11111 1110 111 1111111 256789999999999999999999986
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=297.49 Aligned_cols=216 Identities=26% Similarity=0.327 Sum_probs=170.8
Q ss_pred cccccCCccceEeeeeCCch-hh------------------------------hhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLADGQ-EI------------------------------AHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~-~v------------------------------ah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
+.||+|+||.||+++.+... .+ .||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875421 11 299999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 999988843 335899999999999999999999998 9999999999999999999999999987532221 12
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ... ......... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~----~~i~~~~~~------~~--- 216 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELF----QSILEDEVR------YP--- 216 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHH----HHHHcCCCC------CC---
Confidence 23457899999999999999999999999999999999999998643211 111 111111110 00
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCCh-----HHHHHH
Q 039318 639 NLAEVIRCIHVGLLCVQHHPEDRPCM-----PSVILM 670 (717)
Q Consensus 639 ~~~~~~~~~~l~~~Cl~~dp~~RPs~-----~evl~~ 670 (717)
......+.+++.+||+.||.+||++ .++++.
T Consensus 217 -~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 -RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1112356788999999999999999 888763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=294.42 Aligned_cols=229 Identities=27% Similarity=0.412 Sum_probs=176.9
Q ss_pred cCcccccccccCCccceEeeeeCCc-h-----------------------------hh-hhhhhhhhcceeecCceeeEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-Q-----------------------------EI-AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~-----------------------------~v-ah~niv~l~~~~~~~~~~~lV 472 (717)
++|++.+.||+|+||.||+|+++.. . .+ .||||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 5788899999999999999975321 1 11 299999999999999999999
Q ss_pred EeccCCCChhhHhhhcc-------------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCc
Q 039318 473 YEFMPNRSLDSFIFDQT-------------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP 539 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~ 539 (717)
|||+++++|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999996432 1235788999999999999999999988 9999999999999999999
Q ss_pred eeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHH
Q 039318 540 KISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAW 618 (717)
Q Consensus 540 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~ 618 (717)
||+|||+++..... .......++..|+|||++.+..++.++|||||||++|||++ |..||......+ ..
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~---- 233 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY---- 233 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HH----
Confidence 99999998642111 11112234567999999988889999999999999999998 999986432211 11
Q ss_pred HHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 619 KLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 619 ~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.......... .+......+.+++.+||+.+|++||++.+++++|+..
T Consensus 234 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 234 EKLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHhcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111111000 0011123467899999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=285.92 Aligned_cols=229 Identities=31% Similarity=0.496 Sum_probs=177.9
Q ss_pred hcCcccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCceeeEEEeccC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.++|++.++||+|+||.||+|....+..++ |+|++++++++. .+..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 357889999999999999999865543222 999999999875 456899999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++... ....+++..+..++.+++.||+|||+.+ |+||||||+||++++++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 99999998543 2345789999999999999999999998 9999999999999999999999999998654322111
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ..+......
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~----~~~~~~~~~--------- 222 (260)
T cd05070 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVL----EQVERGYRM--------- 222 (260)
T ss_pred -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHHcCCCC---------
Confidence 112335668999999988899999999999999999999 88898643211 111 111111110
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
..+......+.+++.+|++.+|++|||+.+++++|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111223457789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=296.80 Aligned_cols=215 Identities=25% Similarity=0.374 Sum_probs=169.3
Q ss_pred CcccccccccCCccceEeeeeCCc-hhhh------------------------------hhhhhhhcceeecCceeeEEE
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG-QEIA------------------------------HRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~-~~va------------------------------h~niv~l~~~~~~~~~~~lV~ 473 (717)
+|+..+.||+|+||.||+|+.+.. +.+| |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477789999999999999986532 1111 578889999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999998843 345889999999999999999999998 999999999999999999999999998754322
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... .. .... .
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~---i~-~~~~-~----- 219 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQS---IM-EHNV-S----- 219 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH---HH-hCCC-C-----
Confidence 1 1223457999999999999999999999999999999999999998643221 11111 11 1111 0
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCCh
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCM 664 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~ 664 (717)
... .....+.+++.+||+.+|.+|++.
T Consensus 220 ~p~----~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 YPK----SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCc----cCCHHHHHHHHHHcccCHhhCCCC
Confidence 001 112356788999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=290.76 Aligned_cols=229 Identities=27% Similarity=0.361 Sum_probs=178.7
Q ss_pred HHhcCcccccccccCCccceEeeeeCCchhhh-----------------------------hhhhhhhcceeecCceeeE
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADGQEIA-----------------------------HRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-----------------------------h~niv~l~~~~~~~~~~~l 471 (717)
...+.|+++++||+||.+.||++...+.+.+| |.+||+|++|-..++.+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 34568999999999999999999876544332 8999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||= ..+|..+|... ......| .+..+..|+++++.++|+++ |||.||||.|+|+- .|.+||+|||+|..+.
T Consensus 438 vmE~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeecc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 99974 56999998543 2223334 66678899999999999999 99999999999985 5689999999999998
Q ss_pred CCccccccceecccccccCccccccCC-----------CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHH
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGL-----------FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKL 620 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 620 (717)
.+.+.......+||+.||+||.+.... .+.++||||||||||+|+.|+.||+.+. +++..
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~aK---- 581 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQIAK---- 581 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHHHH----
Confidence 887777777899999999999885432 5678999999999999999999987321 11111
Q ss_pred hhCCCCccccchhhhccC-CHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 621 WNNGMPSQLIDAYYQESC-NLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 621 ~~~~~~~~l~d~~~~~~~-~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+..+.|+.-.-.+ ......++++++..||+.||.+||++.|+++.
T Consensus 582 -----l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 -----LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1222333111111 11111227888999999999999999999984
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=287.07 Aligned_cols=231 Identities=27% Similarity=0.437 Sum_probs=179.0
Q ss_pred hcCcccccccccCCccceEeeeeCCch----h---------------------------hhhhhhhhhcceeecCceeeE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ----E---------------------------IAHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~---------------------------vah~niv~l~~~~~~~~~~~l 471 (717)
.++|+..+.||+|+||.||+|+..... . +.||||+++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357888899999999999999864211 0 119999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999998542 346889999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcccccc-ceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 552 GDEIEGST-KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 552 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
........ .....+..|+|||++.+..++.++||||||+++|||++ |+.||...... . ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~----~~~~i~~~~~~-- 229 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---E----VMKAINDGFRL-- 229 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---H----HHHHHhcCCCC--
Confidence 32211111 11223457999999988889999999999999999997 99998543221 1 11111111100
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.........+.+++.+|++.+|++||++.+|++.|+..
T Consensus 230 -------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 -------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00111234567999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=293.61 Aligned_cols=234 Identities=30% Similarity=0.439 Sum_probs=180.0
Q ss_pred hcCcccccccccCCccceEeeeeCC----------------------ch-------h------h-hhhhhhhhcceeecC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD----------------------GQ-------E------I-AHRNLVKLLGCCIQG 466 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~----------------------~~-------~------v-ah~niv~l~~~~~~~ 466 (717)
.++|.+.++||+|+||.||+++... .. + + .||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 3578899999999999999985310 00 1 1 299999999999999
Q ss_pred ceeeEEEeccCCCChhhHhhhcc-------------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQT-------------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL 533 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll 533 (717)
+..++||||+++++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999996532 1235788899999999999999999988 9999999999999
Q ss_pred cCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchh
Q 039318 534 DHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLN 612 (717)
Q Consensus 534 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~ 612 (717)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--- 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--- 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999986543222111222234567999999998899999999999999999999 888875432211
Q ss_pred HHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 613 LIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
............. +......+.+++.+||+.+|++||++.++++.|+...
T Consensus 245 ----~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 245 ----LFKLLREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ----HHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111112111111 1112235668999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-33 Score=286.98 Aligned_cols=226 Identities=31% Similarity=0.475 Sum_probs=178.1
Q ss_pred cccccccccCCccceEeeeeCCchh-----------------------------hhhhhhhhhcceeecCceeeEEEecc
Q 039318 426 FSINKKLGEGGFGPVYKGTLADGQE-----------------------------IAHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~~~~-----------------------------vah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
|++.+.||+|+||.||+++.....+ +.||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6778999999999999998765431 12999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
++++|.+++. ....+++..+..++.||++||.+||+++ |+|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 9999999995 3456899999999999999999999998 99999999999999999999999999975411 12
Q ss_pred cccceecccccccCccccc-cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 557 GSTKRVVGTYGYMAPEYAS-DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
.......++..|+|||++. +..++.++||||||+++++|++|..||......+....+..... . .+......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~---~----~~~~~~~~ 225 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK---R----PLPSSSQQ 225 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH---T----HHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc---c----cccccccc
Confidence 2233567899999999998 88899999999999999999999999875421222211111110 0 00000000
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.. .....+.+++.+||+.+|++||++.++++
T Consensus 226 ~~---~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SR---EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HT---TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cc---hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00156788999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=282.43 Aligned_cols=221 Identities=31% Similarity=0.444 Sum_probs=172.9
Q ss_pred cccccCCccceEeeeeCCchhh---------------------------hhhhhhhhcceeecCceeeEEEeccCCCChh
Q 039318 430 KKLGEGGFGPVYKGTLADGQEI---------------------------AHRNLVKLLGCCIQGEEKLLIYEFMPNRSLD 482 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~~v---------------------------ah~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 482 (717)
++||+|+||.||+|...+++.+ .||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4799999999999986554322 1999999999999999999999999999999
Q ss_pred hHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccccccee
Q 039318 483 SFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV 562 (717)
Q Consensus 483 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 562 (717)
+++... ...+++..+..++.+++++|.|||+++ ++|+||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 988542 335789999999999999999999988 999999999999999999999999999754332211 11123
Q ss_pred cccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHH
Q 039318 563 VGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLA 641 (717)
Q Consensus 563 ~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~ 641 (717)
.++..|+|||++.+..++.++||||||+++|||++ |..||....... . ........... .+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~----~~~~~~~~~~~---------~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---A----REQVEKGYRMS---------CPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---H----HHHHHcCCCCC---------CCCC
Confidence 44568999999998899999999999999999998 999986432111 1 11111111100 0111
Q ss_pred HHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 642 EVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 642 ~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
....+.+++.+|++.+|++||++.|++++|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-33 Score=293.61 Aligned_cols=232 Identities=31% Similarity=0.465 Sum_probs=180.6
Q ss_pred hcCcccccccccCCccceEeeeeCC------c---------------------------hhh-hhhhhhhhcceeecCce
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD------G---------------------------QEI-AHRNLVKLLGCCIQGEE 468 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~---------------------------~~v-ah~niv~l~~~~~~~~~ 468 (717)
.++|.+.+.||+|+||.||++.... + +.+ .||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 3579999999999999999886310 0 012 39999999999999999
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
.++||||+++++|.+++.... ...+++.++..++.|++.||+|||+++ |+|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999995422 234899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
...............++..|+|||.+.+..++.++|||||||++|||++ |+.||......+. ..+....+...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~ 263 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKEGYRM 263 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHHHHHcCCcC
Confidence 6543322112223456788999999999999999999999999999998 9999764332211 11111111110
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
. .+.....++.+++.+||+.+|++||++.+|++.|+.
T Consensus 264 ~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 264 A---------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred C---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0 001112457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-33 Score=284.78 Aligned_cols=220 Identities=29% Similarity=0.405 Sum_probs=169.6
Q ss_pred ccccCCccceEeeeeCC---ch----------------------------hhhhhhhhhhcceeecCceeeEEEeccCCC
Q 039318 431 KLGEGGFGPVYKGTLAD---GQ----------------------------EIAHRNLVKLLGCCIQGEEKLLIYEFMPNR 479 (717)
Q Consensus 431 ~lG~G~fg~Vy~~~~~~---~~----------------------------~vah~niv~l~~~~~~~~~~~lV~E~~~~g 479 (717)
+||+|+||.||+|.++. +. .+.||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 69999999999986421 11 112999999999875 45779999999999
Q ss_pred ChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc-c
Q 039318 480 SLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG-S 558 (717)
Q Consensus 480 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~ 558 (717)
+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||.||++++++.+||+|||+++......... .
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999843 335889999999999999999999998 9999999999999999999999999998654332211 1
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhcc
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 637 (717)
.....++..|+|||.+....++.++|+||||+++|||++ |+.||......+ . ......+.....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~----~~~i~~~~~~~~-------- 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---V----TQMIESGERMEC-------- 219 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHCCCCCCC--------
Confidence 112234578999999988889999999999999999998 999987432211 1 111222211111
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
+......+.+++.+|++.+|++||++.+|+++|++
T Consensus 220 -~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 -PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11122456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-33 Score=290.71 Aligned_cols=234 Identities=23% Similarity=0.309 Sum_probs=172.5
Q ss_pred CcccccccccCCccceEeeeeCCch-h-------------------------------hhhhhhhhhcceeec-----Cc
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ-E-------------------------------IAHRNLVKLLGCCIQ-----GE 467 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~-~-------------------------------vah~niv~l~~~~~~-----~~ 467 (717)
+|++.+.||+|+||.||+|+.+... . +.||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999765321 0 029999999998764 34
Q ss_pred eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla 547 (717)
..++||||+++ +|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57999999985 888887443 2345889999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 548 RTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
+...... ......++..|+|||++.+..++.++|||||||++|||++|++||......+. +.............
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~ 229 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLIGLPPED 229 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH---HHHHHHHhCCCChh
Confidence 8654321 12235689999999999998999999999999999999999999864332221 11111111000000
Q ss_pred ----------cccchhhh---ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 628 ----------QLIDAYYQ---ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 628 ----------~l~d~~~~---~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
....+... ..........+.+++.+||+.||++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 0000112245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-33 Score=286.81 Aligned_cols=228 Identities=25% Similarity=0.390 Sum_probs=165.7
Q ss_pred cccccCCccceEeeeeCCch------------------------h------hhhhhhhhhcceeecCceeeEEEeccCCC
Q 039318 430 KKLGEGGFGPVYKGTLADGQ------------------------E------IAHRNLVKLLGCCIQGEEKLLIYEFMPNR 479 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~------------------------~------vah~niv~l~~~~~~~~~~~lV~E~~~~g 479 (717)
+.||+|+||.||+|+...+. + +.|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 36999999999998643211 0 12999999999999999999999999999
Q ss_pred ChhhHhhhccc--cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 480 SLDSFIFDQTK--RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 480 sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+|.+++..... ....++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999965432 233467788899999999999999998 9999999999999999999999999987543322211
Q ss_pred ccceecccccccCcccccc-------CCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 558 STKRVVGTYGYMAPEYASD-------GLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
......++..|+|||++.. ..++.++|||||||++|||++ |..||...... ..+. ...... ...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~---~~~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVLK---QVVREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHH---HHhhcc-CccC
Confidence 1223445678999998743 456889999999999999999 77887543211 1111 111111 1112
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
.++..... ....+.+++..|+ .+|++||++++|+++|.
T Consensus 231 ~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22211111 1233445666787 59999999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-33 Score=299.55 Aligned_cols=212 Identities=25% Similarity=0.307 Sum_probs=166.9
Q ss_pred cccccCCccceEeeeeC----Cchh----------------------------hhhhhhhhhcceeecCceeeEEEeccC
Q 039318 430 KKLGEGGFGPVYKGTLA----DGQE----------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~----~~~~----------------------------vah~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
+.||+|+||.||+++.. .++. +.||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 67999999999988642 1111 119999999999999999999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 9999999843 345899999999999999999999998 9999999999999999999999999998653321 1
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhcc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 637 (717)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .... ... .... .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~---~i~-~~~~-~--------- 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMT---MIL-KAKL-G--------- 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHH---HHH-cCCC-C---------
Confidence 223467999999999999989999999999999999999999998643211 1111 111 1111 0
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHH
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPS 666 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs~~e 666 (717)
.+......+.+++.+||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 00011234567889999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=282.04 Aligned_cols=228 Identities=20% Similarity=0.383 Sum_probs=166.1
Q ss_pred cccccCCccceEeeeeCCchh------------------------------hhhhhhhhhcceeecCceeeEEEeccCCC
Q 039318 430 KKLGEGGFGPVYKGTLADGQE------------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPNR 479 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~~------------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~g 479 (717)
++||+|+||.||+|+...+.. +.||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 369999999999986432210 12999999999999999999999999999
Q ss_pred ChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 480 SLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 480 sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
+|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999996532 2234667778889999999999999988 99999999999999999999999999864322211112
Q ss_pred cceecccccccCcccccc-------CCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 559 TKRVVGTYGYMAPEYASD-------GLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||..... ...+.. .+.+. ...+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~---~~~~~-~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLNH---VIKDQ-QVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH---HHhhc-ccccC
Confidence 234567889999998743 245789999999999999997 5667643221 111111 11111 12222
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
++...... ..++.+++..|+ .+|++||++++|+++|.
T Consensus 231 ~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22222111 134556777788 57999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-33 Score=303.39 Aligned_cols=176 Identities=27% Similarity=0.359 Sum_probs=150.3
Q ss_pred cCcccccccccCCccceEeeeeCCch-h-----------------------------hhhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-E-----------------------------IAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-~-----------------------------vah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||.||+++.+... . +.||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999865321 1 11899999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999843 345888999999999999999999998 999999999999999999999999998754221
Q ss_pred ccc---------------------------------cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCC
Q 039318 554 EIE---------------------------------GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKK 600 (717)
Q Consensus 554 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~ 600 (717)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00113579999999999999999999999999999999999999
Q ss_pred CCCCC
Q 039318 601 NRGFY 605 (717)
Q Consensus 601 p~~~~ 605 (717)
||...
T Consensus 235 Pf~~~ 239 (360)
T cd05627 235 PFCSE 239 (360)
T ss_pred CCCCC
Confidence 98643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-33 Score=312.32 Aligned_cols=242 Identities=20% Similarity=0.225 Sum_probs=173.8
Q ss_pred HHHHHHHhcCcccccccccCCccceEeeeeCCch-hhh-------------------------------hhhhhhhccee
Q 039318 416 LATIANATDNFSINKKLGEGGFGPVYKGTLADGQ-EIA-------------------------------HRNLVKLLGCC 463 (717)
Q Consensus 416 ~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~va-------------------------------h~niv~l~~~~ 463 (717)
..++...+++|++.++||+|+||.||+|...... .+| |.+|+++++++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3344556789999999999999999999764321 111 34578888887
Q ss_pred ecC-ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhc-CCCcEEeccCCCCceEEcCCC----
Q 039318 464 IQG-EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD-SRLRIIHRDLKASNVLLDHEM---- 537 (717)
Q Consensus 464 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrDlkp~NIll~~~~---- 537 (717)
... .+.++|||++ +++|.+++.+ ...+++..+..|+.||+.||.|||++ + ||||||||+||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 654 5789999988 6688888844 34688999999999999999999974 6 99999999999998765
Q ss_pred ------------CceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCC
Q 039318 538 ------------NPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFY 605 (717)
Q Consensus 538 ------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~ 605 (717)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998864321 123468999999999999999999999999999999999999999754
Q ss_pred CCCCchhHHHHHHH----HhhC--------------CCCccccchh-h---hccC---CHHHHHHHHHHHhhccccCCCC
Q 039318 606 HSDKNLNLIGHAWK----LWNN--------------GMPSQLIDAY-Y---QESC---NLAEVIRCIHVGLLCVQHHPED 660 (717)
Q Consensus 606 ~~~~~~~~~~~~~~----~~~~--------------~~~~~l~d~~-~---~~~~---~~~~~~~~~~l~~~Cl~~dp~~ 660 (717)
...+....+..... .|.. .......++. + .... ...+...+++|+.+||+.||++
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 43222222211100 0000 0000000000 0 0000 0011234679999999999999
Q ss_pred CCChHHHHH
Q 039318 661 RPCMPSVIL 669 (717)
Q Consensus 661 RPs~~evl~ 669 (717)
|||+.|+++
T Consensus 429 R~ta~e~L~ 437 (467)
T PTZ00284 429 RLNARQMTT 437 (467)
T ss_pred CCCHHHHhc
Confidence 999999997
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-34 Score=280.25 Aligned_cols=225 Identities=27% Similarity=0.410 Sum_probs=185.1
Q ss_pred CcccccccccCCccceEeeeeCCchhh-h------------------------hhhhhhhcceeecCceeeEEEeccCCC
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQEI-A------------------------HRNLVKLLGCCIQGEEKLLIYEFMPNR 479 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~~v-a------------------------h~niv~l~~~~~~~~~~~lV~E~~~~g 479 (717)
-|.+.++||+|+||.|||+.++....| | .|++|++||.+.....+++|||||..|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 477788999999999999987654322 1 789999999999999999999999999
Q ss_pred ChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccccc
Q 039318 480 SLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559 (717)
Q Consensus 480 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 559 (717)
+..+.++ .++++|.+.++..+++..++||+|||... -||||||..||||+.+|.+||+|||.|..+... -...
T Consensus 114 SiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKR 186 (502)
T KOG0574|consen 114 SISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKR 186 (502)
T ss_pred cHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--HHhh
Confidence 9999994 45678999999999999999999999876 799999999999999999999999999876433 3344
Q ss_pred ceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCC
Q 039318 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCN 639 (717)
Q Consensus 560 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 639 (717)
+++.||+.|||||++..-.|..++||||||+...||..|++||...++.....++ .-..+..+.. +
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-------PT~PPPTF~K-------P 252 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-------PTKPPPTFKK-------P 252 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-------cCCCCCCCCC-------h
Confidence 5789999999999999999999999999999999999999999876665544332 0111111111 1
Q ss_pred HHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 640 LAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 640 ~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
..=....-+++..||-++|++|-|+-++++.
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1123356678889999999999999887763
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=283.90 Aligned_cols=233 Identities=25% Similarity=0.350 Sum_probs=181.3
Q ss_pred cCcccccccccCCccceEeeeeCC-chh-----------------------------hhhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQE-----------------------------IAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~-----------------------------vah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||.||+++... ++. +.||||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 468889999999999999998532 111 12999999999999999999999
Q ss_pred eccCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 474 EFMPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
||+++++|.+++.... ....+++..+..++.||++||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999985422 2456889999999999999999999998 99999999999999999999999999886543
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .... .+.........
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~----~~~~~~~~~~~---- 227 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSL----CKKIEQCDYPP---- 227 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHH----hhhhhcCCCCC----
Confidence 221 122356889999999999889999999999999999999999998532211 0111 11111111000
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
. ........+.+++.+||+.+|++||||.+|+++++..
T Consensus 228 -~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 -L---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -C---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 0 0111234577889999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=294.16 Aligned_cols=214 Identities=22% Similarity=0.275 Sum_probs=164.9
Q ss_pred cccCCccceEeeeeCCc-hhh--------------------------------hhhhhhhhcceeecCceeeEEEeccCC
Q 039318 432 LGEGGFGPVYKGTLADG-QEI--------------------------------AHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 432 lG~G~fg~Vy~~~~~~~-~~v--------------------------------ah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
||+|+||.||+|+.... +.+ .||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999986532 111 289999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|..++.. ...+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 999988843 345889999999999999999999998 9999999999999999999999999997543221 12
Q ss_pred cceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhcc
Q 039318 559 TKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 637 (717)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .. ......+.. .+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---~~----~~~i~~~~~-~~~~----~- 219 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---QM----YRNIAFGKV-RFPK----N- 219 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---HH----HHHHHcCCC-CCCC----c-
Confidence 2346799999999998765 4899999999999999999999998643211 11 111111111 0100 0
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCC----hHHHHH
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPC----MPSVIL 669 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs----~~evl~ 669 (717)
.....+.+++.+||+.+|++||+ +.++++
T Consensus 220 ---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 ---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11234567889999999999994 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-33 Score=294.40 Aligned_cols=238 Identities=22% Similarity=0.336 Sum_probs=174.2
Q ss_pred cCcccccccccCCccceEeeeeCCchh----------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQE----------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~----------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
++|.+.++||+|+||.||+|+.+.... +.||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 579999999999999999997643211 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++ +|.+++... ...+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 986 787777442 335788889999999999999999998 99999999999999999999999999976432221
Q ss_pred ccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHH-----HhhCCCC-cc
Q 039318 556 EGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWK-----LWNNGMP-SQ 628 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~-~~ 628 (717)
......+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+..... .|..-.. ..
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1223467899999998865 4689999999999999999999999875443332222211100 0000000 00
Q ss_pred ccchhhhc--c-----CCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 629 LIDAYYQE--S-----CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 629 l~d~~~~~--~-----~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
..+..... . ........+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000 0 00011234678999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=284.64 Aligned_cols=233 Identities=24% Similarity=0.351 Sum_probs=182.1
Q ss_pred cCcccccccccCCccceEeeeeCCc-hh-----------------------------hhhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QE-----------------------------IAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~-----------------------------vah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||.||+|+.... +. +.||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999975421 11 12999999999999999999999
Q ss_pred eccCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 474 EFMPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
||+++++|.+++.... ....+++..+..++.||++||+|||+++ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999885432 2345788999999999999999999988 99999999999999999999999999986543
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
... ......+++.|+|||.+.+..++.++|+||||++++||++|+.||...... .... ............
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~----~~~~~~~~~~~~--- 228 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSL----CQKIEQCDYPPL--- 228 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHH----HHHHhcCCCCCC---
Confidence 221 122356888999999998888999999999999999999999997532211 1111 111111111110
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
........+.+++.+||+.+|++||++++|++.|++.
T Consensus 229 -----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 -----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0112234577889999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=333.62 Aligned_cols=239 Identities=24% Similarity=0.464 Sum_probs=190.6
Q ss_pred hcCcccccccccCCccceEeeeeC-Cchh----------------------hhhhhhhhhcceeecCceeeEEEeccCCC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLA-DGQE----------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPNR 479 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~----------------------vah~niv~l~~~~~~~~~~~lV~E~~~~g 479 (717)
...|...+.||+|+||.||+|+.. ++.. +.|||||++++++.+.+..++||||+++|
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g 768 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK 768 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCC
Confidence 356778889999999999999864 2221 22999999999999999999999999999
Q ss_pred ChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccccc
Q 039318 480 SLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559 (717)
Q Consensus 480 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 559 (717)
+|.+++. .++|..+.+++.||++||+|||..+..+|+||||||+||+++.++.+++. |+.+..... .
T Consensus 769 ~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~ 835 (968)
T PLN00113 769 NLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------D 835 (968)
T ss_pred cHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------C
Confidence 9999993 27899999999999999999997655569999999999999999888875 666543321 1
Q ss_pred ceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc--c
Q 039318 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE--S 637 (717)
Q Consensus 560 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~--~ 637 (717)
....+++.|+|||++.+..++.++|||||||++|||++|+.||..... .......+.............+|+.... .
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCCC
Confidence 124678999999999999999999999999999999999999854322 2233444444444444444555555433 3
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.+.++..++.+++.+|++.+|++||+|.||+++|+...
T Consensus 915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 34567778899999999999999999999999998654
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-33 Score=290.71 Aligned_cols=243 Identities=27% Similarity=0.365 Sum_probs=174.9
Q ss_pred cCc-ccccccccCCccceEeeeeC-----Cch---------------------------hhhhhhhhhhcceeecC--ce
Q 039318 424 DNF-SINKKLGEGGFGPVYKGTLA-----DGQ---------------------------EIAHRNLVKLLGCCIQG--EE 468 (717)
Q Consensus 424 ~~~-~~~~~lG~G~fg~Vy~~~~~-----~~~---------------------------~vah~niv~l~~~~~~~--~~ 468 (717)
++| ++.+.||+|+||.||++... +++ .+.||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 88899999999999875421 111 11299999999987653 45
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
.++||||+++++|.+++.. ..+++..++.++.|+++||.|||+++ |+||||||+|||+++++.+||+|||+++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 7899999999999999843 24899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCcccc-ccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 549 TFVGDEIEG-STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 549 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
......... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......- .................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLI 234 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhh
Confidence 654322111 1112345667999999988889999999999999999999999975432110 00000000000000011
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.+.+.......+......+.+++.+||+.+|++||++++|+++|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111111111112234677899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=287.50 Aligned_cols=226 Identities=25% Similarity=0.322 Sum_probs=176.7
Q ss_pred CcccccccccCCccceEeeeeCC-chh-----------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 425 NFSINKKLGEGGFGPVYKGTLAD-GQE-----------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~-----------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
+|++.+.||+|+||.||++.... ++. +.||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 47888999999999999988642 111 129999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999888543 2345889999999999999999999998 9999999999999999999999999998653222
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
......|+..|+|||++.+..++.++||||||+++|||++|+.||...........+ ........
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~---~~~~~~~~--------- 221 (285)
T cd05605 157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV---ERRVKEDQ--------- 221 (285)
T ss_pred ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH---HHHhhhcc---------
Confidence 112357899999999999999999999999999999999999999754322211111 11111110
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRP-----CMPSVILM 670 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~~ 670 (717)
...+......+.+++.+||+.||++|| ++.++++.
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 001112234567899999999999999 77788664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-33 Score=297.54 Aligned_cols=234 Identities=29% Similarity=0.466 Sum_probs=176.0
Q ss_pred hcCcccccccccCCccceEeeeeC------Cchhh----------------------------hhhhhhhhcceeecC-c
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLA------DGQEI----------------------------AHRNLVKLLGCCIQG-E 467 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~v----------------------------ah~niv~l~~~~~~~-~ 467 (717)
.++|++.+.||+|+||.||+|... .++.+ .||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 367999999999999999998631 11111 179999999987654 4
Q ss_pred eeeEEEeccCCCChhhHhhhccc---------------------------------------------------------
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTK--------------------------------------------------------- 490 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 490 (717)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999854210
Q ss_pred -------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccceec
Q 039318 491 -------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVV 563 (717)
Q Consensus 491 -------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 563 (717)
...+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124678888999999999999999998 9999999999999999999999999998653322212222344
Q ss_pred ccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHH
Q 039318 564 GTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAE 642 (717)
Q Consensus 564 gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~ 642 (717)
++..|+|||.+.+..++.++||||||+++|||++ |..||....... .. .....++..... ... .
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~----~~~~~~~~~~~~-----~~~----~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF----CRRLKEGTRMRA-----PDY----T 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HH----HHHHhccCCCCC-----CCC----C
Confidence 5678999999998899999999999999999997 999986432221 11 111111111110 001 1
Q ss_pred HHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 643 VIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 643 ~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
...+.+++.+||+.+|++||++.||++.|+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 13467889999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=299.99 Aligned_cols=235 Identities=23% Similarity=0.315 Sum_probs=173.1
Q ss_pred CcccccccccCCccceEeeeeCC-chh----------------------------hhhhhhhhhcceeecCc-----eee
Q 039318 425 NFSINKKLGEGGFGPVYKGTLAD-GQE----------------------------IAHRNLVKLLGCCIQGE-----EKL 470 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~----------------------------vah~niv~l~~~~~~~~-----~~~ 470 (717)
+|++.++||+|+||.||+++... ++. +.||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47888999999999999998642 211 12999999999998776 789
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
+||||+. ++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 47777773 2346889999999999999999999998 999999999999999999999999999865
Q ss_pred cCCccccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
...... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||.......... .............+
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~g~~~~~~~ 229 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD---LITDLLGTPSLEAM 229 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHHcCCCCHHHH
Confidence 332211 12234678999999998774 47999999999999999999999997544322111 11111110000000
Q ss_pred cc----------------hhhhc--cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 630 ID----------------AYYQE--SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 630 ~d----------------~~~~~--~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.. +.... .........+.+++.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 00000 0001113457789999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=289.21 Aligned_cols=232 Identities=27% Similarity=0.460 Sum_probs=178.4
Q ss_pred hcCcccccccccCCccceEeeeeCC------chh---------------------------hhhhhhhhhcceeecCcee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD------GQE---------------------------IAHRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~---------------------------vah~niv~l~~~~~~~~~~ 469 (717)
.++|++.+.||+|+||.||+++... +.. +.||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 4679999999999999999987531 110 1299999999999999999
Q ss_pred eEEEeccCCCChhhHhhhcc-------------------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCc
Q 039318 470 LLIYEFMPNRSLDSFIFDQT-------------------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASN 530 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~N 530 (717)
++||||+++++|.+++.... ....+++..++.++.|++.||+|||+++ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999996422 1124678888999999999999999998 9999999999
Q ss_pred eEEcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCC
Q 039318 531 VLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDK 609 (717)
Q Consensus 531 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~ 609 (717)
|+++.++.+||+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999886533221111222334667999999998899999999999999999997 88887432211
Q ss_pred chhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 610 NLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
.. ......+..... +.....++.+++.+||+.+|++||++.|+++.|+.
T Consensus 240 --~~----~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 --EV----IYYVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HH----HHHHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 111222211110 11123467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-33 Score=304.73 Aligned_cols=233 Identities=28% Similarity=0.411 Sum_probs=178.5
Q ss_pred cCcccccccccCCccceEeeeeCCc------hh---------------------------hh-hhhhhhhcceeecCcee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG------QE---------------------------IA-HRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~------~~---------------------------va-h~niv~l~~~~~~~~~~ 469 (717)
++|.+.++||+|+||.||+|++... .. +. |||||++++++...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 4677889999999999999975320 00 11 99999999999999999
Q ss_pred eEEEeccCCCChhhHhhhccc-----------------------------------------------------------
Q 039318 470 LLIYEFMPNRSLDSFIFDQTK----------------------------------------------------------- 490 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 490 (717)
++||||+++|+|.+++.....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999964311
Q ss_pred ------------------------------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc
Q 039318 491 ------------------------------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD 534 (717)
Q Consensus 491 ------------------------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~ 534 (717)
...+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence 123567778899999999999999987 99999999999999
Q ss_pred CCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhH
Q 039318 535 HEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNL 613 (717)
Q Consensus 535 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~ 613 (717)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~--- 350 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ--- 350 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH---
Confidence 999999999999986533221111223456789999999998889999999999999999998 8889764322111
Q ss_pred HHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 614 IGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.......+.... .+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 351 ---~~~~~~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 351 ---FYNAIKRGYRMA---------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ---HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111111111000 0111224577889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=284.50 Aligned_cols=229 Identities=31% Similarity=0.457 Sum_probs=179.6
Q ss_pred hcCcccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCceeeEEEeccC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.++|++.++||+|+||.||+|..++++.++ |+||+++++++ ..+..++||||++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCC
Confidence 467899999999999999999876654332 99999999886 4567899999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 84 NGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 99999998543 2346788999999999999999999988 9999999999999999999999999998654322111
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
.....++..|+|||++....++.++||||||+++|||++ |+.||..... .... ..+........
T Consensus 160 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~----~~~~~~~~~~~------- 224 (260)
T cd05067 160 -REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVI----QNLERGYRMPR------- 224 (260)
T ss_pred -ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHH----HHHHcCCCCCC-------
Confidence 112345678999999998899999999999999999998 9999864321 1111 11111111110
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
+......+.+++.+||+.+|++||++++++.+|+.
T Consensus 225 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 --PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11112357789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-34 Score=274.23 Aligned_cols=225 Identities=23% Similarity=0.325 Sum_probs=176.9
Q ss_pred hcCcccccccccCCccceEeeeeCCch-hh-----------------------------------hhhhhhhhcceeecC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ-EI-----------------------------------AHRNLVKLLGCCIQG 466 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~v-----------------------------------ah~niv~l~~~~~~~ 466 (717)
-.+|.-.+.||.|..++|-++.++.+. +. -||+|+++.++++..
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356777788999999888776654321 11 099999999999999
Q ss_pred ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccc
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGL 546 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgl 546 (717)
...++|+|.|+.|.|.+++. ..-.++++...+|++|+.+|+.|||.++ ||||||||+|||++++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 99999999999999999994 3446899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCccccccceecccccccCcccccc------CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHH
Q 039318 547 ARTFVGDEIEGSTKRVVGTYGYMAPEYASD------GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKL 620 (717)
Q Consensus 547 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 620 (717)
+..+.+.+ .....+|||+|+|||.+.. ..|+..+|+||+|||+|.|+.|.+||=... .+- ..++
T Consensus 170 a~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------Qml-MLR~ 239 (411)
T KOG0599|consen 170 ACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------QML-MLRM 239 (411)
T ss_pred eeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------HHH-HHHH
Confidence 99876543 2345899999999999864 347889999999999999999999963210 110 1122
Q ss_pred hhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 621 WNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 621 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+.+++-. +..+.. .+......+|+.+|||.||.+|.|.+|+++
T Consensus 240 ImeGkyq-F~speW-----adis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 240 IMEGKYQ-FRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHhcccc-cCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 2233211 111100 112345678999999999999999999987
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=278.87 Aligned_cols=224 Identities=24% Similarity=0.363 Sum_probs=178.7
Q ss_pred CcccccccccCCccceEeeeeCCch-----------------------------hhhhhhhhhhcceeecCceeeEEEec
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ-----------------------------EIAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~-----------------------------~vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+|++.+.||+|++|.||+|+..... .+.||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999864321 12299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999999653 2346888999999999999999999988 99999999999999999999999999986543321
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
......|++.|+|||++.+..++.++|+||||++++||++|+.||..... .... .....+....+.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~----~~~~~~~~~~~~----- 222 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALI----LKIIRGVFPPVS----- 222 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHH----HHHHcCCCCCCc-----
Confidence 12345688999999999999999999999999999999999999864331 1111 111111111111
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
......+.+++.+||+.+|++||++.++++.
T Consensus 223 ----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 ----QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1123457789999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=283.56 Aligned_cols=228 Identities=30% Similarity=0.476 Sum_probs=177.2
Q ss_pred cCcccccccccCCccceEeeeeCCchhh-------------------------hhhhhhhhcceeecCceeeEEEeccCC
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEI-------------------------AHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~v-------------------------ah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
++|.+.++||+|+||.||++....+..+ .|+|++++++++. .+..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 5688899999999999999986543222 2999999998875 5678999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||+++........ .
T Consensus 85 ~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05069 85 GSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-c
Confidence 9999999543 2345788999999999999999999988 999999999999999999999999999865332211 1
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhcc
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 637 (717)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ........ .
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~---------~ 223 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLE----QVERGYRM---------P 223 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC---------C
Confidence 112345678999999998899999999999999999999 89898643211 1111 11111110 0
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
.+......+.+++.+||+.+|++||++++|+++|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111123457788999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=297.64 Aligned_cols=236 Identities=21% Similarity=0.243 Sum_probs=179.9
Q ss_pred CcccccccccCCccceEeeeeCCch-hhh-------------------------------hhhhhhhcceeecCceeeEE
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ-EIA-------------------------------HRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~-~va-------------------------------h~niv~l~~~~~~~~~~~lV 472 (717)
+|++.+.||+|+||.|.||.+...+ .|| --|+|++++++...++.|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 8999999999999999999887643 333 24799999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC--CCceeccccccccc
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE--MNPKISDFGLARTF 550 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~--~~~kl~Dfgla~~~ 550 (717)
+|.+. .+|.++|+... ...++...+..++.||++||.+||+.+ |||+||||+||||.+. ..+||+|||.+...
T Consensus 267 fELL~-~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 267 FELLS-TNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ehhhh-hhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99985 59999996543 445899999999999999999999998 9999999999999644 36999999999875
Q ss_pred cCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHH-----hh-CC
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKL-----WN-NG 624 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~-----~~-~~ 624 (717)
.... -+++.++.|+|||++.|.+|+.+.|+||||||+.||++|.+.|......+.+..+...... +. ..
T Consensus 342 ~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 SQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred CCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 3322 2688899999999999999999999999999999999998877654443332222221110 00 00
Q ss_pred CCccccch---------------------------------hhh-ccCC------HHHHHHHHHHHhhccccCCCCCCCh
Q 039318 625 MPSQLIDA---------------------------------YYQ-ESCN------LAEVIRCIHVGLLCVQHHPEDRPCM 664 (717)
Q Consensus 625 ~~~~l~d~---------------------------------~~~-~~~~------~~~~~~~~~l~~~Cl~~dp~~RPs~ 664 (717)
+.....+. ... +... ..+-..+++++.+||+.||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 00000100 000 1111 1233457899999999999999999
Q ss_pred HHHHHH
Q 039318 665 PSVILM 670 (717)
Q Consensus 665 ~evl~~ 670 (717)
.++++.
T Consensus 497 ~qal~H 502 (586)
T KOG0667|consen 497 AQALNH 502 (586)
T ss_pred HHHhcC
Confidence 999984
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-33 Score=267.86 Aligned_cols=226 Identities=23% Similarity=0.316 Sum_probs=175.2
Q ss_pred HhcCcccccccccCCccceEeeeeCC-chhh----------------------------hhhhhhhhcceeecCceeeEE
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLAD-GQEI----------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v----------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
.+++|++.+.||+|.|+.|+++.... |++. .|||||++.+.+.+....+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 45789999999999999999986543 2222 299999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC---CCCceecccccccc
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH---EMNPKISDFGLART 549 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~Dfgla~~ 549 (717)
+|+|.|++|..-|-. +...++..+-..++||+++|.|+|.++ |||||+||+|+||.. ..-+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999999877633 345677777889999999999999998 999999999999953 34589999999998
Q ss_pred ccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 550 FVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 550 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
+.... ......|||+|||||+++..+|+..+|||+-|||||-|+.|.+||-.... ..+. +.+..+...
T Consensus 163 l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~rly----e~I~~g~yd-- 230 (355)
T KOG0033|consen 163 VNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLY----EQIKAGAYD-- 230 (355)
T ss_pred eCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---HHHH----HHHhccccC--
Confidence 76322 23357899999999999999999999999999999999999999863221 1111 111111110
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+++... ..-..+..+|+.+||..||.+|.|+.|.+.
T Consensus 231 ~~~~~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 YPSPEW----DTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CCCccc----CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 011000 112235668888999999999999988765
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=293.50 Aligned_cols=229 Identities=19% Similarity=0.211 Sum_probs=171.8
Q ss_pred cCcccccccccCCccceEeeeeCCchh-h-----------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQE-I-----------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~-v-----------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.++||+|+||.||+++.....+ + .|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 478999999999999999998653221 1 1899999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999542 245788899999999999999999998 999999999999999999999999999865433
Q ss_pred ccccccceecccccccCcccccc-----CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASD-----GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ . ............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~---~~~i~~~~~~~~ 228 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE---T---YGKIMNHEERFQ 228 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH---H---HHHHHcCCCccc
Confidence 21 11223579999999999875 568899999999999999999999986432211 1 111111111000
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCC--CCChHHHHHH
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPED--RPCMPSVILM 670 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~--RPs~~evl~~ 670 (717)
+ .... .....++.+++.+||+..+++ |++++++++.
T Consensus 229 ~-p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 F-PSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred C-CCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 0000 011245667787888765543 4678888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=290.33 Aligned_cols=237 Identities=24% Similarity=0.296 Sum_probs=176.3
Q ss_pred cCcccccccccCCccceEeeeeCCchh----------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQE----------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~----------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
++|++.++||+|+||.||+++...... +.||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 468999999999999999997643210 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhc-CCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD-SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
+++++|.+++... +.+++..+..++.|+++||.|||+. + ++|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 9999999999543 4578899999999999999999974 5 999999999999999999999999998754322
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC---------
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM--------- 625 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 625 (717)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......................
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 12346789999999999888899999999999999999999999854321111100000000000000
Q ss_pred --------Cccccchhhhc----cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 626 --------PSQLIDAYYQE----SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 626 --------~~~l~d~~~~~----~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
..++.+..... .........+.+++.+||+.+|++||++.+|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000 0000122357899999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-33 Score=292.04 Aligned_cols=226 Identities=26% Similarity=0.430 Sum_probs=181.0
Q ss_pred hcCcccccccccCCccceEeeeeCCchhhh---------------------------hhhhhhhcceeecCceeeEEEec
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA---------------------------HRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va---------------------------h~niv~l~~~~~~~~~~~lV~E~ 475 (717)
.+.|.|+..||.|+||.||+|..++...+| ||+||+|++.|...+.+++..||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 356888899999999999999987665443 99999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
|+||-++..+..- ...|.+.++..+.+|++.||.|||++. |||||||..|||+.-+|.++|+|||.+..... .
T Consensus 111 C~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T 183 (1187)
T ss_pred cCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--H
Confidence 9999999988543 446899999999999999999999998 99999999999999999999999999865322 2
Q ss_pred ccccceecccccccCccccc-----cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 556 EGSTKRVVGTYGYMAPEYAS-----DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
......+.|||+|||||+.. ..+|+.++||||||+.|.||..+.+|-.... .+.++ .++. ...+..++
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln---pMRVl---lKia-KSePPTLl 256 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN---PMRVL---LKIA-KSEPPTLL 256 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc---hHHHH---HHHh-hcCCCccc
Confidence 22334689999999999874 5789999999999999999999999854222 22222 2222 22333333
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.+.-. ...+.++..+||.+||..||++.++++
T Consensus 257 qPS~W-------s~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 QPSHW-------SRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred Ccchh-------hhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 32221 234567778899999999999988876
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=284.27 Aligned_cols=225 Identities=25% Similarity=0.362 Sum_probs=174.2
Q ss_pred cCcccccccccCCccceEeeeeCCch----------------------------hhhhhhhhhhcceeecCceeeEEEec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ----------------------------EIAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~----------------------------~vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
++|++.+.||+|+||.||+|+..... .+.||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36788899999999999999753211 01299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999996543 3677888899999999999999998 999999999999999999999999999865322
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
......++..|+|||++.+..++.++|+||||+++|+|++|+.||..........................+.
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 221 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP----- 221 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCC-----
Confidence 1234578999999999999999999999999999999999999986533222111111111111111111110
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
......++.+++.+|++.+|++||+++|+++.
T Consensus 222 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 ---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01122356788999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=284.90 Aligned_cols=230 Identities=27% Similarity=0.415 Sum_probs=176.7
Q ss_pred cCcccccccccCCccceEeeeeCCch-------------------------------hhhhhhhhhhcceeecCceeeEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-------------------------------EIAHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-------------------------------~vah~niv~l~~~~~~~~~~~lV 472 (717)
..|++.+.||+|+||.||+|+..... .+.||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 35788899999999999998864221 01199999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++++|.+++... .+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998543 346889999999999999999999998 99999999999999999999999999886543
Q ss_pred Cccccccceec---ccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 553 DEIEGSTKRVV---GTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 553 ~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
........... .+..|+|||.+.+..++.++||||||+++|||++ |..||...... ...... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i----~~~~~~- 230 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI----EQDYRL- 230 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH----HcCCcC-
Confidence 22111111111 2457999999999999999999999999999886 99998543221 111111 111000
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
..+......+.+++.+||+.+|++||++.+|+.+|+..
T Consensus 231 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 --------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00111223467889999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=282.42 Aligned_cols=225 Identities=27% Similarity=0.379 Sum_probs=175.2
Q ss_pred cCcccccccccCCccceEeeeeCCch-----------------------hhhhhhhhhhcceee-cCceeeEEEeccCCC
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-----------------------EIAHRNLVKLLGCCI-QGEEKLLIYEFMPNR 479 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-----------------------~vah~niv~l~~~~~-~~~~~~lV~E~~~~g 479 (717)
++|.+.+.||+|+||.||++...... .+.|+|++++++++. +.+..++||||++++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence 57889999999999999998754211 122999999999754 556789999999999
Q ss_pred ChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccccc
Q 039318 480 SLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559 (717)
Q Consensus 480 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 559 (717)
+|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++......
T Consensus 86 ~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----- 156 (256)
T cd05082 86 SLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----- 156 (256)
T ss_pred cHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-----
Confidence 999998543 2335788999999999999999999998 9999999999999999999999999988543221
Q ss_pred ceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 560 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
....++..|+|||++.+..++.++||||||+++|||++ |+.||...... .. ......+.....
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~~~~--------- 220 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DV----VPRVEKGYKMDA--------- 220 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHhcCCCCCC---------
Confidence 12344678999999998899999999999999999997 99997632211 11 111111111111
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 639 NLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 639 ~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
.......+.+++.+|++.+|++||++.++++.|+.
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11123456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=279.10 Aligned_cols=224 Identities=34% Similarity=0.531 Sum_probs=178.0
Q ss_pred cccccCCccceEeeeeCCc----hh---------------------------hhhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLADG----QE---------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~----~~---------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
+.||+|+||.||+|+.... .. +.|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4799999999999987642 11 1299999999999999999999999999
Q ss_pred CChhhHhhhccc------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 479 RSLDSFIFDQTK------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 479 gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
++|.+++..... ...+++..+..++.|+++||+|||+++ |+|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999955321 367899999999999999999999988 99999999999999999999999999987654
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
...........++..|+|||.+....++.++||||||+++|||++ |+.||...... .. ...........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~~~--- 227 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EV----LEYLRKGYRLP--- 227 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHHcCCCCC---
Confidence 432222334567889999999988899999999999999999999 69998754221 11 11111111100
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
.+......+.+++.+||+.+|.+||++.++++.|+
T Consensus 228 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 ------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01111346778899999999999999999999884
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=282.11 Aligned_cols=214 Identities=26% Similarity=0.453 Sum_probs=165.5
Q ss_pred cccccCCccceEeeeeCCch----------------------------------hhhhhhhhhhcceeecCceeeEEEec
Q 039318 430 KKLGEGGFGPVYKGTLADGQ----------------------------------EIAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~----------------------------------~vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+.||+|+||.||+|..+... .+.||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 47999999999999763210 01199999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC--------ceecccccc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN--------PKISDFGLA 547 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~--------~kl~Dfgla 547 (717)
+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999543 235788999999999999999999998 999999999999987765 589999988
Q ss_pred ccccCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCC-CCCCCCCCCCchhHHHHHHHHhhCCC
Q 039318 548 RTFVGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGK-KNRGFYHSDKNLNLIGHAWKLWNNGM 625 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 625 (717)
...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+........ . ......
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~----~~~~~~- 221 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---L----QFYEDR- 221 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---H----HHHHcc-
Confidence 754321 23567889999999986 45799999999999999999985 55442221110 0 011110
Q ss_pred CccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 626 PSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 626 ~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
.. .+......+.+++.+||+.+|++|||++++++.|+
T Consensus 222 -~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -HQ---------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -cc---------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 01111245678999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=285.04 Aligned_cols=220 Identities=25% Similarity=0.309 Sum_probs=170.0
Q ss_pred cccCCccceEeeeeCCc-hh-----------------------------hhhhhhhhhcceeecCceeeEEEeccCCCCh
Q 039318 432 LGEGGFGPVYKGTLADG-QE-----------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSL 481 (717)
Q Consensus 432 lG~G~fg~Vy~~~~~~~-~~-----------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~gsL 481 (717)
||+|+||+||+++.... +. +.||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999876422 11 1299999999999999999999999999999
Q ss_pred hhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccc
Q 039318 482 DSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTK 560 (717)
Q Consensus 482 ~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 560 (717)
..++.... ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 98885432 3346899999999999999999999998 99999999999999999999999999976543221 123
Q ss_pred eecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCH
Q 039318 561 RVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNL 640 (717)
Q Consensus 561 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~ 640 (717)
...||+.|+|||++.+..++.++||||||+++|||++|+.||............ ....... .. ..+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~-~~----------~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQRILND-SV----------TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH--HHhhccc-CC----------CCcc
Confidence 457899999999999999999999999999999999999998643322111111 0111100 00 0111
Q ss_pred HHHHHHHHHHhhccccCCCCCC-----ChHHHHH
Q 039318 641 AEVIRCIHVGLLCVQHHPEDRP-----CMPSVIL 669 (717)
Q Consensus 641 ~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~ 669 (717)
.....+.+++.+||+.+|++|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 1234567888999999999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=284.78 Aligned_cols=221 Identities=24% Similarity=0.313 Sum_probs=170.3
Q ss_pred cccCCccceEeeeeCCc-hh-----------------------------hhhhhhhhhcceeecCceeeEEEeccCCCCh
Q 039318 432 LGEGGFGPVYKGTLADG-QE-----------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSL 481 (717)
Q Consensus 432 lG~G~fg~Vy~~~~~~~-~~-----------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~gsL 481 (717)
||+|+||.||+++.+.. +. +.||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999876431 11 1299999999999999999999999999999
Q ss_pred hhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccce
Q 039318 482 DSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561 (717)
Q Consensus 482 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 561 (717)
.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 9888543 2335788899999999999999999998 9999999999999999999999999998654322 1223
Q ss_pred ecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHH
Q 039318 562 VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLA 641 (717)
Q Consensus 562 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~ 641 (717)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...........+ ....... .... . ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~--~~~~~~~-~~~~------~---~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL--KRRTLED-EVKF------E---HQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH--HHHhhcc-cccc------c---ccc
Confidence 56899999999999989999999999999999999999998654322211111 1111111 1100 0 001
Q ss_pred HHHHHHHHHhhccccCCCCCCChHHHHHHh
Q 039318 642 EVIRCIHVGLLCVQHHPEDRPCMPSVILML 671 (717)
Q Consensus 642 ~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L 671 (717)
....+.+++.+||+.||++||++.|+++.+
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 123467889999999999999998776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=284.38 Aligned_cols=223 Identities=28% Similarity=0.414 Sum_probs=170.9
Q ss_pred cccccCCccceEeeeeCCch------------------------------hh-hhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLADGQ------------------------------EI-AHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~------------------------------~v-ah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
+.||+|+||.||+|++.+.. .+ .||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36999999999999764321 01 299999999999999999999999999
Q ss_pred CChhhHhhhcc-------------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 479 RSLDSFIFDQT-------------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 479 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999995432 1234788999999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCC
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNG 624 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 624 (717)
++...... ........+..|+|||++....++.++||||||+++|||++ |..||...... ... ......
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~----~~~~~~ 227 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELY----EKLPQG 227 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHH----HHHhCC
Confidence 98632111 11111234567999999988899999999999999999997 99998532211 111 111111
Q ss_pred CCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 625 MPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 625 ~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
..... +......+.+++.+|++.+|.+||++.++++.|+..
T Consensus 228 ~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCCCC---------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 11000 111123567899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=284.12 Aligned_cols=230 Identities=27% Similarity=0.433 Sum_probs=178.2
Q ss_pred cCcccccccccCCccceEeeeeCCch-------------------------------hhhhhhhhhhcceeecCceeeEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-------------------------------EIAHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-------------------------------~vah~niv~l~~~~~~~~~~~lV 472 (717)
.+|++.+.||+|+||.||+|+..... .+.||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888999999999999998753110 01299999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++++|.+++... ...+++.++..++.|++.||+|||+++ ++||||||+|||++.++.++|+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999543 245788999999999999999999998 99999999999999999999999999987643
Q ss_pred Cccccc-cceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 553 DEIEGS-TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 553 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
...... .....++..|+|||++.+..++.++|+||||+++||+++ |+.||......+ .. ....+....
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~----~~~~~~~~~--- 228 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VI----KAIEEGYRL--- 228 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HH----HHHhCCCcC---
Confidence 221111 111223568999999998899999999999999999886 999986432211 11 111111100
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.........+.+++.+|++.+|.+||++.++++.|+..
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 ------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00111223567899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=281.08 Aligned_cols=233 Identities=27% Similarity=0.376 Sum_probs=182.7
Q ss_pred cCcccccccccCCccceEeeeeC-Cchh-----------------------------hhhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLA-DGQE-----------------------------IAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~-----------------------------vah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||.||+|... +++. +.|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999875 2211 12999999999999999999999
Q ss_pred eccCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 474 EFMPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
||+++++|.+++.... ....+++..+..++.++++||+|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999985432 3445789999999999999999999998 99999999999999999999999999886533
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... .. ........+......
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~-~~~~~~~~~~~~~~~-- 229 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LY-SLCKKIEKCDYPPLP-- 229 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HH-HHHhhhhcCCCCCCC--
Confidence 221 122356888999999999888999999999999999999999997532211 11 011111111111110
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.......+.+++.+||+.+|++||++.+|+++|+..
T Consensus 230 ------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 ------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 012234567889999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=290.23 Aligned_cols=231 Identities=28% Similarity=0.433 Sum_probs=177.2
Q ss_pred hcCcccccccccCCccceEeeeeCC-chh-------------------------------hhhhhhhhhcceeecCceee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQE-------------------------------IAHRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~-------------------------------vah~niv~l~~~~~~~~~~~ 470 (717)
.++|+..+.||+|+||.||+|.... +.. +.||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 3567888999999999999997532 110 1199999999998754 577
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
+++||+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999998542 335788899999999999999999998 999999999999999999999999999876
Q ss_pred cCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .............
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~ 232 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGERLPQ 232 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCCCCC
Confidence 43322222223445778999999999999999999999999999997 889986432111 1111111111000
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
+......+.+++..|+..+|++||++.+++++|+...
T Consensus 233 ---------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 233 ---------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred ---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0112235678899999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=282.69 Aligned_cols=230 Identities=31% Similarity=0.485 Sum_probs=180.6
Q ss_pred hcCcccccccccCCccceEeeeeCCchh-------------------------hhhhhhhhhcceeecCceeeEEEeccC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQE-------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-------------------------vah~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.++|.+.++||+|+||.||+|..++++. +.|+||+++++++......++||||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 4689999999999999999998654322 229999999999999899999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++.... ...+++..+..++.+++.||.|||+++ |+|+||||+||+++.++.+||+|||+++........
T Consensus 85 ~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~- 159 (261)
T cd05034 85 KGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT- 159 (261)
T ss_pred CCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh-
Confidence 999999995532 245789999999999999999999998 999999999999999999999999999865432111
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
......++..|+|||.+.+..++.++|+||||+++|||++ |+.||..... ....... ......
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~----~~~~~~--------- 223 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQV----ERGYRM--------- 223 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCCCC---------
Confidence 1112234568999999998899999999999999999998 9999853321 1111111 111000
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
..+......+.+++.+|++.+|++||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011113457789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=294.51 Aligned_cols=229 Identities=17% Similarity=0.217 Sum_probs=170.4
Q ss_pred cCcccccccccCCccceEeeeeCCchhh------------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEI------------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~v------------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.++||+|+||.||+++.+....+ .|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4789999999999999999987543210 1899999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++|+|.+++.+. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999542 335788899999999999999999998 999999999999999999999999999764332
Q ss_pred ccccccceecccccccCccccc-----cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 554 EIEGSTKRVVGTYGYMAPEYAS-----DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||......+ . ............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~---~---~~~i~~~~~~~~ 228 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE---T---YGKIMNHKERFQ 228 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH---H---HHHHhCCCcccc
Confidence 21 1222357999999999986 3468899999999999999999999986432111 1 111111111000
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccC--CCCCCChHHHHHH
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHH--PEDRPCMPSVILM 670 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~d--p~~RPs~~evl~~ 670 (717)
+.. .. ......+.+++.+|+..+ +..|+++.|+++.
T Consensus 229 ~p~-~~-----~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 FPA-QV-----TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCC-cc-----ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000 00 011234556666666544 4447899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-33 Score=289.18 Aligned_cols=237 Identities=26% Similarity=0.406 Sum_probs=173.7
Q ss_pred cCcccccccccCCccceEeeeeC-----Cch--------------------------hhhhhhhhhhcceeec--Cceee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLA-----DGQ--------------------------EIAHRNLVKLLGCCIQ--GEEKL 470 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~--------------------------~vah~niv~l~~~~~~--~~~~~ 470 (717)
.+|++.+.||+|+||.||++..+ .+. .+.||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 47888999999999999998742 111 1129999999998654 34678
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998432 345889999999999999999999998 999999999999999999999999999875
Q ss_pred cCCcccc-ccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCC--------c-hhHHHHHHHH
Q 039318 551 VGDEIEG-STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDK--------N-LNLIGHAWKL 620 (717)
Q Consensus 551 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~--------~-~~~~~~~~~~ 620 (717)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..++......- . ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 4322111 1111223456999999998899999999999999999999877653221100 0 0000001111
Q ss_pred hhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 621 WNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 621 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
...... ..........+.+++.+||+.+|++|||+.||++.|+..
T Consensus 239 ~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGR---------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111100 001111224577899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=285.77 Aligned_cols=228 Identities=27% Similarity=0.414 Sum_probs=174.9
Q ss_pred HHhcCcccccccccCCccceEeeeeCCchh--------------------------h-hhhhhhhhcceeecC------c
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADGQE--------------------------I-AHRNLVKLLGCCIQG------E 467 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~--------------------------v-ah~niv~l~~~~~~~------~ 467 (717)
.+++.|++.+.||+|+||.||+|+.....+ + .|+||+++++++... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 456789999999999999999998653211 1 299999999998753 4
Q ss_pred eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla 547 (717)
..++||||+++++|.+++... ....+++..+..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 679999999999999998542 2345789999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccccccceecccccccCccccc-----cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhh
Q 039318 548 RTFVGDEIEGSTKRVVGTYGYMAPEYAS-----DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWN 622 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 622 (717)
+...... .......|+..|+|||++. +..++.++|||||||++|||++|+.||......... .....
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~------~~~~~ 230 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FLIPR 230 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH------HHHhc
Confidence 8653221 1223467899999999986 345888999999999999999999998643221111 11111
Q ss_pred CCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 623 NGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 623 ~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
. ....+.+ ......+.+++.+||+.+|.+||++.++++
T Consensus 231 ~-~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 N-PAPRLKS--------KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred C-CCCCCCC--------CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1 1111111 011235678899999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=281.87 Aligned_cols=225 Identities=32% Similarity=0.476 Sum_probs=173.8
Q ss_pred cccccCCccceEeeeeCCch-------h---------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 430 KKLGEGGFGPVYKGTLADGQ-------E---------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~-------~---------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+.||+|+||.||+|+..+.. . +.||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36999999999999864211 1 1199999999999999999999999
Q ss_pred cCCCChhhHhhhcc----ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC-----Cceeccccc
Q 039318 476 MPNRSLDSFIFDQT----KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM-----NPKISDFGL 546 (717)
Q Consensus 476 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~-----~~kl~Dfgl 546 (717)
+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996532 2234788999999999999999999988 99999999999999887 899999999
Q ss_pred cccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCC
Q 039318 547 ARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGM 625 (717)
Q Consensus 547 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 625 (717)
++...............++..|+|||++.+..++.++||||||+++|||++ |+.||..... ..... ....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~----~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQ----HVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHH----HHhcCC
Confidence 986543332222223455788999999999999999999999999999998 9999863221 11111 111111
Q ss_pred CccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 626 PSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 626 ~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
... .+......+.+++.+||+.+|.+||++.+|+++|+.
T Consensus 231 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RLQ---------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ccC---------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 000 011122456789999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=282.94 Aligned_cols=237 Identities=24% Similarity=0.368 Sum_probs=177.0
Q ss_pred cCcccccccccCCccceEeeeeC-----Cchh---------------------------hhhhhhhhhcceeecC--cee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLA-----DGQE---------------------------IAHRNLVKLLGCCIQG--EEK 469 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~---------------------------vah~niv~l~~~~~~~--~~~ 469 (717)
+.|++.+.||+|+||.||+++.. .+.. +.||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 45788899999999999998742 1111 1299999999998775 568
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998442 235899999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCccc-cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCC--------CCchhHHHHHHHH
Q 039318 550 FVGDEIE-GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHS--------DKNLNLIGHAWKL 620 (717)
Q Consensus 550 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~--------~~~~~~~~~~~~~ 620 (717)
....... .......++..|+|||.+.+..++.++||||||+++|||++++.|...... .............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 5432211 112235567789999999888999999999999999999998776422110 0000011111111
Q ss_pred hhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 621 WNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 621 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
...+.... ........+.+|+.+||+.+|++||++.++++.|+..
T Consensus 239 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111110 0111234678899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=283.05 Aligned_cols=226 Identities=26% Similarity=0.364 Sum_probs=176.4
Q ss_pred cCcccccccccCCccceEeeeeCCc-hh-------------------------------hhhhhhhhhcceeecCceeeE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QE-------------------------------IAHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~-------------------------------vah~niv~l~~~~~~~~~~~l 471 (717)
++|++.+.||+|++|.||++..... +. +.||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999975321 11 119999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999999854 345788899999999999999999998 9999999999999999999999999997653
Q ss_pred CCccccc-cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 552 GDEIEGS-TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 552 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
....... .....++..|+|||++.+..++.++||||||+++|||++|+.||...... ... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~---~~~~~~~~~~~-- 227 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AAI---FKIATQPTNPQ-- 227 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HHH---HHHhccCCCCC--
Confidence 3211111 12356788999999999999999999999999999999999998632211 111 11111111111
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+......+.+++.+||+.+|.+||++.++++.
T Consensus 228 -------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 -------LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -------CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111122356788899999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=281.26 Aligned_cols=227 Identities=28% Similarity=0.492 Sum_probs=177.1
Q ss_pred cCcccccccccCCccceEeeeeCCchh-------------------------hhhhhhhhhcceeecCceeeEEEeccCC
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQE-------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~-------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
.+|++.+.||+|+||.||++....++. +.||||+++++++......++||||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 468888999999999999997653321 2299999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|.+++... ...+++..+..++.+++.+|+|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 84 ~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~- 157 (256)
T cd05112 84 GCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS- 157 (256)
T ss_pred CcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc-
Confidence 9999998542 335788999999999999999999988 9999999999999999999999999988653322111
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhcc
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 637 (717)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ....... ....+.
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~~~--~~~~~~---- 224 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVV----ETINAGF--RLYKPR---- 224 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHH----HHHhCCC--CCCCCC----
Confidence 112234578999999998899999999999999999998 99998642211 111 1111110 000111
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
.....+.+|+.+||+.+|++||++.+|+++|.
T Consensus 225 ---~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 ---LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 01246788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=280.74 Aligned_cols=214 Identities=24% Similarity=0.422 Sum_probs=165.3
Q ss_pred cccccCCccceEeeeeCCch---------------------------------------hhhhhhhhhhcceeecCceee
Q 039318 430 KKLGEGGFGPVYKGTLADGQ---------------------------------------EIAHRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~---------------------------------------~vah~niv~l~~~~~~~~~~~ 470 (717)
+.||+|+||.||+|+..... .+.||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 46999999999999743110 112999999999999999999
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC-------ceecc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN-------PKISD 543 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~-------~kl~D 543 (717)
+||||+++++|..++... ...+++..++.++.||++||+|||+++ |+||||||+||||+.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999888432 345889999999999999999999998 999999999999987664 89999
Q ss_pred ccccccccCCccccccceecccccccCccccc-cCCCCccccchhHhHHHHHhh-cCCCCCCCCCCCCchhHHHHHHHHh
Q 039318 544 FGLARTFVGDEIEGSTKRVVGTYGYMAPEYAS-DGLFSVKSDVFSFGILLLEIV-SGKKNRGFYHSDKNLNLIGHAWKLW 621 (717)
Q Consensus 544 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~ell-tG~~p~~~~~~~~~~~~~~~~~~~~ 621 (717)
||++...... ....++..|+|||.+. +..++.++|||||||++|||+ .|+.|+......+. ....
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~ 222 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFY 222 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHH
Confidence 9998754221 2345788999999886 467899999999999999998 58887653221111 1111
Q ss_pred hCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 622 NNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 622 ~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
.... .... .....+.+|+.+||+.||.+||++.++++.|+
T Consensus 223 ~~~~--~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQC--MLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcCc--cCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1110 0000 11235678899999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=278.33 Aligned_cols=222 Identities=32% Similarity=0.471 Sum_probs=172.9
Q ss_pred cccccCCccceEeeeeCCchhh---------------------------hhhhhhhhcceeecCceeeEEEeccCCCChh
Q 039318 430 KKLGEGGFGPVYKGTLADGQEI---------------------------AHRNLVKLLGCCIQGEEKLLIYEFMPNRSLD 482 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~~v---------------------------ah~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 482 (717)
++||+|+||.||++...+++.+ .|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 4799999999999987543222 1999999999999999999999999999999
Q ss_pred hHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccccccee
Q 039318 483 SFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV 562 (717)
Q Consensus 483 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 562 (717)
+++... ...+++..+..++.+++.+|.|||+++ ++||||||+|||++.++.+||+|||+++..............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998542 235788899999999999999999998 999999999999999999999999999865422221111223
Q ss_pred cccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHH
Q 039318 563 VGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLA 641 (717)
Q Consensus 563 ~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~ 641 (717)
..+..|+|||.+.+..++.++|+||||+++|||++ |..||......... ......... ..+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-------~~~~~~~~~---------~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-------ERIESGYRM---------PAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-------HHHhcCCCC---------CCCcc
Confidence 34567999999998899999999999999999998 88887543321111 111111000 01111
Q ss_pred HHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 642 EVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 642 ~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
....+.+++.+|++.+|.+||++.||++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2346778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=290.89 Aligned_cols=226 Identities=24% Similarity=0.296 Sum_probs=184.5
Q ss_pred HhcCcccccccccCCccceEeeeeCC-chhh-----------------------------h-hhhhhhhcceeecCceee
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLAD-GQEI-----------------------------A-HRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-----------------------------a-h~niv~l~~~~~~~~~~~ 470 (717)
..+.|++.+.||+|.||.||+++.+. ++.+ . |||||.+++++.+.+..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34678999999999999999998765 3222 2 999999999999999999
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC----CCceeccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE----MNPKISDFGL 546 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~----~~~kl~Dfgl 546 (717)
+|||++.||.|.+.|... .+++.....++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999665 2899999999999999999999988 9999999999999633 4799999999
Q ss_pred cccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC
Q 039318 547 ARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626 (717)
Q Consensus 547 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (717)
++.... .......+||+.|+|||++...+|+..+||||+|+++|.|++|.+||...........+ ..+..
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i-------~~~~~ 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI-------LRGDF 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH-------HcCCC
Confidence 998755 23455789999999999999999999999999999999999999998765443332211 11111
Q ss_pred ccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 627 SQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 627 ~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
++.+ ..-......+.+++..|+..||.+|+|+.++++.
T Consensus 256 -~f~~-----~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -DFTS-----EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -CCCC-----CCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1111 1111224566788999999999999999999994
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=283.12 Aligned_cols=229 Identities=28% Similarity=0.405 Sum_probs=178.0
Q ss_pred cCcccccccccCCccceEeeeeCCchh--------------------------------hhhhhhhhhcceeecCceeeE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQE--------------------------------IAHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~--------------------------------vah~niv~l~~~~~~~~~~~l 471 (717)
.+|++.+.||+|+||.||+|..+.... +.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 578889999999999999997532110 119999999999987 78999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++++|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999999543 335889999999999999999999987 9999999999999999999999999998764
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
............++..|+|||.+....++.++|+||||+++|||++ |+.||......+ ...........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~--- 230 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGERL--- 230 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhCCCCC---
Confidence 3322111112233568999999988899999999999999999998 999986543221 11111111110
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
..+......+.+++.+||..+|++||++.++++.|+..
T Consensus 231 ------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 231 ------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00111223567888999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=288.25 Aligned_cols=174 Identities=26% Similarity=0.430 Sum_probs=138.7
Q ss_pred ccccccCCccceEeeeeCCc---hh------------------------hhhhhhhhhcceeec--CceeeEEEeccCCC
Q 039318 429 NKKLGEGGFGPVYKGTLADG---QE------------------------IAHRNLVKLLGCCIQ--GEEKLLIYEFMPNR 479 (717)
Q Consensus 429 ~~~lG~G~fg~Vy~~~~~~~---~~------------------------vah~niv~l~~~~~~--~~~~~lV~E~~~~g 479 (717)
.++||+|+||.||+|+.+++ +. +.||||+++++++.. ....++||||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence 36899999999999986532 11 129999999998854 4567899999965
Q ss_pred ChhhHhhhcc------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE----cCCCCceecccccccc
Q 039318 480 SLDSFIFDQT------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL----DHEMNPKISDFGLART 549 (717)
Q Consensus 480 sL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~Dfgla~~ 549 (717)
+|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 7777764321 1235788889999999999999999998 9999999999999 4567899999999986
Q ss_pred ccCCccc-cccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCC
Q 039318 550 FVGDEIE-GSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYH 606 (717)
Q Consensus 550 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~ 606 (717)
....... .......||+.|+|||++.+. .++.++|||||||++|||++|++||....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 5432211 122346789999999998774 58999999999999999999999996443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=283.38 Aligned_cols=229 Identities=23% Similarity=0.356 Sum_probs=175.5
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hhh--------------------------hhhhhhhhcceeecCceeeEEEec
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QEI--------------------------AHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v--------------------------ah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
.++|++.+.||+|+||.||+|+.... +.+ .||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999986422 111 199999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 999999998843 345789999999999999999999988 9999999999999999999999999998653221
Q ss_pred ccccceecccccccCccccc---cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 556 EGSTKRVVGTYGYMAPEYAS---DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
.......++..|+|||.+. ...++.++|+|||||++|||++|+.||.......... . +.... +..+
T Consensus 161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~-~~~~~---~~~~ 229 (267)
T cd06646 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------L-MSKSN---FQPP 229 (267)
T ss_pred -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------e-eecCC---CCCC
Confidence 1122356889999999874 4457889999999999999999999975332211100 0 00000 0000
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHh
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L 671 (717)
.... .......+.+++.+||+.+|++||+++++++.|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1110 011124567889999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=283.56 Aligned_cols=233 Identities=20% Similarity=0.244 Sum_probs=170.1
Q ss_pred HhcCcccccccccCCccceEeeeeCCc---hh--------------------------------------hhhhhhhhhc
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADG---QE--------------------------------------IAHRNLVKLL 460 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~---~~--------------------------------------vah~niv~l~ 460 (717)
..++|.+.++||+|+||.||+|+..+. .. +.|++|++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346899999999999999999986543 10 1278888888
Q ss_pred ceeecCc----eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC
Q 039318 461 GCCIQGE----EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE 536 (717)
Q Consensus 461 ~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~ 536 (717)
+++.... ..+++||++.. ++.+.+.. ....++..+..++.|+++||+|||+++ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 8765443 34788887754 55555522 223567788899999999999999998 9999999999999999
Q ss_pred CCceeccccccccccCCcc-----ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCch
Q 039318 537 MNPKISDFGLARTFVGDEI-----EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNL 611 (717)
Q Consensus 537 ~~~kl~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~ 611 (717)
+.++|+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 9999999999986532211 11122357999999999999999999999999999999999999999765322211
Q ss_pred h-HHH-HHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 612 N-LIG-HAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 612 ~-~~~-~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
. ... .....+..+.. ... .....+.+++..|++.+|++||++.++++.|+
T Consensus 243 ~~~~~~~~~~~~~~~~~--------~~~---~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCDFIKRLHEGKI--------KIK---NANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHHHHHHhhhhhh--------ccC---CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1 000 01111111111 000 11245678888899999999999999999874
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=282.83 Aligned_cols=191 Identities=24% Similarity=0.368 Sum_probs=149.5
Q ss_pred hhhhhhhcceeecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceE
Q 039318 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVL 532 (717)
Q Consensus 453 h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIl 532 (717)
||||+++++++.+.+..++||||+++++|..++.. ..+.+++..+..++.||++||+|||+++ |+||||||+|||
T Consensus 75 h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nil 149 (274)
T cd05076 75 HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNIL 149 (274)
T ss_pred CCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEE
Confidence 99999999999999999999999999999998854 2346788999999999999999999988 999999999999
Q ss_pred EcCCC-------CceeccccccccccCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhh-cCCCCCC
Q 039318 533 LDHEM-------NPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIV-SGKKNRG 603 (717)
Q Consensus 533 l~~~~-------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell-tG~~p~~ 603 (717)
++..+ .+||+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.
T Consensus 150 l~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 223 (274)
T cd05076 150 LARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK 223 (274)
T ss_pred EeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcc
Confidence 97654 3799999998653221 12356788999998865 56899999999999999994 6999886
Q ss_pred CCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 604 FYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
.....+... . ..... .+ ... ....+.+++.+||+.+|++||++.+|++.|.
T Consensus 224 ~~~~~~~~~----~---~~~~~--~~-----~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 224 ERTPSEKER----F---YEKKH--RL-----PEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ccChHHHHH----H---HHhcc--CC-----CCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 433221111 1 11000 00 000 1135778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=283.74 Aligned_cols=222 Identities=22% Similarity=0.354 Sum_probs=184.0
Q ss_pred cCcccccccccCCccceEeeeeC-Cch----------------------------hhhhhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLA-DGQ----------------------------EIAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----------------------------~vah~niv~l~~~~~~~~~~~lV~E 474 (717)
.-|.+.+.||+|.|.+|-+|++- .|. .|.|||||+||.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45778889999999998776532 111 1239999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc-CCCCceeccccccccccCC
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD-HEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~Dfgla~~~~~~ 553 (717)
.=.+|+|.+||.++.. -+.+....++++||+.|+.|+|+.. +|||||||+|+.+- +-|-+||.|||++..+.+.
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999976544 4889999999999999999999987 99999999998774 5688999999999877554
Q ss_pred ccccccceecccccccCccccccCCCC-ccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFS-VKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
. ...+.+|+..|-|||++.+..|+ +++||||||||||.|++|+.||+..+..+...++ +|.
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------------mDC 234 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------------MDC 234 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---------------hcc
Confidence 3 34578999999999999999987 7899999999999999999999865554443332 232
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+ ..+..-..+|.+|+..||+.||.+|.+.+||+..
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 22 2344556789999999999999999999999863
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=279.52 Aligned_cols=226 Identities=28% Similarity=0.443 Sum_probs=179.2
Q ss_pred hcCcccccccccCCccceEeeeeCCch------------------------hhhhhhhhhhcceeecCceeeEEEeccCC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ------------------------EIAHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~------------------------~vah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
.++|++.+.||+|+||.||+|...+.. .+.|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 457888999999999999999765211 11299999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|.+++.... ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 85 GSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 99999995432 236899999999999999999999998 99999999999999999999999999987632211
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhcc
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 637 (717)
....+..|+|||.+....++.++||||||++++||++ |+.||......+ +. ...........
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~~~~~~~~-------- 220 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PHVEKGYRMEA-------- 220 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHhcCCCCCC--------
Confidence 2334568999999988899999999999999999997 999986432211 11 11111111111
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
+......+.+++.+||+.+|++||+++|++++|+.
T Consensus 221 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 -PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11112456789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=287.94 Aligned_cols=235 Identities=20% Similarity=0.302 Sum_probs=173.5
Q ss_pred cCcccccccccCCccceEeeeeCCc-hh---------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QE---------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~---------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
++|++.++||+|+||.||+|+.+.. +. +.||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 5799999999999999999976532 11 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
++ ++|.+++... ...+++..+..++.||++||+|||+.+ |+|+||||+|||+++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 5888888442 335788899999999999999999998 99999999999999999999999999976432211
Q ss_pred ccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCC---CCccccc
Q 039318 556 EGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG---MPSQLID 631 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~l~d 631 (717)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+. .......+... ....+.+
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhc
Confidence 12234578899999988654 578999999999999999999999875433221 11111111100 0000000
Q ss_pred ---------hhhhcc----CCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 632 ---------AYYQES----CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 632 ---------~~~~~~----~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+..... ........+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 00011224678999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=279.31 Aligned_cols=229 Identities=30% Similarity=0.464 Sum_probs=178.7
Q ss_pred hcCcccccccccCCccceEeeeeCCchhh-------------------------hhhhhhhhcceeecCceeeEEEeccC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEI-------------------------AHRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~v-------------------------ah~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.++|++.++||+|+||.||++....+..+ .|+||+++.+++.+ ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 46899999999999999999986543221 29999999999887 77899999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 158 (260)
T cd05073 84 KGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-
Confidence 999999995532 345788899999999999999999988 999999999999999999999999999865332211
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
......++..|+|||++....++.++|+||||+++|+|++ |+.||..... .... .....+.....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~----~~~~~~~~~~~------- 224 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVI----RALERGYRMPR------- 224 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHH----HHHhCCCCCCC-------
Confidence 1112345678999999998889999999999999999998 8999863221 1111 11112111110
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
.......+.+++.+|++.+|++||++.+++++|+.
T Consensus 225 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 --PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11123457788999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=313.99 Aligned_cols=234 Identities=20% Similarity=0.271 Sum_probs=175.5
Q ss_pred cCcccccccccCCccceEeeeeCC-chhh-----------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEI-----------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-----------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.++||+|+||.||+|+... ++.+ .||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 579999999999999999997643 2111 2999999999999999999999
Q ss_pred eccCCCChhhHhhhccc--------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 474 EFMPNRSLDSFIFDQTK--------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
||+++++|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999854211 123556778899999999999999998 9999999999999999999999999
Q ss_pred ccccccCCcc----------------ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCC
Q 039318 546 LARTFVGDEI----------------EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDK 609 (717)
Q Consensus 546 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~ 609 (717)
+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 001123579999999999999999999999999999999999999986422111
Q ss_pred chhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCC-ChHHHHHHhcCC
Q 039318 610 NLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP-CMPSVILMLGSE 674 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-s~~evl~~L~~~ 674 (717)
. . .. ..... +... .........+.+++.+||+.||++|| +++++++.|+..
T Consensus 239 i---~-~~-~~i~~--P~~~-------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 I---S-YR-DVILS--PIEV-------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred h---h-hh-hhccC--hhhc-------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 0 00 00000 0000 00001123466889999999999996 566677766543
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=277.68 Aligned_cols=213 Identities=25% Similarity=0.469 Sum_probs=167.8
Q ss_pred cccccCCccceEeeeeCCch-----------hh-------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 430 KKLGEGGFGPVYKGTLADGQ-----------EI-------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~-----------~v-------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
+.||+|+||.||+|.+.... .+ .||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 47999999999999875432 01 19999999999988 7889999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC-------Cceeccccc
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM-------NPKISDFGL 546 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~-------~~kl~Dfgl 546 (717)
||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 80 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 80 EYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 9999999999995432 26889999999999999999999988 99999999999999888 799999999
Q ss_pred cccccCCccccccceecccccccCccccccC--CCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhC
Q 039318 547 ARTFVGDEIEGSTKRVVGTYGYMAPEYASDG--LFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNN 623 (717)
Q Consensus 547 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 623 (717)
+..... .....++..|+|||++.+. .++.++||||||++++||++ |..|+......+... .+..
T Consensus 155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-------~~~~ 221 (259)
T cd05037 155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-------FYQD 221 (259)
T ss_pred cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-------HHhc
Confidence 986533 1234567789999999876 78999999999999999999 577765433211111 1111
Q ss_pred CCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 624 GMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 624 ~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
... . +......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 222 ~~~--~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QHR--L---------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCC--C---------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 100 0 0001156778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-33 Score=316.34 Aligned_cols=228 Identities=26% Similarity=0.395 Sum_probs=179.4
Q ss_pred HhcCcccccccccCCccceEeeeeCCchhhh-----------------------------hhhhhhhcceeecCceeeEE
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQEIA-----------------------------HRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-----------------------------h~niv~l~~~~~~~~~~~lV 472 (717)
.+-+|.-..+||.|.||.||-|...+..++. |||+|++||+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 3457777889999999999999876544322 99999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
||||++|+|.+.+. ..+.+++.....+..|++.|++|||+++ ||||||||.||+|+.+|.+|++|||.|..+..
T Consensus 1313 MEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999993 3445677777778899999999999999 99999999999999999999999999998765
Q ss_pred Cc--cccccceecccccccCccccccCC---CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 553 DE--IEGSTKRVVGTYGYMAPEYASDGL---FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 553 ~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
.. .........||+.|||||++.+.. ...++||||||||++||+||++||..++.+ .....+. ..+...
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIMy~V----~~gh~P 1460 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIMYHV----AAGHKP 1460 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHHhHH----hccCCC
Confidence 42 222334578999999999997644 567899999999999999999998754322 2221111 112222
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+.. .-...-.+++.+||+.||++|.++.++++.
T Consensus 1461 q~P~---------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1461 QIPE---------RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCch---------hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2211 122344578889999999999999877764
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=278.67 Aligned_cols=223 Identities=31% Similarity=0.448 Sum_probs=171.0
Q ss_pred cccccCCccceEeeeeCCch-------------------------------hhhhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLADGQ-------------------------------EIAHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~-------------------------------~vah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
++||+|+||.||+|++.... .+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999998642211 011999999999875 5678999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|.+++... ..+++..+..++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999999543 36889999999999999999999988 99999999999999999999999999986543321111
Q ss_pred -cceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 559 -TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 559 -~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..... .........
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~----~~~~~~~~~-------- 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIA----MLESGERLP-------- 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHH----HHHcCCcCC--------
Confidence 111223567999999999999999999999999999998 9999864322 11111 111111100
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.+......+.+++.+||+.+|++||++.+|+++|+...
T Consensus 219 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 -RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01111245678999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=285.12 Aligned_cols=225 Identities=24% Similarity=0.408 Sum_probs=177.1
Q ss_pred hcCcccccccccCCccceEeeeeCC-chh--------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQE--------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~--------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
..+|++.+.||+|+||.||+|.... ++. +.|+||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 4589999999999999999997532 211 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999999843 34788899999999999999999998 99999999999999999999999999886533221
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||........ .......... .+ .
T Consensus 172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~~~~~~~~~-~~-----~ 237 (296)
T cd06654 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTP-EL-----Q 237 (296)
T ss_pred --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HHHHhcCCCC-CC-----C
Confidence 12235688999999999988899999999999999999999999864332111 1111111110 00 0
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 238 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 --NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 011122456788999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=278.78 Aligned_cols=221 Identities=28% Similarity=0.403 Sum_probs=169.1
Q ss_pred ccccCCccceEeeeeC--C-ch---------------------------hhhhhhhhhhcceeecCceeeEEEeccCCCC
Q 039318 431 KLGEGGFGPVYKGTLA--D-GQ---------------------------EIAHRNLVKLLGCCIQGEEKLLIYEFMPNRS 480 (717)
Q Consensus 431 ~lG~G~fg~Vy~~~~~--~-~~---------------------------~vah~niv~l~~~~~~~~~~~lV~E~~~~gs 480 (717)
.||+|+||.||+|.+. + +. .+.||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999998653 1 11 112999999999875 457899999999999
Q ss_pred hhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc-c
Q 039318 481 LDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS-T 559 (717)
Q Consensus 481 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~ 559 (717)
|.+++.. ....+++..++.++.||++||+|||+++ ++||||||+|||++.++.+||+|||+++.......... .
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999853 2346899999999999999999999998 99999999999999999999999999986533221111 1
Q ss_pred ceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 560 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .......+.... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKRLD---------C 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCCC---------C
Confidence 11223578999999988889999999999999999996 999986432211 111122221111 1
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 639 NLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 639 ~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 11223456688999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=281.47 Aligned_cols=227 Identities=25% Similarity=0.394 Sum_probs=175.4
Q ss_pred cCcccccccccCCccceEeeeeCC-chh---------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQE---------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~---------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
++|++.+.||+|+||.||+++... ++. +.||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 468889999999999999998652 111 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhc-CCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD-SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
+++++|..++........+++..+..++.|+++||.|||++ + |+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999885533344689999999999999999999974 5 999999999999999999999999999765322
Q ss_pred cccccceecccccccCccccccC------CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDG------LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||.......... .. ..........
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~-~~~~~~~~~~ 229 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA---QL-SAIVDGDPPT 229 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH---HH-HHHhhcCCCC
Confidence 12235688899999988554 35889999999999999999999986432211111 11 1111111111
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+......+.+++.+||+.+|++||++.+++..
T Consensus 230 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 230 ---------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111233456788999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=290.19 Aligned_cols=175 Identities=23% Similarity=0.356 Sum_probs=148.5
Q ss_pred cCcccccccccCCccceEeeeeCCc-hhh-----------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QEI-----------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v-----------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||.||+++.... +.+ .|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4789999999999999999986532 111 1999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++++|.+++.+. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999999542 345788899999999999999999998 999999999999999999999999998765332
Q ss_pred ccccccceecccccccCcccccc-----CCCCccccchhHhHHHHHhhcCCCCCCC
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASD-----GLFSVKSDVFSFGILLLEIVSGKKNRGF 604 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~p~~~ 604 (717)
.. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 21 11223569999999999863 4578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=281.71 Aligned_cols=230 Identities=26% Similarity=0.371 Sum_probs=179.1
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hh---------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QE---------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~---------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
.++|++.+.||+|+||.||+++.... +. +.||||+++++++...+.+++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 35788899999999999999886532 11 129999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhc-CCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD-SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
|+++++|.+++.. .+.+++..+..++.+++.+|.|||+. + ++|+||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999998843 34588999999999999999999974 5 999999999999999999999999998754221
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCC-----chhHHHHHHHHhhCCCCcc
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDK-----NLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 628 (717)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||......+ .............+. ...
T Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 232 (284)
T cd06620 158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-PPR 232 (284)
T ss_pred ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-CCC
Confidence 1224578999999999988899999999999999999999999987544321 111111111111111 100
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHh
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L 671 (717)
+ . .......+.+++.+|++.+|++||++.||+++.
T Consensus 233 ~-----~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 233 L-----P---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred C-----C---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0 0 011224577889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=278.21 Aligned_cols=224 Identities=23% Similarity=0.308 Sum_probs=176.6
Q ss_pred CcccccccccCCccceEeeeeCCch----------------------------hhhhhhhhhhcceeecCceeeEEEecc
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ----------------------------EIAHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~----------------------------~vah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
+|++.++||+|+||.||+++..... .+.|+||+++++++.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999764211 122999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
++++|.+++... ....+++..+..++.||+.||.|||+++ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999999988542 3345788899999999999999999998 99999999999999999999999999976533211
Q ss_pred cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 557 GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
......+++.|+|||++.+..++.++|+||||+++|+|++|+.||..... .... .. ...+....+
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~---~~~~---~~-~~~~~~~~~------- 220 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW---KNLI---LK-VCQGSYKPL------- 220 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH---HHHH---HH-HhcCCCCCC-------
Confidence 12245688999999999998999999999999999999999999863221 1111 11 111111111
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+......+.+++.+||+.+|++||++.+++..
T Consensus 221 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 --PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11112346788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=293.43 Aligned_cols=234 Identities=22% Similarity=0.246 Sum_probs=171.8
Q ss_pred HhcCcccccccccCCccceEeeeeCCch-h----------------------------hhhhhhhhhcceeecC------
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQ-E----------------------------IAHRNLVKLLGCCIQG------ 466 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~----------------------------vah~niv~l~~~~~~~------ 466 (717)
..++|++.+.||+|+||.||++...... . +.||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999754211 1 1299999999987543
Q ss_pred ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccc
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGL 546 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgl 546 (717)
...++||||+++ +|.+++. ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999976 6666662 23778889999999999999999998 99999999999999999999999999
Q ss_pred cccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhh----
Q 039318 547 ARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWN---- 622 (717)
Q Consensus 547 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~---- 622 (717)
++...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ........
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~~~ 246 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW---NKVIEQLGTPCP 246 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCCH
Confidence 98653221 223457899999999999999999999999999999999999998654322111 11111000
Q ss_pred --------------CCCC-------ccccchhh-h--ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 623 --------------NGMP-------SQLIDAYY-Q--ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 623 --------------~~~~-------~~l~d~~~-~--~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+... ..+..... . ..........+.+++.+||+.||.+|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 00000000 0 00001112357789999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=283.78 Aligned_cols=238 Identities=24% Similarity=0.386 Sum_probs=180.0
Q ss_pred ccHHHHHHHhcCcccccccccCCccceEeeeeCCch--------------------------hh-hhhhhhhhcceee--
Q 039318 414 FELATIANATDNFSINKKLGEGGFGPVYKGTLADGQ--------------------------EI-AHRNLVKLLGCCI-- 464 (717)
Q Consensus 414 ~~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~--------------------------~v-ah~niv~l~~~~~-- 464 (717)
+.+..+..+.++|++.+.||+|+||.||+++..... .+ .||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 344555667889999999999999999998764321 11 2999999999874
Q ss_pred ---cCceeeEEEeccCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCce
Q 039318 465 ---QGEEKLLIYEFMPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPK 540 (717)
Q Consensus 465 ---~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~k 540 (717)
.++..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+++ |+||||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence 3457899999999999999885432 3346788889999999999999999988 99999999999999999999
Q ss_pred eccccccccccCCccccccceecccccccCcccccc-----CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHH
Q 039318 541 ISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASD-----GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIG 615 (717)
Q Consensus 541 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~ 615 (717)
|+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||........ +
T Consensus 165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~---~- 238 (286)
T cd06638 165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA---L- 238 (286)
T ss_pred EccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH---H-
Confidence 999999986533221 2234568999999998753 4578999999999999999999999864322111 0
Q ss_pred HHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 616 HAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 616 ~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
... .......+.++. .....+.+++.+||+.+|++||++.||++.
T Consensus 239 --~~~-~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 239 --FKI-PRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --hhc-cccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 010 011111111110 112357788999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=281.48 Aligned_cols=225 Identities=25% Similarity=0.344 Sum_probs=174.1
Q ss_pred CcccccccccCCccceEeeeeCCch------------------------------hhhhhhhhhhcceeecCceeeEEEe
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ------------------------------EIAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~------------------------------~vah~niv~l~~~~~~~~~~~lV~E 474 (717)
.|++.+.||+|+||.||++...... .+.|++|+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999998764221 0129999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999885432 335888999999999999999999988 9999999999999999999999999987643222
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
......|+..|+|||++.+..++.++||||||+++|||++|+.||..................... . .
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~-----~ 224 (285)
T cd05630 157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE----E-----Y 224 (285)
T ss_pred ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh----h-----c
Confidence 112347899999999999999999999999999999999999998753322111111111110000 0 0
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPC-----MPSVIL 669 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----~~evl~ 669 (717)
.. .....+.+++.+||+.||++||| +.|+++
T Consensus 225 ~~----~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 SE----KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred Cc----cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 01 11234668889999999999999 778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=283.55 Aligned_cols=235 Identities=25% Similarity=0.329 Sum_probs=172.7
Q ss_pred CcccccccccCCccceEeeeeCCc-hh----------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG-QE----------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~-~~----------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+|++.+.||+|++|.||+|+.... +. +.||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 478889999999999999976421 11 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
++ ++|.+++........+++..+..++.||++||+|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 98 588888855444456899999999999999999999998 9999999999999999999999999997643221
Q ss_pred ccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC------Ccc
Q 039318 556 EGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM------PSQ 628 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 628 (717)
.......+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+... .....+.... ...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF---RIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHHHHhCCCChhhhhcchh
Confidence 111234568899999988654 57899999999999999999999986433211111 1111100000 000
Q ss_pred ccc----------hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 629 LID----------AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 629 l~d----------~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+.+ ..... .......++.+++.+||+.||++|||+.+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 00000 00001235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=278.62 Aligned_cols=229 Identities=24% Similarity=0.314 Sum_probs=179.8
Q ss_pred HHhcCcccccccccCCccceEeeeeCCchhh------------------------------hhhhhhhhcceeecCceee
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADGQEI------------------------------AHRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~v------------------------------ah~niv~l~~~~~~~~~~~ 470 (717)
...+.|+.-++||+||||.||-++.+...++ ..+.||.+--.++..+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 3456788889999999999999887654321 2678888888899999999
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
|||..|.||+|.-+|.+... .-+++..++.++.+|+.||++||... ||.|||||+|||||+.|+++|+|+|||..+
T Consensus 262 lVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999999976554 46889999999999999999999988 999999999999999999999999999977
Q ss_pred cCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
..... ....+||.+|||||++++..|+...|.|||||+||||+.|+.||...........+.+.... ...
T Consensus 338 ~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~----~~~--- 407 (591)
T KOG0986|consen 338 PEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE----DPE--- 407 (591)
T ss_pred CCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc----chh---
Confidence 55432 22348999999999999999999999999999999999999999866544332222111110 001
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP-----CMPSVIL 669 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~ 669 (717)
..+..-..++..|....|+.||.+|. ...+|.+
T Consensus 408 ------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 408 ------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred ------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 11112223455666678899999987 4556654
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=280.50 Aligned_cols=227 Identities=24% Similarity=0.401 Sum_probs=179.0
Q ss_pred CcccccccccCCccceEeeeeCC-c-h-------------------------------------hhhhhhhhhhcceeec
Q 039318 425 NFSINKKLGEGGFGPVYKGTLAD-G-Q-------------------------------------EIAHRNLVKLLGCCIQ 465 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~-~-~-------------------------------------~vah~niv~l~~~~~~ 465 (717)
+|++.+.||+|+||.||+|.... + + .+.||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999998754 1 1 1229999999999999
Q ss_pred CceeeEEEeccCCCChhhHhhhc-cccccCChhhHHHHHHHHHHHHHHHhh-cCCCcEEeccCCCCceEEcCCCCceecc
Q 039318 466 GEEKLLIYEFMPNRSLDSFIFDQ-TKRKLLDWSKRFCIICGTARGLLYLHH-DSRLRIIHRDLKASNVLLDHEMNPKISD 543 (717)
Q Consensus 466 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~D 543 (717)
.+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988542 234468889999999999999999996 55 99999999999999999999999
Q ss_pred ccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhC
Q 039318 544 FGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNN 623 (717)
Q Consensus 544 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 623 (717)
||++....... ......++..|+|||.+.+..++.++|+||||+++|||++|+.||..... .... ....+
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---~~~~----~~~~~ 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLA----TKIVE 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---HHHH----HHHhh
Confidence 99998754332 22345788999999999998899999999999999999999999753211 1111 11111
Q ss_pred CCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 624 GMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 624 ~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
....... .. .....+.+++.+||+.||++||++.||..+|+
T Consensus 228 ~~~~~~~----~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 AVYEPLP----EG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCCcCC----cc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111100 00 11245678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=295.38 Aligned_cols=235 Identities=23% Similarity=0.247 Sum_probs=172.3
Q ss_pred HHhcCcccccccccCCccceEeeeeCCc-hh----------------------------hhhhhhhhhcceeecC-----
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADG-QE----------------------------IAHRNLVKLLGCCIQG----- 466 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~----------------------------vah~niv~l~~~~~~~----- 466 (717)
...++|++.+.||+|+||.||++..... +. +.||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3457899999999999999999975421 11 1299999999988643
Q ss_pred -ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 467 -EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 467 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
...++||||+++ +|.+.+. ..+++..+..++.|+++||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999976 5655552 23788888999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhh---
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWN--- 622 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~--- 622 (717)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .......+.
T Consensus 165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~ 238 (355)
T cd07874 165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ---WNKVIEQLGTPC 238 (355)
T ss_pred ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCC
Confidence 998643221 22345789999999999999999999999999999999999999864332111 111111000
Q ss_pred ---------------CC--CCccc------cchhhh--ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 623 ---------------NG--MPSQL------IDAYYQ--ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 623 ---------------~~--~~~~l------~d~~~~--~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+. ....+ .+.... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00 00000 000000 00011123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=280.98 Aligned_cols=222 Identities=26% Similarity=0.413 Sum_probs=176.1
Q ss_pred cCcccccccccCCccceEeeeeCCc-hhh---------------------------hhhhhhhhcceeecCceeeEEEec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QEI---------------------------AHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v---------------------------ah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+.|+..+.||+|+||.||+|.+... +.+ .||||+++++++...+..++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 3477778999999999999976432 111 199999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++.. ..+++..+..++.|+++||.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 999999998832 35788999999999999999999988 9999999999999999999999999998654322
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
.......++..|+|||++.+..++.++||||||++++||++|+.|+......... ......... ..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~~~-----~~- 221 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-------FLIPKNSPP-----TL- 221 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-------hhhhcCCCC-----CC-
Confidence 1222356889999999999989999999999999999999999997643222111 011111111 01
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.......+.+++.+||+.+|++||++.+|++.
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 ---EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11223456789999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-33 Score=300.81 Aligned_cols=229 Identities=29% Similarity=0.467 Sum_probs=188.9
Q ss_pred CcccccccccCCccceEeeeeCCch-------------------------------hhhhhhhhhhcceeecCceeeEEE
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ-------------------------------EIAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~-------------------------------~vah~niv~l~~~~~~~~~~~lV~ 473 (717)
...|.+.||.|.||.|++|+++.-. +..||||++|.|+........||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4567799999999999999876321 111999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
|||++|+|+.||+.+ .+.+.+.+...++++|+.|+.||-+.+ +|||||...|||++.+...|++||||++.+.++
T Consensus 710 EyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 999999999999654 356899999999999999999999988 999999999999999999999999999977544
Q ss_pred ccccccceecc--cccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 554 EIEGSTKRVVG--TYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 554 ~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
. .....+..| ...|.|||.+....+|.+|||||||+|++|.++ |++||=..... +++ ..+
T Consensus 785 ~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ---dVI-------------kaI 847 (996)
T KOG0196|consen 785 P-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVI-------------KAI 847 (996)
T ss_pred C-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH---HHH-------------HHH
Confidence 3 222222222 468999999999999999999999999999988 99996432222 122 112
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
+..++-+.+++....+.+|+++|||+|-.+||...+|+.+|+..+
T Consensus 848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 333445567778888999999999999999999999999997654
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=278.88 Aligned_cols=237 Identities=28% Similarity=0.404 Sum_probs=178.9
Q ss_pred cCcccccccccCCccceEeeeeCCc-----h---------------------------hhhhhhhhhhcceeec--Ccee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-----Q---------------------------EIAHRNLVKLLGCCIQ--GEEK 469 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-----~---------------------------~vah~niv~l~~~~~~--~~~~ 469 (717)
+.|++.+.||+|+||.||++++... . .+.||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 4677889999999999999975311 1 1129999999999877 5678
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999543 235899999999999999999999988 99999999999999999999999999987
Q ss_pred ccCCcccc-ccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCch--------hHHHHHHHH
Q 039318 550 FVGDEIEG-STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNL--------NLIGHAWKL 620 (717)
Q Consensus 550 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~--------~~~~~~~~~ 620 (717)
........ ......++..|+|||.+.+..++.++||||||++++||++|+.|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 65322111 111234456799999998889999999999999999999999987543221100 011111111
Q ss_pred hhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 621 WNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 621 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
....... ..+......+.+++.+||+.+|++||++.||+++|+..
T Consensus 239 ~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERL---------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcC---------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111110 01111225677899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=294.62 Aligned_cols=234 Identities=22% Similarity=0.256 Sum_probs=171.3
Q ss_pred HhcCcccccccccCCccceEeeeeCCc-hh----------------------------hhhhhhhhhcceeecCc-----
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADG-QE----------------------------IAHRNLVKLLGCCIQGE----- 467 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~----------------------------vah~niv~l~~~~~~~~----- 467 (717)
..++|++.+.||+|+||.||+++.... +. +.||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357899999999999999999976432 11 12999999999886543
Q ss_pred -eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccc
Q 039318 468 -EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGL 546 (717)
Q Consensus 468 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgl 546 (717)
..++||||+++ +|...+. ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 47999999976 4555552 23778888999999999999999998 99999999999999999999999999
Q ss_pred cccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhh----
Q 039318 547 ARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWN---- 622 (717)
Q Consensus 547 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~---- 622 (717)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .........
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~ 243 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ---WNKVIEQLGTPSA 243 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCcH
Confidence 98643221 12345789999999999999999999999999999999999999975432111 111111000
Q ss_pred --------------CCC-------Cccccchhh-hc--cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 623 --------------NGM-------PSQLIDAYY-QE--SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 623 --------------~~~-------~~~l~d~~~-~~--~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
... ..++..... .. .........+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 000000000 00 0000112456789999999999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=282.43 Aligned_cols=239 Identities=23% Similarity=0.313 Sum_probs=176.9
Q ss_pred cCcccccccccCCccceEeeeeCC-chh----------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQE----------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~----------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
++|++.+.||+|+||.||+|+.+. ++. +.||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468899999999999999998653 211 129999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|++++.|..++.. ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999988887632 335889999999999999999999988 9999999999999999999999999998764332
Q ss_pred cccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHH--------hhCC-
Q 039318 555 IEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKL--------WNNG- 624 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~--------~~~~- 624 (717)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+...... +...
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223457889999999876 55889999999999999999999998754332221111111000 0000
Q ss_pred CCccccchhhhccCCHH-----HHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 625 MPSQLIDAYYQESCNLA-----EVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 625 ~~~~l~d~~~~~~~~~~-----~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
....+..+......+.. ....+.+++.+||+.+|++||++.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000111111111 12457789999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=291.27 Aligned_cols=232 Identities=22% Similarity=0.310 Sum_probs=171.3
Q ss_pred HhcCcccccccccCCccceEeeeeCCch-hh----------------------------hhhhhhhhcceeecC------
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQ-EI----------------------------AHRNLVKLLGCCIQG------ 466 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~v----------------------------ah~niv~l~~~~~~~------ 466 (717)
..++|.+.+.||+|+||.||+|...... .+ .||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999764321 11 199999999987543
Q ss_pred ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccc
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGL 546 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgl 546 (717)
...+++||++ +++|.+++. ...+++..+..++.||++||.|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 4568999988 778888773 235889999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC
Q 039318 547 ARTFVGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM 625 (717)
Q Consensus 547 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 625 (717)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ .+......... .
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~-~ 235 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVGT-P 235 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCC-C
Confidence 9865322 224578999999999877 568999999999999999999999986432211 11111111100 0
Q ss_pred Cccccchh--------hh---c--cCCHH-----HHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 626 PSQLIDAY--------YQ---E--SCNLA-----EVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 626 ~~~l~d~~--------~~---~--~~~~~-----~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
..+..... .. . ..... ....+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00 0 00000 01236789999999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=275.47 Aligned_cols=223 Identities=30% Similarity=0.433 Sum_probs=173.6
Q ss_pred cccccCCccceEeeeeCC-ch------------------------------hhhhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLAD-GQ------------------------------EIAHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~-~~------------------------------~vah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
++||+|++|.||+|.+.. +. .+.||||+++++.+.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 479999999999998643 11 0129999999999988 889999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc-c
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE-G 557 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 557 (717)
++|.+++.+... ..+++..+..++.|+++||+|||+++ ++|+||||+||+++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999965432 56899999999999999999999998 999999999999999999999999999876432211 1
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....... ......
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~---~~~~~~-------- 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKIDK---EGERLE-------- 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHh---cCCcCC--------
Confidence 1123457789999999999899999999999999999998 999986332221 1111110 110000
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
.+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01112245778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=279.55 Aligned_cols=228 Identities=23% Similarity=0.389 Sum_probs=174.9
Q ss_pred hcCcccccccccCCccceEeeeeCCch-h--------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ-E--------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~--------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
.++|++.+.||+|+||.||+|+..... . +.||||+++++.+...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888999999999999999764321 1 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 999999999843 346889999999999999999999998 9999999999999999999999999987653221
Q ss_pred ccccceecccccccCccccc---cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 556 EGSTKRVVGTYGYMAPEYAS---DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
.......|+..|+|||++. ...++.++|+|||||++|||++|+.||......... ...........
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~~~~~~~~~---- 229 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMTKSNFQPP---- 229 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------HhhhccCCCCC----
Confidence 1223457899999999874 456889999999999999999999997533221111 01000110000
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
...... .....+.+++.+||+.+|++||++++|++.
T Consensus 230 ~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 230 KLKDKM--KWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cccccC--CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000000 112346788999999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=275.62 Aligned_cols=228 Identities=23% Similarity=0.256 Sum_probs=177.7
Q ss_pred HHHHHHhcCccccccc--ccCCccceEeeeeCCchh-h----------------------hhhhhhhhcceeecCceeeE
Q 039318 417 ATIANATDNFSINKKL--GEGGFGPVYKGTLADGQE-I----------------------AHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 417 ~~i~~~~~~~~~~~~l--G~G~fg~Vy~~~~~~~~~-v----------------------ah~niv~l~~~~~~~~~~~l 471 (717)
.++....++|++.+.+ |+|+||.||+++.+.... + .||||+++++.+...+..++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 3444556778887777 999999999998643211 0 29999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC-Cceeccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM-NPKISDFGLARTF 550 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~Dfgla~~~ 550 (717)
||||+++++|.+++... ..+++..+..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 99999999999999442 36899999999999999999999998 99999999999999998 9999999998865
Q ss_pred cCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
... ....++..|+|||++.+..++.++||||||+++|||++|+.||.....+. .... ...... .... ...
T Consensus 161 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~-~~~~~~-~~~~-~~~ 230 (267)
T PHA03390 161 GTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLE-SLLKRQ-QKKL-PFI 230 (267)
T ss_pred CCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHH-HHHHhh-cccC-Ccc
Confidence 322 23468899999999999999999999999999999999999987332221 1111 111111 1100 110
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCC-hHHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPC-MPSVIL 669 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-~~evl~ 669 (717)
......+.+++.+||+.+|.+||+ ++++++
T Consensus 231 ---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 231 ---------KNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---------cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 122345678889999999999996 688874
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=280.36 Aligned_cols=225 Identities=25% Similarity=0.359 Sum_probs=173.9
Q ss_pred CcccccccccCCccceEeeeeCCchh---------------------------hhhhhhhhhcceeecCceeeEEEeccC
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQE---------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~~---------------------------vah~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.|++.+.||+|+||.||+|+...... +.||||+++++++...+..++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 36788999999999999998654211 129999999999999999999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|..++.. ....+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 9999988743 2346899999999999999999999998 9999999999999999999999999987643221 1
Q ss_pred ccceecccccccCccccc-----cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 558 STKRVVGTYGYMAPEYAS-----DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
......++..|+|||++. +..++.++|||||||++|||++|++||...... .... ....... ..+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~---~~~~~~~-~~~~~- 230 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM---RVLL---KIAKSEP-PTLAQ- 230 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH---HHHH---HHhhcCC-CCCCC-
Confidence 223457899999999884 455788999999999999999999998643211 1111 1111111 01100
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+......+.+++.+||+.+|.+||++.++++.
T Consensus 231 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 231 ------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112456788999999999999999998865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=279.48 Aligned_cols=225 Identities=23% Similarity=0.311 Sum_probs=173.0
Q ss_pred CcccccccccCCccceEeeeeCCc-hh-----------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG-QE-----------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~-~~-----------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
.|+..+.||+|+||.||++..... +. +.|+||+++.+++..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 367778999999999999876421 11 129999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999998885432 335899999999999999999999998 9999999999999999999999999987643221
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.||...........+ ......... . .
T Consensus 157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~---~~~~~~~~~-~-----~ 224 (285)
T cd05632 157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV---DRRVLETEE-V-----Y 224 (285)
T ss_pred ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhhhcccc-c-----c
Confidence 122357899999999999999999999999999999999999998743322111111 111111100 0 0
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPC-----MPSVIL 669 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----~~evl~ 669 (717)
. ......+.+|+..||+.+|++||+ +.+++.
T Consensus 225 ~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 225 S----AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred C----ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0 111234567888999999999999 555555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=310.56 Aligned_cols=230 Identities=22% Similarity=0.301 Sum_probs=173.6
Q ss_pred HHhcCcccccccccCCccceEeeeeCCch-----------------------------hhhhhhhhhhcceeec--Ccee
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADGQ-----------------------------EIAHRNLVKLLGCCIQ--GEEK 469 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-----------------------------~vah~niv~l~~~~~~--~~~~ 469 (717)
...++|.++++||+|+||.||+++..... .+.|||||++++++.. ....
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999865332 1129999999998854 4568
Q ss_pred eEEEeccCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcCC----CcEEeccCCCCceEEcCC--------
Q 039318 470 LLIYEFMPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDSR----LRIIHRDLKASNVLLDHE-------- 536 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~----~~ivHrDlkp~NIll~~~-------- 536 (717)
+|||||+++++|.++|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+..
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999996532 23568999999999999999999998531 249999999999999642
Q ss_pred ---------CCceeccccccccccCCccccccceecccccccCcccccc--CCCCccccchhHhHHHHHhhcCCCCCCCC
Q 039318 537 ---------MNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASD--GLFSVKSDVFSFGILLLEIVSGKKNRGFY 605 (717)
Q Consensus 537 ---------~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~p~~~~ 605 (717)
..+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||++|+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 348999999998653322 1234579999999999854 45889999999999999999999998632
Q ss_pred CCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 606 HSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.. ... ....+....... . ......+.+|+..||+.+|.+||++.++++
T Consensus 247 ~~---~~q---li~~lk~~p~lp-----i-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NN---FSQ---LISELKRGPDLP-----I-----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred Cc---HHH---HHHHHhcCCCCC-----c-----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 21 111 111111111000 0 011245678899999999999999999984
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=278.08 Aligned_cols=224 Identities=27% Similarity=0.414 Sum_probs=174.9
Q ss_pred CcccccccccCCccceEeeeeCCchhh--------------------------------hhhhhhhhcceeecCceeeEE
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQEI--------------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~~v--------------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
+|.+.+.||+|+||.||+|...+++.+ .|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999876433211 199999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999999442 35788899999999999999999988 99999999999999999999999999876422
Q ss_pred Cc----cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhC-CCCc
Q 039318 553 DE----IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNN-GMPS 627 (717)
Q Consensus 553 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ 627 (717)
.. .........++..|+|||++.+..++.++||||||+++|+|++|+.||........ . ...... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~---~~~~~~~~~~~ 228 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---M---FYIGAHRGLMP 228 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH---H---HHhhhccCCCC
Confidence 11 11112235688999999999998999999999999999999999999864321111 1 010000 1111
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.+ +......+.+++.+||+.+|++||++.++++
T Consensus 229 ~~---------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 RL---------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CC---------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11 1112345678999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=277.94 Aligned_cols=227 Identities=28% Similarity=0.407 Sum_probs=175.3
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hh--------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QE--------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~--------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
.+.|++.++||+|+||.||+|+.... +. +.||||+++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 36799999999999999999987542 11 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|..++.+. ...+++..+..++.|++++|+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-- 163 (292)
T cd06644 91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-- 163 (292)
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence 9999998887442 345889999999999999999999988 999999999999999999999999998754222
Q ss_pred ccccceecccccccCccccc-----cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 556 EGSTKRVVGTYGYMAPEYAS-----DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
........++..|+|||++. ...++.++|||||||++|||++|+.||....... ...+. .......+.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~-~~~~~~~~~ 236 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKI-AKSEPPTLS 236 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHH-hcCCCccCC
Confidence 11223456889999999884 3457889999999999999999999986433211 11111 111111110
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+......+.+++.+||+.+|++||+++++++.
T Consensus 237 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 237 -------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 011112356788999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=282.07 Aligned_cols=235 Identities=25% Similarity=0.322 Sum_probs=175.0
Q ss_pred cCcccccccccCCccceEeeeeCCc-hh----------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QE----------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~----------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
++|++.++||+|+||.||+|..++. +. +.||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4688999999999999999987532 11 129999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++++|.++... ...+++..+..++.||++||+|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887632 234889999999999999999999988 9999999999999999999999999998654332
Q ss_pred cccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhC----------
Q 039318 555 IEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNN---------- 623 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---------- 623 (717)
. ......++..|+|||++.+ ..++.++||||||++++||++|++||...... ............
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI---DQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH---HHHHHHHHHhCCCchhhHHHhc
Confidence 1 1223567899999998875 45788999999999999999999998643321 111111111000
Q ss_pred -CC-CccccchhhhccC-----CHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 624 -GM-PSQLIDAYYQESC-----NLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 624 -~~-~~~l~d~~~~~~~-----~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.. ......+...... .......+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 0000000000000 0112346788999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=273.70 Aligned_cols=224 Identities=29% Similarity=0.425 Sum_probs=166.6
Q ss_pred cccccCCccceEeeeeCCc----h---------------------------hhhhhhhhhhcceee-cCceeeEEEeccC
Q 039318 430 KKLGEGGFGPVYKGTLADG----Q---------------------------EIAHRNLVKLLGCCI-QGEEKLLIYEFMP 477 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~----~---------------------------~vah~niv~l~~~~~-~~~~~~lV~E~~~ 477 (717)
+.||+|+||.||+|.+.+. . .+.||||+++++++. .++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 4699999999999875321 0 012999999999765 4556899999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc-
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE- 556 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~- 556 (717)
+++|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999999543 234677788889999999999999988 999999999999999999999999999865332111
Q ss_pred -cccceecccccccCccccccCCCCccccchhHhHHHHHhhcC-CCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 557 -GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSG-KKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 557 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
.......++..|+|||.+.+..++.++||||||+++|||++| .+||.... ...... ......... .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~---~~~~~~~~~-~----- 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITV---YLLQGRRLL-Q----- 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHH---HHhcCCCCC-C-----
Confidence 111123457789999999888999999999999999999995 55554221 111111 111111110 0
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
... ....+.+++.+||+.+|++||++.+|++.|+..
T Consensus 224 ~~~----~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 224 PEY----CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CCc----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 001 123577899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=275.69 Aligned_cols=224 Identities=27% Similarity=0.429 Sum_probs=174.5
Q ss_pred cCcccccccccCCccceEeeeeCCch-----------------------hhhhhhhhhhcceeecCceeeEEEeccCCCC
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-----------------------EIAHRNLVKLLGCCIQGEEKLLIYEFMPNRS 480 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-----------------------~vah~niv~l~~~~~~~~~~~lV~E~~~~gs 480 (717)
++|++.+.||+|+||.||+++..+.. .+.||||+++++++... ..++||||+++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~ 84 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN 84 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence 46889999999999999998753221 11299999999998654 5799999999999
Q ss_pred hhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccc
Q 039318 481 LDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTK 560 (717)
Q Consensus 481 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 560 (717)
|.+++.... ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++..... ..
T Consensus 85 L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~ 155 (254)
T cd05083 85 LVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VD 155 (254)
T ss_pred HHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc-----CC
Confidence 999996532 335788999999999999999999988 999999999999999999999999998754221 11
Q ss_pred eecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCC
Q 039318 561 RVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCN 639 (717)
Q Consensus 561 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 639 (717)
....+..|+|||.+.+..++.++|+||||+++|||++ |+.||......+ . ......+..... .
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~~~~~~~---------~ 219 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---V----KECVEKGYRMEP---------P 219 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---H----HHHHhCCCCCCC---------C
Confidence 2334568999999998899999999999999999997 999986432211 1 111111111110 1
Q ss_pred HHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 640 LAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 640 ~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1122456789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=299.18 Aligned_cols=245 Identities=19% Similarity=0.240 Sum_probs=171.1
Q ss_pred HHhcCcccccccccCCccceEeeeeCCc---------------------------------------------hhhhhhh
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADG---------------------------------------------QEIAHRN 455 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~---------------------------------------------~~vah~n 455 (717)
...++|+++++||+|+||.||++.++.. +.+.|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 3457899999999999999998764210 0112999
Q ss_pred hhhhcceeecCceeeEEEeccCCCChhhHhhhccc--cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE
Q 039318 456 LVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTK--RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL 533 (717)
Q Consensus 456 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll 533 (717)
||++++++...+..++|+|++. ++|.+++..... ........+..++.||+.||.|||+++ |+||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999985 467676643211 122335567789999999999999998 9999999999999
Q ss_pred cCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhH
Q 039318 534 DHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNL 613 (717)
Q Consensus 534 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~ 613 (717)
+.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..++-..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999987643221 122246799999999999999999999999999999999998764322222111111
Q ss_pred HHHHHHHhh---CCCCc---cccchhhh-----ccCCHH-------HHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 614 IGHAWKLWN---NGMPS---QLIDAYYQ-----ESCNLA-------EVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 614 ~~~~~~~~~---~~~~~---~l~d~~~~-----~~~~~~-------~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+......+. +..+. .+.+.... ...... ....+.+++.+||+.||++|||+.|+++.
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111111110 00000 00000000 000000 01234567889999999999999999974
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=274.96 Aligned_cols=228 Identities=24% Similarity=0.387 Sum_probs=178.1
Q ss_pred hcCcccccccccCCccceEeeeeCCch---------------------------hhhhhhhhhhcceeecCceeeEEEec
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ---------------------------EIAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~---------------------------~vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
.++|++.+.||+|+||.||+|+..... .+.||||+++++++...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367899999999999999999865321 11299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++... ...+++..+..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 9999999988542 245889999999999999999999988 9999999999999999999999999998653321
Q ss_pred ccccceecccccccCccccccC---CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 556 EGSTKRVVGTYGYMAPEYASDG---LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
.......++..|+|||.+.+. .++.++|+||||+++|||++|+.||......... ......... ..
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~------~~~~~~~~~----~~ 224 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL------FLISKSNFP----PP 224 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhccCC----Cc
Confidence 112235688899999999777 8899999999999999999999998643321111 111111000 00
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
... ........+.+++.+||+.+|.+||++++|+.
T Consensus 225 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 11223356789999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=282.26 Aligned_cols=238 Identities=27% Similarity=0.404 Sum_probs=180.8
Q ss_pred ccHHHHHHHhcCcccccccccCCccceEeeeeCCch-h-------------------------h-hhhhhhhhcceeecC
Q 039318 414 FELATIANATDNFSINKKLGEGGFGPVYKGTLADGQ-E-------------------------I-AHRNLVKLLGCCIQG 466 (717)
Q Consensus 414 ~~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~-------------------------v-ah~niv~l~~~~~~~ 466 (717)
+.+.++..++++|.+.+.||+|+||.||++...... . + .||||+++++++...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 444556667889999999999999999999864321 1 1 299999999998754
Q ss_pred -----ceeeEEEeccCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCce
Q 039318 467 -----EEKLLIYEFMPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPK 540 (717)
Q Consensus 467 -----~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~k 540 (717)
+..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 35899999999999999885422 3346889999999999999999999988 99999999999999999999
Q ss_pred eccccccccccCCccccccceecccccccCccccccC-----CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHH
Q 039318 541 ISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDG-----LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIG 615 (717)
Q Consensus 541 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~ 615 (717)
|+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.||........
T Consensus 169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~----- 241 (291)
T cd06639 169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT----- 241 (291)
T ss_pred Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-----
Confidence 999999886533221 12235688999999987543 368999999999999999999999864321111
Q ss_pred HHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 616 HAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 616 ~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.... .......+.+ .......+.+++.+||+.+|++||++.|+++.
T Consensus 242 -~~~~-~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 -LFKI-PRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -HHHH-hcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111 1111111111 11122357889999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=283.76 Aligned_cols=172 Identities=27% Similarity=0.438 Sum_probs=137.6
Q ss_pred cccccCCccceEeeeeCCch---h------------------------hhhhhhhhhcceeec--CceeeEEEeccCCCC
Q 039318 430 KKLGEGGFGPVYKGTLADGQ---E------------------------IAHRNLVKLLGCCIQ--GEEKLLIYEFMPNRS 480 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~---~------------------------vah~niv~l~~~~~~--~~~~~lV~E~~~~gs 480 (717)
++||+|+||.||+|+.+++. . +.||||+++++++.. ....++||||+++ +
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~ 85 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-D 85 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-c
Confidence 58999999999999865321 1 129999999998853 5678999999875 6
Q ss_pred hhhHhhhc------cccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE----cCCCCceeccccccccc
Q 039318 481 LDSFIFDQ------TKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL----DHEMNPKISDFGLARTF 550 (717)
Q Consensus 481 L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~Dfgla~~~ 550 (717)
|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 76666321 12235788889999999999999999998 9999999999999 56678999999999865
Q ss_pred cCCccc-cccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCC
Q 039318 551 VGDEIE-GSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFY 605 (717)
Q Consensus 551 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~ 605 (717)
...... .......+|+.|+|||++.+. .++.++|||||||++|||++|++||...
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 432211 122345789999999998764 5899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=281.27 Aligned_cols=234 Identities=26% Similarity=0.413 Sum_probs=177.5
Q ss_pred cHHHHHHHhcCcccccccccCCccceEeeeeCCchh-h--------------------------hhhhhhhhcceeec--
Q 039318 415 ELATIANATDNFSINKKLGEGGFGPVYKGTLADGQE-I--------------------------AHRNLVKLLGCCIQ-- 465 (717)
Q Consensus 415 ~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-v--------------------------ah~niv~l~~~~~~-- 465 (717)
++.++..+.+.|++.+.||+|+||.||+|+.....+ + .|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 445555667899999999999999999998743211 1 19999999999853
Q ss_pred ----CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCcee
Q 039318 466 ----GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKI 541 (717)
Q Consensus 466 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl 541 (717)
....++||||+++++|.+++.... ...+++..+..++.||++||+|||+.+ |+|+||||+||++++++.++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 457899999999999999985432 345778888999999999999999998 999999999999999999999
Q ss_pred ccccccccccCCccccccceecccccccCccccc-----cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHH
Q 039318 542 SDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYAS-----DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGH 616 (717)
Q Consensus 542 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~ 616 (717)
+|||++....... .......|+..|+|||++. ...++.++|||||||++|||++|+.||..........
T Consensus 163 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---- 236 (282)
T cd06636 163 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---- 236 (282)
T ss_pred eeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh----
Confidence 9999987643211 1223467899999999875 3468889999999999999999999985432111110
Q ss_pred HHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 617 AWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 617 ~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
... ......+. .. .....+.+++.+||+.+|.+||++.|+++
T Consensus 237 --~~~-~~~~~~~~----~~----~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 --LIP-RNPPPKLK----SK----KWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --hHh-hCCCCCCc----cc----ccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 11110100 00 11235778899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=275.10 Aligned_cols=231 Identities=27% Similarity=0.409 Sum_probs=179.5
Q ss_pred cCcccccccccCCccceEeeeeCCch----------------------------hhhhhhhhhhcceeecCceeeEEEec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ----------------------------EIAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~----------------------------~vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
++|++.+.||.|+||.||+|...... .+.|+||+++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999854321 12299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++........+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999965444456889999999999999999999988 99999999999999999999999999986644322
Q ss_pred cc--ccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 556 EG--STKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 556 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
.. ......|+..|+|||.+... .++.++|+||||++++||++|+.||........ ..+.... ....
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~-~~~~---- 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTLQN-DPPS---- 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HHHHhcC-CCCC----
Confidence 21 22335688999999998777 789999999999999999999999864332211 1111111 1110
Q ss_pred hhhccCC-HHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 633 YYQESCN-LAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 633 ~~~~~~~-~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
...... ......+.+++.+||+.+|++||++.+|++
T Consensus 227 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 227 -LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 110000 112245678899999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=282.39 Aligned_cols=226 Identities=25% Similarity=0.411 Sum_probs=177.5
Q ss_pred HhcCcccccccccCCccceEeeeeCC-chhh--------------------------hhhhhhhhcceeecCceeeEEEe
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLAD-GQEI--------------------------AHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v--------------------------ah~niv~l~~~~~~~~~~~lV~E 474 (717)
..++|++.++||+|+||.||++.... ++.+ .|+||+++++++..++..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 34689999999999999999998642 2211 29999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999999843 34788899999999999999999988 9999999999999999999999999997653332
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.......... .....+.. .+
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~~~-~~----- 235 (297)
T cd06656 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGTP-EL----- 235 (297)
T ss_pred c--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCCCC-CC-----
Confidence 1 1223568889999999999889999999999999999999999986433221110 00001100 00
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
. .+......+.+++.+||+.+|++||++.+|++.
T Consensus 236 ~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 236 Q--NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred C--CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011122345688899999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=278.63 Aligned_cols=230 Identities=26% Similarity=0.423 Sum_probs=178.3
Q ss_pred cCcccccccccCCccceEeeeeCCc---------------------------------hhhhhhhhhhhcceeecCceee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG---------------------------------QEIAHRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~---------------------------------~~vah~niv~l~~~~~~~~~~~ 470 (717)
++|++.+.||+|+||.||+|+.+.. +.+.|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 5788999999999999999985321 0112999999999999999999
Q ss_pred EEEeccCCCChhhHhhhcccc------ccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKR------KLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDF 544 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 544 (717)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999654322 25899999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhC
Q 039318 545 GLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNN 623 (717)
Q Consensus 545 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 623 (717)
|+++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ... .....
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~----~~~~~ 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVL----NRLQA 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHH----HHHHc
Confidence 99875432221 12223456778999999988889999999999999999998 78887532211 111 11111
Q ss_pred CCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 624 GMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 624 ~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
....... .. .....+.+++.+||+.+|++||++.+++.+|.
T Consensus 234 ~~~~~~~----~~----~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELPV----PE----GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCCC----CC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111000 01 11235778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=274.37 Aligned_cols=226 Identities=28% Similarity=0.422 Sum_probs=179.2
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hh------------------------hhhhhhhhhcceeecCceeeEEEeccC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QE------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~------------------------vah~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.++|++.+.||+|+||.||+|+.... +. +.||||+++++++.+....+++|||++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 36799999999999999999987652 11 129999999999999999999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++.. ....+++..+..++.|+++||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 82 AGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 9999999843 2346899999999999999999999988 99999999999999999999999999987543321
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhcc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 637 (717)
......++..|+|||++.+..++.++||||||+++++|++|+.||.......... ........ ...
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~-----~~~-- 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------MIPNKPPP-----TLS-- 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------hhccCCCC-----CCC--
Confidence 1223557889999999999999999999999999999999999987432221110 00000000 000
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.+......+.+++.+||+.+|++||+++||++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 01112245678899999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=280.08 Aligned_cols=222 Identities=23% Similarity=0.366 Sum_probs=172.4
Q ss_pred cccccccccCCccceEeeeeCCc-hh--------------------------hhhhhhhhhcceeecCceeeEEEeccCC
Q 039318 426 FSINKKLGEGGFGPVYKGTLADG-QE--------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~~-~~--------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
|....+||+|+||.||++..... .. +.|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 44456899999999999976432 11 1299999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+||++++++.+||+|||++....... ..
T Consensus 104 ~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~ 174 (292)
T cd06658 104 GALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PK 174 (292)
T ss_pred CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--cc
Confidence 999998832 34788999999999999999999998 9999999999999999999999999997653322 12
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ........ ....
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~----~~~~~~~~-----~~~~- 241 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMRR----IRDNLPPR-----VKDS- 241 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhcCCCc-----cccc-
Confidence 23457899999999998889999999999999999999999998642211 11111 11111111 1110
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 639 NLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 639 ~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
......+.+++.+|++.+|.+|||++++++.
T Consensus 242 -~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 -HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0122346678889999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=273.39 Aligned_cols=225 Identities=23% Similarity=0.345 Sum_probs=178.3
Q ss_pred CcccccccccCCccceEeeeeCCch-----------------------------hhhhhhhhhhcceeecCceeeEEEec
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ-----------------------------EIAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~-----------------------------~vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+|+..+.||+|+||.||.++..... .+.|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999888753211 11299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999995432 345789999999999999999999988 99999999999999999999999999986543321
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
......+++.|+|||.+.+..++.++|+||||++++||++|+.||...... .. .... ..+.....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~---~~~~-~~~~~~~~------ 221 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NL---VVKI-VQGNYTPV------ 221 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH---HH---HHHH-HcCCCCCC------
Confidence 223457899999999998888999999999999999999999998643211 11 1111 11111111
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHh
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L 671 (717)
.......+.+++.+||+.+|++||++.++++.+
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 ---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 111234577889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=275.88 Aligned_cols=229 Identities=25% Similarity=0.392 Sum_probs=176.4
Q ss_pred hcCcccccccccCCccceEeeeeCCc--h--h---------------------------hhhhhhhhhcceeecCceeeE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG--Q--E---------------------------IAHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~--~--~---------------------------vah~niv~l~~~~~~~~~~~l 471 (717)
.++|.+.+.||+|+||.||+|...+. . . +.||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 35688889999999999999976432 0 1 119999999998865 56789
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++++|.+++... ...+++..+..++.+++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999999542 235789999999999999999999988 9999999999999999999999999998654
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
...... .....++..|+|||.+....++.++||||||+++|||++ |+.||......+ ... ....+.....
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~----~~~~~~~~~~- 229 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIG----RIENGERLPM- 229 (270)
T ss_pred ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHH----HHHcCCcCCC-
Confidence 332111 112334568999999988889999999999999999986 999986433221 111 1111111110
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.. .....+.+++.+|+..+|++||++.++++.|+..
T Consensus 230 ----~~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 230 ----PP----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred ----CC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 1123567889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=275.61 Aligned_cols=223 Identities=25% Similarity=0.435 Sum_probs=174.5
Q ss_pred CcccccccccCCccceEeeeeCCc-h-----------------------------------hhhhhhhhhhcceeecCce
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG-Q-----------------------------------EIAHRNLVKLLGCCIQGEE 468 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~-~-----------------------------------~vah~niv~l~~~~~~~~~ 468 (717)
+|.+.+.||+|+||.||+|..... + .+.||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477888999999999999975321 0 0129999999999999999
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
.++||||+++++|.+++.. .+.+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999943 345788899999999999999999988 9999999999999999999999999998
Q ss_pred cccCCcccc----ccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCC
Q 039318 549 TFVGDEIEG----STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG 624 (717)
Q Consensus 549 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 624 (717)
......... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ..+ .... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~---~~~~-~~ 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAI---FKIG-EN 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHH---HHHh-cc
Confidence 764221111 112346888999999999889999999999999999999999998643211 111 1111 11
Q ss_pred CCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 625 MPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 625 ~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.... .+......+.+++.+||+.+|.+||++.+|++
T Consensus 228 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ASPE---------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCCc---------CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1000 11112345678889999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=273.00 Aligned_cols=224 Identities=24% Similarity=0.333 Sum_probs=175.3
Q ss_pred CcccccccccCCccceEeeeeCCch-h----------------------------hhhhhhhhhcceeec-CceeeEEEe
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ-E----------------------------IAHRNLVKLLGCCIQ-GEEKLLIYE 474 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~-~----------------------------vah~niv~l~~~~~~-~~~~~lV~E 474 (717)
+|++.+.||+|++|.||+++.+.+. . +.|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999865321 1 119999999988764 446789999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++++|.+++... ....+++.+++.++.+++.||+|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999999643 2345899999999999999999999998 9999999999999999999999999998653322
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
.......+++.|+|||++.+..++.++||||||+++++|++|+.||...... .. ..... .+....
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~---~~~~~-~~~~~~------ 221 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SL---VYRII-EGKLPP------ 221 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HH---HHHHH-hcCCCC------
Confidence 1223456889999999999999999999999999999999999998632211 11 11111 111111
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+......+.+++.+|++.+|++||++.++++.
T Consensus 222 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 ---MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111223457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=276.82 Aligned_cols=223 Identities=26% Similarity=0.417 Sum_probs=178.0
Q ss_pred cCcccccccccCCccceEeeeeCCch----------------------------hhhhhhhhhhcceeecCceeeEEEec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ----------------------------EIAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~----------------------------~vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
++|++.+.||.|+||.||+|+..... .+.|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999865321 11299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++... .+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999998432 6889999999999999999999988 9999999999999999999999999998764332
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
.......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... .. ..........+.+.
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~----~~~~~~~~~~~~~~--- 221 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VL----FLIPKNNPPSLEGN--- 221 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HH----HHhhhcCCCCCccc---
Confidence 12234578889999999998889999999999999999999999986443211 11 11111111111110
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.....+.+++.+||+.+|++||+++++++.
T Consensus 222 -----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 -----KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -----ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 022346678899999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=276.03 Aligned_cols=222 Identities=27% Similarity=0.412 Sum_probs=176.9
Q ss_pred cCcccccccccCCccceEeeeeCCc-hhh---------------------------hhhhhhhhcceeecCceeeEEEec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QEI---------------------------AHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v---------------------------ah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
..|+..++||+|+||.||+|..... +.+ .||||+++++++.+.+..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 3577889999999999999986532 111 299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998842 35788889999999999999999988 99999999999999999999999999976543221
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
......++..|+|||++.+..++.++|+||||+++|||++|+.||.......... .......
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~~~~--------- 218 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-------LIPKNNP--------- 218 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-------hhhcCCC---------
Confidence 1223567889999999998899999999999999999999999986433221110 0011111
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11122334567789999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=274.57 Aligned_cols=231 Identities=25% Similarity=0.344 Sum_probs=172.7
Q ss_pred HHhcCcccccccccCCccceEeeeeCCchh---------------------------hhhhhhhhhcceeecCceeeEEE
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADGQE---------------------------IAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~---------------------------vah~niv~l~~~~~~~~~~~lV~ 473 (717)
.+++++.....||+|+||.||+|++...+. +.|+||+++++++..++..++||
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 345566666799999999999998654321 12999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC-CCCceeccccccccccC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH-EMNPKISDFGLARTFVG 552 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~Dfgla~~~~~ 552 (717)
||+++++|.+++.........++..+..++.||++||+|||+++ |+||||||+||+++. ++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999999965322212277888889999999999999988 999999999999986 67899999999976533
Q ss_pred CccccccceecccccccCccccccCC--CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGL--FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
... ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||........ ........ ...
T Consensus 162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~--~~~---- 230 (268)
T cd06624 162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMF--KIH---- 230 (268)
T ss_pred CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhh--ccC----
Confidence 221 122345789999999986644 78999999999999999999999853221110 00000000 000
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
...+.....++.+++.+||+.+|.+||++.++++.
T Consensus 231 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 231 -----PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -----CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111122456788999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=282.40 Aligned_cols=227 Identities=23% Similarity=0.238 Sum_probs=175.5
Q ss_pred cCcccccccccCCccceEeeeeCC-chh-----------------------------hhhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQE-----------------------------IAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~-----------------------------vah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||.||++.... ++. +.||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468899999999999999998653 111 11999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+.+++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+|+.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999998532 3356889999999999999999999988 999999999999999999999999998754221
Q ss_pred cc---------------------------ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCC
Q 039318 554 EI---------------------------EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYH 606 (717)
Q Consensus 554 ~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~ 606 (717)
.. ........|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 10 011123468899999999999899999999999999999999999986433
Q ss_pred CCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCC----hHHHHH
Q 039318 607 SDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPC----MPSVIL 669 (717)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs----~~evl~ 669 (717)
.... ........ . .-.........+.+++.+||+.+|++||+ ++|++.
T Consensus 237 ~~~~------~~~~~~~~-~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDET------FSNILKKE-V--------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHH------HHHHhcCC-c--------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2211 11111111 0 00001113356778999999999999999 555555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=278.46 Aligned_cols=240 Identities=21% Similarity=0.281 Sum_probs=177.8
Q ss_pred cCcccccccccCCccceEeeeeCCch-h----------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-E----------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-~----------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
++|++.+.||+|+||.||+|...+.. . +.|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999875321 1 129999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|++++.+..++.. ...+++..+..++.||+.||.|||+++ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9999777766532 334789999999999999999999998 9999999999999999999999999998764432
Q ss_pred cccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHH--------Hhh-CC
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWK--------LWN-NG 624 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~--------~~~-~~ 624 (717)
. .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+....+..... .+. ..
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 2 122345678999999999888 889999999999999999999999864332221111111000 000 00
Q ss_pred C-----Cccccchh-hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 625 M-----PSQLIDAY-YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 625 ~-----~~~l~d~~-~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
. .....+.. .....+......+.+++.+||+.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 00000000 0000111124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=271.78 Aligned_cols=225 Identities=36% Similarity=0.554 Sum_probs=175.3
Q ss_pred cccccccccCCccceEeeeeCCch-----hh---------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 426 FSINKKLGEGGFGPVYKGTLADGQ-----EI---------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~~~-----~v---------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
|++.+.||+|+||.||+++..... .+ .|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 456789999999999999876421 11 1999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999954322 12899999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
...... ...+++.|+|||.+.+..++.++||||||+++++|++ |+.||..... ..... ..........
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~----~~~~~~~~~~--- 225 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLE----YLKKGYRLPK--- 225 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHhcCCCCCC---
Confidence 221111 2336789999999988889999999999999999998 7888764211 11111 1111111111
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHh
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L 671 (717)
.......+.+++.+|++.+|++|||+.+++++|
T Consensus 226 ------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011234577899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=283.70 Aligned_cols=239 Identities=27% Similarity=0.423 Sum_probs=190.3
Q ss_pred cCcccccccccCCccceEeeeeCCchhhh---------------------------hhhhhhhcceeecCceeeEEEecc
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA---------------------------HRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~va---------------------------h~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
....+.++||+|-||.|.+++......|| |||||+++|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 45677899999999999999876543332 999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
++|+|.+|+..+.... +.-+....|+.||+.||+||.+.+ +|||||.+.|+|++.++++||+|||+++.+...+..
T Consensus 618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999996653322 455667789999999999999988 999999999999999999999999999977655554
Q ss_pred cccceecccccccCccccccCCCCccccchhHhHHHHHhhc--CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 557 GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS--GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
......+-.+.|||||.+.-++++.+||+|+||+.+||+++ .+.||+..+.+ ..+......+..+-....
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~----- 765 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVV----- 765 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCccee-----
Confidence 44445667889999999999999999999999999999865 77887754433 223333333333222111
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
-..+......+.+++++|+..+-.+||+.+++...|.+..
T Consensus 766 -l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 766 -LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred -ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1223334456779999999999999999999999987643
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=274.70 Aligned_cols=229 Identities=25% Similarity=0.370 Sum_probs=175.2
Q ss_pred CcccccccccCCccceEeeeeCC-chh------------------------------------hhhhhhhhhcceeecCc
Q 039318 425 NFSINKKLGEGGFGPVYKGTLAD-GQE------------------------------------IAHRNLVKLLGCCIQGE 467 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~------------------------------------vah~niv~l~~~~~~~~ 467 (717)
+|.+.+.||+|+||.||+|.... ++. +.||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 47788999999999999996432 110 11999999999999999
Q ss_pred eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla 547 (717)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999999543 46888999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCccccccceecccccccCccccccCC--CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC
Q 039318 548 RTFVGDEIEGSTKRVVGTYGYMAPEYASDGL--FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM 625 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 625 (717)
+...............++..|+|||.+.... ++.++|+||||++++||++|..||...... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNKRS 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhcccc
Confidence 8653322122223456889999999987654 889999999999999999999998532111 11111111111
Q ss_pred CccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 626 PSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 626 ~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
...+.+ .........+.+++.+||+.+|++||++.+|++.
T Consensus 230 ~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIPP-----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCCc-----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111 1111223567788999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=277.01 Aligned_cols=235 Identities=26% Similarity=0.337 Sum_probs=175.0
Q ss_pred CcccccccccCCccceEeeeeCC-chh-------------------------------hhhhhhhhhcceeecCceeeEE
Q 039318 425 NFSINKKLGEGGFGPVYKGTLAD-GQE-------------------------------IAHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~-------------------------------vah~niv~l~~~~~~~~~~~lV 472 (717)
+|++.+.||+|+||.||+|.... ++. +.|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 47888999999999999998642 111 1299999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999995422 36899999999999999999999998 99999999999999999999999999986543
Q ss_pred CccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC------
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM------ 625 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 625 (717)
.. .......+++.|+|||.+.+ ..++.++|||||||++|||++|.++|...... ..............
T Consensus 155 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhhhhh
Confidence 22 11223456788999998855 46789999999999999999998777643322 11211111110000
Q ss_pred ---CccccchhhhccCC-----HHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 626 ---PSQLIDAYYQESCN-----LAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 626 ---~~~l~d~~~~~~~~-----~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.............+ ......+.+++.+||+.+|++|||+.||++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000001111 1123567899999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=270.44 Aligned_cols=221 Identities=26% Similarity=0.390 Sum_probs=174.2
Q ss_pred CcccccccccCCccceEeeeeC-Cchh-------------------------------hhhhhhhhhcceeecCceeeEE
Q 039318 425 NFSINKKLGEGGFGPVYKGTLA-DGQE-------------------------------IAHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~-------------------------------vah~niv~l~~~~~~~~~~~lV 472 (717)
+|+..+.||+|+||.||+|... +++. +.|+||+++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999865 2211 1299999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999843 235788999999999999999999998 99999999999999999999999999886533
Q ss_pred CccccccceecccccccCccccccCC-CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGL-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||...... .. ............+
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~---~~---~~~~~~~~~~~~~-- 223 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV---AA---VFKIGRSKELPPI-- 223 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH---HH---HHHHHhcccCCCc--
Confidence 22 123456889999999987766 899999999999999999999998643311 11 1111110111111
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+......+.+++.+||+.+|++||++.++++
T Consensus 224 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 224 -------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1111245667899999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=275.78 Aligned_cols=230 Identities=28% Similarity=0.420 Sum_probs=176.9
Q ss_pred HHhcCcccccccccCCccceEeeeeCCch-h-------------------------h-hhhhhhhhcceeecCc------
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADGQ-E-------------------------I-AHRNLVKLLGCCIQGE------ 467 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~-------------------------v-ah~niv~l~~~~~~~~------ 467 (717)
..+++|++.+.||+|++|.||+|+.+... . + .|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 35689999999999999999999875321 1 1 2999999999997644
Q ss_pred eeeEEEeccCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGL 546 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgl 546 (717)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999985432 2356889999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCccccccceecccccccCcccccc-----CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHh
Q 039318 547 ARTFVGDEIEGSTKRVVGTYGYMAPEYASD-----GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLW 621 (717)
Q Consensus 547 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 621 (717)
+....... .......++..|+|||++.. ..++.++||||||+++|+|++|+.||....... .+ .+..
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~---~~~~ 231 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR---AL---FKIP 231 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH---HH---HHhh
Confidence 87653322 12234568899999998753 346789999999999999999999986332211 11 1111
Q ss_pred hCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 622 NNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 622 ~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
......+. ........+.+++.+||+.||++|||+.++++
T Consensus 232 -~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 -RNPPPTLK-------SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -ccCCCCCC-------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111111 11112346778999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=282.84 Aligned_cols=173 Identities=21% Similarity=0.286 Sum_probs=141.7
Q ss_pred cccccccC--CccceEeeeeCCc-hh----------------------------hhhhhhhhhcceeecCceeeEEEecc
Q 039318 428 INKKLGEG--GFGPVYKGTLADG-QE----------------------------IAHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 428 ~~~~lG~G--~fg~Vy~~~~~~~-~~----------------------------vah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
++++||+| +|++||+++.+.. +. +.||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7889999976432 11 12999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
++++|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999995432 234789999999999999999999998 999999999999999999999999876543211100
Q ss_pred -----cccceecccccccCcccccc--CCCCccccchhHhHHHHHhhcCCCCCCC
Q 039318 557 -----GSTKRVVGTYGYMAPEYASD--GLFSVKSDVFSFGILLLEIVSGKKNRGF 604 (717)
Q Consensus 557 -----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~p~~~ 604 (717)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 01122356778999999876 4589999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=284.79 Aligned_cols=223 Identities=24% Similarity=0.399 Sum_probs=176.9
Q ss_pred cccccccCCccceEeeeeCC-chhhh------------------------------hhhhhhhcceeecCce--eeEEEe
Q 039318 428 INKKLGEGGFGPVYKGTLAD-GQEIA------------------------------HRNLVKLLGCCIQGEE--KLLIYE 474 (717)
Q Consensus 428 ~~~~lG~G~fg~Vy~~~~~~-~~~va------------------------------h~niv~l~~~~~~~~~--~~lV~E 474 (717)
...+||+|+|-+||||.+.. |-+|| |||||++|.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 34689999999999998753 33333 9999999999987766 778999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc-CCCCceeccccccccccCC
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD-HEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~Dfgla~~~~~~ 553 (717)
.|..|+|..|+.++. .++.+.+..|++||++||.|||++. ++|||||||-+||+|+ .-|.|||+|+|||......
T Consensus 124 L~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999995543 4788899999999999999999986 6899999999999997 5589999999999986433
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
. ....+|||.|||||+.. ..|++.+||||||++++||+|+..||..-.. ...+.++...+....-+...
T Consensus 200 ~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------~AQIYKKV~SGiKP~sl~kV 268 (632)
T KOG0584|consen 200 H----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------PAQIYKKVTSGIKPAALSKV 268 (632)
T ss_pred c----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------HHHHHHHHHcCCCHHHhhcc
Confidence 2 34589999999999887 7899999999999999999999999863221 12233333334322221111
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH--HhcCC
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL--MLGSE 674 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~--~L~~~ 674 (717)
.-.++.+|+.+||.. ..+|||+.|+|. +|...
T Consensus 269 --------~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 269 --------KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred --------CCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 113456789999998 999999999998 45554
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=279.59 Aligned_cols=224 Identities=25% Similarity=0.419 Sum_probs=176.5
Q ss_pred cCcccccccccCCccceEeeeeCC-chh--------------------------hhhhhhhhhcceeecCceeeEEEecc
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQE--------------------------IAHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~--------------------------vah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
.+|++.+.||.|+||.||+|.... ++. +.||||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 479999999999999999987532 211 12999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
++++|.+++.. ..+++.++..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 99999998843 34789999999999999999999998 99999999999999999999999999886543321
Q ss_pred cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 557 GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||......... ........ ..+..
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~~~~-~~~~~----- 237 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNGT-PELQN----- 237 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcCC-cccCC-----
Confidence 122356889999999999888999999999999999999999998653322111 11111111 00000
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+......+.+++.+||+.+|++||++.++++.
T Consensus 238 --~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 238 --PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred --cccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 01112346678899999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=274.55 Aligned_cols=225 Identities=26% Similarity=0.382 Sum_probs=172.7
Q ss_pred cCcccccccccCCccceEeeeeCC-chhh----------------------------hhhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEI----------------------------AHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v----------------------------ah~niv~l~~~~~~~~~~~lV~E 474 (717)
++|++.+.||+|+||.||+++... ++.+ .||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 478899999999999999998653 2211 18999999999999999999999
Q ss_pred ccCCCChhhHhhhc-cccccCChhhHHHHHHHHHHHHHHHhhc-CCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 475 FMPNRSLDSFIFDQ-TKRKLLDWSKRFCIICGTARGLLYLHHD-SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 475 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|++ ++|.+++... .....+++..+..++.||+.||+|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 6888887542 2335689999999999999999999987 6 99999999999999999999999999986532
Q ss_pred CccccccceecccccccCcccccc----CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASD----GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||..... ....+ ..... .....
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~---~~~~~-~~~~~ 227 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQL---KQVVE-EPSPQ 227 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHH---HHHHh-cCCCC
Confidence 21 1223568889999998865 4568999999999999999999999853221 11111 11111 11111
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+... .....+.+++.+||+.+|++||+++++++
T Consensus 228 ~~~~--------~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 LPAE--------KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCcc--------ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1100 11235678999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=280.51 Aligned_cols=231 Identities=20% Similarity=0.217 Sum_probs=176.2
Q ss_pred cCcccccccccCCccceEeeeeCCch-h-----------------------------hhhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-E-----------------------------IAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-~-----------------------------vah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||.||++...... . +.||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46889999999999999998764321 0 11999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++++|.+++.. .+.+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999944 345888999999999999999999988 999999999999999999999999998742110
Q ss_pred c-------------cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHH
Q 039318 554 E-------------IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKL 620 (717)
Q Consensus 554 ~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 620 (717)
. .........++..|+|||.+.+..++.++|+||||+++|||++|+.||...... ... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~~----~~ 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELF----GQ 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HH
Confidence 0 000111246788999999998889999999999999999999999998532211 111 11
Q ss_pred hhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 621 WNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 621 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
....... .+.... .....+.+++.+||+.+|++||+..++.++|+..
T Consensus 228 ~~~~~~~---~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 228 VISDDIE---WPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHhcccC---CCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 1111100 000000 1223457889999999999999988888887653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=283.06 Aligned_cols=219 Identities=28% Similarity=0.411 Sum_probs=174.7
Q ss_pred cCcccccccccCCccceEeeeeCCchhh------------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEI------------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~v------------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
..|+-++.||.|+||.||-|++....+| .|||+|.+-|||..+...+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3577778999999999999987654332 2999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
|||-| +-.+++. ..++++-+..+..|..+.++||+|||+++ .||||||..||||.+.|.|||+|||.|.+..+
T Consensus 106 EYClG-SAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 106 EYCLG-SASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred HHHhc-cHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 99955 7777773 34567889999999999999999999998 99999999999999999999999999987543
Q ss_pred ccccccceecccccccCccccc---cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 554 EIEGSTKRVVGTYGYMAPEYAS---DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
.+.++|||.|||||++. .+.|+-|+||||||+...||...++|.-..+ .+..+.++.+ .....
T Consensus 179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN---AMSALYHIAQ----NesPt-- 244 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQ----NESPT-- 244 (948)
T ss_pred -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch---HHHHHHHHHh----cCCCC--
Confidence 44799999999999874 5789999999999999999999999953222 2222222211 11111
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
++ ..+=...+.+++..||++=|.+|||.++++.
T Consensus 245 ---Lq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 245 ---LQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred ---CC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 11 2223345678889999999999999887765
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=274.15 Aligned_cols=227 Identities=26% Similarity=0.397 Sum_probs=176.2
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hh--------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QE--------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~--------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
.++|++.++||+|+||.||+++.... .. +.||||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 46799999999999999999987532 11 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 9999999998542 345899999999999999999999998 9999999999999999999999999987543221
Q ss_pred ccccceecccccccCccccc-----cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 556 EGSTKRVVGTYGYMAPEYAS-----DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
.......+++.|+|||++. ...++.++|+||||+++|||++|+.||...... ..+ ... .......+.
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~---~~~---~~~-~~~~~~~~~ 229 (280)
T cd06611 158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM---RVL---LKI-LKSEPPTLD 229 (280)
T ss_pred -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH---HHH---HHH-hcCCCCCcC
Confidence 1223457899999999874 345788999999999999999999998643221 111 111 111111110
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
. +......+.+++.+||+.+|.+||++.+|++.
T Consensus 230 ~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 Q-------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred C-------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 01112356688899999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=275.10 Aligned_cols=235 Identities=22% Similarity=0.314 Sum_probs=171.1
Q ss_pred CcccccccccCCccceEeeeeCCc-h----------------------------hhhhhhhhhhcceeecCceeeEEEec
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG-Q----------------------------EIAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~-~----------------------------~vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+|++.+.||+|+||.||+|+.... + .+.||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478889999999999999986421 1 12399999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++ +|.+++... ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 975 777776432 345899999999999999999999998 9999999999999999999999999998653221
Q ss_pred ccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC------cc
Q 039318 556 EGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP------SQ 628 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 628 (717)
.......++..|+|||++.+. .++.++|||||||++|||++|+.|+.... ..........+....... ..
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC--CHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 112234678899999988764 47899999999999999999998853211 111111111111110000 00
Q ss_pred ccch----hhhcc-----CCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 629 LIDA----YYQES-----CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 629 l~d~----~~~~~-----~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+.+. ..... ........+.+++.+||+.||.+|||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 00000 00112245678999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=279.13 Aligned_cols=242 Identities=21% Similarity=0.308 Sum_probs=174.2
Q ss_pred CcccccccccCCccceEeeeeCC---chh-----------------------------hhhhhhhhhcceeecC--ceee
Q 039318 425 NFSINKKLGEGGFGPVYKGTLAD---GQE-----------------------------IAHRNLVKLLGCCIQG--EEKL 470 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~---~~~-----------------------------vah~niv~l~~~~~~~--~~~~ 470 (717)
+|++.++||+|+||.||+|+... ++. +.||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999998754 111 1299999999999988 8899
Q ss_pred EEEeccCCCChhhHhhhccc--cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC----CCCceeccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTK--RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH----EMNPKISDF 544 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~----~~~~kl~Df 544 (717)
+||||+++ +|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 56666633221 236788999999999999999999998 999999999999999 899999999
Q ss_pred cccccccCCcc-ccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCch------hHHHH
Q 039318 545 GLARTFVGDEI-EGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNL------NLIGH 616 (717)
Q Consensus 545 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~------~~~~~ 616 (717)
|+++....... ........++..|+|||.+.+. .++.++||||||+++++|++|+.||.....+... ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543221 1122345788999999987664 5889999999999999999999999755433210 11111
Q ss_pred HHHHhhCCCC---------ccccc---hhhhccC---CH--------HHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 617 AWKLWNNGMP---------SQLID---AYYQESC---NL--------AEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 617 ~~~~~~~~~~---------~~l~d---~~~~~~~---~~--------~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
....+..... .+... ....... .. ....++.+++.+||+.+|++|||+.|+++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111110000 00000 0000000 00 122457899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=273.90 Aligned_cols=230 Identities=23% Similarity=0.383 Sum_probs=173.1
Q ss_pred cccccccccCCccceEeeeeCC----chh----------------------------hhhhhhhhhcceeecCc------
Q 039318 426 FSINKKLGEGGFGPVYKGTLAD----GQE----------------------------IAHRNLVKLLGCCIQGE------ 467 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~----~~~----------------------------vah~niv~l~~~~~~~~------ 467 (717)
|.+.+.||+|+||.||+|.+.. ++. +.||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5677899999999999997531 111 12999999999886542
Q ss_pred eeeEEEeccCCCChhhHhhhcc---ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQT---KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDF 544 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 544 (717)
..++++||+++++|..++.... ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875321 2234788899999999999999999988 999999999999999999999999
Q ss_pred cccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhC
Q 039318 545 GLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNN 623 (717)
Q Consensus 545 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 623 (717)
|+++...............++..|++||.+....++.++||||||+++|||++ |+.||..... ...... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~----~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNY----LIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHH----HHc
Confidence 99986543322222223345678999999998899999999999999999999 8888753221 111111 111
Q ss_pred CCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 624 GMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 624 ~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
..... .+......+.+++.+|++.+|++||++.++++.|++.
T Consensus 231 ~~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11000 0112234678899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=270.48 Aligned_cols=227 Identities=25% Similarity=0.405 Sum_probs=175.7
Q ss_pred CcccccccccCCccceEeeeeCCc-hh--------------------------------hhhhhhhhhcceeecCceeeE
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG-QE--------------------------------IAHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~-~~--------------------------------vah~niv~l~~~~~~~~~~~l 471 (717)
+|+..+.||+|+||.||+++.... +. +.|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999875321 10 129999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC-Cceeccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM-NPKISDFGLARTF 550 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~Dfgla~~~ 550 (717)
||||+++++|.+++.+ .+.+++..+..++.||+.||.|||+++ ++|+||||+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999854 345788999999999999999999998 99999999999998776 5999999999866
Q ss_pred cCCccc--cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 551 VGDEIE--GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 551 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
...... .......++..|+|||.+.+..++.++|+||||+++++|++|+.||...........+ .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~-- 229 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKIASATTA-- 229 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---HHHhccCCC--
Confidence 433111 1122356889999999998888999999999999999999999998643322221111 111111110
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
...+......+.+++.+||+.+|++||++.+++.
T Consensus 230 -------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 230 -------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 1112223356778999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=270.60 Aligned_cols=228 Identities=27% Similarity=0.369 Sum_probs=177.3
Q ss_pred cCcccccccccCCccceEeeeeCCc-hh---------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QE---------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~---------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
++|++.+.||+|+||.||++..+.. +. +.||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 3678889999999999999987532 11 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhh-cCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHH-DSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
+++++|.+++.... ..+++..+..++.|+++||+|||+ .+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999985432 568889999999999999999999 77 9999999999999999999999999987653221
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
.....++..|+|||.+.+..++.++||||||+++++|++|+.||....... ....... +.........+...
T Consensus 156 ----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~-- 227 (265)
T cd06605 156 ----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELL-QYIVNEPPPRLPSG-- 227 (265)
T ss_pred ----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHH-HHHhcCCCCCCChh--
Confidence 112678889999999999999999999999999999999999986432211 1111111 11111111111000
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.....+.+++.+||+.+|++||++.+++..
T Consensus 228 ------~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 228 ------KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ------hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 023346788999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=277.40 Aligned_cols=236 Identities=22% Similarity=0.319 Sum_probs=173.4
Q ss_pred cCcccccccccCCccceEeeeeCCc-h---------------------------hhhhhhhhhhcceeecCceeeEEEec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-Q---------------------------EIAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~---------------------------~vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
++|++.+.||+|++|.||+|+.+.. + .+.|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 6799999999999999999986522 1 12299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++ +|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 898888543 236788999999999999999999998 99999999999999999999999999875422111
Q ss_pred ccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccc-----
Q 039318 556 EGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL----- 629 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l----- 629 (717)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||..... ...........+........
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhhh
Confidence 1112346789999998875 4588999999999999999999999864321 11111111111111000000
Q ss_pred ------------cchhhhc-cCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 630 ------------IDAYYQE-SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 630 ------------~d~~~~~-~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
....... .........+.+++.+||+.+|++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000 001111256678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=272.45 Aligned_cols=233 Identities=26% Similarity=0.303 Sum_probs=177.0
Q ss_pred cCcccccccccCCccceEeeeeCCch-h---------------------------hhhhhhhhhcceeecC--ceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-E---------------------------IAHRNLVKLLGCCIQG--EEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-~---------------------------vah~niv~l~~~~~~~--~~~~lV~ 473 (717)
++|+..++||.|++|.||++...... . +.||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999875321 1 1299999999988653 4689999
Q ss_pred eccCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 474 EFMPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
||+++++|.+++.... ....+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999875322 3345788899999999999999999998 99999999999999999999999999875432
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCC--CCchhHHHHHHHHhhCCCCcccc
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHS--DKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ........+ ........+.
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 229 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY----IVNMPNPELK 229 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH----HhcCCchhhc
Confidence 21 1234578899999999999999999999999999999999999875432 111111111 1111111111
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+.... .......+.+++.+||+.+|.+|||+.||++.
T Consensus 230 ~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 230 DEPGN---GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred cCCCC---CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 11100 01123457789999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=277.61 Aligned_cols=222 Identities=24% Similarity=0.367 Sum_probs=172.6
Q ss_pred cccccccccCCccceEeeeeCC-chh--------------------------hhhhhhhhhcceeecCceeeEEEeccCC
Q 039318 426 FSINKKLGEGGFGPVYKGTLAD-GQE--------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~-~~~--------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
|+...+||+|+||.||++.... ++. +.||||+++++++..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 3444689999999999997642 221 1299999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|.+++.. ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++....... ..
T Consensus 103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~ 173 (297)
T cd06659 103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PK 173 (297)
T ss_pred CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--cc
Confidence 999987732 35789999999999999999999998 9999999999999999999999999987543322 11
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
.....++..|+|||++.+..++.++||||||+++|||++|+.||......+ .+. .+..........
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~----~~~~~~~~~~~~------- 239 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMK----RLRDSPPPKLKN------- 239 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHhccCCCCccc-------
Confidence 234678999999999998899999999999999999999999986432211 111 111111100000
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 639 NLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 639 ~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.......+.+++.+||+.+|++||++++|++.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00112345678889999999999999999994
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=274.46 Aligned_cols=216 Identities=23% Similarity=0.268 Sum_probs=167.9
Q ss_pred ccccCCccceEeeeeCCc-hhh--------------------------------hhhhhhhhcceeecCceeeEEEeccC
Q 039318 431 KLGEGGFGPVYKGTLADG-QEI--------------------------------AHRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 431 ~lG~G~fg~Vy~~~~~~~-~~v--------------------------------ah~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.||+|+||.||++..... +.+ .||||+++++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999876432 111 17899999999999999999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++.. .+.+++..+..++.|++.||.|||+++ |+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999998843 345899999999999999999999998 9999999999999999999999999987543221
Q ss_pred ccceecccccccCccccc-cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYAS-DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
.....|+..|+|||.+. +..++.++|||||||++|||++|+.||......... .+..... .. ...+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~----~~-----~~~~-- 218 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL----TV-----NVEL-- 218 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh----cC-----CcCC--
Confidence 22356899999999886 456899999999999999999999998654322211 1111100 00 0001
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRP-----CMPSVILM 670 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~~ 670 (717)
+.....++.+++.+||+.||++|| ++.|+++.
T Consensus 219 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 --PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred --ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 111234567888999999999999 59999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=270.12 Aligned_cols=224 Identities=22% Similarity=0.331 Sum_probs=176.2
Q ss_pred CcccccccccCCccceEeeeeCCc-hh----------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG-QE----------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~-~~----------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+|++.++||+|+||.||+++.... +. +.||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588899999999999999876432 11 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++... ....+++..++.++.|++.||+|||+++ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999988542 2235788899999999999999999988 99999999999999999999999999986533221
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
......|++.|+|||++.+..++.++|+||||+++++|++|+.||..... ... ........ ...
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~~~---~~~~~~~~-~~~------- 220 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---KNL---VLKIIRGS-YPP------- 220 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH---HHH---HHHHhcCC-CCC-------
Confidence 12235688899999999999999999999999999999999999863221 111 11111111 110
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+......+.+++.+||+.+|++||++.+|++.
T Consensus 221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 --VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111223457789999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=270.16 Aligned_cols=228 Identities=25% Similarity=0.352 Sum_probs=176.1
Q ss_pred CcccccccccCCccceEeeeeCCch-h----------------------------hhhhhhhhhcceeec--CceeeEEE
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ-E----------------------------IAHRNLVKLLGCCIQ--GEEKLLIY 473 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~-~----------------------------vah~niv~l~~~~~~--~~~~~lV~ 473 (717)
+|++.+.||.|+||.||++...... . +.||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999998754321 1 129999999997753 45679999
Q ss_pred eccCCCChhhHhhhc-cccccCChhhHHHHHHHHHHHHHHHhhcC--CCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 474 EFMPNRSLDSFIFDQ-TKRKLLDWSKRFCIICGTARGLLYLHHDS--RLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 474 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
||+++++|.+++... .....+++..+..++.||++||+|||..+ ..+|+|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999553 22456899999999999999999999332 223999999999999999999999999999876
Q ss_pred cCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
..... ......++..|+|||.+.+..++.++|+||||+++++|++|+.||..... ... .+....+....
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~----~~~~~~~~~~~-- 229 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQL----ASKIKEGKFRR-- 229 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHH----HHHHhcCCCCC--
Confidence 43321 12235689999999999988899999999999999999999999875331 111 11112221111
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+......+.+++.+||+.+|++||++.+|+++
T Consensus 230 -------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 -------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111223467789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=269.66 Aligned_cols=224 Identities=25% Similarity=0.364 Sum_probs=168.1
Q ss_pred cCcccccccccCCccceEeeeeCCch--------------------------------hhhhhhhhhhcceeec--Ccee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ--------------------------------EIAHRNLVKLLGCCIQ--GEEK 469 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~--------------------------------~vah~niv~l~~~~~~--~~~~ 469 (717)
.+|+..+.||+|+||.||+|...... .+.||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46889999999999999999754210 1129999999998865 3567
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
+++|||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999943 234788899999999999999999988 99999999999999999999999999976
Q ss_pred ccCCcc-ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 550 FVGDEI-EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 550 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.||..... ... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~---~~~---~~~~~~~~~~-- 227 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAA---IFKIATQPTN-- 227 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch---HHH---HHHHhcCCCC--
Confidence 532111 1112235688999999999998899999999999999999999999864321 111 1111111110
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+.. +......+..++ +|+..+|++||+++||++
T Consensus 228 ---~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 ---PQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---CCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 000 111112233343 688899999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=275.11 Aligned_cols=238 Identities=22% Similarity=0.274 Sum_probs=171.8
Q ss_pred cCcccccccccCCccceEeeeeCCc-hhh-----------------------------hhhhhhhhcceeecCce-----
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QEI-----------------------------AHRNLVKLLGCCIQGEE----- 468 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v-----------------------------ah~niv~l~~~~~~~~~----- 468 (717)
++|++.+.||+|+||.||+|+.... +.+ .||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688999999999999999986532 111 16999999999887665
Q ss_pred eeEEEeccCCCChhhHhhhccc--cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC-CCCceecccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTK--RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH-EMNPKISDFG 545 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~Dfg 545 (717)
.++||||+++ +|.+++..... ...+++..+..++.||++||.|||+++ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 78888854322 346899999999999999999999998 999999999999998 8899999999
Q ss_pred ccccccCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCC
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG 624 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 624 (717)
+++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...... .........+...
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL---QQLLHIFKLLGTP 231 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHhCCC
Confidence 9986432211 1122356888999998865 45789999999999999999999998643221 1111111111110
Q ss_pred CCcc------ccchh--------hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 625 MPSQ------LIDAY--------YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 625 ~~~~------l~d~~--------~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.... +.+.. ............+.+++.+||+.+|.+||++.|++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 00000 0000001123457789999999999999999998863
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=270.85 Aligned_cols=236 Identities=23% Similarity=0.332 Sum_probs=176.0
Q ss_pred CcccccccccCCccceEeeeeCC-chh----------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 425 NFSINKKLGEGGFGPVYKGTLAD-GQE----------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~----------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+|++.+.||+|+||.||+|+... ++. +.||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58889999999999999998642 211 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+ +++|.+++.... ..+++..+..++.||++||+|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999985432 56899999999999999999999998 99999999999999999999999999987643321
Q ss_pred ccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC------cc
Q 039318 556 EGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP------SQ 628 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 628 (717)
.......++..|+|||.+.+. .++.++||||||++++||++|+++|..... ..........+..... .+
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccC
Confidence 112245688999999988654 468999999999999999999877753322 2222222221111000 00
Q ss_pred ccch-----hhhcc-----CCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 629 LIDA-----YYQES-----CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 629 l~d~-----~~~~~-----~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+.+. ..... ........+.+++.+||+.+|++||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 00000 001122577899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=270.30 Aligned_cols=218 Identities=23% Similarity=0.250 Sum_probs=170.9
Q ss_pred cccccCCccceEeeeeCC-chhh------------------------------hhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLAD-GQEI------------------------------AHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~-~~~v------------------------------ah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
+.||+|+||.||+|.... ++.+ .|+||+++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999997643 1111 189999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|.+++.. ...+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999999843 345889999999999999999999988 99999999999999999999999999876432
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
.....++..|+|||.+.+..++.++||||||+++|||++|..||...... ... ......... .....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~~~------~~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AVF----DNILSRRIN------WPEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHhcccC------CCCcc
Confidence 22456888999999998888999999999999999999999998643221 111 111111110 00000
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 639 NLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 639 ~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
.......+.+++.+||+.+|++||++.++.+.|.
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1112345778999999999999998887777664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=268.41 Aligned_cols=226 Identities=27% Similarity=0.374 Sum_probs=180.6
Q ss_pred cCcccccccccCCccceEeeeeCC-chh---------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQE---------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~---------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
++|++.+.||+|++|.||+++... ++. +.|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999998764 211 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhh-cCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHH-DSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
+++++|.+++... ..+++..+..++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999543 568999999999999999999999 88 9999999999999999999999999998764332
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||............... .......+
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~----~~~~~~~~----- 223 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI----CDGPPPSL----- 223 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH----hcCCCCCC-----
Confidence 21 22456889999999999999999999999999999999999998654331222222111 11111111
Q ss_pred hccCCHH-HHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 635 QESCNLA-EVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 635 ~~~~~~~-~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+.. ....+.+++.+||+.+|++||++.++++.
T Consensus 224 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 ----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 23467788999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=270.93 Aligned_cols=225 Identities=24% Similarity=0.343 Sum_probs=171.5
Q ss_pred cCcccccccccCCccceEeeeeCCc-h-------------------------------hhhhhhhhhhcceeecC--cee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-Q-------------------------------EIAHRNLVKLLGCCIQG--EEK 469 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~-------------------------------~vah~niv~l~~~~~~~--~~~ 469 (717)
.+|++.+.||+|+||.||+|...+. . .+.||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4788999999999999999875431 1 11299999999988764 467
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999998532 34788889999999999999999998 99999999999999999999999999986
Q ss_pred ccCCccc-cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 550 FVGDEIE-GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 550 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...... .. .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~---~~~~~~~~~--- 226 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM---AA---IFKIATQPT--- 226 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH---HH---HHHHhcCCC---
Confidence 5322111 1122356889999999998888999999999999999999999998643111 11 111111111
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
....+......+.+++.+|+. +|++||+++||++.
T Consensus 227 ------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 ------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 011122233456677888885 89999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=274.98 Aligned_cols=235 Identities=22% Similarity=0.300 Sum_probs=174.6
Q ss_pred cCcccccccccCCccceEeeeeCCch-----------------------------hhhhhhhhhhcceeecC--ceeeEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-----------------------------EIAHRNLVKLLGCCIQG--EEKLLI 472 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-----------------------------~vah~niv~l~~~~~~~--~~~~lV 472 (717)
++|++.+.||+|+||.||+|+.+... .+.||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57889999999999999999875321 11299999999998877 889999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++ +|.+++... ...+++..+..++.||++||+|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999985 898888442 236899999999999999999999998 99999999999999999999999999986643
Q ss_pred CccccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhC--------
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNN-------- 623 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-------- 623 (717)
... ......+++.|+|||.+.+. .++.++|+||||++++||++|+.||........ .......+..
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ---LNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchHHHHH
Confidence 321 12234578899999988764 468999999999999999999999875433221 1111111100
Q ss_pred ---------CCCccccchhhhccCCHH-HHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 624 ---------GMPSQLIDAYYQESCNLA-EVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 624 ---------~~~~~l~d~~~~~~~~~~-~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
..........+....+.. ....+.+++.+||+.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000111111111 2345678899999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=292.83 Aligned_cols=235 Identities=21% Similarity=0.252 Sum_probs=181.2
Q ss_pred cHHHHHHHhcCcccccccccCCccceEeeeeCCchhhh------------------------------hhhhhhhcceee
Q 039318 415 ELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA------------------------------HRNLVKLLGCCI 464 (717)
Q Consensus 415 ~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va------------------------------h~niv~l~~~~~ 464 (717)
...++....++|.+++.||+|+||.|..++++...+|. .+-||++.-.|+
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 34455566789999999999999999999997765543 466999999999
Q ss_pred cCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccc
Q 039318 465 QGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDF 544 (717)
Q Consensus 465 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 544 (717)
+..++|+|||||+||+|-.++.+.. .+++..+..++..|+.||.-||+.| +|||||||+|||||..|++||+||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 9999999999999999999994433 6899999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCccccccceecccccccCccccc----c-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHH
Q 039318 545 GLARTFVGDEIEGSTKRVVGTYGYMAPEYAS----D-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWK 619 (717)
Q Consensus 545 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 619 (717)
|.+-.+..+. .......+|||.|++||+++ + +.|+..+|.||+||++|||+.|..||-... +..-.-+
T Consensus 220 GsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~K 292 (1317)
T KOG0612|consen 220 GSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGK 292 (1317)
T ss_pred hhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHH
Confidence 9998776443 33455689999999999985 3 569999999999999999999999985322 1111122
Q ss_pred HhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCC---hHHHHHH
Q 039318 620 LWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPC---MPSVILM 670 (717)
Q Consensus 620 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs---~~evl~~ 670 (717)
+........+.+ ...-.....+|+...+ -+|+.|.. ++++-..
T Consensus 293 Im~hk~~l~FP~-------~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 293 IMNHKESLSFPD-------ETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred HhchhhhcCCCc-------ccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 222211111111 1112234455665544 47788877 8888764
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=264.69 Aligned_cols=216 Identities=27% Similarity=0.356 Sum_probs=173.2
Q ss_pred hcCcccccccccCCccceEeeeeCCchhhh-------------------------------hhhhhhhcceeecCceeeE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------------HRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------------h~niv~l~~~~~~~~~~~l 471 (717)
..+|..+..||+|+||.|.+|+-+...++. -|.++++..+++.-+++|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 347888899999999999999866544321 6899999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+.||+|.-+|.+ -+.+.+..+..++.+|+-||-+||+++ ||.||||.+|||||.+|++||+|||+++.-.
T Consensus 428 VMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999988844 334667778889999999999999999 9999999999999999999999999998543
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
-+ ...+.+++||+.|+|||++...+|+..+|.||+||+||||+.|++||+..+.++-...+ .+..+
T Consensus 502 ~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI-------~ehnv----- 567 (683)
T KOG0696|consen 502 FD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI-------MEHNV----- 567 (683)
T ss_pred cC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------HHccC-----
Confidence 22 23456799999999999999999999999999999999999999999865544432221 11111
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCC
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPC 663 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs 663 (717)
..+-....+.+.++...|.++|.+|..
T Consensus 568 -----syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 568 -----SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -----cCcccccHHHHHHHHHHhhcCCccccC
Confidence 111222334556667778899999863
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=271.76 Aligned_cols=221 Identities=27% Similarity=0.416 Sum_probs=174.9
Q ss_pred CcccccccccCCccceEeeeeCCc-hhh---------------------------hhhhhhhhcceeecCceeeEEEecc
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG-QEI---------------------------AHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~-~~v---------------------------ah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
-|++.++||+|+||.||+|..... ..+ .||||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 477788999999999999976422 111 1999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
++++|.+++.. ..+++..+..++.|++.++.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999998832 35789999999999999999999988 99999999999999999999999999876543221
Q ss_pred cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 557 GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
......++..|+|||.+.+..++.++|+|||||++++|++|..||....... .. ..........
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~----~~~~~~~~~~-------- 220 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VL----FLIPKNNPPT-------- 220 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HH----HHHhcCCCCC--------
Confidence 1223568889999999988889999999999999999999999986432111 11 1111111111
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
........+.+++.+||+.+|.+||++.++++.
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 -LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111123456788999999999999999999994
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=259.98 Aligned_cols=216 Identities=25% Similarity=0.320 Sum_probs=171.3
Q ss_pred HhcCcccccccccCCccceEeeeeCCch-----------------hhh-------------hhhhhhhcceeecCceeeE
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQ-----------------EIA-------------HRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-----------------~va-------------h~niv~l~~~~~~~~~~~l 471 (717)
..++|..++.||+|.||.|.+++-+... +|| ||.+..+--.++..+++++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3467888999999999999998765432 222 9999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||..||.|.-++. +.+.+++.....+-.+|+.||.|||+++ ||.||||.+|+|||.+|++||+|||+++.-.
T Consensus 246 VMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999988883 3456778887888999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
.. ....++++|||.|+|||++....|..++|.|.+|||+|||++|+.||-....+.-..++.. .++
T Consensus 320 ~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~----------ed~-- 385 (516)
T KOG0690|consen 320 KY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM----------EDL-- 385 (516)
T ss_pred cc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh----------hhc--
Confidence 22 3345679999999999999999999999999999999999999999864433332222211 000
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCC
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP 662 (717)
.. +-....+...|..-.|.+||.+|.
T Consensus 386 -kF----Pr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 -KF----PRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -cC----CccCCHHHHHHHHHHhhcChHhhc
Confidence 01 111112344556668899999996
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=271.09 Aligned_cols=218 Identities=26% Similarity=0.300 Sum_probs=174.2
Q ss_pred cCcccccccccCCccceEeeeeCCc-hh-----------------------------hhhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QE-----------------------------IAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~-----------------------------vah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||.||+++.... +. +.||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4688999999999999999986532 11 12999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+|+||+|.||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998543 46889999999999999999999988 999999999999999999999999999875433
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...... .. .+....+...
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~----~~~~~~~~~~------ 216 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QI----YEKILEGKVR------ 216 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HH----HHHHhcCCcc------
Confidence 22456889999999998888999999999999999999999998643311 11 1111111110
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRP-----CMPSVIL 669 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~ 669 (717)
. +......+.+++.+||+.+|.+|| +++|+++
T Consensus 217 ~----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 217 F----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred C----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0 001124566889999999999999 6666664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=272.58 Aligned_cols=236 Identities=23% Similarity=0.345 Sum_probs=175.3
Q ss_pred CcccccccccCCccceEeeeeCCc-hh---------------------------hhhhhhhhhcceeecCceeeEEEecc
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG-QE---------------------------IAHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~-~~---------------------------vah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
+|++.++||+|++|.||+|+.... +. +.||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 588899999999999999987532 11 12999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
++ +|.+++........+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.++|+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 88888865444456899999999999999999999998 99999999999999999999999999975432211
Q ss_pred cccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC---------C
Q 039318 557 GSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM---------P 626 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~ 626 (717)
......++..|++||.+.+. .++.++||||||+++|+|++|+.||......+. ............ .
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ---LLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCChhhHHHHhcC
Confidence 11234578899999988664 578999999999999999999999875433221 111111110000 0
Q ss_pred ccccchhh------hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 627 SQLIDAYY------QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 627 ~~l~d~~~------~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
..+..... ...........+.+++.+|++.+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 00000112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=272.68 Aligned_cols=232 Identities=21% Similarity=0.271 Sum_probs=170.6
Q ss_pred cccccccccCCccceEeeeeCCc-h---------------------h------h-hhhhhhhhcceeecC--ceeeEEEe
Q 039318 426 FSINKKLGEGGFGPVYKGTLADG-Q---------------------E------I-AHRNLVKLLGCCIQG--EEKLLIYE 474 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~~-~---------------------~------v-ah~niv~l~~~~~~~--~~~~lV~E 474 (717)
|++.++||+|+||.||+|+.... + + + .|+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56788999999999999975421 1 1 1 199999999999987 88999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9974 777777432 346899999999999999999999998 999999999999999 999999999998654322
Q ss_pred cccccceecccccccCccccc-cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhh-----------
Q 039318 555 IEGSTKRVVGTYGYMAPEYAS-DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWN----------- 622 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~----------- 622 (717)
. .....++..|+|||.+. +..++.++|||||||++|||++|+.||......+ .+........
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhc
Confidence 1 12346788999999764 4567899999999999999999999986543222 1111111110
Q ss_pred CCCCccccchhhhc----cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 623 NGMPSQLIDAYYQE----SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 623 ~~~~~~l~d~~~~~----~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.........+.... .........+.+++.+||+.+|++||+++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000000 0001224677899999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=266.99 Aligned_cols=221 Identities=25% Similarity=0.309 Sum_probs=175.9
Q ss_pred CcccccccccCCccceEeeeeCC-chh-----------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 425 NFSINKKLGEGGFGPVYKGTLAD-GQE-----------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~-----------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
+|++.++||.|+||.||+++... ++. +.||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58889999999999999998753 111 129999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++++|.+++... ..+++..+..++.||++||.|||+++ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998442 46889999999999999999999998 9999999999999999999999999998754332
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.......... ........ .
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~-~-------- 218 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ----IRAKQETA-D-------- 218 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH----HHHHhccc-c--------
Confidence 1234568889999999988889999999999999999999999987554331111 11111110 0
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCCh--HHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCM--PSVI 668 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~--~evl 668 (717)
...+......+.+++.+||+.+|.+||+. +|++
T Consensus 219 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 -VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 00111122567789999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=266.17 Aligned_cols=223 Identities=25% Similarity=0.405 Sum_probs=174.6
Q ss_pred CcccccccccCCccceEeeeeCCch-----------------------------hhhhhhhhhhcceeecCceeeEEEec
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ-----------------------------EIAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~-----------------------------~vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+|++.+.||+|+||.||++...... .+.||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999998754221 11299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC-CceeccccccccccCCc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM-NPKISDFGLARTFVGDE 554 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~Dfgla~~~~~~~ 554 (717)
+++++|.+++.... ...+++..+..++.+++++|.|||+++ |+|+||||+||++++++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999995432 345788999999999999999999998 99999999999998654 57999999998754322
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
......++..|+|||.+.+..++.++||||||+++++|++|+.||....... .. .... ......+.+
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~---~~~~-~~~~~~~~~--- 223 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LV---LKIM-SGTFAPISD--- 223 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HH---HHHH-hcCCCCCCC---
Confidence 1223568899999999998889999999999999999999999986432211 11 1111 111111111
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.....+.+++.+||+.+|++|||+.|+++.
T Consensus 224 ------~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 224 ------RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ------CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 122356788999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=278.82 Aligned_cols=228 Identities=29% Similarity=0.469 Sum_probs=184.1
Q ss_pred cCcccccccccCCccceEeeeeCCc--------------------------hhhhhhhhhhhcceeecCceeeEEEeccC
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG--------------------------QEIAHRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~--------------------------~~vah~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.+..+..+||-|-||.||.|.++.- +++.|||+|+|+|+|..+...|||+|||.
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 3556678999999999999987642 23349999999999999999999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
.|.|.+||++. ++..++....+.++.||+.|+.||..++ +|||||...|.|+.++..+||+||||++++..+....
T Consensus 347 yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 347 YGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred CccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 99999999653 4556777888899999999999999998 9999999999999999999999999999987765544
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
+.. .--.+-|.|||-+.-..++.|+|||+|||+|||+.| |-.||... + +.....++..+ ++.
T Consensus 423 HAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi---d----lSqVY~LLEkg---------yRM 485 (1157)
T KOG4278|consen 423 HAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI---D----LSQVYGLLEKG---------YRM 485 (1157)
T ss_pred ccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc---c----HHHHHHHHhcc---------ccc
Confidence 332 223568999999999999999999999999999988 77776421 1 11222333222 222
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
..+.-...++.+|+..||+.+|.+||++.|+-+.+|
T Consensus 486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 223334457788999999999999999999988775
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=272.09 Aligned_cols=238 Identities=24% Similarity=0.345 Sum_probs=172.4
Q ss_pred HhcCcccccccccCCccceEeeeeCC-ch---------------------------hhhhhhhhhhcceeecCceeeEEE
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLAD-GQ---------------------------EIAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~---------------------------~vah~niv~l~~~~~~~~~~~lV~ 473 (717)
++++|.+.+.||+|+||.||+|.... ++ .+.|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 35789999999999999999997532 11 112999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||++ ++|.+++... ...+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 6777666432 235678888889999999999999998 999999999999999999999999999754322
Q ss_pred ccccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC-------
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM------- 625 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 625 (717)
. .......++..|+|||++.+. .++.++||||||+++|||++|+.||..... ....+...+..+....
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 S--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred C--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhhhh
Confidence 1 112234578999999998764 578999999999999999999999864332 1122222221111000
Q ss_pred --Cccccchhhhc---------cCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 626 --PSQLIDAYYQE---------SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 626 --~~~l~d~~~~~---------~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
........... .........+.+++.+|++.||.+|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000 000111245668899999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=253.87 Aligned_cols=243 Identities=22% Similarity=0.311 Sum_probs=178.1
Q ss_pred cCcccccccccCCccceEeeeeCCc---------------------------------hhhhhhhhhhhcceeec-Ccee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG---------------------------------QEIAHRNLVKLLGCCIQ-GEEK 469 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~---------------------------------~~vah~niv~l~~~~~~-~~~~ 469 (717)
..|+.+.+||+|.||.||+|.-+++ +++.||||+.+..++.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 4688899999999999999953321 12239999999999887 7889
Q ss_pred eEEEeccCCCChhhHhhhc--cccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC----CCceecc
Q 039318 470 LLIYEFMPNRSLDSFIFDQ--TKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE----MNPKISD 543 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~----~~~kl~D 543 (717)
+|++||.+. +|.+.|+-+ ...+.++...+..|+.||+.|+.|||++- |+||||||.||||-.+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999977 777777433 33467899999999999999999999987 9999999999999766 8999999
Q ss_pred ccccccccCCcccc-ccceecccccccCccccccCC-CCccccchhHhHHHHHhhcCCCCCCCCCCCC------chhHHH
Q 039318 544 FGLARTFVGDEIEG-STKRVVGTYGYMAPEYASDGL-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDK------NLNLIG 615 (717)
Q Consensus 544 fgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~p~~~~~~~~------~~~~~~ 615 (717)
||+++.+...-... ....++-|..|+|||++.|.. ||.+.||||+|||+.||++-++.|.....+. ..+.+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999875432221 334578899999999998865 8999999999999999999998886433221 122333
Q ss_pred HHHHHhhCCC---Cccc---------cchhh-h--ccCCHHHH--------HHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 616 HAWKLWNNGM---PSQL---------IDAYY-Q--ESCNLAEV--------IRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 616 ~~~~~~~~~~---~~~l---------~d~~~-~--~~~~~~~~--------~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+.+++.-.. ...+ +.... . ....+... ....+|..++|+.||.+|.|+++.++.
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 3333332111 0000 00000 0 01111110 125688899999999999999998774
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=272.41 Aligned_cols=235 Identities=23% Similarity=0.291 Sum_probs=171.9
Q ss_pred CcccccccccCCccceEeeeeCCc-hh----------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG-QE----------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~-~~----------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+|++.+.||+|++|.||+|+.... +. +.||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478899999999999999976421 11 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
++ ++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 5888888543 2346889999999999999999999988 99999999999999999999999999876532211
Q ss_pred ccccceecccccccCccccccCC-CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC--------
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGL-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP-------- 626 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 626 (717)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.||......+ ..............
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCCChhhhhhhhH
Confidence 122345688999999887644 6889999999999999999999986432211 11111111100000
Q ss_pred --------ccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 627 --------SQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 627 --------~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
........... .......+.+++.+||+.||++||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000 00112346789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=270.57 Aligned_cols=222 Identities=23% Similarity=0.412 Sum_probs=173.5
Q ss_pred CcccccccccCCccceEeeeeCCc-h---------------------------hhh---hhhhhhhcceeecCceeeEEE
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG-Q---------------------------EIA---HRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~-~---------------------------~va---h~niv~l~~~~~~~~~~~lV~ 473 (717)
.|++.+.||+|+||.||+|..... + .+. |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999986321 1 111 899999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++++|.+++.. ..+++..+..++.|+++||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998843 26889999999999999999999998 999999999999999999999999999876443
Q ss_pred ccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
. .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......... ..........+
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------~~~~~~~~~~~--- 222 (277)
T cd06917 155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------MLIPKSKPPRL--- 222 (277)
T ss_pred c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-------hccccCCCCCC---
Confidence 2 12234578899999998865 45789999999999999999999998643221110 01111111111
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
... .....+.+++.+||+.+|++||++.+++..
T Consensus 223 --~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 223 --EDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 110 022456788899999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=275.07 Aligned_cols=241 Identities=22% Similarity=0.297 Sum_probs=171.4
Q ss_pred cCcccccccccCCccceEeeeeCCc-h----------------------------hhhhhhhhhhcceeecCc-------
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-Q----------------------------EIAHRNLVKLLGCCIQGE------- 467 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~----------------------------~vah~niv~l~~~~~~~~------- 467 (717)
++|++.++||+|+||.||+|+.... + .+.||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 5799999999999999999976421 1 112999999999887654
Q ss_pred -eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccc
Q 039318 468 -EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGL 546 (717)
Q Consensus 468 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgl 546 (717)
..++||||+.+ +|.+++.. ....+++..+..++.||++||+|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 45999999975 77777733 2235889999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCccc--cccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhC
Q 039318 547 ARTFVGDEIE--GSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNN 623 (717)
Q Consensus 547 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 623 (717)
+......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+.........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9865332211 112234678899999988664 4789999999999999999999998654332222222111110000
Q ss_pred CCCccc-----cch----------hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 624 GMPSQL-----IDA----------YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 624 ~~~~~l-----~d~----------~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
...... .+. .........+...+.+++.+||+.+|++|||++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000 000 00000000112356789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=271.82 Aligned_cols=225 Identities=25% Similarity=0.414 Sum_probs=177.2
Q ss_pred hcCcccccccccCCccceEeeeeCC-chh--------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQE--------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~--------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
.++|.+.+.||+|+||.||++.... ++. +.||||+++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 3689999999999999999997532 211 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++.+ ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999999843 24788899999999999999999998 99999999999999999999999999876543321
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||........... ....+... .
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~~~~------~- 235 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGTPE------L- 235 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCCCCC------C-
Confidence 12235688899999999888899999999999999999999999864332211110 00011100 0
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.........+.+++.+||+.+|++||++.+++.+
T Consensus 236 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011122356688999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=266.12 Aligned_cols=243 Identities=28% Similarity=0.425 Sum_probs=183.2
Q ss_pred cCcccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCc----eeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGE----EKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~----~~~lV~E 474 (717)
+...+.+.||+|.||.||||++.+ +.|| |+||++++++-.... +.+||+|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred CchhhHHHhhcCccceeehhhccC-ceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 345567899999999999999875 3333 999999999876655 8899999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcC------CCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS------RLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
|.+.|+|.+||.. ..++|....+|+..+++||+|||+.- +.+|+|||||.+||||.+|++..|+|||||.
T Consensus 289 fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 289 FHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 9999999999944 35899999999999999999999752 4679999999999999999999999999999
Q ss_pred cccCCccccccceecccccccCccccccCC-CC-----ccccchhHhHHHHHhhcCCCCCCCCCCCCc----------hh
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYASDGL-FS-----VKSDVFSFGILLLEIVSGKKNRGFYHSDKN----------LN 612 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDvwSlG~il~elltG~~p~~~~~~~~~----------~~ 612 (717)
.+............+||.+|||||++.+.- +. .+.||||+|.||+||++...-+......+. ..
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 887665555555689999999999997643 22 358999999999999987654321111100 00
Q ss_pred HHHHHHHHh-hCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 613 LIGHAWKLW-NNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 613 ~~~~~~~~~-~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
-+...+... ++.....+.+..... ..+.-+.+.+..||.+||+-|.|+.=|-+.+.+..
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 011122222 222222333333321 34455677888999999999999988888876654
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=279.31 Aligned_cols=179 Identities=28% Similarity=0.445 Sum_probs=154.6
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh---------------------------hhhhhhhcceeecCc------ee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA---------------------------HRNLVKLLGCCIQGE------EK 469 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va---------------------------h~niv~l~~~~~~~~------~~ 469 (717)
..|...+.||+|+||.||+|+.+. |+.|| |+|||++++.=.+.. ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 346667899999999999999653 44444 999999999866544 56
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc--CCCC--ceecccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD--HEMN--PKISDFG 545 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~--~~~~--~kl~Dfg 545 (717)
.+|||||.+|+|...+.+..+..-|++.+.+.++..++.||.|||+++ |+||||||.||++- ++|. -||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 899999999999999988888888999999999999999999999998 99999999999994 3343 6999999
Q ss_pred ccccccCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCC
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSD 608 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~ 608 (717)
.|+.+..+. ......||+.|++||+... +.|+..+|.|||||++||++||..||......
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 999876554 3457899999999999984 88999999999999999999999999866544
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=265.24 Aligned_cols=226 Identities=27% Similarity=0.450 Sum_probs=173.9
Q ss_pred CcccccccccCCccceEeeeeCCc-h----------------------------hhhhhhhhhhcceeecCceeeEEEec
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG-Q----------------------------EIAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~-~----------------------------~vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+|++.+.||+|+||.||+|..... + .+.|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588889999999999999975421 1 11299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++.. ...+++..+..++.++++||.|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999843 335788899999999999999999998 99999999999999999999999999987643322
Q ss_pred ccc--cceecccccccCccccccCC---CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 556 EGS--TKRVVGTYGYMAPEYASDGL---FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 556 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
... .....++..|+|||++.+.. ++.++||||||++++||++|+.||..... .. .... .... .....+.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~-~~~~--~~~~-~~~~~~~ 228 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EF-QIMF--HVGA-GHKPPIP 228 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hH-HHHH--HHhc-CCCCCCC
Confidence 111 11356788999999998766 88999999999999999999999864321 11 1111 1111 1111110
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+ .......+.+++.+||+.+|.+||++.+++.
T Consensus 229 ~-------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 D-------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred c-------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 0011234568889999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=279.73 Aligned_cols=219 Identities=21% Similarity=0.243 Sum_probs=175.4
Q ss_pred HhcCcccccccccCCccceEeeeeCCchh------------------------hhhhhhhhhcceeecCceeeEEEeccC
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQE------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~------------------------vah~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
+++.|.+...||.|+|+.|-.+......+ ..||||+++.+.+.++.+.++|||.+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 46788888999999999999887643211 119999999999999999999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE-cCCCCceeccccccccccCCccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL-DHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll-~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
++-|.+.+.... ... ..+..|+++|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++...+.
T Consensus 400 g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 400 GGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred ccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 998888774322 222 667779999999999999998 9999999999999 69999999999999976443
Q ss_pred cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 557 GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
....+-|..|.|||++....|++++||||||++||+||+|+.||.....+ . .+...+..+..
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~----ei~~~i~~~~~---------- 531 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--I----EIHTRIQMPKF---------- 531 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--H----HHHHhhcCCcc----------
Confidence 33467789999999999999999999999999999999999998755444 1 11111111111
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
...-.....+|+.+|||.||.+||+|.++...
T Consensus 532 --s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 532 --SECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred --ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 11122356688999999999999999998763
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=268.57 Aligned_cols=216 Identities=23% Similarity=0.286 Sum_probs=168.2
Q ss_pred ccccCCccceEeeeeCCc-hhh--------------------------------hhhhhhhhcceeecCceeeEEEeccC
Q 039318 431 KLGEGGFGPVYKGTLADG-QEI--------------------------------AHRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 431 ~lG~G~fg~Vy~~~~~~~-~~v--------------------------------ah~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.||+|+||.||+++.... +.+ .||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999875421 111 17999999999999999999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++.. .+.+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---- 150 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence 9999988843 346899999999999999999999988 999999999999999999999999998755322
Q ss_pred ccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
......|+..|+|||.+.++ .++.++||||+|+++|||++|+.||............ ...... ......
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~------~~~~~~ 220 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTM------AVELPD 220 (278)
T ss_pred CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhhcc------CCCCCC
Confidence 12245789999999998754 6899999999999999999999998754322211111 100000 000111
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRP-----CMPSVILM 670 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~~ 670 (717)
.....+.+++.+||+.+|.+|| ++.++++.
T Consensus 221 ----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 221 ----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1134577888899999999999 89999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-30 Score=262.44 Aligned_cols=225 Identities=26% Similarity=0.399 Sum_probs=178.3
Q ss_pred CcccccccccCCccceEeeeeCC-chh----------------------------hhhhhhhhhcceeecC--ceeeEEE
Q 039318 425 NFSINKKLGEGGFGPVYKGTLAD-GQE----------------------------IAHRNLVKLLGCCIQG--EEKLLIY 473 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~----------------------------vah~niv~l~~~~~~~--~~~~lV~ 473 (717)
+|.+.+.||+|++|.||+|.... ++. +.||||+++++.+.+. ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47788999999999999998752 211 1199999999999988 8999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999999543 26899999999999999999999988 999999999999999999999999999876544
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
..........++..|+|||.+.+..++.++||||||+++++|++|+.||.... . ................+
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~---~~~~~~~~~~~~~~~~~---- 225 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--N---PMAALYKIGSSGEPPEI---- 225 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--c---hHHHHHhccccCCCcCC----
Confidence 32111234568899999999988889999999999999999999999987544 1 11111111111111111
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+......+.+++.+|++.+|++||++.++++
T Consensus 226 -----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 -----PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -----CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1111356778899999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=252.14 Aligned_cols=232 Identities=23% Similarity=0.257 Sum_probs=176.8
Q ss_pred HhcCcccc-cccccCCccceEeeeeCCchh-hh----------------------hhhhhhhcceeec----CceeeEEE
Q 039318 422 ATDNFSIN-KKLGEGGFGPVYKGTLADGQE-IA----------------------HRNLVKLLGCCIQ----GEEKLLIY 473 (717)
Q Consensus 422 ~~~~~~~~-~~lG~G~fg~Vy~~~~~~~~~-va----------------------h~niv~l~~~~~~----~~~~~lV~ 473 (717)
.+++|++. ++||-|--|.|-.+..+..++ .| |||||.+++++.. ...+++||
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 45677765 689999999999998765432 22 9999999998754 45678999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc---CCCCceeccccccccc
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD---HEMNPKISDFGLARTF 550 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~Dfgla~~~ 550 (717)
|+|+||.|.+.|.++ ....++++++-.|..||+.|+.|||+.+ |.||||||+|+|.. .+..+||+|||+|+..
T Consensus 139 E~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred ecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccccccc
Confidence 999999999999654 4456899999999999999999999998 99999999999995 4556899999999975
Q ss_pred cCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
.. .....+.+-|+.|.|||++....|+..+|+||+|||+|-||+|.+||--.+...- ..-....+..+. .++.
T Consensus 215 ~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spgMk~rI~~gq-y~FP 287 (400)
T KOG0604|consen 215 QE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKRRIRTGQ-YEFP 287 (400)
T ss_pred CC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---ChhHHhHhhccC-ccCC
Confidence 33 2334567899999999999999999999999999999999999999853332110 000011111110 0010
Q ss_pred chhhhccCCHHHH-HHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 631 DAYYQESCNLAEV-IRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 631 d~~~~~~~~~~~~-~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.....++ +...+++..+|..+|.+|.|+.+++..
T Consensus 288 ------~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 288 ------EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ------ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1112222 345678888999999999999999874
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=274.12 Aligned_cols=237 Identities=25% Similarity=0.340 Sum_probs=172.7
Q ss_pred hcCcccccccccCCccceEeeeeCC-chh----------------------------hhhhhhhhhcceeecC--ceeeE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQE----------------------------IAHRNLVKLLGCCIQG--EEKLL 471 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~----------------------------vah~niv~l~~~~~~~--~~~~l 471 (717)
.++|++.+.||+|+||.||+|+... ++. +.|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4689999999999999999998643 211 1299999999998755 56899
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++ +|.+++... ...+++..+..++.||++||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 788887432 356899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC---c
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP---S 627 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~ 627 (717)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .............. .
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWP 234 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhch
Confidence 3221 1122345788999998865 458899999999999999999999986433222 11111111110000 0
Q ss_pred ccc-----chh-hh--ccCCH-----HHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 628 QLI-----DAY-YQ--ESCNL-----AEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 628 ~l~-----d~~-~~--~~~~~-----~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+. ... .. ..... .....+.+++.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 000 00 00000 013456789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=279.53 Aligned_cols=220 Identities=24% Similarity=0.343 Sum_probs=181.7
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhhh----------------------------hhhhhhhcceeecCceeeEEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------------HRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va----------------------------h~niv~l~~~~~~~~~~~lV~ 473 (717)
...|.+.+.||+|.|+.|.+|++.. +.+|| ||||||++++......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 4578999999999999999998653 22222 999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+.+|.+.+++.++.. ..+.....++.|+.+|++|||+++ |||||||++||||+.+.++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999965443 444777788999999999999999 999999999999999999999999999987533
Q ss_pred ccccccceecccccccCccccccCCC-CccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
....+.+|++.|.|||++.+..| ++++|+||+|++||-|+.|..||+... +.++-+.
T Consensus 209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-------------------lk~Lr~r 266 (596)
T KOG0586|consen 209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-------------------LKELRPR 266 (596)
T ss_pred ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-------------------cccccch
Confidence 33457899999999999999886 489999999999999999999997422 2222233
Q ss_pred hhhcc--CCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 633 YYQES--CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 633 ~~~~~--~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+.+. .+.-...+|.+++.++|-.+|.+|++++++.+.
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 22222 222233467788999999999999999999874
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=277.15 Aligned_cols=234 Identities=24% Similarity=0.264 Sum_probs=172.5
Q ss_pred HhcCcccccccccCCccceEeeeeCCc-hh----------------------------hhhhhhhhhcceeecC------
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADG-QE----------------------------IAHRNLVKLLGCCIQG------ 466 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~----------------------------vah~niv~l~~~~~~~------ 466 (717)
..++|++.+.||+|+||.||+|..... +. +.||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999975421 11 1299999999987643
Q ss_pred ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccc
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGL 546 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgl 546 (717)
...++||||+++ +|.+.+.. .++...+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 357999999965 77777632 2788889999999999999999998 99999999999999999999999999
Q ss_pred cccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHh-----
Q 039318 547 ARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLW----- 621 (717)
Q Consensus 547 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~----- 621 (717)
++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||....... ........+
T Consensus 165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 238 (353)
T cd07850 165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID---QWNKIIEQLGTPSD 238 (353)
T ss_pred ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence 98653322 1223567899999999999999999999999999999999999986433211 111111100
Q ss_pred -------------hCCCC-------ccccchhh----hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 622 -------------NNGMP-------SQLIDAYY----QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 622 -------------~~~~~-------~~l~d~~~----~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
..... ..+..... ...........+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 00000000 000011223456789999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=269.63 Aligned_cols=225 Identities=25% Similarity=0.406 Sum_probs=171.7
Q ss_pred cCcccccccccCCccceEeeeeCC-chhh----------------------------hhhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEI----------------------------AHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v----------------------------ah~niv~l~~~~~~~~~~~lV~E 474 (717)
++|++.+.||+|+||.||+|+.+. ++.+ .||||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 578889999999999999998764 2111 18999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhc-CCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD-SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
|+++ +|.+++... ...+++..+..++.||++||+|||+. + |+||||+|+||++++++.+||+|||++..+...
T Consensus 95 ~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9864 777766442 23688999999999999999999974 6 999999999999999999999999999765332
Q ss_pred ccccccceecccccccCccccccCC----CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGL----FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
.. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... ...+ ....... ...+
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~---~~~~~~~-~~~~ 239 (296)
T cd06618 169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVL---TKILQEE-PPSL 239 (296)
T ss_pred Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHH---HHHhcCC-CCCC
Confidence 21 12235788999999987554 889999999999999999999998642211 1111 1111111 1111
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.. . .....++.+++.+||+.+|++||++.++++.
T Consensus 240 ~~-----~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 PP-----N--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC-----C--CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0 0122456788999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=266.73 Aligned_cols=230 Identities=24% Similarity=0.330 Sum_probs=175.7
Q ss_pred CcccccccccCCccceEeeeeCC----ch------------------------h------h-hhhhhhhhcceeecCcee
Q 039318 425 NFSINKKLGEGGFGPVYKGTLAD----GQ------------------------E------I-AHRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~----~~------------------------~------v-ah~niv~l~~~~~~~~~~ 469 (717)
+|++.+.||+|+||.||+++... +. + + .||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 47788999999999999987421 10 0 1 189999999999999999
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||+++++|.+++.. ...+++..+..++.|++++|.|||+.+ ++|+||||.||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999999843 345788899999999999999999988 99999999999999999999999999886
Q ss_pred ccCCccccccceecccccccCccccccCC--CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 550 FVGDEIEGSTKRVVGTYGYMAPEYASDGL--FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 550 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
....... ......|+..|+|||.+.+.. .+.++||||||+++|||++|+.||...........+ .........
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~--~~~~~~~~~-- 229 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI--SRRILKSKP-- 229 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH--HHHHHccCC--
Confidence 5433211 122356889999999987765 788999999999999999999998643222111111 111111100
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.. +......+.+++.+||+.+|++|||+.+|.+.|+..
T Consensus 230 -----~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 230 -----PF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -----CC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 00 111123466889999999999999999998888653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=261.18 Aligned_cols=224 Identities=24% Similarity=0.370 Sum_probs=175.0
Q ss_pred CcccccccccCCccceEeeeeCCc-hh----------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG-QE----------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~-~~----------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+|++.+.||+|+||.||++..+.. .. +.|+||+++++.+.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 578889999999999999987532 11 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC-ceeccccccccccCCc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN-PKISDFGLARTFVGDE 554 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~-~kl~Dfgla~~~~~~~ 554 (717)
+++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999985432 235789999999999999999999988 999999999999998864 6999999998654322
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
. ......|++.|+|||++.+..++.++|+||||++++||++|+.||...... . ...... ......+
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~---~~~~~~-~~~~~~~----- 222 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH---Q---LVLKIC-QGYFAPI----- 222 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---H---HHHHHh-cccCCCC-----
Confidence 1 122346889999999998888999999999999999999999998633211 1 111111 1111111
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.......+.+++.+|++.+|++|||+.+|++.
T Consensus 223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 ----SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11122357788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=270.39 Aligned_cols=230 Identities=26% Similarity=0.398 Sum_probs=179.9
Q ss_pred HHHhcCcccccccccCCccceEeeeeCC-ch-------------------------hhhhhhhhhhcceeecCceeeEEE
Q 039318 420 ANATDNFSINKKLGEGGFGPVYKGTLAD-GQ-------------------------EIAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 420 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~-------------------------~vah~niv~l~~~~~~~~~~~lV~ 473 (717)
....+.|+..+.||+|++|.||+|.... ++ .+.|+||+++++++...+..++|+
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 3456788999999999999999998762 11 112999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999995532 36899999999999999999999988 999999999999999999999999998755332
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
.. ......++..|+|||++.+..++.++|+||||+++|+|++|+.||........ . .... ......+.+
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~---~---~~~~-~~~~~~~~~-- 238 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA---L---FLIT-TKGIPPLKN-- 238 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH---H---HHHH-hcCCCCCcc--
Confidence 21 12234578899999999988899999999999999999999999864322211 1 1111 111111111
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.......+.+++.+||+.+|.+||++.+|++.
T Consensus 239 -----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 239 -----PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -----hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00012356788999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=279.14 Aligned_cols=237 Identities=22% Similarity=0.301 Sum_probs=171.8
Q ss_pred hcCcccccccccCCccceEeeeeCC-chh---------------------------hhhhhhhhhcceeecC-----cee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQE---------------------------IAHRNLVKLLGCCIQG-----EEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~---------------------------vah~niv~l~~~~~~~-----~~~ 469 (717)
+++|++.++||+|+||.||+|+... ++. +.||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 5789999999999999999997542 211 1299999999987654 357
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||+++ +|..++. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 7776662 335889999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCcccc-ccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 550 FVGDEIEG-STKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 550 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
........ ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... .........+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCHH
Confidence 53322111 1123568899999998754 56899999999999999999999998643211 1111111111111000
Q ss_pred c---ccchh---------hhccCCH-----HHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 628 Q---LIDAY---------YQESCNL-----AEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 628 ~---l~d~~---------~~~~~~~-----~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
. +.+.. .....+. .....+.+++.+||+.+|++||++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00000 0000011 113457799999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=277.62 Aligned_cols=235 Identities=23% Similarity=0.300 Sum_probs=173.1
Q ss_pred hcCcccccccccCCccceEeeeeCCc-h----------------------------hhhhhhhhhhcceeecC-----ce
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-Q----------------------------EIAHRNLVKLLGCCIQG-----EE 468 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~----------------------------~vah~niv~l~~~~~~~-----~~ 468 (717)
.++|.+.+.||+|+||.||+|+.... + .+.|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46799999999999999999975421 1 11299999999988654 35
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
.++||||+. ++|.+++.. ...+++..+..++.|+++||.|||+++ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 688888743 345899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC--
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM-- 625 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 625 (717)
...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .............
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~ 231 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEE 231 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChH
Confidence 654321 12234567899999998765 468999999999999999999999986432211 1111111111000
Q ss_pred ---------Ccccc-------chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 626 ---------PSQLI-------DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 626 ---------~~~l~-------d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
....+ +..... .......++.+++.+||+.+|++||+++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000 000000 001123457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=268.29 Aligned_cols=235 Identities=23% Similarity=0.341 Sum_probs=173.5
Q ss_pred cccccccccCCccceEeeeeCCc-h----------------------------hhhhhhhhhhcceeecC--ceeeEEEe
Q 039318 426 FSINKKLGEGGFGPVYKGTLADG-Q----------------------------EIAHRNLVKLLGCCIQG--EEKLLIYE 474 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~~-~----------------------------~vah~niv~l~~~~~~~--~~~~lV~E 474 (717)
|++.+.||+|+||.||+|+.... + .+.|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 56788999999999999986531 1 11299999999999988 89999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++ +|.+++... ...+++..++.++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9985 888888432 246889999999999999999999988 9999999999999999999999999998764432
Q ss_pred cccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC--------
Q 039318 555 IEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM-------- 625 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 625 (717)
.. ......++..|+|||.+.+ ..++.++||||||++++||++|+.||........ ............
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhccccc
Confidence 11 1223456788999997765 4578999999999999999999999865443221 111111111000
Q ss_pred ---------CccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 626 ---------PSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 626 ---------~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
........+.......+...+++++.+||+.+|.+||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000000001124567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=268.05 Aligned_cols=223 Identities=23% Similarity=0.353 Sum_probs=173.7
Q ss_pred CcccccccccCCccceEeeeeCCc-hh--------------------------hhhhhhhhhcceeecCceeeEEEeccC
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG-QE--------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~-~~--------------------------vah~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.|...+.||+|++|.||++..... +. +.||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 355567999999999999975421 11 129999999999999999999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 9999999844 35788999999999999999999998 99999999999999999999999999875433211
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhcc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 637 (717)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ..... .........+..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---~~~~~----~~~~~~~~~~~~------ 237 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAMK----RIRDNLPPKLKN------ 237 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---HHHHH----HHHhcCCCCCcc------
Confidence 12235688999999999988899999999999999999999999753221 11111 111111111110
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.......+.+++.+||+.+|++||++.++++.
T Consensus 238 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 238 -LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred -cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 01122467889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-30 Score=262.28 Aligned_cols=223 Identities=28% Similarity=0.391 Sum_probs=178.6
Q ss_pred CcccccccccCCccceEeeeeCCch-h----------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ-E----------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~-~----------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+|++.++||+|+||.||+++..... . +.|+||+++.+++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999998754221 1 1299999999999999999999999
Q ss_pred cCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 476 MPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 476 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
+++++|.+++.+.. ....+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999985532 2356788999999999999999999998 999999999999999999999999999876443
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
......++..|++||.+.+..++.++|+||||++++||++|+.||...... .. ...........+
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~----~~~~~~~~~~~~----- 221 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DL----RYKVQRGKYPPI----- 221 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH----HHHHhcCCCCCC-----
Confidence 122356788999999999999999999999999999999999998643321 11 111111111111
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 ----PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ----chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11233567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=269.06 Aligned_cols=229 Identities=27% Similarity=0.375 Sum_probs=170.3
Q ss_pred cCcccccccccCCccceEeeeeCCch-h---------------------------h-hhhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-E---------------------------I-AHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-~---------------------------v-ah~niv~l~~~~~~~~~~~lV~E 474 (717)
++|...+.||+|+||.||+++..... . + .|+||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35666789999999999998864321 1 1 18999999999999999999999
Q ss_pred ccCCCChhhHhhh--ccccccCChhhHHHHHHHHHHHHHHHhhc-CCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 475 FMPNRSLDSFIFD--QTKRKLLDWSKRFCIICGTARGLLYLHHD-SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 475 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
|++. +|.++... ......+++..+..++.++++||+|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9874 55444321 11235688999999999999999999975 5 9999999999999999999999999997653
Q ss_pred CCccccccceecccccccCccccccC---CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDG---LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
... ......|+..|+|||++.+. .++.++||||||+++|||++|+.||.... .......+... .....
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~~~~ 230 (288)
T cd06616 160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GDPPI 230 (288)
T ss_pred cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CCCCc
Confidence 321 11234688999999998776 68999999999999999999999986432 11111111111 11111
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+...........+.+++.+||+.+|++||++++|+..
T Consensus 231 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 -----LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -----CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111233467789999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=276.45 Aligned_cols=238 Identities=20% Similarity=0.306 Sum_probs=173.5
Q ss_pred hcCcccccccccCCccceEeeeeCC-chh----------------------------hhhhhhhhhcceeec----Ccee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQE----------------------------IAHRNLVKLLGCCIQ----GEEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~----------------------------vah~niv~l~~~~~~----~~~~ 469 (717)
.++|++.+.||+|+||.||+|.... ++. +.||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 4789999999999999999997643 111 129999999998753 3568
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||+. ++|.+++. ..+.+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 58888873 2345899999999999999999999988 99999999999999999999999999986
Q ss_pred ccCCcccc--ccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhC---
Q 039318 550 FVGDEIEG--STKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNN--- 623 (717)
Q Consensus 550 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--- 623 (717)
........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~---~~~~~~~~~g~~~~ 233 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH---QLKLILSVLGSPSE 233 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH---HHHHHHHHhCCChh
Confidence 54322111 1123578899999998865 458899999999999999999999986432211 11111111000
Q ss_pred --------CCCccccchh-hhccCC-----HHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 624 --------GMPSQLIDAY-YQESCN-----LAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 624 --------~~~~~l~d~~-~~~~~~-----~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.......+.. ...... ......+.+++.+||+.+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000 000111 1123567899999999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=258.75 Aligned_cols=224 Identities=31% Similarity=0.477 Sum_probs=177.3
Q ss_pred CcccccccccCCccceEeeeeCC-chh--------------------------hhhhhhhhhcceeecCceeeEEEeccC
Q 039318 425 NFSINKKLGEGGFGPVYKGTLAD-GQE--------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~--------------------------vah~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
+|+..+.||+|++|.||++.... ++. +.|+||+++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 47788999999999999998752 211 129999999999999999999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++.... ..+++..+..++.|++++|.|||..+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999985432 46899999999999999999999987 99999999999999999999999999987644321
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhcc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 637 (717)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......... . ........+...
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~----~~~~~~~~~~~~----- 220 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF---K----IATNGPPGLRNP----- 220 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH---H----HHhcCCCCcCcc-----
Confidence 235678899999999998889999999999999999999999986433211111 1 111111111110
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
......+.+++.+||+.+|++|||+.++++.
T Consensus 221 --~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 --EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred --cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0013457788999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-30 Score=266.96 Aligned_cols=234 Identities=24% Similarity=0.297 Sum_probs=174.6
Q ss_pred cccccccccCCccceEeeeeCCch-----------------------------hhhhhhhhhhcceeecCceeeEEEecc
Q 039318 426 FSINKKLGEGGFGPVYKGTLADGQ-----------------------------EIAHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~~~-----------------------------~vah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
|++.+.||+|++|.||+++...+. .+.|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999864321 112999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
++ +|.+++... ...+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 86 888877442 246899999999999999999999998 9999999999999999999999999998764432
Q ss_pred cccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC---Cccccc-
Q 039318 557 GSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM---PSQLID- 631 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~l~d- 631 (717)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...... ..+......+.... ...+.+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI---DQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCchHhcccchhh
Confidence 112234578899999998776 7899999999999999999999998643322 22211111111110 000000
Q ss_pred ----------hhhh--ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 632 ----------AYYQ--ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 632 ----------~~~~--~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.... .........++.+++.+||+.+|.+||++.+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 00011123567899999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=266.22 Aligned_cols=234 Identities=24% Similarity=0.343 Sum_probs=173.5
Q ss_pred cccccccccCCccceEeeeeCCch----------------------------hhh-hhhhhhhcceeecCceeeEEEecc
Q 039318 426 FSINKKLGEGGFGPVYKGTLADGQ----------------------------EIA-HRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~~~----------------------------~va-h~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
|.+.+.||+|++|.||+|+..+.. .+. |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999875321 112 999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
+++|.+++.... ...+++..+..++.|++.+|.|||+++ ++|+||||+||+++.++.++|+|||+++......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 789988885432 246799999999999999999999998 9999999999999999999999999998654321
Q ss_pred cccceecccccccCccccc-cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC---------
Q 039318 557 GSTKRVVGTYGYMAPEYAS-DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP--------- 626 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 626 (717)
......++..|+|||++. ...++.++|+||||++++||++|+.||......+... .....+.....
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY---KICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH---HHHHhcCCCChhhhhhHhhh
Confidence 122356788999999875 4557899999999999999999999986543222111 11110000000
Q ss_pred ccccchhhhcc--CCH-----HHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 627 SQLIDAYYQES--CNL-----AEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 627 ~~l~d~~~~~~--~~~-----~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
....+...... ... .....+.+++.+||+.+|++||+++|++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000000 000 113568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=268.32 Aligned_cols=235 Identities=23% Similarity=0.310 Sum_probs=171.2
Q ss_pred cccccccccCCccceEeeeeCC-ch----------------------------hhhhhhhhhhcceeecCceeeEEEecc
Q 039318 426 FSINKKLGEGGFGPVYKGTLAD-GQ----------------------------EIAHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~-~~----------------------------~vah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
|++.++||+|++|.||+|..+. +. .+.||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 5678899999999999997542 11 112999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
+ ++|.+++.... ...+++..+..++.|+++||+|||+++ ++|+||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 68998885432 235899999999999999999999987 99999999999999999999999999976432211
Q ss_pred cccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC---------C
Q 039318 557 GSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM---------P 626 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~ 626 (717)
......++..|+|||++.+. .++.++|+||||+++|+|++|+.||........ .....+...... .
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ---LFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhhhhhc
Confidence 11223568899999987664 578999999999999999999999864332211 111111100000 0
Q ss_pred ccccchhhh------ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 627 SQLIDAYYQ------ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 627 ~~l~d~~~~------~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+....... ..........+.+++.+||+.+|++||+++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000 00001112467789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=262.03 Aligned_cols=223 Identities=24% Similarity=0.350 Sum_probs=174.3
Q ss_pred CcccccccccCCccceEeeeeCCch--------------------------------hhhhhhhhhhcceeecCceeeEE
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ--------------------------------EIAHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~--------------------------------~vah~niv~l~~~~~~~~~~~lV 472 (717)
+|.+.++||+|+||.||+++..... .+.||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888899999999999998653210 01299999999999999999999
Q ss_pred EeccCCCChhhHhhhc-cccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 473 YEFMPNRSLDSFIFDQ-TKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
|||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++|+||||+||+++. +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988542 23456899999999999999999999988 999999999999975 569999999998654
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
.... ......+++.|+|||.+.+..++.++|+||||+++++|++|+.||.... . ........ .+....
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~---~---~~~~~~~~-~~~~~~--- 224 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN---F---LSVVLRIV-EGPTPS--- 224 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---H---HHHHHHHH-cCCCCC---
Confidence 3321 1224568889999999988889999999999999999999999985321 1 11111111 111111
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.+......+.+++.+||+.+|++||++.|+++
T Consensus 225 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 ------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11122346678999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=276.76 Aligned_cols=241 Identities=26% Similarity=0.360 Sum_probs=174.0
Q ss_pred HhcCcccccccccCCccceEeeeeCCch-----------------------------hh-hhhhhhhhcceeecC--cee
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQ-----------------------------EI-AHRNLVKLLGCCIQG--EEK 469 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-----------------------------~v-ah~niv~l~~~~~~~--~~~ 469 (717)
..++|++.+.||+|+||.||+|....+. .+ .||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3568999999999999999999764311 12 499999999988653 468
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||+++ +|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~~-~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYMET-DLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEeccccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 999999984 88888733 26788889999999999999999988 99999999999999999999999999986
Q ss_pred ccCCccc---cccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHH-------
Q 039318 550 FVGDEIE---GSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAW------- 618 (717)
Q Consensus 550 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~------- 618 (717)
....... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 5433211 12234578999999998765 457899999999999999999999986433222111110000
Q ss_pred -HHhhCCCCccccchhhh-ccCCHH-----HHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 619 -KLWNNGMPSQLIDAYYQ-ESCNLA-----EVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 619 -~~~~~~~~~~l~d~~~~-~~~~~~-----~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
..+.......+++.... ...... ....+.+++.+||+.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000011110000 000011 23467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-30 Score=271.27 Aligned_cols=221 Identities=27% Similarity=0.389 Sum_probs=170.8
Q ss_pred hcCcccccccccCCccceEeeeeCC-chh-----------------------------hhhhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQE-----------------------------IAHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~-----------------------------vah~niv~l~~~~~~~~~~~lV 472 (717)
.+.|++.+.||+|+||.||+|+... ++. +.||||+++.+++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 3568889999999999999997642 111 1299999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 466666633 2345899999999999999999999988 99999999999999999999999999876432
Q ss_pred CccccccceecccccccCccccc---cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYAS---DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
. ....++..|+|||++. ...++.++||||||+++|||++|+.||...... ... .... ......+
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~---~~~---~~~~-~~~~~~~ 234 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SAL---YHIA-QNDSPTL 234 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH---HHH---HHHh-cCCCCCC
Confidence 2 2356788999999874 456889999999999999999999997532211 111 1111 1111111
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
. .......+.+++.+||+.+|++||++.+|+..
T Consensus 235 ~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 235 S--------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred C--------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 11123457888999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=265.66 Aligned_cols=233 Identities=23% Similarity=0.346 Sum_probs=173.7
Q ss_pred cccccccccCCccceEeeeeCC-chhh-------------------------------hhhhhhhhcceeecCce-----
Q 039318 426 FSINKKLGEGGFGPVYKGTLAD-GQEI-------------------------------AHRNLVKLLGCCIQGEE----- 468 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~-~~~v-------------------------------ah~niv~l~~~~~~~~~----- 468 (717)
|++.+.||+|+||.||+|+.+. ++.+ .|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999998753 2111 18999999999988776
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
.+++|||+++ +|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 7888885432 235899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC---
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM--- 625 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 625 (717)
....... .....++..|+|||++.+..++.++|+||||+++|||++|+.||......+. +...........
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---LDKIFDVIGLPSEEE 229 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---HHHHHHHcCCCChHh
Confidence 7643321 1234578899999999999999999999999999999999999875433221 111111110000
Q ss_pred -C------ccccchhhh---ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 626 -P------SQLIDAYYQ---ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 626 -~------~~l~d~~~~---~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
. ......... ..........+.+++.+||+.+|.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 000000000 0001122356678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=263.63 Aligned_cols=221 Identities=26% Similarity=0.323 Sum_probs=172.0
Q ss_pred cccCCccceEeeeeCC-chh-----------------------------hhhhhhhhhcceeecCceeeEEEeccCCCCh
Q 039318 432 LGEGGFGPVYKGTLAD-GQE-----------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSL 481 (717)
Q Consensus 432 lG~G~fg~Vy~~~~~~-~~~-----------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~gsL 481 (717)
||+|+||.||+++... ++. +.||||+++++.+..++..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999998764 211 1299999999999999999999999999999
Q ss_pred hhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc------
Q 039318 482 DSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI------ 555 (717)
Q Consensus 482 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~------ 555 (717)
.+++.+. ..+++..+..++.||++||+|||+++ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9999543 36899999999999999999999998 99999999999999999999999999886433211
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
........++..|+|||.+.....+.++||||||+++|+|++|+.||......+. . .....+... . .
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~----~~~~~~~~~-~-----~ 221 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI---F----QNILNGKIE-W-----P 221 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---H----HHHhcCCcC-C-----C
Confidence 1122335678899999999888899999999999999999999999864432211 1 111111110 0 0
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 222 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 222 --EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred --ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 000013456789999999999999999777777754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-30 Score=266.57 Aligned_cols=223 Identities=26% Similarity=0.335 Sum_probs=176.6
Q ss_pred cCcccccccccCCccceEeeeeCC-ch-----------------------------hhh-hhhhhhhcceeecCceeeEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQ-----------------------------EIA-HRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~-----------------------------~va-h~niv~l~~~~~~~~~~~lV 472 (717)
++|.+.+.||+|+||.||+++... ++ .+. ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 478899999999999999998642 11 122 99999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999954 336899999999999999999999988 99999999999999999999999999986543
Q ss_pred Cccc------------------cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHH
Q 039318 553 DEIE------------------GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLI 614 (717)
Q Consensus 553 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~ 614 (717)
.... .......++..|+|||.+.+..++.++|+||||+++++|++|+.||..... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~ 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTF 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHH
Confidence 3211 222345678999999999888899999999999999999999999874331 1111
Q ss_pred HHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCCh----HHHHH
Q 039318 615 GHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCM----PSVIL 669 (717)
Q Consensus 615 ~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~----~evl~ 669 (717)
.... ... ...+......+.+++.+||+.+|.+||++ +++++
T Consensus 232 ---~~~~-~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 ---QKIL-KLE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---HHHH-hcC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111 000 00111113457789999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=263.30 Aligned_cols=216 Identities=26% Similarity=0.332 Sum_probs=169.2
Q ss_pred cccCCccceEeeeeCCc-hh-----------------------------hhhhhhhhhcceeecCceeeEEEeccCCCCh
Q 039318 432 LGEGGFGPVYKGTLADG-QE-----------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSL 481 (717)
Q Consensus 432 lG~G~fg~Vy~~~~~~~-~~-----------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~gsL 481 (717)
||.|+||.||+++.... +. +.||||+++++.+.+++..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 79999999999987631 11 1299999999999999999999999999999
Q ss_pred hhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccce
Q 039318 482 DSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561 (717)
Q Consensus 482 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 561 (717)
.+++.+ ...+++..+..++.||++||.|||+++ ++|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999944 235888999999999999999999988 9999999999999999999999999998764332 1223
Q ss_pred ecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHH
Q 039318 562 VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLA 641 (717)
Q Consensus 562 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~ 641 (717)
..++..|++||.+.+..++.++|+||||+++|+|++|+.||.....+ ..... ......... ...+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~---~~~~~~~~~---------~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PMEIY---NDILKGNGK---------LEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HHHHH---HHHhccCCC---------CCCCcc
Confidence 56889999999998888999999999999999999999998754321 11111 111110100 011111
Q ss_pred HHHHHHHHHhhccccCCCCCCC-----hHHHHH
Q 039318 642 EVIRCIHVGLLCVQHHPEDRPC-----MPSVIL 669 (717)
Q Consensus 642 ~~~~~~~l~~~Cl~~dp~~RPs-----~~evl~ 669 (717)
....+.+++.+||+.+|++||+ +.|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1346788999999999999999 556554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-30 Score=271.44 Aligned_cols=224 Identities=29% Similarity=0.405 Sum_probs=171.8
Q ss_pred CcccccccccCCccceEeeeeCCch-h-----------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ-E-----------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~-~-----------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
.|+..+.||+|+||.||+++..... . +.|||++++++++.+++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4777889999999999999754211 1 129999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++ +|.+++... ...+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9975 777766432 345889999999999999999999998 99999999999999999999999999875432
Q ss_pred cccccceecccccccCccccc---cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 555 IEGSTKRVVGTYGYMAPEYAS---DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
.....+++.|+|||++. ...++.++|||||||++|||++|+.||...... ..+ .......... .
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~---~~~~~~~~~~-~-- 244 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SAL---YHIAQNESPT-L-- 244 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHH---HHHHhccCCC-C--
Confidence 22356888999999873 456899999999999999999999997532111 111 1111111110 0
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
. .......+.+++.+||+.+|.+||++.+|++.+-...
T Consensus 245 ---~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 245 ---Q---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ---C---CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0 1112234678899999999999999999998764443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=264.03 Aligned_cols=218 Identities=26% Similarity=0.334 Sum_probs=166.9
Q ss_pred cccCCccceEeeeeCCch-h-----------------------------hhhhhhhhhcceeecCceeeEEEeccCCCCh
Q 039318 432 LGEGGFGPVYKGTLADGQ-E-----------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSL 481 (717)
Q Consensus 432 lG~G~fg~Vy~~~~~~~~-~-----------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~gsL 481 (717)
||+|+||.||++...... . +.||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999998754211 1 1299999999999999999999999999999
Q ss_pred hhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccce
Q 039318 482 DSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561 (717)
Q Consensus 482 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 561 (717)
.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 999865332 35889999999999999999999998 9999999999999999999999999987653311 1223
Q ss_pred ecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHH
Q 039318 562 VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLA 641 (717)
Q Consensus 562 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~ 641 (717)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+... ... .... .+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~-~~~~---------~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR---TLE-MAVE---------YPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc---ccc-cccc---------CCcc
Confidence 46788999999998888999999999999999999999998654332211111110 000 0000 0111
Q ss_pred HHHHHHHHHhhccccCCCCCC-----ChHHHHH
Q 039318 642 EVIRCIHVGLLCVQHHPEDRP-----CMPSVIL 669 (717)
Q Consensus 642 ~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~ 669 (717)
....+.+++.+||+.+|++|| ++.+++.
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 133567889999999999999 5555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=264.50 Aligned_cols=225 Identities=24% Similarity=0.309 Sum_probs=169.8
Q ss_pred CcccccccccCCccceEeeeeC----Cchhh-------------------------------hhhhhhhhcceeecCcee
Q 039318 425 NFSINKKLGEGGFGPVYKGTLA----DGQEI-------------------------------AHRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~----~~~~v-------------------------------ah~niv~l~~~~~~~~~~ 469 (717)
+|++.+.||+|+||.||+++.. ++..+ .|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788899999999999998753 12111 189999999999999999
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999854 345788888999999999999999988 99999999999999999999999999986
Q ss_pred ccCCccccccceecccccccCccccccC--CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 550 FVGDEIEGSTKRVVGTYGYMAPEYASDG--LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 550 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
....... ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||...........+ ..........
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~--~~~~~~~~~~- 230 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSEPP- 230 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHH--HHHhhccCCC-
Confidence 5432211 12245688999999998753 4688999999999999999999998643222111111 1111111100
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHH
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP-----CMPSVIL 669 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~ 669 (717)
.+......+.+++.+||+.+|++|| ++.+++.
T Consensus 231 ----------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 231 ----------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0111223556888999999999997 5566554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=266.45 Aligned_cols=237 Identities=22% Similarity=0.288 Sum_probs=170.5
Q ss_pred cCcccccccccCCccceEeeeeCC-chh----------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQE----------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~----------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
++|++.+.||+|++|.||+|+... ++. +.||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 578999999999999999998652 211 129999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC-CCCceeccccccccccCC
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH-EMNPKISDFGLARTFVGD 553 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~Dfgla~~~~~~ 553 (717)
|++ ++|.+++... ....+++..+..++.||+.||+|||+++ |+|+||||+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 4777777432 2223577788889999999999999988 999999999999985 557999999999764322
Q ss_pred ccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc-----
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS----- 627 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 627 (717)
. .......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...... ..+......+......
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI---DELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChhhcccc
Confidence 1 11123467889999998866 45789999999999999999999998643222 1111111111111000
Q ss_pred -cccch---hh--h----ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 628 -QLIDA---YY--Q----ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 628 -~l~d~---~~--~----~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+.+. .. . .........++.+++.+||+.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00 0 00001112456789999999999999999999873
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=268.58 Aligned_cols=239 Identities=24% Similarity=0.326 Sum_probs=173.4
Q ss_pred HHhcCcccccccccCCccceEeeeeCCc-hh----------------------------hhhhhhhhhcceeecCc----
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADG-QE----------------------------IAHRNLVKLLGCCIQGE---- 467 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~----------------------------vah~niv~l~~~~~~~~---- 467 (717)
...++|++.+.||+|+||.||+|..+.. +. +.||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4567899999999999999999987532 11 12999999999887655
Q ss_pred ------eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCcee
Q 039318 468 ------EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKI 541 (717)
Q Consensus 468 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl 541 (717)
..++||||+++ +|..++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999987 666666332 345889999999999999999999998 999999999999999999999
Q ss_pred ccccccccccCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHH
Q 039318 542 SDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKL 620 (717)
Q Consensus 542 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 620 (717)
+|||++........ .......++..|+|||.+.+ ..++.++|||||||+++||++|++||...... ..+....+.
T Consensus 158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~ 233 (302)
T cd07864 158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRL 233 (302)
T ss_pred CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHH
Confidence 99999986543321 11122346788999998765 45789999999999999999999998643322 122112221
Q ss_pred hhCCCCcc---cc--------ch------hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 621 WNNGMPSQ---LI--------DA------YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 621 ~~~~~~~~---l~--------d~------~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
........ +. +. ....... .....+.+++.+||+.+|.+||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111000 00 00 0000000 012457889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=250.28 Aligned_cols=225 Identities=24% Similarity=0.379 Sum_probs=170.3
Q ss_pred CcccccccccCCccceEeeeeCCchhh-h----------------------------hhhhhhhcceeecCceeeEEEec
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQEI-A----------------------------HRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~~v-a----------------------------h~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+.+.+..||.|+.|.|++++.+....+ | +|.||+.+|+|......++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 344557899999999999987652211 1 69999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
|. ..++.++.+ ..+++++...-++...+++||.||.++. .|+|||+||+|||||+.|++||+|||++..+.....
T Consensus 173 Ms-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 173 MS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 84 356666643 2345788877889999999999999876 599999999999999999999999999987654322
Q ss_pred ccccceecccccccCcccccc---CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 556 EGSTKRVVGTYGYMAPEYASD---GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
.....|.+.|||||-+.- ..|+.++||||||+.|+||.||+.||..-..+ +..+.. .+. ..+ ..++.
T Consensus 248 ---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltk---vln-~eP-P~L~~ 317 (391)
T KOG0983|consen 248 ---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTK---VLN-EEP-PLLPG 317 (391)
T ss_pred ---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHH---HHh-cCC-CCCCc
Confidence 235679999999998853 45889999999999999999999998753322 222221 121 222 22222
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
... -....++++..||++|+.+||...++++.
T Consensus 318 ~~g------FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 318 HMG------FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ccC------cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 221 12235567778999999999999999874
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=271.55 Aligned_cols=225 Identities=27% Similarity=0.449 Sum_probs=181.0
Q ss_pred CcccccccccCCccceEeeeeCC---chhhh-----------------------------hhhhhhhcceeecCceeeEE
Q 039318 425 NFSINKKLGEGGFGPVYKGTLAD---GQEIA-----------------------------HRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~---~~~va-----------------------------h~niv~l~~~~~~~~~~~lV 472 (717)
.....++||+|-||.||+|.+.+ +..+| |||||+++|+|.+ ...+||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 44556789999999999998643 33322 9999999999975 578999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
||.++-|.|.+|+.. +...|+......++.||+.||+|||+.. +|||||...|||+...-.+||+|||+++.+..
T Consensus 469 mEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 469 MELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999954 3445888999999999999999999997 99999999999999999999999999998766
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
+..-... ...-.+-|||||.+.-..++.+||||.|||++||++. |..||......+... .++
T Consensus 544 ~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~----------------~iE 606 (974)
T KOG4257|consen 544 DAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG----------------HIE 606 (974)
T ss_pred cchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE----------------Eec
Confidence 5443222 3445678999999999999999999999999999977 999987543332211 111
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
...+-+.++.....+..|+.+||..+|.+||...|+...|+
T Consensus 607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 12223345556667788999999999999999888777653
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=267.88 Aligned_cols=238 Identities=24% Similarity=0.334 Sum_probs=170.6
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hh----------------------------hhhhhhhhhcceeecCc------
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QE----------------------------IAHRNLVKLLGCCIQGE------ 467 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~----------------------------vah~niv~l~~~~~~~~------ 467 (717)
.++|++.++||+|+||.||+|+.... +. +.||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999986432 11 12999999999875443
Q ss_pred --eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 468 --EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 468 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
..++||||+.+ +|...+.. ....+++..+..++.||++||.|||+++ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999976 56666633 2346899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCccc---------cccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHH
Q 039318 546 LARTFVGDEIE---------GSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIG 615 (717)
Q Consensus 546 la~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~ 615 (717)
+++........ .......+++.|+|||.+.+. .++.++||||||+++|||++|++||..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~--- 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH--- 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH---
Confidence 99865332211 111234678889999987654 58899999999999999999999986433322111
Q ss_pred HHHHHhhCCCC---------ccccchh--hhccCCH-----HHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 616 HAWKLWNNGMP---------SQLIDAY--YQESCNL-----AEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 616 ~~~~~~~~~~~---------~~l~d~~--~~~~~~~-----~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
........... ....+.. ....... .....+.+++.+||+.+|.+|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11111111000 0000000 0000001 11246789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=282.15 Aligned_cols=238 Identities=27% Similarity=0.426 Sum_probs=193.2
Q ss_pred cccHHHHHHHhcCcccccccccCCccceEeeeeCCchhhh---------------------------hhhhhhhcceeec
Q 039318 413 LFELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA---------------------------HRNLVKLLGCCIQ 465 (717)
Q Consensus 413 ~~~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va---------------------------h~niv~l~~~~~~ 465 (717)
.+.+..+...++.|++.+.||.|.+|.||+++.++..+++ |||++.+++++..
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3455556667889999999999999999999876543332 9999999999864
Q ss_pred -----CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCce
Q 039318 466 -----GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPK 540 (717)
Q Consensus 466 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~k 540 (717)
++.++||||||.+|+..+++..-. ...+.|..+..|++.++.||.+||.+. ++|||||=.||||..++.+|
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 578999999999999999997655 667899999999999999999999987 99999999999999999999
Q ss_pred eccccccccccCCccccccceecccccccCccccccC-----CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHH
Q 039318 541 ISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDG-----LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIG 615 (717)
Q Consensus 541 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~ 615 (717)
|+|||++..+.. +....++..||+.|||||++... .|+..+|+||||++..||..|.+|+...++...+.++
T Consensus 164 LvDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I- 240 (953)
T KOG0587|consen 164 LVDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI- 240 (953)
T ss_pred Eeeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC-
Confidence 999999987643 33445678999999999999653 3778999999999999999999998876665543332
Q ss_pred HHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 616 HAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 616 ~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
. ...+..+. .+-.=..++.+++..||.+|-++||++.++++.
T Consensus 241 -----p-RNPPPkLk-------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 -----P-RNPPPKLK-------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -----C-CCCCcccc-------chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1 11111111 122334577889999999999999999888763
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=261.44 Aligned_cols=232 Identities=27% Similarity=0.373 Sum_probs=174.1
Q ss_pred HhcCcccccccccCCccceEeeeeCCch----------------------------------hhhhhhhhhhcceee-cC
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQ----------------------------------EIAHRNLVKLLGCCI-QG 466 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----------------------------------~vah~niv~l~~~~~-~~ 466 (717)
..++|-++..||+|||+.||||.+-..+ ++.||.||++|+++. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3568889999999999999998643221 122999999999986 55
Q ss_pred ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC---CCCceecc
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH---EMNPKISD 543 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~D 543 (717)
+..|-|+|||+|.+|+-|+.. .+.++++++..|+.||+.||.||.+.. .+|||-||||.||||-. -|.+||.|
T Consensus 541 dsFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 678899999999999999944 456899999999999999999999985 68999999999999954 47899999
Q ss_pred ccccccccCCcccc-----ccceecccccccCccccccC----CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHH
Q 039318 544 FGLARTFVGDEIEG-----STKRVVGTYGYMAPEYASDG----LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLI 614 (717)
Q Consensus 544 fgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~ 614 (717)
|||++++..+.... .+....||..|++||.+.-+ .++.|+||||+|||+|.++.|++||+........ +
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI--L 694 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI--L 694 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH--H
Confidence 99999987654331 23457899999999977433 4789999999999999999999999853322111 1
Q ss_pred HHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHH
Q 039318 615 GHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVI 668 (717)
Q Consensus 615 ~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl 668 (717)
....+++...+. -+..+.-..+...++.+||+..-++|....++.
T Consensus 695 -qeNTIlkAtEVq--------FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 695 -QENTILKATEVQ--------FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -hhhchhcceecc--------CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111111111111 111112233566788999999999998655543
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=269.43 Aligned_cols=235 Identities=22% Similarity=0.311 Sum_probs=167.6
Q ss_pred cccccC--CccceEeeeeCC-chh----------------------------hhhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEG--GFGPVYKGTLAD-GQE----------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G--~fg~Vy~~~~~~-~~~----------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
..||+| +||+||+++... ++. +.||||+++++++..++..++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467777 899999998642 211 1299999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc-
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG- 557 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 557 (717)
++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999985532 234788888999999999999999988 9999999999999999999999998654332211100
Q ss_pred ----ccceecccccccCccccccC--CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHH-------------
Q 039318 558 ----STKRVVGTYGYMAPEYASDG--LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAW------------- 618 (717)
Q Consensus 558 ----~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~------------- 618 (717)
......++..|+|||++.+. .++.++|||||||++|||++|+.||........ ......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccc
Confidence 01112345679999998764 478999999999999999999999864322110 000000
Q ss_pred ---HHh----------------hCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 619 ---KLW----------------NNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 619 ---~~~----------------~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
..+ .......+.+..+...........+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 0000001111111111222344568899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=255.87 Aligned_cols=225 Identities=24% Similarity=0.339 Sum_probs=178.9
Q ss_pred CcccccccccCCccceEeeeeCCc-h----------------------------hhhhhhhhhhcceeecCceeeEEEec
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG-Q----------------------------EIAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~-~----------------------------~vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+|.+.+.||+|+||.||++..... + .+.|||++++.+.+...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 578889999999999999987521 1 11299999999999999999999999
Q ss_pred cCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 476 MPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 476 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
+++++|.+++.... ....+++..+..++.++++||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999995532 2357899999999999999999999998 9999999999999999999999999998754332
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
.......|++.|+|||.+.+..++.++|+||+|+++++|++|+.||...... . ............+.
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~----~~~~~~~~~~~~~~---- 224 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---E----LALKILKGQYPPIP---- 224 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---H----HHHHHhcCCCCCCC----
Confidence 1223457889999999999889999999999999999999999998643211 1 11111111111111
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
......+.+++.+||+.+|++||++.++++.
T Consensus 225 -----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 225 -----SQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1122456788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=287.37 Aligned_cols=181 Identities=27% Similarity=0.399 Sum_probs=132.2
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
+||-||||+..+|.+++.+..... .....++++++|++||+|+|+++ ||||||||.||+|+++..|||+|||+|.
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt 745 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLAT 745 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccch
Confidence 468899999988888885432211 35677889999999999999999 9999999999999999999999999998
Q ss_pred ccc----------------CCccccccceecccccccCccccccCC---CCccccchhHhHHHHHhhcCCCCCCCCCCCC
Q 039318 549 TFV----------------GDEIEGSTKRVVGTYGYMAPEYASDGL---FSVKSDVFSFGILLLEIVSGKKNRGFYHSDK 609 (717)
Q Consensus 549 ~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~elltG~~p~~~~~~~~ 609 (717)
... ........+..+||.-|+|||++.+.. |+.|+|+|||||||+||+. ||. ...+
T Consensus 746 ~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~--TsME 820 (1351)
T KOG1035|consen 746 DLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFG--TSME 820 (1351)
T ss_pred hhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCC--chHH
Confidence 721 001111334579999999999997655 9999999999999999985 333 2222
Q ss_pred chhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 610 NLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
....+ ..++.+.+... ..+...+...-..++.|++++||.+|||+.|++.
T Consensus 821 Ra~iL----~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 821 RASIL----TNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHH----HhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 22222 12222222211 1122233344457889999999999999999876
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=272.29 Aligned_cols=240 Identities=25% Similarity=0.323 Sum_probs=177.0
Q ss_pred CcccccccccCCccceEeeeeCC-chh----------------------------hhhhhhhhhcceeecCc-----eee
Q 039318 425 NFSINKKLGEGGFGPVYKGTLAD-GQE----------------------------IAHRNLVKLLGCCIQGE-----EKL 470 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~----------------------------vah~niv~l~~~~~~~~-----~~~ 470 (717)
+|++.++||+|+||.||+|+... ++. +.|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58889999999999999998653 211 12999999999988775 789
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
+||||+++ +|.+++.. ...+++..+..++.||++||+|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 78888843 337899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCccc-cccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC---
Q 039318 551 VGDEIE-GSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM--- 625 (717)
Q Consensus 551 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 625 (717)
...... .......++..|+|||++.+. .++.++|+||||+++|+|++|+.||......+... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN---LIVEVLGTPSEED 230 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHH---HHHHhcCCCChhH
Confidence 443210 112335678899999999887 78999999999999999999999986544322111 1111110000
Q ss_pred --------Cccccchhh-hccCC-----HHHHHHHHHHHhhccccCCCCCCChHHHHHH--hcCC
Q 039318 626 --------PSQLIDAYY-QESCN-----LAEVIRCIHVGLLCVQHHPEDRPCMPSVILM--LGSE 674 (717)
Q Consensus 626 --------~~~l~d~~~-~~~~~-----~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~--L~~~ 674 (717)
....+.... ....+ ......+.+++.+||+.+|.+||++.++++. +++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 000000000 00000 1123456789999999999999999999984 4443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=274.32 Aligned_cols=235 Identities=21% Similarity=0.309 Sum_probs=170.3
Q ss_pred hcCcccccccccCCccceEeeeeCC-chh----------------------------hhhhhhhhhcceeecCc------
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQE----------------------------IAHRNLVKLLGCCIQGE------ 467 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~----------------------------vah~niv~l~~~~~~~~------ 467 (717)
.++|.+.+.||+|+||.||+|+... ++. +.||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 4789999999999999999997542 211 12999999999987543
Q ss_pred eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla 547 (717)
..++||||+.. +|..++ ...+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999974 666554 234788999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC
Q 039318 548 RTFVGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (717)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+........ ...
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~-~~~ 235 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTG-VPG 235 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcC-CCC
Confidence 864221 223567889999999876 468899999999999999999999987432211 1111111000 000
Q ss_pred ccccchh-----------hh--ccCCH-----HHHHHHHHHHhhccccCCCCCCChHHHHHH--hcCCC
Q 039318 627 SQLIDAY-----------YQ--ESCNL-----AEVIRCIHVGLLCVQHHPEDRPCMPSVILM--LGSEI 675 (717)
Q Consensus 627 ~~l~d~~-----------~~--~~~~~-----~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~--L~~~~ 675 (717)
..+.+.. .. ..... .....+.+++.+||+.||++||++.+++.. ++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000000 00 00000 112357789999999999999999999964 55543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=265.27 Aligned_cols=219 Identities=24% Similarity=0.371 Sum_probs=170.1
Q ss_pred ccccccCCccceEeeeeCC-chh--------------------------hhhhhhhhhcceeecCceeeEEEeccCCCCh
Q 039318 429 NKKLGEGGFGPVYKGTLAD-GQE--------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSL 481 (717)
Q Consensus 429 ~~~lG~G~fg~Vy~~~~~~-~~~--------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~gsL 481 (717)
..+||+|+||.||++.... ++. +.|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 3589999999999997643 211 1299999999999999999999999999999
Q ss_pred hhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccce
Q 039318 482 DSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561 (717)
Q Consensus 482 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 561 (717)
.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++....... .....
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~ 175 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS 175 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccc
Confidence 988732 24788999999999999999999998 9999999999999999999999999987654322 11233
Q ss_pred ecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHH
Q 039318 562 VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLA 641 (717)
Q Consensus 562 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~ 641 (717)
..++..|+|||.+.+..++.++|+||||+++|||++|+.||....... ... .........+ .. ...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~----~~~~~~~~~~-----~~--~~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMK----MIRDNLPPKL-----KN--LHK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhhCCccc-----CC--ccc
Confidence 568899999999988889999999999999999999999986432211 111 1111111110 00 001
Q ss_pred HHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 642 EVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 642 ~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
....+.+++.+||+.+|.+||++.++++.
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 12345678899999999999999998883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=269.49 Aligned_cols=235 Identities=24% Similarity=0.313 Sum_probs=168.7
Q ss_pred CcccccccccCCccceEeeeeCCc---hhh-----------------------------hhhhhhhhcceeecC----ce
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG---QEI-----------------------------AHRNLVKLLGCCIQG----EE 468 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~---~~v-----------------------------ah~niv~l~~~~~~~----~~ 468 (717)
+|++.+.||+|+||.||+++.... ..+ .||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 478889999999999999987543 111 199999999875432 45
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
.+++|||+. ++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 789999986 58888883 3446889999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCccc--cccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhC--
Q 039318 549 TFVGDEIE--GSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNN-- 623 (717)
Q Consensus 549 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-- 623 (717)
........ .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||....... ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 230 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPD 230 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCC
Confidence 65432211 11223578999999998765 468999999999999999999999986533211 11111111000
Q ss_pred ---------CCCccccchh-hhccCCHH-----HHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 624 ---------GMPSQLIDAY-YQESCNLA-----EVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 624 ---------~~~~~l~d~~-~~~~~~~~-----~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.......... ........ ....+.+++.+||+.+|.+|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 00000011 1245778999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=275.78 Aligned_cols=223 Identities=27% Similarity=0.405 Sum_probs=178.7
Q ss_pred cccccccccCCccceEeeeeCC--chh-----------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 426 FSINKKLGEGGFGPVYKGTLAD--GQE-----------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~--~~~-----------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
..+.++||+|.||+|++|.+.. |+. +.|||+++|||+..+ ....+|||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 3456799999999999998753 211 119999999999987 78899999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
.++.|+|.+.|++ ..+..+.......++.|||.||.||.++. +|||||...||||.....+||+||||.+.+...+
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999977 55667888889999999999999999998 9999999999999999999999999999775443
Q ss_pred cc-cccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 555 IE-GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 555 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
.. .......-...|.|||.++...|+.++|||+|||.||||++ |+.||-...... + .+.+|.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q---I-------------L~~iD~ 330 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ---I-------------LKNIDA 330 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH---H-------------HHhccc
Confidence 21 22222334568999999999999999999999999999999 888876432211 1 112222
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
...-..+....++++++++.||.++|++||++..+.+
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 2222334456678999999999999999999999974
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=256.80 Aligned_cols=256 Identities=23% Similarity=0.310 Sum_probs=191.9
Q ss_pred CCCCCcccHHHHHHHhcCcccccccccCCccceEeeeeCCchhh-------------------------hhhhhhhhcce
Q 039318 408 DLELPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEI-------------------------AHRNLVKLLGC 462 (717)
Q Consensus 408 ~~~~~~~~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~v-------------------------ah~niv~l~~~ 462 (717)
...+|++-..+|+ ++..+.+.||+|.||+||+|+++.. .| .|+||+.+++.
T Consensus 198 GSGlplLVQRTia---rqI~L~e~IGkGRyGEVwrG~wrGe-~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaa 273 (513)
T KOG2052|consen 198 GSGLPLLVQRTIA---RQIVLQEIIGKGRFGEVWRGRWRGE-DVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAA 273 (513)
T ss_pred CCCchhHhHHhhh---heeEEEEEecCccccceeeccccCC-ceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhc
Confidence 4567777766654 5888999999999999999998743 22 29999999988
Q ss_pred eecCc----eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhh-----cCCCcEEeccCCCCceEE
Q 039318 463 CIQGE----EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHH-----DSRLRIIHRDLKASNVLL 533 (717)
Q Consensus 463 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-----~~~~~ivHrDlkp~NIll 533 (717)
-..++ +++||++|.+.|||.+||. +..++.+..++++..+|.||++||. ++++.|.|||||..|||+
T Consensus 274 D~~~~gs~TQLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV 349 (513)
T KOG2052|consen 274 DNKDNGSWTQLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 349 (513)
T ss_pred cccCCCceEEEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE
Confidence 66543 6799999999999999993 3568999999999999999999995 467889999999999999
Q ss_pred cCCCCceeccccccccccCC--ccccccceecccccccCccccccCC----CC--ccccchhHhHHHHHhhcC-------
Q 039318 534 DHEMNPKISDFGLARTFVGD--EIEGSTKRVVGTYGYMAPEYASDGL----FS--VKSDVFSFGILLLEIVSG------- 598 (717)
Q Consensus 534 ~~~~~~kl~Dfgla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~~--~~sDvwSlG~il~elltG------- 598 (717)
.+++...|+|+|||...... ......+..+||..|||||++...- |. ..+||||||.|++|+.-.
T Consensus 350 Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ 429 (513)
T KOG2052|consen 350 KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIV 429 (513)
T ss_pred ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEe
Confidence 99999999999999876543 3344556789999999999986532 11 358999999999998642
Q ss_pred ---CCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 599 ---KKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 599 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
+.||-...+.+. -.....+..--++.+..+ .+...+.+.+..+.+++..||..+|.-|-|+-.+-+.|....
T Consensus 430 eey~~Pyyd~Vp~DP--s~eeMrkVVCv~~~RP~i---pnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 430 EEYQLPYYDVVPSDP--SFEEMRKVVCVQKLRPNI---PNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred hhhcCCcccCCCCCC--CHHHHhcceeecccCCCC---CcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 234432221111 111111211112222222 223345567778889999999999999999999988886655
Q ss_pred C
Q 039318 676 M 676 (717)
Q Consensus 676 ~ 676 (717)
.
T Consensus 505 ~ 505 (513)
T KOG2052|consen 505 N 505 (513)
T ss_pred c
Confidence 3
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=260.05 Aligned_cols=241 Identities=23% Similarity=0.273 Sum_probs=191.8
Q ss_pred cCcccccccccCCccceEeeeeCCchh-hh-----------------------------hhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQE-IA-----------------------------HRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~-va-----------------------------h~niv~l~~~~~~~~~~~lV~ 473 (717)
.+++++..||-||||.|=+++.+.... .| .|.||++|..|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 456677789999999999887764432 11 588999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
|-|-||.|...+.+ ++.++..+...++..+++|+.|||.++ ||.|||||+|+||+.+|-+||.|||+|+.+...
T Consensus 500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999944 556888888889999999999999998 999999999999999999999999999987544
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
. .+-+++||+.|.|||++.+...+.++|.||||+++||||+|.+||...++....+++.....++.
T Consensus 574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~----------- 639 (732)
T KOG0614|consen 574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE----------- 639 (732)
T ss_pred C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh-----------
Confidence 3 35579999999999999999999999999999999999999999997776666555544433321
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHHH--h-----cCCC--CCCCCCCCCcccc
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPC-----MPSVILM--L-----GSEI--MLPQPKQPGFLAD 688 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----~~evl~~--L-----~~~~--~~~~p~~p~~~~~ 688 (717)
.+-.-.....+++.+....+|.+|.. +.++-+. + +++. .+++|-.|....+
T Consensus 640 ----~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~p 704 (732)
T KOG0614|consen 640 ----FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANP 704 (732)
T ss_pred ----cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCc
Confidence 11112234567777788899999985 6666653 2 3332 4566655555443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=281.74 Aligned_cols=239 Identities=19% Similarity=0.238 Sum_probs=156.4
Q ss_pred HhcCcccccccccCCccceEeeeeCCc-----hhhh----------------------hhhhhhhcce------eecCce
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADG-----QEIA----------------------HRNLVKLLGC------CIQGEE 468 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~va----------------------h~niv~l~~~------~~~~~~ 468 (717)
..++|++.++||+|+||.||+|++... ..++ +.+++.++.. ......
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 457899999999999999999998654 2221 1222222222 135667
Q ss_pred eeEEEeccCCCChhhHhhhcccc-----------------ccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCce
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKR-----------------KLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNV 531 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NI 531 (717)
.+|||||+++++|.+++...... .......+..++.||+.||.|||+++ |+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHE
Confidence 89999999999999998542210 01122345578999999999999998 99999999999
Q ss_pred EEcC-CCCceeccccccccccCCccccccceecccccccCccccccC----------------------CCCccccchhH
Q 039318 532 LLDH-EMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDG----------------------LFSVKSDVFSF 588 (717)
Q Consensus 532 ll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDvwSl 588 (717)
||+. ++.+||+|||+++.+.... ........+++.|+|||.+... .++.++|||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 9986 5789999999998653322 1223356889999999965322 23456799999
Q ss_pred hHHHHHhhcCCCCCCCCCCCCchhHHHHHHH-------HhhCCCCccccchhhhccCCH--HHHHHHHHHHhhccccCCC
Q 039318 589 GILLLEIVSGKKNRGFYHSDKNLNLIGHAWK-------LWNNGMPSQLIDAYYQESCNL--AEVIRCIHVGLLCVQHHPE 659 (717)
Q Consensus 589 G~il~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~d~~~~~~~~~--~~~~~~~~l~~~Cl~~dp~ 659 (717)
|||||||+++..+++. .......... .|....... ..+........ .......+|+.+||+.||+
T Consensus 366 GviL~el~~~~~~~~~-----~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 366 GLIFLQMAFPNLRSDS-----NLIQFNRQLKRNDYDLVAWRKLVEPR-ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHhCcCCCch-----HHHHHHHHHHhcCCcHHHHHHhhccc-cchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 9999999987665331 1111100000 010000000 00000000000 0112345799999999999
Q ss_pred CCCChHHHHHH
Q 039318 660 DRPCMPSVILM 670 (717)
Q Consensus 660 ~RPs~~evl~~ 670 (717)
+|||+.++++.
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999984
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=255.11 Aligned_cols=224 Identities=25% Similarity=0.353 Sum_probs=171.0
Q ss_pred cCcccccccccCCccceEeeeeCCc-h-------------------------------hhhhhhhhhhcceeecC--cee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-Q-------------------------------EIAHRNLVKLLGCCIQG--EEK 469 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~-------------------------------~vah~niv~l~~~~~~~--~~~ 469 (717)
.+|++.+.||+|+||.||+|+.... . .+.|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4788999999999999999975321 0 11299999999998764 457
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999999843 234788889999999999999999998 99999999999999999999999999986
Q ss_pred ccCCcc-ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 550 FVGDEI-EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 550 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
...... ........++..|+|||++.+..++.++|+||||+++|||++|+.||..... .. ...+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~---~~~~~~~~~~~~~ 229 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---MA---AIFKIATQPTKPM 229 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---HH---HHHHHHcCCCCCC
Confidence 532111 1111235688999999999988899999999999999999999999864311 11 1111111111111
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.+......+.+++.+|++ +|..||+..+++.
T Consensus 230 ---------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 230 ---------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---------CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111223456788889999 5799999998775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=253.94 Aligned_cols=221 Identities=27% Similarity=0.401 Sum_probs=175.2
Q ss_pred CcccccccccCCccceEeeeeCCch-----------------------------hhhhhhhhhhcceeecCceeeEEEec
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ-----------------------------EIAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~-----------------------------~vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+|++.+.||+|++|.||+++..... .+.|+|++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999764321 11299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998443 56899999999999999999999988 99999999999999999999999999987643322
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
. .....++..|+|||.+.+..++.++||||||+++++|++|+.||...... .. .+... ......+
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~---~~---~~~~~-~~~~~~~------ 219 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM---AA---LFRIV-QDDHPPL------ 219 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH---HH---HHHHh-ccCCCCC------
Confidence 1 22356888999999998888999999999999999999999998643211 11 11111 1111111
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+......+.+++.+||+.+|++||++.+++.
T Consensus 220 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 ---PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0111245668899999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=264.51 Aligned_cols=221 Identities=28% Similarity=0.390 Sum_probs=169.9
Q ss_pred cCcccccccccCCccceEeeeeCCch------------------------------hhhhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ------------------------------EIAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~------------------------------~vah~niv~l~~~~~~~~~~~lV~ 473 (717)
+.|+..+.||+|+||.||+|+..... .+.|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45777789999999999999864321 112999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+. ++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~- 167 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence 9997 5777776432 345788999999999999999999988 99999999999999999999999999876432
Q ss_pred ccccccceecccccccCccccc---cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 554 EIEGSTKRVVGTYGYMAPEYAS---DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
.....+++.|+|||.+. ...++.++|||||||++|||++|+.||......+ ... ... .......
T Consensus 168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~---~~~-~~~~~~~- 234 (308)
T cd06634 168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALY---HIA-QNESPAL- 234 (308)
T ss_pred -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HHH---HHh-hcCCCCc-
Confidence 12356888999999874 3567889999999999999999999975432111 111 111 1111000
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHh
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L 671 (717)
. .......+.+++.+||+.+|++||++.+|+...
T Consensus 235 ----~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 235 ----Q---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ----C---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0 111224467889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=266.98 Aligned_cols=238 Identities=23% Similarity=0.314 Sum_probs=172.5
Q ss_pred HHHhcCcccccccccCCccceEeeeeCCc-h----------------------------hhhhhhhhhhcceeec-Ccee
Q 039318 420 ANATDNFSINKKLGEGGFGPVYKGTLADG-Q----------------------------EIAHRNLVKLLGCCIQ-GEEK 469 (717)
Q Consensus 420 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~----------------------------~vah~niv~l~~~~~~-~~~~ 469 (717)
...+++|++.+.||+|+||.||++..... + .+.||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 34678999999999999999999975421 1 1129999999998865 5678
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||+ +++|.+++. ...+++.....++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999998 458888773 234677888889999999999999998 99999999999999999999999999875
Q ss_pred ccCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHH--------HHH
Q 039318 550 FVGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHA--------WKL 620 (717)
Q Consensus 550 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~--------~~~ 620 (717)
.... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+... ...
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 4221 123467889999998765 56899999999999999999999998644321111111000 000
Q ss_pred hhCCCCccccchh-hhccCCHH-----HHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 621 WNNGMPSQLIDAY-YQESCNLA-----EVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 621 ~~~~~~~~l~d~~-~~~~~~~~-----~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+.......+.... .....+.. ....+.+++.+||+.+|++||++++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000 00111111 12467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=255.31 Aligned_cols=235 Identities=20% Similarity=0.241 Sum_probs=180.4
Q ss_pred HhcCcccccccccCCccceEeeeeCCch-hhh---------------------------hh----hhhhhcceeecCcee
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQ-EIA---------------------------HR----NLVKLLGCCIQGEEK 469 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~va---------------------------h~----niv~l~~~~~~~~~~ 469 (717)
.+++|.+...+|+|.||.|-++.+.... .+| -| -+|++.+++...++.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 3689999999999999999999876541 111 11 257777888889999
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc---------------
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD--------------- 534 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~--------------- 534 (717)
+||+|.+ |-++.+++.. .+-.+++...+..|+.|+++++++||+.+ ++|-||||+|||+-
T Consensus 167 Civfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999988 5589999954 34556889999999999999999999998 99999999999992
Q ss_pred -----CCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCC
Q 039318 535 -----HEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDK 609 (717)
Q Consensus 535 -----~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~ 609 (717)
++..+||+|||.|....... ...+.|..|+|||++.+-.++..+||||+||||+||.+|...|......+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 13458999999998754332 46789999999999999999999999999999999999999987554334
Q ss_pred chhHHHHHHHHhhCCCCccccchh---------------------------------hhccCCHHHHHHHHHHHhhcccc
Q 039318 610 NLNLIGHAWKLWNNGMPSQLIDAY---------------------------------YQESCNLAEVIRCIHVGLLCVQH 656 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~d~~---------------------------------~~~~~~~~~~~~~~~l~~~Cl~~ 656 (717)
.+.+.+.+.. ..+..++... ........+..++.+|+..||..
T Consensus 317 HLaMMerIlG----p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 317 HLAMMERILG----PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred HHHHHHHhhC----CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 3333322211 1111111110 00112335667899999999999
Q ss_pred CCCCCCChHHHHHH
Q 039318 657 HPEDRPCMPSVILM 670 (717)
Q Consensus 657 dp~~RPs~~evl~~ 670 (717)
||.+|+|+.|+++.
T Consensus 393 DP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 393 DPARRITLREALSH 406 (415)
T ss_pred CccccccHHHHhcC
Confidence 99999999999863
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=250.60 Aligned_cols=230 Identities=27% Similarity=0.365 Sum_probs=172.8
Q ss_pred CcccccccccCCccceEeeeeCCch-hhh----------------------------hhhhhhhcceeecCceeeEEEec
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ-EIA----------------------------HRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~-~va----------------------------h~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+.+.+..||.|+||+|+|-.++... .+| +||||++||.+..++..++.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3344578999999999998765422 111 79999999999999999999999
Q ss_pred cCCCChhhHhhhc--cccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 476 MPNRSLDSFIFDQ--TKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 476 ~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
|. .+|+.+...- .....+++.-.-.|..-++.||.||.+.- +|||||+||+||||+..|.+||+|||++..+...
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 95 4776665321 23345777777788888899999998864 5999999999999999999999999999876432
Q ss_pred ccccccceecccccccCcccccc--CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASD--GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
. ....-.|...|||||-+.. ..|+.+|||||||+.|||+.||+.|+..+.. +..+..... .+.+..+..
T Consensus 222 i---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv-~gdpp~l~~ 292 (361)
T KOG1006|consen 222 I---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVV-IGDPPILLF 292 (361)
T ss_pred H---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHH-cCCCCeecC
Confidence 2 2234578899999998853 3589999999999999999999999864432 222232322 222222221
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.....+....+++++-.||-+|..+||...++.++
T Consensus 293 ----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 ----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 12223455678888899999999999999998875
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=227.21 Aligned_cols=111 Identities=51% Similarity=0.798 Sum_probs=79.9
Q ss_pred CCeEEEeeCCCCCCcCC--cceEEEecCCCEEEEcCCCcEEEEe-ccccCcCCcEEEEEccCCCeEEEeccCCCCcceee
Q 039318 39 VKTVVWVANRINPINDS--SGVLVVNKTGNLVLTSQNKSVVWSA-NLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLW 115 (717)
Q Consensus 39 ~~tvvW~ANr~~p~~~~--~~~l~l~~~G~Lvl~~~~~~~vWst-~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lW 115 (717)
++||||+|||+.|+... ..+|.|+.||+|+|.+.+++++|++ ++.+.+...+.|.|+|+|||||++.. +.+||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~----~~~lW 76 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS----GNVLW 76 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT----SEEEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec----ceEEE
Confidence 47999999999999653 3799999999999999999999999 56554324566999999999999853 35999
Q ss_pred eecCCCCccccccCeeceeeccCCceEEEEecCCCCCC
Q 039318 116 QSFDYPSDTLLPGMKLGWDFKTGLERRITSWKSSDDPS 153 (717)
Q Consensus 116 QSFd~PTDTlLpgq~l~~~~~~~~~~~l~S~~s~~dps 153 (717)
|||||||||+||||+|+.+..++....++||++.+|||
T Consensus 77 ~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 77 QSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp ESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred eecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 99999999999999999887777667899999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=260.37 Aligned_cols=212 Identities=20% Similarity=0.244 Sum_probs=154.8
Q ss_pred hhhhhhhcceeecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceE
Q 039318 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVL 532 (717)
Q Consensus 453 h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIl 532 (717)
|+||+++++++.+.+..+++|||+++++|.+++.... ...+++..+..++.|+++||+|||+++ |+||||||+||+
T Consensus 58 h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nil 133 (314)
T cd08216 58 HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHIL 133 (314)
T ss_pred CcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEE
Confidence 9999999999999999999999999999999996542 234788889999999999999999998 999999999999
Q ss_pred EcCCCCceeccccccccccCCcc-----ccccceecccccccCcccccc--CCCCccccchhHhHHHHHhhcCCCCCCCC
Q 039318 533 LDHEMNPKISDFGLARTFVGDEI-----EGSTKRVVGTYGYMAPEYASD--GLFSVKSDVFSFGILLLEIVSGKKNRGFY 605 (717)
Q Consensus 533 l~~~~~~kl~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~p~~~~ 605 (717)
++.++.+||+|||.+........ ........++..|+|||++.. ..++.++|+|||||+++||++|+.||...
T Consensus 134 i~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 134 LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred EecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999875432211 111223457788999999876 35889999999999999999999998743
Q ss_pred CCCCchhHHHHHHHH----hhCC-------CCcc----ccchhh----hccCCHHHHHHHHHHHhhccccCCCCCCChHH
Q 039318 606 HSDKNLNLIGHAWKL----WNNG-------MPSQ----LIDAYY----QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPS 666 (717)
Q Consensus 606 ~~~~~~~~~~~~~~~----~~~~-------~~~~----l~d~~~----~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~e 666 (717)
.... ......... +... .... ..+... ...........+.+++.+||+.+|++|||+++
T Consensus 214 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 291 (314)
T cd08216 214 PATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291 (314)
T ss_pred CHHH--HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHH
Confidence 2211 111110000 0000 0000 000000 00111122346778999999999999999999
Q ss_pred HHHH
Q 039318 667 VILM 670 (717)
Q Consensus 667 vl~~ 670 (717)
+++.
T Consensus 292 ll~~ 295 (314)
T cd08216 292 LLNH 295 (314)
T ss_pred HhcC
Confidence 9884
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=260.12 Aligned_cols=218 Identities=28% Similarity=0.439 Sum_probs=167.4
Q ss_pred cccccccccCCccceEeeeeCCch------------------------------hhhhhhhhhhcceeecCceeeEEEec
Q 039318 426 FSINKKLGEGGFGPVYKGTLADGQ------------------------------EIAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~~~------------------------------~vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
|...++||+|+||.||+|+..... .+.|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999753211 11299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++ +|.+++.. ....+++..+..++.||+.+|.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 964 67777643 2345889999999999999999999998 99999999999999999999999999865321
Q ss_pred ccccceecccccccCccccc---cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 556 EGSTKRVVGTYGYMAPEYAS---DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
.....|+..|+|||++. ...++.++||||||+++|||++|+.||...... ... ......... ....
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~---~~~---~~~~~~~~~-~~~~- 242 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SAL---YHIAQNDSP-TLQS- 242 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHH---HHHHhcCCC-CCCc-
Confidence 22457889999999874 456889999999999999999999997543211 111 111111111 1110
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
. .....+.+++.+||+.+|.+||++.+++..
T Consensus 243 ---~----~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 ---N----EWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---c----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 111246678999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=253.94 Aligned_cols=199 Identities=20% Similarity=0.134 Sum_probs=157.5
Q ss_pred CCccceEeeeeCCchh-h---------------------hhhhhhhhcceeecCceeeEEEeccCCCChhhHhhhccccc
Q 039318 435 GGFGPVYKGTLADGQE-I---------------------AHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRK 492 (717)
Q Consensus 435 G~fg~Vy~~~~~~~~~-v---------------------ah~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~ 492 (717)
|.+|.||+++.....+ + .||||+++++++.+.+..++||||+++++|.+++... .
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~ 80 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF---L 80 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh---c
Confidence 7899999988754321 1 1899999999999999999999999999999998543 3
Q ss_pred cCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccceecccccccCcc
Q 039318 493 LLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE 572 (717)
Q Consensus 493 ~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE 572 (717)
.+++..+..++.|+++||.|||+++ |+||||||+||+++.++.++|+|||++...... .....++..|+|||
T Consensus 81 ~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE 152 (237)
T cd05576 81 NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPE 152 (237)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCc
Confidence 4889999999999999999999988 999999999999999999999999988754321 12345577899999
Q ss_pred ccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhh
Q 039318 573 YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLL 652 (717)
Q Consensus 573 ~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~ 652 (717)
.+.+..++.++|+||+|+++|||++|+.|+........ ... .+ ..+......+.+++.+
T Consensus 153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~~--~~-------~~~~~~~~~~~~li~~ 211 (237)
T cd05576 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------THT--TL-------NIPEWVSEEARSLLQQ 211 (237)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------ccc--cc-------CCcccCCHHHHHHHHH
Confidence 99888899999999999999999999988653211100 000 00 0011122456788999
Q ss_pred ccccCCCCCCChH
Q 039318 653 CVQHHPEDRPCMP 665 (717)
Q Consensus 653 Cl~~dp~~RPs~~ 665 (717)
||+.||++||++.
T Consensus 212 ~l~~dp~~R~~~~ 224 (237)
T cd05576 212 LLQFNPTERLGAG 224 (237)
T ss_pred HccCCHHHhcCCC
Confidence 9999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=269.75 Aligned_cols=238 Identities=23% Similarity=0.320 Sum_probs=173.8
Q ss_pred HHHHHHHhcCcccccccccCCccceEeeeeCC-chhh----------------------------hhhhhhhhcceeecC
Q 039318 416 LATIANATDNFSINKKLGEGGFGPVYKGTLAD-GQEI----------------------------AHRNLVKLLGCCIQG 466 (717)
Q Consensus 416 ~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v----------------------------ah~niv~l~~~~~~~ 466 (717)
..++....++|.+.+.||+|+||.||+|.... ++.+ .||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 34566678999999999999999999997542 2111 299999999987543
Q ss_pred ------ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCce
Q 039318 467 ------EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPK 540 (717)
Q Consensus 467 ------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~k 540 (717)
...++++|++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467888887 7789887732 34889999999999999999999998 99999999999999999999
Q ss_pred eccccccccccCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHH
Q 039318 541 ISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWK 619 (717)
Q Consensus 541 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 619 (717)
|+|||+++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .......
T Consensus 161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~ 232 (345)
T cd07877 161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILR 232 (345)
T ss_pred Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHH
Confidence 999999886422 1223567899999998866 568899999999999999999999986432221 1111111
Q ss_pred HhhCCCCccccch--------hhh-----ccCCH-----HHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 620 LWNNGMPSQLIDA--------YYQ-----ESCNL-----AEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 620 ~~~~~~~~~l~d~--------~~~-----~~~~~-----~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
... .....+... ... ..... .....+.+++.+||+.+|.+||++.+++..
T Consensus 233 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 233 LVG-TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhC-CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 100 000000000 000 00000 112356789999999999999999998875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=258.20 Aligned_cols=233 Identities=25% Similarity=0.331 Sum_probs=172.8
Q ss_pred cccccccccCCccceEeeeeCC-chh----------------------------hhhhhhhhhcceeecCceeeEEEecc
Q 039318 426 FSINKKLGEGGFGPVYKGTLAD-GQE----------------------------IAHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~-~~~----------------------------vah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
|+..+.||+|++|.||+|+... ++. +.|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5667899999999999998653 111 12999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
+ ++|.+++.... ..+++..+..++.|+++||+|||+++ |+|+||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 48999995432 45889999999999999999999998 99999999999999999999999999986543221
Q ss_pred cccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC---------
Q 039318 557 GSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP--------- 626 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 626 (717)
......++..|+|||.+.+. .++.++||||||++++||++|+.||......+ .+......+.....
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhccc
Confidence 12234457789999998776 78999999999999999999999986433221 11111111110000
Q ss_pred ---ccccchhhhc---cCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 627 ---SQLIDAYYQE---SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 627 ---~~l~d~~~~~---~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.......... .........+.+++.+||+.+|++||++++|+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000 000011346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=270.63 Aligned_cols=232 Identities=22% Similarity=0.311 Sum_probs=173.0
Q ss_pred HhcCcccccccccCCccceEeeeeCCch-h----------------------------hhhhhhhhhcceeecCce----
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQ-E----------------------------IAHRNLVKLLGCCIQGEE---- 468 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~----------------------------vah~niv~l~~~~~~~~~---- 468 (717)
..++|++.+.||+|+||.||+|+...+. . +.||||+++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999865321 1 129999999998876655
Q ss_pred --eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccc
Q 039318 469 --KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGL 546 (717)
Q Consensus 469 --~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgl 546 (717)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5689888843 35899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC
Q 039318 547 ARTFVGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM 625 (717)
Q Consensus 547 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 625 (717)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..+....... +..
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---~~~~~i~~~~-~~~ 235 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI---DQLKRIMNLV-GTP 235 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhc-CCC
Confidence 9865322 223567889999998865 46789999999999999999999998643221 1111111111 000
Q ss_pred Cccccchh------------h-hccCCH-----HHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 626 PSQLIDAY------------Y-QESCNL-----AEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 626 ~~~l~d~~------------~-~~~~~~-----~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
...+.+.. . ...... .....+.+++.+||+.+|++|||+.+|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000 0 000001 113568899999999999999999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=275.96 Aligned_cols=224 Identities=29% Similarity=0.441 Sum_probs=184.4
Q ss_pred cccccccccCCccceEeeee-CCchhh-------------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 426 FSINKKLGEGGFGPVYKGTL-ADGQEI-------------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~-~~~~~v-------------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
....++||+|+||+||||.+ .+++.| .||||+||+++|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34457899999999999975 223221 1999999999998776 88999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
+|||.|+|.+|++. ++..+-.+..+.|..|||+||.|||++. +|||||-..|+|+.+-.++||.|||+++.+..+
T Consensus 777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999965 4556888999999999999999999987 999999999999999999999999999998776
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
..+.......-.+-|||-|.+....|+.++|||||||.+||||| |..|+.....++-. ++++.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~----------------dlle~ 915 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP----------------DLLEK 915 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh----------------HHHhc
Confidence 65555444455678999999999999999999999999999999 99998754433322 22222
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHh
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L 671 (717)
-.+-+.++...+.+..++++||..|+..||+++++...+
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~f 954 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEF 954 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHH
Confidence 223345666778889999999999999999999888764
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=239.27 Aligned_cols=240 Identities=23% Similarity=0.307 Sum_probs=172.5
Q ss_pred cccccCCccceEeeee-CCchhhh---------------------------hhhhhhhcceeecCceeeEEEeccCCCCh
Q 039318 430 KKLGEGGFGPVYKGTL-ADGQEIA---------------------------HRNLVKLLGCCIQGEEKLLIYEFMPNRSL 481 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~-~~~~~va---------------------------h~niv~l~~~~~~~~~~~lV~E~~~~gsL 481 (717)
+.||+|+|+.|--+.. ..+.+.| |+||++++++|+++...|||||-|.||.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 6799999999987653 2333222 99999999999999999999999999999
Q ss_pred hhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC---ceeccccccccccCC-----
Q 039318 482 DSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN---PKISDFGLARTFVGD----- 553 (717)
Q Consensus 482 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~Dfgla~~~~~~----- 553 (717)
..+|.+ ++.+++.++-+++.+|+.||.+||.++ |.||||||+|||-..... +||+||.|...+...
T Consensus 164 LshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999944 456889999999999999999999999 999999999999965543 799999988643221
Q ss_pred ccccccceecccccccCccccc-----cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCC-c-------hhHHHHHHHH
Q 039318 554 EIEGSTKRVVGTYGYMAPEYAS-----DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDK-N-------LNLIGHAWKL 620 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~-~-------~~~~~~~~~~ 620 (717)
.......+.+|+..|||||+.. ...|+.++|.||||||||-||+|.+||...-..+ . ..-....+..
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 1122234578999999999763 3358899999999999999999999996543322 0 1111111222
Q ss_pred hhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH-----HhcCCCCCCCCC
Q 039318 621 WNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL-----MLGSEIMLPQPK 681 (717)
Q Consensus 621 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~-----~L~~~~~~~~p~ 681 (717)
+.++.- ++.|.... .-..+..+++...|..++.+|-++..++. +...++.+|.|+
T Consensus 318 IQEGkY-eFPdkdWa-----hIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp~ 377 (463)
T KOG0607|consen 318 IQEGKY-EFPDKDWA-----HISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTPQ 377 (463)
T ss_pred HhccCC-cCChhhhH-----HhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCCc
Confidence 222221 22221111 11234556777788899999999988877 233334555554
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=246.90 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=188.4
Q ss_pred hcCcccccccccCCccceEeeeeCCchhhh-------------------------------hhhhhhhcceeecCceeeE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------------HRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------------h~niv~l~~~~~~~~~~~l 471 (717)
..+|.+++.||+|+|..|..++++...++. ||.+|-+..+++.+.++++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 357888999999999999999887654432 8999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
|.||++||+|.-++.+ ...|+++.+..+..+|+.||.|||+.+ ||.||||.+|+|||..|++||.|+|+++.-.
T Consensus 329 vieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999999777633 345888888889999999999999999 9999999999999999999999999998533
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCC-chhHHHHHHHHhhCCCCcccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDK-NLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~ 630 (717)
.. ...+.+++||+.|+|||++++..|...+|.|+|||+++||+.|+.||+....+. ..+--.+..+.+-+..++
T Consensus 403 ~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--- 477 (593)
T KOG0695|consen 403 GP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--- 477 (593)
T ss_pred CC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc---
Confidence 22 223557999999999999999999999999999999999999999998654332 122222233332222111
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCC------hHHHHH----------HhcCCCCCCCCCCCCccccCCCC
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPC------MPSVIL----------MLGSEIMLPQPKQPGFLADRKST 692 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs------~~evl~----------~L~~~~~~~~p~~p~~~~~~~~~ 692 (717)
.+-....+...+...-|.+||.+|.. ..++-. +| +.+.+-+|=+|+.......+
T Consensus 478 -------iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~l-eqk~v~ppf~p~i~~d~~l~ 547 (593)
T KOG0695|consen 478 -------IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLL-EQKQVLPPFQPQITDDYGLD 547 (593)
T ss_pred -------ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHH-hhcccCCCCCCccccccCcc
Confidence 01111223445555678888988752 223221 23 23455666677776665443
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=265.71 Aligned_cols=237 Identities=23% Similarity=0.315 Sum_probs=172.4
Q ss_pred cCccc-ccccccCCccceEeeeeCC-c----------------------------------------hhhhhhhhhhhcc
Q 039318 424 DNFSI-NKKLGEGGFGPVYKGTLAD-G----------------------------------------QEIAHRNLVKLLG 461 (717)
Q Consensus 424 ~~~~~-~~~lG~G~fg~Vy~~~~~~-~----------------------------------------~~vah~niv~l~~ 461 (717)
++|.. .+.||+|+||.||+|+... + ..+.|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 46654 4679999999999997532 1 0112999999999
Q ss_pred eeecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCcee
Q 039318 462 CCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKI 541 (717)
Q Consensus 462 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl 541 (717)
++...+..++||||++ ++|.+++.. ...+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 588888843 345889999999999999999999988 999999999999999999999
Q ss_pred ccccccccccCCcc------------ccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCC
Q 039318 542 SDFGLARTFVGDEI------------EGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSD 608 (717)
Q Consensus 542 ~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~ 608 (717)
+|||+++....... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999986541110 1111223568899999998764 4789999999999999999999998754322
Q ss_pred CchhHHHHHHHHhhCCCCccccc--------hhh-hccC-----CHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 609 KNLNLIGHAWKLWNNGMPSQLID--------AYY-QESC-----NLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~l~d--------~~~-~~~~-----~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
..+................+ +.. .... .......+.+++.+||+.+|++||+++|++..
T Consensus 241 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 ---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred ---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 22222222221111000000 000 0000 00113457789999999999999999999974
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=265.32 Aligned_cols=240 Identities=22% Similarity=0.287 Sum_probs=167.5
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hh--------------------------hhhhhhhhhcceeecC---------
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QE--------------------------IAHRNLVKLLGCCIQG--------- 466 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~--------------------------vah~niv~l~~~~~~~--------- 466 (717)
..+|.+.+.||+|+||.||+|..... +. +.||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36899999999999999999986532 11 1299999999876544
Q ss_pred -----ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc-CCCCce
Q 039318 467 -----EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD-HEMNPK 540 (717)
Q Consensus 467 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~-~~~~~k 540 (717)
...++||||++ ++|.+++. ...+++..+..++.||++||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 48887773 235788999999999999999999998 99999999999997 456789
Q ss_pred eccccccccccCCccc-cccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHH
Q 039318 541 ISDFGLARTFVGDEIE-GSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAW 618 (717)
Q Consensus 541 l~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~ 618 (717)
|+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||................
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999765322111 11122457889999997654 568899999999999999999999986443211111100000
Q ss_pred --------HHhhCCCCccccchhhhccCCHH-----HHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 619 --------KLWNNGMPSQLIDAYYQESCNLA-----EVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 619 --------~~~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
..........+.........+.. ...++.+++.+||+.+|.+||++++++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000000000000000001111 12457789999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=260.26 Aligned_cols=182 Identities=23% Similarity=0.365 Sum_probs=152.7
Q ss_pred hcCcccccccccCCccceEeeeeCCchh-----------------hh-------------hhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQE-----------------IA-------------HRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-----------------va-------------h~niv~l~~~~~~~~~~~lV 472 (717)
..-|..++.||-|+||+|-++.-.+... || .+-||+||-.|++++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3467888999999999999987555432 23 45689999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||++||++..+|.+ .+.+++..+..++.++..|+++.|..| +|||||||+|||||.+|++||.||||+.-+.-
T Consensus 708 MdYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EeccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 999999999999954 556888888889999999999999988 99999999999999999999999999964310
Q ss_pred ---------Cc-------------------------------cccccceecccccccCccccccCCCCccccchhHhHHH
Q 039318 553 ---------DE-------------------------------IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILL 592 (717)
Q Consensus 553 ---------~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il 592 (717)
.. ........+||+.|+|||++....|+..+|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 00 00011235899999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCCCc
Q 039318 593 LEIVSGKKNRGFYHSDKN 610 (717)
Q Consensus 593 ~elltG~~p~~~~~~~~~ 610 (717)
|||+.|+.||-...+.+.
T Consensus 862 ~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHHhhCCCCccCCCCCcc
Confidence 999999999976655543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-29 Score=268.90 Aligned_cols=234 Identities=22% Similarity=0.305 Sum_probs=170.7
Q ss_pred HHHhcCcccccccccCCccceEeeeeCC-chh----------------------------hhhhhhhhhcceeecCc---
Q 039318 420 ANATDNFSINKKLGEGGFGPVYKGTLAD-GQE----------------------------IAHRNLVKLLGCCIQGE--- 467 (717)
Q Consensus 420 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~----------------------------vah~niv~l~~~~~~~~--- 467 (717)
....++|++.+.||+|+||.||++.... +.. +.||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 3457789999999999999999997532 111 12999999999887654
Q ss_pred ---eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccc
Q 039318 468 ---EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDF 544 (717)
Q Consensus 468 ---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 544 (717)
..++||||+ +++|.+++. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 358999999 678888773 235889999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHH---
Q 039318 545 GLARTFVGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKL--- 620 (717)
Q Consensus 545 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~--- 620 (717)
|++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... .........
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---~~~~~~~~~~~~ 234 (343)
T cd07880 163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL---DQLMEIMKVTGT 234 (343)
T ss_pred ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCC
Confidence 999865322 223567889999998876 45889999999999999999999998643221 111111110
Q ss_pred --------hhCCCCccccchhhh-ccCC-----HHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 621 --------WNNGMPSQLIDAYYQ-ESCN-----LAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 621 --------~~~~~~~~l~d~~~~-~~~~-----~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+.............. .... ......+.+++.+||+.||++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000000 0000 011234678999999999999999999995
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=286.95 Aligned_cols=119 Identities=30% Similarity=0.469 Sum_probs=106.2
Q ss_pred cCcccccccccCCccceEeeeeCC-chhh-----------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEI-----------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-----------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|.+.++||+|+||.||+|++.. ++.+ .||||+++++++...+..+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 679999999999999999998752 1111 1999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
||+++++|.+++.. .+.+++..++.++.||+.||.|||.++ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999843 235788899999999999999999988 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-29 Score=224.98 Aligned_cols=238 Identities=23% Similarity=0.309 Sum_probs=172.9
Q ss_pred CcccccccccCCccceEeeeeCCchhh-----------------------------hhhhhhhhcceeecCceeeEEEec
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQEI-----------------------------AHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~~v-----------------------------ah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
+|...++||+|.||+||||+.++..++ .|+|||+++++...++..-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466678999999999999987654433 299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
|.. +|..+.. .-.+.++.+....++.|+++||.++|+++ +.||||||+|+||+.+|++||+|||+++.+.-...
T Consensus 83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 964 7776663 23456888889999999999999999998 99999999999999999999999999997643211
Q ss_pred ccccceecccccccCccccccCC-CCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCC---Ccccc
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGL-FSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGM---PSQLI 630 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~l~ 630 (717)
....-+-|..|++|.++-+.. |+...|+||.|||+.||.. |++.|...+.++....+-+......+.. +..+.
T Consensus 157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 112345689999999987754 8999999999999999987 6555554444433333322222222221 11222
Q ss_pred chhhh----ccCCHHHH-----HHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 631 DAYYQ----ESCNLAEV-----IRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 631 d~~~~----~~~~~~~~-----~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
|-..- ......++ .+-.++....|.-+|.+|.++++.++.
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 21111 11111111 123567777888899999999988764
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=247.83 Aligned_cols=210 Identities=27% Similarity=0.316 Sum_probs=166.0
Q ss_pred cccCCccceEeeeeCC-chh-----------------------------hhhhhhhhhcceeecCceeeEEEeccCCCCh
Q 039318 432 LGEGGFGPVYKGTLAD-GQE-----------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSL 481 (717)
Q Consensus 432 lG~G~fg~Vy~~~~~~-~~~-----------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~gsL 481 (717)
||+|+||.||++.... ++. +.||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 7999999999998643 111 1299999999999999999999999999999
Q ss_pred hhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccce
Q 039318 482 DSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561 (717)
Q Consensus 482 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 561 (717)
.+++... ..+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 9999442 35889999999999999999999988 9999999999999999999999999998654321 12334
Q ss_pred ecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHH
Q 039318 562 VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLA 641 (717)
Q Consensus 562 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~ 641 (717)
..++..|+|||.+.+...+.++|+||||+++|+|++|+.||..... ....... . .... ..+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~---~-~~~~----------~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKI---L-KDPL----------RFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH---h-cCCC----------CCCCC
Confidence 6788899999999888899999999999999999999999864322 1111111 1 1100 01111
Q ss_pred HHHHHHHHHhhccccCCCCCCChHH
Q 039318 642 EVIRCIHVGLLCVQHHPEDRPCMPS 666 (717)
Q Consensus 642 ~~~~~~~l~~~Cl~~dp~~RPs~~e 666 (717)
....+.+++.+||+.+|++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1345678999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=272.64 Aligned_cols=233 Identities=30% Similarity=0.424 Sum_probs=180.9
Q ss_pred HhcCcccccccccCCccceEeeeeCCc--------hhhh----------------------------hhhhhhhcceeec
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADG--------QEIA----------------------------HRNLVKLLGCCIQ 465 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~--------~~va----------------------------h~niv~l~~~~~~ 465 (717)
..++..+.+.||+|.||.|++|..... ..|| |+||+.++|+|.+
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 334556667999999999999975411 1111 9999999999999
Q ss_pred CceeeEEEeccCCCChhhHhhhcc-----c------c--ccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceE
Q 039318 466 GEEKLLIYEFMPNRSLDSFIFDQT-----K------R--KLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVL 532 (717)
Q Consensus 466 ~~~~~lV~E~~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIl 532 (717)
.+..++|+||+..|+|.+++++.. . . ..+.....+.++.|||.|++||++.. +|||||-..|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence 999999999999999999996544 0 0 23888899999999999999999987 999999999999
Q ss_pred EcCCCCceeccccccccccCCccccccceec--ccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCC
Q 039318 533 LDHEMNPKISDFGLARTFVGDEIEGSTKRVV--GTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDK 609 (717)
Q Consensus 533 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~ 609 (717)
|.++..+||+|||+|+........... ... -...|||||.+....|+.|+|||||||+||||++ |..|+......
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~- 528 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT- 528 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH-
Confidence 999999999999999965443322211 111 2346999999999999999999999999999999 88887642111
Q ss_pred chhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 610 NLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
.. ..+.++++.. ...+.....++.+++..||+.+|++||+..++++.|+.
T Consensus 529 -~~----l~~~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 529 -EE----LLEFLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred -HH----HHHHHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 11 1223333321 12223335567789999999999999999999999977
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-28 Score=252.80 Aligned_cols=217 Identities=25% Similarity=0.358 Sum_probs=168.9
Q ss_pred ccccccCCccceEeeeeCC-chhhh----------------------------hhhhhhhcceeecCceeeEEEeccCCC
Q 039318 429 NKKLGEGGFGPVYKGTLAD-GQEIA----------------------------HRNLVKLLGCCIQGEEKLLIYEFMPNR 479 (717)
Q Consensus 429 ~~~lG~G~fg~Vy~~~~~~-~~~va----------------------------h~niv~l~~~~~~~~~~~lV~E~~~~g 479 (717)
.+.||+|-||+||-|+++. |+.|| ||.||.+..-|+..++.++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 3789999999999998754 33333 999999999999999999999999765
Q ss_pred ChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC---CCceeccccccccccCCccc
Q 039318 480 SLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE---MNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 480 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~---~~~kl~Dfgla~~~~~~~~~ 556 (717)
-|+-.+ . ...+.|++.....++.||+.||.|||.++ |+|+||||+||||... ..+||+|||+|+++.....
T Consensus 649 MLEMIL-S-sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 649 MLEMIL-S-SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred HHHHHH-H-hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 555554 3 23456888888889999999999999998 9999999999999654 4699999999998865443
Q ss_pred cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 557 GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
....+||+.|+|||+++...|...-|+||.|||+|--++|..||... ++-.+.++.+.-++.
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyP-------------- 784 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYP-------------- 784 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccC--------------
Confidence 34689999999999999999999999999999999999999998632 111122222211111
Q ss_pred cCCHHHH-HHHHHHHhhccccCCCCCCChHHHHH
Q 039318 637 SCNLAEV-IRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 637 ~~~~~~~-~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
..+..++ ...++++...||..-.+|-+....+.
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1122222 34677888888888899988776554
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-28 Score=231.41 Aligned_cols=241 Identities=22% Similarity=0.337 Sum_probs=172.1
Q ss_pred cCcccccccccCCccceEeeeeCCch-hhh----------------------------hhhhhhhcceeecC--------
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-EIA----------------------------HRNLVKLLGCCIQG-------- 466 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-~va----------------------------h~niv~l~~~~~~~-------- 466 (717)
..|+...+||+|.||.||+|+.+++. .|+ |+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 35666789999999999999876543 223 99999999887532
Q ss_pred ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccc
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGL 546 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgl 546 (717)
...+|||++|+. +|.-++.+. ...++..++.++..++..||.|+|... |+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 347999999976 787777432 235788999999999999999999887 99999999999999999999999999
Q ss_pred cccccCC--ccccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhC
Q 039318 547 ARTFVGD--EIEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNN 623 (717)
Q Consensus 547 a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 623 (717)
++.+... .........+-|..|++||.+.+. .|+++.|||..|||+.||.++.+-+..........++...-.-...
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9765432 222233445679999999988775 5999999999999999999999887654433333333222111111
Q ss_pred CCCcc-----ccchh-----hhccC--CHHH------HHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 624 GMPSQ-----LIDAY-----YQESC--NLAE------VIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 624 ~~~~~-----l~d~~-----~~~~~--~~~~------~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+.... +.... .++.. -.+. -.+.++++..++..||.+|+.+.+++..
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 11111 11100 00000 0011 1256788888999999999998887753
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-28 Score=234.12 Aligned_cols=237 Identities=25% Similarity=0.340 Sum_probs=171.9
Q ss_pred ccccccccCCccceEeeeeC-Cchhhh----------------------------hhhhhhhcceeecC-----ceeeEE
Q 039318 427 SINKKLGEGGFGPVYKGTLA-DGQEIA----------------------------HRNLVKLLGCCIQG-----EEKLLI 472 (717)
Q Consensus 427 ~~~~~lG~G~fg~Vy~~~~~-~~~~va----------------------------h~niv~l~~~~~~~-----~~~~lV 472 (717)
+-.+.||-|+||+||...+. +++.++ |.|++..++..... +++|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 44578999999999988764 444443 78887777765543 356788
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
+|.|.. +|...| .....|+...+.-++.||++||.|||+.+ |.||||||.|+|++.+..+||+|||+++....
T Consensus 136 TELmQS-DLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQS-DLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHh-hhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 898854 777766 44556888888889999999999999998 99999999999999999999999999998665
Q ss_pred CccccccceecccccccCccccccCC-CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHH--------HhhC
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGL-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWK--------LWNN 623 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~--------~~~~ 623 (717)
++....+ .-+-|..|+|||++++.. |+.+.||||.|||+.||+..+..|....+.....++..... ..-+
T Consensus 209 d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 209 RDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 5543333 456688999999998864 89999999999999999999988876665554444433211 1111
Q ss_pred CCCccccchh---------hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHh
Q 039318 624 GMPSQLIDAY---------YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671 (717)
Q Consensus 624 ~~~~~l~d~~---------~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L 671 (717)
+-...++... ..-+.+.....+.+.+.++++..+|++|.+..+.+..+
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1100111000 00111112223455677788999999999999998865
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=257.10 Aligned_cols=237 Identities=19% Similarity=0.234 Sum_probs=158.8
Q ss_pred HhcCcccccccccCCccceEeeeeCC-----------------chhh---------------------------------
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLAD-----------------GQEI--------------------------------- 451 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~v--------------------------------- 451 (717)
..++|++.++||+|+||.||+|.+.. ++.|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 35789999999999999999985310 0000
Q ss_pred ------------hhhhhhhhcceeec--------CceeeEEEeccCCCChhhHhhhccc---------------------
Q 039318 452 ------------AHRNLVKLLGCCIQ--------GEEKLLIYEFMPNRSLDSFIFDQTK--------------------- 490 (717)
Q Consensus 452 ------------ah~niv~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------- 490 (717)
+|+++++++++|.. .+..+|||||+++++|.+++.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 13344667777643 3568999999999999999854211
Q ss_pred cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccceecccccccC
Q 039318 491 RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMA 570 (717)
Q Consensus 491 ~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 570 (717)
...+++..+..++.|++++|.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 122456778889999999999999988 99999999999999999999999999976433211 11112345789999
Q ss_pred ccccccCC--------------------C--CccccchhHhHHHHHhhcCCC-CCCCCCCCC-chh---HHHHHHHHhhC
Q 039318 571 PEYASDGL--------------------F--SVKSDVFSFGILLLEIVSGKK-NRGFYHSDK-NLN---LIGHAWKLWNN 623 (717)
Q Consensus 571 PE~~~~~~--------------------~--~~~sDvwSlG~il~elltG~~-p~~~~~~~~-~~~---~~~~~~~~~~~ 623 (717)
||.+.... + ..+.||||+|||+|||++|.. |+....... ... .....++....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99875432 1 134799999999999999875 654221110 000 01111222211
Q ss_pred CCCccccchhhhccCCHHHHHHHHHHHhhccccCC---CCCCChHHHHHH
Q 039318 624 GMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHP---EDRPCMPSVILM 670 (717)
Q Consensus 624 ~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp---~~RPs~~evl~~ 670 (717)
.... + +..........+++.++|..+| .+|+|++|+++.
T Consensus 459 ~~~~-~-------~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QKYD-F-------SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cCCC-c-------ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1110 0 0001112356678888888765 689999999864
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=205.02 Aligned_cols=114 Identities=51% Similarity=0.783 Sum_probs=100.3
Q ss_pred CCCCCCEEEeCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEEe
Q 039318 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSA 80 (717)
Q Consensus 1 ~l~~~~~l~S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst 80 (717)
+|++|++|+|+++.|++|||.+......+.+|||.+++ +++||.||++.|. ...++|.|+.||+|+|.|.+|.++|++
T Consensus 3 ~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 3 PLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred CcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 58899999999999999999987654489999999887 8999999999984 556789999999999999999999999
Q ss_pred ccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCC
Q 039318 81 NLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYP 121 (717)
Q Consensus 81 ~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~P 121 (717)
++++ .....+|+|+|+|||||++.+ +.+||||||||
T Consensus 81 ~~~~-~~~~~~~~L~ddGnlvl~~~~----~~~~W~Sf~~P 116 (116)
T cd00028 81 NTTR-VNGNYVLVLLDDGNLVLYDSD----GNFLWQSFDYP 116 (116)
T ss_pred cccC-CCCceEEEEeCCCCEEEECCC----CCEEEcCCCCC
Confidence 9876 345566999999999999864 24899999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=259.46 Aligned_cols=223 Identities=24% Similarity=0.347 Sum_probs=166.6
Q ss_pred cccccccccCCcc-ceEeeeeCCchhhh------------------------hhhhhhhcceeecCceeeEEEeccCCCC
Q 039318 426 FSINKKLGEGGFG-PVYKGTLADGQEIA------------------------HRNLVKLLGCCIQGEEKLLIYEFMPNRS 480 (717)
Q Consensus 426 ~~~~~~lG~G~fg-~Vy~~~~~~~~~va------------------------h~niv~l~~~~~~~~~~~lV~E~~~~gs 480 (717)
|.-.+.+|.|+-| .||+|... ++.|| |||||++++.-.+.+.+||..|.|.. +
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s 588 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S 588 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence 4445778999886 57999885 34444 99999999999999999999999955 9
Q ss_pred hhhHhhhc-cccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC---C--CCceeccccccccccCCc
Q 039318 481 LDSFIFDQ-TKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH---E--MNPKISDFGLARTFVGDE 554 (717)
Q Consensus 481 L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~---~--~~~kl~Dfgla~~~~~~~ 554 (717)
|.+++... ...........+.++.|+++||++||+.+ ||||||||+||||.. + ..++|+|||+++.+..+.
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 99999553 11111111344668899999999999987 999999999999976 3 468999999999887654
Q ss_pred ccc-ccceecccccccCccccccCCCCccccchhHhHHHHHhhcC-CCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 555 IEG-STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSG-KKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 555 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
... +.....||-+|+|||++....-+.++||||||||+|+.++| .+||+.....+ ..++........+
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L~~L-- 735 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTLVHL-- 735 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCccceeee--
Confidence 332 23457899999999999998888999999999999999985 99997432111 0111111100000
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
....+. ...+|+.+|+..+|..||++.+|+.
T Consensus 736 ----~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 ----EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ----ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 001111 6678999999999999999999985
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=234.47 Aligned_cols=240 Identities=23% Similarity=0.372 Sum_probs=191.0
Q ss_pred cHHHHHHHhcCcccccccccCCccceEeeeeCCc------hhhh---------------------------hhhhhhhcc
Q 039318 415 ELATIANATDNFSINKKLGEGGFGPVYKGTLADG------QEIA---------------------------HRNLVKLLG 461 (717)
Q Consensus 415 ~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~va---------------------------h~niv~l~~ 461 (717)
...++.....+++....+-+|.||.||+|.+.+. +++. |||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 4556666677899999999999999999966532 2211 999999999
Q ss_pred eeecC-ceeeEEEeccCCCChhhHhh-----hccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC
Q 039318 462 CCIQG-EEKLLIYEFMPNRSLDSFIF-----DQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH 535 (717)
Q Consensus 462 ~~~~~-~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~ 535 (717)
++.+. ...+++|.++.-|.|..|+. +....+.+...+...++.|++.|++|||.++ |||.||...|.+||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 98754 56789999999999999997 3344455677788889999999999999998 999999999999999
Q ss_pred CCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHH
Q 039318 536 EMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLI 614 (717)
Q Consensus 536 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~ 614 (717)
...+||+|=.+++-+.+.+.......--....||+||.+....|+.++|+|||||++|||++ |+.|+..-++.+-..
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-- 509 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-- 509 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH--
Confidence 99999999999998776665544444445678999999999999999999999999999999 999976443332211
Q ss_pred HHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 615 GHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 615 ~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
.++++. +-..+.....++..++.-||...|++||+.+++++-|.+
T Consensus 510 -----ylkdGy---------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 510 -----YLKDGY---------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -----HHhccc---------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 112221 122344455667788888999999999999999998853
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=202.19 Aligned_cols=109 Identities=47% Similarity=1.041 Sum_probs=103.2
Q ss_pred EecCCCCCceeecc-ccccccceeeEEeecCCeEEEEEEecCCceEEEEEEeeccceEEEEEEecCCCcEEEEeccCCCC
Q 039318 179 YRTGPWNGLIFSAS-SLRLNPIFKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSLRQRFIWRKANQSWELYSNLPKDQ 257 (717)
Q Consensus 179 ~~~~~~~g~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~~~~~~~w~~~~~~W~~~~~~p~~~ 257 (717)
||+|||||..|+++ ++.....+.+.|+.+.++.+++|...+.+.++|++|+.+| .++++.|++..++|.++|.+|.|+
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G-~l~~~~w~~~~~~W~~~~~~p~d~ 79 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDG-QLQRYIWNESTQSWSVFWSAPKDQ 79 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeee-EEEEEEEecCCCcEEEEEEecccC
Confidence 89999999999999 5666678899999999999999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCccccccCCCCcccccCCcccCC
Q 039318 258 CDTYGLCGAYGICIISQSPICQCLEGFHPKS 288 (717)
Q Consensus 258 C~~~~~CG~~g~C~~~~~~~C~C~~gf~~~~ 288 (717)
||+|+.||+||+|+.+..+.|+|++||+|++
T Consensus 80 Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 80 CDVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 9999999999999988889999999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=228.78 Aligned_cols=195 Identities=27% Similarity=0.337 Sum_probs=155.3
Q ss_pred hhhhhhhcceeecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceE
Q 039318 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVL 532 (717)
Q Consensus 453 h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIl 532 (717)
|+||+++++++......+++|||+++++|.+++.... .+++..+..++.++++++.|||+.+ ++|+||+|.||+
T Consensus 46 ~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~ 119 (244)
T smart00220 46 HPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENIL 119 (244)
T ss_pred CCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeE
Confidence 9999999999999999999999999999999985432 2788999999999999999999998 999999999999
Q ss_pred EcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchh
Q 039318 533 LDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLN 612 (717)
Q Consensus 533 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~ 612 (717)
++.++.++|+|||.+....... ......++..|++||.+.+..++.++||||||+++++|++|..||.... ....
T Consensus 120 ~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~ 194 (244)
T smart00220 120 LDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLE 194 (244)
T ss_pred ECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHH
Confidence 9999999999999998764432 2234668889999999998889999999999999999999999986421 1111
Q ss_pred HHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 613 LIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
............. . . ......++.+++.+|+..+|++||++.++++
T Consensus 195 ----~~~~~~~~~~~~~-~---~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 195 ----LFKKIGKPKPPFP-P---P---EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ----HHHHHhccCCCCc-c---c---cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 1111111111100 0 0 0002246778999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-27 Score=218.30 Aligned_cols=176 Identities=28% Similarity=0.370 Sum_probs=142.7
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hhh----------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QEI----------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v----------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
.+...-+..||+|++|.|=+-++... +.+ .+|.+|.+||.+......++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 34455567899999999877655322 111 1899999999999999999999
Q ss_pred eccCCCChhhHhhhc-cccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 474 EFMPNRSLDSFIFDQ-TKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 474 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|.|.- +|+.+..+- ...+.+++...=+|+..+.+||.|||++- .+||||+||+||||+.+|++|+||||++..+.+
T Consensus 125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 99954 888777543 34556888888899999999999999974 699999999999999999999999999987643
Q ss_pred CccccccceecccccccCcccccc----CCCCccccchhHhHHHHHhhcCCCCCCC
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASD----GLFSVKSDVFSFGILLLEIVSGKKNRGF 604 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlG~il~elltG~~p~~~ 604 (717)
.- ......|...|||||.+.. ..|+.|+||||||+.+.||.+++.||+.
T Consensus 202 Si---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 202 SI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 32 1222467889999998753 3689999999999999999999999763
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.6e-26 Score=238.30 Aligned_cols=169 Identities=28% Similarity=0.385 Sum_probs=148.3
Q ss_pred cCcccccccccCCccceEeeeeCCchhh-----------------------------h---------hhhhhhhcceeec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEI-----------------------------A---------HRNLVKLLGCCIQ 465 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~v-----------------------------a---------h~niv~l~~~~~~ 465 (717)
.+|..++.||+|+||.|+.|.++..... + |+||+|++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4689999999999999999987654211 0 9999999999999
Q ss_pred CceeeEEEecc-CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccc
Q 039318 466 GEEKLLIYEFM-PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDF 544 (717)
Q Consensus 466 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 544 (717)
.+..||+||-. ++.+|.++| ...+.+++.+...|+.||+.|+++||+++ |||||||-+|+.++.+|.+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999976 567899999 34455889999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCccccccceecccccccCccccccCCCC-ccccchhHhHHHHHhhcCCCCC
Q 039318 545 GLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFS-VKSDVFSFGILLLEIVSGKKNR 602 (717)
Q Consensus 545 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~elltG~~p~ 602 (717)
|.|....... ...++||..|.|||++.|.+|- ..-|||+||++||.++..+.||
T Consensus 715 gsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 9998764432 4468999999999999998875 5689999999999999988885
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=193.14 Aligned_cols=112 Identities=51% Similarity=0.800 Sum_probs=98.0
Q ss_pred CCCCCCEEEeCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEEe
Q 039318 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSA 80 (717)
Q Consensus 1 ~l~~~~~l~S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst 80 (717)
.|+.|++|+|+++.|++|||.+... ..+.+|||++.+ +++||+||++.|+.+ ++.|.|+.||+|+|.+.+|.++|+|
T Consensus 3 ~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 3 TLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred ccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 3789999999999999999998754 588999999987 899999999999866 4789999999999999999999999
Q ss_pred ccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCC
Q 039318 81 NLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDY 120 (717)
Q Consensus 81 ~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~ 120 (717)
++.. ..+..+|+|+|+|||||++.++ .+|||||||
T Consensus 80 ~t~~-~~~~~~~~L~ddGnlvl~~~~~----~~~W~Sf~~ 114 (114)
T smart00108 80 NTTG-ANGNYVLVLLDDGNLVIYDSDG----NFLWQSFDY 114 (114)
T ss_pred cccC-CCCceEEEEeCCCCEEEECCCC----CEEeCCCCC
Confidence 9872 3455669999999999997642 399999997
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=266.03 Aligned_cols=197 Identities=16% Similarity=0.204 Sum_probs=140.8
Q ss_pred hhhh-hhhhhhccee-------ecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcE
Q 039318 450 EIAH-RNLVKLLGCC-------IQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRI 521 (717)
Q Consensus 450 ~vah-~niv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i 521 (717)
...| +||+++++++ .+....+++|||+ +++|.+++... ...+++.+++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3446 7999999987 3334567888987 55999999532 345899999999999999999999998 9
Q ss_pred EeccCCCCceEEcC-------------------CCCceeccccccccccCCcc--------------ccccceecccccc
Q 039318 522 IHRDLKASNVLLDH-------------------EMNPKISDFGLARTFVGDEI--------------EGSTKRVVGTYGY 568 (717)
Q Consensus 522 vHrDlkp~NIll~~-------------------~~~~kl~Dfgla~~~~~~~~--------------~~~~~~~~gt~~y 568 (717)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 45567777777764211000 0001124688999
Q ss_pred cCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHH
Q 039318 569 MAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIH 648 (717)
Q Consensus 569 ~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 648 (717)
||||++.+..++.++|||||||+||||++|..|+.... ..+. .+... .+.+. ......+...
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~----~~~~~----~~~~~-----~~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMS----SLRHR----VLPPQ-----ILLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHH----HHHHh----hcChh-----hhhcCHHHHH
Confidence 99999999999999999999999999999888754210 0110 00000 00110 0112234567
Q ss_pred HHhhccccCCCCCCChHHHHHH
Q 039318 649 VGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 649 l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
++.+||+.+|.+||+|.||++.
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8889999999999999999863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=240.42 Aligned_cols=228 Identities=25% Similarity=0.382 Sum_probs=178.6
Q ss_pred HhcCcccccccccCCccceEeeeeCCchhhh---------------------------hhhhhhhcceeecCceeeEEEe
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQEIA---------------------------HRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va---------------------------h~niv~l~~~~~~~~~~~lV~E 474 (717)
..++|+...++|+|.||.|||+++....+++ |||||.+++.+...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3468999999999999999999986554433 9999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
||.+|+|.+.. ...+++++.++....++.++||+|||+.+ =+|||||-.|||+.+.|.+|++|||.+..+...
T Consensus 93 ycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat- 165 (829)
T KOG0576|consen 93 YCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT- 165 (829)
T ss_pred ecCCCccccee---eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh-
Confidence 99999999887 34667899999999999999999999998 799999999999999999999999999866432
Q ss_pred cccccceecccccccCcccc---ccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 555 IEGSTKRVVGTYGYMAPEYA---SDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
-...+.+.||+.|||||+. +.+.|..++|||++|+...||-.-++|.-..++.....+... ....+..+-|
T Consensus 166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk-----S~~qpp~lkD 239 (829)
T KOG0576|consen 166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK-----SGFQPPTLKD 239 (829)
T ss_pred -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc-----cCCCCCcccC
Confidence 2334568999999999976 456799999999999999999887777433332222211100 0112222222
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+.-. ...+-+++..||.++|++||+++.+++
T Consensus 240 k~kw-------s~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 240 KTKW-------SEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred Cccc-------hHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2211 223446677799999999999987765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-25 Score=213.45 Aligned_cols=228 Identities=21% Similarity=0.328 Sum_probs=167.9
Q ss_pred hcCcccccccccCCccceEeeeeCCchh-hh--------------------------hhhhhhhcce-eecCceeeEEEe
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQE-IA--------------------------HRNLVKLLGC-CIQGEEKLLIYE 474 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-va--------------------------h~niv~l~~~-~~~~~~~~lV~E 474 (717)
.+.|.+.+.||+|-||.+-+++++..+. ++ |.||+.-|++ |+..+..++++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 4679999999999999999999875432 11 9999988875 566778889999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc--CCCCceeccccccccccC
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD--HEMNPKISDFGLARTFVG 552 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~--~~~~~kl~Dfgla~~~~~ 552 (717)
|+|.|+|.+-+.. .-+-+....+++.|++.||.|+|+++ +||||||.+||||- +.-.+||+|||+.+....
T Consensus 103 ~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999988833 23667778889999999999999998 99999999999993 334799999999875421
Q ss_pred CccccccceecccccccCccccccC-----CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDG-----LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
.....--+..|.+||..... ...+.+|||.||+|+|.+|+|+.||.....+ ....+-+..|..+...
T Consensus 176 -----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~---d~~Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 176 -----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM---DKPYWEWEQWLKRKNP 247 (378)
T ss_pred -----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc---CchHHHHHHHhcccCc
Confidence 12233456789999976432 2457899999999999999999999733332 2334455566666554
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHh
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L 671 (717)
.+.+.... -..++.++..+-|..++++|--+-++.+|.
T Consensus 248 ~~P~~F~~------fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 248 ALPKKFNP------FSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred cCchhhcc------cCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 33332221 112344555667889999996655555553
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-25 Score=221.00 Aligned_cols=220 Identities=25% Similarity=0.268 Sum_probs=157.5
Q ss_pred hhhhhhhhcceeecC------ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEecc
Q 039318 452 AHRNLVKLLGCCIQG------EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRD 525 (717)
Q Consensus 452 ah~niv~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrD 525 (717)
.|+||++++.++.-. ...|+|||||.. +|...+. -.++.+++..|+.|++.|++|||+.+ |+|||
T Consensus 73 ~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRd 143 (369)
T KOG0665|consen 73 NHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRD 143 (369)
T ss_pred cccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecc
Confidence 399999999998643 457999999954 7777773 34788889999999999999999998 99999
Q ss_pred CCCCceEEcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCC
Q 039318 526 LKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFY 605 (717)
Q Consensus 526 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~ 605 (717)
|||+||++..+..+||.|||+|+..... .....++.|+.|.|||++.+..+.+.+||||+|||+.||+.|+.-|...
T Consensus 144 LkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 144 LKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred cCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 9999999999999999999999875433 2344678999999999999988999999999999999999999987643
Q ss_pred CCCCchhHHHH---------------HHHHhhCCCC--------ccccchhhhc--cCCHHHHHHHHHHHhhccccCCCC
Q 039318 606 HSDKNLNLIGH---------------AWKLWNNGMP--------SQLIDAYYQE--SCNLAEVIRCIHVGLLCVQHHPED 660 (717)
Q Consensus 606 ~~~~~~~~~~~---------------~~~~~~~~~~--------~~l~d~~~~~--~~~~~~~~~~~~l~~~Cl~~dp~~ 660 (717)
...+....+.. ....+.+... +.+.|..... ..+......+.+++.+||-.+|++
T Consensus 221 d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~ 300 (369)
T KOG0665|consen 221 DHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEK 300 (369)
T ss_pred hHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhh
Confidence 32221111111 0000000000 0001111100 011122334567899999999999
Q ss_pred CCChHHHHHH--hc---CCCCCCCCCCC
Q 039318 661 RPCMPSVILM--LG---SEIMLPQPKQP 683 (717)
Q Consensus 661 RPs~~evl~~--L~---~~~~~~~p~~p 683 (717)
|.++.++++. ++ ...+++.|+.|
T Consensus 301 Risv~daL~HPY~~vw~~~~ev~ap~pe 328 (369)
T KOG0665|consen 301 RISVDDALRHPYIKVWYDPDEVEAPPPE 328 (369)
T ss_pred cccHHHHhcCCeeeeecccccccCCCCc
Confidence 9999999984 43 33344444444
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=224.64 Aligned_cols=107 Identities=30% Similarity=0.424 Sum_probs=89.1
Q ss_pred hcCcccccccccCCccceEeeeeCCchh-hh---------------------------------hhhhhhhcceeec---
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQE-IA---------------------------------HRNLVKLLGCCIQ--- 465 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-va---------------------------------h~niv~l~~~~~~--- 465 (717)
..+|.+.++||-|-|++||++.+..+.. || ..+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 3689999999999999999998654321 11 3579999999864
Q ss_pred -CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE
Q 039318 466 -GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL 533 (717)
Q Consensus 466 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll 533 (717)
+.++++|+|++ |..|..+|... ..+-++...+..|++||+.||.|||.++ +|||.||||+||||
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56899999999 55777787543 3445889999999999999999999987 69999999999999
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-24 Score=206.23 Aligned_cols=234 Identities=21% Similarity=0.325 Sum_probs=170.8
Q ss_pred HhcCcccccccccCCccceEeeeeCCc-hh-----------------hh-------hhhhhhhcceeecC--ceeeEEEe
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADG-QE-----------------IA-------HRNLVKLLGCCIQG--EEKLLIYE 474 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~-----------------va-------h~niv~l~~~~~~~--~~~~lV~E 474 (717)
..++|++.+++|+|.+++||.|..-.. ++ +. ||||+++++...+. ....||+|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 357899999999999999999974221 11 11 99999999998765 45679999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC-CCceeccccccccccCC
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE-MNPKISDFGLARTFVGD 553 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~Dfgla~~~~~~ 553 (717)
|+.+.+...+. ..|+...+..++.++++||.|+|+.| |.|||+||.|+|||.. -.++|+|+|+|.+..+.
T Consensus 116 ~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 116 YVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 99998876655 23666778889999999999999999 9999999999999854 56999999999987554
Q ss_pred ccccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc----
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ---- 628 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 628 (717)
. ..+..+.+..|--||++..- .|+..-|+|||||+|..|+..+.||- +..++.+++..+.+.+.-..+..
T Consensus 187 ~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF--hG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 187 K---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF--HGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred c---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc--CCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 3 23345678889999988764 58899999999999999999999963 44444333333332221100000
Q ss_pred ---ccchhhhc------cCCHH----------HHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 629 ---LIDAYYQE------SCNLA----------EVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 629 ---l~d~~~~~------~~~~~----------~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.+|+.... ..+.. ...++++++...|..|-.+|||+.|.+.
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 01211111 00010 1146778888999999999999999876
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=226.12 Aligned_cols=179 Identities=21% Similarity=0.232 Sum_probs=152.9
Q ss_pred HHHhcCcccccccccCCccceEeeeeCC-chhhh-------------------------------hhhhhhhcceeecCc
Q 039318 420 ANATDNFSINKKLGEGGFGPVYKGTLAD-GQEIA-------------------------------HRNLVKLLGCCIQGE 467 (717)
Q Consensus 420 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va-------------------------------h~niv~l~~~~~~~~ 467 (717)
+....+|.+....|+|-|+.|.+|.+.. ++.|| --|+++|+..|...+
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 4456799999999999999999998643 33333 357899999999999
Q ss_pred eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC-Cceeccccc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM-NPKISDFGL 546 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~Dfgl 546 (717)
++|||+|-+ ...|.+.+......--|....+..++.|+.-||..|...+ |+|.||||+|||+++.- .+||||||.
T Consensus 508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcc
Confidence 999999987 4589999977766667888999999999999999999888 99999999999998764 579999999
Q ss_pred cccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCC
Q 039318 547 ARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYH 606 (717)
Q Consensus 547 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~ 606 (717)
|-.....+. ..+.-+..|.|||++.|.+|+...|+||.||.||||.||+..|....
T Consensus 584 A~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 584 ASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred ccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 987654442 24567789999999999999999999999999999999999886543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=204.06 Aligned_cols=164 Identities=19% Similarity=0.197 Sum_probs=123.5
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
|+|.+++... ...+++..++.++.||++||.|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence 6888988542 346899999999999999999999875 999999999999999 9999865332
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
...||+.|||||++.+..++.++|||||||++|||++|+.||....... ..+............ ....
T Consensus 63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~--------~~~~ 130 (176)
T smart00750 63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADDP--------RDRS 130 (176)
T ss_pred --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCCc--------cccc
Confidence 2368899999999999999999999999999999999999985432211 111111111111000 0001
Q ss_pred CHHHH---HHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 639 NLAEV---IRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 639 ~~~~~---~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
..... ..+.+++.+||+.+|.+||++.++++.+.
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence 11222 25889999999999999999999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=205.65 Aligned_cols=185 Identities=36% Similarity=0.585 Sum_probs=157.2
Q ss_pred cccCCccceEeeeeCC-ch---------------------------hhhhhhhhhhcceeecCceeeEEEeccCCCChhh
Q 039318 432 LGEGGFGPVYKGTLAD-GQ---------------------------EIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDS 483 (717)
Q Consensus 432 lG~G~fg~Vy~~~~~~-~~---------------------------~vah~niv~l~~~~~~~~~~~lV~E~~~~gsL~~ 483 (717)
||+|++|.||++.... ++ .+.|++|+++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998753 11 0128999999999999999999999999999999
Q ss_pred HhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC-CCCceeccccccccccCCcccccccee
Q 039318 484 FIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH-EMNPKISDFGLARTFVGDEIEGSTKRV 562 (717)
Q Consensus 484 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~ 562 (717)
++.... ..+++..+..++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985432 35788999999999999999999998 999999999999999 89999999999986543321 12235
Q ss_pred cccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHH
Q 039318 563 VGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLA 641 (717)
Q Consensus 563 ~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~ 641 (717)
.+...|++||.+... .++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 678899999999887 888999999999999998
Q ss_pred HHHHHHHHHhhccccCCCCCCChHHHHHHh
Q 039318 642 EVIRCIHVGLLCVQHHPEDRPCMPSVILML 671 (717)
Q Consensus 642 ~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L 671 (717)
..+.+++.+|++.+|++||++.+++..|
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4566788899999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-24 Score=219.06 Aligned_cols=177 Identities=25% Similarity=0.424 Sum_probs=144.2
Q ss_pred HHHhcCcccccccccCCccceEeeeeCC---c-hhhh-------------------------hhhhhhhcceeecCceee
Q 039318 420 ANATDNFSINKKLGEGGFGPVYKGTLAD---G-QEIA-------------------------HRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 420 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~---~-~~va-------------------------h~niv~l~~~~~~~~~~~ 470 (717)
....+.|..+++||+|.|++||++.+.. . ..+| +.||+++.+++...+.+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 3445688999999999999999998755 2 1222 889999999999999999
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC-CCceecccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE-MNPKISDFGLART 549 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~Dfgla~~ 549 (717)
+||||++.....+++.. ++...+..+++.++.||+++|.+| ||||||||+|+|.+.. +.-.|.|||+|..
T Consensus 112 ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred EEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHH
Confidence 99999999999888843 667888899999999999999999 9999999999999854 5678999999972
Q ss_pred ccCC-------------cc-----------------------------ccccceecccccccCcccccc-CCCCccccch
Q 039318 550 FVGD-------------EI-----------------------------EGSTKRVVGTYGYMAPEYASD-GLFSVKSDVF 586 (717)
Q Consensus 550 ~~~~-------------~~-----------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvw 586 (717)
.... .. ....-...||++|+|||++.. ...+.++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 1100 00 000112479999999998865 4578999999
Q ss_pred hHhHHHHHhhcCCCCCCCC
Q 039318 587 SFGILLLEIVSGKKNRGFY 605 (717)
Q Consensus 587 SlG~il~elltG~~p~~~~ 605 (717)
|.|||++-+++++.||-..
T Consensus 263 s~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eccceeehhhccccccccC
Confidence 9999999999999997543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=202.74 Aligned_cols=172 Identities=33% Similarity=0.492 Sum_probs=146.0
Q ss_pred cccccccccCCccceEeeeeCC-ch---------------------------hhhhhhhhhhcceeecCceeeEEEeccC
Q 039318 426 FSINKKLGEGGFGPVYKGTLAD-GQ---------------------------EIAHRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~-~~---------------------------~vah~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
|.+.+.||+|++|.||++...+ ++ .+.|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999998764 21 1129999999999999999999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||++....... ..
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AA 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-cc
Confidence 9999999854321 1788999999999999999999997 9999999999999999999999999998764432 01
Q ss_pred ccceecccccccCcccc-ccCCCCccccchhHhHHHHHhhcCCCCCC
Q 039318 558 STKRVVGTYGYMAPEYA-SDGLFSVKSDVFSFGILLLEIVSGKKNRG 603 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~elltG~~p~~ 603 (717)
......++..|++||.+ ....++.++|+|+||++++||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 22346678899999998 67778889999999999999999999985
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=192.60 Aligned_cols=233 Identities=22% Similarity=0.254 Sum_probs=169.3
Q ss_pred CcccccccccCCccceEeeeeCCch--hhh------------------------h------hhhhhhccee-ecCceeeE
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ--EIA------------------------H------RNLVKLLGCC-IQGEEKLL 471 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~--~va------------------------h------~niv~l~~~~-~~~~~~~l 471 (717)
+|.+.++||+|+||.||++...... .+| . +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 8999999999999999999865432 111 1 3666777777 46778899
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC-----CCceeccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE-----MNPKISDFGL 546 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~-----~~~kl~Dfgl 546 (717)
||+.+ |.+|.++..... .+.++..+.+.|+.|++.+|.+||+.+ ++||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 779999775544 567899999999999999999999999 9999999999999865 4589999999
Q ss_pred cc--cccCCcc----ccc--cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHH
Q 039318 547 AR--TFVGDEI----EGS--TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAW 618 (717)
Q Consensus 547 a~--~~~~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~ 618 (717)
++ ....... ... .....||..|+++..+.+...+.+.|+||++.++.||+.|..||................
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 4322211 111 224569999999999999999999999999999999999999986544333222211111
Q ss_pred HHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 619 KLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 619 ~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
. ... ... .....+.+...+ ...+-..+..++|....+...|...
T Consensus 254 ~---~~~----~~~--~~~~~~~~~~~~---~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 254 R---KLL----TDR--FGDLKPEEFAKI---LEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred h---hhc----ccc--ccCCChHHHHHH---HHHhhccCCcCCCCHHHHHHHHHHH
Confidence 1 000 010 112223333333 3334447889999999998887544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-20 Score=213.68 Aligned_cols=203 Identities=23% Similarity=0.260 Sum_probs=154.9
Q ss_pred hhhhhhhcceeecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceE
Q 039318 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVL 532 (717)
Q Consensus 453 h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIl 532 (717)
|+|++..+..+.+.....-+||||+. +|..++.. ...+....+..++.|++.|+.|||..+ |.|||||++|++
T Consensus 380 h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll 452 (601)
T KOG0590|consen 380 HPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLL 452 (601)
T ss_pred CCchhhhHHHHhhcccchhhhhcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEE
Confidence 89988888877777777777999999 99999943 245778888999999999999999999 999999999999
Q ss_pred EcCCCCceeccccccccccCCccc--cccceecccccccCccccccCCCCc-cccchhHhHHHHHhhcCCCCCCCCCCCC
Q 039318 533 LDHEMNPKISDFGLARTFVGDEIE--GSTKRVVGTYGYMAPEYASDGLFSV-KSDVFSFGILLLEIVSGKKNRGFYHSDK 609 (717)
Q Consensus 533 l~~~~~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwSlG~il~elltG~~p~~~~~~~~ 609 (717)
+..++.+||+|||.+..+.-.... ......+|+..|+|||++.+..|.+ ..||||.|+|+..|++|+.||......+
T Consensus 453 ~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~ 532 (601)
T KOG0590|consen 453 VTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSD 532 (601)
T ss_pred EecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccc
Confidence 999999999999999876433222 3344578999999999999999875 5899999999999999999998665544
Q ss_pred chhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 610 NLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.... .........+.... .........+...++-++||.+|.+|.||++|++.
T Consensus 533 ~~~~------~~~~~~~~~~~~~~--~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 533 NSFK------TNNYSDQRNIFEGP--NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cchh------hhccccccccccCh--HHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 3320 00000000000000 00111223456778889999999999999999874
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-19 Score=178.33 Aligned_cols=184 Identities=21% Similarity=0.329 Sum_probs=153.1
Q ss_pred cCcccccccccCCccceEeeeeC-Cchhhh-------------------------hhhhhhhcceeecCceeeEEEeccC
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLA-DGQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
-+|.+.++||+|+||++|.|+.- +++.|| .+.|...|-|..++.+-.||||.+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 47999999999999999999742 333333 678888888888999999999988
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC-----CceeccccccccccC
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM-----NPKISDFGLARTFVG 552 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~-----~~kl~Dfgla~~~~~ 552 (717)
|.+|+++..- -...++.+++..++.|++.-++|+|++. +|.|||||+|+||...+ .+.|+|||+|+....
T Consensus 107 GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 7788887722 2335899999999999999999999998 99999999999996443 478999999998765
Q ss_pred Cccccc-----cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhH
Q 039318 553 DEIEGS-----TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNL 613 (717)
Q Consensus 553 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~ 613 (717)
..+..+ .+...||..||+--...+...+.+.|+-|||-+++..|-|..||.....+.....
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k 247 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK 247 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH
Confidence 443322 3456899999999999999999999999999999999999999988776655443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.9e-19 Score=174.52 Aligned_cols=222 Identities=22% Similarity=0.327 Sum_probs=165.6
Q ss_pred ccccccccCCccceEeeeeCCchhhh---------------------------hhhhhhhcceeecCceeeEEEeccCCC
Q 039318 427 SINKKLGEGGFGPVYKGTLADGQEIA---------------------------HRNLVKLLGCCIQGEEKLLIYEFMPNR 479 (717)
Q Consensus 427 ~~~~~lG~G~fg~Vy~~~~~~~~~va---------------------------h~niv~l~~~~~~~~~~~lV~E~~~~g 479 (717)
.+..+|.+...|+.|+|++.....|+ ||||..+++.|.......++..|||-|
T Consensus 193 nl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 34457889999999999987654443 999999999999999999999999999
Q ss_pred ChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEec-cCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 480 SLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHR-DLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 480 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHr-Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
+|...++.+.. -.++..+..+++.+|++|++|||+..+ ++-| -|....++||++.+++|+ .+-+++ +..
T Consensus 273 slynvlhe~t~-vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltaris-mad~kf------sfq 342 (448)
T KOG0195|consen 273 SLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARIS-MADTKF------SFQ 342 (448)
T ss_pred HHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhhee-ccccee------eee
Confidence 99999965432 346778899999999999999999873 4443 588899999999998875 122221 111
Q ss_pred cceecccccccCccccccCCCC---ccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 559 TKRVVGTYGYMAPEYASDGLFS---VKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~---~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
.....-.+.||+||.++..+-+ .++|+|||+++++||.|.+.||....+.+-...+ .-++. +
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki------alegl---------r 407 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI------ALEGL---------R 407 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh------hhccc---------c
Confidence 1223457899999999876643 6799999999999999999999876655432211 11111 1
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
-..++.-...+.+++.-|+..||.+||....|+-+||.
T Consensus 408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 11122222334556666999999999999999998874
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.3e-19 Score=170.36 Aligned_cols=185 Identities=20% Similarity=0.325 Sum_probs=148.3
Q ss_pred HhcCcccccccccCCccceEeeee-CCchhhh---------hhh----------------hhhhcceeecCceeeEEEec
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTL-ADGQEIA---------HRN----------------LVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~va---------h~n----------------iv~l~~~~~~~~~~~lV~E~ 475 (717)
...+|.++++||+|+||.+|.|.. ..|.+|| ||. |..+..+..+...-.+|||.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 356899999999999999999985 4566655 543 44556677788888999998
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC---CCceeccccccccccC
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE---MNPKISDFGLARTFVG 552 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~---~~~kl~Dfgla~~~~~ 552 (717)
+ |.+|+++..-. .+.++.++++-++-|++.-++|+|.++ +|||||||+|+|..-+ ..+.|+|||+|+.+..
T Consensus 93 L-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 93 L-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred c-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 8 77898887322 234788899999999999999999999 9999999999999754 4578999999997644
Q ss_pred Ccccc-----ccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchh
Q 039318 553 DEIEG-----STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLN 612 (717)
Q Consensus 553 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~ 612 (717)
..... ......||..|.+--.+.+...+.+.|+-|+|.+|..+.-|..||....+.....
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q 231 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ 231 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH
Confidence 32221 1234689999999988888888999999999999999999999998766554433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.5e-18 Score=181.61 Aligned_cols=238 Identities=27% Similarity=0.350 Sum_probs=172.5
Q ss_pred cccccccccCCccceEeeeeCCc---------------------------hhhhhh-hhhhhcceeecCceeeEEEeccC
Q 039318 426 FSINKKLGEGGFGPVYKGTLADG---------------------------QEIAHR-NLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~~---------------------------~~vah~-niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
|.+.+.||.|+||.||++..... ..+.|+ +|+++++.+......++++|++.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 66778999999999999986511 011155 79999999977777899999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC-CceeccccccccccCCccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM-NPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~~ 556 (717)
++++.+++........+.......+..|++.++.|+|+.+ ++||||||+||+++..+ .++++|||+++........
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999966633221125788899999999999999999998 99999999999999998 7999999999865443322
Q ss_pred c----ccceecccccccCcccccc---CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 557 G----STKRVVGTYGYMAPEYASD---GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 557 ~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
. ......|+..|+|||.+.+ ..+....|+||+|+++++++.|..||......... ......+...... .
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~-~ 234 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT---SQTLKIILELPTP-S 234 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccH---HHHHHHHHhcCCc-c
Confidence 1 2356789999999999987 57889999999999999999999996544331001 1111111111110 0
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
................+.+++..|+..+|..|.++.+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000001223456678888999999999999887764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.2e-19 Score=188.43 Aligned_cols=150 Identities=21% Similarity=0.243 Sum_probs=111.0
Q ss_pred HHHhcCcccccccccCCccceEeeeeCC--chh-------------------------------hhhhhhhh-hcceeec
Q 039318 420 ANATDNFSINKKLGEGGFGPVYKGTLAD--GQE-------------------------------IAHRNLVK-LLGCCIQ 465 (717)
Q Consensus 420 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~-------------------------------vah~niv~-l~~~~~~ 465 (717)
....++|.+.+.||+|+||+||+|.++. ++. +.|+|++. ++.
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 4456789999999999999999997542 111 11888874 433
Q ss_pred CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccC-CCCceEEcCCCCceeccc
Q 039318 466 GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDL-KASNVLLDHEMNPKISDF 544 (717)
Q Consensus 466 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDl-kp~NIll~~~~~~kl~Df 544 (717)
.+..+|||||+++++|.. + . .. . ...++.+++++|.|||+++ |+|||| ||+|||++.++.+||+||
T Consensus 90 ~~~~~LVmE~~~G~~L~~-~-~--~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHL-A-R--PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred cCCcEEEEEccCCCCHHH-h-C--cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 246899999999999962 2 1 11 1 1457889999999999998 999999 999999999999999999
Q ss_pred cccccccCCccccc------cceecccccccCccccccCC------CCccccch
Q 039318 545 GLARTFVGDEIEGS------TKRVVGTYGYMAPEYASDGL------FSVKSDVF 586 (717)
Q Consensus 545 gla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~~sDvw 586 (717)
|+|+.+........ .....++..|+|||.+.... .+..+|-|
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99997654322111 13567888999999986432 23446666
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.6e-18 Score=173.86 Aligned_cols=195 Identities=19% Similarity=0.251 Sum_probs=130.8
Q ss_pred hhhhhhhcceeec---------------------------CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHH
Q 039318 453 HRNLVKLLGCCIQ---------------------------GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICG 505 (717)
Q Consensus 453 h~niv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ 505 (717)
|||||+++++|.+ ....|+||.-.+. +|.+++-. ...+.....-|+.|
T Consensus 275 HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 275 HPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILAQ 349 (598)
T ss_pred CCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHHH
Confidence 9999999988754 2345899987755 78888833 23556677779999
Q ss_pred HHHHHHHHhhcCCCcEEeccCCCCceEE--cCCC--CceeccccccccccCCcc----ccccceecccccccCccccccC
Q 039318 506 TARGLLYLHHDSRLRIIHRDLKASNVLL--DHEM--NPKISDFGLARTFVGDEI----EGSTKRVVGTYGYMAPEYASDG 577 (717)
Q Consensus 506 i~~~l~yLH~~~~~~ivHrDlkp~NIll--~~~~--~~kl~Dfgla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~ 577 (717)
+++|+.|||.++ |.|||+|.+|||| |+++ .+.|+|||.+---..... ....-...|...-||||+....
T Consensus 350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999999 9999999999999 3443 468999998854222111 1111224678889999988654
Q ss_pred C------CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHh
Q 039318 578 L------FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGL 651 (717)
Q Consensus 578 ~------~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~ 651 (717)
+ --.|+|.|+.|.+.||+++...||-.. .+-..... .+.+..+..+ .+..++ .+.+++.
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r-Gem~L~~r-----~Yqe~qLPal-----p~~vpp----~~rqlV~ 491 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR-GEMLLDTR-----TYQESQLPAL-----PSRVPP----VARQLVF 491 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCccccc-chheechh-----hhhhhhCCCC-----cccCCh----HHHHHHH
Confidence 3 236899999999999999999997421 11111100 0112222211 122222 3446777
Q ss_pred hccccCCCCCCChHHHHHH
Q 039318 652 LCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 652 ~Cl~~dp~~RPs~~evl~~ 670 (717)
..|+.||.+|++..-....
T Consensus 492 ~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred HHhcCCccccCCccHHHhH
Confidence 7899999999986544333
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=181.59 Aligned_cols=213 Identities=25% Similarity=0.372 Sum_probs=159.5
Q ss_pred hhhhhhhhhhcceeecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcE-EeccCCC
Q 039318 450 EIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRI-IHRDLKA 528 (717)
Q Consensus 450 ~vah~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i-vHrDlkp 528 (717)
.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++.-...++++|++||+|||... | .|+.|++
T Consensus 3 ~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~s 77 (484)
T KOG1023|consen 3 QLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALKS 77 (484)
T ss_pred ccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeecc
Confidence 46699999999999999999999999999999999965 3445888899999999999999999875 4 9999999
Q ss_pred CceEEcCCCCceeccccccccccCCccccccceecccccccCccccccCC-------CCccccchhHhHHHHHhhcCCCC
Q 039318 529 SNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL-------FSVKSDVFSFGILLLEIVSGKKN 601 (717)
Q Consensus 529 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwSlG~il~elltG~~p 601 (717)
.|.++|....+||+|||+.................-..-|.|||.+.+.. .+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999988764311111112233456799999987642 46779999999999999999999
Q ss_pred CCCCCCCCch-hHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 602 RGFYHSDKNL-NLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 602 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
|......... .++....+ .+. ....+...... +....++.++..||..+|.+||++..|-..++..
T Consensus 158 ~~~~~~~~~~~eii~~~~~---~~~--~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK---GGS--NPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred cccccccCChHHHHHHHHh---cCC--CCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 9875443332 22222211 011 11111111000 1222578889999999999999999999887654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.1e-18 Score=196.99 Aligned_cols=228 Identities=16% Similarity=0.190 Sum_probs=165.3
Q ss_pred CcccccccccCCccceEeeeeCCchhhh----------------------------hhhhhhhcceeecCceeeEEEecc
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQEIA----------------------------HRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~~va----------------------------h~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
++...+.||++.|=+|.+|++++|..|. |||.+.+.-+.......|||-+|.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 4566688999999999999888775322 888888887777777788999998
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc-c
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE-I 555 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~-~ 555 (717)
.+ +|.+.+ .-+..|...+...|+.|++.||..+|..+ |+|+|||.+||||..=..+.|+||...+...-.+ .
T Consensus 104 kh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 104 KH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred hh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 65 787777 45667888888889999999999999998 9999999999999999999999998877432111 1
Q ss_pred cc----ccceecccccccCcccccc----------CC-CCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHH
Q 039318 556 EG----STKRVVGTYGYMAPEYASD----------GL-FSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWK 619 (717)
Q Consensus 556 ~~----~~~~~~gt~~y~aPE~~~~----------~~-~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~ 619 (717)
.. ...+...-.+|+|||-+.. .+ .+++-||||+|||+.||++ |+++|+.. ....
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----------QL~a 246 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----------QLLA 246 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----------HHHh
Confidence 11 1122233458999997643 12 6788999999999999987 78888631 1111
Q ss_pred HhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 620 LWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 620 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
++.+. .......+++-.+ ..+.++++.|+|.||.+|.++++.++.-.+.+
T Consensus 247 -Yr~~~-~~~~e~~Le~Ied----~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 247 -YRSGN-ADDPEQLLEKIED----VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred -HhccC-ccCHHHHHHhCcC----ccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 11111 1111112221111 14567889999999999999999999855544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.1e-18 Score=194.27 Aligned_cols=178 Identities=24% Similarity=0.310 Sum_probs=150.2
Q ss_pred HHHHHhcCcccccccccCCccceEeeeeCCchhhh--------------------------hhhhhhhcceeecCceeeE
Q 039318 418 TIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA--------------------------HRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 418 ~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va--------------------------h~niv~l~~~~~~~~~~~l 471 (717)
+.....+.|.|.+.||+|+||.||+|...+++.+| -+.|..+..++.-.+.-+|
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 33455678999999999999999999998877665 2556677777777888999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc-------CCCCceeccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD-------HEMNPKISDF 544 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~-------~~~~~kl~Df 544 (717)
|+||.+.|+|.+++. ..+.++|..+..++.|+++.+..||..+ |||+||||+|+||. ....++|+||
T Consensus 772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence 999999999999993 5667899999999999999999999998 99999999999994 2345899999
Q ss_pred cccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCC
Q 039318 545 GLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKN 601 (717)
Q Consensus 545 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p 601 (717)
|-+.-+..-..........+|-.+-.+|+..|.++++.+|.|-|+.+++-||.|+..
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999754322222234457788999999999999999999999999999999999865
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=7.4e-18 Score=179.04 Aligned_cols=176 Identities=23% Similarity=0.312 Sum_probs=131.7
Q ss_pred ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccc
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGL 546 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgl 546 (717)
...++.|++|...+|.+||.+.......++...+.++.|++.|+.| ++ .+|||+||.||+...+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 4578999999999999999766666677889999999999999999 55 99999999999999999999999999
Q ss_pred cccccCCc----cccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHh
Q 039318 547 ARTFVGDE----IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLW 621 (717)
Q Consensus 547 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 621 (717)
........ .........||..||+||.+.+..|+.|+||||||+||+||+. -...++. ..+..-+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d~ 472 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTDI 472 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhhh
Confidence 98765443 2233456789999999999999999999999999999999987 2222210 0011111
Q ss_pred hCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHH
Q 039318 622 NNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSV 667 (717)
Q Consensus 622 ~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~ev 667 (717)
.++.+. +... .+...-..+.++++...|.+||+..++
T Consensus 473 r~g~ip----~~~~-----~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 473 RDGIIP----PEFL-----QDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hcCCCC----hHHh-----hcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 122211 0000 111122467889999999999955443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.8e-17 Score=179.28 Aligned_cols=138 Identities=32% Similarity=0.362 Sum_probs=121.0
Q ss_pred hhhhhhhcceeecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceE
Q 039318 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVL 532 (717)
Q Consensus 453 h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIl 532 (717)
||.+|++.-.++.+...+++++|..+|.|...+. ................++-++.++|+.+ |+|||+|++||+
T Consensus 56 ~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enil 129 (612)
T KOG0603|consen 56 TPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVL 129 (612)
T ss_pred CCceeeeeeeeccccchhHhhhhcccchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhccccccee
Confidence 8999999999999999999999999999987773 3344566666677888999999999998 999999999999
Q ss_pred EcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCC
Q 039318 533 LDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGF 604 (717)
Q Consensus 533 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~ 604 (717)
++.+|++++.|||+++...... ..+||..|||||++. ....++|.||||++.+||++|..||..
T Consensus 130 ld~~Ghi~~tdfglske~v~~~------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 130 LLLEGHIKLTDFGLSKEAVKEK------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ecccCccccCCchhhhHhHhhh------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 9999999999999999754332 228999999999998 677899999999999999999999874
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.3e-17 Score=159.68 Aligned_cols=147 Identities=13% Similarity=0.146 Sum_probs=111.6
Q ss_pred HHhcCcccccccccCCccceEeeeeCCc----------------------------------hhhhhhhhhhhcceeecC
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADG----------------------------------QEIAHRNLVKLLGCCIQG 466 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~----------------------------------~~vah~niv~l~~~~~~~ 466 (717)
...++|.+.+.||.|+||.||+.....+ ..+.|++|..+.+++...
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 3468999999999999999999765211 012289998888876533
Q ss_pred --------ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC
Q 039318 467 --------EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN 538 (717)
Q Consensus 467 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~ 538 (717)
...+|||||++|.+|.++. .++. ....+++.+|..||..+ ++||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 3578999999999997764 1222 24558999999999998 99999999999999988
Q ss_pred ceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhh
Q 039318 539 PKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIV 596 (717)
Q Consensus 539 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell 596 (717)
++|+|||.......+... ..+.....+..++|+|+||+.+..+.
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999998754221110 01344455778999999999887765
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.6e-16 Score=162.42 Aligned_cols=162 Identities=19% Similarity=0.263 Sum_probs=106.4
Q ss_pred eEEEeccCCCChhhHhh---hccc-cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 470 LLIYEFMPNRSLDSFIF---DQTK-RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
+++|+-+ .++|.+++. .... ...+....++.+..|+++.+++||..+ ++|+||||+|++++++|.++|+||+
T Consensus 115 ~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~ 190 (288)
T PF14531_consen 115 FLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDFS 190 (288)
T ss_dssp EEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--GG
T ss_pred hhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcChH
Confidence 5677766 458877763 2111 223455667778899999999999999 9999999999999999999999998
Q ss_pred ccccccCCccccccceecccccccCcccccc--------CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHH
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASD--------GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHA 617 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~ 617 (717)
.......... ....+..|.+||.... ..++.+.|.|+||+++|.|.+++.||+..........
T Consensus 191 ~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---- 261 (288)
T PF14531_consen 191 SLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---- 261 (288)
T ss_dssp GEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----
T ss_pred HHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----
Confidence 8875432111 1234578999997743 2578999999999999999999999986533322111
Q ss_pred HHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCC
Q 039318 618 WKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDR 661 (717)
Q Consensus 618 ~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~R 661 (717)
. -..+. +..+.+..|+..+|+.+|++|
T Consensus 262 ---------------~-f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 ---------------D-FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ---------------G-GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ---------------c-chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 1 12233 445566678889999999988
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.7e-16 Score=179.72 Aligned_cols=208 Identities=22% Similarity=0.290 Sum_probs=143.1
Q ss_pred hcCcccccccccCCccceEeeeeCCchh-hh---------hhhhhhhcceeecCceeeEEEeccCCCChhhHhhhccccc
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQE-IA---------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRK 492 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-va---------h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~ 492 (717)
..+|..++.|..|++|.||..+++..++ .+ -+||..+ .+..++| |+-...+ ...+
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~lilRnilt~------a~npfvv------gDc~tll---k~~g 146 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLILRNILTF------AGNPFVV------GDCATLL---KNIG 146 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccchhhhccccc------cCCccee------chhhhhc---ccCC
Confidence 4689999999999999999998874332 22 2332222 2233343 3333334 2233
Q ss_pred cCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC-------------Ccccccc
Q 039318 493 LLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG-------------DEIEGST 559 (717)
Q Consensus 493 ~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~-------------~~~~~~~ 559 (717)
.++... +.+++|||..+ |+|||+||+|.+|..-|++|+.|||+.+.... .......
T Consensus 147 ~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~d 215 (1205)
T KOG0606|consen 147 PLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQD 215 (1205)
T ss_pred CCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhh
Confidence 344332 67899999998 99999999999999999999999999975311 1112234
Q ss_pred ceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCC
Q 039318 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCN 639 (717)
Q Consensus 560 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 639 (717)
+..+||+.|+|||++....|...+|+|++|+|+||.+-|+.||....+++-+.........|.++ +
T Consensus 216 KqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~--------------d 281 (1205)
T KOG0606|consen 216 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE--------------D 281 (1205)
T ss_pred ccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc--------------C
Confidence 55799999999999999999999999999999999999999998766555433332222222222 1
Q ss_pred HHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 640 LAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 640 ~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.....++.+++.+.|+.+|..|--....+++
T Consensus 282 ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ev 312 (1205)
T KOG0606|consen 282 EALPPEAQDLIEQLLRQNPLCRLGTGGALEV 312 (1205)
T ss_pred cCCCHHHHHHHHHHHHhChHhhcccchhhhh
Confidence 1112244556777899999999654444443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.7e-16 Score=152.31 Aligned_cols=115 Identities=24% Similarity=0.265 Sum_probs=86.9
Q ss_pred ccccccCCccceEeeeeCCchhhh--------------------------------------------hhhhhhhcceee
Q 039318 429 NKKLGEGGFGPVYKGTLADGQEIA--------------------------------------------HRNLVKLLGCCI 464 (717)
Q Consensus 429 ~~~lG~G~fg~Vy~~~~~~~~~va--------------------------------------------h~niv~l~~~~~ 464 (717)
...||+|+||.||+|...+++.+| ++++.++.....
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 468999999999999876554333 133444432111
Q ss_pred ------cCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHH-hhcCCCcEEeccCCCCceEEcCCC
Q 039318 465 ------QGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYL-HHDSRLRIIHRDLKASNVLLDHEM 537 (717)
Q Consensus 465 ------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivHrDlkp~NIll~~~~ 537 (717)
.....+|||||++++++...+.. ...++......++.|++.+|.|| |+.+ |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CC
Confidence 11234899999999877655422 24578889999999999999999 6877 99999999999998 47
Q ss_pred Cceeccccccccc
Q 039318 538 NPKISDFGLARTF 550 (717)
Q Consensus 538 ~~kl~Dfgla~~~ 550 (717)
.++|+|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.2e-16 Score=150.74 Aligned_cols=159 Identities=18% Similarity=0.164 Sum_probs=116.0
Q ss_pred ccccccccCCccceEeeeeCCchhh------------------h------------hhhhhhhcceeecCceeeEEEecc
Q 039318 427 SINKKLGEGGFGPVYKGTLADGQEI------------------A------------HRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 427 ~~~~~lG~G~fg~Vy~~~~~~~~~v------------------a------------h~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
.+...|++|+||+||.+.-.+...+ + |+++++++++ +..+++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 3457899999999998764322111 0 4677777775 4569999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccC-CCCceEEcCCCCceeccccccccccCCcc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDL-KASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDl-kp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+|.+|...+. . ....++.|++++|.++|+++ |+|||| ||+|||++.++.++|+|||+|........
T Consensus 81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9999865431 0 11346789999999999998 999999 79999999999999999999986543221
Q ss_pred c----c-------ccceecccccccCccccccC-CCC-ccccchhHhHHHHHhhcCCCCC
Q 039318 556 E----G-------STKRVVGTYGYMAPEYASDG-LFS-VKSDVFSFGILLLEIVSGKKNR 602 (717)
Q Consensus 556 ~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlG~il~elltG~~p~ 602 (717)
. . .......++.|++|+...-- ..+ ...+.++.|.-+|.++|+..+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 0 0 01112467888888855322 233 5678999999999999998874
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=1e-15 Score=150.36 Aligned_cols=76 Identities=18% Similarity=0.218 Sum_probs=64.1
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhh-cCCCcEEeccCCCCceEEcCCCCceecccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHH-DSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla 547 (717)
.+|||||++++++...... ...++......++.|++.+|.+||+ .+ |+||||||+|||++ ++.++|+|||++
T Consensus 92 ~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~~liDFG~a 164 (190)
T cd05145 92 NVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKPYIIDVSQA 164 (190)
T ss_pred CEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCEEEEEcccc
Confidence 4899999999865443211 2346778889999999999999999 87 99999999999999 889999999999
Q ss_pred cccc
Q 039318 548 RTFV 551 (717)
Q Consensus 548 ~~~~ 551 (717)
....
T Consensus 165 ~~~~ 168 (190)
T cd05145 165 VELD 168 (190)
T ss_pred eecC
Confidence 8654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.3e-15 Score=119.69 Aligned_cols=66 Identities=45% Similarity=1.051 Sum_probs=57.4
Q ss_pred CCCCCceEEEeeccCCCCcccceecccChhhHHHhhcCCCCccccccccccCCCceeEEEecccccc
Q 039318 306 YSRKDGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAYTNSDITRGGSGCVMWFGDLIDM 372 (717)
Q Consensus 306 c~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~g~gc~~~~g~L~~~ 372 (717)
|+.+++|+++++|++|++.......++++++|++.||+||||+||+|.+.. ++++|.+|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 445699999999999999777766779999999999999999999997544 678899999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.7e-14 Score=142.78 Aligned_cols=112 Identities=21% Similarity=0.261 Sum_probs=83.1
Q ss_pred ccccccccCCccceEeeeeCCch-------------------------hh-----hhhhhhhhcceeecCc---eee-EE
Q 039318 427 SINKKLGEGGFGPVYKGTLADGQ-------------------------EI-----AHRNLVKLLGCCIQGE---EKL-LI 472 (717)
Q Consensus 427 ~~~~~lG~G~fg~Vy~~~~~~~~-------------------------~v-----ah~niv~l~~~~~~~~---~~~-lV 472 (717)
.-.+.||+|+||.||.-. .+.. .+ .||||+++++++.++. ..+ +|
T Consensus 5 ~~~~~LG~G~~~~Vy~hp-~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 5 SEQSPLGTGRHRKCYAHP-EDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CCcceecCCCceEEEECC-CCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 345789999999999621 1110 11 2799999999998864 334 78
Q ss_pred Eec--cCCCChhhHhhhccccccCChhhHHHHHHHHHHHH-HHHhhcCCCcEEeccCCCCceEEcCC----CCceecccc
Q 039318 473 YEF--MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGL-LYLHHDSRLRIIHRDLKASNVLLDHE----MNPKISDFG 545 (717)
Q Consensus 473 ~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~yLH~~~~~~ivHrDlkp~NIll~~~----~~~kl~Dfg 545 (717)
||| +++++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++.. ..++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 6689999999431 24444 34577888777 9999998 9999999999999743 479999954
Q ss_pred ccc
Q 039318 546 LAR 548 (717)
Q Consensus 546 la~ 548 (717)
.+.
T Consensus 155 G~~ 157 (210)
T PRK10345 155 GES 157 (210)
T ss_pred CCc
Confidence 443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=7.1e-15 Score=167.03 Aligned_cols=230 Identities=24% Similarity=0.316 Sum_probs=167.8
Q ss_pred cCcccccccccCCccceEeeeeCCch------------------------------hh-hhhhhhhhcceeecCceeeEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ------------------------------EI-AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~------------------------------~v-ah~niv~l~~~~~~~~~~~lV 472 (717)
..|.+.+.||+|+|+.|-........ .. .|+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 35667778999999888665432111 11 199999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHh-hcCCCcEEeccCCCCceEEcCCC-Cceeccccccccc
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH-HDSRLRIIHRDLKASNVLLDHEM-NPKISDFGLARTF 550 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~ivHrDlkp~NIll~~~~-~~kl~Dfgla~~~ 550 (717)
+||..++++.+.+.. ......+....-.++.|+..++.|+| ..+ +.||||||+|.+++..+ .++++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999988842 12213455666678899999999999 777 99999999999999999 9999999999987
Q ss_pred cC-Cccccccceecc-cccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 551 VG-DEIEGSTKRVVG-TYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 551 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.......... ..|.+....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~------~~~~~~~~~ 249 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY------SSWKSNKGR 249 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc------eeecccccc
Confidence 76 444555556788 9999999999884 45678999999999999999999987654433110 001111100
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
. ....... -.....++..+++..+|..|.+.+++..
T Consensus 250 ~--~~~~~~~----~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 F--TQLPWNS----ISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred c--ccCcccc----CChhhhhcccccccCCchhccccccccc
Confidence 0 0000000 1123345666788889999999888765
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.1e-13 Score=140.30 Aligned_cols=130 Identities=20% Similarity=0.228 Sum_probs=95.0
Q ss_pred ccHHHHHHHhcCcccccccccCCccceEeee--eCCchhhh---------------------------------------
Q 039318 414 FELATIANATDNFSINKKLGEGGFGPVYKGT--LADGQEIA--------------------------------------- 452 (717)
Q Consensus 414 ~~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~--~~~~~~va--------------------------------------- 452 (717)
.++..+.....-|.+.+.||+|+||.||+|. ..+++.++
T Consensus 18 ~~~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (237)
T smart00090 18 LALYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWA 97 (237)
T ss_pred HHHHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHH
Confidence 3344455556679999999999999999998 33333222
Q ss_pred ---hhhhhhhcc-------eeecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEE
Q 039318 453 ---HRNLVKLLG-------CCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRII 522 (717)
Q Consensus 453 ---h~niv~l~~-------~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iv 522 (717)
+.++.++.. .+. ....++||||+++.+|...... ...+.......++.||+.+|.+||+++ .|+
T Consensus 98 ~~E~~~L~~L~~~~i~~p~~~~-~~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~ii 171 (237)
T smart00090 98 EKEFRNLQRLYEAGVPVPKPIA-WRRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELV 171 (237)
T ss_pred HHHHHHHHHHHhcCCCCCeeeE-ecCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEE
Confidence 223333321 122 2345899999999888765522 223455667789999999999999886 499
Q ss_pred eccCCCCceEEcCCCCceeccccccccc
Q 039318 523 HRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 523 HrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
||||||+||+++ ++.++|+|||.+...
T Consensus 172 H~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 172 HGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred eCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 999999999999 889999999998854
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.3e-13 Score=136.28 Aligned_cols=124 Identities=20% Similarity=0.206 Sum_probs=91.7
Q ss_pred HHHHHHHhcCcccccccccCCccceEeeeeCCchhhh----------------------------------------hhh
Q 039318 416 LATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA----------------------------------------HRN 455 (717)
Q Consensus 416 ~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va----------------------------------------h~n 455 (717)
..++......|.+.+.||+|+||.||++...+++.++ +..
T Consensus 7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 86 (198)
T cd05144 7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA 86 (198)
T ss_pred HHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence 3455555556888899999999999999876543322 111
Q ss_pred hhhhcce------eecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCC
Q 039318 456 LVKLLGC------CIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKAS 529 (717)
Q Consensus 456 iv~l~~~------~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~ 529 (717)
+.++... .......++||||+++++|..... ......++.++++++.++|+.+ |+|+||||+
T Consensus 87 l~~l~~~~i~v~~~~~~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~ 154 (198)
T cd05144 87 LKALYEEGFPVPKPIDWNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEF 154 (198)
T ss_pred HHHHHHcCCCCCceeecCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCcc
Confidence 2222111 112345689999999999876541 1344568899999999999988 999999999
Q ss_pred ceEEcCCCCceecccccccccc
Q 039318 530 NVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 530 NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||+|++++.++|+|||++....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.46 E-value=8.2e-14 Score=158.76 Aligned_cols=112 Identities=19% Similarity=0.283 Sum_probs=92.2
Q ss_pred hcCcccccccccCCccceEeeeeCCchh---------------------------------hhhhhhhhhcceeecCcee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQE---------------------------------IAHRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~---------------------------------vah~niv~l~~~~~~~~~~ 469 (717)
...|...++||+|+||.||+|.+..... +.|++++....++......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 4455677899999999999976532211 1167777776677777788
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||+++++|.+++. ....++.+++++|.|||+.+ |+||||||+|||+ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998883 34668999999999999998 9999999999999 678999999999986
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.4e-13 Score=137.42 Aligned_cols=109 Identities=22% Similarity=0.301 Sum_probs=88.9
Q ss_pred cccccCCccceEeeeeCCch---------------------------------hhhhhhhhhhcceeecCceeeEEEecc
Q 039318 430 KKLGEGGFGPVYKGTLADGQ---------------------------------EIAHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~---------------------------------~vah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
+.||+|++|.||+|...... .+.|++|.....++...+..++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 57999999999999642211 011566666666666778889999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
+|++|.+++... .. .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999988431 11 77889999999999999998 99999999999999 78899999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.6e-13 Score=133.29 Aligned_cols=105 Identities=19% Similarity=0.321 Sum_probs=82.4
Q ss_pred ccccCCccceEeeeeCCchh---------------------------------hhhhhhhhhcceeecCceeeEEEeccC
Q 039318 431 KLGEGGFGPVYKGTLADGQE---------------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 431 ~lG~G~fg~Vy~~~~~~~~~---------------------------------vah~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.||+|+||.||+|....... +.|+++.....++...+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 48999999999998432110 114444444444556667799999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
+++|.+++.... . .++.+++++|.+||+.+ ++|+|++|.||+++ ++.++++|||+++.
T Consensus 81 g~~l~~~~~~~~---~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGN---D-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcH---H-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999998873311 0 68899999999999998 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.1e-12 Score=126.42 Aligned_cols=75 Identities=19% Similarity=0.212 Sum_probs=58.7
Q ss_pred eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhh-cCCCcEEeccCCCCceEEcCCCCceeccccc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHH-DSRLRIIHRDLKASNVLLDHEMNPKISDFGL 546 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgl 546 (717)
..++||||++++.+......... .. .....++.+++.++.++|. .+ |+|+||||+||+++ ++.++|+|||.
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liDfg~ 160 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIIDVPQ 160 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEECcc
Confidence 46899999999544321111100 11 5667899999999999999 77 99999999999999 88999999999
Q ss_pred cccc
Q 039318 547 ARTF 550 (717)
Q Consensus 547 a~~~ 550 (717)
+...
T Consensus 161 a~~~ 164 (187)
T cd05119 161 AVEI 164 (187)
T ss_pred cccc
Confidence 9754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=5.5e-12 Score=126.51 Aligned_cols=151 Identities=24% Similarity=0.297 Sum_probs=115.1
Q ss_pred hhhhhhhhhhcceeecCc-----eeeEEEeccCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEe
Q 039318 450 EIAHRNLVKLLGCCIQGE-----EKLLIYEFMPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIH 523 (717)
Q Consensus 450 ~vah~niv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH 523 (717)
+..|.|||++..++.+.+ +..++.|||..|+|..+|++.. ..+.+....-.+++-||+.||.|||+.. .+|+|
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Ppiih 201 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PPIIH 201 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Ccccc
Confidence 445999999999886543 4689999999999999996643 3455777788889999999999999975 67999
Q ss_pred ccCCCCceEEcCCCCceeccc--cccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCC
Q 039318 524 RDLKASNVLLDHEMNPKISDF--GLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKN 601 (717)
Q Consensus 524 rDlkp~NIll~~~~~~kl~Df--gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p 601 (717)
+++.-.-|++..++-+|+.-- ...................+-++|.|||.-.....+.++|||+||+..+||.-+..-
T Consensus 202 gnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 202 GNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred CCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheec
Confidence 999999999999988887421 111111011111122234577899999987777788899999999999999877653
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.3e-12 Score=104.13 Aligned_cols=70 Identities=20% Similarity=0.315 Sum_probs=60.6
Q ss_pred CCCCceEEEeeccCCCCcccceecccChhhHHHhhcC---CCCccccccccccCCCceeEEEeccc-ccceecccCCcce
Q 039318 307 SRKDGFIKFSELKLPDSTSSWVSKSMNLKECREKCLE---NSSCMAYTNSDITRGGSGCVMWFGDL-IDMRNFQDGGQDL 382 (717)
Q Consensus 307 ~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~~~~~~g~gc~~~~g~L-~~~~~~~~~~~~l 382 (717)
....+|+++.+|++|++.. +++++|++.|++ ||||.||+|.+ .+.||.+|.++| .+++.....+.++
T Consensus 6 ~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~---~~~gC~~W~~~l~~d~~~~~~~g~~L 76 (80)
T cd00129 6 KSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAK---ARKQCLWFPFNSMSGVRKEFSHGFDL 76 (80)
T ss_pred ecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccC---CCCCeEEecCcchhhHHhccCCCcee
Confidence 3447899999999999754 589999999999 99999999954 246899999999 9998887778899
Q ss_pred EEe
Q 039318 383 YIR 385 (717)
Q Consensus 383 ~ir 385 (717)
|+|
T Consensus 77 y~r 79 (80)
T cd00129 77 YEN 79 (80)
T ss_pred EeE
Confidence 997
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.4e-11 Score=102.20 Aligned_cols=80 Identities=45% Similarity=1.000 Sum_probs=63.7
Q ss_pred CCCCCCC---CceEEEeeccCCCCcccceecccChhhHHHhhcCCCCccccccccccCCCceeEEEecccccceecccCC
Q 039318 303 PLNYSRK---DGFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSSCMAYTNSDITRGGSGCVMWFGDLIDMRNFQDGG 379 (717)
Q Consensus 303 ~l~c~~~---~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~g~gc~~~~g~L~~~~~~~~~~ 379 (717)
+++|... ++|+.++++++|++.... .++++++|+++||+||+|.||+|.+ ++++|.+|.+.+.+.+.....+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence 3456443 689999999999875543 6789999999999999999999853 4678999999888877655455
Q ss_pred cceEEeec
Q 039318 380 QDLYIRMS 387 (717)
Q Consensus 380 ~~l~ir~~ 387 (717)
..+|+|++
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 78999874
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.6e-11 Score=113.39 Aligned_cols=112 Identities=25% Similarity=0.211 Sum_probs=90.4
Q ss_pred cccccccCCccceEeeeeCCch-------------h----------hhh--hhhhhhcceeecCceeeEEEeccCCCChh
Q 039318 428 INKKLGEGGFGPVYKGTLADGQ-------------E----------IAH--RNLVKLLGCCIQGEEKLLIYEFMPNRSLD 482 (717)
Q Consensus 428 ~~~~lG~G~fg~Vy~~~~~~~~-------------~----------vah--~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 482 (717)
+.+.||+|.++.||++.....+ . +.| .++++++.+....+..+++|||++++.+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 4578999999999998864311 0 114 47788888887778899999999988775
Q ss_pred hHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 483 SFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 483 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
.+ +......++.+++++|++||......++|+||+|.|||+++.+.++++|||.+..
T Consensus 82 ~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 82 EV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 43 4456677889999999999986544599999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.4e-11 Score=122.38 Aligned_cols=87 Identities=18% Similarity=0.218 Sum_probs=66.0
Q ss_pred hhhh--hhhcceeecCc----eeeEEEeccCC-CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEecc
Q 039318 453 HRNL--VKLLGCCIQGE----EKLLIYEFMPN-RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRD 525 (717)
Q Consensus 453 h~ni--v~l~~~~~~~~----~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrD 525 (717)
|++| ++.+++..... ..++||||+++ .+|.+++.. ..++.. .+.+|+++|.+||+.+ |+|||
T Consensus 99 ~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrD 167 (239)
T PRK01723 99 EAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHAD 167 (239)
T ss_pred hCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCC
Confidence 5553 55555543322 23599999997 689888732 223332 3568999999999998 99999
Q ss_pred CCCCceEEcCCCCceeccccccccc
Q 039318 526 LKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 526 lkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
|||.|||++.++.++|+|||.+...
T Consensus 168 lkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 168 LNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred CCchhEEEcCCCCEEEEECCCcccC
Confidence 9999999999999999999998753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=8.3e-11 Score=128.17 Aligned_cols=222 Identities=23% Similarity=0.332 Sum_probs=158.1
Q ss_pred Cccccccccc--CCccceEeeee--CC-chhhh-----------------------------hhhhhhhcceeecCceee
Q 039318 425 NFSINKKLGE--GGFGPVYKGTL--AD-GQEIA-----------------------------HRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 425 ~~~~~~~lG~--G~fg~Vy~~~~--~~-~~~va-----------------------------h~niv~l~~~~~~~~~~~ 470 (717)
.|.+.+.+|. |.+|.||.+.. .. ...++ |+|.|+.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4667788999 99999999887 21 11111 899999999999999999
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHH----HHHHHhhcCCCcEEeccCCCCceEEcCC-CCceecccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTAR----GLLYLHHDSRLRIIHRDLKASNVLLDHE-MNPKISDFG 545 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~Dfg 545 (717)
+-+|++. .+|.++... ....++.......+.+..+ ||..+|... |+|-|+||.||++..+ ...++.|||
T Consensus 195 iqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999996 677777733 3334667777777778888 999999998 9999999999999999 889999999
Q ss_pred ccccccCCccccc---cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhh
Q 039318 546 LARTFVGDEIEGS---TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWN 622 (717)
Q Consensus 546 la~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 622 (717)
+...+........ .....|...|++||..+ +.++.++|||++|.++.+-..+........... |..+.
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W~~~r 339 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS--------WSQLR 339 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC--------ccccc
Confidence 9998765543222 12336788999999875 467899999999999999988876643211111 11111
Q ss_pred CCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 623 NGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 623 ~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+.. +-+.... . -..++...+.++++.+|..|++.+.+..
T Consensus 340 ~~~---ip~e~~~-~----~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QGY---IPLEFCE-G----GSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccc---Cchhhhc-C----cchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111 0010110 0 0112223667789999999998876655
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.12 E-value=1e-10 Score=129.13 Aligned_cols=77 Identities=22% Similarity=0.275 Sum_probs=60.3
Q ss_pred ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHH-HHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTAR-GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
...+|||||++|++|.++...... .. .+..++..+++ .+..+|..+ ++|+|+||.||+++.++.++|+|||
T Consensus 231 ~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG 302 (437)
T TIGR01982 231 SERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFG 302 (437)
T ss_pred CCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCC
Confidence 346799999999999887632211 11 23456666665 467889887 9999999999999999999999999
Q ss_pred cccccc
Q 039318 546 LARTFV 551 (717)
Q Consensus 546 la~~~~ 551 (717)
++..+.
T Consensus 303 ~~~~l~ 308 (437)
T TIGR01982 303 IVGRLS 308 (437)
T ss_pred CeeECC
Confidence 998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.3e-10 Score=130.72 Aligned_cols=182 Identities=21% Similarity=0.248 Sum_probs=137.4
Q ss_pred HHhcCcccccccccCCccceEeeeeCCch-----h-------------------------hhhhhhhhhcceeecCceee
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADGQ-----E-------------------------IAHRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-----~-------------------------vah~niv~l~~~~~~~~~~~ 470 (717)
...+.+.+.+.+-+|.++.++.++-.... . +.||.++.....+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34567888888999999999876532211 0 01455665555555677889
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
||++|..+++|...++. .+.++.+.....+..+.++++|||... ++|||++|.|+|+..+++.+++||+.....
T Consensus 881 L~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 99999999999988843 334555555556677889999999986 899999999999999999999999844321
Q ss_pred cC-------------------------Cccc----cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCC
Q 039318 551 VG-------------------------DEIE----GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKN 601 (717)
Q Consensus 551 ~~-------------------------~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p 601 (717)
.. .... .......||+.|.+||.+.+......+|+|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 0000 112346899999999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 039318 602 RGFYHSD 608 (717)
Q Consensus 602 ~~~~~~~ 608 (717)
|......
T Consensus 1035 ~na~tpq 1041 (1205)
T KOG0606|consen 1035 FNAETPQ 1041 (1205)
T ss_pred CCCcchh
Confidence 8754433
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.1e-09 Score=122.44 Aligned_cols=118 Identities=21% Similarity=0.289 Sum_probs=79.7
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh----h---------------------------------------------
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA----H--------------------------------------------- 453 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va----h--------------------------------------------- 453 (717)
..|+. +.||+|++|+||+|++++ |+.|| +
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35776 799999999999999987 76554 2
Q ss_pred ---------hhhhhhcceeecC-------------ceeeEEEeccCCCChhhHhhhccc---cccCChhhHHHHHHHHHH
Q 039318 454 ---------RNLVKLLGCCIQG-------------EEKLLIYEFMPNRSLDSFIFDQTK---RKLLDWSKRFCIICGTAR 508 (717)
Q Consensus 454 ---------~niv~l~~~~~~~-------------~~~~lV~E~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~i~~ 508 (717)
+|+.++...+.+. ...+|||||++|+.+.++..-... .+.+.......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 2444554444333 334599999999999875311111 111222222222222
Q ss_pred HHHHHhhcCCCcEEeccCCCCceEEcCCC----CceeccccccccccC
Q 039318 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEM----NPKISDFGLARTFVG 552 (717)
Q Consensus 509 ~l~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~Dfgla~~~~~ 552 (717)
++..+ ++|+|+||.||+++.++ .++++|||++..+..
T Consensus 276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33455 99999999999999888 899999999987644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.1e-09 Score=119.46 Aligned_cols=222 Identities=19% Similarity=0.179 Sum_probs=155.4
Q ss_pred hcCcccccccccCCccceEeeeeC-Cchh------------------------------hhhhhhhhhcceeecCceeeE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLA-DGQE------------------------------IAHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~------------------------------vah~niv~l~~~~~~~~~~~l 471 (717)
..+|..+..||.|.|+.|++...+ .+.. ..|.++++++..+.+-...++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 457888899999999999986543 1110 018899999999988889999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC-CCceeccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE-MNPKISDFGLARTF 550 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~Dfgla~~~ 550 (717)
--|||.++++...+ .-...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||.+..+
T Consensus 344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence 99999999988776 23345778889999999999999999887 9999999999999886 78899999998743
Q ss_pred cCCccccccceecccccc-cCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 551 VGDEIEGSTKRVVGTYGY-MAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
.-.. ......+..| .+|+......+..+.|++|||.-+.|.+++..--+-.. .+.....+...
T Consensus 418 ~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----------~~~~i~~~~~p-- 481 (524)
T KOG0601|consen 418 AFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----------QSLTIRSGDTP-- 481 (524)
T ss_pred ceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc----------cceeeeccccc--
Confidence 2111 1112233344 46666677788999999999999999999875422100 00011111111
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
...... .....++..++..++..||.+.++..+.+.+
T Consensus 482 -----~~~~~~---~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 482 -----NLPGLK---LQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred -----CCCchH---HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 111111 2222344447778899999888877765543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.7e-08 Score=96.77 Aligned_cols=107 Identities=25% Similarity=0.183 Sum_probs=74.6
Q ss_pred ccccccCCccceEeeeeCCchh------------------------hhhhhh-hhhcceeecCceeeEEEeccCCCChhh
Q 039318 429 NKKLGEGGFGPVYKGTLADGQE------------------------IAHRNL-VKLLGCCIQGEEKLLIYEFMPNRSLDS 483 (717)
Q Consensus 429 ~~~lG~G~fg~Vy~~~~~~~~~------------------------vah~ni-v~l~~~~~~~~~~~lV~E~~~~gsL~~ 483 (717)
++.|+.|.++.||+++...++- +++.++ .+++.+ ..+..++||||+++.++..
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLT 80 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcccc
Confidence 3578899999999876542210 012222 234433 2344689999999988754
Q ss_pred HhhhccccccCChhhHHHHHHHHHHHHHHHhhcC--CCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 484 FIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS--RLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 484 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
.. .....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 81 ~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 20 111235678999999999986 23469999999999999 66899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.1e-07 Score=104.99 Aligned_cols=154 Identities=18% Similarity=0.268 Sum_probs=113.3
Q ss_pred ccccCCccceEeeeeCCch-------------hhhhhhhhhhcceeecCceeeEEEeccCCCChhhHhhhccccccCChh
Q 039318 431 KLGEGGFGPVYKGTLADGQ-------------EIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWS 497 (717)
Q Consensus 431 ~lG~G~fg~Vy~~~~~~~~-------------~vah~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~ 497 (717)
+...|++-.||......+. .+.||||++++..+..++..|||+|-+. .|..++.+ +...
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~ 104 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKE 104 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHH
Confidence 3455777788887776661 2339999999999999999999999874 45555533 2245
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccceecccccccCccccccC
Q 039318 498 KRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDG 577 (717)
Q Consensus 498 ~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 577 (717)
.....+.||+.||.|||..+ .++|++|..+.|++++.|+-||++|.++.....-.. ......--..|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 56667899999999999776 599999999999999999999999998865322111 11112222345666654322
Q ss_pred CCCccccchhHhHHHHHhhcC
Q 039318 578 LFSVKSDVFSFGILLLEIVSG 598 (717)
Q Consensus 578 ~~~~~sDvwSlG~il~elltG 598 (717)
. -..|.|-||++++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 1 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.62 E-value=9.3e-08 Score=93.18 Aligned_cols=77 Identities=14% Similarity=0.132 Sum_probs=57.6
Q ss_pred ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHH-hhcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYL-HHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
..-+|||||+.+..+..... ....++......+..+++.+|..| |..+ |||+||++.|||++ ++.+.|+|||
T Consensus 97 ~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NIL~~-~~~v~iIDF~ 169 (197)
T cd05146 97 KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYNMLWH-DGKVWFIDVS 169 (197)
T ss_pred cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEE-CCcEEEEECC
Confidence 45679999998754422111 111244455667788999999999 7777 99999999999997 4689999999
Q ss_pred ccccc
Q 039318 546 LARTF 550 (717)
Q Consensus 546 la~~~ 550 (717)
.+...
T Consensus 170 qav~~ 174 (197)
T cd05146 170 QSVEP 174 (197)
T ss_pred CceeC
Confidence 98754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2e-07 Score=87.92 Aligned_cols=73 Identities=25% Similarity=0.373 Sum_probs=62.1
Q ss_pred eecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceec
Q 039318 463 CIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKIS 542 (717)
Q Consensus 463 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 542 (717)
..+.+...|+|||++|..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++.... +.++
T Consensus 68 dvD~~~~~I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~I 133 (204)
T COG3642 68 DVDPDNGLIVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFI 133 (204)
T ss_pred EEcCCCCEEEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEE
Confidence 45677788999999999998888332 2557788888999999999 99999999999998775 9999
Q ss_pred ccccccc
Q 039318 543 DFGLART 549 (717)
Q Consensus 543 Dfgla~~ 549 (717)
||||+..
T Consensus 134 DfGLg~~ 140 (204)
T COG3642 134 DFGLGEF 140 (204)
T ss_pred ECCcccc
Confidence 9999985
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.3e-06 Score=89.54 Aligned_cols=197 Identities=12% Similarity=0.097 Sum_probs=123.6
Q ss_pred eeEEEeccCCCCh-hhHh---hhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccc
Q 039318 469 KLLIYEFMPNRSL-DSFI---FDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDF 544 (717)
Q Consensus 469 ~~lV~E~~~~gsL-~~~l---~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 544 (717)
.-+.|..+++..= ..++ .+........|.-.++.++.++.+.+-||+.| .+-+|+.++|+|+.+++.+.|.|=
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence 5677777766422 2222 12233455789999999999999999999999 888999999999999999999985
Q ss_pred cccccccCCccccccceecccccccCccccc-----cCCCCccccchhHhHHHHHhhcC-CCCCCCCCCCC-chh----H
Q 039318 545 GLARTFVGDEIEGSTKRVVGTYGYMAPEYAS-----DGLFSVKSDVFSFGILLLEIVSG-KKNRGFYHSDK-NLN----L 613 (717)
Q Consensus 545 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG-~~p~~~~~~~~-~~~----~ 613 (717)
........+ ......+|...|.+||... +..-+...|.|-||+++++|+.| ++||....... ... .
T Consensus 162 Dsfqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 162 DSFQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred cceeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 544432111 1123467899999999765 33456789999999999999886 99997533211 111 1
Q ss_pred HHHHHHHhhCCCCccccchhhhccCCHHHH-HHHHHHHhhccccC--CCCCCChHHHHHHhcC
Q 039318 614 IGHAWKLWNNGMPSQLIDAYYQESCNLAEV-IRCIHVGLLCVQHH--PEDRPCMPSVILMLGS 673 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~l~~~Cl~~d--p~~RPs~~evl~~L~~ 673 (717)
|.+..-......-.-.. ....+.++..+ ..+-.+..+|+... +.-|||++-.+..|..
T Consensus 239 Ia~g~f~ya~~~~~g~~--p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 239 IAHGRFAYASDQRRGLK--PPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred hhcceeeechhccCCCC--CCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 11110000000000000 00112222222 23334555677543 5689999988887753
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=5.6e-07 Score=84.43 Aligned_cols=118 Identities=24% Similarity=0.293 Sum_probs=84.1
Q ss_pred cccccccCCccceEeeeeCCchh---------hhhhhh----------------hhhc--------ceeecCceeeEEEe
Q 039318 428 INKKLGEGGFGPVYKGTLADGQE---------IAHRNL----------------VKLL--------GCCIQGEEKLLIYE 474 (717)
Q Consensus 428 ~~~~lG~G~fg~Vy~~~~~~~~~---------vah~ni----------------v~l~--------~~~~~~~~~~lV~E 474 (717)
....|-+|+-+.|+++.+..... ..||-| .++. -++.+...-.|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 45788999999999987754331 124422 1111 13455666789999
Q ss_pred ccCC-CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC---ceecccccccc
Q 039318 475 FMPN-RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN---PKISDFGLART 549 (717)
Q Consensus 475 ~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~Dfgla~~ 549 (717)
|+++ .++.+++......... ......++..|-+.+.-||..+ |+|+||..+||+|..++. +.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~-d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESE-DEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCccc-chhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9987 6788888654433222 2233668888999999999998 999999999999976654 47999999875
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.40 E-value=5.7e-07 Score=90.12 Aligned_cols=116 Identities=22% Similarity=0.275 Sum_probs=82.6
Q ss_pred cccccCCccceEeeeeCCchhhh---------------------------h--hhhhhhcceeecC---ceeeEEEeccC
Q 039318 430 KKLGEGGFGPVYKGTLADGQEIA---------------------------H--RNLVKLLGCCIQG---EEKLLIYEFMP 477 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~~~va---------------------------h--~niv~l~~~~~~~---~~~~lV~E~~~ 477 (717)
+.|+.|..+.||+++..+++.++ + ..+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57888999999998765522111 1 2345556655543 25689999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS---------------------------------------- 517 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~---------------------------------------- 517 (717)
+.++.+.+.. ..++...+..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988765521 23566677777888888888887421
Q ss_pred -------------CCcEEeccCCCCceEEcC--CCCceecccccccc
Q 039318 518 -------------RLRIIHRDLKASNVLLDH--EMNPKISDFGLART 549 (717)
Q Consensus 518 -------------~~~ivHrDlkp~NIll~~--~~~~kl~Dfgla~~ 549 (717)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 56688999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.1e-07 Score=103.18 Aligned_cols=103 Identities=24% Similarity=0.429 Sum_probs=79.0
Q ss_pred HHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC-cc------ccccceecccccccCcc
Q 039318 500 FCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD-EI------EGSTKRVVGTYGYMAPE 572 (717)
Q Consensus 500 ~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~-~~------~~~~~~~~gt~~y~aPE 572 (717)
+.=+.+++.|+.|+|..- .+||+.|.|++|.++.++..||+.|+.+...... .. ........-...|.|||
T Consensus 102 f~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE 179 (700)
T KOG2137|consen 102 FANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPE 179 (700)
T ss_pred hhhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccch
Confidence 334456679999999865 6999999999999999999999999988754331 10 00111124467899999
Q ss_pred ccccCCCCccccchhHhHHHHHhh-cCCCCCCC
Q 039318 573 YASDGLFSVKSDVFSFGILLLEIV-SGKKNRGF 604 (717)
Q Consensus 573 ~~~~~~~~~~sDvwSlG~il~ell-tG~~p~~~ 604 (717)
++.+...+.++|+||+|+++|.+. .|+.-+..
T Consensus 180 ~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a 212 (700)
T KOG2137|consen 180 YLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAA 212 (700)
T ss_pred hhccccccccccceeeeeEEEEEecCCcchhhc
Confidence 999988899999999999999999 45555443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.25 E-value=2.1e-06 Score=88.45 Aligned_cols=79 Identities=22% Similarity=0.224 Sum_probs=64.6
Q ss_pred ceeeEEEeccCCC-ChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC-------CCC
Q 039318 467 EEKLLIYEFMPNR-SLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH-------EMN 538 (717)
Q Consensus 467 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~-------~~~ 538 (717)
...+||||++++. +|.+++.+.. ....+...+..++.++++.+.-||..+ |+|+|+++.|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 3568999999986 8988884322 223455677789999999999999999 999999999999985 467
Q ss_pred ceecccccccc
Q 039318 539 PKISDFGLART 549 (717)
Q Consensus 539 ~kl~Dfgla~~ 549 (717)
+.|+||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998864
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.19 E-value=7.2e-06 Score=73.17 Aligned_cols=88 Identities=23% Similarity=0.357 Sum_probs=61.3
Q ss_pred EEEecCCCEEEEcCC-CcEEEEeccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCccccccCeeceeecc
Q 039318 59 LVVNKTGNLVLTSQN-KSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTLLPGMKLGWDFKT 137 (717)
Q Consensus 59 l~l~~~G~Lvl~~~~-~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~~ 137 (717)
+....||+||+.+.. +.+||++++.........+.|.++|||||++.++ .++|+| ++ -
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g----~~vW~S--~t---~------------ 82 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDG----RVVWSS--NT---T------------ 82 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCC----CEEEEe--cc---c------------
Confidence 445578999998765 5899999986543333568999999999997642 378987 11 0
Q ss_pred CCceEEEEecCCCCCCCceeEEeeccCCCcEEEEEcCCeeEEecC
Q 039318 138 GLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYRTG 182 (717)
Q Consensus 138 ~~~~~l~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~ 182 (717)
...|.|.+.|+++|...++-. ...+.|.+.
T Consensus 83 --------------~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf 112 (114)
T smart00108 83 --------------GANGNYVLVLLDDGNLVIYDS-DGNFLWQSF 112 (114)
T ss_pred --------------CCCCceEEEEeCCCCEEEECC-CCCEEeCCC
Confidence 124568889999997665422 235778653
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.6e-06 Score=81.76 Aligned_cols=74 Identities=24% Similarity=0.345 Sum_probs=49.7
Q ss_pred eeeEEEeccC--CCChhhHhhhccccccCChhhHHHHHHHHHHHHHH-HhhcCCCcEEeccCCCCceEEcCCCCceeccc
Q 039318 468 EKLLIYEFMP--NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLY-LHHDSRLRIIHRDLKASNVLLDHEMNPKISDF 544 (717)
Q Consensus 468 ~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~y-LH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 544 (717)
.-.|||||++ |..+..+. +. .++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|+||
T Consensus 80 ~~~ivME~I~~~G~~~~~l~-~~----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 RNVIVMEYIGEDGVPLPRLK-DV----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp TTEEEEE--EETTEEGGCHH-HC----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--G
T ss_pred CCEEEEEecCCCccchhhHH-hc----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEec
Confidence 4579999998 65554433 11 11234556677788885555 56777 9999999999999988 9999999
Q ss_pred cccccc
Q 039318 545 GLARTF 550 (717)
Q Consensus 545 gla~~~ 550 (717)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.15 E-value=4.1e-06 Score=68.88 Aligned_cols=72 Identities=39% Similarity=0.792 Sum_probs=52.6
Q ss_pred CceEEEeeccCCCCcccceecccChhhHHHhhcC-CCCccccccccccCCCceeEEEe-cccccceecccCCcceEEe
Q 039318 310 DGFIKFSELKLPDSTSSWVSKSMNLKECREKCLE-NSSCMAYTNSDITRGGSGCVMWF-GDLIDMRNFQDGGQDLYIR 385 (717)
Q Consensus 310 ~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~-nCsC~a~~~~~~~~~g~gc~~~~-g~L~~~~~~~~~~~~l~ir 385 (717)
..|.+++++.+++..... ....++++|++.|++ +|+|.||+|.. .+.+|.+|. +.+.+.......+.++|.+
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEEe
Confidence 568999999998654432 456799999999999 99999999953 467799999 6666655333334445543
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.2e-05 Score=86.42 Aligned_cols=131 Identities=20% Similarity=0.361 Sum_probs=101.5
Q ss_pred hhhhhhhhhhhcceee----cCceeeEEEeccCC-CChhhHhhhccc------------cccCChhhHHHHHHHHHHHHH
Q 039318 449 QEIAHRNLVKLLGCCI----QGEEKLLIYEFMPN-RSLDSFIFDQTK------------RKLLDWSKRFCIICGTARGLL 511 (717)
Q Consensus 449 ~~vah~niv~l~~~~~----~~~~~~lV~E~~~~-gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~ 511 (717)
+++.|+|+|++..++. .+..+++||+|.|+ ++|.++.+.... ...+++...+.++.|+..||.
T Consensus 328 kkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~ 407 (655)
T KOG3741|consen 328 KKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALY 407 (655)
T ss_pred HHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHH
Confidence 3456999999998876 34568999999986 788888765321 234677889999999999999
Q ss_pred HHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHH
Q 039318 512 YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGIL 591 (717)
Q Consensus 512 yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~i 591 (717)
++|+.| +.-+-|.|.+||+..+..++|+..|....+..+... .+. --.+-|.=.||.+
T Consensus 408 sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~~----------------~le---~~Qq~D~~~lG~l 465 (655)
T KOG3741|consen 408 SIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPTE----------------PLE---SQQQNDLRDLGLL 465 (655)
T ss_pred HHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCCCc----------------chh---HHhhhhHHHHHHH
Confidence 999998 777999999999999989999888877665433310 011 1135688999999
Q ss_pred HHHhhcCCCC
Q 039318 592 LLEIVSGKKN 601 (717)
Q Consensus 592 l~elltG~~p 601 (717)
++-|.+|...
T Consensus 466 l~aLAt~~~n 475 (655)
T KOG3741|consen 466 LLALATGTEN 475 (655)
T ss_pred HHHHhhcccc
Confidence 9999999655
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.5e-06 Score=82.32 Aligned_cols=77 Identities=30% Similarity=0.360 Sum_probs=65.1
Q ss_pred eeeEEEeccCC-CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC---Cceecc
Q 039318 468 EKLLIYEFMPN-RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM---NPKISD 543 (717)
Q Consensus 468 ~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~D 543 (717)
..+||+|++++ .+|.+++..... ++......++.++++.++-||+.+ |+|+|+++.|||++.+. .+.|+|
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lID 164 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLID 164 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEc
Confidence 45899999998 479998854222 556677889999999999999999 99999999999999887 799999
Q ss_pred ccccccc
Q 039318 544 FGLARTF 550 (717)
Q Consensus 544 fgla~~~ 550 (717)
|+-++..
T Consensus 165 ld~~~~~ 171 (206)
T PF06293_consen 165 LDRMRFR 171 (206)
T ss_pred chhceeC
Confidence 9988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.4e-05 Score=71.52 Aligned_cols=88 Identities=23% Similarity=0.333 Sum_probs=61.0
Q ss_pred EEEec-CCCEEEEcCC-CcEEEEeccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCccccccCeeceeec
Q 039318 59 LVVNK-TGNLVLTSQN-KSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTLLPGMKLGWDFK 136 (717)
Q Consensus 59 l~l~~-~G~Lvl~~~~-~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~ 136 (717)
+.... ||+||+.+.. +++||++|+.......+.+.|.++|||||++.++ .++|+|=-.
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g----~~vW~S~~~---------------- 83 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSG----TVVWSSNTT---------------- 83 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCC----cEEEEeccc----------------
Confidence 33444 8999998754 5899999986543345568999999999997642 378975321
Q ss_pred cCCceEEEEecCCCCCCCceeEEeeccCCCcEEEEEcCCeeEEecC
Q 039318 137 TGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYRTG 182 (717)
Q Consensus 137 ~~~~~~l~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~ 182 (717)
.+.+.+.+.|+++|...++-.+ ..+.|.+.
T Consensus 84 ---------------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf 113 (116)
T cd00028 84 ---------------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSF 113 (116)
T ss_pred ---------------CCCCceEEEEeCCCCEEEECCC-CCEEEcCC
Confidence 0245688899999876654332 46678765
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.1e-05 Score=80.88 Aligned_cols=126 Identities=20% Similarity=0.217 Sum_probs=85.0
Q ss_pred cccHHHHHHHhcCcccccccccCCccceEeeeeCCchhhh----------------------------------------
Q 039318 413 LFELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA---------------------------------------- 452 (717)
Q Consensus 413 ~~~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va---------------------------------------- 452 (717)
.+.+..+.....-..+..+||-|--+.||.|....+.+++
T Consensus 80 ~LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rE 159 (304)
T COG0478 80 ALALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAERE 159 (304)
T ss_pred HHHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHH
Confidence 3444444444445567789999999999999988766544
Q ss_pred hhhhhhhcce--e----ecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccC
Q 039318 453 HRNLVKLLGC--C----IQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDL 526 (717)
Q Consensus 453 h~niv~l~~~--~----~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDl 526 (717)
+.-+.+++.. - .+-+.-.+||||+++-.|...- ++.+..-.++..|++-+.-+-..| |||+|+
T Consensus 160 f~~L~~L~~~G~~VP~P~~~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDl 228 (304)
T COG0478 160 FEALQRLYPEGVKVPKPIAWNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDL 228 (304)
T ss_pred HHHHHHhhhcCCCCCCccccccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCC
Confidence 2334444433 1 1234557999999996664322 133444445555555555555555 999999
Q ss_pred CCCceEEcCCCCceecccccccc
Q 039318 527 KASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 527 kp~NIll~~~~~~kl~Dfgla~~ 549 (717)
.+-||+++++|.+.++||-.+..
T Consensus 229 SefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 229 SEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred chheEEEecCCCEEEEeCccccc
Confidence 99999999999999999976654
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=98.02 E-value=5.8e-06 Score=60.18 Aligned_cols=44 Identities=52% Similarity=0.752 Sum_probs=38.7
Q ss_pred CCCCCCCCCCCccccCCCCCCCCCCCcc--cccccceeeeecccCC
Q 039318 674 EIMLPQPKQPGFLADRKSTGPNSSSSML--ESSSTNTITISTLEGR 717 (717)
Q Consensus 674 ~~~~~~p~~p~~~~~~~~~~~~~~~~~~--~~~s~~~~~~s~~~~~ 717 (717)
...+|.|++|+|+..+......++++.. +..|+|.+|+|++|||
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 4679999999999999887777766666 8899999999999999
|
; GO: 0004674 protein serine/threonine kinase activity |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.88 E-value=1.4e-05 Score=89.30 Aligned_cols=79 Identities=18% Similarity=0.238 Sum_probs=54.6
Q ss_pred CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHH-HHHHhhcCCCcEEeccCCCCceEEcCCCCceeccc
Q 039318 466 GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARG-LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDF 544 (717)
Q Consensus 466 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~-l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 544 (717)
.....|+|||++|..+.+...... ...+.+ .++..++++ +..+-..+ ++|.|.+|.||+++.++.+.+.||
T Consensus 238 t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k---~ia~~~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDf 309 (517)
T COG0661 238 TTRRVLTMEWIDGIKISDIAALKS--AGIDRK---ELAELLVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDF 309 (517)
T ss_pred cCCcEEEEEeeCCEecccHHHHHh--cCCCHH---HHHHHHHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcC
Confidence 456789999999999988863322 123322 233333322 22222234 999999999999999999999999
Q ss_pred cccccccC
Q 039318 545 GLARTFVG 552 (717)
Q Consensus 545 gla~~~~~ 552 (717)
|+...+..
T Consensus 310 Gi~g~l~~ 317 (517)
T COG0661 310 GIVGRLDP 317 (517)
T ss_pred cceecCCH
Confidence 99986643
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.71 E-value=5.9e-05 Score=83.97 Aligned_cols=78 Identities=14% Similarity=0.213 Sum_probs=52.4
Q ss_pred CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHH-hhcCCCcEEeccCCCCceEEcC----CCCce
Q 039318 466 GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYL-HHDSRLRIIHRDLKASNVLLDH----EMNPK 540 (717)
Q Consensus 466 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivHrDlkp~NIll~~----~~~~k 540 (717)
...+.|+||||+|..+.+.-.-.. .-++... ++..+.++...+ =..| ++|+|-+|.||++.. ++.+.
T Consensus 274 st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~---i~~~l~~~~~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~iv 345 (538)
T KOG1235|consen 274 STKRVLTMEYVDGIKINDLDAIDK--RGISPHD---ILNKLVEAYLEQIFKTG---FFHADPHPGNILVRPNPEGDEEIV 345 (538)
T ss_pred CcceEEEEEecCCccCCCHHHHHH--cCCCHHH---HHHHHHHHHHHHHHhcC---CccCCCCCCcEEEecCCCCCccEE
Confidence 346789999999988887653222 1234333 333333332221 1223 999999999999984 66799
Q ss_pred ecccccccccc
Q 039318 541 ISDFGLARTFV 551 (717)
Q Consensus 541 l~Dfgla~~~~ 551 (717)
+.|||+...+.
T Consensus 346 llDhGl~~~is 356 (538)
T KOG1235|consen 346 LLDHGLYAVIS 356 (538)
T ss_pred EEccccccccc
Confidence 99999998654
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00061 Score=60.56 Aligned_cols=100 Identities=28% Similarity=0.415 Sum_probs=64.3
Q ss_pred CEEEeCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEee-CCCCCCcCCcceEEEecCCCEEEEcCCCcEEEEecccc
Q 039318 6 RTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVA-NRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSANLSK 84 (717)
Q Consensus 6 ~~l~S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~A-Nr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~ 84 (717)
+.+.+.+|.+.|-|-..|+ |-|. .. ..++||.. +...... ....+.|..+|||||.|..+.++|++....
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl~-~~--~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~p 82 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVLY-DS--NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFDYP 82 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEEE-ET--TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTTSS
T ss_pred cccccccccccceECCCCe-----EEEE-cC--CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecCCC
Confidence 4565655889999887664 5553 32 25779999 4333332 357899999999999999999999994322
Q ss_pred CcCCcEEEEEcc--CCCeEEEeccCCCCcceeeeecCCCC
Q 039318 85 EVRTPVVLQLLD--SGNLVLRGERDGDSETYLWQSFDYPS 122 (717)
Q Consensus 85 ~~~~~~~~~Lld--sGNlVl~~~~~~~~~~~lWQSFd~PT 122 (717)
....+.+++ .||++ .... ..+.|.|=+.|+
T Consensus 83 ---tdt~L~~q~l~~~~~~-~~~~----~~~sw~s~~dps 114 (114)
T PF01453_consen 83 ---TDTLLPGQKLGDGNVT-GKND----SLTSWSSNTDPS 114 (114)
T ss_dssp ---S-EEEEEET--TSEEE-EEST----SSEEEESS----
T ss_pred ---ccEEEeccCcccCCCc-cccc----eEEeECCCCCCC
Confidence 223366666 88988 5432 137898876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00012 Score=71.97 Aligned_cols=68 Identities=19% Similarity=0.230 Sum_probs=53.2
Q ss_pred ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccc
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGL 546 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgl 546 (717)
...+|+|||++|..|.++. .++. .+...+.+++.-||+.| ++|+|+.|.|+++.+++ ++++||+.
T Consensus 116 ~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID~~~ 180 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIIDTQG 180 (229)
T ss_pred eEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEECcc
Confidence 3457999999998886554 1222 24456778899999999 99999999999998654 99999987
Q ss_pred ccc
Q 039318 547 ART 549 (717)
Q Consensus 547 a~~ 549 (717)
.+.
T Consensus 181 k~~ 183 (229)
T PF06176_consen 181 KRM 183 (229)
T ss_pred ccc
Confidence 664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.49 E-value=1.3e-05 Score=88.39 Aligned_cols=167 Identities=17% Similarity=0.149 Sum_probs=119.3
Q ss_pred cCcccccccccCCccceEeeeeCCchh---------------------hhhhh-hhhhcceeecCceeeEEEeccCCC-C
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQE---------------------IAHRN-LVKLLGCCIQGEEKLLIYEFMPNR-S 480 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~---------------------vah~n-iv~l~~~~~~~~~~~lV~E~~~~g-s 480 (717)
+-+....-.++|+++.++|.+....+. +.||| .++.++-+..++...++|+++..+ +
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 334444567889999999987544332 23788 677777777778889999999876 2
Q ss_pred hhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccccc
Q 039318 481 LDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTK 560 (717)
Q Consensus 481 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 560 (717)
-..... .....+...+...+.+.-++++++||+.. =+|+| ||+..+ +..|..||+.+..+.+.. ..+
T Consensus 322 ~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~ 388 (829)
T KOG0576|consen 322 SALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPR 388 (829)
T ss_pred ccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---ccc
Confidence 211110 01112333344556666778999999864 48888 777766 578999999988765443 344
Q ss_pred eecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCC
Q 039318 561 RVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRG 603 (717)
Q Consensus 561 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~ 603 (717)
...+++.++|||+.....+..+.|+|++|+-..++--|-+|-.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 6789999999999999999999999999998888877777743
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0003 Score=70.03 Aligned_cols=132 Identities=22% Similarity=0.268 Sum_probs=85.7
Q ss_pred cccHHHHHHHhcCcccccc---cccCCccceEeeeeCCchhhh-------------------------------------
Q 039318 413 LFELATIANATDNFSINKK---LGEGGFGPVYKGTLADGQEIA------------------------------------- 452 (717)
Q Consensus 413 ~~~~~~i~~~~~~~~~~~~---lG~G~fg~Vy~~~~~~~~~va------------------------------------- 452 (717)
..++..+.....+..+... |+.|--+.||+|.-.++..+|
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 3455555555555555544 555667789998765443332
Q ss_pred -----hhhhhhhcceeecCc------eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcE
Q 039318 453 -----HRNLVKLLGCCIQGE------EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRI 521 (717)
Q Consensus 453 -----h~niv~l~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i 521 (717)
-.|+-++++....-. .-.|||||+...-+-.-. .+.-.+.......+..++++.+.-|-... ++
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~nVLvMEfIg~~g~pAP~---LkDv~~e~~e~~~~~~~~v~~~~~l~~~a--~L 188 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPR---LKDVPLELEEAEGLYEDVVEYMRRLYKEA--GL 188 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeecCCeEEEEeccCCCCCCCC---cccCCcCchhHHHHHHHHHHHHHHHHHhc--Cc
Confidence 567777777654322 336999999764111000 01111222246667778888888887733 39
Q ss_pred EeccCCCCceEEcCCCCceeccccccccc
Q 039318 522 IHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 522 vHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
||+||..-|||+. ++.+.|+||+-|...
T Consensus 189 VHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 189 VHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred ccccchhhheEEE-CCeEEEEECcccccc
Confidence 9999999999999 889999999998754
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00021 Score=69.72 Aligned_cols=93 Identities=19% Similarity=0.175 Sum_probs=72.9
Q ss_pred hhhhhhcceeecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE
Q 039318 454 RNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL 533 (717)
Q Consensus 454 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll 533 (717)
+++.+++|+| ..++|.||.+.+++..........-..+|..|.+|+.++++.+.+|+......+.-+|++|+|+-+
T Consensus 20 ~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv 95 (188)
T PF12260_consen 20 EPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGV 95 (188)
T ss_pred CCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEE
Confidence 3788999998 347899999877664221000111246899999999999999999998655569999999999999
Q ss_pred cCCCCceeccccccccc
Q 039318 534 DHEMNPKISDFGLARTF 550 (717)
Q Consensus 534 ~~~~~~kl~Dfgla~~~ 550 (717)
++++.+|++|...+...
T Consensus 96 ~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 96 NDDGRLKLIDLDDVFVE 112 (188)
T ss_pred eCCCcEEEEechhcchh
Confidence 99999999999887654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00037 Score=68.34 Aligned_cols=78 Identities=15% Similarity=0.118 Sum_probs=63.8
Q ss_pred eeeEEEeccCC-CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC--ceeccc
Q 039318 468 EKLLIYEFMPN-RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN--PKISDF 544 (717)
Q Consensus 468 ~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~--~kl~Df 544 (717)
..+||+|-+++ .+|.+++.+. .....+...+..++.++++.++-||..+ +.|+|+-+.||+++.++. ++++||
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDl 174 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDL 174 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEh
Confidence 45799997764 6888888432 2334567778889999999999999998 999999999999986667 999999
Q ss_pred ccccc
Q 039318 545 GLART 549 (717)
Q Consensus 545 gla~~ 549 (717)
.-++.
T Consensus 175 Ek~r~ 179 (216)
T PRK09902 175 EKSRR 179 (216)
T ss_pred hccch
Confidence 87764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0026 Score=64.13 Aligned_cols=30 Identities=17% Similarity=0.164 Sum_probs=26.5
Q ss_pred CcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 519 LRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 519 ~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
..++|+|+.|.||++++++ +.|+||+.+..
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 4579999999999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.0031 Score=74.70 Aligned_cols=186 Identities=21% Similarity=0.210 Sum_probs=124.1
Q ss_pred hhhhhhhhhcceeecCceee----EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccC
Q 039318 451 IAHRNLVKLLGCCIQGEEKL----LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDL 526 (717)
Q Consensus 451 vah~niv~l~~~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDl 526 (717)
++|+|++.++.+..+...+- +..|++...++...+ .....++....+.+..++.+||+|+|+.. ..|.-|
T Consensus 239 ~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~h~~~---l~~v~L 312 (1351)
T KOG1035|consen 239 IAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYLHSLS---LEHVVL 312 (1351)
T ss_pred hccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHHHHhc---cceeEE
Confidence 34999999998877654443 445788888887777 33456778888889999999999999985 555444
Q ss_pred CCC---ceEEcCCCCceec--cccccccccCCccccccceecccccccCccccccCCCCc--cccchhHhHHHHHhhcCC
Q 039318 527 KAS---NVLLDHEMNPKIS--DFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSV--KSDVFSFGILLLEIVSGK 599 (717)
Q Consensus 527 kp~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDvwSlG~il~elltG~ 599 (717)
... +--.+..+.+.+. ||+..+........ ....-+..+.+||......+.. ..|+|.+|..+..+..|.
T Consensus 313 ~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~ 389 (1351)
T KOG1035|consen 313 SASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGE 389 (1351)
T ss_pred ecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcC
Confidence 443 4444555666666 88888765433221 1233455677888777666554 479999999999999987
Q ss_pred CCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHh
Q 039318 600 KNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671 (717)
Q Consensus 600 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L 671 (717)
.+-... ..+..+++..... ...+....|+..++++|++..+++.+.
T Consensus 390 ~i~~~~------------------~~~~~~l~~~~~~--------~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 390 DISEKS------------------AVPVSLLDVLSTS--------ELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred cccccc------------------cchhhhhccccch--------hhhhhhhhhcchhhhhccchhhhhhch
Confidence 663211 0011111111110 234455679999999999999999864
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.0047 Score=62.02 Aligned_cols=32 Identities=34% Similarity=0.383 Sum_probs=21.9
Q ss_pred CCcEEeccCCCCceEEc-CCCCceecccccccc
Q 039318 518 RLRIIHRDLKASNVLLD-HEMNPKISDFGLART 549 (717)
Q Consensus 518 ~~~ivHrDlkp~NIll~-~~~~~kl~Dfgla~~ 549 (717)
...++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus 165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp CEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred CcEEEEeccccccceeeeccceeEEEecccceE
Confidence 45699999999999999 556667999988764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.0026 Score=51.59 Aligned_cols=48 Identities=19% Similarity=0.435 Sum_probs=34.4
Q ss_pred eeccCCCCcccceecccChhhHHHhhcCCCCccccccccccCCCceeEEEec
Q 039318 316 SELKLPDSTSSWVSKSMNLKECREKCLENSSCMAYTNSDITRGGSGCVMWFG 367 (717)
Q Consensus 316 ~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~g~gc~~~~g 367 (717)
+++.++.++.... ...+.++|+..|+.+|+|.||+|.. ....|+++..
T Consensus 10 ~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~ 57 (73)
T cd01100 10 SNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSS 57 (73)
T ss_pred CCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccC
Confidence 4555655444332 2558999999999999999999952 3456988764
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.01 Score=60.43 Aligned_cols=31 Identities=23% Similarity=0.288 Sum_probs=27.2
Q ss_pred CcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 519 LRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 519 ~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
..++|+|+.|.|||++++..+.|+||+.+..
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 4599999999999999987788999998763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.027 Score=67.99 Aligned_cols=30 Identities=23% Similarity=0.395 Sum_probs=24.6
Q ss_pred cEEeccCCCCceEEcCC-CC-ceecccccccc
Q 039318 520 RIIHRDLKASNVLLDHE-MN-PKISDFGLART 549 (717)
Q Consensus 520 ~ivHrDlkp~NIll~~~-~~-~kl~Dfgla~~ 549 (717)
.+||+|+++.|||++.+ .. +-|.||.++..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 49999999999999853 33 46899998864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.023 Score=58.77 Aligned_cols=122 Identities=17% Similarity=0.223 Sum_probs=79.7
Q ss_pred HHHHHHHhcCcccccccccCCccceEeeeeCCchhhh--------------------hh--------------------h
Q 039318 416 LATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA--------------------HR--------------------N 455 (717)
Q Consensus 416 ~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va--------------------h~--------------------n 455 (717)
++++....--+.+.+.||-|--+-||.+-..+|+..+ |+ .
T Consensus 84 lktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfaf 163 (465)
T KOG2268|consen 84 LKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAF 163 (465)
T ss_pred HHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHH
Confidence 3344444445678889999999999999888776554 11 1
Q ss_pred hhhhcc--e----eecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCC
Q 039318 456 LVKLLG--C----CIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKAS 529 (717)
Q Consensus 456 iv~l~~--~----~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~ 529 (717)
+-.|+. + -.+.++-++|||++.+-.|...- ...+..++ ...+..-+.-|-.+| +||+|..-=
T Consensus 164 mkaL~e~gfpVPkpiD~~RH~Vvmelv~g~Pl~~v~------~v~d~~~l---y~~lm~~Iv~la~~G---lIHgDFNEF 231 (465)
T KOG2268|consen 164 MKALYERGFPVPKPIDHNRHCVVMELVDGYPLRQVR------HVEDPPTL---YDDLMGLIVRLANHG---LIHGDFNEF 231 (465)
T ss_pred HHHHHHcCCCCCCcccccceeeHHHhhcccceeeee------ecCChHHH---HHHHHHHHHHHHHcC---ceecccchh
Confidence 111111 0 12345668999999887774332 12233333 333344455566677 999999999
Q ss_pred ceEEcCCCCceecccccccc
Q 039318 530 NVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 530 NIll~~~~~~kl~Dfgla~~ 549 (717)
||++++++.++++||--...
T Consensus 232 Nimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 232 NIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred eeEEecCCCEEEeechHhhc
Confidence 99999999999999966543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.0034 Score=76.00 Aligned_cols=149 Identities=13% Similarity=-0.028 Sum_probs=107.3
Q ss_pred hhhhhhhcceee--cCceeeEEEeccCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcC--CCcEEeccCC
Q 039318 453 HRNLVKLLGCCI--QGEEKLLIYEFMPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDS--RLRIIHRDLK 527 (717)
Q Consensus 453 h~niv~l~~~~~--~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivHrDlk 527 (717)
|+++++.+.-.. +..+.+.+++|+..|.+.+.|.+.. +...++..-+.....+...+..-+|... ....+|++||
T Consensus 1288 h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lk 1367 (2724)
T KOG1826|consen 1288 HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLK 1367 (2724)
T ss_pred ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhh
Confidence 555555443332 2345688999999999999996543 3334444444444444355555555442 3347999999
Q ss_pred CCceEEcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCC
Q 039318 528 ASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRG 603 (717)
Q Consensus 528 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~ 603 (717)
+-|.+|..+-.+|+.++|+.+...+ .....+...+++.|++|++.....++.++|+|..++-+|++--|..+|.
T Consensus 1368 f~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1368 FTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred hhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 9999999999999999999994322 2223345678889999999999999999999999999999988887753
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.037 Score=58.21 Aligned_cols=56 Identities=13% Similarity=0.173 Sum_probs=36.6
Q ss_pred cccccccccCCccceEeeeeCCchh-------------hh---------h----hhhhhhcceeec---CceeeEEEecc
Q 039318 426 FSINKKLGEGGFGPVYKGTLADGQE-------------IA---------H----RNLVKLLGCCIQ---GEEKLLIYEFM 476 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~~~~-------------va---------h----~niv~l~~~~~~---~~~~~lV~E~~ 476 (717)
....+.||+|..+.||+....+++. +. + ..+.++++++.. .+..+||||++
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred hheeeecCCccceeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 3445689999999999855432221 10 1 235666766644 36689999999
Q ss_pred CCCCh
Q 039318 477 PNRSL 481 (717)
Q Consensus 477 ~~gsL 481 (717)
++.++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.021 Score=54.06 Aligned_cols=110 Identities=23% Similarity=0.291 Sum_probs=67.3
Q ss_pred ccccccccCCccceEeeeeCCchhhh--------hhhh------hhh---ccee---ecCceeeEEEeccCCCChhhHhh
Q 039318 427 SINKKLGEGGFGPVYKGTLADGQEIA--------HRNL------VKL---LGCC---IQGEEKLLIYEFMPNRSLDSFIF 486 (717)
Q Consensus 427 ~~~~~lG~G~fg~Vy~~~~~~~~~va--------h~ni------v~l---~~~~---~~~~~~~lV~E~~~~gsL~~~l~ 486 (717)
...+.|++|.+|.||+|.+..+..+. -+|+ ..+ .++. ..-++.++.|||+.|-.|.+.-.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~~~~~ 104 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLGKLEI 104 (201)
T ss_pred hhhhhhhcccccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchhhhhh
Confidence 34578999999999999887553221 1121 111 1111 11133456699999988876552
Q ss_pred hccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCC-CCceEEcCCCCceecccccccc
Q 039318 487 DQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLK-ASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 487 ~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk-p~NIll~~~~~~kl~Dfgla~~ 549 (717)
. .+-++ +..+++.---|...+ |-|..|. |..++|-.+..+.|+||.-|..
T Consensus 105 ~------~~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 105 G------GDRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred c------ccHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 1 11222 234455544455555 8888887 6666666666999999999874
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.044 Score=55.35 Aligned_cols=31 Identities=23% Similarity=0.393 Sum_probs=27.2
Q ss_pred CcEEeccCCCCceEEcC-CCCceecccccccc
Q 039318 519 LRIIHRDLKASNVLLDH-EMNPKISDFGLART 549 (717)
Q Consensus 519 ~~ivHrDlkp~NIll~~-~~~~kl~Dfgla~~ 549 (717)
..++|+|+.+.|||++. +..+.|+||..|..
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 45999999999999998 57899999988764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.074 Score=51.99 Aligned_cols=38 Identities=34% Similarity=0.380 Sum_probs=31.9
Q ss_pred HHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccc
Q 039318 502 IICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547 (717)
Q Consensus 502 i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla 547 (717)
-+.+|.+-|..+|..+ |+-+|+|+.|.. .-||+|||.+
T Consensus 169 ~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 169 DIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 4557778888999988 999999999986 5689999864
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.63 E-value=0.078 Score=55.88 Aligned_cols=117 Identities=28% Similarity=0.305 Sum_probs=85.0
Q ss_pred ccccccccCCccceEeeeeCCchhhh--------------------------------------------hhhhhhhcce
Q 039318 427 SINKKLGEGGFGPVYKGTLADGQEIA--------------------------------------------HRNLVKLLGC 462 (717)
Q Consensus 427 ~~~~~lG~G~fg~Vy~~~~~~~~~va--------------------------------------------h~niv~l~~~ 462 (717)
.+...|..|--+.||.+.-.+|..+| -+|+.++...
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 44567888999999999887776644 4788888777
Q ss_pred eecCce------eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC
Q 039318 463 CIQGEE------KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE 536 (717)
Q Consensus 463 ~~~~~~------~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~ 536 (717)
...... -.|||+|+..... -....+.-.++...+..+..+++.-+.-|.+.+ ++||.||.--|+|+. +
T Consensus 227 GIP~PePIlLk~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 227 GIPCPEPILLKNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCCCCceeeecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-C
Confidence 654333 2589999964222 111122334566677788889999999998887 599999999999985 4
Q ss_pred CCceecccccccc
Q 039318 537 MNPKISDFGLART 549 (717)
Q Consensus 537 ~~~kl~Dfgla~~ 549 (717)
|.+.|+|-+-+..
T Consensus 301 G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 301 GKLYIIDVSQSVE 313 (520)
T ss_pred CEEEEEEcccccc
Confidence 5889999887764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=94.57 E-value=0.079 Score=53.62 Aligned_cols=31 Identities=26% Similarity=0.345 Sum_probs=26.1
Q ss_pred CcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 519 LRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 519 ~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
..++|+|+.|.|||++.+...-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 4489999999999998765567999998764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.56 E-value=0.095 Score=57.12 Aligned_cols=30 Identities=23% Similarity=0.381 Sum_probs=25.7
Q ss_pred CcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 519 LRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 519 ~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
..++|+|+.+.|||+.++ .++|+||.++..
T Consensus 223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~~ 252 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAFY 252 (401)
T ss_pred CceeeccCCcccEEeeCC-CcEEEecccccc
Confidence 459999999999999776 689999987763
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=94.17 E-value=0.091 Score=51.58 Aligned_cols=81 Identities=16% Similarity=0.190 Sum_probs=56.6
Q ss_pred hhhhhhhhcceeecCceeeEEEeccCC------CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEecc
Q 039318 452 AHRNLVKLLGCCIQGEEKLLIYEFMPN------RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRD 525 (717)
Q Consensus 452 ah~niv~l~~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrD 525 (717)
.+.+|.+++|+.+++.-.-+|+|.+.+ .+|.+++. .+.++. .....+. +-..||-++. |+.+|
T Consensus 75 ~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~d 143 (199)
T PF10707_consen 75 DWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALD---EFKRYLLDHH---IVIRD 143 (199)
T ss_pred cccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHH---HHHHHHHHcC---CeecC
Confidence 377899999999999999999998743 45777772 223444 3333333 4455666665 99999
Q ss_pred CCCCceEEcCCC----Cceecc
Q 039318 526 LKASNVLLDHEM----NPKISD 543 (717)
Q Consensus 526 lkp~NIll~~~~----~~kl~D 543 (717)
|+|.||++.... .+.|+|
T Consensus 144 l~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 144 LNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CCcccEEEEecCCCceEEEEEe
Confidence 999999996442 366666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.41 E-value=0.16 Score=53.51 Aligned_cols=74 Identities=22% Similarity=0.183 Sum_probs=55.6
Q ss_pred CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 466 GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 466 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
....|++|++- |+.+. ..+...+++...++.+.+..+.-+..+- +.=|||+.-.||||+ +|++.|+||-
T Consensus 298 ~~y~yl~~kdh-gt~is-------~ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 298 TLYLYLHFKDH-GTPIS-------IIKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred ceEEEEEEecC-Cceee-------eeecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence 34556777764 33442 2234567888888888777777776654 689999999999999 9999999999
Q ss_pred ccccc
Q 039318 546 LARTF 550 (717)
Q Consensus 546 la~~~ 550 (717)
+++.-
T Consensus 367 lsRl~ 371 (488)
T COG5072 367 LSRLS 371 (488)
T ss_pred eeecc
Confidence 99953
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.34 E-value=0.27 Score=51.74 Aligned_cols=33 Identities=21% Similarity=0.329 Sum_probs=29.2
Q ss_pred CCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 518 ~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
+..++|+|+++.||+|+...-+-|.||+++..-
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 356999999999999999988999999998763
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=90.35 E-value=0.46 Score=50.00 Aligned_cols=33 Identities=30% Similarity=0.376 Sum_probs=28.4
Q ss_pred CCCcEEeccCCCCceEEcCC----CCceecccccccc
Q 039318 517 SRLRIIHRDLKASNVLLDHE----MNPKISDFGLART 549 (717)
Q Consensus 517 ~~~~ivHrDlkp~NIll~~~----~~~kl~Dfgla~~ 549 (717)
....++|+|+.|.|||++++ +.++|+||..|..
T Consensus 177 ~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 177 SPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred CCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 34569999999999999985 7899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.75 E-value=0.38 Score=50.17 Aligned_cols=51 Identities=20% Similarity=0.212 Sum_probs=33.1
Q ss_pred HHHHHHHHHHHHHHHhh-cCCCcEEeccCCCCceEEcCCC------------------Cceecccccccc
Q 039318 499 RFCIICGTARGLLYLHH-DSRLRIIHRDLKASNVLLDHEM------------------NPKISDFGLART 549 (717)
Q Consensus 499 ~~~i~~~i~~~l~yLH~-~~~~~ivHrDlkp~NIll~~~~------------------~~kl~Dfgla~~ 549 (717)
+..+..||+.-.-.+-+ .+....+|-||||+||||-+.. .++|-||.+++.
T Consensus 281 ikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 281 IKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred HHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence 44567777755434423 3345699999999999994332 256677777664
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=88.46 E-value=0.77 Score=47.91 Aligned_cols=28 Identities=29% Similarity=0.401 Sum_probs=18.8
Q ss_pred CCcEEeccCCCCceEEcCCCCceecccc
Q 039318 518 RLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 518 ~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
.+.++|+||-+.|++.+.++.+.|.|=.
T Consensus 187 ~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 187 KPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp --EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred CceeeEcCccccceeecCCCCceeeccc
Confidence 3469999999999999999989998843
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=87.27 E-value=0.54 Score=49.32 Aligned_cols=49 Identities=27% Similarity=0.377 Sum_probs=31.7
Q ss_pred HHHHHHHHHHHHHH--Hhhc-CCCcEEeccCCCCceEEcCC------------------CCceecccccccc
Q 039318 499 RFCIICGTARGLLY--LHHD-SRLRIIHRDLKASNVLLDHE------------------MNPKISDFGLART 549 (717)
Q Consensus 499 ~~~i~~~i~~~l~y--LH~~-~~~~ivHrDlkp~NIll~~~------------------~~~kl~Dfgla~~ 549 (717)
+..+..||| |.| +-+. +....+|-||||+||||-+. -.++|-||.+++.
T Consensus 277 vkfifLQia--LLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 277 VKFIFLQIA--LLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred HHHHHHHHH--HHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence 344566665 444 3233 23459999999999999332 2357778887765
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PF00024 PAN_1: PAN domain This Prosite entry concerns apple domains, a subset of PAN domains; InterPro: IPR003014 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=86.95 E-value=0.57 Score=37.97 Aligned_cols=54 Identities=19% Similarity=0.470 Sum_probs=40.3
Q ss_pred ceEEEeeccCCCCcccceecccChhhHHHhhcCCCC-ccccccccccCCCceeEEEecc
Q 039318 311 GFIKFSELKLPDSTSSWVSKSMNLKECREKCLENSS-CMAYTNSDITRGGSGCVMWFGD 368 (717)
Q Consensus 311 ~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCs-C~a~~~~~~~~~g~gc~~~~g~ 368 (717)
.|.++++..+........ ...++++|...|+.+-. |.+|.|.. ....|.+....
T Consensus 3 ~f~~~~~~~l~~~~~~~~-~v~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~L~~~~ 57 (79)
T PF00024_consen 3 AFERIPGYRLSGHSIKEI-NVPSLEECAQLCLNEPRRCKSFNYDP---SSKTCYLSSSD 57 (79)
T ss_dssp TEEEEEEEEEESCEEEEE-EESSHHHHHHHHHHSTT-ESEEEEET---TTTEEEEECSS
T ss_pred CeEEECCEEEeCCcceEE-cCCCHHHHHhhcCcCcccCCeEEEEC---CCCEEEEcCCC
Confidence 477888888877544433 44589999999999999 99999852 34569887643
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs It has been shown that, the N-terminal N domains of members of the plasminogen/hepatocyte growth factor family, the apple domains of the plasma prekallikrein/coagulation factor XI family, and domains of various nematode proteins belong to the same module superfamily, the PAN module []. PAN contains a conserved core of three disulphide bridges. In some members of the family there is an additional fourth disulphide bridge that links the N and C termini of the domain.; PDB: 1GP9_C 2QJ2_B 1GMO_H 1NK1_B 3MKP_B 1BHT_B 3HN4_A 1GMN_A 3HMS_A 3HMT_B .... |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=86.18 E-value=0.95 Score=48.03 Aligned_cols=31 Identities=32% Similarity=0.388 Sum_probs=26.2
Q ss_pred CcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 519 LRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 519 ~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
..++|+|+.|.|||++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3599999999999999765567999998764
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=86.12 E-value=0.52 Score=45.64 Aligned_cols=30 Identities=23% Similarity=0.335 Sum_probs=26.3
Q ss_pred CcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 519 LRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 519 ~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
...+|+|+.|.||++.+++ ++|+||+.+..
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 3479999999999998877 99999999864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=85.67 E-value=1.1 Score=47.24 Aligned_cols=31 Identities=39% Similarity=0.464 Sum_probs=27.2
Q ss_pred CcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 519 LRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 519 ~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
..++|+|+++.||+++.++...|+||+.+..
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 4599999999999999887678999998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=84.61 E-value=1.4 Score=46.42 Aligned_cols=30 Identities=23% Similarity=0.329 Sum_probs=25.8
Q ss_pred CcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 519 LRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 519 ~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
..++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 45999999999999987 6789999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=84.47 E-value=0.71 Score=47.30 Aligned_cols=30 Identities=27% Similarity=0.372 Sum_probs=26.4
Q ss_pred CcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 519 LRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 519 ~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
..++|+|+.|.||++++++ +.|+||..+..
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 3589999999999999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 717 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-44 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-33 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-27 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-27 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 363 bits (934), Expect = e-121
Identities = 114/303 (37%), Positives = 160/303 (52%), Gaps = 36/303 (11%)
Query: 407 EDLELPL-----FELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA--------- 452
ED E+ L F L + A+DNFS LG GGFG VYKG LADG +A
Sbjct: 8 EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT 67
Query: 453 ------------------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKL- 493
HRNL++L G C+ E+LL+Y +M N S+ S + ++ + +
Sbjct: 68 QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 127
Query: 494 LDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553
LDW KR I G+ARGL YLH +IIHRD+KA+N+LLD E + DFGLA+
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
Query: 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKN--RGFYHSDKNL 611
+ +T V GT G++APEY S G S K+DVF +G++LLE+++G++ +D ++
Sbjct: 188 DTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 612 NLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
L+ L L+D Q + EV + I V LLC Q P +RP M V+ ML
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
Query: 672 GSE 674
+
Sbjct: 307 EGD 309
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 361 bits (929), Expect = e-120
Identities = 94/309 (30%), Positives = 133/309 (43%), Gaps = 46/309 (14%)
Query: 401 ENED-QNEDLELPLFELATIANATDNFS------INKKLGEGGFGPVYKGTLADGQEIA- 452
EN+ + D F + N T+NF K+GEGGFG VYKG + + +A
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 453 -----------------------------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDS 483
H NLV+LLG G++ L+Y +MPN SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 484 FIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISD 543
+ L W R I G A G+ +LH + IHRD+K++N+LLD KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 544 FGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRG 603
FGLAR T R+VGT YMAPE G + KSD++SFG++LLEI++G
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 604 FYHSDKNLNLIGHAWKLWNNGMP-SQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
+ + L+ ++ + ID + V V C+ RP
Sbjct: 236 EHREPQ--LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 663 CMPSVILML 671
+ V +L
Sbjct: 293 DIKKVQQLL 301
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = e-101
Identities = 98/314 (31%), Positives = 145/314 (46%), Gaps = 32/314 (10%)
Query: 386 MSASELGGNNRRTDQENEDQNEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGTL 445
M + N D + E L + AT+NF +G G FG VYKG L
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60
Query: 446 ADGQEIA--------------------------HRNLVKLLGCCIQGEEKLLIYEFMPNR 479
DG ++A H +LV L+G C + E +LIY++M N
Sbjct: 61 RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 480 SLDSFIFDQTKRKL-LDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN 538
+L ++ + + W +R I G ARGL YLH + IIHRD+K+ N+LLD
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV 177
Query: 539 PKISDFGLARTF-VGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
PKI+DFG+++ D+ ST V GT GY+ PEY G + KSDV+SFG++L E++
Sbjct: 178 PKITDFGISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
Query: 598 GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHH 657
+ + +NL A + NNG Q++D + + + + C+
Sbjct: 237 ARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALS 296
Query: 658 PEDRPCMPSVILML 671
EDRP M V+ L
Sbjct: 297 SEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 4e-78
Identities = 67/322 (20%), Positives = 115/322 (35%), Gaps = 61/322 (18%)
Query: 400 QENEDQNEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA------- 452
+ + ++L L + + + G FG V+K L + +A
Sbjct: 3 HHHHHHSSGVDLGTENLYF---QSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ 58
Query: 453 ------------------HRNLVKLLGCCIQGE----EKLLIYEFMPNRSLDSFIFDQTK 490
H N+++ +G +G + LI F SL F+ K
Sbjct: 59 DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----K 114
Query: 491 RKLLDWSKRFCIICGTARGLLYLHHD-------SRLRIIHRDLKASNVLLDHEMNPKISD 543
++ W++ I ARGL YLH D + I HRD+K+ NVLL + + I+D
Sbjct: 115 ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 544 FGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL-----FSVKSDVFSFGILLLEIVSG 598
FGLA F + G T VGT YMAPE + ++ D+++ G++L E+ S
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
Query: 599 KKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA--------YYQESCNLAEVIRCI-HV 649
+ L ++ + + + ++ + +
Sbjct: 235 CTAADGPVDEYMLPF---EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCET 291
Query: 650 GLLCVQHHPEDRPCMPSVILML 671
C H E R V +
Sbjct: 292 IEECWDHDAEARLSAGCVGERI 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 3e-65
Identities = 66/322 (20%), Positives = 112/322 (34%), Gaps = 66/322 (20%)
Query: 422 ATDNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNL 456
DN + + +G G +G VYKG+L D + +A H N+
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNI 69
Query: 457 VKLLGCCIQGE-----EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLL 511
+ + + E LL+ E+ PN SL ++ T DW + RGL
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLA 125
Query: 512 YLHHD------SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG------DEIEGST 559
YLH + + I HRDL + NVL+ ++ ISDFGL+ G E + +
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 560 KRVVGTYGYMAPEYASDGL-------FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLN 612
VGT YMAPE + + D+++ G++ EI + S
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245
Query: 613 LIGHAWKLWNNGMPSQLIDAYYQ--------ESCNLAEVIRCIHVGLL--CVQHHPEDRP 662
+ ++ N+ + + E+ + + C E R
Sbjct: 246 MA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL 304
Query: 663 CMPSVILMLGS-EIMLPQPKQP 683
+ ++ + K
Sbjct: 305 TAQXAEERMAELMMIWERNKSV 326
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-51
Identities = 75/323 (23%), Positives = 133/323 (41%), Gaps = 71/323 (21%)
Query: 394 NNRRTDQENEDQNEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA- 452
+ +D+++P +L +I +K+G G FG V++ G ++A
Sbjct: 17 TTENLYFQGAMDGDDMDIPWCDL----------NIKEKIGAGSFGTVHRAEW-HGSDVAV 65
Query: 453 ---------------------------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFI 485
H N+V +G Q ++ E++ SL +
Sbjct: 66 KILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL 125
Query: 486 FDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545
R+ LD +R + A+G+ YLH+ I+HR+LK+ N+L+D + K+ DFG
Sbjct: 126 HKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFG 184
Query: 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFY 605
L+R + S+K GT +MAPE D + KSDV+SFG++L E+ + ++ +
Sbjct: 185 LSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ---PW 239
Query: 606 HSDKNLNLIGHAWKLWNNG----MPSQLIDAYYQESCN--LAEVIRCIHVGLLCVQHHPE 659
NLN + +P + N +A +I C + P
Sbjct: 240 ---GNLNPAQVVAAVGFKCKRLEIP---------RNLNPQVAAIIE------GCWTNEPW 281
Query: 660 DRPCMPSVILMLGS--EIMLPQP 680
RP +++ +L + +P P
Sbjct: 282 KRPSFATIMDLLRPLIKSAVPPP 304
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-51
Identities = 64/286 (22%), Positives = 106/286 (37%), Gaps = 48/286 (16%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA------------------------HRNLVKL 459
+ + +G G FG V K +++A H N+VKL
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKL 66
Query: 460 LGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRL 519
G C+ L+ E+ SL + + + ++G+ YLH
Sbjct: 67 YGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 520 RIIHRDLKASNVLLDHEMN-PKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL 578
+IHRDLK N+LL KI DFG A +I+ G+ +MAPE
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 579 FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638
+S K DVFS+GI+L E+++ +K + + W + N P + +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRK---PF-DEIGGPAFRIMWAVHNGTRPP--LIKNLPKP- 232
Query: 639 NLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS-EIMLPQPKQP 683
+ ++ C P RP M ++ ++ P +P
Sbjct: 233 -IESLMTR------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-49
Identities = 68/312 (21%), Positives = 126/312 (40%), Gaps = 60/312 (19%)
Query: 391 LGGNNRRTDQENEDQNEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKG------- 443
+ + + D +D E+P ++ ++ +++G G FG VYKG
Sbjct: 1 MKKGHHHHHHGSRDAADDWEIPDGQI----------TVGQRIGSGSFGTVYKGKWHGDVA 50
Query: 444 --TLADG-----------QEIA------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSF 484
L E+ H N++ +G + ++ ++ SL
Sbjct: 51 VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHH 109
Query: 485 IFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDF 544
+ + K I TARG+ YLH IIHRDLK++N+ L + KI DF
Sbjct: 110 L--HASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDF 164
Query: 545 GLARTFVGDEIEGSTKRVVGTYGYMAPE---YASDGLFSVKSDVFSFGILLLEIVSGKKN 601
GLA +++ G+ +MAPE +S +SDV++FGI+L E+++G+
Sbjct: 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
Query: 602 RGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCN--LAEVIRCIHVGLLCVQHHPE 659
Y + N + I + + L + +C + ++ C++ +
Sbjct: 225 ---YSNINNRDQI--IEMVGRGSLSPDLSKV--RSNCPKRMKRLMA------ECLKKKRD 271
Query: 660 DRPCMPSVILML 671
+RP P ++ +
Sbjct: 272 ERPSFPRILAEI 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-49
Identities = 72/328 (21%), Positives = 113/328 (34%), Gaps = 90/328 (27%)
Query: 424 DNFSINKKLGEGGFGPVYKGTL-ADGQEIA--------------------------HRNL 456
+ + LG+G FG K T G+ + H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 457 VKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD 516
+K +G + + I E++ +L I ++ WS+R A G+ YLH
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLH-- 125
Query: 517 SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE------------IEGSTKRVVG 564
+ IIHRDL + N L+ N ++DFGLAR V ++ VVG
Sbjct: 126 -SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 565 TYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG 624
+MAPE + + K DVFSFGI+L EI+ +
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV-------------------NADPDY 225
Query: 625 MPSQ-----LIDAYYQ----ESC--NLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML-- 671
+P + + +C + + + C PE RP + L
Sbjct: 226 LPRTMDFGLNVRGFLDRYCPPNCPPSFFPIT------VRCCDLDPEKRPSFVKLEHWLET 279
Query: 672 ------GSEIMLPQPKQ--PGFLADRKS 691
G + PQ +Q GF +
Sbjct: 280 LRMHLAGHLPLGPQLEQLDRGFWETYRR 307
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-48
Identities = 67/295 (22%), Positives = 118/295 (40%), Gaps = 76/295 (25%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA------------------------------ 452
+ K++G+GGFG V+KG + D +A
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 453 ---HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARG 509
H N+VKL G ++ EF+P L + K + WS + ++ A G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALG 134
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLD-----HEMNPKISDFGLARTFVGDEIEGSTKRVVG 564
+ Y+ + I+HRDL++ N+ L + K++DFGL++ + S ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 565 TYGYMAPE--YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWN 622
+ +MAPE A + ++ K+D +SF ++L I++G+ + + + I +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PF-DEYSYGKIKFINMIRE 244
Query: 623 NGM----PSQLIDAYYQESCN--LAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
G+ P E C L VI LC P+ RP ++ L
Sbjct: 245 EGLRPTIP---------EDCPPRLRNVIE------LCWSGDPKKRPHFSYIVKEL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-48
Identities = 70/284 (24%), Positives = 120/284 (42%), Gaps = 66/284 (23%)
Query: 428 INKKLGEGGFGPVYKGTLADGQEIA------------------------------HRNLV 457
+ + +G GGFG VY+ G E+A H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS 517
L G C++ L+ EF L+ + K + ARG+ YLH ++
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 518 RLRIIHRDLKASNVLLDHEMNP--------KISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
+ IIHRDLK+SN+L+ ++ KI+DFGLAR + + G Y +M
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWM 181
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629
APE +FS SDV+S+G+LL E+++G+ + + ++ + A+ + N + +
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEV---PF---RGIDGLAVAYGVAMNKLALPI 235
Query: 630 IDAYYQESCN--LAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
+C A+++ C P RP +++ L
Sbjct: 236 P-----STCPEPFAKLME------DCWNPDPHSRPSFTNILDQL 268
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 8e-47
Identities = 54/287 (18%), Positives = 107/287 (37%), Gaps = 70/287 (24%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA----------------------------HRN 455
+ KL E G ++KG G +I H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 456 LVKLLGCCIQGEEKLL--IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYL 513
++ +LG C I +MP SL + + + T + D S+ ARG+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFL 127
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE- 572
H L I L + +V++D +M +IS + +F + + ++APE
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEA 179
Query: 573 --YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM----P 626
+ +D++SF +LL E+V+ + + +L+ + K+ G+ P
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREV---PF---ADLSNMEIGMKVALEGLRPTIP 233
Query: 627 SQLIDAYYQESCN--LAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
+ ++++++ +C+ P RP ++ +L
Sbjct: 234 ---------PGISPHVSKLMK------ICMNEDPAKRPKFDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 8e-45
Identities = 65/318 (20%), Positives = 114/318 (35%), Gaps = 73/318 (22%)
Query: 394 NNRRTDQENEDQNEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGT--------- 444
+ R + ++ ++P +L I + +G+G FG VY G
Sbjct: 13 SFPRKASQTSIFLQEWDIPFEQL----------EIGELIGKGRFGQVYHGRWHGEVAIRL 62
Query: 445 LADG-----------QEIA------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFD 487
+ +E+ H N+V +G C+ +I R+L S +
Sbjct: 63 IDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV-- 120
Query: 488 QTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547
+ + +LD +K I +G+ YLH I+H+DLK+ NV D I+DFGL
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLF 176
Query: 548 R---TFVGDEIEGSTKRVVGTYGYMAPE---------YASDGLFSVKSDVFSFGILLLEI 595
E + G ++APE FS SDVF+ G + E+
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236
Query: 596 VSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCN--LAEVIRCIHVGLLC 653
+ + + K W++ P+ Q +++++ C
Sbjct: 237 HAREWP---F---KTQPAEAIIWQMGTGMKPNLS-----QIGMGKEISDILL------FC 279
Query: 654 VQHHPEDRPCMPSVILML 671
E+RP ++ ML
Sbjct: 280 WAFEQEERPTFTKLMDML 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 68/320 (21%), Positives = 117/320 (36%), Gaps = 79/320 (24%)
Query: 411 LPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA------------------ 452
LPL TIA + K++G+G +G V+ G G+++A
Sbjct: 27 LPLLVQRTIA---KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEI 82
Query: 453 -------HRNLVKLLGCCIQGEEK----LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFC 501
H N++ + I+G LI ++ N SL ++ K LD
Sbjct: 83 YQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLK 138
Query: 502 IICGTARGLLYLHHDSRLR-----IIHRDLKASNVLLDHEMNPKISDFGLARTFVG--DE 554
+ + GL +LH + I HRDLK+ N+L+ I+D GLA F+ +E
Sbjct: 139 LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198
Query: 555 IEGSTKRVVGTYGYMAPE------YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSD 608
++ VGT YM PE + + +D++SFG++L E+ + G
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258
Query: 609 KNLNLIGHAWKLWNNGMPS--QLIDA-------------YYQESC--NLAEVIRCIHVGL 651
+ + PS + + + + C + +++
Sbjct: 259 Q------LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMT------ 306
Query: 652 LCVQHHPEDRPCMPSVILML 671
C H+P R V L
Sbjct: 307 ECWAHNPASRLTALRVKKTL 326
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-42
Identities = 50/228 (21%), Positives = 91/228 (39%), Gaps = 50/228 (21%)
Query: 418 TIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA------------------------- 452
T+A + ++ + +G+G +G V++G+ G+ +A
Sbjct: 5 TVA---RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLR 60
Query: 453 HRNLVKLLGCCIQGEEK----LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTAR 508
H N++ + + LI + SL ++ + LD I+ A
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIAS 116
Query: 509 GLLYLHHDSRLR-----IIHRDLKASNVLLDHEMNPKISDFGLAR--TFVGDEIEGSTKR 561
GL +LH + I HRDLK+ N+L+ I+D GLA + ++++
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 562 VVGTYGYMAPE------YASDGLFSVKSDVFSFGILLLEIVSGKKNRG 603
VGT YMAPE + D+++FG++L E+ + G
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 55/237 (23%), Positives = 92/237 (38%), Gaps = 50/237 (21%)
Query: 411 LPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA------------------ 452
LPL TIA + + +G+G FG V++G G+E+A
Sbjct: 32 LPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEI 87
Query: 453 -------HRNLVKLLGCCIQGEEK----LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFC 501
H N++ + + L+ ++ + SL ++ R +
Sbjct: 88 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIK 143
Query: 502 IICGTARGLLYLHHD-----SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF--VGDE 554
+ TA GL +LH + + I HRDLK+ N+L+ I+D GLA D
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203
Query: 555 IEGSTKRVVGTYGYMAPE------YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFY 605
I+ + VGT YMAPE ++D+++ G++ EI G +
Sbjct: 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-40
Identities = 66/304 (21%), Positives = 107/304 (35%), Gaps = 86/304 (28%)
Query: 424 DNFSINKKLGEGGFGPVYKGTL-ADGQEIA---------------------------HRN 455
++ + +++G G FG V+ G L AD +A H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 456 LVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHH 515
+V+L+G C Q + ++ E + +F+ +T+ L ++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLE- 230
Query: 516 DSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYAS 575
IHRDL A N L+ + KISDFG++R S + APE +
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 576 DGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634
G +S +SDV+SFGILL E S G P Y
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGA-------------------------SP-------Y 316
Query: 635 QESCNLAEVIRCIHVG-----------------LLCVQHHPEDRPCMPSVILMLGSEIML 677
+ + + G C + P RP ++ L + +
Sbjct: 317 PN-LSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL--QSIR 373
Query: 678 PQPK 681
+ +
Sbjct: 374 KRHR 377
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 6e-38
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 41/205 (20%)
Query: 424 DNFSINKKLGEGGFGPVYKG------------TLADG--------------QEIAHRNLV 457
+ ++ KLG G +G VY+G TL + +EI H NLV
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS 517
+LLG C + +I EFM +L ++ + R+ + + + + YL
Sbjct: 73 QLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL---E 128
Query: 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTK-----RVVGTYGYMAPE 572
+ IHRDL A N L+ K++DFGL+R GD + + APE
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPE 182
Query: 573 YASDGLFSVKSDVFSFGILLLEIVS 597
+ FS+KSDV++FG+LL EI +
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 37/202 (18%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVK 458
+ +++G G FG V+ G + ++A H LV+
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
L G C++ L+ EFM + L ++ +T+R L + G+ YL
Sbjct: 68 LYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EE 122
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT---YGYMAPEYAS 575
+IHRDL A N L+ K+SDFG+ R + D+ ST GT + +PE S
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFS 178
Query: 576 DGLFSVKSDVFSFGILLLEIVS 597
+S KSDV+SFG+L+ E+ S
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFS 200
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 37/202 (18%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVK 458
+ ++ K+LG G FG V G ++A H LVK
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVK 67
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
G C + ++ E++ N L +++ ++ K L+ S+ + G+ +L
Sbjct: 68 FYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ES 122
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT---YGYMAPEYAS 575
+ IHRDL A N L+D ++ K+SDFG+ R + D+ S GT + APE
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFH 178
Query: 576 DGLFSVKSDVFSFGILLLEIVS 597
+S KSDV++FGIL+ E+ S
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFS 200
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 4e-37
Identities = 55/198 (27%), Positives = 84/198 (42%), Gaps = 33/198 (16%)
Query: 424 DNFSINKKLGEGGFGPVYKG----------TLADG-------QEIA------HRNLVKLL 460
+ + +G+G FG V G + + E + H NLV+LL
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLL 252
Query: 461 GCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRL 519
G ++ + L ++ E+M SL ++ + R +L + YL
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL---EGN 308
Query: 520 RIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLF 579
+HRDL A NVL+ + K+SDFGL + + + + APE + F
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKL-PVKWTAPEALREKKF 363
Query: 580 SVKSDVFSFGILLLEIVS 597
S KSDV+SFGILL EI S
Sbjct: 364 STKSDVWSFGILLWEIYS 381
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 39/207 (18%)
Query: 424 DNFSINKKLGEGGFGPVYKG---------------TLADG----------QEIA------ 452
I K +G G G V G L G E +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLY 512
H N+++L G +G +++ E+M N SLD+F+ +T + ++ G G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY--MA 570
L S L +HRDL A NVL+D + K+SDFGL+R + D+ + + G A
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR-VLEDDPDAAYTTTGGKIPIRWTA 222
Query: 571 PEYASDGLFSVKSDVFSFGILLLEIVS 597
PE + FS SDV+SFG+++ E+++
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 37/202 (18%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVK 458
+ + K+LG G FG V G ++A H LV+
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
L G C + +I E+M N L +++ + R + + + YL
Sbjct: 84 LYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ES 138
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT---YGYMAPEYAS 575
+ +HRDL A N L++ + K+SDFGL+R + DE VG+ + PE
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVLM 194
Query: 576 DGLFSVKSDVFSFGILLLEIVS 597
FS KSD+++FG+L+ EI S
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYS 216
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 40/229 (17%)
Query: 403 EDQNEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADGQE------------ 450
D + L + ++ I + ++ +G+G FG VY G D +
Sbjct: 1 RDLDSALLAEVKDVL-IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR 59
Query: 451 -------------------IAHRNLVKLLGCCIQGEE-KLLIYEFMPNRSLDSFIFDQTK 490
+ H N++ L+G + E ++ +M + L FI ++
Sbjct: 60 ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSP 117
Query: 491 RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550
++ ARG+ YL + + +HRDL A N +LD K++DFGLAR
Sbjct: 118 QRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174
Query: 551 VGDEIEGSTKRVVGTY--GYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+ E + + A E F+ KSDV+SFG+LL E+++
Sbjct: 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 79/328 (24%), Positives = 127/328 (38%), Gaps = 91/328 (27%)
Query: 424 DNFSINKKLGEGGFGPVYKG----------------TLADG----------QEIA----- 452
+ K +G G FG VYKG TL G E
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 453 -HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLL 511
H N+++L G + + ++I E+M N +LD F+ + K + ++ G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 512 YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY--M 569
YL + + +HRDL A N+L++ + K+SDFGL+R + D+ E + G
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRWT 217
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628
APE S F+ SDV+SFGI++ E+++ G+ P
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGE-------------------------RP-- 250
Query: 629 LIDAYYQESCNLAEVIRCIHVG-----------------LLCVQHHPEDRPCMPSVILML 671
Y E N EV++ I+ G + C Q RP ++ +L
Sbjct: 251 -----YWELSN-HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304
Query: 672 GSEIMLPQPKQPGFLADRKSTGPNSSSS 699
I P + D + + S+S
Sbjct: 305 DKLIRAPDSLKTLADFDPRVSIRLPSTS 332
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 58/205 (28%), Positives = 83/205 (40%), Gaps = 47/205 (22%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA------------------------HRNLVKL 459
+ + +G+G FG V G G ++A H NLV+L
Sbjct: 21 KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 460 LGCCIQGEEKLLI-YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
LG ++ + L I E+M SL ++ + R +L + YL
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL---EG 135
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST------KRVVGTYGYMAPE 572
+HRDL A NVL+ + K+SDFGL + + K + APE
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVK-------WTAPE 184
Query: 573 YASDGLFSVKSDVFSFGILLLEIVS 597
+ FS KSDV+SFGILL EI S
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 63/300 (21%), Positives = 105/300 (35%), Gaps = 75/300 (25%)
Query: 424 DNFSINKKLGEGGFGPVYKG----------------TLADG---------QEIA------ 452
+ ++LG+G FG V L +EI
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 453 HRNLVKLLGCCIQGEEK--LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGL 510
H N+VK G C + LI E++P SL ++ Q ++ +D K +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY--GY 568
YL R IHRDL N+L+++E KI DFGL + + + E + G +
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFW 183
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628
APE ++ FSV SDV+SFG++L E+ + + ++ +
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV----- 238
Query: 629 LIDAYYQESCNLAEVIRCIHVG-----------------LLCVQHHPEDRPCMPSVILML 671
+I + C ++ RP + L +
Sbjct: 239 ------------FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 57/219 (26%)
Query: 424 DNFSINKKLGEGGFGPVYKG----------------TLADG----------------QEI 451
F K LG G FG VYKG L + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 452 AHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQ----TKRKLLDWSKRFCIICGTA 507
+ ++ +LLG C+ LI + MP L ++ + + LL+W A
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
+G+ YL R++HRDL A NVL+ + KI+DFGLA+ +E E + G
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----G 179
Query: 568 -----YMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKK 600
+MA E +++ +SDV+S+G+ + E+++ G K
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 80/337 (23%), Positives = 131/337 (38%), Gaps = 90/337 (26%)
Query: 424 DNFSINKKLGEGGFGPVYKG---------------TLADG----------QEIA------ 452
N SI+K +G G FG V G TL G E +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLY 512
H N+++L G + + +++ E+M N SLDSF+ + + ++ G A G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY--MA 570
L S + +HRDL A N+L++ + K+SDFGL R + D+ E + G +
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGR-VLEDDPEAAYTTRGGKIPIRWTS 218
Query: 571 PEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629
PE + F+ SDV+S+GI+L E++S G+ P
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGE-------------------------RP--- 250
Query: 630 IDAYYQESCNLAEVIRCIHVG-----------------LLCVQHHPEDRPCMPSVILMLG 672
Y E N +VI+ + G L C Q +RP ++ +L
Sbjct: 251 ----YWEMSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
Query: 673 SEIMLPQPKQPGFLADRKSTGPNSSSSMLESSSTNTI 709
I P + A + + S ++ ++ T
Sbjct: 306 KLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTT 342
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 60/252 (23%), Positives = 90/252 (35%), Gaps = 70/252 (27%)
Query: 395 NRRTDQENEDQNEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADG------ 448
+ + N D L ++ +GEG FG V K +
Sbjct: 6 HHHHGKNNPDPTIYPVLDW----------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDA 55
Query: 449 ------------------QEIA-------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDS 483
E+ H N++ LLG C L E+ P+ +L
Sbjct: 56 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 115
Query: 484 F-------------IFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASN 530
F + L + ARG+ YL S+ + IHRDL A N
Sbjct: 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARN 172
Query: 531 VLLDHEMNPKISDFGLARTFVGDEIEGSTK-----RVVGTYGYMAPEYASDGLFSVKSDV 585
+L+ KI+DFGL+R + T R +MA E + +++ SDV
Sbjct: 173 ILVGENYVAKIADFGLSRG--QEVYVKKTMGRLPVR------WMAIESLNYSVYTTNSDV 224
Query: 586 FSFGILLLEIVS 597
+S+G+LL EIVS
Sbjct: 225 WSYGVLLWEIVS 236
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-36
Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 31/200 (15%)
Query: 424 DNFSINKKLGEGGFGPVYKG------------TLADG--------QEIA------HRNLV 457
+ ++ KLG G +G VY+G TL + +E A H NLV
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS 517
+LLG C + +I EFM +L ++ + R+ + + + + YL
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL---E 335
Query: 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDG 577
+ IHR+L A N L+ K++DFGL+R GD + APE +
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYN 394
Query: 578 LFSVKSDVFSFGILLLEIVS 597
FS+KSDV++FG+LL EI +
Sbjct: 395 KFSIKSDVWAFGVLLWEIAT 414
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 61/228 (26%), Positives = 91/228 (39%), Gaps = 62/228 (27%)
Query: 424 DNFSINKKLGEGGFGPVYKG-------------------TLADG----------QEIA-- 452
D ++ K LGEG FG V L D E+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 453 -----HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSF-------------IFDQTKRKLL 494
H+N++ LLG C Q +I E+ +L + ++ + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 495 DWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554
+ ARG+ YL + + IHRDL A NVL+ KI+DFGLAR +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----D 206
Query: 555 IEGSTKRVVGTYG-----YMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
I T G +MAPE D +++ +SDV+SFG+L+ EI +
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 63/291 (21%), Positives = 103/291 (35%), Gaps = 75/291 (25%)
Query: 424 DNFSINKKLGEGGFGPVYKG----------------TLADG---------QEIA------ 452
+ ++LG+G FG V L +EI
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 453 HRNLVKLLGCCIQGEEK--LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGL 510
H N+VK G C + LI E++P SL ++ Q ++ +D K +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY--GY 568
YL R IHRDL N+L+++E KI DFGL + + + E + G +
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFW 214
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628
APE ++ FSV SDV+SFG++L E+ + + ++ + M
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG----QMIVF 270
Query: 629 LIDAYYQESCNLAEVIRCIHVG-----------------LLCVQHHPEDRP 662
+I + C ++ RP
Sbjct: 271 -------------HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 308
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 47/209 (22%)
Query: 427 SINKKLGEGGFGPVYKGTLADG-------------------------------QEIAHRN 455
N+ +G G FG VY GTL D ++ +H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 456 LVKLLGCCIQGEEKLL-IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH 514
++ LLG C++ E L + +M + L +FI + + A+G+ YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 144
Query: 515 HDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG------Y 568
+ + +HRDL A N +LD + K++DFGLAR D + V G +
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKW 198
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVS 597
MA E F+ KSDV+SFG+LL E+++
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-36
Identities = 62/201 (30%), Positives = 93/201 (46%), Gaps = 35/201 (17%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVK 458
+ + ++LG G FG V+ G ++A H+ LV+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
L Q E +I E+M N SL F+ L +K + A G+ ++
Sbjct: 73 LYAVVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EE 127
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY--MAPEYASD 576
IHRDL+A+N+L+ ++ KI+DFGLAR +E T R + APE +
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINY 184
Query: 577 GLFSVKSDVFSFGILLLEIVS 597
G F++KSDV+SFGILL EIV+
Sbjct: 185 GTFTIKSDVWSFGILLTEIVT 205
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 69/316 (21%), Positives = 105/316 (33%), Gaps = 85/316 (26%)
Query: 424 DNFSINKKLGEGGFGPVYKGTL---ADGQEIA---------------------------- 452
+ LGEG FG V DG
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 453 -HRNLVKLLGCCIQGEEK--LLIYEFMPNRSLDSFIFDQ--TKRKLLDWSKRFCIICGTA 507
H +++K GCC L+ E++P SL ++ +LL ++
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFA------QQIC 144
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY- 566
G+ YLH IHRDL A NVLLD++ KI DFGLA+ V + E R G
Sbjct: 145 EGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSP 200
Query: 567 -GYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNG 624
+ APE + F SDV+SFG+ L E+++ ++ L G
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-----------IG 249
Query: 625 MPSQLIDAYYQESCNLAEVIRCIHVG-----------------LLCVQHHPEDRPCMPSV 667
+ + + + G C + RP ++
Sbjct: 250 IA-------QGQMTV-LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENL 301
Query: 668 ILMLGSEIMLPQPKQP 683
I +L + Q + P
Sbjct: 302 IPILKTVHEKYQGQAP 317
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-36
Identities = 61/228 (26%), Positives = 91/228 (39%), Gaps = 62/228 (27%)
Query: 424 DNFSINKKLGEGGFGPVYKG-------------------TLADG----------QEIA-- 452
D ++ K LGEG FG V L D E+
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 453 -----HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSF-------------IFDQTKRKLL 494
H+N++ LLG C Q +I E+ +L + ++ + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 495 DWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554
+ ARG+ YL + + IHRDL A NVL+ KI+DFGLAR +
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----D 252
Query: 555 IEGSTKRVVGTYG-----YMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
I T G +MAPE D +++ +SDV+SFG+L+ EI +
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-36
Identities = 76/337 (22%), Positives = 126/337 (37%), Gaps = 103/337 (30%)
Query: 424 DNFSINKKLGEGGFGPVYKG-----------------TLADG----------------QE 450
+ +++++LG+G FG VY+G T+ + +E
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 451 IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSF-------IFDQTKRKLLDWSKRFCII 503
++V+LLG QG+ L+I E M L S+ + + SK +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 504 CGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVV 563
A G+ YL + + +HRDL A N ++ + KI DFG+ R +I +
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRK 196
Query: 564 GTYGY-----MAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAW 618
G G M+PE DG+F+ SDV+SFG++L EI +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----LA--------------- 237
Query: 619 KLWNNGMPSQLIDAYYQESCNLAEVIRCIHVG-----------------LLCVQHHPEDR 661
P YQ N +V+R + G +C Q++P+ R
Sbjct: 238 -----EQP-------YQGLSN-EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMR 284
Query: 662 PCMPSVILMLGSEIMLPQPKQPGFLADRKSTGPNSSS 698
P +I + E M P ++ F ++ P
Sbjct: 285 PSFLEIISSI-KEEMEPGFREVSFYYSEENKLPEPEE 320
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 61/297 (20%), Positives = 102/297 (34%), Gaps = 87/297 (29%)
Query: 424 DNFSINKKLGEGGFGPVYKG----------------TLADG----------QEIA----- 452
+ LGEG FG V +L +EI
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 453 -HRNLVKLLGCCIQGEEK--LLIYEFMPNRSLDSFIFDQ----TKRKLLDWSKRFCIICG 505
H N+VK G C + LI EF+P+ SL ++ ++ L ++
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA------VQ 134
Query: 506 TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT 565
+G+ YL + +HRDL A NVL++ E KI DFGL + + + E T +
Sbjct: 135 ICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDRD 190
Query: 566 Y--GYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWN 622
+ APE F + SDV+SFG+ L E+++ +
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS------------------P 232
Query: 623 NGMPSQLIDAYYQESCNLAEVIRCIHVG-----------------LLCVQHHPEDRP 662
+ ++I + + ++ + G C + P +R
Sbjct: 233 MALFLKMIGPTHGQMTV-TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRT 288
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 72/341 (21%), Positives = 120/341 (35%), Gaps = 96/341 (28%)
Query: 424 DNFSINKKLGEGGFGPVYKG----------------TLADG---------QEIA------ 452
+ +LG+G FG V L +EI
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 453 HRNLVKLLGCCIQGEEK--LLIYEFMPNRSLDSFIFDQ----TKRKLLDWSKRFCIICGT 506
+VK G + L+ E++P+ L F+ +LL +S
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS------SQI 136
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
+G+ YL R +HRDL A N+L++ E + KI+DFGLA+ D+ VV
Sbjct: 137 CKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY----YVVREP 189
Query: 567 G-----YMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKL 620
G + APE SD +FS +SDV+SFG++L E+ + K+
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS------------------- 230
Query: 621 WNNGMPSQLIDAYYQESCNLAEVIRCIHVG-----------------LLCVQHHPEDRPC 663
+ + ++ L+ ++ + G LC P+DRP
Sbjct: 231 CSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPS 290
Query: 664 MPSVILMLGSEIMLPQPKQPGFLADRKSTGPNSSSSMLESS 704
++ L +++ + G + P L S
Sbjct: 291 FSALGPQL--DMLWSGSR--GCETHAFTAHPEGKHHSLSFS 327
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 39/205 (19%)
Query: 427 SINKKLGEGGFGPVYKGTLADG-------------------------------QEIAHRN 455
N+ +G G FG VY GTL D ++ +H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 456 LVKLLGCCIQGEEKLL-IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH 514
++ LLG C++ E L + +M + L +FI + + A+G+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL- 208
Query: 515 HDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY--GYMAPE 572
+ + +HRDL A N +LD + K++DFGLAR E + + +MA E
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 573 YASDGLFSVKSDVFSFGILLLEIVS 597
F+ KSDV+SFG+LL E+++
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 65/230 (28%), Positives = 91/230 (39%), Gaps = 66/230 (28%)
Query: 424 DNFSINKKLGEGGFGPVYKG-----------------TLADG----------QEIA---- 452
+ S K LG G FG V + L E+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 453 ---HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGT--- 506
H N+V LLG C G L+I E+ L +F+ + KR SK I
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDDEL 140
Query: 507 --------------ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552
A+G+ +L + IHRDL A N+LL H KI DFGLAR
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR---- 193
Query: 553 DEIEGSTKRVVGTYG-----YMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+I+ + VV +MAPE + +++ +SDV+S+GI L E+ S
Sbjct: 194 -DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-35
Identities = 62/202 (30%), Positives = 90/202 (44%), Gaps = 37/202 (18%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVK 458
++ + KKLG G FG V+ T ++A H LVK
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK 247
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
L + E +I EFM SL F+ + K A G+ ++ +
Sbjct: 248 LHAVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---EQ 302
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT---YGYMAPEYAS 575
IHRDL+A+N+L+ + KI+DFGLAR +E G + APE +
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAIN 358
Query: 576 DGLFSVKSDVFSFGILLLEIVS 597
G F++KSDV+SFGILL+EIV+
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVT 380
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 72/317 (22%), Positives = 114/317 (35%), Gaps = 111/317 (35%)
Query: 424 DNFSINKKLGEGGFGPVYKG-----------------TLADG---------QEIA----- 452
+ + ++LGEG FG V+ L D +E
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 453 -HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSF-------------IFDQTKRKLLDWSK 498
H ++VK G C G+ ++++E+M + L+ F + + L S+
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 499 RFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE---I 555
I A G++YL + +HRDL N L+ + KI DFG++R + +
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 556 EGSTK---RVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNL 611
G T R +M PE F+ +SDV+SFG++L EI + GK
Sbjct: 192 GGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------ 233
Query: 612 NLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVG-----------------LLCV 654
P ++Q S EVI CI G L C
Sbjct: 234 -------------QP------WFQLS--NTEVIECITQGRVLERPRVCPKEVYDVMLGCW 272
Query: 655 QHHPEDRPCMPSVILML 671
Q P+ R + + +L
Sbjct: 273 QREPQQRLNIKEIYKIL 289
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 62/233 (26%), Positives = 93/233 (39%), Gaps = 67/233 (28%)
Query: 424 DNFSINKKLGEGGFGPVYKG-----------------TLADG----------------QE 450
N + K LGEG FG V K L + ++
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 451 IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSF---------------------IFDQT 489
+ H +++KL G C Q LLI E+ SL F D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 490 KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549
+ L ++G+ YL + ++++HRDL A N+L+ KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR- 198
Query: 550 FVGDEIEGSTKRVVGTYG-----YMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
D E + + G +MA E D +++ +SDV+SFG+LL EIV+
Sbjct: 199 ---DVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 68/226 (30%), Positives = 94/226 (41%), Gaps = 62/226 (27%)
Query: 424 DNFSINKKLGEGGFGPVYKG-----------------TLADG----------QEIA---- 452
+N K LG G FG V + L E+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 453 ---HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGT--- 506
H N+V LLG C G L+I E+ L +F+ + K ++L+ F I T
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFAIANSTAST 163
Query: 507 ----------ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556
A+G+ +L + IHRD+ A NVLL + KI DFGLAR D +
Sbjct: 164 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMN 216
Query: 557 GSTKRVVGTYG-----YMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
S V +MAPE D +++V+SDV+S+GILL EI S
Sbjct: 217 DSNYIV-KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-35
Identities = 62/228 (27%), Positives = 88/228 (38%), Gaps = 62/228 (27%)
Query: 424 DNFSINKKLGEGGFGPVYKG-------------------TLADG----------QEIA-- 452
D + K LGEG FG V L E+
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 453 -----HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGT- 506
H+N++ LLG C Q +I E+ +L ++ + L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 507 ------------ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554
ARG+ YL + + IHRDL A NVL+ + KI+DFGLAR +
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----D 240
Query: 555 IEGSTKRVVGTYG-----YMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
I T G +MAPE D +++ +SDV+SFG+LL EI +
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 53/223 (23%), Positives = 88/223 (39%), Gaps = 57/223 (25%)
Query: 424 DNFSINKKLGEGGFGPVYKG-----------------TLADG---------------QEI 451
+ + +LGEG FG V+ L + +
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 452 AHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSF------------IFDQTKRKLLDWSKR 499
H+++V+ G C +G L+++E+M + L+ F + L +
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 500 FCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559
+ A G++YL + L +HRDL N L+ + KI DFG++R D
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDY 213
Query: 560 KRVVGTYG-----YMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
RV G +M PE F+ +SDV+SFG++L EI +
Sbjct: 214 YRV-GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 60/296 (20%), Positives = 118/296 (39%), Gaps = 81/296 (27%)
Query: 424 DNFSINKKLGEGGFGPVYKG-------------------TLADG---------QEIA--- 452
++ N+ LG+G F ++KG L + +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 453 ---HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARG 509
H++LV G C+ G+E +L+ EF+ SLD+++ + + ++ + + A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNP--------KISDFGLARTFVGDEIEGSTKR 561
+ +L +IH ++ A N+LL E + K+SD G++ T + +I +R
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL--QER 180
Query: 562 VVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWK 619
+ ++ PE + ++ +D +SFG L EI S G K + + +
Sbjct: 181 I----PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP---LSALDSQRKL----- 228
Query: 620 LWNNGMPSQLIDAYYQ----ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
Q + +Q ++ LA +I C+ + P+ RP ++I L
Sbjct: 229 --------QFYEDRHQLPAPKAAELANLI------NNCMDYEPDHRPSFRAIIRDL 270
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 49/215 (22%), Positives = 83/215 (38%), Gaps = 56/215 (26%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADG--------------------------------QEI 451
K LG G FG V+KG +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 452 AHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQ----TKRKLLDWSKRFCIICGTA 507
H ++V+LLG C L+ +++P SL + + LL+W A
Sbjct: 73 DHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG------VQIA 125
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
+G+ YL ++HR+L A NVLL +++DFG+A D+ +
Sbjct: 126 KGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----A 177
Query: 568 -----YMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+MA E G ++ +SDV+S+G+ + E+++
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 58/250 (23%), Positives = 103/250 (41%), Gaps = 63/250 (25%)
Query: 393 GNNRRTDQENEDQNEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADG---- 448
G R +E +++ ED+ + + + K LGEG FG V +G L
Sbjct: 13 GLVPRGSEELQNKLEDVVIDR----------NLLILGKILGEGEFGSVMEGNLKQEDGTS 62
Query: 449 ----------------------------QEIAHRNLVKLLGCCIQGE-----EKLLIYEF 475
++ +H N+++LLG CI+ + ++I F
Sbjct: 63 LKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPF 122
Query: 476 MPNRSLDSFI---FDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVL 532
M L +++ +T K + + A G+ YL S +HRDL A N +
Sbjct: 123 MKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCM 179
Query: 533 LDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG-----YMAPEYASDGLFSVKSDVFS 587
L +M ++DFGL++ +I G ++A E +D +++ KSDV++
Sbjct: 180 LRDDMTVCVADFGLSK-----KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWA 234
Query: 588 FGILLLEIVS 597
FG+ + EI +
Sbjct: 235 FGVTMWEIAT 244
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 56/215 (26%)
Query: 424 DNFSINKKLGEGGFGPVYKG----------------TLADG----------------QEI 451
F K LG G FG VYKG L + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 452 AHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQ----TKRKLLDWSKRFCIICGTA 507
+ ++ +LLG C+ LI + MP L ++ + + LL+W A
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
+G+ YL R++HRDL A NVL+ + KI+DFGLA+ +E E + G
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----G 179
Query: 568 -----YMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+MA E +++ +SDV+S+G+ + E+++
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 59/225 (26%), Positives = 91/225 (40%), Gaps = 59/225 (26%)
Query: 424 DNFSINKKLGEGGFGPVYKG-----------------TLADG----------QEIA---- 452
++LGE FG VYKG TL D E
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 453 --HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSF-------------IFDQTKRKLLDWS 497
H N+V LLG + + +I+ + + L F D+T + L+
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 498 KRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557
++ A G+ YL S ++H+DL NVL+ ++N KISD GL R E+
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYA 180
Query: 558 STKRVVGTYG-----YMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+ + +MAPE G FS+ SD++S+G++L E+ S
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 74/310 (23%), Positives = 108/310 (34%), Gaps = 102/310 (32%)
Query: 424 DNFSINKKLGEGGFGPVYKG-----------------TLADG----------------QE 450
N ++ + LG G FG VY+G TL + +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 451 IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFI----FDQTKRKLLDWSKRFCIICGT 506
H+N+V+ +G +Q + ++ E M L SF+ ++ L +
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLD---HEMNPKISDFGLARTFVGDEIEGSTKRVV 563
A G YL IHRD+ A N LL KI DFG+AR +I ++
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRK 201
Query: 564 GTYGY-----MAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAW 618
G M PE +G+F+ K+D +SFG+LL EI S G
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LG--------------- 242
Query: 619 KLWNNGMPSQLIDAYYQESCNLAEVIRCIHVG-----------------LLCVQHHPEDR 661
MP Y N EV+ + G C QH PEDR
Sbjct: 243 -----YMP-------YPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289
Query: 662 PCMPSVILML 671
P ++ +
Sbjct: 290 PNFAIILERI 299
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 51/210 (24%), Positives = 84/210 (40%), Gaps = 48/210 (22%)
Query: 424 DNFSINKKLGEGGFGPVYKGTL--ADGQEIA----------------------------- 452
+ + + +GEG FG V++G + +A
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLY 512
H ++VKL+G + +I E L SF+ Q ++ LD + + L Y
Sbjct: 75 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTK-----RVVGTYG 567
L R +HRD+ A NVL+ K+ DFGL+R ++K +
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------ 182
Query: 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+MAPE + F+ SDV+ FG+ + EI+
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 63/227 (27%), Positives = 91/227 (40%), Gaps = 61/227 (26%)
Query: 424 DNFSINKKLGEGGFGPVYKG-----------------TLADG----------QEIA---- 452
D + K LG G FG V + L +G E+
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 453 ---HRNLVKLLGCCIQGEEKL-LIYEFMPNRSLDSF-------------IFDQTKRKLLD 495
H N+V LLG C + L +I EF +L ++ + + L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 496 WSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555
C A+G+ +L + + IHRDL A N+LL + KI DFGLAR +I
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DI 198
Query: 556 EGSTKRVVGTYG-----YMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
V +MAPE D +++++SDV+SFG+LL EI S
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 64/239 (26%), Positives = 91/239 (38%), Gaps = 79/239 (33%)
Query: 424 DNFSINKKLGEGGFGPVYKG-----------------TLADG----------QEIA---- 452
+N K LG G FG V L + E+
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 453 ---HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSF------------------------- 484
H N+V LLG C LI+E+ L ++
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 485 -IFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISD 543
+ T LL ++ + + A+G+ +L +HRDL A NVL+ H KI D
Sbjct: 165 DLNVLTFEDLLCFA--YQV----AKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICD 215
Query: 544 FGLARTFVGDEIEGSTKRVVGTYG-----YMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
FGLAR D + S V +MAPE +G++++KSDV+S+GILL EI S
Sbjct: 216 FGLAR----DIMSDSNYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-34
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 31/199 (15%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVK 458
++ + KLG+G FG V+ GT +A H LV+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
L + E ++ E+M SL F+ + K L + + A G+ Y+ R
Sbjct: 244 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ER 298
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL 578
+ +HRDL+A+N+L+ + K++DFGLAR +E + APE A G
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGR 357
Query: 579 FSVKSDVFSFGILLLEIVS 597
F++KSDV+SFGILL E+ +
Sbjct: 358 FTIKSDVWSFGILLTELTT 376
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 58/219 (26%), Positives = 86/219 (39%), Gaps = 53/219 (24%)
Query: 424 DNFSINKKLGEGGFGPVYKG-----------------TLADG----------------QE 450
N ++ + LG G FG VY+G TL + +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 451 IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFI----FDQTKRKLLDWSKRFCIICGT 506
H+N+V+ +G +Q + ++ E M L SF+ ++ L +
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLD---HEMNPKISDFGLARTFVGDEIEGSTKRVV 563
A G YL IHRD+ A N LL KI DFG+AR +I +
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRK 242
Query: 564 GTYGY-----MAPEYASDGLFSVKSDVFSFGILLLEIVS 597
G M PE +G+F+ K+D +SFG+LL EI S
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 57/245 (23%), Positives = 97/245 (39%), Gaps = 64/245 (26%)
Query: 399 DQENEDQNEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADG---------- 448
E +++ ED+ +P F++ + LG+G FG V + L
Sbjct: 8 SDELKEKLEDVLIPE----------QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVK 57
Query: 449 ----------------------QEIAHRNLVKLLGCCIQGEEK------LLIYEFMPNRS 480
+E H ++ KL+G ++ K ++I FM +
Sbjct: 58 MLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGD 117
Query: 481 LDSFIFD---QTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM 537
L +F+ L + A G+ YL S IHRDL A N +L +M
Sbjct: 118 LHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDM 174
Query: 538 NPKISDFGLARTFVGDEIEGSTKRVVGTYG-----YMAPEYASDGLFSVKSDVFSFGILL 592
++DFGL+R +I G ++A E +D L++V SDV++FG+ +
Sbjct: 175 TVCVADFGLSR-----KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTM 229
Query: 593 LEIVS 597
EI++
Sbjct: 230 WEIMT 234
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 48/214 (22%), Positives = 86/214 (40%), Gaps = 56/214 (26%)
Query: 424 DNFSINKKLGEGGFGPVYKGTL--ADGQEIA----------------------------- 452
++ +N+ LGEG FG VY+G G++I
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQ----TKRKLLDWSKRFCIICGTAR 508
H ++VKL+G + E +I E P L ++ L+ +S +
Sbjct: 72 HPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL------QICK 124
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTK-----RVV 563
+ YL + +HRD+ N+L+ K+ DFGL+R ++ ++ +
Sbjct: 125 AMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-- 179
Query: 564 GTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+M+PE + F+ SDV+ F + + EI+S
Sbjct: 180 ----WMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-33
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 31/199 (15%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVK 458
++ + KLG+G FG V+ GT +A H LV+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 326
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
L + E ++ E+M SL F+ + K L + + A G+ Y+ R
Sbjct: 327 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ER 381
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL 578
+ +HRDL+A+N+L+ + K++DFGLAR +E + APE A G
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGR 440
Query: 579 FSVKSDVFSFGILLLEIVS 597
F++KSDV+SFGILL E+ +
Sbjct: 441 FTIKSDVWSFGILLTELTT 459
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 55/233 (23%), Positives = 87/233 (37%), Gaps = 67/233 (28%)
Query: 424 DNFSINKKLGEGGFGPVYKG-----------------TLADG----------------QE 450
+N + +GEG FG V++ L + E
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 451 IAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSF---------------------IFDQT 489
+ N+VKLLG C G+ L++E+M L+ F
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 490 KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549
L +++ CI A G+ YL S + +HRDL N L+ M KI+DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR- 222
Query: 550 FVGDEIEGSTKRVVGTYGY-----MAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+ + M PE ++ +SDV+++G++L EI S
Sbjct: 223 ---NIYSADYYKA-DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 47/206 (22%)
Query: 428 INKKLGEGGFGPVYKG--------------TLADG----------QEIA------HRNLV 457
+ +LG G FG V +G L G +E + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS 517
+L+G C Q E +L+ E L F+ KR+ + S ++ + G+ YL
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG------YMAP 571
+HRDL A NVLL + KISDFGL++ D+ + + + AP
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAP 182
Query: 572 EYASDGLFSVKSDVFSFGILLLEIVS 597
E + FS +SDV+S+G+ + E +S
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 57/227 (25%), Positives = 83/227 (36%), Gaps = 51/227 (22%)
Query: 410 ELPLFELATIANATDNFSINKKLGEGGFGPVYKGTL--ADGQEIA--------------- 452
E PL L + D + +KLG+G FG V +G G+ ++
Sbjct: 5 EGPLQSLTCLIGEKD-LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE 63
Query: 453 ----------------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKR----K 492
HRNL++L G + ++ E P SL +
Sbjct: 64 AMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGT 122
Query: 493 LLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552
L ++ A G+ YL R IHRDL A N+LL KI DFGL R +
Sbjct: 123 LSRYA------VQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMR-ALP 172
Query: 553 DEIEGSTKRVVGTYGY--MAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+ + + APE FS SD + FG+ L E+ +
Sbjct: 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 41/202 (20%)
Query: 429 NKKLGEGGFGPVYKG--------------TLADG-----------QEIA------HRNLV 457
+K+LG G FG V KG L + E + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS 517
+++G C + E +L+ E L+ ++ + + + ++ + G+ YL
Sbjct: 82 RMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---E 134
Query: 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY--GYMAPEYAS 575
+HRDL A NVLL + KISDFGL++ + + + G + + APE +
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 576 DGLFSVKSDVFSFGILLLEIVS 597
FS KSDV+SFG+L+ E S
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFS 215
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 1e-32
Identities = 57/282 (20%), Positives = 101/282 (35%), Gaps = 43/282 (15%)
Query: 347 CMAYTNSDITRGGSGCVMWFGDLIDMRNFQDGGQDLYIRMSASELGGNNRRTDQENEDQN 406
C + + L + + + + S ++ + ED
Sbjct: 318 CRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTY 377
Query: 407 EDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGTL--ADGQEIA------------ 452
+E+ + + + +GEG FG V++G + +A
Sbjct: 378 TMPSTRDYEIQR-----ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD 432
Query: 453 -----------------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLD 495
H ++VKL+G + +I E L SF+ Q ++ LD
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLD 489
Query: 496 WSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555
+ + L YL R +HRD+ A NVL+ K+ DFGL+R
Sbjct: 490 LASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546
Query: 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
++K + +MAPE + F+ SDV+ FG+ + EI+
Sbjct: 547 YKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 62/284 (21%), Positives = 107/284 (37%), Gaps = 67/284 (23%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------HRNLVKLL 460
+F + +G GGFG V+K DG+ H N+V
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYN 70
Query: 461 GC---------------CIQGEEKLLIY-EFMPNRSLDSFIFDQTKRKLLDWSKRFCIIC 504
GC + L I EF +L+ +I ++ + + LD +
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFE 129
Query: 505 GTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVG 564
+G+ Y+H ++I+RDLK SN+ L KI DFGL + + +G R G
Sbjct: 130 QITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSKG 183
Query: 565 TYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG 624
T YM+PE S + + D+++ G++L E++ F S K + +
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-TAFETS-----------KFFTDL 231
Query: 625 MPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVI 668
+ D + +++ + PEDRP ++
Sbjct: 232 RDGIISDIF---DKKEKTLLQ------KLLSKKPEDRPNTSEIL 266
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 62/301 (20%), Positives = 119/301 (39%), Gaps = 65/301 (21%)
Query: 400 QENEDQNEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA------ 452
+E Q +D+E + ++N + ++G G F VYKG E+A
Sbjct: 2 EERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD 61
Query: 453 ----------------------HRNLVKLLGCCI---QGEEKLLIY-EFMPNRSLDSFIF 486
H N+V+ +G++ +++ E M + +L +++
Sbjct: 62 RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL- 120
Query: 487 DQTKRKLLDWS--KRFC--IICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM-NPKI 541
+ K++ + +C I+ +GL +LH + IIHRDLK N+ + + KI
Sbjct: 121 --KRFKVMKIKVLRSWCRQIL----KGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKI 173
Query: 542 SDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKN 601
D GLA K V+GT +MAPE + + DV++FG+ +LE+ + +
Sbjct: 174 GDLGLATLKRAS----FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYP 228
Query: 602 RGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDR 661
+ + +G+ D + E+I C++ + ++R
Sbjct: 229 YSECQNAAQIYRRV------TSGVKPASFDK--VAIPEVKEIIE------GCIRQNKDER 274
Query: 662 P 662
Sbjct: 275 Y 275
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 54/289 (18%), Positives = 89/289 (30%), Gaps = 71/289 (24%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA---------------------------HRN 455
+F + LG GGFG V++ D A H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 456 LVKLLGCCI---------QGEEKLLIY---EFMPNRSLDSFIFDQTKRKLLDWSKRFCII 503
+V+ + K+ +Y + +L ++ + + + S I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 504 CGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR----------TFVGD 553
A + +LH ++HRDLK SN+ + K+ DFGL
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNL 613
VGT YM+PE +S K D+FS G++L E++ F
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPFSTQ----ME 232
Query: 614 IGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
N L Y +++ + P +RP
Sbjct: 233 RVRTLTDVRNLKFPPLFTQKYPC---EYVMVQ------DMLSPSPMERP 272
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 5e-31
Identities = 56/233 (24%), Positives = 93/233 (39%), Gaps = 50/233 (21%)
Query: 398 TDQENEDQNEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGTL-ADGQEIA---- 452
E +++ L L L + +LG G FG V +G ++I
Sbjct: 319 FSDPEELKDKKLFLKRDNLLIA---------DIELGCGNFGSVRQGVYRMRKKQIDVAIK 369
Query: 453 -------------------------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFD 487
+ +V+L+G C Q E +L+ E L F+
Sbjct: 370 VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFL-- 426
Query: 488 QTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547
KR+ + S ++ + G+ YL +HR+L A NVLL + KISDFGL+
Sbjct: 427 VGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483
Query: 548 RTFVGDEIEGSTKRVVGT---YGYMAPEYASDGLFSVKSDVFSFGILLLEIVS 597
+ D+ + + + APE + FS +SDV+S+G+ + E +S
Sbjct: 484 KALGADDSYYTAR--SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 60/331 (18%), Positives = 113/331 (34%), Gaps = 75/331 (22%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------HR 454
+ + +K+GEG FG DG++ H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 455 NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKL-----LDWSKRFCIICGTARG 509
N+V+ + ++ ++ L I Q LDW F IC
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW---FVQIC---LA 137
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
L ++H +I+HRD+K+ N+ L + ++ DFG+AR +GT Y+
Sbjct: 138 LKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYL 192
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKN--LNLIGHAWKLWNNGMPS 627
+PE + ++ KSD+++ G +L E+ + K F + I +G
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLK--HAFEAGSMKNLVLKI-------ISGSFP 243
Query: 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP----------CMPSVILMLGSEIML 677
+ Y S +L ++ + +P DRP + L +++
Sbjct: 244 PVSLHY---SYDLRSLVS------QLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIA 294
Query: 678 PQPKQPGFLADRKSTGPNSSSSMLESSSTNT 708
+ F P + ++S +
Sbjct: 295 EEFCLKTFSKFGSQPIPAKRPASGQNSISVM 325
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 72/278 (25%), Positives = 110/278 (39%), Gaps = 65/278 (23%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA-----------------------------H 453
NF I KK+G G F VY+ L DG +A H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 454 RNLVKLLGCCIQGEEKLLIY-EFMPNRSLDSFIFDQTKRK-------LLDWSKRFCIICG 505
N++K I+ + +L I E L I K+K + + F +C
Sbjct: 92 PNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY---FVQLC- 146
Query: 506 TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT 565
L ++H R++HRD+K +NV + K+ D GL R F + +VGT
Sbjct: 147 --SALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
Query: 566 YGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNL-NLIGHAWKLWNNG 624
YM+PE + ++ KSD++S G LL E+ + + FY NL +L K
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMNLYSLC----KKIEQC 253
Query: 625 MPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
L +Y S L +++ +C+ PE RP
Sbjct: 254 DYPPLPSDHY--SEELRQLVN------MCINPDPEKRP 283
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 66/307 (21%), Positives = 109/307 (35%), Gaps = 72/307 (23%)
Query: 425 NFSINKKLGEGGFGPVYKGT-LADGQEIA--------------------------HRNLV 457
++ +KLGEGGF V L DG A H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 458 KLLGCCIQ----GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRF------CIICGTA 507
+L+ C++ E L+ F +L + I +L D ++ G
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLTEDQILWLLLGIC 144
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV----- 562
RGL +H HRDLK +N+LL E P + D G +EGS + +
Sbjct: 145 RGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC-IHVEGSRQALTLQDW 200
Query: 563 ---VGTYGYMAPE---YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGH 616
T Y APE S + ++DV+S G +L ++ G+ + + + +
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE--GPYDMVFQKGDSV-- 256
Query: 617 AWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM 676
A + N + + L + + P RP +P ++ L +
Sbjct: 257 ALAV-QNQLSIPQSPRHSSALWQL---LNS------MMTVDPHQRPHIPLLLSQL-EALQ 305
Query: 677 LPQPKQP 683
P P Q
Sbjct: 306 PPAPGQH 312
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 50/215 (23%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------HR 454
D+ +LG G +G V K + GQ +A
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 455 NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRF------CIICGTAR 508
V G + + + E M + SLD F ++++D + I +
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
L +LH S+L +IHRD+K SNVL++ K+ DFG++ V D++ G Y
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDI--DAGCKPY 175
Query: 569 MAPE----YASDGLFSVKSDVFSFGILLLEIVSGK 599
MAPE + +SVKSD++S GI ++E+ +
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 54/270 (20%), Positives = 91/270 (33%), Gaps = 60/270 (22%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA-----------------------------H 453
+F +LG G +G V+K DG+ A H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 454 RNLVKLLGCCIQGEEKLLIY-EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLY 512
V+L + L + E SL + L ++ + + T L +
Sbjct: 117 PCCVRLEQ-AWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE 572
LH ++H D+K +N+ L K+ DFGL G+ + G YMAPE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA---GAGEVQEGDPRYMAPE 226
Query: 573 YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632
+ +DVFS G+ +LE+ + H + +L +P +
Sbjct: 227 LLQGS-YGTAADVFSLGLTILEVACNME---LPHGGEGWQ------QLRQGYLPPEFTAG 276
Query: 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
S L V+ + ++ P+ R
Sbjct: 277 L---SSELRSVLV------MMLEPDPKLRA 297
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 62/296 (20%), Positives = 97/296 (32%), Gaps = 80/296 (27%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA-------------------------HRNL 456
+F LG+G FG V K D + A H+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 457 VKLLGC----------CIQGEEKLLIY---EFMPNRSLDSFIFDQTKRKLLDWSKRFCI- 502
V+ ++K ++ E+ N +L I + + D R
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF------------ 550
I L Y+H IIHRDLK N+ +D N KI DFGLA+
Sbjct: 125 IL---EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 551 VGDEIEGSTKRVVGTYGYMAPE-YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDK 609
+ +GT Y+A E G ++ K D++S GI+ E++ ++
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF----STGMER 234
Query: 610 NLNLIGHAWKLWNNG---MPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
+ K + P D + + IR L + H P RP
Sbjct: 235 V-----NILKKLRSVSIEFPPDFDDNKMKVEKKI---IR------LLIDHDPNKRP 276
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 57/241 (23%), Positives = 96/241 (39%), Gaps = 52/241 (21%)
Query: 396 RRTDQEN--EDQNEDLELPLFELATIANAT-DNFSINKKLGEGGFGPVYKGTLADGQEIA 452
++ ++ E Q + LE L + + D+F +LG G G V+K + +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61
Query: 453 ----------------------------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSF 484
+V G E + E M SLD
Sbjct: 62 ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-- 119
Query: 485 IFDQTKRKLLDWSKRF------CIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN 538
++L + R + +GL YL + +I+HRD+K SN+L++
Sbjct: 120 -------QVLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGE 170
Query: 539 PKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSG 598
K+ DFG++ G I+ VGT YM+PE +SV+SD++S G+ L+E+ G
Sbjct: 171 IKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226
Query: 599 K 599
+
Sbjct: 227 R 227
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 66/279 (23%), Positives = 101/279 (36%), Gaps = 64/279 (22%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------HR 454
+++ + +G G +G K +DG+ + H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 455 NLVKLLGCCIQGEEKLL--IYEFMPNRSLDSFIFDQTKRK-------LLDWSKRFCIICG 505
N+V+ I L + E+ L S I TK + +L +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV---MTQLT- 121
Query: 506 TARGLLYLH--HDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVV 563
L H D ++HRDLK +NV LD + N K+ DFGLAR D T V
Sbjct: 122 --LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FV 177
Query: 564 GTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNN 623
GT YM+PE + ++ KSD++S G LL E+ + F + A K+
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM--PPFTAF----SQKELAGKI-RE 230
Query: 624 GMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
G ++ Y S L E+I + RP
Sbjct: 231 GKFRRIPYRY---SDELNEIIT------RMLNLKDYHRP 260
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 59/244 (24%), Positives = 101/244 (41%), Gaps = 40/244 (16%)
Query: 385 RMSASELGGNNRRTDQENEDQNEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGT 444
S+ G Q +E + L + + K+GEG G V
Sbjct: 6 HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR 65
Query: 445 -LADGQEIA--------------------------HRNLVKLLGCCIQGEEKLLIYEFMP 477
G+++A H N+V++ + GEE ++ EF+
Sbjct: 66 EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125
Query: 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM 537
+L D + L+ + + + L YLH +IHRD+K+ ++LL +
Sbjct: 126 GGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDG 178
Query: 538 NPKISDFGLARTFVGDEIEGSTKR--VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEI 595
K+SDFG F + KR +VGT +MAPE S L++ + D++S GI+++E+
Sbjct: 179 RVKLSDFG----FCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEM 234
Query: 596 VSGK 599
V G+
Sbjct: 235 VDGE 238
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 57/243 (23%), Positives = 87/243 (35%), Gaps = 38/243 (15%)
Query: 387 SASELGGNNRRTDQENEDQNEDLELPLFELATI--ANATDNFSINKKLGEGGFGPVYKGT 444
+ S +R E ED L + + ++G G FG V++
Sbjct: 19 TWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMK 78
Query: 445 -LADGQEIA---------------------HRNLVKLLGCCIQGEEKLLIY-EFMPNRSL 481
G + A +V L G +G + I+ E + SL
Sbjct: 79 DKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGP-WVNIFMELLEGGSL 137
Query: 482 DSFIFDQTKRKLLDWSKRFCIICG-TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP- 539
I + L R G GL YLH RI+H D+KA NVLL + +
Sbjct: 138 GQLI---KQMGCLP-EDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRA 190
Query: 540 KISDFGLARTFVGDEIEGSTKR---VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIV 596
+ DFG A D + S + GT +MAPE K D++S ++L ++
Sbjct: 191 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250
Query: 597 SGK 599
+G
Sbjct: 251 NGC 253
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 57/223 (25%), Positives = 84/223 (37%), Gaps = 65/223 (29%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------HR 454
++ ++G G +G V K GQ +A
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 455 NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRF------CIICGTAR 508
+V+ G + + + E M + S D F K I T +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG--------LARTFVGDEIEGSTK 560
L +L + L+IIHRD+K SN+LLD N K+ DFG +A+T
Sbjct: 137 ALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR---------- 184
Query: 561 RVVGTYGYMAPE----YASDGLFSVKSDVFSFGILLLEIVSGK 599
G YMAPE AS + V+SDV+S GI L E+ +G+
Sbjct: 185 -DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 54/214 (25%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA-----------------------------H 453
+ + LG+GGF ++ + + A H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 454 RNLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF------CIICGT 506
+++V G + + + ++ E RSL + KR+ K +
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRR-----KALTEPEARYYLRQI 124
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVV-GT 565
G YLH R R+IHRDLK N+ L+ ++ KI DFGLA E +G K+V+ GT
Sbjct: 125 VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGT 178
Query: 566 YGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
Y+APE S S + DV+S G ++ ++ GK
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 55/223 (24%), Positives = 104/223 (46%), Gaps = 40/223 (17%)
Query: 406 NEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA------------ 452
+E++ L + ++ + ++ +K+G+G G VY +A GQE+A
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 453 --------------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSK 498
+ N+V L + G+E ++ E++ SL D +D +
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQ 117
Query: 499 RFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558
+ + L +LH + ++IHRD+K+ N+LL + + K++DFG F
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQ 170
Query: 559 TKR--VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+KR +VGT +MAPE + + K D++S GI+ +E++ G+
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 46/210 (21%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA-----------------------------H 453
+ + LG+GGF ++ + + A H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 454 RNLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCI--ICGTARGL 510
+++V G + + + ++ E RSL + ++ L + R+ + I G
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVL---GC 154
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVV-GTYGYM 569
YLH R R+IHRDLK N+ L+ ++ KI DFGLA D G K+V+ GT Y+
Sbjct: 155 QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYI 208
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGK 599
APE S S + DV+S G ++ ++ GK
Sbjct: 209 APEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 62/283 (21%), Positives = 105/283 (37%), Gaps = 65/283 (22%)
Query: 425 NFSINKKLGEGGFGPVYKGTLADGQEIA------------------------------HR 454
+SI K++G GG V++ Q A
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 455 NLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYL 513
+++L ++ + ++ E N L+S++ K+K +D +R + +
Sbjct: 89 KIIRLYDY-EITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 143
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE- 572
H + I+H DLK +N L+ + K+ DFG+A D VGT YM PE
Sbjct: 144 H---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 573 ----------YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWN 622
S S KSDV+S G +L + GK F ++ KL
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQIS------KLHA 251
Query: 623 NGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMP 665
P+ I+ +L +V++C C++ P+ R +P
Sbjct: 252 IIDPNHEIEFPDIPEKDLQDVLKC------CLKRDPKQRISIP 288
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 62/283 (21%), Positives = 105/283 (37%), Gaps = 65/283 (22%)
Query: 425 NFSINKKLGEGGFGPVYKGTLADGQEIA------------------------------HR 454
+SI K++G GG V++ Q A
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 455 NLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYL 513
+++L ++ + ++ E N L+S++ K+K +D +R + +
Sbjct: 70 KIIRLYDY-EITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE- 572
H + I+H DLK +N L+ + K+ DFG+A D VGT YM PE
Sbjct: 125 H---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 573 ----------YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWN 622
S S KSDV+S G +L + GK F ++ KL
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQIS------KLHA 232
Query: 623 NGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMP 665
P+ I+ +L +V++C C++ P+ R +P
Sbjct: 233 IIDPNHEIEFPDIPEKDLQDVLKC------CLKRDPKQRISIP 269
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 60/282 (21%), Positives = 102/282 (36%), Gaps = 63/282 (22%)
Query: 425 NFSINKKLGEGGFGPVYKGTLADGQEIA------------------------------HR 454
+SI K++G GG V++ Q A
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 455 NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH 514
+++L ++ + + N L+S++ K+K +D +R + +H
Sbjct: 117 KIIRLYDY-EITDQYIYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 515 HDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE-- 572
+ I+H DLK +N L+ + K+ DFG+A D VG YM PE
Sbjct: 173 ---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 573 ---------YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNN 623
S S KSDV+S G +L + GK F ++ KL
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQIS------KLHAI 280
Query: 624 GMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMP 665
P+ I+ +L +V++C C++ P+ R +P
Sbjct: 281 IDPNHEIEFPDIPEKDLQDVLKC------CLKRDPKQRISIP 316
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 413 LFELATIANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA------------------- 452
L E + + F + +KLGEG +G VYK GQ +A
Sbjct: 18 LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISI 77
Query: 453 -----HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTA 507
++VK G + + ++ E+ S+ I + + K L + I+ T
Sbjct: 78 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTL 135
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR--VVGT 565
+GL YLH R IHRD+KA N+LL+ E + K++DFG+A G + KR V+GT
Sbjct: 136 KGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA----GQLTDTMAKRNTVIGT 188
Query: 566 YGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+MAPE + ++ +D++S GI +E+ GK
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 43/199 (21%), Positives = 73/199 (36%), Gaps = 31/199 (15%)
Query: 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL 533
+ +L ++ + + + I A + +LH ++HRDLK SN+
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFF 197
Query: 534 DHEMNPKISDFGLARTFVGDEIEGSTK----------RVVGTYGYMAPEYASDGLFSVKS 583
+ K+ DFGL DE E + VGT YM+PE +S K
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 584 DVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEV 643
D+FS G++L E+ Y + + + N P L Y + +
Sbjct: 258 DIFSLGLILFEL--------LYSFSTQMERVRIITDVRNLKFPL-LFTQKYPQ---EHMM 305
Query: 644 IRCIHVGLLCVQHHPEDRP 662
++ + P +RP
Sbjct: 306 VQ------DMLSPSPTERP 318
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 41/210 (19%)
Query: 420 ANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA-------------------------- 452
A+ + F+ +K+G+G FG V+KG + +A
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 453 -HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLL 511
+ K G ++ + +I E++ S D + LD ++ I+ +GL
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLD 133
Query: 512 YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR--VVGTYGYM 569
YLH + + IHRD+KA+NVLL K++DFG+A G + KR VGT +M
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGTPFWM 186
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGK 599
APE + K+D++S GI +E+ G+
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 52/292 (17%), Positives = 93/292 (31%), Gaps = 81/292 (27%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------- 452
T F +K+G G FG V+K DG A
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 453 HRNLVKLLGCCIQGEEKLLIY-EFMPNRSLDSFIFDQTKR-KLLDWSKRFCIICGTARGL 510
H ++V+ + + +LI E+ SL I + + ++ ++ RGL
Sbjct: 70 HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNP-------------------KISDFGLARTFV 551
Y+H ++H D+K SN+ + P KI D G
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI- 184
Query: 552 GDEIEGSTKRVVGTYGYMAPE-YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKN 610
S + G ++A E + K+D+F+ + ++ + +N
Sbjct: 185 -----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE------PLPRN 233
Query: 611 LNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
G W G ++ S E+++ + + PE RP
Sbjct: 234 ----GDQWHEIRQGRLPRIPQVL---SQEFTELLK------VMIHPDPERRP 272
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 53/214 (24%), Positives = 87/214 (40%), Gaps = 53/214 (24%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA-----------------------------H 453
++F + LG+G F VY+ + G E+A H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 454 RNLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF------CIICGT 506
++++L + + L+ E N + K + K F +
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNR----VKPFSENEARHFMHQI 121
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVV-GT 565
G+LYLH I+HRDL SN+LL MN KI+DFGLA ++ + GT
Sbjct: 122 ITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLA---TQLKMPHEKHYTLCGT 175
Query: 566 YGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
Y++PE A+ ++SDV+S G + ++ G+
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 43/244 (17%), Positives = 76/244 (31%), Gaps = 54/244 (22%)
Query: 392 GGNNRRTDQENEDQNEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEI 451
G + Q ++ ++G G G V+K +
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQA--------EINDLENLGEMGSGTCGQVWKMRFRKTGHV 52
Query: 452 -----------------------------AHRNLVKLLGCCIQGEEKLLIYEFMPNRSLD 482
+V+ G I + + E M +
Sbjct: 53 IAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAE 111
Query: 483 SFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKIS 542
+ + + L YL + +IHRD+K SN+LLD K+
Sbjct: 112 KLKKRMQGPIPERILGK--MTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLC 167
Query: 543 DFGLARTFVGDEIEGSTKR--VVGTYGYMAPE-----YASDGLFSVKSDVFSFGILLLEI 595
DFG + + + G YMAPE + + +++DV+S GI L+E+
Sbjct: 168 DFG-----ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
Query: 596 VSGK 599
+G+
Sbjct: 223 ATGQ 226
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 39/202 (19%)
Query: 430 KKLGEGGFGPVYKGT-LADGQEIA--------------------------HRNLVKLLGC 462
LG+G +G VY G L++ IA H+N+V+ LG
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 463 CIQGEEKLLIY-EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRI 521
+ I+ E +P SL + + + + GL YLH + +I
Sbjct: 88 F-SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143
Query: 522 IHRDLKASNVLLD-HEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE---YASDG 577
+HRD+K NVL++ + KISDFG ++ G I T+ GT YMAPE G
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 578 LFSVKSDVFSFGILLLEIVSGK 599
+ +D++S G ++E+ +GK
Sbjct: 202 -YGKAADIWSLGCTIIEMATGK 222
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 43/222 (19%), Positives = 79/222 (35%), Gaps = 50/222 (22%)
Query: 421 NATDNFSINKKLGEGGFGPVYKGT-LADGQEIA--------------------------- 452
+ + ++ LG+G V++G G A
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 453 HRNLVKLLGCCIQGEEKLLIY---EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARG 509
H+N+VKL + EF P SL + + + + L S+ ++ G
Sbjct: 66 HKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 510 LLYLHHDSRLRIIHRDLKASNVLL----DHEMNPKISDFGLARTFVGDEIEGSTKRVVGT 565
+ +L I+HR++K N++ D + K++DFG AR DE + GT
Sbjct: 125 MNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGT 178
Query: 566 YGYMAPEYASDGL--------FSVKSDVFSFGILLLEIVSGK 599
Y+ P+ + + D++S G+ +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 56/222 (25%), Positives = 87/222 (39%), Gaps = 49/222 (22%)
Query: 413 LFELATIANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA------------------- 452
+ EL + FS +++G G FG VY + + + +A
Sbjct: 43 VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 102
Query: 453 ----------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCI 502
H N ++ GC ++ L+ E+ + D + +K L + +
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAV 159
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR- 561
G +GL YLH +IHRD+KA N+LL K+ DFG A
Sbjct: 160 THGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM--------APAN 208
Query: 562 -VVGTYGYMAPE---YASDGLFSVKSDVFSFGILLLEIVSGK 599
VGT +MAPE +G + K DV+S GI +E+ K
Sbjct: 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 415 ELATIANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA--------------------- 452
+ + + + I +LG+G FG VYK G A
Sbjct: 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEI 69
Query: 453 -----HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTA 507
H +VKLLG + ++ EF P ++D+ + + L + +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQML 127
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR--VVGT 565
L +LH RIIHRDLKA NVL+ E + +++DFG++ ++ KR +GT
Sbjct: 128 EALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGT 180
Query: 566 YGYMAPE-----YASDGLFSVKSDVFSFGILLLEIVSGK 599
+MAPE D + K+D++S GI L+E+ +
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 51/205 (24%), Positives = 83/205 (40%), Gaps = 43/205 (20%)
Query: 428 INKKLGEGGFGPVYKGT----------------LADGQE--------------IAHRNLV 457
I KLG GG VY + +E ++H+N+V
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 458 KLLGCCIQGEEKLLIY---EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH 514
++ EE Y E++ +L +I L G+ + H
Sbjct: 75 SMID---VDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH 128
Query: 515 HDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYA 574
+RI+HRD+K N+L+D KI DFG+A+ + + T V+GT Y +PE A
Sbjct: 129 ---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA-LSETSLTQTNHVLGTVQYFSPEQA 184
Query: 575 SDGLFSVKSDVFSFGILLLEIVSGK 599
+D++S GI+L E++ G+
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGE 209
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 60/226 (26%), Positives = 92/226 (40%), Gaps = 48/226 (21%)
Query: 414 FELATIANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA-------------------- 452
+L+ + + F + + +G G +G VYKG + GQ A
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINM 73
Query: 453 ------HRNLVKLLGCCIQG-----EEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF 500
HRN+ G I+ +++L L+ EF S+ + TK L
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIA 132
Query: 501 CIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTK 560
I RGL +LH ++IHRD+K NVLL K+ DFG++ +
Sbjct: 133 YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVGR 185
Query: 561 R--VVGTYGYMAPE-----YASDGLFSVKSDVFSFGILLLEIVSGK 599
R +GT +MAPE D + KSD++S GI +E+ G
Sbjct: 186 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-24
Identities = 46/208 (22%), Positives = 80/208 (38%), Gaps = 41/208 (19%)
Query: 425 NFSINKKLGEGGFGPVYKGTLADGQEIA------------------------HRNLVKLL 460
+F LG G G + + D +++A H N+++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYF 84
Query: 461 GCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRL 519
C + + + E +L ++ + K + ++ T GL +LH L
Sbjct: 85 -CTEKDRQFQYIAIELCAA-TLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS---L 137
Query: 520 RIIHRDLKASNVLL-----DHEMNPKISDFGLARTFVGDEIE-GSTKRVVGTYGYMAPEY 573
I+HRDLK N+L+ ++ ISDFGL + V GT G++APE
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 574 ASDGLF---SVKSDVFSFGILLLEIVSG 598
S+ + D+FS G + ++S
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 43/222 (19%), Positives = 79/222 (35%), Gaps = 50/222 (22%)
Query: 421 NATDNFSINKKLGEGGFGPVYKGT-LADGQEIA--------------------------- 452
+ + ++ LG+G V++G G A
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 453 HRNLVKLLGCCIQGEEKLLIY---EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARG 509
H+N+VKL + EF P SL + + + + L S+ ++ G
Sbjct: 66 HKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 510 LLYLHHDSRLRIIHRDLKASNVLL----DHEMNPKISDFGLARTFVGDEIEGSTKRVVGT 565
+ +L I+HR++K N++ D + K++DFG AR DE + GT
Sbjct: 125 MNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGT 178
Query: 566 YGYMAPEYASDGL--------FSVKSDVFSFGILLLEIVSGK 599
Y+ P+ + + D++S G+ +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 67/327 (20%), Positives = 109/327 (33%), Gaps = 72/327 (22%)
Query: 425 NFSINKKLGEGGFGPVYKGT-LADGQEIA---------------------------HRNL 456
+ + L EGGF VY+ + G+E A H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 457 VKLLGCCIQGEEK-------LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARG 509
V+ G+E+ L+ + L F+ R L I T R
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR-------- 561
+ ++H + IIHRDLK N+LL ++ K+ DFG A T + +
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 562 --VVGTYGYMAPE---YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGH 616
T Y PE S+ K D+++ G +L + + F D I +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--FE--DGAKLRIVN 263
Query: 617 AWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVI----LMLG 672
+P D Y +L IR +Q +PE+R + V+ +
Sbjct: 264 G----KYSIPPH--DTQYTVFHSL---IRA------MLQVNPEERLSIAEVVHQLQEIAA 308
Query: 673 SEIMLPQPKQPGFLADRKSTGPNSSSS 699
+ + P+ L G + S
Sbjct: 309 ARNVNPKSPITELLEQNGGYGSATLSR 335
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 53/208 (25%), Positives = 81/208 (38%), Gaps = 44/208 (21%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA-----------------------------H 453
++F I + LG+G FG VY +A H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 454 RNLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLY 512
N+++L G ++ LI E+ P ++ + Q K + I A L Y
Sbjct: 69 PNILRLYG-YFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTAT-YITELANALSY 124
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVV-GTYGYMAP 571
H R+IHRD+K N+LL KI+DFG + S + + GT Y+ P
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV-----HAPSSRRTDLCGTLDYLPP 176
Query: 572 EYASDGLFSVKSDVFSFGILLLEIVSGK 599
E + K D++S G+L E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 54/215 (25%), Positives = 81/215 (37%), Gaps = 45/215 (20%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA---------------------------HR 454
+ + ++LG GGFG V + G+++A H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 455 NLVKLLGCCIQGEEKL-------LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTA 507
N+V G +KL L E+ L ++ L ++ +
Sbjct: 73 NVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLD---HEMNPKISDFGLARTFVGDEIEGSTKRVVG 564
L YLH RIIHRDLK N++L + KI D G A+ E+ VG
Sbjct: 132 SALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVG 185
Query: 565 TYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
T Y+APE ++V D +SFG L E ++G
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 41/205 (20%), Positives = 74/205 (36%), Gaps = 43/205 (20%)
Query: 428 INKKLGEGGFGPVYKGT----------------LADGQE--------------IAHRNLV 457
+ + +G GG G VY+ L+ + ++V
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 458 KLLGCCIQGEEKLLIY---EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH 514
+ GE +Y + L + + ++ L + I+ L H
Sbjct: 98 PIHD---FGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH 151
Query: 515 HDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYA 574
HRD+K N+L+ + + DFG+A DE VGT YMAPE
Sbjct: 152 ---AAGATHRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGTLYYMAPERF 207
Query: 575 SDGLFSVKSDVFSFGILLLEIVSGK 599
S+ + ++D+++ +L E ++G
Sbjct: 208 SESHATYRADIYALTCVLYECLTGS 232
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 51/212 (24%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA----------------------------HRN 455
+ + +K+GEG +G VYK + G+ +A H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 456 LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH 514
+V L+ I E L L++EFM L + + L S+ + RG+ + H
Sbjct: 81 IVSLI-DVIHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 515 HDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE-- 572
RI+HRDLK N+L++ + K++DFGLAR F G + T VV T Y AP+
Sbjct: 137 QH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVL 191
Query: 573 -----YASDGLFSVKSDVFSFGILLLEIVSGK 599
Y++ SV D++S G + E+++GK
Sbjct: 192 MGSKKYST----SV--DIWSIGCIFAEMITGK 217
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 52/226 (23%), Positives = 89/226 (39%), Gaps = 57/226 (25%)
Query: 424 DNFSINKKLGEGGFGPVY---------------KGTLADGQ------------------- 449
+++ I + L +G F + K L +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 450 --EIA------HRNLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFI-----FDQTKRKLLD 495
E+ + + G I +++ +IYE+M N S+ F D+ +
Sbjct: 91 KNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 496 WSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555
CII Y+H + I HRD+K SN+L+D K+SDFG + V +I
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 556 EGSTKRVVGTYGYMAPE-YASDGLFS-VKSDVFSFGILLLEIVSGK 599
+GS GTY +M PE ++++ ++ K D++S GI L +
Sbjct: 208 KGS----RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 38/209 (18%), Positives = 71/209 (33%), Gaps = 56/209 (26%)
Query: 428 INKKLGEGGFGPVYKG--TLADGQEIA---------------------------HRNLVK 458
+ + GG G +Y +G+ + H ++V+
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 459 LLGCCIQGEE-----KLLIY---EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGL 510
+ E + Y E++ +SL + L ++ + L
Sbjct: 144 IFN---FVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPAL 195
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMA 570
YLH + +++ DLK N++L E K+ D G S + GT G+ A
Sbjct: 196 SYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI------NSFGYLYGTPGFQA 245
Query: 571 PEYASDGLFSVKSDVFSFGILLLEIVSGK 599
PE G +V +D+++ G L +
Sbjct: 246 PEIVRTGP-TVATDIYTVGRTLAALTLDL 273
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 1e-22
Identities = 33/222 (14%), Positives = 63/222 (28%), Gaps = 48/222 (21%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT------LADGQEIA------------------------ 452
+ ++ LGEG F VY+ T + Q+
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 453 --HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFI--FDQTKRKLLDWSKRFCIICGTAR 508
+K + +L+ E +L + I + T K++
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNP-----------KISDFGLARTFVGDEIEG 557
+ +H IIH D+K N +L + + D G +
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
T G+ E S+ ++ + D F + ++ G
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 56/232 (24%), Positives = 90/232 (38%), Gaps = 42/232 (18%)
Query: 421 NATDNFSINKKLGEGGFGPVYKGT-LADGQEIA--------------------------- 452
D++ + + +G G V +++A
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRF------CIICGT 506
H N+V + +E L+ + + S+ I K S I+
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGL-ARTFVGDEIEGSTKR--VV 563
GL YLH + IHRD+KA N+LL + + +I+DFG+ A G +I + R V
Sbjct: 131 LEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 564 GTYGYMAPE-YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLI 614
GT +MAPE + K+D++SFGI +E+ +G Y K L L
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT 239
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 50/213 (23%)
Query: 424 DNFSINKKLGEGGFGPVYKG-----------------TLADG------------QEIAHR 454
+ +K+GEG +G V+K +G +E+ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 455 NLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCI-ICGTARGLLY 512
N+V+L + ++KL L++EF L + + K F + +GL +
Sbjct: 62 NIVRLH-DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGF 116
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE 572
H ++HRDLK N+L++ K+++FGLAR F G + + VV T Y P+
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPD 171
Query: 573 YASDGLFSVKS-----DVFSFGILLLEIVSGKK 600
LF K D++S G + E+ + +
Sbjct: 172 V----LFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 68/220 (30%), Positives = 106/220 (48%), Gaps = 56/220 (25%)
Query: 421 NATDNFSINKKLGEGGFGPVYKG-------TLA---------DG------------QEIA 452
+++ F +KLG G + VYKG +A +G +E+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 453 HRNLVKLLGCCIQGEEKL-LIYEFMPN---RSLDSFIFDQTKRKL-LDWSKRFCI-ICGT 506
H N+V+L I E KL L++EFM N + +DS T R L L+ K F +
Sbjct: 62 HENIVRLY-DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL-- 118
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
+GL + H + +I+HRDLK N+L++ K+ DFGLAR F G + + VV T
Sbjct: 119 -QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TL 172
Query: 567 GYMAPE-------YASDGLFSVKSDVFSFGILLLEIVSGK 599
Y AP+ Y++ S+ D++S G +L E+++GK
Sbjct: 173 WYRAPDVLMGSRTYST----SI--DIWSCGCILAEMITGK 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 96.4 bits (241), Expect = 3e-22
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 49/211 (23%)
Query: 424 DNFSINKKLGEGGFGPVYKG----------------TLADG------------QEIAHRN 455
+ + +K+GEG +G VYK +G +E+ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 456 LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCI-ICGTARGLLYL 513
+VKL I +++L L++E + L + +K F + + G+ Y
Sbjct: 62 IVKLY-DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYC 116
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEY 573
H R++HRDLK N+L++ E KI+DFGLAR F G + T +V T Y AP+
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPDV 171
Query: 574 ASDGLFSVKS-----DVFSFGILLLEIVSGK 599
L K D++S G + E+V+G
Sbjct: 172 ----LMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 5e-22
Identities = 62/214 (28%), Positives = 91/214 (42%), Gaps = 51/214 (23%)
Query: 424 DNFSINKKLGEGGFGPVYKGT--------------------LADG------------QEI 451
+ LGEG F VYK DG QE+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 452 AHRNLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGL 510
+H N++ LL + + L+++FM L+ I + +L S + T +GL
Sbjct: 70 SHPNIIGLLDA-FGHKSNISLVFDFME-TDLEVII--KDNSLVLTPSHIKAYMLMTLQGL 125
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMA 570
YLH I+HRDLK +N+LLD K++DFGLA++F G T +VV T Y A
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRWYRA 180
Query: 571 PEYASDGLF-----SVKSDVFSFGILLLEIVSGK 599
PE LF V D+++ G +L E++
Sbjct: 181 PEL----LFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 46/211 (21%), Positives = 84/211 (39%), Gaps = 49/211 (23%)
Query: 428 INKKLGEGGFGPVYKGT----------------LADGQE--------------IAHRNLV 457
+ + LG GG V+ LA + H +V
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 458 KLLGCCIQGEEKL-------LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGL 510
+ GE + ++ E++ +L + + + +I + L
Sbjct: 76 AVYD---TGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQAL 129
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTK--RVVGTYGY 568
+ H + IIHRD+K +N+++ K+ DFG+AR + D T+ V+GT Y
Sbjct: 130 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA-IADSGNSVTQTAAVIGTAQY 185
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
++PE A +SDV+S G +L E+++G+
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 8e-22
Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 47/210 (22%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLA----------------DG------------QEIAHRN 455
+ + KLGEG + VYKG +G +++ H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 456 LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH 514
+V L I E+ L L++E++ ++ L ++ +++ + RGL Y H
Sbjct: 62 IVTLH-DIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 515 HDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYA 574
+++HRDLK N+L++ K++DFGLAR + VV T Y P+
Sbjct: 118 RQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPPDI- 171
Query: 575 SDGLF-----SVKSDVFSFGILLLEIVSGK 599
L S + D++ G + E+ +G+
Sbjct: 172 ---LLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 8e-22
Identities = 56/216 (25%), Positives = 85/216 (39%), Gaps = 56/216 (25%)
Query: 424 DNFSINKKLGEGGFGPVY----KGT-----------------------------LADGQE 450
++FS+++ +G GGFG VY T L+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 451 IAHRNLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF---CIICGT 506
+V + +KL I + M L + + RF II
Sbjct: 249 GDCPFIVC-MSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIIL-- 303
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
GL ++H +++RDLK +N+LLD + +ISD GLA F + VGT+
Sbjct: 304 --GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTH 354
Query: 567 GYMAPEYASDGL---FSVKSDVFSFGILLLEIVSGK 599
GYMAPE G+ S D FS G +L +++ G
Sbjct: 355 GYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 49/207 (23%), Positives = 80/207 (38%), Gaps = 42/207 (20%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQ-------EIA------H 453
D+F I + LG+G FG VY K L EI H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 454 RNLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLY 512
N++++ +++ L+ EF P L + Q + + + A L Y
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSAT-FMEELADALHY 129
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE 572
H ++IHRD+K N+L+ ++ KI+DFG + + + GT Y+ PE
Sbjct: 130 CH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLDYLPPE 182
Query: 573 YASDGLFSVKSDVFSFGILLLEIVSGK 599
K D++ G+L E + G
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 56/224 (25%), Positives = 85/224 (37%), Gaps = 70/224 (31%)
Query: 424 DNFSINKKLGEGGFGPVYKG-----------------TLADG------------QEIAHR 454
D + KLGEG +G VYK +G +E+ HR
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 455 NLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF------CIICGTA 507
N+++L I +L LI+E+ + +K +D + +
Sbjct: 94 NIIELK-SVIHHNHRLHLIFEYA----------ENDLKKYMDKNPDVSMRVIKSFLYQLI 142
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP-----KISDFGLARTFVGDEIEGSTKRV 562
G+ + H R +HRDLK N+LL KI DFGLAR F G I T +
Sbjct: 143 NGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEI 198
Query: 563 VGTYGYMAPE-------YASDGLFSVKSDVFSFGILLLEIVSGK 599
+ T Y PE Y++ SV D++S + E++
Sbjct: 199 I-TLWYRPPEILLGSRHYST----SV--DIWSIACIWAEMLMKT 235
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 44/210 (20%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQEIAH----RN------- 455
++F K LGEG F V K + ++ + R+
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 456 --LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF---CIICGTARG 509
VKL Q +EKL + N L +I + + RF I+
Sbjct: 90 PFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS----A 142
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
L YLH IIHRDLK N+LL+ +M+ +I+DFG A+ + + VGT Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+PE ++ SD+++ G ++ ++V+G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 8e-21
Identities = 37/222 (16%), Positives = 74/222 (33%), Gaps = 42/222 (18%)
Query: 416 LATIANATDNFSINKKLGEG--GFGPVYKGT-LADGQEIA-------------------- 452
+++ + + +G+G V G+ +
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 453 --------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIIC 504
H N+V I E ++ FM S + ++ I+
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQ 135
Query: 505 GTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE-----IEGST 559
G + L Y+HH +HR +KAS++L+ + +S + + +
Sbjct: 136 GVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 560 KRVVGTYGYMAPE--YASDGLFSVKSDVFSFGILLLEIVSGK 599
K V +++PE + + KSD++S GI E+ +G
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 9e-21
Identities = 54/216 (25%), Positives = 82/216 (37%), Gaps = 54/216 (25%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQEIAH----RNLVKL--- 459
D F + LG GGFG V+ K L + + ++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 460 -----LGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF----------CII 503
L + + L L+ M + I++ + F I+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN-----PGFQEPRAIFYTAQIV 299
Query: 504 CGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVV 563
GL +LH + II+RDLK NVLLD + N +ISD GLA + TK
Sbjct: 300 S----GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTKGYA 350
Query: 564 GTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
GT G+MAPE + D F+ G+ L E+++ +
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 53/220 (24%), Positives = 81/220 (36%), Gaps = 66/220 (30%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------HR 454
+ + K+GEG +G V+K GQ +A H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 455 NLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF-------CIICGT 506
NLV LL + + +L L++E+ D T LD +R I T
Sbjct: 63 NLVNLL-EVFRRKRRLHLVFEYC----------DHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
+ + + H + IHRD+K N+L+ K+ DFG AR + V T
Sbjct: 112 LQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-TR 166
Query: 567 GYMAPE-------YASDGLFSVKSDVFSFGILLLEIVSGK 599
Y +PE Y V DV++ G + E++SG
Sbjct: 167 WYRSPELLVGDTQYGP----PV--DVWAIGCVFAELLSGV 200
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 48/226 (21%), Positives = 73/226 (32%), Gaps = 56/226 (24%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA------------------------HRNLVKL 459
+ K LG G G V G+ +A H N+++
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 460 LGCCIQGEEKL-LIYEFMPNRSLDSFI----FDQTKRKLLDWSKRFCIICGTARGLLYLH 514
C + L + E +L + KL ++ A G+ +LH
Sbjct: 75 Y-CSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 515 HDSRLRIIHRDLKASNVLLDHEMNP-------------KISDFGLARTFVGDE--IEGST 559
L+IIHRDLK N+L+ ISDFGL + + +
Sbjct: 133 S---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 560 KRVVGTYGYMAPEYASDGLFSV-------KSDVFSFGILLLEIVSG 598
GT G+ APE + D+FS G + I+S
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 4e-20
Identities = 31/344 (9%), Positives = 68/344 (19%), Gaps = 86/344 (25%)
Query: 388 ASELGGNNRRTDQENEDQNEDLELPLFELAT-------IANATDNFSINKKLGEGGFGPV 440
+G +E E + ++ ++ + + L G V
Sbjct: 19 EELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVV 78
Query: 441 YKGT-LADGQEIA-----------------------------HRNLVKLLGCC------- 463
+ + ++ A + +
Sbjct: 79 FLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD 138
Query: 464 ---IQGEEK----------------LLIYEFMP---NRSLDSFIFDQTKRKLLDWSKRFC 501
+Q + LL+ + F R
Sbjct: 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHI 198
Query: 502 IICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561
+ R L ++H N+ + + + D G+
Sbjct: 199 LTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWK------VGTRGP 249
Query: 562 VVGTYGYMAPE---YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAW 618
AP AS F+ + + G+ + + F +
Sbjct: 250 ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF--LPFGLVTPGIKGSWKRP 307
Query: 619 KLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
L G S + + +I L R
Sbjct: 308 SLRVPGTDSLAFGSCTPLPDFVKTLIG----RFL--NFDRRRRL 345
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 4e-20
Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 43/209 (20%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQEIAH----RNLVKL--- 459
+ F + LG+GGFG V K + + A + +++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 460 -----LGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF---CIICGTARGL 510
L + ++ L L+ M L I+ + + F I C GL
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC----GL 299
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMA 570
LH R RI++RDLK N+LLD + +ISD GLA + + K VGT GYMA
Sbjct: 300 EDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMA 353
Query: 571 PEYASDGLFSVKSDVFSFGILLLEIVSGK 599
PE + ++ D ++ G LL E+++G+
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 5e-20
Identities = 27/198 (13%), Positives = 59/198 (29%), Gaps = 40/198 (20%)
Query: 481 LDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPK 540
+ + + K L R + R L LH ++H L+ +++LD
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVF 251
Query: 541 ISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYAS----------DGLFSVKSDVFSFGI 590
++ F +G++ G+ PE + L + D ++ G+
Sbjct: 252 LTGFEHLV------RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305
Query: 591 LLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVG 650
+ I + ++ N+ + +R + G
Sbjct: 306 AIYWIWCAD--LPNTDDA-----------------ALGGSEWIFRSCKNIPQPVRALLEG 346
Query: 651 LLCVQHHPEDRPCMPSVI 668
L ++ EDR +
Sbjct: 347 FL--RYPKEDRLLPLQAM 362
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-20
Identities = 50/216 (23%), Positives = 88/216 (40%), Gaps = 54/216 (25%)
Query: 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA----------------------HRNLVKLL 460
++ K +G G FG V++ L + E+A H N+V L
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLK 98
Query: 461 GCCIQGEEKL------LIYEFMP---NRSLDSFIFDQTKRKL-LDWSKRFCI-ICGTARG 509
+K L+ E++P R+ + + K+ + + K + + R
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPETVYRASRH--YAKLKQTMPMLLIKLYMYQLL---RS 153
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNP-KISDFGLARTFVGDEIEGSTKRVVGTYGY 568
L Y+H + I HRD+K N+LLD K+ DFG A+ + E + + Y Y
Sbjct: 154 LAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSYICSRY-Y 207
Query: 569 MAPEYASDGLF-----SVKSDVFSFGILLLEIVSGK 599
APE +F + D++S G ++ E++ G+
Sbjct: 208 RAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 6e-20
Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 58/220 (26%)
Query: 424 DNFSINKKLGEGGFGPVYKG--TLADGQ----------------------EIA------- 452
+ ++GEG +G V+K G+ E+A
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 453 --HRNLVKLL----GCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICG 505
H N+V+L E KL L++E + ++ L +++ D+ + ++
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQ 128
Query: 506 TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT 565
RGL +LH R++HRDLK N+L+ K++DFGLAR + ++ T VV T
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMA-LTSVVV-T 182
Query: 566 YGYMAPE------YASDGLFSVKSDVFSFGILLLEIVSGK 599
Y APE YA+ V D++S G + E+ K
Sbjct: 183 LWYRAPEVLLQSSYAT----PV--DLWSVGCIFAEMFRRK 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 47/218 (21%), Positives = 80/218 (36%), Gaps = 56/218 (25%)
Query: 425 NFSINKKLGEGGFGPVYKGT-LADGQEIA------------------------------H 453
+ + LGEG +G V + A H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 454 RNLVKLLGCCIQGEEKLLIY---EFMPNRSLDSFIFDQ-TKRKLLDWSKR--FC-IICGT 506
+N+++L+ + EEK +Y E+ + + D +++ FC +I G
Sbjct: 66 KNVIQLVDV-LYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
YLH I+H+D+K N+LL KIS G+A + + + G+
Sbjct: 123 E----YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 567 GYMAPEYAS-----DGLFSVKSDVFSFGILLLEIVSGK 599
+ PE A+ G K D++S G+ L I +G
Sbjct: 176 AFQPPEIANGLDTFSGF---KVDIWSAGVTLYNITTGL 210
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 91.2 bits (226), Expect = 8e-20
Identities = 23/144 (15%), Positives = 47/144 (32%), Gaps = 23/144 (15%)
Query: 470 LLIYEFMPNRSLDSF--IFD-QTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDL 526
+Y M + + + K L R + R L LHH ++H L
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYL 232
Query: 527 KASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASD---------- 576
+ +++LD ++ F +G+ + G+ PE +
Sbjct: 233 RPVDIVLDQRGGVFLTGFEHLVR------DGARVVSSVSRGFEPPELEARRATISYHRDR 286
Query: 577 -GLFSVKSDVFSFGILLLEIVSGK 599
L + D ++ G+++ I
Sbjct: 287 RTLMTFSFDAWALGLVIYWIWCAD 310
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 52/220 (23%), Positives = 79/220 (35%), Gaps = 66/220 (30%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------HR 454
+ + +GEG +G V K G+ +A H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 455 NLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF-------CIICGT 506
NLV LL + +++ L++EF+ D T L+ +
Sbjct: 85 NLVNLL-EVCKKKKRWYLVFEFV----------DHTILDDLELFPNGLDYQVVQKYLFQI 133
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
G+ + H IIHRD+K N+L+ K+ DFG ART E V T
Sbjct: 134 INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-TR 188
Query: 567 GYMAPE-------YASDGLFSVKSDVFSFGILLLEIVSGK 599
Y APE Y +V DV++ G L+ E+ G+
Sbjct: 189 WYRAPELLVGDVKYGK----AV--DVWAIGCLVTEMFMGE 222
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 46/136 (33%), Positives = 65/136 (47%), Gaps = 9/136 (6%)
Query: 462 CCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRI 521
EEK L D + T L+ +S F + A+G+ +L + +
Sbjct: 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYS--FQV----AKGMEFL---ASRKC 214
Query: 522 IHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSV 581
IHRDL A N+LL + KI DFGLAR D +MAPE D ++++
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 582 KSDVFSFGILLLEIVS 597
+SDV+SFG+LL EI S
Sbjct: 275 QSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 32/162 (19%), Positives = 50/162 (30%), Gaps = 45/162 (27%)
Query: 424 DNFSINKKLGEGGFGPVYKGTL--------------------ADGQEIA----------- 452
D + K LG G FG V + A E
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 453 ---HRNLVKLLGCCIQ-GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTAR 508
H N+V LLG C + G ++I EF +L +++ SKR + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550
G + + I DLK + + S F ++
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 7e-19
Identities = 58/224 (25%), Positives = 93/224 (41%), Gaps = 60/224 (26%)
Query: 422 ATDNFSINKKLGEGGFGPVYKGT-LADGQ-------------------------EIA--- 452
AT + ++G G +G VYK G E+A
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 453 ------HRNLVKLL----GCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFC 501
H N+V+L+ E K+ L++E + ++ L +++ D+ L
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 502 IICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561
++ RGL +LH + I+HRDLK N+L+ K++DFGLAR + ++ T
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMA-LTPV 179
Query: 562 VVGTYGYMAPE------YASDGLFSVKSDVFSFGILLLEIVSGK 599
VV T Y APE YA+ V D++S G + E+ K
Sbjct: 180 VV-TLWYRAPEVLLQSTYAT----PV--DMWSVGCIFAEMFRRK 216
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 8e-19
Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 57/218 (26%)
Query: 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------HRNLVKL 459
+++ K +G G FG VY+ L D G+ +A H N+V+L
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRL 112
Query: 460 LGCCIQGEEKL------LIYEFMPNRSLDSFI--FDQTKRKLLDWSKRFCI--ICGTARG 509
EK L+ +++P ++ + + K+ L + + + R
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF---RS 168
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNP-KISDFGLARTFVGDEIEGSTKRVVGTYGY 568
L Y+H I HRD+K N+LLD + K+ DFG A+ V E + + Y Y
Sbjct: 169 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRY-Y 222
Query: 569 MAPE-------YASDGLFSVKSDVFSFGILLLEIVSGK 599
APE Y + DV+S G +L E++ G+
Sbjct: 223 RAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 47/225 (20%), Positives = 82/225 (36%), Gaps = 61/225 (27%)
Query: 421 NATDNFSINKKLGEGGFGPVYKGTLAD-GQEIA-------------------------HR 454
D F + + G+G FG V G G +A H
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHP 79
Query: 455 NLVKLLGC-CIQGEEKL------LIYEFMP---NRSLDSFIFDQTKRKLLDWSKRFCI-- 502
N+V+L GE ++ E++P +R ++ + + + +
Sbjct: 80 NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYY--RRQVAPPPILIKVFLFQ 137
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP-KISDFGLARTFVGDEIEGSTKR 561
+ R + LH S + + HRD+K NVL++ K+ DFG A+ E +
Sbjct: 138 LI---RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVAY 191
Query: 562 VVGTYGYMAPE-------YASDGLFSVKSDVFSFGILLLEIVSGK 599
+ Y Y APE Y + D++S G + E++ G+
Sbjct: 192 ICSRY-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 55/210 (26%), Positives = 84/210 (40%), Gaps = 47/210 (22%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA---------------------------HRN 455
+++ + + LGEG +G V + +A H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 456 LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQ--TKRKLLDWSKRFC---IICGTARG 509
+VK G + L E+ L FD+ + + + ++ G
Sbjct: 67 VVKFYGH-RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
YLH + I HRD+K N+LLD N KISDFGLA F + E ++ GT Y+
Sbjct: 120 --YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 570 APEYASDGLFS-VKSDVFSFGILLLEIVSG 598
APE F DV+S GI+L +++G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 44/187 (23%), Positives = 71/187 (37%), Gaps = 48/187 (25%)
Query: 428 INKKLGEGGFGPVYKGTLADG---------------------------QEIAHRNLVKLL 460
K+G G +G VYK DG +E+ H N++ L
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQ 84
Query: 461 GCCIQ-GEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF------CIICGTARGLLY 512
+ + K+ L++++ L I K + ++ G+ Y
Sbjct: 85 KVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNP----KISDFGLARTFVGDEIEG---STKRVVGT 565
LH + ++HRDLK +N+L+ E KI+D G AR F ++ VV T
Sbjct: 144 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKPLADLDPVVV-T 198
Query: 566 YGYMAPE 572
+ Y APE
Sbjct: 199 FWYRAPE 205
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 54/231 (23%), Positives = 90/231 (38%), Gaps = 57/231 (24%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQEIAH----RN------- 455
D+F I + +G+G FG V K + E+ +
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 456 --LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF---CIICGTARG 509
LV L Q EE + ++ + + L + Q + + + ++
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICELVM----A 127
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
L YL RIIHRD+K N+LLD + I+DF +A + + GT YM
Sbjct: 128 LDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYM 181
Query: 570 APE-YASDGL----FSVKSDVFSFGILLLEIVSGKKNRGFY-HSDKNLNLI 614
APE ++S F+V D +S G+ E++ G+ R ++ S + I
Sbjct: 182 APEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGR--RPYHIRSSTSSKEI 228
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 52/228 (22%), Positives = 86/228 (37%), Gaps = 70/228 (30%)
Query: 424 DNFSINKKLGEGGFGPVYKG-----------------TLADG------------QEIAHR 454
+ K+G+G FG V+K +G Q + H
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 455 NLVKLLGCCIQGEEKL--------LIYEFMPN---RSLDS--FIFDQTKRKLLDWSKRFC 501
N+V L+ C L+++F + L + F ++ K
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK--------R 128
Query: 502 IICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF---VGDEIEGS 558
++ GL Y+H + +I+HRD+KA+NVL+ + K++DFGLAR F +
Sbjct: 129 VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 559 TKRVVGTYGYMAPE-------YASDGLFSVKSDVFSFGILLLEIVSGK 599
T RVV T Y PE Y D++ G ++ E+ +
Sbjct: 186 TNRVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 58/211 (27%), Positives = 87/211 (41%), Gaps = 51/211 (24%)
Query: 425 NFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------HRN 455
N+ + K +G+G F V + G+E+A H N
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 456 LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFD--QTKRKLL-DWSKRFC--IICGTARG 509
+VKL I+ E+ L LI E+ + FD ++ ++ I+
Sbjct: 76 IVKLFEV-IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ-- 128
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
Y H + RI+HRDLKA N+LLD +MN KI+DFG + F G Y
Sbjct: 129 --YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYA 180
Query: 570 APEYASDGLFS-VKSDVFSFGILLLEIVSGK 599
APE + + DV+S G++L +VSG
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 30/167 (17%)
Query: 449 QEIA------HRNLVKLLGCCIQGEEKLLIY---EFMPNRSLDSFIFDQTKRKLL--DWS 497
QEIA H N+VKL+ + + +Y E + + + K L D +
Sbjct: 85 QEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLSEDQA 139
Query: 498 KRFC--IICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555
+ + +I G + YLH +IIHRD+K SN+L+ + + KI+DFG++ F G
Sbjct: 140 RFYFQDLIKG----IEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS-- 190
Query: 556 EGSTKRVVGTYGYMAPEYASDGLFSV---KSDVFSFGILLLEIVSGK 599
+ VGT +MAPE S+ DV++ G+ L V G+
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 55/210 (26%), Positives = 84/210 (40%), Gaps = 47/210 (22%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA---------------------------HRN 455
+++ + + LGEG +G V + +A H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 456 LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQ--TKRKLLDWSKRFC---IICGTARG 509
+VK G + L E+ L FD+ + + + ++ G
Sbjct: 67 VVKFYGH-RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
YLH + I HRD+K N+LLD N KISDFGLA F + E ++ GT Y+
Sbjct: 120 --YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 570 APEYASDGLFS-VKSDVFSFGILLLEIVSG 598
APE F DV+S GI+L +++G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 7e-18
Identities = 57/221 (25%), Positives = 89/221 (40%), Gaps = 47/221 (21%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQEIAH----RN------- 455
+ F K LG+G FG V K + E+AH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 456 --LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF---CIICGTARG 509
L L Q ++L + E+ L F +R + RF I+
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSA---- 260
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
L YLH S +++RDLK N++LD + + KI+DFGL + + D + K GT Y+
Sbjct: 261 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYL 316
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKN 610
APE D + D + G+++ E++ G+ FY+ D
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHE 355
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 8e-18
Identities = 54/237 (22%), Positives = 85/237 (35%), Gaps = 51/237 (21%)
Query: 394 NNRRTDQENEDQNEDLELPLFELATIANATDNFS----INKKLGEGGFGPVYKGT-LADG 448
+ T N D + + D+ I+++LG G FG V++ T A G
Sbjct: 123 RGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATG 182
Query: 449 QEIA--------------------------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLD 482
A H LV L E ++IYEFM L
Sbjct: 183 NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL- 241
Query: 483 SFIFDQTKRKLLDWSKRFCI-----ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM 537
F++ + S+ + +C GL ++H +H DLK N++ +
Sbjct: 242 ---FEKVADEHNKMSEDEAVEYMRQVCK---GLCHMH---ENNYVHLDLKPENIMFTTKR 292
Query: 538 NP--KISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILL 592
+ K+ DFGL + S K GT + APE A +D++S G+L
Sbjct: 293 SNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 8e-18
Identities = 53/244 (21%), Positives = 87/244 (35%), Gaps = 51/244 (20%)
Query: 387 SASELGGNNRRTDQENEDQNEDLELPLFELATI----ANATDNFSINKKLGEGGFGPVYK 442
S++ G + D+ + + + + D + I ++LG G FG V++
Sbjct: 10 HGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHR 69
Query: 443 GT-LADGQEIA--------------------------HRNLVKLLGCCIQGEEKLLIYEF 475
A G+ H L+ L E +LI EF
Sbjct: 70 CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129
Query: 476 MPNRSLDSFIFDQTKRKLLDWSKRFCI-----ICGTARGLLYLHHDSRLRIIHRDLKASN 530
+ L FD+ + S+ I C GL ++H I+H D+K N
Sbjct: 130 LSGGEL----FDRIAAEDYKMSEAEVINYMRQACE---GLKHMH---EHSIVHLDIKPEN 179
Query: 531 VLLDHEMNP--KISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSF 588
++ + + KI DFGLA DEI K T + APE +D+++
Sbjct: 180 IMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAI 236
Query: 589 GILL 592
G+L
Sbjct: 237 GVLG 240
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 8e-18
Identities = 41/205 (20%), Positives = 77/205 (37%), Gaps = 46/205 (22%)
Query: 421 NATDNFSINKKLGEGGFGPVYKGT-LADGQEIA-------------------------HR 454
+ + I + LG G FG V++ + + HR
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHR 61
Query: 455 NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCI-----ICGTARG 509
N++ L EE ++I+EF+ + F++ + ++R + +C
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCE---A 114
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNP--KISDFGLARTFVGDEIEGSTKRVVGTYG 567
L +LH I H D++ N++ + KI +FG AR + + +
Sbjct: 115 LQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPE 168
Query: 568 YMAPEYASDGLFSVKSDVFSFGILL 592
Y APE + S +D++S G L+
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 51/259 (19%), Positives = 86/259 (33%), Gaps = 69/259 (26%)
Query: 387 SASELGGNNRRTDQENEDQNEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGT-L 445
A +L + + Q+ E L + A + +G G V +
Sbjct: 57 EAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR 116
Query: 446 ADGQEIA-----------------------------------HRNLVKLLGCCIQGEEKL 470
A G E A H +++ L+ E
Sbjct: 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---ESSS 173
Query: 471 LIY---EFMPNRSLDSFIFDQ-TKRKLL---DWSKRFCIICGTARGLLYLHHDSRLRIIH 523
++ + M L FD T++ L + + + +LH I+H
Sbjct: 174 FMFLVFDLMRKGEL----FDYLTEKVALSEKETRSIMRSLLE---AVSFLH---ANNIVH 223
Query: 524 RDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE------YASDG 577
RDLK N+LLD M ++SDFG + E + + GT GY+APE +
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHP 280
Query: 578 LFSVKSDVFSFG----ILL 592
+ + D+++ G LL
Sbjct: 281 GYGKEVDLWACGVILFTLL 299
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQEIAH----RN------- 455
+F + + +G G + V K + D ++I ++
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 456 ---LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF---CIICGTAR 508
LV L C Q E +L + E++ L Q +RKL + RF I
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA--- 122
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
L YLH II+RDLK NVLLD E + K++D+G+ + + +T GT Y
Sbjct: 123 -LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNY 176
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+APE + D ++ G+L+ E+++G+
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 50/214 (23%)
Query: 424 DNFSINKKLGEGGFGPVY-------KGT--------------LADGQEIAH----RN--- 455
+ F + + LG+GG+G V+ T + + ++ AH RN
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 456 ------LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF---CIICG 505
+V L+ Q KL LI E++ L F+ + + ++ + F I
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMA 133
Query: 506 TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT 565
L +LH + II+RDLK N++L+H+ + K++DFGL + + D T GT
Sbjct: 134 ----LGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD--GTVTHTFCGT 184
Query: 566 YGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
YMAPE + D +S G L+ ++++G
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 47/210 (22%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQEIAH----RN------- 455
++F ++K LG+G FG V+ K + ++ +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 456 ---LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF---CIICGTAR 508
L + C Q +E L + E++ L Q+ K F II G
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILG--- 130
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
L +LH I++RDLK N+LLD + + KI+DFG+ + + + T GT Y
Sbjct: 131 -LQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNTFCGTPDY 184
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVSG 598
+APE ++ D +SFG+LL E++ G
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 44/217 (20%), Positives = 73/217 (33%), Gaps = 58/217 (26%)
Query: 425 NFSINKKLGEGGFGPVYKGT-LADGQEIA------------------------------- 452
+S LG G FG V+ +E+
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 453 ---HRNLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLL-DWSKRFC--IICG 505
H N++K+L + + L+ E + LD F F +L + ++
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 506 TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT 565
YL IIHRD+K N+++ + K+ DFG A ++ GT
Sbjct: 143 VG----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGT 192
Query: 566 YGYMAPEYAS----DGLFSVKSDVFSFGILLLEIVSG 598
Y APE G + +++S G+ L +V
Sbjct: 193 IEYCAPEVLMGNPYRGP---ELEMWSLGVTLYTLVFE 226
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 46/210 (21%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQEIAH----RN------- 455
++F K LG+G FG V K + E+AH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 456 --LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF---CIICGTARG 509
L L Q ++L + E+ L F +R + RF I+
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSA---- 117
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
L YLH +++RD+K N++LD + + KI+DFGL + + D + K GT Y+
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYL 172
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGK 599
APE D + D + G+++ E++ G+
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 49/222 (22%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQEIAH----RN------- 455
DNF + LG+G FG V K + ++ +
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 456 ---LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF---CIICGTAR 508
L +L CC Q ++L + EF+ L Q R+ + RF II
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISA--- 136
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
L++LH II+RDLK NVLLDHE + K++DFG+ + + + +T GT Y
Sbjct: 137 -LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN--GVTTATFCGTPDY 190
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKN 610
+APE + L+ D ++ G+LL E++ G F +++
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP--FEAENED 230
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 50/218 (22%), Positives = 82/218 (37%), Gaps = 56/218 (25%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA------------------------------ 452
+ + LG+GGFG V+ G L D ++A
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 453 ------HRNLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLL-DWSKRFC--I 502
H +++LL + +E L+ E P + D F + K L S+ F +
Sbjct: 91 VGAGGGHPGVIRLLDW-FETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRCFFGQV 148
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP-KISDFGLARTFVGDEIEGSTKR 561
+ + + H ++HRD+K N+L+D K+ DFG
Sbjct: 149 VAA----IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD----EPYTD 197
Query: 562 VVGTYGYMAPEYASDGLFS-VKSDVFSFGILLLEIVSG 598
GT Y PE+ S + + + V+S GILL ++V G
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-17
Identities = 55/215 (25%), Positives = 81/215 (37%), Gaps = 54/215 (25%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------H 453
++ + KKLG G +G V E A H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 454 RNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRF------CIICGTA 507
N++KL L+ E L FD+ + +F II
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHR-----MKFNEVDAAVIIKQVL 146
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLL---DHEMNPKISDFGLARTFVGDEIEGSTKRVVG 564
G+ YLH I+HRDLK N+LL + + KI DFGL+ F + K +G
Sbjct: 147 SGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLG 200
Query: 565 TYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
T Y+APE + K DV+S G++L +++G
Sbjct: 201 TAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-17
Identities = 60/216 (27%), Positives = 88/216 (40%), Gaps = 57/216 (26%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------- 452
+D + + LG+G FG V GQE A
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 453 HRNLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF------CIICG 505
H N++KL + + L+ E L FD+ + KRF II
Sbjct: 85 HPNIMKLYEFF-EDKGYFYLVGEVYTGGEL----FDEIISR-----KRFSEVDAARIIRQ 134
Query: 506 TARGLLYLHHDSRLRIIHRDLKASNVLL---DHEMNPKISDFGLARTFVGDEIEGSTKRV 562
G+ Y+H +I+HRDLK N+LL + N +I DFGL+ F + K
Sbjct: 135 VLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDK 188
Query: 563 VGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSG 598
+GT Y+APE G + K DV+S G++L ++SG
Sbjct: 189 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 47/211 (22%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQEIAH----RN------- 455
+F + + +G G + V K + D ++I ++
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 456 ---LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF---CIICGTAR 508
LV L C Q E +L + E++ L Q +RKL + RF I
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA--- 165
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
L YLH II+RDLK NVLLD E + K++D+G+ + + +T GT Y
Sbjct: 166 -LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNY 219
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+APE + D ++ G+L+ E+++G+
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 48/214 (22%), Positives = 83/214 (38%), Gaps = 54/214 (25%)
Query: 420 ANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA-------------------------- 452
+ D++ + ++LG G F V K G+E A
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 453 ------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQ-TKRKLL---DWSKRFCI 502
H N++ L + +LI E + L FD +++ L + ++
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQ 116
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP----KISDFGLARTFVGDEIEGS 558
I G+ YLH RI H DLK N++L + P K+ DFG+A
Sbjct: 117 ILD---GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--- 167
Query: 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILL 592
K + GT ++APE + +++D++S G++
Sbjct: 168 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 48/217 (22%), Positives = 81/217 (37%), Gaps = 60/217 (27%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------- 452
+N+ + LG G V + +E A
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 453 -------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQ-TKRKLL---DWSKRFC 501
H N+++L L+++ M L FD T++ L + K
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMR 131
Query: 502 IICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR 561
+ + LH +L I+HRDLK N+LLD +MN K++DFG + E +
Sbjct: 132 ALLE---VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LRE 182
Query: 562 VVGTYGYMAPE------YASDGLFSVKSDVFSFGILL 592
V GT Y+APE + + + D++S G+++
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 45/215 (20%), Positives = 83/215 (38%), Gaps = 53/215 (24%)
Query: 421 NATDNFSINKKLGEGGFGPVYKGT-LADGQEIA------------------------HRN 455
D++ + +KLG G + V++ + + +++ N
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPN 92
Query: 456 LVKLLGCCIQGEEK--LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCI--ICGTARGLL 511
++ L + L++E + N + L D+ RF + I + L
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEIL---KALD 144
Query: 512 YLHHDSRLRIIHRDLKASNVLLDHE-MNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMA 570
Y H S I+HRD+K NV++DHE ++ D+GLA + RV Y +
Sbjct: 145 YCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FKG 198
Query: 571 PEYASDGLFSVKS-----DVFSFGILLLEIVSGKK 600
PE L + D++S G +L ++ K+
Sbjct: 199 PEL----LVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 47/211 (22%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQEIAH----RN------- 455
+F+ LG+G FG V K + ++ +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 456 ---LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF---CIICGTAR 508
L +L C Q ++L + E++ L Q + + F I G
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIG--- 133
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
L +L II+RDLK NV+LD E + KI+DFG+ + + D +TK GT Y
Sbjct: 134 -LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKTFCGTPDY 187
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+APE + + D ++FG+LL E+++G+
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 47/204 (23%), Positives = 76/204 (37%), Gaps = 48/204 (23%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA-----------------------HRNLVK 458
TD + + + +G G + + A E A H N++
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRF------CIICGTARGLLY 512
L G+ ++ E M L D+ R+ K F ++ + + Y
Sbjct: 81 LKDVYDDGKYVYVVTELMKGGEL----LDKILRQ-----KFFSEREASAVLFTITKTVEY 131
Query: 513 LHHDSRLRIIHRDLKASNVLL-DHEMNP---KISDFGLARTFVGDEIEGSTKRVVGTYGY 568
LH ++HRDLK SN+L D NP +I DFG A+ + G T +
Sbjct: 132 LH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYTANF 186
Query: 569 MAPEYASDGLFSVKSDVFSFGILL 592
+APE + D++S G+LL
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLL 210
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 57/259 (22%), Positives = 103/259 (39%), Gaps = 52/259 (20%)
Query: 387 SASELGGNNRRTDQENEDQNEDLELPLFELATIANAT-DNFSINKKLGEGGFGPVY---- 441
+A+ G+ + + +E + ++ L +E + A D F K LG G FG V
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62
Query: 442 -------------KGTLADGQEIAHRN-------------LVKLLGCCIQGEEKL-LIYE 474
K + ++I H LVKL + L ++ E
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-KDNSNLYMVME 121
Query: 475 FMPNRSLDSFIFDQTKRKLLDWSKRF---CIICGTARGLLYLHHDSRLRIIHRDLKASNV 531
++ + F + + + RF I+ YLH L +I+RDLK N+
Sbjct: 122 YVAGGEM--FSHLRRIGRFSEPHARFYAAQIVL----TFEYLHS---LDLIYRDLKPENL 172
Query: 532 LLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGIL 591
L+D + +++DFG A+ ++G T + GT +APE ++ D ++ G+L
Sbjct: 173 LIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVL 227
Query: 592 LLEIVSGKKNRGFYHSDKN 610
+ E+ +G F+
Sbjct: 228 IYEMAAGYPP--FFADQPI 244
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 56/211 (26%), Positives = 84/211 (39%), Gaps = 47/211 (22%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQEIAH----RN------- 455
+F K +G+G FG V K + +E H RN
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 456 ---LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF---CIICGTAR 508
LV L Q +KL + +++ L F Q +R L+ RF I
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASA--- 151
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
L YLH L I++RDLK N+LLD + + ++DFGL + + +T GT Y
Sbjct: 152 -LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NSTTSTFCGTPEY 205
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+APE + D + G +L E++ G
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 61/217 (28%), Positives = 88/217 (40%), Gaps = 60/217 (27%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------H 453
+ ++I LG+G FG V K QE A H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 454 RNLVKLLGCCIQGEEKLLIY---EFMPNRSLDSFIFDQTKRKLLDWSKRF------CIIC 504
N++KL E+ Y E L FD+ ++ KRF II
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVGELYTGGEL----FDEIIKR-----KRFSEHDAARIIK 128
Query: 505 GTARGLLYLHHDSRLRIIHRDLKASNVLL---DHEMNPKISDFGLARTFVGDEIEGSTKR 561
G+ Y+H I+HRDLK N+LL + + + KI DFGL+ F + K
Sbjct: 129 QVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKD 182
Query: 562 VVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSG 598
+GT Y+APE G + K DV+S G++L ++SG
Sbjct: 183 RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 48/212 (22%)
Query: 424 DNFSINKKLGEGGFGPVY---KGTLADGQEI--------------------AHRN----- 455
F + K LG+G FG V+ K + +D +++ R+
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 456 ----LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF---CIICGTA 507
+VKL Q E KL LI +F+ L F + + +F +
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALA-- 138
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
L +LH L II+RDLK N+LLD E + K++DFGL++ + E GT
Sbjct: 139 --LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVE 191
Query: 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
YMAPE + + +D +SFG+L+ E+++G
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 49/214 (22%), Positives = 80/214 (37%), Gaps = 54/214 (25%)
Query: 420 ANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA-------------------------- 452
D + I ++LG G F V K + G E A
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 453 ------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQ-TKRKLL---DWSKRFCI 502
H N++ L + +LI E + L FD +++ L + +
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQ 123
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP----KISDFGLARTFVGDEIEGS 558
I G+ YLH +I H DLK N++L + P K+ DFGLA
Sbjct: 124 ILD---GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--- 174
Query: 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILL 592
K + GT ++APE + +++D++S G++
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 47/227 (20%), Positives = 77/227 (33%), Gaps = 74/227 (32%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLD 482
+ + LG GGFG VY G ++D +A +K + ++++ + +PN
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVA----IKHVE-----KDRISDWGELPN---- 89
Query: 483 SFIFDQTKR----------------KLLDW---SKRFCII------CG------------ 505
+ +LLDW F +I
Sbjct: 90 ---GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 146
Query: 506 ---TAR--------GLLYLHHDSRLRIIHRDLKASNVLLDHE-MNPKISDFGLARTFVGD 553
AR + + H ++HRD+K N+L+D K+ DFG
Sbjct: 147 QEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD- 202
Query: 554 EIEGSTKRVVGTYGYMAPEYASDGLFS-VKSDVFSFGILLLEIVSGK 599
GT Y PE+ + + V+S GILL ++V G
Sbjct: 203 ---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 4e-16
Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 47/211 (22%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQEIAH----RN------- 455
+F+ LG+G FG V K + ++ +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 456 ---LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF---CIICGTAR 508
L +L C Q ++L + E++ L Q + + F I G
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIG--- 454
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
L +L II+RDLK NV+LD E + KI+DFG+ + + D +TK GT Y
Sbjct: 455 -LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKTFCGTPDY 508
Query: 569 MAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+APE + + D ++FG+LL E+++G+
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 49/214 (22%), Positives = 80/214 (37%), Gaps = 54/214 (25%)
Query: 420 ANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA-------------------------- 452
D + I ++LG G F V K + G E A
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 453 ------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQ-TKRKLL---DWSKRFCI 502
H N++ L + +LI E + L FD +++ L + +
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQ 123
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP----KISDFGLARTFVGDEIEGS 558
I G+ YLH +I H DLK N++L + P K+ DFGLA
Sbjct: 124 ILD---GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--- 174
Query: 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILL 592
K + GT ++APE + +++D++S G++
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 50/213 (23%), Positives = 81/213 (38%), Gaps = 54/213 (25%)
Query: 421 NATDNFSINKKLGEGGFGPVYKGT-LADGQEIA--------------------------- 452
N D + ++LG G F V K + G + A
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 453 -----HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQ-TKRKLL---DWSKRFCII 503
H N++ L + +LI E + L FD +++ L + ++ I
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQI 123
Query: 504 CGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP----KISDFGLARTFVGDEIEGST 559
G+ YLH L+I H DLK N++L P KI DFGLA
Sbjct: 124 LN---GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---F 174
Query: 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILL 592
K + GT ++APE + +++D++S G++
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 43/275 (15%), Positives = 75/275 (27%), Gaps = 80/275 (29%)
Query: 401 ENEDQNEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA------- 452
+ + E F+ ++ + + +G+G +G V A
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 453 ------------------------HRNLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFD 487
H N+ +L + E+ + L+ E L +
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLNV 121
Query: 488 QTKRKLLDWSKRFCIICGTAR-------------------------------------GL 510
+ L
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 511 LYLHHDSRLRIIHRDLKASNVLL--DHEMNPKISDFGLARTFVGDEIEGST--KRVVGTY 566
YLH I HRD+K N L + K+ DFGL++ F GT
Sbjct: 182 HYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238
Query: 567 GYMAPE--YASDGLFSVKSDVFSFGILLLEIVSGK 599
++APE ++ + K D +S G+LL ++ G
Sbjct: 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 64/272 (23%), Positives = 105/272 (38%), Gaps = 60/272 (22%)
Query: 371 DMRNFQDGGQDLYIRMSASELGGNNRRTDQENEDQNEDLELPLFELATIANATDNFSINK 430
+ ++GG ++++ G + + E I +NF + K
Sbjct: 5 HHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGI----ENFELLK 60
Query: 431 KLGEGGFGPVY-------KGT--------------LADGQEIAH----RN---------- 455
LG G +G V+ T + + H R
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 456 LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF---CIICGTARGLL 511
LV L Q E KL LI +++ L F + + + + I+ L
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVLA----LE 173
Query: 512 YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAP 571
+LH +L II+RD+K N+LLD + ++DFGL++ FV DE E GT YMAP
Sbjct: 174 HLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAP 229
Query: 572 E---YASDG-LFSVKSDVFSFGILLLEIVSGK 599
+ G +V D +S G+L+ E+++G
Sbjct: 230 DIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-16
Identities = 54/255 (21%), Positives = 93/255 (36%), Gaps = 67/255 (26%)
Query: 394 NNRRTDQENEDQNEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA 452
++ + Q + ++ +++ +KLG G +G V E A
Sbjct: 6 HHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKA 65
Query: 453 ---------------------------------------HRNLVKLLGCCIQGEEKL-LI 472
H N++KL + ++ L+
Sbjct: 66 IKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF-EDKKYFYLV 124
Query: 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRF------CIICGTARGLLYLHHDSRLRIIHRDL 526
EF L F+Q + +F I+ G+ YLH I+HRD+
Sbjct: 125 TEFYEGGEL----FEQIINR-----HKFDECDAANIMKQILSGICYLHK---HNIVHRDI 172
Query: 527 KASNVLL---DHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKS 583
K N+LL + +N KI DFGL+ F D + +GT Y+APE ++ K
Sbjct: 173 KPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPE-VLKKKYNEKC 228
Query: 584 DVFSFGILLLEIVSG 598
DV+S G+++ ++ G
Sbjct: 229 DVWSCGVIMYILLCG 243
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 53/213 (24%)
Query: 420 ANATDNFSINKK--LGEGGFGPVYKGT-LADGQEIA------------------------ 452
++++K LG G FG V+K A G ++A
Sbjct: 83 GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQ 142
Query: 453 --HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCI-----ICG 505
H NL++L + +L+ E++ L FD+ + + ++ I IC
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICE 198
Query: 506 TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP--KISDFGLARTFVGDEIEGSTKRVV 563
G+ ++H ++ I+H DLK N+L + KI DFGLAR + E K
Sbjct: 199 ---GIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNF 249
Query: 564 GTYGYMAPEYASDGLFSVKSDVFSFG----ILL 592
GT ++APE + S +D++S G +LL
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 9e-16
Identities = 43/213 (20%), Positives = 83/213 (38%), Gaps = 47/213 (22%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQEIAH----RN------- 455
++F I K +G G FG V K + E A R+
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 456 --LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFC--IICGTARGL 510
+ L Q + L L+ ++ L + + R + ++ + ++ +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA----I 188
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMA 570
+H +L +HRD+K N+L+D + +++DFG + D + VGT Y++
Sbjct: 189 DSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYIS 244
Query: 571 PE-----YASDGLFSVKSDVFSFGILLLEIVSG 598
PE G + + D +S G+ + E++ G
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 47/209 (22%), Positives = 72/209 (34%), Gaps = 47/209 (22%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------- 452
D + + + +G+G F V + GQ+ A
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 453 --HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLL----DWSKRFCIICGT 506
H ++V+LL +++EFM L I + + S I
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE- 141
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP---KISDFGLARTFVGDEIEGSTKRVV 563
L Y H IIHRD+K VLL + N K+ FG+A + V
Sbjct: 142 --ALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RV 194
Query: 564 GTYGYMAPEYASDGLFSVKSDVFSFGILL 592
GT +MAPE + DV+ G++L
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 61/220 (27%), Positives = 84/220 (38%), Gaps = 74/220 (33%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------H 453
+ ++I LG+G FG V K QE A H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 454 RNLVKLLGCCIQGEEKLLIY---EFMPNRSLDSFIFDQTKRKLLDWSKRF------CIIC 504
N++KL E+ Y E L FD+ ++ KRF II
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVGELYTGGEL----FDEIIKR-----KRFSEHDAARIIK 128
Query: 505 GTARGLLYLHHDSRLRIIHRDLKASNVLL---DHEMNPKISDFGLARTFVGDEIEGSTKR 561
G+ Y+H + I+HRDLK N+LL + + + KI DFGL+ F + K
Sbjct: 129 QVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKD 182
Query: 562 VVGTYGYMAPE-----YASDGLFSVKSDVFSFG----ILL 592
+GT Y+APE Y K DV+S G ILL
Sbjct: 183 RIGTAYYIAPEVLRGTY------DEKCDVWSAGVILYILL 216
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 52/208 (25%), Positives = 86/208 (41%), Gaps = 44/208 (21%)
Query: 425 NFSINKKLGEGGFGPVYKGT-LADGQEIA-----------------------------HR 454
++ + LG G FG V G G ++A H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 455 NLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFC-IICGTARGLLY 512
+++KL I ++ E++ L +I + + ++ + F I+ Y
Sbjct: 72 HIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----Y 126
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE 572
H R ++HRDLK NVLLD MN KI+DFGL+ E + G+ Y APE
Sbjct: 127 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPE 180
Query: 573 YASDGLFS-VKSDVFSFGILLLEIVSGK 599
S L++ + D++S G++L ++ G
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 51/213 (23%), Positives = 79/213 (37%), Gaps = 59/213 (27%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------H 453
+DN+ + ++LG+G F V + G E A H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 454 RNLVKLLGCCIQGEEKLLIY---EFMPNRSLDSFIFDQ-TKRKLL---DWSKRFCIICGT 506
N+V+L +E+ Y + + L F+ R+ D S I
Sbjct: 65 PNIVRLHDSI---QEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILE- 116
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP---KISDFGLARTFVGDEIEGSTKRVV 563
+ Y H I+HR+LK N+LL + K++DFGLA E
Sbjct: 117 --SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFA 168
Query: 564 GTYGYMAPEYASDGLFSVKSDVFSFG----ILL 592
GT GY++PE +S D+++ G ILL
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 46/215 (21%), Positives = 82/215 (38%), Gaps = 49/215 (22%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQEIAH----RN------- 455
D+F I K +G G F V K + E++ R+
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 456 --LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFC--IICGTARGL 510
+ +L Q E L L+ E+ L + + +R + ++ + I+ +
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA----I 175
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMA 570
+H RL +HRD+K N+LLD + +++DFG D + VGT Y++
Sbjct: 176 DSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-TVRSLVAVGTPDYLS 231
Query: 571 PE-------YASDGLFSVKSDVFSFGILLLEIVSG 598
PE G + + D ++ G+ E+ G
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 48/215 (22%), Positives = 77/215 (35%), Gaps = 59/215 (27%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------- 452
D + ++K LG G G V +++A
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 453 -----HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQ-TKRKLL---DWSKRFCII 503
H ++K+ E+ ++ E M L FD+ K L F +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQM 123
Query: 504 CGTARGLLYLHHDSRLRIIHRDLKASNVLL---DHEMNPKISDFGLARTFVGDEIEGSTK 560
+ YLH IIHRDLK NVLL + + KI+DFG ++ + +
Sbjct: 124 LL---AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MR 174
Query: 561 RVVGTYGYMAPE---YASDGLFSVKSDVFSFGILL 592
+ GT Y+APE ++ D +S G++L
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 45/211 (21%), Positives = 74/211 (35%), Gaps = 51/211 (24%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------- 452
D + ++K LG G G V +++A
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 453 -----HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTA 507
H ++K+ E+ ++ E M L + + K F +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL-- 250
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP---KISDFGLARTFVGDEIEGSTKRVVG 564
+ YLH IIHRDLK NVLL + KI+DFG ++ + + + G
Sbjct: 251 -AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCG 303
Query: 565 TYGYMAPE---YASDGLFSVKSDVFSFGILL 592
T Y+APE ++ D +S G++L
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 51/213 (23%), Positives = 72/213 (33%), Gaps = 55/213 (25%)
Query: 420 ANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA-------------------------- 452
D F +KLG G FG V+ + G E
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 453 -HRNLVKLLGCCIQGEEKLLIY---EFMPNRSLDSFIFDQTKRKLLDWSKRF------CI 502
H N++K+ E+ +Y E L I R K +
Sbjct: 78 DHPNIIKIFEVF---EDYHNMYIVMETCEGGELLERIVSAQARG-----KALSEGYVAEL 129
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLL---DHEMNPKISDFGLARTFVGDEIEGST 559
+ L Y H ++H+DLK N+L KI DFGLA F DE +
Sbjct: 130 MKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---S 183
Query: 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILL 592
GT YMAPE + K D++S G+++
Sbjct: 184 TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 56/213 (26%), Positives = 82/213 (38%), Gaps = 56/213 (26%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQ---EIA------HRNLV 457
D + K +G G FG +G D EI H N+V
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79
Query: 458 KLLGCCIQGEEKL-LIYEFMPNRSLDSFIFD--QTKRKLL-DWSKRF--CIICGTARGLL 511
+ I L +I E+ L ++ + D ++ F ++ G +
Sbjct: 80 RFKEV-ILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS---- 130
Query: 512 YLHHDSRLRIIHRDLKASNVLLDH--EMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
Y H ++I HRDLK N LLD KI DFG +++ V ST VGT Y+
Sbjct: 131 YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYI 184
Query: 570 APEYAS----DGLFSVKSDVFSFGILLLEIVSG 598
APE DG +DV+S G+ L ++ G
Sbjct: 185 APEVLLRQEYDGK---IADVWSCGVTLYVMLVG 214
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 44/214 (20%), Positives = 78/214 (36%), Gaps = 58/214 (27%)
Query: 420 ANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA-------------------------- 452
+ +++ +G G +G V A
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 453 HRNLVKLLGCCIQGEEKLLIY---EFMPNRSLDSFIFDQ-TKRKLL---DWSKRFCIICG 505
H N+++L E+ IY E L F++ +++ D ++ +
Sbjct: 65 HPNIIRLYETF---EDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAARIMKDVLS 117
Query: 506 TARGLLYLHHDSRLRIIHRDLKASNVLL---DHEMNPKISDFGLARTFVGDEIEGSTKRV 562
+ Y H +L + HRDLK N L + K+ DFGLA F ++ +
Sbjct: 118 ---AVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTK 168
Query: 563 VGTYGYMAPEYASDGLFSVKSDVFSFG----ILL 592
VGT Y++P+ +GL+ + D +S G +LL
Sbjct: 169 VGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLL 201
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 9e-15
Identities = 49/213 (23%), Positives = 70/213 (32%), Gaps = 62/213 (29%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA--------------------------HRN 455
F + LG G F V+ G+ A H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 456 LVKLLGCCIQGEEKLLIY---EFMPNRSLDSFIFDQTKRKLLDWSKRF------CIICGT 506
+V L E Y + + L FD+ + + +I
Sbjct: 68 IVTLEDIY---ESTTHYYLVMQLVSGGEL----FDRILER-----GVYTEKDASLVIQQV 115
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLL---DHEMNPKISDFGLARTFVGDEIEGSTKRVV 563
+ YLH I+HRDLK N+L + I+DFGL++ G
Sbjct: 116 LSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTAC 168
Query: 564 GTYGYMAPEYASDGLFSVKSDVFSFG----ILL 592
GT GY+APE + +S D +S G ILL
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 49/198 (24%), Positives = 72/198 (36%), Gaps = 48/198 (24%)
Query: 429 NKKLGEGGFGPVYKGT-LADGQEIA------------------------HRNLVKLLGCC 463
+K LGEG F K Q A H N+VKL
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 464 IQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRF------CIICGTARGLLYLHHDS 517
L+ E + L F++ K+K K F I+ + ++H
Sbjct: 76 HDQLHTFLVMELLNGGEL----FERIKKK-----KHFSETEASYIMRKLVSAVSHMH--- 123
Query: 518 RLRIIHRDLKASNVLL---DHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYA 574
+ ++HRDLK N+L + + KI DFG AR D T T Y APE
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELL 181
Query: 575 SDGLFSVKSDVFSFGILL 592
+ + D++S G++L
Sbjct: 182 NQNGYDESCDLWSLGVIL 199
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 49/209 (23%)
Query: 424 DNFSINKKLGEGGFGPVY-----------------KGTLADGQEIAH----RN------- 455
+F I + LG G FG V+ K + +++ H R
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 456 --LVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF---CIICGTARG 509
++++ G Q +++ +I +++ L F + ++ + +F +
Sbjct: 66 PFIIRMWGTF-QDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAEVCL----A 118
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
L YLH II+RDLK N+LLD + KI+DFG A+ + T + GT Y+
Sbjct: 119 LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYI 170
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSG 598
APE S ++ D +SFGIL+ E+++G
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 53/211 (25%), Positives = 81/211 (38%), Gaps = 55/211 (26%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------H 453
+DN+ + ++LG+G F V + G E A H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 454 RNLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQ-TKRKLL---DWSKRFCIICGTAR 508
N+V+L IQ E L+++ + L F+ R+ D S I
Sbjct: 88 PNIVRLHDS-IQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILE--- 139
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNP---KISDFGLARTFVGDEIEGSTKRVVGT 565
+ Y H I+HR+LK N+LL + K++DFGLA E GT
Sbjct: 140 SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 193
Query: 566 YGYMAPEYASDGLFSVKSDVFSFG----ILL 592
GY++PE +S D+++ G ILL
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILL 224
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 56/212 (26%), Positives = 87/212 (41%), Gaps = 52/212 (24%)
Query: 425 NFSINKKLGEGGFGPVYKGT-LADGQEIA-----------------------------HR 454
++ + LG G FG V G G ++A H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 455 NLVKLLGCCIQGEEKL-LIYEFMPNRSLDSFIFDQ--TKRKLL-DWSKRFC--IICGTAR 508
+++KL I + ++ E++ L FD +L S+R I+ G
Sbjct: 77 HIIKLYQV-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD- 130
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
Y H R ++HRDLK NVLLD MN KI+DFGL+ E + G+ Y
Sbjct: 131 ---YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNY 181
Query: 569 MAPEYASDGLFS-VKSDVFSFGILLLEIVSGK 599
APE S L++ + D++S G++L ++ G
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 57/220 (25%), Positives = 88/220 (40%), Gaps = 69/220 (31%)
Query: 425 NFSINKKLGEGGFGPVYKGT-LADGQEIA-----------------------------HR 454
+ I + LGEG FG V T Q++A H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 455 NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFI---------FDQ--TKRKLLDWSKRFC-- 501
+++KL Y+ + + D + FD K+++ + R
Sbjct: 70 HIIKL-------------YDVITTPT-DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQ 115
Query: 502 -IICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTK 560
IIC Y H R +I+HRDLK N+LLD +N KI+DFGL+ K
Sbjct: 116 QIICAIE----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LK 165
Query: 561 RVVGTYGYMAPEYASDGLFS-VKSDVFSFGILLLEIVSGK 599
G+ Y APE + L++ + DV+S GI+L ++ G+
Sbjct: 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 49/233 (21%), Positives = 81/233 (34%), Gaps = 53/233 (22%)
Query: 400 QENEDQNEDLELPLFELATIANATDNFSINKK-LGEGGFGPVYKGT-LADGQEIA----- 452
+ DL ++ N + + + K LG G F V + + GQE A
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 453 ------------------------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQ 488
++ L E +LI E+ + F
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSL 119
Query: 489 -TKRKLLDWSKRFCI-----ICGTARGLLYLHHDSRLRIIHRDLKASNVLL---DHEMNP 539
S+ I I G+ YLH + I+H DLK N+LL +
Sbjct: 120 CLPELAEMVSENDVIRLIKQILE---GVYYLH---QNNIVHLDLKPQNILLSSIYPLGDI 173
Query: 540 KISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILL 592
KI DFG++R + ++GT Y+APE + + +D+++ GI+
Sbjct: 174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 45/204 (22%), Positives = 82/204 (40%), Gaps = 45/204 (22%)
Query: 423 TDNFSINKK-LGEGGFGPVYKGT-LADGQEIA----------------------HRNLVK 458
TD++ ++K+ LG G G V + GQ+ A ++V
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVC 86
Query: 459 LLGCC---IQGEEKL-LIYEFMPNRSLDSFIFDQ-TKRKLLDWSKRFC--IICGTARGLL 511
+L G+ L +I E M L F + +R +++R I+ +
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 512 YLHHDSRLRIIHRDLKASNVLL---DHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
+LH I HRD+K N+L + + K++DFG A+ + + + T Y
Sbjct: 143 FLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT----QNALQTPCYTPYY 195
Query: 569 MAPEYASDGLFSVKSDVFSFGILL 592
+APE + D++S G+++
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 47/218 (21%), Positives = 75/218 (34%), Gaps = 60/218 (27%)
Query: 423 TDNFSINKK-LGEGGFGPVYKGT-LADGQEIA---------------------------H 453
D + + + LGEG V L QE A H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 454 RNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRF------CIICGTA 507
RN+++L+ + + L++E M S+ ++ + F ++ A
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHKR-----RHFNELEASVVVQDVA 121
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP---KISDFGLARTF-----VGDEIEGST 559
L +LH I HRDLK N+L +H KI DF L
Sbjct: 122 SALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 560 KRVVGTYGYMAPE-----YASDGLFSVKSDVFSFGILL 592
G+ YMAPE ++ + D++S G++L
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-14
Identities = 52/222 (23%), Positives = 87/222 (39%), Gaps = 60/222 (27%)
Query: 416 LATI--ANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA-------------------- 452
+ATI T+ + + ++LG+G F V + + GQE A
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 453 --------HRNLVKLLGCCIQGEEKLLIY---EFMPNRSLDSFIFDQ-TKRKLL---DWS 497
H N+V+L E+ Y + + L F+ R+ D S
Sbjct: 61 ARICRLLKHPNIVRLHDSI---SEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADAS 113
Query: 498 KRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP---KISDFGLARTFVGDE 554
I +L+ H + ++HR+LK N+LL ++ K++DFGLA G++
Sbjct: 114 HCIQQILE---AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167
Query: 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFG----ILL 592
GT GY++PE + D+++ G ILL
Sbjct: 168 QAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 207
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 52/249 (20%), Positives = 95/249 (38%), Gaps = 83/249 (33%)
Query: 421 NATDNFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------HRNLV 457
++ +S+ K LG G FG V + + G+ A H N++
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNII 63
Query: 458 KLLGCCIQGEEKL--------------------------------------LIYEFMP-- 477
KL+ ++ +I E++P
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 478 -NRSLDSFIFDQTKRKLLDWSKRFCI--ICGTARGLLYLHHDSRLRIIHRDLKASNVLLD 534
++ L SFI ++ R + I + R + ++H L I HRD+K N+L++
Sbjct: 124 LHKVLKSFI--RSGRSIPMNLISIYIYQLF---RAVGFIHS---LGICHRDIKPQNLLVN 175
Query: 535 HEMNP-KISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEY---ASDGLFSVKSDVFSFGI 590
+ N K+ DFG A+ + E S + + Y APE A++ ++ D++S G
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEP--SVAYICSRF-YRAPELMLGATE--YTPSIDLWSIGC 230
Query: 591 LLLEIVSGK 599
+ E++ GK
Sbjct: 231 VFGELILGK 239
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 51/205 (24%), Positives = 74/205 (36%), Gaps = 47/205 (22%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA------------------------HRNLV 457
+D F + +LG G VY+ + A H N++
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNII 111
Query: 458 KLLGCCIQGEEKLLIY---EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH 514
KL E I E + L I ++ D + I + YLH
Sbjct: 112 KLKEIF---ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE---AVAYLH 165
Query: 515 HDSRLRIIHRDLKASNVLL---DHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAP 571
I+HRDLK N+L + KI+DFGL++ + K V GT GY AP
Sbjct: 166 E---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAP 219
Query: 572 EYASDGLFSVKSDVFSFG----ILL 592
E + + D++S G ILL
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILL 244
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 50/247 (20%), Positives = 95/247 (38%), Gaps = 48/247 (19%)
Query: 389 SELGGNNRRTDQENEDQNEDLELPLFELATIANATDNFSINKKLGEGGFGPVY------- 441
+L R ++ ++ + + ++ + +++ + K +G G FG V
Sbjct: 34 YDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST 93
Query: 442 ----------KGTLADGQEIAH----RN---------LVKLLGCCIQGEEKL-LIYEFMP 477
K + + A R+ +V+L Q + L ++ E+MP
Sbjct: 94 RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMP 152
Query: 478 NRSLDSFIFDQTKRKLLDWSKRFC--IICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH 535
L W++ + ++ L +H + IHRD+K N+LLD
Sbjct: 153 GGDL--VNLMSNYDVPEKWARFYTAEVVL----ALDAIH---SMGFIHRDVKPDNMLLDK 203
Query: 536 EMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE----YASDGLFSVKSDVFSFGIL 591
+ K++DFG + E VGT Y++PE DG + + D +S G+
Sbjct: 204 SGHLKLADFGTCMK-MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262
Query: 592 LLEIVSG 598
L E++ G
Sbjct: 263 LYEMLVG 269
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 39/198 (19%), Positives = 72/198 (36%), Gaps = 43/198 (21%)
Query: 428 INKKLGEGGFGPVYKGT-LADGQEIA----------------------HRNLVKLLGCC- 463
++ LG G G V + ++ A ++V+++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYE 125
Query: 464 --IQGEEKL-LIYEFMPNRSLDSFIFDQ-TKRKLLDWSKR--FCIICGTARGLLYLHHDS 517
G + L ++ E + L F + R +++R I+ + YLH
Sbjct: 126 NLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 178
Query: 518 RLRIIHRDLKASNVLL---DHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYA 574
+ I HRD+K N+L K++DFG A+ S T Y+APE
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVL 235
Query: 575 SDGLFSVKSDVFSFGILL 592
+ D++S G+++
Sbjct: 236 GPEKYDKSCDMWSLGVIM 253
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 449 QEIAHRNLVKLL------GCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCI 502
+ + H+N++ LL + ++ ++ E M +L I + +L + +
Sbjct: 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMELDHERMSY-L 132
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV 562
+ G+ +LH S IIHRDLK SN+++ + KI DFGLART T V
Sbjct: 133 LYQMLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYV 187
Query: 563 VGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
V T Y APE + D++S G ++ E++ G
Sbjct: 188 V-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 449 QEIAHRNLVKLL------GCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCI 502
+ + H+N++ LL + ++ L+ E M +L I + +L + +
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI----QMELDHERMSY-L 169
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV 562
+ G+ +LH IIHRDLK SN+++ + KI DFGLART T V
Sbjct: 170 LYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYV 224
Query: 563 VGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
V T Y APE + D++S G ++ E+V K
Sbjct: 225 V-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 38/188 (20%), Positives = 67/188 (35%), Gaps = 41/188 (21%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------H 453
D + I +G G +G V + + + +A H
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNH 111
Query: 454 RNLVKLLGCCIQGEEKL-----LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTAR 508
++VK+L I + + ++ E +T L + + ++
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLF--RTPVYLTELHIKT-LLYNLLV 167
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
G+ Y+H S I+HRDLK +N L++ + + K+ DFGLART E S +
Sbjct: 168 GVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 569 MAPEYASD 576
M
Sbjct: 225 MNLVTFPH 232
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 21/158 (13%)
Query: 449 QEIAHRNLVKLL------GCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCI 502
+ + H N++ LL + L+ FM L + K + ++ +
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM----GLKFSEEKIQY-L 131
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV 562
+ +GL Y+H S ++HRDLK N+ ++ + KI DFGLAR + T V
Sbjct: 132 VYQMLKGLKYIH--SA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYV 184
Query: 563 VGTYGYMAPEYA-SDGLFSVKSDVFSFGILLLEIVSGK 599
V T Y APE S ++ D++S G ++ E+++GK
Sbjct: 185 V-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 51/217 (23%), Positives = 84/217 (38%), Gaps = 53/217 (24%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA---------------------------HR 454
++ +GEG +G V + +A H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 455 NLVKLLGCCI-QGEEKL----LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARG 509
N++ + E++ ++ + M L + Q L + + + RG
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ---HLSNDHICY-FLYQILRG 140
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS--TKRVVGTYG 567
L Y+H S ++HRDLK SN+LL+ + KI DFGLAR D T+ V T
Sbjct: 141 LKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRW 196
Query: 568 YMAPEYASDGLFSVKS-----DVFSFGILLLEIVSGK 599
Y APE + + K D++S G +L E++S +
Sbjct: 197 YRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 47/220 (21%), Positives = 77/220 (35%), Gaps = 52/220 (23%)
Query: 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA------------------------------ 452
+++ + + G +G V G ++G +A
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 453 -------HRNLVKLLGCCI-QGEEKL----LIYEFMPNRSLDSFIFDQTKRKLLDWSKRF 500
H N++ L + E + L+ E M L I DQ + + ++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ-RIVISPQHIQY 138
Query: 501 CIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTK 560
+ GL LH ++HRDL N+LL + I DF LAR D T
Sbjct: 139 -FMYHILLGLHVLH--EA-GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN--KTH 192
Query: 561 RVVGTYGYMAPEY-ASDGLFSVKSDVFSFGILLLEIVSGK 599
V Y APE F+ D++S G ++ E+ + K
Sbjct: 193 YVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 20/158 (12%)
Query: 449 QEIAHRNLVKLL------GCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCI 502
+ + H N++ LL + + L+ M L++ + Q KL D +F +
Sbjct: 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQ---KLTDDHVQF-L 137
Query: 503 ICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV 562
I RGL Y+H S IIHRDLK SN+ ++ + KI DFGLAR + T V
Sbjct: 138 IYQILRGLKYIH--SA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYV 190
Query: 563 VGTYGYMAPEYA-SDGLFSVKSDVFSFGILLLEIVSGK 599
T Y APE + ++ D++S G ++ E+++G+
Sbjct: 191 A-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 32/105 (30%), Positives = 46/105 (43%), Gaps = 20/105 (19%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV----- 562
R + LH +IHRDLK SN+L++ + K+ DFGLAR + S
Sbjct: 123 RAVKVLH--GS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 563 ---VGTYGYMAPEYASDGLFSVKS-----DVFSFGILLLEIVSGK 599
V T Y APE + + DV+S G +L E+ +
Sbjct: 180 VEFVATRWYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 30/96 (31%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHE-MNPKISDFGLARTFVGDEIEGS--TKRVVG 564
RGL Y+H + ++HRDLK +N+ ++ E + KI DFGLAR ++ +V
Sbjct: 131 RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV- 186
Query: 565 TYGYMAPE-YASDGLFSVKSDVFSFGILLLEIVSGK 599
T Y +P S ++ D+++ G + E+++GK
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
+GL Y+H + IIHRDLK N+ ++ + KI DFGLAR + T VV T
Sbjct: 139 KGLRYIH--AA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVV-TRW 190
Query: 568 YMAPEYA-SDGLFSVKSDVFSFGILLLEIVSGK 599
Y APE + ++ D++S G ++ E+++GK
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 20/70 (28%), Positives = 30/70 (42%), Gaps = 3/70 (4%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
G ++H IIHRDLK +N LL+ + + K+ DFGLART ++ +
Sbjct: 140 LGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 568 YMAPEYASDG 577
Sbjct: 197 PGPHNKNLKK 206
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 36/116 (31%), Positives = 54/116 (46%), Gaps = 31/116 (26%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRV----- 562
+ + YLH S ++HRD+K SN+LL+ E + K++DFGL+R+FV + +
Sbjct: 120 KVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 563 --------------VGTYGYMAPEYASDGLFSVKS-----DVFSFGILLLEIVSGK 599
V T Y APE L D++S G +L EI+ GK
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEI----LLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 2e-09
Identities = 22/120 (18%), Positives = 42/120 (35%), Gaps = 20/120 (16%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
L G++L + + + Y + T VW +N V
Sbjct: 9 GLYAGQSLDV--EPYHFIMQEDCNL------VLYDH---STSVWASNTGILGKKGC-KAV 56
Query: 61 VNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDY 120
+ GN V+ +W+++ + VL L + GN+V+ G + +W + Y
Sbjct: 57 LQSDGNFVVYDAEGRSLWASHSVRG-NGNYVLVLQEDGNVVIYG-------SDIWSTGTY 108
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 2e-09
Identities = 32/197 (16%), Positives = 50/197 (25%), Gaps = 70/197 (35%)
Query: 422 ATDNFSINKKLGEGGFGPVYKGT------------------------------------- 444
T+ +K+GEG FG V++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 445 -----LADGQEIAHRNLVKLLGCCI-QG---EEKLLIYEFM----------PNRSLDSFI 485
L+ + L QG L ++ P+ D +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 486 F------------DQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL 533
F +Q + KL + I+ L LR HRDL NVLL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLL 195
Query: 534 DHEMNPKISDFGLARTF 550
K+ ++
Sbjct: 196 KKTSLKKLHYTLNGKSS 212
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 45/217 (20%), Positives = 78/217 (35%), Gaps = 52/217 (23%)
Query: 428 INKKLGEGGFGPVYKGT-LADGQEIA---HRNL----------VKLLGCCIQGEEKLLIY 473
+ +KLG G F V+ + + +A R +KLL +
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 474 EFMPN--RSLDSFIFDQTKRK------------LLDWSKRFC-------IICGTAR---- 508
+ + LD F LL K++ + ++
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNP------KISDFGLARTFVGDEIEGSTKRV 562
GL Y+H R IIH D+K NVL++ +P KI+D G A + +
Sbjct: 143 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHY----TNS 195
Query: 563 VGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+ T Y +PE + +D++S L+ E+++G
Sbjct: 196 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 2e-08
Identities = 25/117 (21%), Positives = 42/117 (35%), Gaps = 20/117 (17%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
SL G +L S+ L + + Y + VW +N + L
Sbjct: 9 SLFTGHSL-EVGPSYRLIMQGDCNF------VLYDS---GKPVWASNTGGLGSGCRLTL- 57
Query: 61 VNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQS 117
+ GNLV+ Q+ V+W + + VL L N+V+ G +W +
Sbjct: 58 -HNNGNLVIYDQSNRVIWQTKTNGK-EDHYVLVLQQDRNVVIYG-------PVVWAT 105
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 2e-08
Identities = 24/117 (20%), Positives = 41/117 (35%), Gaps = 21/117 (17%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
+L +L + G++ L + + + Y+N +W +N S L
Sbjct: 10 TLHADHSLQA--GAYTLTIQNKCNL------VKYQN---GRQIWASNTDR--RGSGCRLT 56
Query: 61 VNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQS 117
+ GNLV+ N + VW + + L L G V+ G LW
Sbjct: 57 LLSDGNLVIYDHNNNDVWGSACWGD-NGKYALVLQKDGRFVIYG-------PVLWSL 105
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 2e-08
Identities = 49/320 (15%), Positives = 93/320 (29%), Gaps = 85/320 (26%)
Query: 43 VWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVL 102
V A N N S +L+ T++ K V LS T + L +
Sbjct: 253 VQNAKAWNAFNLSCKILL---------TTRFKQVT--DFLSAATTTHISLDHHSMT--LT 299
Query: 103 RGERDGDSETYLWQSF-DYPSD-------------TLLPGMKLGWDF--KTGLERRITSW 146
E YL D P + + WD ++ T
Sbjct: 300 PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359
Query: 147 KSS-DDPSPGDFIWKIERQFYPELVMWKGSRKFYRTGP-------WNGLIFSASSLRLNP 198
+SS + P ++ R+ + L ++ S P W +I S + +N
Sbjct: 360 ESSLNVLEPAEY-----RKMFDRLSVFPPSAHI----PTILLSLIWFDVIKSDVMVVVNK 410
Query: 199 IFKYRFVFNEDELYYTFYLTDKDVISRTVMNQTVSLRQRFIWR-KANQSWELYSNLPKDQ 257
+ KY V + T + + + + +L + + ++++ +L
Sbjct: 411 LHKYSLV-EKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFD-SDDLIPPY 468
Query: 258 CDTYGLCGAYGICIISQSPICQCLEGFHPKSGGYVDWSQGCVHNKPLNYSRKDGF----- 312
D Y + G H K+ + R F
Sbjct: 469 LDQY---------------FYSHI-GHHLKNIE--------------HPERMTLFRMVFL 498
Query: 313 -IKFSELKLPDSTSSWVSKS 331
+F E K+ +++W +
Sbjct: 499 DFRFLEQKIRHDSTAWNASG 518
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 2e-04
Identities = 82/615 (13%), Positives = 157/615 (25%), Gaps = 193/615 (31%)
Query: 125 LLPGMKLGWDFK--TGLERRITSWKSSDD----PSPGDFIWKIERQFYPELVMW----KG 174
+D K + + I S + D + W K
Sbjct: 25 FEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDA-------VSGTL--RLFWTLLSKQ 75
Query: 175 SRKFYRTGPWNGLIFSASSLRLNPIF---KYRFVFNEDELYYTFYLTDKDVISRTVMNQT 231
+ F LR+N F + + + Y+ +D + N
Sbjct: 76 EEMVQK--------FVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRL----YNDN 123
Query: 232 VSLRQRFIWRKANQSWELYSNLPKDQCDTY-GLCGAYGI---CIISQSPICQCLEGFHPK 287
+ + R +L L + + + G G + +C K
Sbjct: 124 QVFAKYNVSRL-QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALD--VCLS-YKVQCK 179
Query: 288 SGGYVDW-SQG---------------CVHNKPLNYSRKDGFIKFSELKLP-DSTSSWVSK 330
+ W + P SR D S +KL S + + +
Sbjct: 180 MDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHS---SNIKLRIHSIQAELRR 236
Query: 331 SMNLKECREKCL------ENSSCM-AYTNSDITRGGSGCVMWFGDLIDMRN-----FQDG 378
+ K E CL +N+ A+ ++ C + L+ R F
Sbjct: 237 LLKSKP-YENCLLVLLNVQNAKAWNAF---NL-----SCKI----LLTTRFKQVTDFLSA 283
Query: 379 GQDLYIRMSASELGGNNRRTDQENEDQNEDL----------ELPL-------FELATIA- 420
+I + + D+ + L +LP L+ IA
Sbjct: 284 ATTTHISLDHHSMT--------LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAE 335
Query: 421 ------NATDNF--------------SINKKLGEGGFGPVYKGTLA---DGQEIAHRNLV 457
DN+ S+N L + ++ L+ I L
Sbjct: 336 SIRDGLATWDNWKHVNCDKLTTIIESSLNV-LEPAEYRKMFD-RLSVFPPSAHIPTILLS 393
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSL------------DSFIFDQTK---------RKLLD- 495
L+ + + +++ + SL S + R ++D
Sbjct: 394 -LIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDH 452
Query: 496 --WSKRFC---IICGTARGLLYLH---HDSRLRIIHRDLKASNVLLDHE-MNPKISDFGL 546
K F +I Y H H + R V LD + KI
Sbjct: 453 YNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDST 512
Query: 547 ARTFVGD----------------EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGI 590
A G + + +R+V P+ + + S +D+ +
Sbjct: 513 AWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIAL 572
Query: 591 LLLEIVSGKKNRGFY 605
+ ++ +
Sbjct: 573 M-------AEDEAIF 580
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 6e-08
Identities = 23/117 (19%), Positives = 43/117 (36%), Gaps = 19/117 (16%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
L G +L G + + + + Y N VW + + VL
Sbjct: 9 QLDTGGSLAE--GGYLFIIQNDCNL------VLYDN---NRAVWASGTNGKASGC--VLK 55
Query: 61 VNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQS 117
+ GNLV+ S ++ +W++N + L L N+V+ +S +W +
Sbjct: 56 MQNDGNLVIYSGSR-AIWASN-TNRQNGNYYLILQRDRNVVIY----DNSNNAIWAT 106
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 32/172 (18%), Positives = 59/172 (34%), Gaps = 46/172 (26%)
Query: 412 PLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA------------------ 452
++ A D ++ LG G G V + ++ A
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHW 65
Query: 453 ----HRNLVKLLGCC---IQGEEKL-LIYEFMPNRSLDSFIFDQ-TKRKLLDWSKR---- 499
++V+++ G + L ++ E + L F + R +++R
Sbjct: 66 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASE 121
Query: 500 -FCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE---MNPKISDFGLA 547
I + YLH + I HRD+K N+L + K++DFG A
Sbjct: 122 IMKSIGEA---IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 18/199 (9%), Positives = 39/199 (19%), Gaps = 67/199 (33%)
Query: 431 KLGEGGFGPVYKGT-----------------LADGQEIA-------------HRNLVKLL 460
G ++ + + + ++L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 461 GCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLR 520
L++ E++ SL + A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 521 IIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFS 580
+ S V +S G V+ M +
Sbjct: 150 VALSIDHPSRVR--------VSIDGDV--------------VLAYPATMPDA-------N 180
Query: 581 VKSDVFSFGILLLEIVSGK 599
+ D+ G L ++ +
Sbjct: 181 PQDDIRGIGASLYALLVNR 199
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 37/156 (23%), Positives = 64/156 (41%), Gaps = 35/156 (22%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA---------HRNLV---------------- 457
+ + + +K+G G FG +Y GT +A G+E+A H L
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS 517
+ C +G+ +++ E + SL+ +F+ RK + + Y+H +
Sbjct: 69 TIRWCGAEGDYNVMVMELL-GPSLED-LFNFCSRKF-SLKTVLLLADQMISRIEYIHSKN 125
Query: 518 RLRIIHRDLKASNVLLDHEMNPK---ISDFGLARTF 550
IHRD+K N L+ I DFGLA+ +
Sbjct: 126 ---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 7e-07
Identities = 17/78 (21%), Positives = 29/78 (37%), Gaps = 10/78 (12%)
Query: 40 KTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGN 99
+W N N V+ G LV+ + VW + ++ + VL L N
Sbjct: 48 NNPIWATNTGGLGNGCR--AVLQPDGVLVVITNENVTVWQSPVAGK-AGHYVLVLQPDRN 104
Query: 100 LVLRGERDGDSETYLWQS 117
+V+ G+ LW +
Sbjct: 105 VVIYGDA-------LWAT 115
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-06
Identities = 25/117 (21%), Positives = 40/117 (34%), Gaps = 21/117 (17%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
+LS G L + G + + + Y +W N D L
Sbjct: 9 TLSPGEFLNN--GRYVFIMQEDCNL------VLYDV---DKPIWATNTGG--LDRRCHLS 55
Query: 61 VNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQS 117
+ GNLV+ S + +W++N E V L N+V+ G T W +
Sbjct: 56 MQSDGNLVVYSPRNNPIWASNTGGE-NGNYVCVLQKDRNVVIYG-------TARWAT 104
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 8/93 (8%)
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNP--KISDFGLARTFVGDEIEGSTKRVVGTY 566
LL+L L IIH DLK N+LL + KI DFG + +G I + +
Sbjct: 169 ALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRI--YQ--YIQSR 222
Query: 567 GYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
Y +PE + + D++S G +L+E+ +G+
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 10/93 (10%)
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNP--KISDFGLARTFVGDEIEGSTKRVVGTY 566
L LH + RIIH DLK N+LL + K+ DFG + + + T + +
Sbjct: 212 CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRV--YT--YIQSR 263
Query: 567 GYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
Y APE + + D++S G +L E+++G
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 31/164 (18%), Positives = 66/164 (40%), Gaps = 49/164 (29%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA---------HRNLV---------------- 457
++ + +++GEG FG +++GT L + Q++A L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCI--ICGTARGLL---- 511
+ +G +L+ + + SL+ + D RK F + + A+ +L
Sbjct: 70 NVYYFGQEGLHNVLVIDLLG-PSLED-LLDLCGRK-------FSVKTVAMAAKQMLARVQ 120
Query: 512 YLHHDSRLRIIHRDLKASNVLLDHEMNPK-----ISDFGLARTF 550
+H S +++RD+K N L+ + + DFG+ + +
Sbjct: 121 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 37/208 (17%), Positives = 66/208 (31%), Gaps = 74/208 (35%)
Query: 425 NFSINKKLGEGGFGPVYKGT-LADGQEIAH--------------------RNLVKLLGCC 463
+ + KK+G GGFG +Y ++ A + + K
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 464 IQGEEKLLIYEFMPN-----------------------RSLDSFIFDQTKRKLLDWSKRF 500
E K L Y +P L K+ + F
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQ---------KISGQNGTF 148
Query: 501 CI--ICGTARGLL----YLHHDSRLRIIHRDLKASNVLLDHEMNPKI--SDFGLARTFVG 552
+ +L Y+H + +H D+KA+N+LL ++ ++ +D+GL+ +
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP 205
Query: 553 DE-----IEGSTKRVVGTYGYMAPEYAS 575
+ E K GT E+ S
Sbjct: 206 NGNHKQYQENPRKGHNGT-----IEFTS 228
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 5e-06
Identities = 24/128 (18%), Positives = 44/128 (34%), Gaps = 29/128 (22%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
+L L + G F+L N+ + W +N N N L
Sbjct: 11 TLDTEGHLKN--GDFDLVMQDDC------------NLVLYNGNWQSNTAN--NGRDCKLT 54
Query: 61 VNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDY 120
+ G LV+ + + S VW + ++ V+ + G LV+ G +++
Sbjct: 55 LTDYGELVIKNGDGSTVWKSG-AQSVKGNYAAVVHPDGRLVVFG-------PSVFK---- 102
Query: 121 PSDTLLPG 128
D + G
Sbjct: 103 -IDPWVRG 109
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 36/163 (22%), Positives = 60/163 (36%), Gaps = 49/163 (30%)
Query: 425 NFSINKKLGEGGFGPVYKGT-LADGQEIA---------HRNLV----------------K 458
NF + KK+G G FG + G L + +A L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQ 69
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCI--ICGTARGLL----Y 512
+ G+ ++ E + SL+ +FD R F + + A L+ Y
Sbjct: 70 VYYFGPCGKYNAMVLELL-GPSLED-LFDLCDRT-------FSLKTVLMIAIQLISRMEY 120
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPK-----ISDFGLARTF 550
+H + +I+RD+K N L+ N I DF LA+ +
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-05
Identities = 20/102 (19%), Positives = 35/102 (34%), Gaps = 15/102 (14%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
L L + + +L + + Y W +N N L
Sbjct: 14 VLYGDGRLTA--KNHQLVMQGDCNL------VLYGG----KYGWQSNTHG--NGEHCFLR 59
Query: 61 VNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVL 102
+N G L++ + +WS+ S + + VL L D G V+
Sbjct: 60 LNHKGELIIKDDDFKTIWSSRSSSK-QGEYVLILQDDGFGVI 100
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 36/158 (22%), Positives = 66/158 (41%), Gaps = 39/158 (24%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA---------HRNLV---------------- 457
+ F + +K+G G FG +Y GT + +E+A H L+
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKR--FCIICGTARGLLYLHH 515
+ ++G+ +L+ + + SL+ +F+ RKL S + + + ++H
Sbjct: 67 NVRWFGVEGDYNVLVMDLL-GPSLED-LFNFCSRKL---SLKTVLMLADQMINRVEFVHS 121
Query: 516 DSRLRIIHRDLKASNVLLDHEMNPK---ISDFGLARTF 550
S +HRD+K N L+ I DFGLA+ +
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 31/204 (15%), Positives = 61/204 (29%), Gaps = 63/204 (30%)
Query: 425 NFSINKKLGEGGFGPVYKGT---------LADGQEIA----HRN---------------- 455
+ + G +Y+ Q+ + ++
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 456 --------LVKLLGCCI---------QGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSK 498
L I Q + + L+ + RSL S D + + +L
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSERS 160
Query: 499 RFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKI--SDFGLARTFV--GDE 554
+ C L +LH + +H ++ A N+ +D E ++ + +G A + G
Sbjct: 161 VLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
Query: 555 I---EGSTKRVVGTYGYMAPEYAS 575
+ EGS G E+ S
Sbjct: 218 VAYVEGSRSPHEGD-----LEFIS 236
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 2e-04
Identities = 18/117 (15%), Positives = 37/117 (31%), Gaps = 19/117 (16%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
+ D L + + L + + K +VW + +
Sbjct: 14 VMYDNAQLAT--RDYSLVMRDDCNL------VLTKG-SKTNIVWESGTSG--RGQHCFMR 62
Query: 61 VNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQS 117
+ +G L +T + V+ +N + VL L +G V+ G +W +
Sbjct: 63 LGHSGELDITDDRLNTVFVSNTVGQ-EGDYVLILQINGQAVVYG-------PAVWST 111
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 39/117 (33%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP-------------------KISDFGLAR 548
L +LH ++ H DLK N+L + +++DFG A
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 189
Query: 549 TFVGDEIEGSTKRVVGTYGYMAPE------YASDGLFSVKSDVFSFGILLLEIVSGK 599
TF + +T +V T Y PE + + DV+S G +L E G
Sbjct: 190 TFDHEHH--TT--IVATRHYRPPEVILELGW------AQPCDVWSIGCILFEYYRGF 236
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 33/206 (16%), Positives = 63/206 (30%), Gaps = 67/206 (32%)
Query: 425 NFSINKKLGEGGFGPVYKGT------LADGQEIA-----------------HRNLVKLLG 461
+ + +G+GGFG +Y + ++ K
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 462 CCIQGEEKLLIYEFMPN-----------------------RSLDSFIFDQTKRKLLDWSK 498
+ L Y +P L I++ ++ S+
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK-IYEANAKRF---SR 151
Query: 499 R--FCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKI--SDFGLARTF---- 550
+ + L Y+H +H D+KASN+LL+++ ++ D+GLA +
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 551 VGDEI-EGSTKRVVGTYGYMAPEYAS 575
V + GT E+ S
Sbjct: 209 VHKAYAADPKRCHDGT-----IEFTS 229
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 32/167 (19%), Positives = 52/167 (31%), Gaps = 67/167 (40%)
Query: 493 LLDWSKRF-----------CIICGTARGLLYLHHDSRLRIIHRDLKASNVLL-------- 533
LL W + II +GL YLH ++ RIIH D+K N+LL
Sbjct: 131 LLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIR 188
Query: 534 -----------------------------------------DHEMNPKISDFGLARTFVG 552
++ KI+D G A +V
Sbjct: 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC-WVH 247
Query: 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+ T Y + E ++ +D++S + E+ +G
Sbjct: 248 KHFTED----IQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 40.8 bits (94), Expect = 8e-04
Identities = 29/143 (20%), Positives = 45/143 (31%), Gaps = 13/143 (9%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSS--KNRYVGIWYKNMPVKTVVWVANRINPINDSSGV 58
+LS G+ L+S F+L G+ ++ +W N + R +
Sbjct: 22 TLSAGQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFSSTIPLR-----NKKAP 76
Query: 59 LVVNKTGNLVLTSQNKSVVW----SANLSKEVRTPVVLQLLDSGNLVLRGERDG--DSET 112
L L ++ VW S S + L L D GN+VL +
Sbjct: 77 LAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVDSLALWNGTPA 136
Query: 113 YLWQSFDYPSDTLLPGMKLGWDF 135
S L PG +L
Sbjct: 137 IPLVPGAIDSLLLAPGSELVQGV 159
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 9e-04
Identities = 30/117 (25%), Positives = 44/117 (37%), Gaps = 39/117 (33%)
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP-------------------KISDFGLAR 548
+ + +LH ++ H DLK N+L K+ DFG A
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA- 184
Query: 549 TFVGDEIEGSTKRVVGTYGYMAPE------YASDGLFSVKSDVFSFGILLLEIVSGK 599
T+ + ST +V T Y APE + S DV+S G +L+E G
Sbjct: 185 TYDDEHH--ST--LVSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYYLGF 231
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 40.7 bits (94), Expect = 9e-04
Identities = 15/78 (19%), Positives = 23/78 (29%), Gaps = 10/78 (12%)
Query: 40 KTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGN 99
VW N VL G + + + VW++ + V L N
Sbjct: 168 DDRVWSTNTAGKGTGCRAVL--QPNGRMDVLTNQNIAVWTSG-NSRSAGRYVFVLQPDRN 224
Query: 100 LVLRGERDGDSETYLWQS 117
L + G LW +
Sbjct: 225 LAIYGGA-------LWTT 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 717 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.98 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.98 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.98 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.98 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.98 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.86 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.78 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.76 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.76 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.76 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.71 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.67 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.64 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.63 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.6 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.55 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.54 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.51 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.51 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.5 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.47 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.36 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.23 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.19 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.17 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.98 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.98 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 98.98 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.91 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.77 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.72 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.52 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.44 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.36 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.03 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.51 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.09 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 96.8 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.65 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.57 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.48 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 95.58 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.55 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.39 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 93.25 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 92.22 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 89.89 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.8 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 86.25 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 84.42 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 82.92 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 82.66 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 81.4 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 80.33 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=401.81 Aligned_cols=234 Identities=26% Similarity=0.410 Sum_probs=178.1
Q ss_pred cCcccccccccCCccceEeeeeCCchh--------------------------hhhhhhhhhcceeecCceeeEEEeccC
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQE--------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~--------------------------vah~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
+++.+.++||+|+||+||+|+++.... +.|||||++++++.+ +..+||||||+
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~ 114 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCE 114 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence 567888999999999999998754311 119999999998865 56899999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+|+|.+++... ...+++..++.|+.||++||+|||+++ ||||||||+||||++++.+||+|||+|+.........
T Consensus 115 gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 115 GSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp SCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 99999999543 346899999999999999999999998 9999999999999999999999999998765443333
Q ss_pred ccceecccccccCcccccc---CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 558 STKRVVGTYGYMAPEYASD---GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
.....+||+.|||||++.+ .+|+.++|||||||++|||++|+.||...... ..+ ......+.....+.. .
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~---~~~---~~~~~~~~~~p~~~~-~ 262 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR---DQI---IFMVGRGYASPDLSK-L 262 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHH---HHHHHTTCCCCCSTT-S
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH---HHH---HHHHhcCCCCCCccc-c
Confidence 4456789999999999864 46899999999999999999999998643322 111 111222211110000 1
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
+......+.+|+.+||+.||++|||+.||+++|+.+
T Consensus 263 ----~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 263 ----YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ----cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111224567889999999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=403.93 Aligned_cols=233 Identities=27% Similarity=0.408 Sum_probs=188.6
Q ss_pred cCcccccccccCCccceEeeeeCC------chhhh---------------------------hhhhhhhcceeecCceee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD------GQEIA---------------------------HRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~va---------------------------h~niv~l~~~~~~~~~~~ 470 (717)
.++++.++||+|+||.||+|++.. ++.|| |||||++++++.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 356778899999999999998631 22222 999999999999999999
Q ss_pred EEEeccCCCChhhHhhhcc-------------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC
Q 039318 471 LIYEFMPNRSLDSFIFDQT-------------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM 537 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~ 537 (717)
||||||++|+|.++|.... ....+++..++.|+.||++||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999996532 1346899999999999999999999998 99999999999999999
Q ss_pred CceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHH
Q 039318 538 NPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGH 616 (717)
Q Consensus 538 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~ 616 (717)
.+||+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||..... ..++
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~-- 257 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVV-- 257 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHH--
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHH--
Confidence 999999999997654443334455789999999999999999999999999999999998 8999875432 1222
Q ss_pred HHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 617 AWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 617 ~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
..+..+..... +......+.+|+.+||+.||++|||+.||++.|+...
T Consensus 258 --~~i~~~~~~~~---------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 258 --EMIRNRQVLPC---------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp --HHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --HHHHcCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 22222222111 1112345778999999999999999999999998654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=402.72 Aligned_cols=233 Identities=26% Similarity=0.439 Sum_probs=187.0
Q ss_pred cCcccccccccCCccceEeeeeCC------chhhh--------------------------hhhhhhhcceeecCceeeE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD------GQEIA--------------------------HRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~va--------------------------h~niv~l~~~~~~~~~~~l 471 (717)
++|.+.++||+|+||.||+|++.. +..|| |||||++++++.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 578889999999999999998642 22222 9999999999999999999
Q ss_pred EEeccCCCChhhHhhhcc----------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCcee
Q 039318 472 IYEFMPNRSLDSFIFDQT----------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKI 541 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl 541 (717)
|||||++|+|.++|.... ....+++..++.|+.||++||+|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996532 2346899999999999999999999998 999999999999999999999
Q ss_pred ccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHH
Q 039318 542 SDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKL 620 (717)
Q Consensus 542 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 620 (717)
+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||...... .++. .
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~----~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE----C 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHH----H
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----H
Confidence 99999987654443333445679999999999999999999999999999999998 89998753321 2221 1
Q ss_pred hhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 621 WNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 621 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
+..+..... +.....++.+|+.+||+.||++|||+++|+++|+...
T Consensus 243 i~~~~~~~~---------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 243 ITQGRVLQR---------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 112221111 1112245778999999999999999999999997653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=407.45 Aligned_cols=234 Identities=25% Similarity=0.428 Sum_probs=180.3
Q ss_pred cCcccccccccCCccceEeeeeCC------chhhh--------------------------hhhhhhhcceeecCceeeE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD------GQEIA--------------------------HRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~va--------------------------h~niv~l~~~~~~~~~~~l 471 (717)
++|.+.++||+|+||.||+|+++. ++.|| |||||+++++|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 467888999999999999998642 22222 9999999999999999999
Q ss_pred EEeccCCCChhhHhhhcc------------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCc
Q 039318 472 IYEFMPNRSLDSFIFDQT------------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP 539 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~ 539 (717)
|||||++|+|.+++.... ....++|.+++.|+.||++||+|||+++ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999996542 2346899999999999999999999988 9999999999999999999
Q ss_pred eeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHH
Q 039318 540 KISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAW 618 (717)
Q Consensus 540 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~ 618 (717)
||+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||...... ..+..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~-- 272 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAIDC-- 272 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHHHH--
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHHHH--
Confidence 9999999997654443334445789999999999999999999999999999999999 99998753322 22211
Q ss_pred HHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCC
Q 039318 619 KLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM 676 (717)
Q Consensus 619 ~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~ 676 (717)
+..+..... ... ....+.+|+.+||+.||++|||+.||+++|+....
T Consensus 273 --i~~g~~~~~-----p~~----~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 273 --ITQGRELER-----PRA----CPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp --HHHTCCCCC-----CTT----CCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --HHcCCCCCC-----ccc----ccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 111211111 111 12356789999999999999999999999987654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=395.92 Aligned_cols=230 Identities=23% Similarity=0.274 Sum_probs=183.3
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh---------------------hhhhhhhcceeecCceeeEEEeccCCCCh
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA---------------------HRNLVKLLGCCIQGEEKLLIYEFMPNRSL 481 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va---------------------h~niv~l~~~~~~~~~~~lV~E~~~~gsL 481 (717)
+.|++.++||+|+||.||+|+++. ++.+| |||||++++++.+++..+||||||++|+|
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 568888999999999999999764 33333 99999999999999999999999999999
Q ss_pred hhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC-CceeccccccccccCCcccc---
Q 039318 482 DSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM-NPKISDFGLARTFVGDEIEG--- 557 (717)
Q Consensus 482 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~~~--- 557 (717)
.+++.+ .+.+++..+..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+.+.......
T Consensus 138 ~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 138 GQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp HHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 999954 346899999999999999999999998 99999999999999987 69999999999765432211
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhcc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 637 (717)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+ ..+..... .
T Consensus 212 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~~~~~--------~ 277 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------ASEPPPIR--------E 277 (336)
T ss_dssp --CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH------HHSCCGGG--------G
T ss_pred cCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------HcCCCCch--------h
Confidence 223468999999999999999999999999999999999999999755443322211 11111100 0
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
.+......+.+++.+||+.||++|||+.|+++.|..
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 111122456788999999999999999999987643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=392.71 Aligned_cols=222 Identities=23% Similarity=0.307 Sum_probs=183.3
Q ss_pred cCcccccccccCCccceEeeeeCCc-hhhh-----------------------------hhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QEIA-----------------------------HRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~va-----------------------------h~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||+||+|+.+.. +.+| |||||++++++.+.+..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999987542 2222 999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
|||++|+|.+++.+ .+.+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999954 346899999999999999999999998 999999999999999999999999999987654
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
.........+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ..+... ..... . .+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~---i~~~~-~-~~---- 253 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLIFAK---IIKLE-Y-DF---- 253 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH---HHHTC-C-CC----
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH---HHcCC-C-CC----
Confidence 444445568999999999999999999999999999999999999999964321 122111 11111 1 11
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVI 668 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl 668 (717)
.... ..++.+|+.+||+.||++|||++|++
T Consensus 254 -p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 -PEKF----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -CTTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -Cccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1111 23567899999999999999999863
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=396.87 Aligned_cols=224 Identities=23% Similarity=0.370 Sum_probs=176.7
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh----------------------------hhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------------HRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va----------------------------h~niv~l~~~~~~~~~~~lV~E 474 (717)
++|+++++||+|+||.||+|+... ++.+| |||||++++++.+.+..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 689999999999999999998753 32222 9999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
||++|+|.++|..+ ....+++..++.++.||+.||.|||+++ ||||||||+||||++++.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999543 3445788899999999999999999998 9999999999999999999999999999764321
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
......+||+.|||||++.+..|+.++||||||||+|||++|+.||..... ..++ .+....... .+
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~---~~i~~~~~~-~~----- 245 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNLV---LKIISGSFP-PV----- 245 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH---HHHHHTCCC-CC-----
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHH---HHHHcCCCC-CC-----
Confidence 123457899999999999999999999999999999999999999974322 1121 122222211 11
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+......+.+|+.+||+.||++|||++|+++
T Consensus 246 ----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 ----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111235678999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=388.99 Aligned_cols=243 Identities=21% Similarity=0.276 Sum_probs=182.7
Q ss_pred cCcccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCc----eeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGE----EKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~----~~~lV~E 474 (717)
++|.+.++||+|+||.||+|+++ ++.|| |||||++++++.+.+ ..+||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 56888899999999999999985 33333 999999999998764 5799999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcC-----CCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS-----RLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
||++|+|.+++.. ..+++..+++++.|+++||+|||++. +.+||||||||+||||+.++.+||+|||+|+.
T Consensus 82 y~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999999999953 35899999999999999999999871 23599999999999999999999999999987
Q ss_pred ccCCccc--cccceecccccccCccccccC------CCCccccchhHhHHHHHhhcCCCCCCCCCCCCc--------hhH
Q 039318 550 FVGDEIE--GSTKRVVGTYGYMAPEYASDG------LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKN--------LNL 613 (717)
Q Consensus 550 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~--------~~~ 613 (717)
....... ......+||+.|||||++.+. .++.++|||||||++|||++|++|+........ ...
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 6443221 223346899999999999764 467899999999999999999988754322110 011
Q ss_pred HHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 614 IGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.........+......+.. ...+.+....+.+|+.+||+.||++||||.||+++|+.+
T Consensus 238 ~~~~~~~~~~~~~rp~~p~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhcccCCCCCCc---cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1122222222221111111 112234556788999999999999999999999999754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=400.11 Aligned_cols=242 Identities=29% Similarity=0.452 Sum_probs=191.8
Q ss_pred cHHHHHHHhcCcccccccccCCccceEeeeeCCc------hhhh----------------------------hhhhhhhc
Q 039318 415 ELATIANATDNFSINKKLGEGGFGPVYKGTLADG------QEIA----------------------------HRNLVKLL 460 (717)
Q Consensus 415 ~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~va----------------------------h~niv~l~ 460 (717)
+..+++...++|++.++||+|+||.||+|++... +.|| |||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 4444555568899999999999999999975421 1111 59999999
Q ss_pred ceeec-CceeeEEEeccCCCChhhHhhhccc-------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccC
Q 039318 461 GCCIQ-GEEKLLIYEFMPNRSLDSFIFDQTK-------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDL 526 (717)
Q Consensus 461 ~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDl 526 (717)
++|.+ ++..+||||||++|+|.++|+.... ...+++..++.++.|||+||+|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 99876 4578999999999999999965322 345899999999999999999999998 999999
Q ss_pred CCCceEEcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCC
Q 039318 527 KASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFY 605 (717)
Q Consensus 527 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~ 605 (717)
||+||||++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999997755444344456789999999999999999999999999999999998 99998754
Q ss_pred CCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 606 HSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
..... ....+.++...... .. ...++.+++.+||+.||++|||+.||++.|+..
T Consensus 292 ~~~~~------~~~~i~~g~~~~~p-----~~----~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 292 KIDEE------FCRRLKEGTRMRAP-----DY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCSHH------HHHHHHHTCCCCCC-----TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHH------HHHHHHcCCCCCCC-----cc----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 33221 11222222211111 11 123577889999999999999999999998654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=392.67 Aligned_cols=223 Identities=24% Similarity=0.378 Sum_probs=181.9
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh--------------------------hhhhhhhcceeecCceeeEEEecc
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA--------------------------HRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va--------------------------h~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
..|++.++||+|+||.||+|+.+. ++.+| |||||++++++.+.+..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 569999999999999999998764 33232 999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
++|+|.+++.+ ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 224 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 224 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence 99999999843 35899999999999999999999998 9999999999999999999999999999764432
Q ss_pred cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 557 GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
......+||+.|||||++.+..|+.++||||||||+|||++|+.||..... ...+... .......+.. ..
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i----~~~~~~~~~~---~~ 294 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMI----RDNLPPRLKN---LH 294 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHH----HHSSCCCCSC---GG
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHH----HcCCCCCCCc---cc
Confidence 223457899999999999999999999999999999999999999864322 2222111 1111111100 00
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.....+.+|+.+||+.||++|||++|+++
T Consensus 295 ----~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 295 ----KVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp ----GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11235678999999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=376.03 Aligned_cols=220 Identities=24% Similarity=0.399 Sum_probs=172.7
Q ss_pred ccccccccCCccceEeeeeCCc-hhhh----------------------------hhhhhhhcceeec----CceeeEEE
Q 039318 427 SINKKLGEGGFGPVYKGTLADG-QEIA----------------------------HRNLVKLLGCCIQ----GEEKLLIY 473 (717)
Q Consensus 427 ~~~~~lG~G~fg~Vy~~~~~~~-~~va----------------------------h~niv~l~~~~~~----~~~~~lV~ 473 (717)
++.++||+|+||.||+|++... ..+| |||||++++++.+ .+..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5667899999999999987542 2222 9999999999865 35689999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc-CCCCceeccccccccccC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD-HEMNPKISDFGLARTFVG 552 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~Dfgla~~~~~ 552 (717)
|||++|+|.+++.+ .+.+++..+..++.||++||+|||+++ .+|+||||||+||||+ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999954 346899999999999999999999875 3599999999999997 479999999999986432
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
. .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||...... . ........+......
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~---~---~~~~~i~~~~~~~~~-- 251 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA---A---QIYRRVTSGVKPASF-- 251 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---H---HHHHHHTTTCCCGGG--
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH---H---HHHHHHHcCCCCCCC--
Confidence 2 2346789999999999875 6999999999999999999999998632211 1 112222222211111
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
....+ .++.+|+.+||+.||++|||++|+++
T Consensus 252 --~~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 --DKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112 24678899999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=382.93 Aligned_cols=221 Identities=25% Similarity=0.315 Sum_probs=177.3
Q ss_pred cCcccccccccCCccceEeeeeCC----chhhh----------------------------hhhhhhhcceeecCceeeE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD----GQEIA----------------------------HRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~va----------------------------h~niv~l~~~~~~~~~~~l 471 (717)
++|++.+.||+|+||+||+|+... ++.+| |||||++++++.+.+..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 579999999999999999997632 22222 9999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
|||||++|+|.+++.+ .+.+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999954 346899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...... ..... ..... .. +
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~---i~~~~-~~-~-- 245 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---ETMTM---ILKAK-LG-M-- 245 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HHHCC-CC-C--
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---HHHHH---HHcCC-CC-C--
Confidence 322 2234578999999999999999999999999999999999999999743221 22211 11111 10 0
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCCh-----HHHHH
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCM-----PSVIL 669 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~-----~evl~ 669 (717)
.... ...+.+|+.+||+.||++|||+ +|+++
T Consensus 246 ---p~~~----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 246 ---PQFL----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ---CTTS----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ---CCcC----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1111 2356789999999999999984 56665
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=394.47 Aligned_cols=224 Identities=24% Similarity=0.376 Sum_probs=182.3
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhhh--------------------------hhhhhhhcceeecCceeeEEEec
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEIA--------------------------HRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va--------------------------h~niv~l~~~~~~~~~~~lV~E~ 475 (717)
.+.|++.++||+|+||.||+|+.+. ++.+| |||||++++++.+.+..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 3579999999999999999998764 33222 99999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
|++|+|.+++.. ..+++..+..++.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 999999999843 34899999999999999999999998 9999999999999999999999999998764432
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ...+.. +.......+.. .
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~----i~~~~~~~~~~---~ 370 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKM----IRDNLPPRLKN---L 370 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHH----HHHSCCCCCSC---T
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHH----HHcCCCCCCcc---c
Confidence 223467899999999999999999999999999999999999999864322 222211 11111111100 0
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.. ....+.+|+.+||+.||++|||+.|+++
T Consensus 371 ~~----~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 HK----VSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TS----SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01 1235678899999999999999999987
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=372.24 Aligned_cols=219 Identities=27% Similarity=0.396 Sum_probs=166.0
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh-----------------------------hhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA-----------------------------HRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va-----------------------------h~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||+||+|+... ++.+| |||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 689999999999999999998653 22222 999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||| +|+|.+++.+ .+.+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6799999854 346899999999999999999999998 999999999999999999999999999875432
Q ss_pred ccccccceecccccccCccccccCCC-CccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
. .....+||+.|||||++.+..+ +.++|||||||++|||++|+.||..... ..+.. ....+... +
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~~~----~i~~~~~~-~--- 231 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVLFK----NISNGVYT-L--- 231 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHTCCC-C---
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHH----HHHcCCCC-C---
Confidence 2 2335789999999999998886 5899999999999999999999964321 11111 11111111 1
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.... ...+.+|+.+||+.||++|||++|+++
T Consensus 232 --p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 --PKFL----SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --CTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCCC----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111 235678899999999999999999987
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=368.30 Aligned_cols=225 Identities=24% Similarity=0.331 Sum_probs=165.0
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh---------------------------hhhhhhhcceeecCc--------
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA---------------------------HRNLVKLLGCCIQGE-------- 467 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va---------------------------h~niv~l~~~~~~~~-------- 467 (717)
++|++++.||+|+||+||+|+.+. ++.+| |||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 469999999999999999998753 22222 999999999987654
Q ss_pred ----eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecc
Q 039318 468 ----EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISD 543 (717)
Q Consensus 468 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 543 (717)
..++|||||++|+|.+++.........++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999966544445666778899999999999999998 99999999999999999999999
Q ss_pred ccccccccCCcccc----------ccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhH
Q 039318 544 FGLARTFVGDEIEG----------STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNL 613 (717)
Q Consensus 544 fgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~ 613 (717)
||+|+.+....... .....+||+.|||||++.+..|+.++|||||||++|||++ ||.. ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~-----~~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-----QMER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS-----HHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC-----ccHH
Confidence 99998765432211 1234689999999999999999999999999999999996 6532 1111
Q ss_pred HHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 614 IGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
... ............. ......+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~-~~~~~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRT-LTDVRNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHH-HHHHHTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH-HHHHhcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 1111122111111 112234567899999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=366.77 Aligned_cols=174 Identities=26% Similarity=0.413 Sum_probs=148.1
Q ss_pred HHhcCcccccccccCCccceEeeeeC----Cchhhh-------------------------hhhhhhhcceeecCceeeE
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLA----DGQEIA-------------------------HRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~va-------------------------h~niv~l~~~~~~~~~~~l 471 (717)
...++|++.++||+|+||+||+|+.+ .++.+| |||||++++++.+.++.+|
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 34678999999999999999999753 122222 9999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC-CCceeccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE-MNPKISDFGLARTF 550 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~Dfgla~~~ 550 (717)
|||||++|+|.+++. .+++..+..++.||+.||+|||+++ |+||||||+||||+.+ +.+||+|||+|+..
T Consensus 98 vmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 98 AMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 999999999999882 3889999999999999999999998 9999999999999877 79999999999865
Q ss_pred cCCccc--------------------------cccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCC
Q 039318 551 VGDEIE--------------------------GSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRG 603 (717)
Q Consensus 551 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~ 603 (717)
...... ......+||+.|||||++.+. .|+.++||||+|||+|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 332110 112345799999999999876 48999999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=355.58 Aligned_cols=267 Identities=42% Similarity=0.678 Sum_probs=224.7
Q ss_pred CCCCcccHHHHHHHhcCcccccccccCCccceEeeeeCCchhhh---------------------------hhhhhhhcc
Q 039318 409 LELPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA---------------------------HRNLVKLLG 461 (717)
Q Consensus 409 ~~~~~~~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va---------------------------h~niv~l~~ 461 (717)
..+..+++.++....++|++.+.||+|+||.||+|+..+++.+| ||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34567899999999999999999999999999999876554333 999999999
Q ss_pred eeecCceeeEEEeccCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCce
Q 039318 462 CCIQGEEKLLIYEFMPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPK 540 (717)
Q Consensus 462 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~k 540 (717)
++.+.+..++||||+++++|.+++.... ....+++..+..++.|++.||+|||++...+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999996543 334589999999999999999999999222299999999999999999999
Q ss_pred eccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCC--CCCchhHHHHHH
Q 039318 541 ISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYH--SDKNLNLIGHAW 618 (717)
Q Consensus 541 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~--~~~~~~~~~~~~ 618 (717)
|+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... .........+..
T Consensus 175 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 175 VGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp ECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred eccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 999999987643322 22334569999999999999999999999999999999999999996322 223334445555
Q ss_pred HHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCC
Q 039318 619 KLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM 676 (717)
Q Consensus 619 ~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~ 676 (717)
..........+.+..............+.+++.+||+.||.+|||+.||+++|++...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 5566667777778777778888889999999999999999999999999999987643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=355.72 Aligned_cols=256 Identities=35% Similarity=0.605 Sum_probs=216.6
Q ss_pred HHHHHHhcCcccccccccCCccceEeeeeCCchhhh--------------------------hhhhhhhcceeecCceee
Q 039318 417 ATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA--------------------------HRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 417 ~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va--------------------------h~niv~l~~~~~~~~~~~ 470 (717)
.++...+++|++.+.||+|+||.||+|++++++.++ ||||+++++++.+.+..+
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 344556789999999999999999999976554332 999999999999999999
Q ss_pred EEEeccCCCChhhHhhhccc-cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTK-RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
+||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999999954322 235899999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 550 FVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 550 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
..............||+.|+|||++.+..++.++||||||+++|||++|+.||......+......+.......+.....
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 54332222333467899999999999999999999999999999999999999876666555556555555556666677
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
+++.............+.+++.+||+.||++|||+.||++.|+...
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 7777776777888889999999999999999999999999997654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=382.90 Aligned_cols=223 Identities=24% Similarity=0.314 Sum_probs=180.5
Q ss_pred hcCcccccccccCCccceEeeeeCCch-hhh--------------------------------hhhhhhhcceeecCcee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ-EIA--------------------------------HRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~va--------------------------------h~niv~l~~~~~~~~~~ 469 (717)
.++|++.+.||+|+||.||+|+.+... .+| |||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 368999999999999999999876432 111 99999999999999999
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
|||||||+||+|.++|.+ .+.+++..+..++.||+.||.|||+++ ||||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999954 346899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 550 FVGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 550 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
+.... ..+.+||+.|||||++.+ ..|+.++||||||||+|||++|+.||......+...+.. ....... .
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~i~~~~~--~ 412 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTLTMAV--E 412 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---HHHHCCC--C
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hhcCCCC--C
Confidence 64332 345789999999999964 579999999999999999999999997544333222111 1111111 0
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHH
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPC-----MPSVIL 669 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----~~evl~ 669 (717)
+ .... ...+.+|+.+||+.||.+|++ ++||++
T Consensus 413 ~-----p~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 413 L-----PDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp C-----CTTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred C-----CccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0 1111 235678999999999999998 577765
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=365.76 Aligned_cols=236 Identities=22% Similarity=0.312 Sum_probs=177.6
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhhh----------------------------hhhhhhhcceeec------Cc
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------------HRNLVKLLGCCIQ------GE 467 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va----------------------------h~niv~l~~~~~~------~~ 467 (717)
.++|++.+.||+|+||+||+|+.+. ++.+| |||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 3689999999999999999998753 32222 9999999998753 46
Q ss_pred eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla 547 (717)
..|||||||+ |+|.+++. ..+.+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 67999884 3457999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCcc--ccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCC
Q 039318 548 RTFVGDEI--EGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG 624 (717)
Q Consensus 548 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 624 (717)
+.+..... .......+||+.|||||++.+. .++.++||||+|||+|||++|++||......+ .+..+.......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~---~l~~I~~~~g~p 282 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH---QLQLIMMVLGTP 282 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCC
Confidence 87643221 2223457999999999998875 46999999999999999999999997543222 222222211111
Q ss_pred CCccccch--------h-----hhccCCHHH-----HHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 625 MPSQLIDA--------Y-----YQESCNLAE-----VIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 625 ~~~~l~d~--------~-----~~~~~~~~~-----~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
. ...... . .....+... ...+++|+.+||+.||++|||+.|+++
T Consensus 283 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 283 S-PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp C-GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 000000 0 000111111 235778999999999999999999987
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=343.47 Aligned_cols=222 Identities=18% Similarity=0.196 Sum_probs=167.9
Q ss_pred CCCCCCEEEeCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCC----cceEEEecCCCEEE--EcCCC
Q 039318 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDS----SGVLVVNKTGNLVL--TSQNK 74 (717)
Q Consensus 1 ~l~~~~~l~S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~----~~~l~l~~~G~Lvl--~~~~~ 74 (717)
+|++|++|+|++|.|+||||+++ ++|| |+ +.+ |||+|||++|+.++ +++|+|+.||+||| .|++|
T Consensus 22 ~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G~Lvl~~~~~~~ 92 (276)
T 3m7h_A 22 TLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSR 92 (276)
T ss_dssp EBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEEESSSEEEEEGGG
T ss_pred EecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCCCcEEEEEeCCCC
Confidence 47889999999999999999543 5676 76 777 99999999999885 78999999999999 88889
Q ss_pred cEEEEeccccCc----CCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCccccccCeeceeeccCCceEEEEecCCC
Q 039318 75 SVVWSANLSKEV----RTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTLLPGMKLGWDFKTGLERRITSWKSSD 150 (717)
Q Consensus 75 ~~vWst~~~~~~----~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~~~~~~~l~S~~s~~ 150 (717)
++||+|+++... .+.++|+|+|+|||||++ +.+|||| ||||||||||+|+++.++| ..| ++.+
T Consensus 93 ~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~------~~~lWqS--~ptdtlLpg~~~~~~l~~g--~~L---~S~~ 159 (276)
T 3m7h_A 93 RRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD------SLALWNG--TPAIPLVPGAIDSLLLAPG--SEL---VQGV 159 (276)
T ss_dssp TEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE------EEEEEES--CTTSCCCCSCTTCEEECSS--EEE---CTTC
T ss_pred CEEEEeCCCcccccccCCceEEEEeCCCCEEecC------CceeeCc--ccccccccccccccccccC--ccc---ccCC
Confidence 999999986421 234569999999999997 2499999 9999999999999999888 446 6789
Q ss_pred CCCCceeEEeeccCCCcEEEEEc-CCeeEEecCCCCCceeeccccccccceeeEEeecCC-eEEEEEEecCCceEEEEEE
Q 039318 151 DPSPGDFIWKIERQFYPELVMWK-GSRKFYRTGPWNGLIFSASSLRLNPIFKYRFVFNED-ELYYTFYLTDKDVISRTVM 228 (717)
Q Consensus 151 dps~G~~~~~~~~~~~~~~~~~~-~~~~y~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~r~~l 228 (717)
||++|.|++.++++|. ++++. +..+||++++|++.. ....+.... .+.+..+.+ .+.+++ .......|++|
T Consensus 160 dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~-~~l~l~~dG--nLvl~d~~~~~vWsS~--t~~~~~~rl~L 232 (276)
T 3m7h_A 160 VYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGA-VRAVFQGDG--NLVVYGAGNAVLWHSH--TGGHASAVLRL 232 (276)
T ss_dssp EEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTC-CEEEECTTS--CEEEECTTSCEEEECS--CTTCTTCEEEE
T ss_pred CCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCcc-EEEEEcCCC--eEEEEeCCCcEEEEec--CCCCCCEEEEE
Confidence 9999999999999985 44554 469999999997643 111111111 112222222 222222 22223479999
Q ss_pred eeccceEEEEEEecCCCcEEEEeccCC
Q 039318 229 NQTVSLRQRFIWRKANQSWELYSNLPK 255 (717)
Q Consensus 229 ~~~G~~~~~~~w~~~~~~W~~~~~~p~ 255 (717)
+.+| ++++|.| ...|..++..|.
T Consensus 233 d~dG-nLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 233 QANG-SIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp CTTS-CEEEEEE---EEEEESSSCCTT
T ss_pred cCCc-cEEEEcC---CCeEEccCccCC
Confidence 9999 9999998 245666665554
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=373.89 Aligned_cols=225 Identities=24% Similarity=0.320 Sum_probs=181.2
Q ss_pred cCcccccccccCCccceEeeeeCCc-hhh--------------------------hhhhhhhhcceeecCceeeEEEecc
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QEI--------------------------AHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v--------------------------ah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
++|++.+.||+|+||.||+|+.+.. +.+ .|||||++++++.+.+..+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 6899999999999999999987542 222 2999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC--CCceeccccccccccCCc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE--MNPKISDFGLARTFVGDE 554 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~--~~~kl~Dfgla~~~~~~~ 554 (717)
++|+|.++|.+ ....+++..+..++.||++||.|||+++ |+||||||+||||+.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999843 3346899999999999999999999998 9999999999999854 899999999999865432
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||...... ..+.. .. .... .+.+..
T Consensus 312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~~~~---i~-~~~~-~~~~~~- 379 (573)
T 3uto_A 312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRN---VK-SCDW-NMDDSA- 379 (573)
T ss_dssp ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHH---HH-TTCC-CCCSGG-
T ss_pred ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHH---HH-hCCC-CCCccc-
Confidence 234578999999999999999999999999999999999999998643322 11111 11 1111 000111
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.... ...+.+|+.+||+.||++|||+.|+++
T Consensus 380 ~~~~----s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 380 FSGI----SEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 235678999999999999999999988
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=330.70 Aligned_cols=260 Identities=35% Similarity=0.517 Sum_probs=205.8
Q ss_pred CCCCcccHHHHHHHhcCcccc------cccccCCccceEeeeeCCch-----------------------------hhhh
Q 039318 409 LELPLFELATIANATDNFSIN------KKLGEGGFGPVYKGTLADGQ-----------------------------EIAH 453 (717)
Q Consensus 409 ~~~~~~~~~~i~~~~~~~~~~------~~lG~G~fg~Vy~~~~~~~~-----------------------------~vah 453 (717)
...+.|++.++..++++|... ++||+|+||.||+|+..... .+.|
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 356789999999999999887 89999999999999764211 1129
Q ss_pred hhhhhhcceeecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE
Q 039318 454 RNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL 533 (717)
Q Consensus 454 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll 533 (717)
|||+++++++.+.+..++||||+++++|.+++........+++..++.++.||++||.|||+++ |+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999976555667899999999999999999999998 9999999999999
Q ss_pred cCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhH
Q 039318 534 DHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNL 613 (717)
Q Consensus 534 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~ 613 (717)
+.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 9999999999999987544332222334679999999998865 589999999999999999999999976554433222
Q ss_pred HHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 614 IGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
+...... ........++..+ ...+......+.+++.+||+.+|.+||++.+|+++|+..
T Consensus 246 ~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 246 IKEEIED-EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHHT-TSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHhhh-hhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 2111110 0111222222222 223556667888999999999999999999999999764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=336.24 Aligned_cols=241 Identities=27% Similarity=0.401 Sum_probs=186.2
Q ss_pred hcCcccccccccCCccceEeeeeCCchhh-------------------------hhhhhhhhcceeecCc----eeeEEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEI-------------------------AHRNLVKLLGCCIQGE----EKLLIY 473 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~v-------------------------ah~niv~l~~~~~~~~----~~~lV~ 473 (717)
.++|++.++||+|+||.||+|+..+ +.+ .|||||++++++.+.. ..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEETT-EEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEECC-CEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 3689999999999999999998753 222 2999999999998754 469999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhc----------CCCcEEeccCCCCceEEcCCCCceecc
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD----------SRLRIIHRDLKASNVLLDHEMNPKISD 543 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~----------~~~~ivHrDlkp~NIll~~~~~~kl~D 543 (717)
||+++|+|.+++.. ..+++..+..++.||++||+|||+. + |+||||||+||||+.++.+||+|
T Consensus 102 e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 102 AFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECC
T ss_pred ecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEcc
Confidence 99999999999944 3489999999999999999999998 6 99999999999999999999999
Q ss_pred ccccccccCCccccccceecccccccCcccccc-----CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHH----
Q 039318 544 FGLARTFVGDEIEGSTKRVVGTYGYMAPEYASD-----GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLI---- 614 (717)
Q Consensus 544 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~---- 614 (717)
||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999987654433333344679999999999986 35677899999999999999999998754433221111
Q ss_pred -----HHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 615 -----GHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 615 -----~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
...............+..... .......+.+|+.+||+.||++|||+.||++.|+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQ---KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGG---SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCcccccc---ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111112211111111111 223455688999999999999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=341.35 Aligned_cols=233 Identities=28% Similarity=0.410 Sum_probs=186.0
Q ss_pred hcCcccccccccCCccceEeeeeCC--------ch---------------------------hh-hhhhhhhhcceeecC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD--------GQ---------------------------EI-AHRNLVKLLGCCIQG 466 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~---------------------------~v-ah~niv~l~~~~~~~ 466 (717)
.++|++.+.||+|+||.||+|+... +. .+ .||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 4689999999999999999997521 11 11 299999999999999
Q ss_pred ceeeEEEeccCCCChhhHhhhccc-------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTK-------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL 533 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll 533 (717)
+..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999965431 235789999999999999999999998 9999999999999
Q ss_pred cCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchh
Q 039318 534 DHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLN 612 (717)
Q Consensus 534 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~ 612 (717)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~-- 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 9999999999999987654333233334567889999999999999999999999999999999 9999875432221
Q ss_pred HHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 613 LIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
. .....+..... +......+.+++.+||+.+|++||++.|+++.|+..
T Consensus 315 -~----~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 315 -F----KLLKEGHRMDK---------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp -H----HHHHTTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -H----HHHhcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 11122211111 111223577889999999999999999999999764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.77 Aligned_cols=238 Identities=26% Similarity=0.424 Sum_probs=179.2
Q ss_pred HhcCcccccccccCCccceEeeeeCCch---------------------------hhhhhhhhhhcceeecCceeeEEEe
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQ---------------------------EIAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~---------------------------~vah~niv~l~~~~~~~~~~~lV~E 474 (717)
..++|++.++||+|+||.||+|+..... .+.||||+++++++.+.+..++|||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 3468999999999999999999764211 1129999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++++|.+++........+++..++.++.||++||+|||+++ .+|+||||||+||||+.++.+||+|||+++......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 9999999999965444445899999999999999999999875 349999999999999999999999999998643322
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..... ........+
T Consensus 194 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~~---~~~~~~~~~----- 260 (309)
T 3p86_A 194 --LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVAAV---GFKCKRLEI----- 260 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHHHH---HHSCCCCCC-----
T ss_pred --cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---HhcCCCCCC-----
Confidence 12334679999999999999999999999999999999999999987433221 11111 111111111
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCCC
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIML 677 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~ 677 (717)
.. .....+.+++.+||+.+|++|||+.+|+++|+.....
T Consensus 261 ~~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 261 PR----NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred Cc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 01 1123467889999999999999999999999877643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=332.80 Aligned_cols=228 Identities=25% Similarity=0.358 Sum_probs=181.4
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh---------------------------hhhhhhhhcceeecCceeeEEEe
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI---------------------------AHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v---------------------------ah~niv~l~~~~~~~~~~~lV~E 474 (717)
.++|++.+.||+|+||.||+|+... ++.+ .||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 3689999999999999999998653 2211 29999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999983 3445899999999999999999999998 9999999999999999999999999998764333
Q ss_pred cccccceecccccccCccccccCCC-CccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
.........||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... . ..+...... ....
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~----~~~~~~~~~--~~~~ 231 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--Y----SDWKEKKTY--LNPW 231 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH--H----HHHHTTCTT--STTG
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH--H----HHHhccccc--CCcc
Confidence 3333345789999999999988775 78999999999999999999999754332211 1 111111110 0000
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
. .....+.+|+.+||+.||++|||+.|+++.
T Consensus 232 --~----~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 232 --K----KIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --G----GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --c----cCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 112345688999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.19 Aligned_cols=234 Identities=28% Similarity=0.427 Sum_probs=183.8
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hhh--------------------------hhhhhhhhcceeecCceeeEEEec
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QEI--------------------------AHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v--------------------------ah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
.++|.+.++||+|+||.||+|++... +.+ .||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 36799999999999999999987542 111 299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999542 346899999999999999999999998 99999999999999999999999999987643322
Q ss_pred cc------------ccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhC
Q 039318 556 EG------------STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNN 623 (717)
Q Consensus 556 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 623 (717)
.. ......||+.|+|||++.+..++.++||||||+++|||++|..|+............. .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~~~-- 240 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VRGFL-- 240 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HHHHH--
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hhccc--
Confidence 11 0114579999999999999999999999999999999999999987543322111000 00000
Q ss_pred CCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 624 GMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 624 ~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
+. ..+......+.+++.+||+.||++|||+.++++.|+...
T Consensus 241 -------~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 241 -------DR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp -------HH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------cc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 001111134667889999999999999999999998654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=334.29 Aligned_cols=230 Identities=25% Similarity=0.346 Sum_probs=181.0
Q ss_pred cCcccccccccCCccceEeeeeCCch-h-------------------------------hhhhhhhhhcceeecCceeeE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-E-------------------------------IAHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-~-------------------------------vah~niv~l~~~~~~~~~~~l 471 (717)
++|++.+.||+|+||.||+|++.... . +.||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57999999999999999999864321 1 12999999999886 567899
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++++|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999999543 346899999999999999999999998 9999999999999999999999999999775
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
............+++.|+|||++.+..++.++||||||+++|||++ |+.||......+... ...........
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~~~~~~ 239 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-------LLEKGERLAQP 239 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH-------HHHTTCBCCCC
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH-------HHHcCCCCCCC
Confidence 5443333445678889999999999999999999999999999999 999987543322111 11111111100
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
. .....+.+++.+||+.||++||++.+|++.|+...
T Consensus 240 ~---------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 240 Q---------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp T---------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred C---------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 01123557888999999999999999999997654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=323.36 Aligned_cols=226 Identities=24% Similarity=0.418 Sum_probs=180.8
Q ss_pred HhcCcccccccccCCccceEeeeeCC-chhh--------------------------hhhhhhhhcceeecCceeeEEEe
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLAD-GQEI--------------------------AHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v--------------------------ah~niv~l~~~~~~~~~~~lV~E 474 (717)
..++|++.++||+|+||.||+|+... ++.+ .||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 34689999999999999999997543 2222 29999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999943 24889999999999999999999998 9999999999999999999999999998764432
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .. .......... +..
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~---~~~~~~~~~~-~~~--- 238 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---AL---YLIATNGTPE-LQN--- 238 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH---HHHHHHCSCC-CSC---
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHhCCCCC-CCC---
Confidence 2 2334679999999999999999999999999999999999999986432211 11 1111111110 000
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+......+.+++.+||+.||++|||+.|+++.
T Consensus 239 ----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 239 ----PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 01112346788999999999999999999873
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=324.54 Aligned_cols=237 Identities=22% Similarity=0.304 Sum_probs=181.5
Q ss_pred hcCcccccccccCCccceEeeeeCCchhh-------------------------hhhhhhhhcceeec----CceeeEEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEI-------------------------AHRNLVKLLGCCIQ----GEEKLLIY 473 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~v-------------------------ah~niv~l~~~~~~----~~~~~lV~ 473 (717)
.++|++.+.||+|+||.||+|+.. ++.+ .||||+++++++.+ ....++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEEC-CEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 578999999999999999999874 2222 29999999998654 35689999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHh--------hcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH--------HDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
||+++|+|.+++. ...+++..++.++.||++||+||| +++ |+||||||+||||+.++.+||+|||
T Consensus 86 e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 86 HYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp CCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCT
T ss_pred hhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCC
Confidence 9999999999993 335899999999999999999999 666 9999999999999999999999999
Q ss_pred ccccccCCccc--cccceecccccccCccccccC------CCCccccchhHhHHHHHhhcC----------CCCCCCCCC
Q 039318 546 LARTFVGDEIE--GSTKRVVGTYGYMAPEYASDG------LFSVKSDVFSFGILLLEIVSG----------KKNRGFYHS 607 (717)
Q Consensus 546 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~il~elltG----------~~p~~~~~~ 607 (717)
+++........ .......||+.|+|||++.+. .++.++||||||+++|||++| +.||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 99865433221 112335799999999999876 556799999999999999999 777754433
Q ss_pred CCchhHHHHHHHHhh-CCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 608 DKNLNLIGHAWKLWN-NGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 608 ~~~~~~~~~~~~~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
...... ....... ......+... .........+.+++.+||+.||++|||+.+|+++|+.
T Consensus 239 ~~~~~~--~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 239 NDPSFE--DMRKVVCVDQQRPNIPNR----WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp SSCCHH--HHHHHHTTSCCCCCCCGG----GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred CCcchh--hhhHHHhccCCCCCCChh----hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 222111 1111111 1111111111 1122355678899999999999999999999999964
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=339.87 Aligned_cols=244 Identities=28% Similarity=0.436 Sum_probs=190.1
Q ss_pred cccHHHHHHHhcCcccccccccCCccceEeeeeCC------chhh----------------------------hhhhhhh
Q 039318 413 LFELATIANATDNFSINKKLGEGGFGPVYKGTLAD------GQEI----------------------------AHRNLVK 458 (717)
Q Consensus 413 ~~~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~v----------------------------ah~niv~ 458 (717)
.+.........++|++.++||+|+||.||+|++.. ++.+ .||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 35556666678899999999999999999997321 1111 2899999
Q ss_pred hcceeecCce-eeEEEeccCCCChhhHhhhccc-----------------------------------------------
Q 039318 459 LLGCCIQGEE-KLLIYEFMPNRSLDSFIFDQTK----------------------------------------------- 490 (717)
Q Consensus 459 l~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------- 490 (717)
+++++.+.+. .++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999887554 8999999999999999965432
Q ss_pred ----------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 491 ----------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 491 ----------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
...+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122889999999999999999999998 9999999999999999999999999998764443
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
.........||+.|+|||++.+..++.++||||||+++|||++ |+.||......+.. .............
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~~~~~~~~~~~~--- 318 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTRMRAP--- 318 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHHHTCCCCCC---
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH------HHHHHcCCCCCCC---
Confidence 3333445678999999999999999999999999999999998 99998654333211 1111111111111
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
......+.+++.+||+.||++|||+.||+++|+..
T Consensus 319 ------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 319 ------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11123567889999999999999999999999754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=339.62 Aligned_cols=231 Identities=27% Similarity=0.401 Sum_probs=183.8
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhhh---------------------------hhhhhhhcceeecCceeeEEEe
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEIA---------------------------HRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va---------------------------h~niv~l~~~~~~~~~~~lV~E 474 (717)
.++|.+.+.||+|+||.||+|++.. ++.+| ||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 4678999999999999999998762 22221 9999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999999999543 335889999999999999999999998 9999999999999999999999999998654333
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
.........+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... . ......+.....
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~~~---- 336 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---T----REFVEKGGRLPC---- 336 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---H----HHHHHTTCCCCC----
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCCCCC----
Confidence 2222223446788999999999999999999999999999998 999986433211 1 111112111110
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
+......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 337 -----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 337 -----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111123567889999999999999999999999753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=340.39 Aligned_cols=235 Identities=29% Similarity=0.404 Sum_probs=188.3
Q ss_pred hcCcccccccccCCccceEeeeeCC--------ch---------------------------hh-hhhhhhhhcceeecC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD--------GQ---------------------------EI-AHRNLVKLLGCCIQG 466 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~---------------------------~v-ah~niv~l~~~~~~~ 466 (717)
.++|.+.++||+|+||.||+|+... +. .+ .|||||++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4689999999999999999997421 00 11 299999999999999
Q ss_pred ceeeEEEeccCCCChhhHhhhccc-------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTK-------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL 533 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll 533 (717)
+..++||||+++++|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999965432 245899999999999999999999998 9999999999999
Q ss_pred cCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchh
Q 039318 534 DHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLN 612 (717)
Q Consensus 534 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~ 612 (717)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~--- 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999987654333333344567899999999999999999999999999999999 999986432211
Q ss_pred HHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCC
Q 039318 613 LIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM 676 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~ 676 (717)
....+......... ......+.+++.+||+.+|++||++.||++.|+....
T Consensus 302 ----~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 302 ----LFKLLKEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp ----HHHHHHTTCCCCCC---------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHcCCCCCCC---------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 12222222111111 1112356788999999999999999999999987754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.55 Aligned_cols=230 Identities=25% Similarity=0.402 Sum_probs=180.6
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hh-------------------------------hhhhhhhhhcceeecCceee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QE-------------------------------IAHRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~-------------------------------vah~niv~l~~~~~~~~~~~ 470 (717)
.++|++.++||+|+||.||+|++... +. +.||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 36799999999999999999986422 11 11999999999998754 78
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
+||||+++|+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999999553 346899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......... .........
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-------~~~~~~~~~-- 238 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGERL-- 238 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTCCC--
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-------HHHHcCCCC--
Confidence 54443333334567889999999999999999999999999999999 99998754332211 111111110
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
..+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 239 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 239 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp -------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred -------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 01111234577899999999999999999999998654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.63 Aligned_cols=232 Identities=27% Similarity=0.422 Sum_probs=186.9
Q ss_pred hcCcccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCceeeEEEeccC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.++|++.+.||+|+||.||+|+.+++..++ ||||+++++++.+.+..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 468999999999999999999887654333 9999999999999999999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++... ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 87 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 87 NGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp TCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred CCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 99999999553 345899999999999999999999998 9999999999999999999999999998764433221
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .. ........... + .
T Consensus 162 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~~~~~~~~--~---~ 228 (268)
T 3sxs_A 162 -SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---VV----LKVSQGHRLYR--P---H 228 (268)
T ss_dssp -CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH----HHHHTTCCCCC--C---T
T ss_pred -ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH---HH----HHHHcCCCCCC--C---C
Confidence 223456778999999999999999999999999999999 999986433221 11 11111111000 0 0
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM 676 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~ 676 (717)
. ....+.+++.+||+.+|++|||+.++++.|+...+
T Consensus 229 ~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 229 L----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp T----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred c----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 0 12356788999999999999999999999987653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=319.91 Aligned_cols=238 Identities=14% Similarity=0.173 Sum_probs=187.9
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh-------------------------hhhhhhhhcceeecCceeeEEEecc
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI-------------------------AHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-------------------------ah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
.++|++.+.||+|+||.||+|+... ++.+ .|+|++++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 4689999999999999999998532 2222 2899999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC-----ceecccccccccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN-----PKISDFGLARTFV 551 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~-----~kl~Dfgla~~~~ 551 (717)
+++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+||||+.++. +||+|||+++...
T Consensus 89 -~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 89 -GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred -CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999999543 335899999999999999999999998 999999999999987776 9999999998765
Q ss_pred CCccc-----cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC
Q 039318 552 GDEIE-----GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626 (717)
Q Consensus 552 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (717)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........................
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 43221 1233567999999999999999999999999999999999999999865544433333222221111111
Q ss_pred ccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 627 SQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 627 ~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.. .... ....+.+++.+||+.+|++||++.+|++.|+...
T Consensus 243 ~~-----~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 243 RE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HH-----HHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 00 0011 1245678899999999999999999999997653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.65 Aligned_cols=222 Identities=25% Similarity=0.377 Sum_probs=179.7
Q ss_pred hcCcccccccccCCccceEeeeeC-Cchhhh----------------------------hhhhhhhcceeecCceeeEEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLA-DGQEIA----------------------------HRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~va----------------------------h~niv~l~~~~~~~~~~~lV~ 473 (717)
.++|++.+.||+|+||.||+|++. .++.+| ||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 468999999999999999999874 222221 999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++++|.+++... +.+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999999543 45889999999999999999999998 999999999999999999999999999865433
Q ss_pred ccccccceecccccccCccccccCCCC-ccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFS-VKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
. .....+||+.|+|||++.+..+. .++|||||||++|||++|+.||....... .. ..... +...
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~---~~i~~-~~~~----- 232 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LR---ERVLR-GKYR----- 232 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHH-CCCC-----
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---HH---HHHHh-CCCC-----
Confidence 2 23356899999999999888875 89999999999999999999987432211 11 11111 1110
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+......+.+++.+||+.||.+|||++|+++.
T Consensus 233 -----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 -----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011122356788999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.30 Aligned_cols=230 Identities=27% Similarity=0.463 Sum_probs=185.0
Q ss_pred hcCcccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCceeeEEEeccC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.++|++.+.||+|+||.||+|+..+++.++ ||||+++++++.+.+..++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 367999999999999999999886554333 9999999999999999999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++.. ....+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 162 (269)
T 4hcu_A 89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 162 (269)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc-
Confidence 9999999954 3346899999999999999999999998 999999999999999999999999999865433221
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ... .......... .
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~----~~~~~~~~~~--~----- 228 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVV----EDISTGFRLY--K----- 228 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH----HHHHTTCCCC--C-----
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHH----HHHhcCccCC--C-----
Confidence 2223566788999999999999999999999999999999 99998643221 111 1111111100 0
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
+......+.+++.+||+.+|++||++.++++.|+..
T Consensus 229 --~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 229 --PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 001123467889999999999999999999999754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=339.04 Aligned_cols=238 Identities=16% Similarity=0.210 Sum_probs=185.2
Q ss_pred cHHHHHHHhcCcccccccccCCccceEeeeeCCchh-h-----------------------------hhhhhhhhcceee
Q 039318 415 ELATIANATDNFSINKKLGEGGFGPVYKGTLADGQE-I-----------------------------AHRNLVKLLGCCI 464 (717)
Q Consensus 415 ~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-v-----------------------------ah~niv~l~~~~~ 464 (717)
.+.++....++|++.++||+|+||.||+|+.+.+.+ + .||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 445555667899999999999999999999865321 1 1999999999999
Q ss_pred cCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccc
Q 039318 465 QGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDF 544 (717)
Q Consensus 465 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 544 (717)
+.+..+||||||++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999999542 346899999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCccccccceecccccccCccccc-----cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHH
Q 039318 545 GLARTFVGDEIEGSTKRVVGTYGYMAPEYAS-----DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWK 619 (717)
Q Consensus 545 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 619 (717)
|+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||......+ .......
T Consensus 220 Gla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~---~~~~i~~ 295 (437)
T 4aw2_A 220 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGKIMN 295 (437)
T ss_dssp TTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHT
T ss_pred hhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH---HHHhhhh
Confidence 99986543322 1223468999999999987 5678999999999999999999999987433222 1111111
Q ss_pred HhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCC--CCChHHHHHH
Q 039318 620 LWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPED--RPCMPSVILM 670 (717)
Q Consensus 620 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~--RPs~~evl~~ 670 (717)
....-...... . .....+.+|+.+||+.+|++ ||+++|+++.
T Consensus 296 ~~~~~~~p~~~-----~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 296 HKERFQFPTQV-----T----DVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHHCCCCSSC-----C----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccccccCCccc-----c----cCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 00000000000 0 01234667888999888888 9999999983
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.90 Aligned_cols=235 Identities=18% Similarity=0.203 Sum_probs=185.2
Q ss_pred hcCcccccccccCCccceEeeeeCC-chh------------------------h-hhhhhhhhcceeecCceeeEEEecc
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQE------------------------I-AHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~------------------------v-ah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
.++|++.+.||+|+||.||+|+... ++. + .||||+++++++...+..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 4689999999999999999998632 221 2 3999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC-----ceecccccccccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN-----PKISDFGLARTFV 551 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~-----~kl~Dfgla~~~~ 551 (717)
+++|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||||+.++. +||+|||+++...
T Consensus 88 -~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 88 -GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred -CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999999543 346899999999999999999999998 999999999999998887 9999999998754
Q ss_pred CCcccc-----ccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC
Q 039318 552 GDEIEG-----STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626 (717)
Q Consensus 552 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (717)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..................-... .
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~-~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT-P 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS-C
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC-C
Confidence 332211 1235689999999999999999999999999999999999999998665444333222221110000 0
Q ss_pred ccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 627 SQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 627 ~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
...+... . ..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 241 ----~~~~~~~-~----p~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 241 ----IEVLCEN-F----PEMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp ----HHHHTTT-C----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ----HHHHhcc-C----hHHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 0000000 1 167788999999999999999999998863
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=333.59 Aligned_cols=241 Identities=16% Similarity=0.222 Sum_probs=184.7
Q ss_pred HhcCcccccccccCCccceEeeeeCCch------hh-------------------------------------hhhhhhh
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQ------EI-------------------------------------AHRNLVK 458 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~------~v-------------------------------------ah~niv~ 458 (717)
..++|++.++||+|+||.||+|++..++ .+ .||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 4568999999999999999999875431 11 1899999
Q ss_pred hcceeecC----ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc
Q 039318 459 LLGCCIQG----EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD 534 (717)
Q Consensus 459 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~ 534 (717)
+++++... ...+|||||+ +++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998765 5589999999 9999999954 2356899999999999999999999998 99999999999999
Q ss_pred --CCCCceeccccccccccCCcccc-----ccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCC
Q 039318 535 --HEMNPKISDFGLARTFVGDEIEG-----STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHS 607 (717)
Q Consensus 535 --~~~~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~ 607 (717)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998764332111 11335699999999999999999999999999999999999999874332
Q ss_pred CCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 608 DKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
... .......... ..+..+++..+..... ...+.+++.+||+.+|++||++.+|+++|+..
T Consensus 267 ~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 267 DPK--YVRDSKIRYR-ENIASLMDKCFPAANA---PGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp CHH--HHHHHHHHHH-HCHHHHHHHHSCTTCC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CHH--HHHHHHHHhh-hhHHHHHHHhcccccC---HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 221 1111111111 1222333332221111 23566788899999999999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=329.17 Aligned_cols=232 Identities=27% Similarity=0.423 Sum_probs=182.1
Q ss_pred hcCcccccccccCCccceEeeeeCCch----hh---------------------------hhhhhhhhcceeecCceeeE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ----EI---------------------------AHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~v---------------------------ah~niv~l~~~~~~~~~~~l 471 (717)
.++|++.+.||+|+||.||+|++.... .+ .||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999874211 11 19999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999999542 346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccc-ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 552 GDEIEG-STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 552 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ... ..........
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~----~~~~~~~~~~- 274 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVI----SSVEEGYRLP- 274 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHH----HHHHTTCCCC-
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHH----HHHHcCCCCC-
Confidence 432111 1223456778999999999999999999999999999999 99998643221 111 1111111100
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.+......+.+++.+||+.||++||++.+|+++|+...
T Consensus 275 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 275 --------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11112245778999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=323.80 Aligned_cols=236 Identities=25% Similarity=0.341 Sum_probs=181.2
Q ss_pred hcCcccccccccCCccceEeeeeCCchhhh----------------------------hhhhhhhcceeecCceeeEEEe
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA----------------------------HRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va----------------------------h~niv~l~~~~~~~~~~~lV~E 474 (717)
.++|++.++||+|+||.||+|+..+++.+| ||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 468999999999999999999986554332 9999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++ +|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9985 78777743 3345899999999999999999999998 9999999999999999999999999998754322
Q ss_pred cccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch-
Q 039318 555 IEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA- 632 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~- 632 (717)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.... ................
T Consensus 174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK---IFSILGTPNPREWPQVQ 248 (311)
T ss_dssp --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH---HHHHHCCCCTTTSGGGT
T ss_pred --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHHCCCChHHhhhhh
Confidence 12234578999999999876 5689999999999999999999999976554443322 2222221111110000
Q ss_pred --h--------hhccCCH-----HHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 633 --Y--------YQESCNL-----AEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 633 --~--------~~~~~~~-----~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
. ....... ....++.+|+.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 0000011 11245678999999999999999999987
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=323.17 Aligned_cols=235 Identities=23% Similarity=0.344 Sum_probs=181.4
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hh-----------------------------hhhhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QE-----------------------------IAHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~-----------------------------vah~niv~l~~~~~~~~~~~lV 472 (717)
.++|++.+.||+|+||.||+|+.... +. +.||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46899999999999999999986432 11 1299999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++++|.+++... +.+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999543 46899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ............ ... .
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~-~~~-~ 234 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDSVP-NVT-T 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSCCC-CHH-H
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhccCC-Ccc-h
Confidence 321 2233467999999999999999999999999999999999999998643211 111222222211 110 0
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCC-ChHHHHHHhcCCCC
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRP-CMPSVILMLGSEIM 676 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-s~~evl~~L~~~~~ 676 (717)
.... .....+.+++.+||+.||++|| +++++.+.|+....
T Consensus 235 ~~~~----~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 235 DVRK----DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HSCT----TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred hccc----CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 1111 1224567889999999999998 89999999987653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=324.54 Aligned_cols=237 Identities=24% Similarity=0.358 Sum_probs=186.4
Q ss_pred CCcccHHHHHHHhcC----------cccccccccCCccceEeeeeC-Cchhhh--------------------------h
Q 039318 411 LPLFELATIANATDN----------FSINKKLGEGGFGPVYKGTLA-DGQEIA--------------------------H 453 (717)
Q Consensus 411 ~~~~~~~~i~~~~~~----------~~~~~~lG~G~fg~Vy~~~~~-~~~~va--------------------------h 453 (717)
.+.+++.++..+++. |+..++||+|+||.||+|+.. +++.+| |
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 355777777776653 777889999999999999876 343322 9
Q ss_pred hhhhhhcceeecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE
Q 039318 454 RNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL 533 (717)
Q Consensus 454 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll 533 (717)
|||+++++++...+..++||||+++++|.+++.. ..+++..+..++.||++||.|||+++ |+||||||+||||
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll 174 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL 174 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999998832 35899999999999999999999998 9999999999999
Q ss_pred cCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhH
Q 039318 534 DHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNL 613 (717)
Q Consensus 534 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~ 613 (717)
+.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~ 249 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQA 249 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH
T ss_pred CCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHH
Confidence 9999999999999987643321 22346799999999999999999999999999999999999999864321 111
Q ss_pred HHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 614 IGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.. .+.......+.. .. .....+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~----~~~~~~~~~~~~---~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 MK----RLRDSPPPKLKN---SH----KVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HH----HHHHSSCCCCTT---GG----GSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HH----HHhcCCCCCcCc---cc----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 111111111110 00 112346788899999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.21 Aligned_cols=229 Identities=22% Similarity=0.316 Sum_probs=179.4
Q ss_pred hcCcccccccccCCccceEeeeeCCchh-h------------------------------hhhhhhhhcceeecCceeeE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQE-I------------------------------AHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-v------------------------------ah~niv~l~~~~~~~~~~~l 471 (717)
.++|++.++||+|+||.||+|+.+...+ + .|||||++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4689999999999999999998754321 1 29999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999954 345899999999999999999999998 9999999999999999999999999998632
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCch--hHHHHHHHHhhCCCCccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNL--NLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~l 629 (717)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .......+........
T Consensus 205 ~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-- 280 (396)
T 4dc2_A 205 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-- 280 (396)
T ss_dssp CTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC--
T ss_pred cCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC--
Confidence 221 2234578999999999999999999999999999999999999999654322111 1111111111111110
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCCh------HHHHH
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCM------PSVIL 669 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~------~evl~ 669 (717)
.+......+.+|+.+||+.||++||++ .||++
T Consensus 281 --------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 281 --------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred --------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 011112356788999999999999996 56655
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=333.84 Aligned_cols=222 Identities=26% Similarity=0.385 Sum_probs=175.4
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hhh------------------------------hhhhhhhhcceeecCceeeE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QEI------------------------------AHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v------------------------------ah~niv~l~~~~~~~~~~~l 471 (717)
.++|++.+.||+|+||.||+|+.+.. +.+ .||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 47899999999999999999987542 111 19999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999999543 45899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ........
T Consensus 176 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~---~i~~~~~~----- 242 (353)
T 3txo_A 176 CNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DLFE---AILNDEVV----- 242 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHCCCC-----
T ss_pred cCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HHHH---HHHcCCCC-----
Confidence 222 2234578999999999999999999999999999999999999998643322 1111 11111110
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCCh------HHHHH
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCM------PSVIL 669 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~------~evl~ 669 (717)
.+......+.+++.+||+.||++||++ .|+++
T Consensus 243 ------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 ------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 011112346788999999999999998 77776
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=335.52 Aligned_cols=232 Identities=29% Similarity=0.465 Sum_probs=172.0
Q ss_pred hcCcccccccccCCccceEeeeeC----Cchhh---------------------------hhhhhhhhcceeecCceeeE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLA----DGQEI---------------------------AHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~v---------------------------ah~niv~l~~~~~~~~~~~l 471 (717)
.++|++.+.||+|+||.||+|++. .+..+ .||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 358999999999999999999764 22211 19999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++++|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999954 2346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccc-ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 552 GDEIEG-STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 552 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
...... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ... .....+.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~----~~i~~~~---- 267 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVI----KAVDEGY---- 267 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHH----HHHHTTE----
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCC----
Confidence 332111 1122345778999999999999999999999999999998 99998643211 111 1111111
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
....+......+.+++.+||+.+|++||++.+|+++|+...
T Consensus 268 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 268 -----RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp -----ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 01111122345778999999999999999999999997653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=327.51 Aligned_cols=234 Identities=29% Similarity=0.430 Sum_probs=186.5
Q ss_pred HhcCcccccccccCCccceEeeeeCC------chhh---------------------------hhhhhhhhcceeecCce
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLAD------GQEI---------------------------AHRNLVKLLGCCIQGEE 468 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~v---------------------------ah~niv~l~~~~~~~~~ 468 (717)
..++|.+.+.||+|+||.||+|+... ++.+ .||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 35789999999999999999997521 1111 29999999999999999
Q ss_pred eeEEEeccCCCChhhHhhhccc---------------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCC
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTK---------------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLK 527 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk 527 (717)
.++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999965432 234889999999999999999999998 9999999
Q ss_pred CCceEEcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCC
Q 039318 528 ASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYH 606 (717)
Q Consensus 528 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~ 606 (717)
|+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987654433333334567889999999999999999999999999999999 999987543
Q ss_pred CCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 607 SDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.... . ........... +......+.+++.+||+.||++||++.+|++.|+..
T Consensus 258 ~~~~---~----~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 258 PERL---F----NLLKTGHRMER---------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GGGH---H----HHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH---H----HHhhcCCcCCC---------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3221 1 11112111111 111224577899999999999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=327.22 Aligned_cols=223 Identities=21% Similarity=0.275 Sum_probs=179.6
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hhh-----------------------------hhhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QEI-----------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v-----------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
.++|++.+.||+|+||.||+|+.+.. +.+ .||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 36899999999999999999987532 211 199999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999999854 345889999999999999999999998 99999999999999999999999999986432
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ...... .. +
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~---~i~~~~-~~-~--- 224 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE---LILMEE-IR-F--- 224 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHCC-CC-C---
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHH---HHHcCC-CC-C---
Confidence 22 1234578999999999999999999999999999999999999998643211 1111 111111 10 0
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRP-----CMPSVILM 670 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~~ 670 (717)
... ....+.+++.+||+.||++|| +++||++.
T Consensus 225 --p~~----~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 --PRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCC----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 011 123567889999999999999 89998873
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=336.08 Aligned_cols=234 Identities=27% Similarity=0.435 Sum_probs=183.6
Q ss_pred hcCcccccccccCCccceEeeeeCC------chhh---------------------------hhhhhhhhcceeecCcee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD------GQEI---------------------------AHRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~v---------------------------ah~niv~l~~~~~~~~~~ 469 (717)
.++|++.++||+|+||.||+|++.. ++.+ .|||||++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 3679999999999999999998532 1111 299999999999999999
Q ss_pred eEEEeccCCCChhhHhhhccc----cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC---Cceec
Q 039318 470 LLIYEFMPNRSLDSFIFDQTK----RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM---NPKIS 542 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~ 542 (717)
++||||+++|+|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999965432 245889999999999999999999998 99999999999999555 59999
Q ss_pred cccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHh
Q 039318 543 DFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLW 621 (717)
Q Consensus 543 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 621 (717)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||...... ... ...
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~----~~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVL----EFV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH----HHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHH
Confidence 9999986533322233334678999999999999999999999999999999998 99998643221 111 111
Q ss_pred hCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 622 NNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 622 ~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
..+..... +......+.+|+.+||+.+|++||++.+|++.|+...
T Consensus 300 ~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 300 TSGGRMDP---------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCCCCC---------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 11111111 1111234678899999999999999999999997553
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=322.17 Aligned_cols=243 Identities=23% Similarity=0.349 Sum_probs=183.2
Q ss_pred HHHhcCcccccccccCCccceEeeeeCCchhh-------------------------hhhhhhhhcceeecC----ceee
Q 039318 420 ANATDNFSINKKLGEGGFGPVYKGTLADGQEI-------------------------AHRNLVKLLGCCIQG----EEKL 470 (717)
Q Consensus 420 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~v-------------------------ah~niv~l~~~~~~~----~~~~ 470 (717)
....++|++.++||+|+||.||+|+... +.+ .||||+++++++.+. ...+
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWRG-EKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEETT-EEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEECC-ceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 3445789999999999999999998763 222 299999999999877 7889
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhc--------CCCcEEeccCCCCceEEcCCCCceec
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD--------SRLRIIHRDLKASNVLLDHEMNPKIS 542 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~--------~~~~ivHrDlkp~NIll~~~~~~kl~ 542 (717)
+||||+++++|.+++.. ..+++..++.++.|++.||+|||++ + |+||||||+||||+.++.+||+
T Consensus 112 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEEC
T ss_pred EEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEE
Confidence 99999999999999943 2589999999999999999999988 6 9999999999999999999999
Q ss_pred cccccccccCCcccc--ccceecccccccCccccccCCCCcc------ccchhHhHHHHHhhcC----------CCCCCC
Q 039318 543 DFGLARTFVGDEIEG--STKRVVGTYGYMAPEYASDGLFSVK------SDVFSFGILLLEIVSG----------KKNRGF 604 (717)
Q Consensus 543 Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlG~il~elltG----------~~p~~~ 604 (717)
|||+++......... ......||+.|+|||++.+.....+ +|||||||++|||++| +.||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999997654332211 1224579999999999988776665 9999999999999999 555543
Q ss_pred CCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 605 YHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
........ .................... ........+.+++.+||+.||++|||+.+|++.|+...
T Consensus 265 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 265 LVPSDPSY--EDMREIVCIKKLRPSFPNRW---SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp TSCSSCCH--HHHHHHHTTSCCCCCCCGGG---GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCCch--hhhHHHHhhhccCccccccc---hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 32222111 11111111111111111111 11245567889999999999999999999999997654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=336.37 Aligned_cols=234 Identities=18% Similarity=0.193 Sum_probs=183.3
Q ss_pred HHHHHHHhcCcccccccccCCccceEeeeeCCch-hh-----------------------------hhhhhhhhcceeec
Q 039318 416 LATIANATDNFSINKKLGEGGFGPVYKGTLADGQ-EI-----------------------------AHRNLVKLLGCCIQ 465 (717)
Q Consensus 416 ~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~v-----------------------------ah~niv~l~~~~~~ 465 (717)
+.++....++|++.++||+|+||.||+|+.+... .+ .|||||++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3444556789999999999999999999876432 11 19999999999999
Q ss_pred CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 466 GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 466 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
.+..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999999843 24789999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCccccccceecccccccCccccccCC----CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHh
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL----FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLW 621 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 621 (717)
+++....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... ........-
T Consensus 214 ~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~~~~ 289 (410)
T 3v8s_A 214 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TYSKIMNHK 289 (410)
T ss_dssp TCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHTHH
T ss_pred eeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh---HHHHHHhcc
Confidence 9987644322 1233578999999999998765 8899999999999999999999986432221 111111100
Q ss_pred hCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCC--CCChHHHHHH
Q 039318 622 NNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPED--RPCMPSVILM 670 (717)
Q Consensus 622 ~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~--RPs~~evl~~ 670 (717)
..-.. . ........+.+|+.+||+.+|.+ ||+++||++.
T Consensus 290 ~~~~~--------p--~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 290 NSLTF--------P--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHCCC--------C--TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccccC--------C--CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00000 0 00011235678889999999988 9999999984
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=329.43 Aligned_cols=236 Identities=31% Similarity=0.522 Sum_probs=186.8
Q ss_pred HhcCcccccccccCCccceEeeeeC------Cch---------------------------hh-hhhhhhhhcceeecCc
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLA------DGQ---------------------------EI-AHRNLVKLLGCCIQGE 467 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~---------------------------~v-ah~niv~l~~~~~~~~ 467 (717)
..++|.+.+.||+|+||.||+|+.. .+. .+ .||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3478999999999999999999852 111 11 3999999999999999
Q ss_pred eeeEEEeccCCCChhhHhhhcccc--------------------ccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCC
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTKR--------------------KLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLK 527 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk 527 (717)
..++||||+++++|.+++...... ..+++..++.++.||++||+|||+++ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999653321 34789999999999999999999998 9999999
Q ss_pred CCceEEcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCC
Q 039318 528 ASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYH 606 (717)
Q Consensus 528 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~ 606 (717)
|+||||+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654433223344667889999999999999999999999999999998 999987544
Q ss_pred CCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 607 SDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
..... ........... .+......+.+++.+||+.||.+||++.+|++.|+...
T Consensus 280 ~~~~~------~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 280 VDANF------YKLIQNGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp CSHHH------HHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cHHHH------HHHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 32211 11122221111 01111245678899999999999999999999997654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=319.06 Aligned_cols=247 Identities=21% Similarity=0.276 Sum_probs=189.8
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh---------------------------hhhhhhhhcceeecCc--eeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI---------------------------AHRNLVKLLGCCIQGE--EKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v---------------------------ah~niv~l~~~~~~~~--~~~lV 472 (717)
.++|.+.++||+|+||.||+|+... ++.+ .||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4689999999999999999998764 2211 2999999999988765 77999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE----cCCCCceeccccccc
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL----DHEMNPKISDFGLAR 548 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~Dfgla~ 548 (717)
|||+++++|.+++........+++..++.++.||++||+|||+++ |+||||||+|||| +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976555555899999999999999999999998 9999999999999 778889999999998
Q ss_pred cccCCccccccceecccccccCccccc--------cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCC-chhHHHHHHH
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYAS--------DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDK-NLNLIGHAWK 619 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~-~~~~~~~~~~ 619 (717)
...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||....... ....+.....
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 764432 223467999999999886 5778999999999999999999999986544322 2222222221
Q ss_pred HhhCCCCccccc-----------hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 620 LWNNGMPSQLID-----------AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 620 ~~~~~~~~~l~d-----------~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
......+..+.. ..............+.+++.+||+.||++|||++|+++......
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 111111111100 00111233455567789999999999999999999999886544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=324.22 Aligned_cols=227 Identities=21% Similarity=0.296 Sum_probs=181.0
Q ss_pred hcCcccccccccCCccceEeeeeCCch-h-------------------------hhhhhhhhhcceeecCceeeEEEecc
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ-E-------------------------IAHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~-------------------------vah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
.++|++.+.||+|+||.||+|+..... . +.||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 468999999999999999999875422 1 11999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC--CCCceeccccccccccCCc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH--EMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~--~~~~kl~Dfgla~~~~~~~ 554 (717)
++++|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++. ++.+||+|||+++......
T Consensus 84 ~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 84 SGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999943 2346899999999999999999999998 999999999999987 7899999999998764332
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .... ....... . . +...
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~---~i~~~~~-~-~-~~~~ 226 (321)
T 1tki_A 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIE---NIMNAEY-T-F-DEEA 226 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH---HHHHTCC-C-C-CHHH
T ss_pred ---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHH---HHHcCCC-C-C-Chhh
Confidence 223467999999999999988999999999999999999999998643221 1111 1111111 0 0 0000
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
... ....+.+++.+||+.||++|||+.|+++.
T Consensus 227 ~~~----~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 227 FKE----ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hcc----CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001 12356789999999999999999999983
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=335.41 Aligned_cols=246 Identities=23% Similarity=0.282 Sum_probs=187.0
Q ss_pred CCCcccHHHHHHHhcCcccccccccCCccceEeeeeCCc-hhh------------------------------hhhhhhh
Q 039318 410 ELPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADG-QEI------------------------------AHRNLVK 458 (717)
Q Consensus 410 ~~~~~~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v------------------------------ah~niv~ 458 (717)
+...+++.+.....++|++.++||+|+||.||+|+.... +.+ .||||++
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 344455555566678999999999999999999987432 111 1999999
Q ss_pred hcceeecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC---
Q 039318 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH--- 535 (717)
Q Consensus 459 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~--- 535 (717)
+++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||||+.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 999999999999999999 99999999653 2335889999999999999999999998 999999999999975
Q ss_pred ----------------------CCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHH
Q 039318 536 ----------------------EMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLL 593 (717)
Q Consensus 536 ----------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ 593 (717)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 789999999999864322 23467899999999999999999999999999999
Q ss_pred HhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh------------------hhccCCHH--------------
Q 039318 594 EIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY------------------YQESCNLA-------------- 641 (717)
Q Consensus 594 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~------------------~~~~~~~~-------------- 641 (717)
||++|+.||......+....+ .... ...+....... ........
T Consensus 251 ell~g~~pf~~~~~~~~~~~~---~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 326 (360)
T 3llt_A 251 ELYTGSLLFRTHEHMEHLAMM---ESII-QPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326 (360)
T ss_dssp HHHHSSCSCCCSSHHHHHHHH---HHHT-CCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred HHHHCCCCCCCCcHHHHHHHH---HHhc-CCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence 999999999754322221111 1111 11111110000 00000000
Q ss_pred -HHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 642 -EVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 642 -~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
....+.+|+.+||+.||++|||+.|+++
T Consensus 327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 327 IKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred chHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0145678999999999999999999985
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=320.06 Aligned_cols=230 Identities=26% Similarity=0.413 Sum_probs=181.9
Q ss_pred hcCcccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCceeeEEEeccC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.++|++.+.||+|+||.||+++...+..++ ||||+++++++.+.+..++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 468999999999999999999877654332 9999999999999999999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 103 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 176 (283)
T 3gen_A 103 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 176 (283)
T ss_dssp TCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH-
T ss_pred CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc-
Confidence 99999999542 345899999999999999999999998 999999999999999999999999999865433221
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... .. ........... ..
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~~----~~~~~~~~~~~-----~~ 244 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TA----EHIAQGLRLYR-----PH 244 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH----HHHHTTCCCCC-----CT
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---HH----HHHhcccCCCC-----CC
Confidence 1223456788999999999999999999999999999998 999987543221 11 11111111000 00
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.....+.+++.+||+.+|++|||+.++++.|+..
T Consensus 245 ----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 245 ----LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp ----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1123567889999999999999999999998653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=329.51 Aligned_cols=238 Identities=26% Similarity=0.423 Sum_probs=188.5
Q ss_pred HHHhcCcccccccccCCccceEeeeeCC------chhh---------------------------hhhhhhhhcceeecC
Q 039318 420 ANATDNFSINKKLGEGGFGPVYKGTLAD------GQEI---------------------------AHRNLVKLLGCCIQG 466 (717)
Q Consensus 420 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~v---------------------------ah~niv~l~~~~~~~ 466 (717)
....++|++.+.||+|+||.||+|+... ++.+ .||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 3456899999999999999999998752 1111 199999999999999
Q ss_pred ceeeEEEeccCCCChhhHhhhccc---------------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEecc
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTK---------------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRD 525 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrD 525 (717)
+..++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 999999999999999999965321 256899999999999999999999998 99999
Q ss_pred CCCCceEEcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCC
Q 039318 526 LKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGF 604 (717)
Q Consensus 526 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~ 604 (717)
|||+||||+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999986543332233344678899999999999999999999999999999999 9999864
Q ss_pred CCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCC
Q 039318 605 YHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM 676 (717)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~ 676 (717)
.... .. ......+...... ......+.+++.+||+.||++||++.+|+++|+....
T Consensus 280 ~~~~---~~----~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 280 MAHE---EV----IYYVRDGNILACP---------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp SCHH---HH----HHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CChH---HH----HHHHhCCCcCCCC---------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 3211 11 1122222221111 1112357788999999999999999999999987654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=329.38 Aligned_cols=231 Identities=25% Similarity=0.393 Sum_probs=176.2
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hh-------------------------------hhhhhhhhhcceeecCceee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QE-------------------------------IAHRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~-------------------------------vah~niv~l~~~~~~~~~~~ 470 (717)
.++|++.++||+|+||.||+|++... +. +.||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 36899999999999999999986422 11 11999999999998754 88
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
+||||+++++|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999999553 345889999999999999999999998 999999999999999999999999999876
Q ss_pred cCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ..........
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-------~~~~~~~~~~- 239 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGERLP- 239 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTCCCC-
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHcCCCCC-
Confidence 54433333334567889999999999999999999999999999999 99998754333211 1111111111
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.+......+.+++.+||+.||.+||++.|+++.|+...
T Consensus 240 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 240 --------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp --------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01112235678899999999999999999999998664
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=327.22 Aligned_cols=240 Identities=17% Similarity=0.246 Sum_probs=178.6
Q ss_pred hcCcccccccccCCccceEeeeeCC----chh-------------------------------------hhhhhhhhhcc
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD----GQE-------------------------------------IAHRNLVKLLG 461 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~-------------------------------------vah~niv~l~~ 461 (717)
.++|.+.+.||+|+||.||+|+... +.. +.||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999998753 110 12899999999
Q ss_pred eeec----CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC
Q 039318 462 CCIQ----GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM 537 (717)
Q Consensus 462 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~ 537 (717)
++.. ....++||||+ +++|.+++... +.+++..++.++.||++||+|||+++ |+||||||+||||+.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9987 78899999999 99999999442 36899999999999999999999998 99999999999999887
Q ss_pred --CceeccccccccccCCccc-----cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCc
Q 039318 538 --NPKISDFGLARTFVGDEIE-----GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKN 610 (717)
Q Consensus 538 --~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~ 610 (717)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP- 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence 9999999999876432211 11234679999999999999999999999999999999999999986322221
Q ss_pred hhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 611 LNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.................+.+ ... .......+.+++.+||+.||++||++.+|+++|+...
T Consensus 268 -~~~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 268 -VAVQTAKTNLLDELPQSVLK-WAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp -HHHHHHHHHHHHTTTHHHHH-HSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred -HHHHHHHHhhcccccHHHHh-hcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 11111111111111111111 000 0012235778889999999999999999999998754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=317.77 Aligned_cols=231 Identities=27% Similarity=0.435 Sum_probs=174.5
Q ss_pred cCcccccccccCCccceEeeeeCCch-----------------------hhhhhhhhhhcceeecCceeeEEEeccCCCC
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-----------------------EIAHRNLVKLLGCCIQGEEKLLIYEFMPNRS 480 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-----------------------~vah~niv~l~~~~~~~~~~~lV~E~~~~gs 480 (717)
++|++.+.||+|+||.||+|+..... .+.||||+++++++. +..++||||+++++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~ 85 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGS 85 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCB
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCC
Confidence 57899999999999999999865321 112999999999887 45899999999999
Q ss_pred hhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC-ceeccccccccccCCcccccc
Q 039318 481 LDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN-PKISDFGLARTFVGDEIEGST 559 (717)
Q Consensus 481 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~-~kl~Dfgla~~~~~~~~~~~~ 559 (717)
|.+++........+++..++.++.||++||+|||+.+..+|+||||||+||||+.++. +||+|||++...... .
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~ 160 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----M 160 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----c
Confidence 9999966544445788999999999999999999932223999999999999998887 799999999764322 2
Q ss_pred ceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCC
Q 039318 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCN 639 (717)
Q Consensus 560 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~ 639 (717)
....||+.|+|||++.+..++.++||||||+++|||++|+.||........ .+ .+... ......... ..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~--~~~~~-~~~~~~~~~-----~~- 229 (307)
T 2eva_A 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RI--MWAVH-NGTRPPLIK-----NL- 229 (307)
T ss_dssp ----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HH--HHHHH-TTCCCCCBT-----TC-
T ss_pred ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HH--HHHHh-cCCCCCccc-----cc-
Confidence 235689999999999999999999999999999999999999874332211 11 11111 111111111 11
Q ss_pred HHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 640 LAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 640 ~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
...+.+++.+||+.||++|||+.+++++|+...
T Consensus 230 ---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 230 ---PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred ---CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 234678899999999999999999999998764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=329.03 Aligned_cols=225 Identities=25% Similarity=0.366 Sum_probs=179.5
Q ss_pred HHHhcCcccccccccCCccceEeeeeCCc-hhh------------------------------hhhhhhhhcceeecCce
Q 039318 420 ANATDNFSINKKLGEGGFGPVYKGTLADG-QEI------------------------------AHRNLVKLLGCCIQGEE 468 (717)
Q Consensus 420 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v------------------------------ah~niv~l~~~~~~~~~ 468 (717)
....++|.+.+.||+|+||.||+|+.+.. +.+ .||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34567999999999999999999987542 111 29999999999999999
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999954 245899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... ... ....
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~---i~~-~~~~- 236 (345)
T 1xjd_A 167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHS---IRM-DNPF- 236 (345)
T ss_dssp CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HHH-CCCC-
T ss_pred hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHHH---HHh-CCCC-
Confidence 643222 2234578999999999999999999999999999999999999998643221 11111 111 1110
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChH-HHHH
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMP-SVIL 669 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~-evl~ 669 (717)
.... ....+.+++.+||+.||++||++. +|++
T Consensus 237 -----~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 237 -----YPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -----CCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----CCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 0011 123567889999999999999998 6664
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=326.94 Aligned_cols=223 Identities=24% Similarity=0.348 Sum_probs=179.4
Q ss_pred cCcccccccccCCccceEeeeeCCchh-h-----------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQE-I-----------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~-v-----------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||.||+++.....+ + .|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 679999999999999999998764321 1 1999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999943 345899999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccceecccccccCcccccc---CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASD---GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||................ .....
T Consensus 169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----~~~~~--- 238 (384)
T 4fr4_A 169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----TTVVT--- 238 (384)
T ss_dssp C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH----HCCCC---
T ss_pred C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----hcccC---
Confidence 2 2345789999999999864 458999999999999999999999997554433322221111 11110
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCC-hHHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPC-MPSVIL 669 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-~~evl~ 669 (717)
.+......+.+|+.+||+.||.+||+ +++|++
T Consensus 239 -------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 239 -------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01111245678899999999999998 677665
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=342.85 Aligned_cols=232 Identities=27% Similarity=0.432 Sum_probs=186.2
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh-------------------------hhhhhhhhcceeecCceeeEEEecc
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI-------------------------AHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-------------------------ah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
.++|++.++||+|+||.||+|+++. +..+ .|||||++++++.+.+..+|||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 3578899999999999999998764 2222 2999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 299 ~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 299 TYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp TTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred CCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 999999999653 3346889999999999999999999998 999999999999999999999999999876443322
Q ss_pred cccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 557 GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
. .....+++.|+|||++.+..++.++|||||||++|||++ |+.||....... .. ..+..+...
T Consensus 375 ~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~-------- 438 (495)
T 1opk_A 375 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VY----ELLEKDYRM-------- 438 (495)
T ss_dssp C-CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH----HHHHTTCCC--------
T ss_pred e-cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCCC--------
Confidence 1 223456789999999999999999999999999999999 999987543222 11 111111110
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
..+......+.+|+.+||+.||++|||+.+|+++|+...
T Consensus 439 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 -ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 011112245678899999999999999999999998764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.53 Aligned_cols=238 Identities=19% Similarity=0.222 Sum_probs=183.4
Q ss_pred ccHHHHHHHhcCcccccccccCCccceEeeeeCC-chhhh-----------------------------hhhhhhhccee
Q 039318 414 FELATIANATDNFSINKKLGEGGFGPVYKGTLAD-GQEIA-----------------------------HRNLVKLLGCC 463 (717)
Q Consensus 414 ~~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va-----------------------------h~niv~l~~~~ 463 (717)
+.+.++....++|++.+.||+|+||.||+++.+. ++.+| ||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 3445555667899999999999999999998753 22211 99999999999
Q ss_pred ecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecc
Q 039318 464 IQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISD 543 (717)
Q Consensus 464 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 543 (717)
.+.+..+|||||+++|+|.+++.+. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++++||+|
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence 9999999999999999999999543 235889999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCccccccceecccccccCccccc-------cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHH
Q 039318 544 FGLARTFVGDEIEGSTKRVVGTYGYMAPEYAS-------DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGH 616 (717)
Q Consensus 544 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~ 616 (717)
||+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||......+ ....
T Consensus 206 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~ 281 (412)
T 2vd5_A 206 FGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE---TYGK 281 (412)
T ss_dssp CTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHH
T ss_pred chhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH---HHHH
Confidence 999987644322 1223468999999999987 4578999999999999999999999986433221 1111
Q ss_pred HHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCC---CChHHHHHH
Q 039318 617 AWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDR---PCMPSVILM 670 (717)
Q Consensus 617 ~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~R---Ps~~evl~~ 670 (717)
....-..-... ..... ....+.+|+.+||+ +|.+| |+++|+++.
T Consensus 282 i~~~~~~~~~p-----~~~~~----~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 282 IVHYKEHLSLP-----LVDEG----VPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHTHHHHCCCC---------C----CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHhcccCcCCC-----ccccC----CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11100000000 00011 12356788999999 99998 589998873
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=341.12 Aligned_cols=232 Identities=30% Similarity=0.423 Sum_probs=184.3
Q ss_pred hcCcccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCceeeEEEeccC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.++|++.++||+|+||.||+|+++.+..+| |||||++++++. .+..++||||++
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~ 265 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA 265 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence 467899999999999999999987554333 999999999986 667899999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+|+|.+++.... ...+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.........
T Consensus 266 ~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 266 KGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp TCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred CCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 999999995432 235788899999999999999999998 9999999999999999999999999998764332211
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
.....+++.|+|||++....++.++|||||||++|||++ |+.||...... ....... ....+.
T Consensus 342 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~---~~~~~~--------- 405 (454)
T 1qcf_A 342 -REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALE---RGYRMP--------- 405 (454)
T ss_dssp -TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHH---HTCCCC---------
T ss_pred -cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---cCCCCC---------
Confidence 123456788999999999999999999999999999999 99998643221 1111111 111110
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM 676 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~ 676 (717)
.+......+.+|+.+||+.||++|||+.+|+++|+....
T Consensus 406 -~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 406 -RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred -CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 011122457789999999999999999999999988753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=323.85 Aligned_cols=235 Identities=24% Similarity=0.419 Sum_probs=172.2
Q ss_pred HhcCcccccccccCCccceEeeeeCCch----hh----------------------------hhhhhhhhcceeecCcee
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQ----EI----------------------------AHRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~v----------------------------ah~niv~l~~~~~~~~~~ 469 (717)
..++|++.+.||+|+||.||+|++.... .+ .||||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 3468999999999999999999865432 11 199999999999877665
Q ss_pred ------eEEEeccCCCChhhHhhhccc---cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCce
Q 039318 470 ------LLIYEFMPNRSLDSFIFDQTK---RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPK 540 (717)
Q Consensus 470 ------~lV~E~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~k 540 (717)
++||||+++++|.+++..... ...+++..+..++.||++||+|||+++ |+||||||+||||+.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 999999999999999965432 225889999999999999999999998 99999999999999999999
Q ss_pred eccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHH
Q 039318 541 ISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWK 619 (717)
Q Consensus 541 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~ 619 (717)
|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~--- 251 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYNY--- 251 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH---
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHHH---
Confidence 999999987644433333334567889999999999999999999999999999999 999987543322 1111
Q ss_pred HhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 620 LWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 620 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
......... +......+.+++.+||+.||++|||+.++++.|+...
T Consensus 252 -~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 252 -LIGGNRLKQ---------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp -HHTTCCCCC---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HhcCCCCCC---------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111111111 1112245778999999999999999999999998654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=317.88 Aligned_cols=220 Identities=22% Similarity=0.313 Sum_probs=174.0
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh-----------------------------hhhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI-----------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-----------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
.++|++.++||+|+||.||+|++.. ++.+ .||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 3689999999999999999998763 3222 199999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 66898888553 346899999999999999999999998 99999999999999999999999999986543
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|..|+... ..+..+...... +
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~~----~ 271 (311)
T 3p1a_A 210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYLP----P 271 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCCC----H
T ss_pred CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCCC----c
Confidence 22 2234579999999999876 7999999999999999999997765321 011122222111 1
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
..... ....+.+++.+||+.||++|||+.|+++.
T Consensus 272 ~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 272 EFTAG----LSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccC----CCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 11111 12457789999999999999999999873
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=320.99 Aligned_cols=219 Identities=25% Similarity=0.317 Sum_probs=178.7
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh-----------------------------hhhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI-----------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-----------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
.++|++.+.||+|+||.||+++... ++.+ .||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 3679999999999999999998753 2211 199999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999954 345889999999999999999999998 99999999999999999999999999986532
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ....... .. +
T Consensus 159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~---~~i~~~~-~~-~--- 222 (318)
T 1fot_A 159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTY---EKILNAE-LR-F--- 222 (318)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHH---HHHHHCC-CC-C---
T ss_pred -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHH---HHHHhCC-CC-C---
Confidence 22356899999999999999999999999999999999999999864321 1111 1112111 10 0
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRP-----CMPSVIL 669 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~ 669 (717)
.. .....+.+++.+||+.||++|| +++++++
T Consensus 223 --p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 223 --PP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --CT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CC----CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 01 1123567889999999999999 8899986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=322.81 Aligned_cols=234 Identities=29% Similarity=0.452 Sum_probs=185.6
Q ss_pred hcCcccccccccCCccceEeeeeC------Cch---------------------------hh-hhhhhhhhcceeecCce
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLA------DGQ---------------------------EI-AHRNLVKLLGCCIQGEE 468 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~---------------------------~v-ah~niv~l~~~~~~~~~ 468 (717)
.++|++.+.||+|+||.||+|+.. .++ .+ .||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 468999999999999999999741 111 11 39999999999999999
Q ss_pred eeEEEeccCCCChhhHhhhccc---------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTK---------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL 533 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll 533 (717)
.++||||+++++|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999965432 124899999999999999999999998 9999999999999
Q ss_pred cCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchh
Q 039318 534 DHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLN 612 (717)
Q Consensus 534 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~ 612 (717)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~- 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF- 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH-
Confidence 9999999999999987654433333334567889999999999999999999999999999998 99998754332211
Q ss_pred HHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 613 LIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.......... .. +......+.+++.+||+.||.+|||+.|++++|+..
T Consensus 258 -----~~~~~~~~~~-~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 258 -----YKMIKEGFRM-LS--------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp -----HHHHHHTCCC-CC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHhccCCCC-CC--------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1111111110 00 011124567889999999999999999999999754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=323.79 Aligned_cols=228 Identities=22% Similarity=0.323 Sum_probs=178.0
Q ss_pred cCcccccccccCCccceEeeeeCCch-hh------------------------------hhhhhhhhcceeecCceeeEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-EI------------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-~v------------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
++|++.+.||+|+||.||+|+.+... .+ .||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999875321 11 299999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999999543 45899999999999999999999998 99999999999999999999999999986432
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCch--hHHHHHHHHhhCCCCcccc
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNL--NLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~ 630 (717)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ................ +
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-~- 238 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-I- 238 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-C-
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-C-
Confidence 21 2234578999999999999999999999999999999999999999653221110 1111111111111111 0
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCCh------HHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCM------PSVIL 669 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~------~evl~ 669 (717)
+......+.+++.+||+.||++||++ .|+++
T Consensus 239 --------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 239 --------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred --------CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 11112356788999999999999996 56655
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=319.31 Aligned_cols=227 Identities=23% Similarity=0.330 Sum_probs=174.9
Q ss_pred hcCcccccccccCCccceEeeeeC-Cchhhh---------------------------hhhhhhhcceeecCc-------
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLA-DGQEIA---------------------------HRNLVKLLGCCIQGE------- 467 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~va---------------------------h~niv~l~~~~~~~~------- 467 (717)
.++|++.+.||+|+||.||+|+.. +++.+| ||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999876 332222 999999999986543
Q ss_pred --------------------------------------------------eeeEEEeccCCCChhhHhhhccccccCChh
Q 039318 468 --------------------------------------------------EKLLIYEFMPNRSLDSFIFDQTKRKLLDWS 497 (717)
Q Consensus 468 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~ 497 (717)
..++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 279999999999999999776555566777
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc----------cccceeccccc
Q 039318 498 KRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE----------GSTKRVVGTYG 567 (717)
Q Consensus 498 ~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt~~ 567 (717)
.++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 88999999999999999998 999999999999999999999999999876543211 11234579999
Q ss_pred ccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHH
Q 039318 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCI 647 (717)
Q Consensus 568 y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 647 (717)
|+|||++.+..++.++||||||+++|||++|..|+. ... .............. .......+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~-~~~~~~~~~~~~~~---------~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERV-RIITDVRNLKFPLL---------FTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHH-HHHHHHHTTCCCHH---------HHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHH-HHHHHhhccCCCcc---------cccCChhHH
Confidence 999999999999999999999999999999876631 001 11111111111111 011223557
Q ss_pred HHHhhccccCCCCCCChHHHHHH
Q 039318 648 HVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 648 ~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+++.+||+.||++|||+.|+++.
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 89999999999999999999873
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=322.49 Aligned_cols=225 Identities=22% Similarity=0.285 Sum_probs=179.3
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hh--------------------------------hhhhhhhhhcceeecCcee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QE--------------------------------IAHRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~--------------------------------vah~niv~l~~~~~~~~~~ 469 (717)
.++|++.+.||+|+||.||+|+.+.. +. +.||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 46899999999999999999976531 11 1299999999999999999
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC----Cceecccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM----NPKISDFG 545 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~Dfg 545 (717)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999943 446899999999999999999999998 99999999999998877 79999999
Q ss_pred ccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM 625 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 625 (717)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .... .+....
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~~~----~i~~~~ 234 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLA----NITAVS 234 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH----HHHTTC
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhcC
Confidence 998764322 223567999999999999999999999999999999999999998643211 1111 111111
Q ss_pred CccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 626 PSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 626 ~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
. .+ +....... ...+.+++.+||+.||++|||+.|+++
T Consensus 235 ~-~~-~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 Y-DF-DEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C-CC-CHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C-CC-CchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 00 11111111 235678999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.09 Aligned_cols=235 Identities=24% Similarity=0.333 Sum_probs=175.6
Q ss_pred cCcccccccccCCccceEeeeeCCchhhh----------------------------hhhhhhhcceeecCceeeEEEec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA----------------------------HRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~va----------------------------h~niv~l~~~~~~~~~~~lV~E~ 475 (717)
++|++.+.||+|+||.||+|+...++.+| ||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999875443322 99999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++ +|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 986 88888843 2345889999999999999999999998 9999999999999999999999999998653221
Q ss_pred ccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccc-----
Q 039318 556 EGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL----- 629 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l----- 629 (717)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+...............
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHCCCChhhchhhhc
Confidence 112345789999999998764 5899999999999999999999998653322 222222222211110000
Q ss_pred ---cchhhh-------ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 630 ---IDAYYQ-------ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 630 ---~d~~~~-------~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.++... ..........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0000111245678999999999999999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=335.00 Aligned_cols=229 Identities=21% Similarity=0.297 Sum_probs=179.0
Q ss_pred HHhcCcccccccccCCccceEeeeeCCc-hh----------------------------hhhhhhhhhcceeecCceeeE
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADG-QE----------------------------IAHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~----------------------------vah~niv~l~~~~~~~~~~~l 471 (717)
...++|++.+.||+|+||.||+|..... +. +.|||||++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3467899999999999999999976422 11 129999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc---CCCCceeccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD---HEMNPKISDFGLAR 548 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~Dfgla~ 548 (717)
||||+++|+|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999999954 345899999999999999999999998 99999999999998 46789999999998
Q ss_pred cccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..... .+..+...
T Consensus 162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~~~~----~i~~~~~~- 231 (444)
T 3soa_A 162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HRLYQ----QIKAGAYD- 231 (444)
T ss_dssp CCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHH----HHHHTCCC-
T ss_pred EecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HHHHH----HHHhCCCC-
Confidence 7644321 22346899999999999999999999999999999999999999864321 11111 11111110
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
...+.. .. ....+.+|+.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~-~~----~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 FPSPEW-DT----VTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CCTTTT-TT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCcccc-cc----CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000 01 12356788999999999999999999984
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=326.56 Aligned_cols=236 Identities=29% Similarity=0.425 Sum_probs=186.0
Q ss_pred HHhcCcccccccccCCccceEeeeeCCch---------------------------------hh-hhhhhhhhcceeecC
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADGQ---------------------------------EI-AHRNLVKLLGCCIQG 466 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~---------------------------------~v-ah~niv~l~~~~~~~ 466 (717)
...++|++.+.||+|+||.||+|+..... .+ .||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 34578999999999999999999864211 11 299999999999999
Q ss_pred ceeeEEEeccCCCChhhHhhhccc-----------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTK-----------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH 535 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~ 535 (717)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 999999999999999999965321 345789999999999999999999998 999999999999999
Q ss_pred CCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHH
Q 039318 536 EMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLI 614 (717)
Q Consensus 536 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~ 614 (717)
++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||.........
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--- 276 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF--- 276 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH---
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH---
Confidence 99999999999986644332223334567889999999999999999999999999999998 99998654332211
Q ss_pred HHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 615 GHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 615 ~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
........... .+......+.+++.+||+.||.+|||+.+|+++|+..
T Consensus 277 ---~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 277 ---YKLVKDGYQMA---------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp ---HHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHhcCCCCC---------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11111111100 0011123567889999999999999999999999753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=324.94 Aligned_cols=229 Identities=15% Similarity=0.139 Sum_probs=180.6
Q ss_pred HhcCcccccccccCCccceEeeee------CCchhhh--------------------------hhhhhhhcceeecCcee
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTL------ADGQEIA--------------------------HRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~va--------------------------h~niv~l~~~~~~~~~~ 469 (717)
..++|.+.++||+|+||.||+|.. ..++.+| |+||+++++++...+..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 457899999999999999999942 2222221 89999999999999999
Q ss_pred eEEEeccCCCChhhHhhhcc--ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC-----------C
Q 039318 470 LLIYEFMPNRSLDSFIFDQT--KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH-----------E 536 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~-----------~ 536 (717)
+|||||+++|+|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+||||+. +
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------C
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccccccc
Confidence 99999999999999996532 3456899999999999999999999998 999999999999998 8
Q ss_pred CCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHH
Q 039318 537 MNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGH 616 (717)
Q Consensus 537 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~ 616 (717)
+.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------ 293 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------ 293 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------
Confidence 99999999999765422222233456799999999999999999999999999999999999999853221110
Q ss_pred HHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCC-CChHHHHHHhcCC
Q 039318 617 AWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDR-PCMPSVILMLGSE 674 (717)
Q Consensus 617 ~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~R-Ps~~evl~~L~~~ 674 (717)
.+......... ...+.+++..||+.+|.+| |++.++.+.|+..
T Consensus 294 ------------~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 294 ------------KPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ------------EECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ------------eechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 00111111111 2344567788999999998 6788888777643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.21 Aligned_cols=232 Identities=24% Similarity=0.271 Sum_probs=159.9
Q ss_pred Ccccc---cccccCCccceEeeeeCCc-hhhh------------------------hhhhhhhcceeecCceeeEEEecc
Q 039318 425 NFSIN---KKLGEGGFGPVYKGTLADG-QEIA------------------------HRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 425 ~~~~~---~~lG~G~fg~Vy~~~~~~~-~~va------------------------h~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
+|++. ++||+|+||.||+|+.... +.+| ||||+++++++.+....++||||+
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 88 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL 88 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence 45543 7899999999999987642 2211 999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC---CceeccccccccccCC
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM---NPKISDFGLARTFVGD 553 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~Dfgla~~~~~~ 553 (717)
++++|.+++.. .+.+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 89 ~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 89 NGGELFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CSCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 99999999954 346899999999999999999999998 99999999999997765 7999999999865432
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||..................+..+.... ....
T Consensus 163 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~ 239 (325)
T 3kn6_A 163 N--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF-EGEA 239 (325)
T ss_dssp -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC-CSHH
T ss_pred C--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC-Cccc
Confidence 2 122346789999999999999999999999999999999999999975443221111222222222222111 0000
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
. . .....+.+|+.+||+.||++|||+.|+++.
T Consensus 240 ~-~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 W-K----NVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp H-H----TSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred c-c----CCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 0 0 112457789999999999999999998853
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=318.89 Aligned_cols=238 Identities=23% Similarity=0.324 Sum_probs=178.5
Q ss_pred HhcCcccccccccCCccceEeeeeCCc-hh-------------------------------hh---hhhhhhhcceeecC
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADG-QE-------------------------------IA---HRNLVKLLGCCIQG 466 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~-------------------------------va---h~niv~l~~~~~~~ 466 (717)
..++|++.++||+|+||.||+|+.... +. +. ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467999999999999999999985321 10 11 99999999999875
Q ss_pred c-----eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCcee
Q 039318 467 E-----EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKI 541 (717)
Q Consensus 467 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl 541 (717)
. ..++||||++ ++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 5799999997 5999998543 2334899999999999999999999998 999999999999999999999
Q ss_pred ccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHh
Q 039318 542 SDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLW 621 (717)
Q Consensus 542 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 621 (717)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+.......
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~ 235 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLI 235 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHH
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHh
Confidence 9999998654322 2235678999999999999999999999999999999999999986533222 222222222
Q ss_pred hCCCCccc------cchhh--hccCCH-----HHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 622 NNGMPSQL------IDAYY--QESCNL-----AEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 622 ~~~~~~~l------~d~~~--~~~~~~-----~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
........ ..... ...... .....+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 11110000 00000 000111 122467789999999999999999999873
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=325.76 Aligned_cols=239 Identities=26% Similarity=0.423 Sum_probs=188.4
Q ss_pred HHHHhcCcccccccccCCccceEeeeeCC------chh---------------------------hhhhhhhhhcceeec
Q 039318 419 IANATDNFSINKKLGEGGFGPVYKGTLAD------GQE---------------------------IAHRNLVKLLGCCIQ 465 (717)
Q Consensus 419 i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~---------------------------vah~niv~l~~~~~~ 465 (717)
+....++|++.+.||+|+||.||+|+... ++. +.||||+++++++.+
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 34456789999999999999999987542 111 129999999999999
Q ss_pred CceeeEEEeccCCCChhhHhhhccc-------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC
Q 039318 466 GEEKLLIYEFMPNRSLDSFIFDQTK-------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN 538 (717)
Q Consensus 466 ~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~ 538 (717)
.+..++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCe
Confidence 9999999999999999999965321 245688999999999999999999998 999999999999999999
Q ss_pred ceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHH
Q 039318 539 PKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHA 617 (717)
Q Consensus 539 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~ 617 (717)
+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ..
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~---- 249 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QV---- 249 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HH----
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HH----
Confidence 99999999986644333333334567899999999999999999999999999999999 88998643211 11
Q ss_pred HHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCC
Q 039318 618 WKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM 676 (717)
Q Consensus 618 ~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~ 676 (717)
............ +......+.+++.+||+.||++||++.|+++.|+....
T Consensus 250 ~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 LRFVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111112211111 11122356788999999999999999999999987643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=327.32 Aligned_cols=231 Identities=19% Similarity=0.222 Sum_probs=172.1
Q ss_pred cCcccc-cccccCCccceEeeeeCCc-hhh----------------------hhhhhhhhcceeec----CceeeEEEec
Q 039318 424 DNFSIN-KKLGEGGFGPVYKGTLADG-QEI----------------------AHRNLVKLLGCCIQ----GEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~-~~lG~G~fg~Vy~~~~~~~-~~v----------------------ah~niv~l~~~~~~----~~~~~lV~E~ 475 (717)
++|.+. +.||+|+||.||+++.... +.+ .||||+++++++.. .+..+|||||
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~ 140 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEe
Confidence 567776 6899999999999987643 212 29999999998875 6778999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC---CCCceeccccccccccC
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH---EMNPKISDFGLARTFVG 552 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~Dfgla~~~~~ 552 (717)
|++|+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||||+. ++.+||+|||+++....
T Consensus 141 ~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 141 LDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp CCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred CCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 9999999999543 2345899999999999999999999998 999999999999997 78899999999986543
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||................. .+... +..+
T Consensus 217 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~~~~~-~~~~ 289 (400)
T 1nxk_A 217 HN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQYE-FPNP 289 (400)
T ss_dssp -------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---HTCCC-CCTT
T ss_pred CC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---cCccc-CCCc
Confidence 21 22356889999999999999999999999999999999999999975443321111111111 11100 0000
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.. . .....+.+|+.+||+.||++|||+.|+++.
T Consensus 290 ~~-~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 EW-S----EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TT-T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cc-c----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0 112356789999999999999999999984
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=310.79 Aligned_cols=228 Identities=29% Similarity=0.457 Sum_probs=173.9
Q ss_pred hcCcccccccccCCccceEeeeeCCch-----------------------------hhhhhhhhhhcceeecCceeeEEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ-----------------------------EIAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-----------------------------~vah~niv~l~~~~~~~~~~~lV~ 473 (717)
.++|++.+.||+|+||.||+|++.... .+.||||+++++++.+.+..++||
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 368999999999999999999764211 112999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC--------CCCceecccc
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH--------EMNPKISDFG 545 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~--------~~~~kl~Dfg 545 (717)
||+++++|.+++. .+.+++..+..++.|+++||+|||+++..+|+||||||+|||++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999983 346899999999999999999999987556899999999999986 6789999999
Q ss_pred ccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM 625 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 625 (717)
+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ..........
T Consensus 162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~ 231 (271)
T 3dtc_A 162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYGVAMNKL 231 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHTSCC
T ss_pred ccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHhhhcCCC
Confidence 998654322 224578999999999999999999999999999999999999986432111 1111111111
Q ss_pred CccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 626 PSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 626 ~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
.... +......+.+++.+||+.+|++|||+.|++++|+.
T Consensus 232 ~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 232 ALPI---------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCC---------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111 11112457788999999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=311.67 Aligned_cols=240 Identities=18% Similarity=0.258 Sum_probs=180.9
Q ss_pred HHhcCcccccccccCCccceEeeeeCC-chhhh------------------------hhhhhhhccee-ecCceeeEEEe
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLAD-GQEIA------------------------HRNLVKLLGCC-IQGEEKLLIYE 474 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va------------------------h~niv~l~~~~-~~~~~~~lV~E 474 (717)
...++|++.+.||+|+||.||+|+... ++.+| |++++..+..+ .+.+..++|||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 345789999999999999999998643 22221 66666655554 67778899999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE---cCCCCceecccccccccc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL---DHEMNPKISDFGLARTFV 551 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~Dfgla~~~~ 551 (717)
|+ +++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred cc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 99 99999999532 345899999999999999999999998 9999999999999 789999999999998764
Q ss_pred CCccc-----cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC
Q 039318 552 GDEIE-----GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626 (717)
Q Consensus 552 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (717)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+............
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 43221 1223567999999999999999999999999999999999999999865544433333222211101000
Q ss_pred ccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 627 SQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 627 ~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
....... ...+.+++.+||+.+|++||++.+|+++|+...
T Consensus 240 -----~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 240 -----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp -----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred -----hhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 0000111 235778899999999999999999999997653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=325.54 Aligned_cols=223 Identities=24% Similarity=0.335 Sum_probs=178.5
Q ss_pred HhcCcccccccccCCccceEeeeeCCc-hhh------------------------------hhhhhhhhcceeecCceee
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADG-QEI------------------------------AHRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v------------------------------ah~niv~l~~~~~~~~~~~ 470 (717)
..++|++.+.||+|+||.||+|+.+.. +.+ .||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 346899999999999999999987642 111 1999999999999999999
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
+||||+++|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999999543 35899999999999999999999998 999999999999999999999999999864
Q ss_pred cCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ..... ... +
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~---~i~~~-~~~-~- 240 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ---SIMEH-NVA-Y- 240 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHC-CCC-C-
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHHH---HHHhC-CCC-C-
Confidence 3222 2234578999999999999999999999999999999999999998643221 1111 11111 110 0
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPC-----MPSVIL 669 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----~~evl~ 669 (717)
.. .....+.+++.+||+.||++||+ ++++++
T Consensus 241 ----p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 241 ----PK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ----CT----TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ----CC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 01 11235678899999999999996 466665
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=327.37 Aligned_cols=228 Identities=23% Similarity=0.298 Sum_probs=170.2
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hhh-------------------------hhhhhhhhcceeecCceeeEEEecc
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QEI-------------------------AHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v-------------------------ah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
.++|++.+.||+|+||.||+++.... +.+ .||||+++++++.+.+..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 46899999999999999999987632 222 2999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC--ceeccccccccccCCc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN--PKISDFGLARTFVGDE 554 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~--~kl~Dfgla~~~~~~~ 554 (717)
++++|.+++.. .+.+++..+..++.||++||+|||+++ |+||||||+||||+.++. +||+|||+++.....
T Consensus 99 ~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 99 SGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp CSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 99999999954 335899999999999999999999998 999999999999987766 999999999853222
Q ss_pred cccccceecccccccCccccccCCCCcc-ccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVK-SDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||............ ......... . +.
T Consensus 172 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~~~~~~~~-~-~~--- 242 (361)
T 3uc3_A 172 --SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT--IQRILSVKY-S-IP--- 242 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH--HHHHHTTCC-C-CC---
T ss_pred --CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH--HHHHhcCCC-C-CC---
Confidence 12234679999999999988887655 89999999999999999999754433322211 111111110 0 00
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
........+.+|+.+||+.||++|||+.|+++.
T Consensus 243 ----~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 ----DDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ----CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 000112456789999999999999999999984
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.35 Aligned_cols=219 Identities=22% Similarity=0.289 Sum_probs=176.1
Q ss_pred hcCcccccccccCCccceEeeeeCCchh-------------------------------hhhhhhhhhcceeecCceeeE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQE-------------------------------IAHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-------------------------------vah~niv~l~~~~~~~~~~~l 471 (717)
.++|++.+.||+|+||.||+|+.+.... +.||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 3689999999999999999998754221 129999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999954 345788999999999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ...... . .+
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~---~i~~~~-~-~~-- 258 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYD---NILNKP-L-QL-- 258 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---HHHH---HHHHSC-C-CC--
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHHH---HHHhcc-c-CC--
Confidence 221 2234578999999999999999999999999999999999999998643211 1111 111111 1 00
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHH
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPS 666 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~e 666 (717)
... ....+.+|+.+||+.||.+||++.+
T Consensus 259 ---~~~----~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 259 ---KPN----ITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ---CSS----SCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ---CCC----CCHHHHHHHHHHcccCHHhCCCCCC
Confidence 011 1235678899999999999999854
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.48 Aligned_cols=243 Identities=26% Similarity=0.366 Sum_probs=177.6
Q ss_pred hcCcccccccccCCccceEeeeeCCchhh-------------------------hhhhhhhhcceee-----cCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEI-------------------------AHRNLVKLLGCCI-----QGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~v-------------------------ah~niv~l~~~~~-----~~~~~~lV 472 (717)
.++|++.+.||+|+||.||+|+... +.+ .||||+++++.+. .....++|
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDE-RPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETT-EEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEECC-eEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 3689999999999999999997642 221 2999999997543 33467899
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhc---------CCCcEEeccCCCCceEEcCCCCceecc
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD---------SRLRIIHRDLKASNVLLDHEMNPKISD 543 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~---------~~~~ivHrDlkp~NIll~~~~~~kl~D 543 (717)
|||+++|+|.+++... ..++..+..++.||++||+|||++ + |+||||||+||||+.++.+||+|
T Consensus 91 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp ECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECC
T ss_pred EecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEee
Confidence 9999999999999432 348889999999999999999998 7 99999999999999999999999
Q ss_pred ccccccccCCcc------ccccceecccccccCcccccc-------CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCc
Q 039318 544 FGLARTFVGDEI------EGSTKRVVGTYGYMAPEYASD-------GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKN 610 (717)
Q Consensus 544 fgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~ 610 (717)
||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..|+........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999987643221 111224579999999999987 4567899999999999999999877543222111
Q ss_pred -hhHH----------HHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 611 -LNLI----------GHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 611 -~~~~----------~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.... ...............+.... .........+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 1000 01111111111111111111 112234556889999999999999999999999997654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=320.16 Aligned_cols=235 Identities=20% Similarity=0.321 Sum_probs=174.6
Q ss_pred cCcccccccccCCccceEeeeeCC-chhh---------------------------hhhhhhhhcceeecCceeeEEEec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEI---------------------------AHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v---------------------------ah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
++|.+.++||+|+||.||+|+... ++.+ .||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 579999999999999999998753 2222 299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
++ ++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 98 4888888543 346889999999999999999999998 9999999999999999999999999998653222
Q ss_pred ccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC---ccccc
Q 039318 556 EGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP---SQLID 631 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~l~d 631 (717)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .............. .....
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhc
Confidence 12234578999999999876 568999999999999999999999987543332 22222222221111 11110
Q ss_pred hh-hh-------cc-----CCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 632 AY-YQ-------ES-----CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 632 ~~-~~-------~~-----~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.. .. .. ........+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00 00 00 00011235678999999999999999999998
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=315.30 Aligned_cols=238 Identities=25% Similarity=0.384 Sum_probs=177.8
Q ss_pred hcCcccccccccCCccceEeeeeC-----Cchhh--------------------------hhhhhhhhcceeecC--cee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLA-----DGQEI--------------------------AHRNLVKLLGCCIQG--EEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~v--------------------------ah~niv~l~~~~~~~--~~~ 469 (717)
.++|++.++||+|+||.||+|++. .++.+ .||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 468999999999999999999842 22222 299999999998654 458
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999999553 335899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccc-cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCC---------CchhHHHHHHH
Q 039318 550 FVGDEIE-GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSD---------KNLNLIGHAWK 619 (717)
Q Consensus 550 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~---------~~~~~~~~~~~ 619 (717)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6433211 1122345778899999999999999999999999999999999997642110 00011111112
Q ss_pred HhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 620 LWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 620 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
......... .+......+.+++.+||+.||++|||+.||++.|+..
T Consensus 244 ~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 244 LLKNNGRLP---------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHTTCCCC---------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccCcCC---------CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 221111111 1112234577899999999999999999999999754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=314.25 Aligned_cols=236 Identities=26% Similarity=0.440 Sum_probs=171.6
Q ss_pred hcCcccccccccCCccceEeeeeCCch--------------------------hhhhhhhhhhcceeecCceeeEEEecc
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ--------------------------EIAHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~--------------------------~vah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
.++|++.++||+|+||.||+|+....- .+.||||++++++. ..+..++||||+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~ 101 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWC 101 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred ccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEec
Confidence 468999999999999999999764321 11299999999965 556789999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
++++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 102 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 102 EGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp CEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred CCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccccc
Confidence 99999999943 3456899999999999999999999998 999999999999999999999999999865433323
Q ss_pred cccceecccccccCccccc---cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 557 GSTKRVVGTYGYMAPEYAS---DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
.......||+.|+|||++. +..++.++||||||+++|||++|+.||......+ .. ...............
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~----~~~~~~~~~~~~~~~- 249 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QI----IEMVGRGSLSPDLSK- 249 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HH----HHHHHHTSCCCCTTS-
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HH----HHHhcccccCcchhh-
Confidence 3334567999999999986 6678999999999999999999999986433221 11 111111111111110
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
. .......+.+++.+||+.+|++||++.+++++|+...
T Consensus 250 ~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 250 V----RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp S----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred c----cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 0 1112245778899999999999999999999998654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=313.22 Aligned_cols=237 Identities=20% Similarity=0.266 Sum_probs=177.0
Q ss_pred cCcccccccccCCccceEeeeeCCc-hhh----------------------------hhhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QEI----------------------------AHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v----------------------------ah~niv~l~~~~~~~~~~~lV~E 474 (717)
++|++.++||+|+||.||+|+.... +.+ .||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999987532 111 29999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++ +|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9986 55555532 2356899999999999999999999998 9999999999999999999999999998754322
Q ss_pred cccccceecccccccCccccccCC-CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch-
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGL-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA- 632 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~- 632 (717)
.......||+.|+|||++.+.. ++.++|||||||++|||++|..|+-. .......+..................
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~--~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC--CCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 1223467899999999998766 89999999999999999998888532 22222333333332221111100000
Q ss_pred --------------hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 633 --------------YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 633 --------------~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.............+.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000011123456789999999999999999999873
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=322.41 Aligned_cols=227 Identities=25% Similarity=0.327 Sum_probs=172.1
Q ss_pred HhcCcccccccccCCccceEeeeeCCchhhh----------------------------h--hhhhhhcceeecCceeeE
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQEIA----------------------------H--RNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va----------------------------h--~niv~l~~~~~~~~~~~l 471 (717)
..++|++.+.||+|+||.||++...+++.+| | |||+++++++.+.+..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 3567999999999999999999876554332 4 999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||| +.+++|.+++.. .+.+++..+..++.||++||.|||+++ |+||||||+||||+ ++.+||+|||+++...
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 568899999954 346889999999999999999999998 99999999999997 5789999999998765
Q ss_pred CCccccccceecccccccCcccccc-----------CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHH
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASD-----------GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKL 620 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 620 (717)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ........
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~ 233 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAI 233 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHH
Confidence 4433333445689999999999865 6789999999999999999999999863221 11112222
Q ss_pred hhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 621 WNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 621 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
......... +......+.+++.+||+.||.+|||+.|+++.
T Consensus 234 ~~~~~~~~~---------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 234 IDPNHEIEF---------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HCTTSCCCC---------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcCCcccCC---------cccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 211111111 11112356788999999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=324.40 Aligned_cols=232 Identities=22% Similarity=0.328 Sum_probs=170.7
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh-----------------------------hhhhhhhhcceeecCcee---
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI-----------------------------AHRNLVKLLGCCIQGEEK--- 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-----------------------------ah~niv~l~~~~~~~~~~--- 469 (717)
.++|++.+.||+|+||.||+|+... ++.+ .||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4689999999999999999998642 2211 199999999998776544
Q ss_pred -eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 470 -LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 470 -~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
++||||+++++|.+++.. ...+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 999999999999999954 345899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCccc-cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 549 TFVGDEIE-GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 549 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCCC
Confidence 65433211 12234679999999999999999999999999999999999999986432211 111222221111
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH-HhcC
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL-MLGS 673 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~-~L~~ 673 (717)
....... ....+.+++.+||+.||++||+..++++ .|..
T Consensus 239 ---~~~~~~~----~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 239 ---PSARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp ---HHHHSTT----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---cccccCC----CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 0000111 1235678899999999999997766654 4433
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=320.24 Aligned_cols=228 Identities=21% Similarity=0.253 Sum_probs=178.9
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hhh-------------------------------hhhhhhhhcceeecCceee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QEI-------------------------------AHRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v-------------------------------ah~niv~l~~~~~~~~~~~ 470 (717)
.++|++.+.||+|+||.||+|+.+.. +.+ .||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35799999999999999999986532 111 1999999999999999999
Q ss_pred EEEeccCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC---ceeccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN---PKISDFGL 546 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~Dfgl 546 (717)
+||||+++++|.+++.... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998885543 2345889999999999999999999998 999999999999987655 99999999
Q ss_pred cccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC
Q 039318 547 ARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626 (717)
Q Consensus 547 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (717)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .... ........
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~----~~i~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLF----EGIIKGKY 249 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHH----HHHHHTCC
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHH----HHHHcCCC
Confidence 987644321 2234679999999999999999999999999999999999999986421 1111 11111111
Q ss_pred ccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 627 SQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 627 ~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.. .+..... ....+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~--~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 KM--NPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC--CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--Ccccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0000011 1235678999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.57 Aligned_cols=229 Identities=25% Similarity=0.364 Sum_probs=170.3
Q ss_pred hcCcccccccccCCccceEeeeeCCch----h---------------------------hhhhhhhhhcceeecCceeeE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ----E---------------------------IAHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~---------------------------vah~niv~l~~~~~~~~~~~l 471 (717)
.++|++.+.||+|+||.||+|++.... . +.||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 468999999999999999999864321 0 11999999999984 567899
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++++|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999999542 345899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
..... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ .... ........+
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~----i~~~~~~~~- 238 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR----IENGERLPM- 238 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTCCCCC-
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHH----HHcCCCCCC-
Confidence 33211 1223456789999999999999999999999999999996 999987543322 1111 111111111
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
+......+.+++.+||+.||++||++.++++.|+..
T Consensus 239 --------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 239 --------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111224567889999999999999999999998753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=322.57 Aligned_cols=234 Identities=29% Similarity=0.428 Sum_probs=185.2
Q ss_pred hcCcccccccccCCccceEeeeeCC--------chh---------------------------h-hhhhhhhhcceeecC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD--------GQE---------------------------I-AHRNLVKLLGCCIQG 466 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~---------------------------v-ah~niv~l~~~~~~~ 466 (717)
.++|++.+.||+|+||.||+|+... +.. + .||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 4789999999999999999997531 111 1 399999999999999
Q ss_pred ceeeEEEeccCCCChhhHhhhccc-------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTK-------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL 533 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll 533 (717)
+..++||||+++++|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+||||
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999965432 234889999999999999999999998 9999999999999
Q ss_pred cCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchh
Q 039318 534 DHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLN 612 (717)
Q Consensus 534 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~ 612 (717)
+.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence 9999999999999987654433233334567889999999999899999999999999999999 999986432211
Q ss_pred HHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 613 LIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.. ..+........ +......+.+++.+||+.+|.+||++.+|++.|+...
T Consensus 268 ~~----~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 268 LF----KLLKEGHRMDK---------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HH----HHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HHHhcCCCCCC---------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 11111111111 1112235678899999999999999999999997654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=338.09 Aligned_cols=232 Identities=28% Similarity=0.456 Sum_probs=179.9
Q ss_pred hcCcccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCceeeEEEeccC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.++|++.++||+|+||.||+|+++.+..+| ||||+++++++.+ +..++||||++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 357889999999999999999987654332 9999999999876 77899999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 262 ~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~- 336 (452)
T 1fmk_A 262 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 336 (452)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCcee-
Confidence 99999999542 2345889999999999999999999998 999999999999999999999999999876433221
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ... .....+....
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~----~~i~~~~~~~-------- 401 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL----DQVERGYRMP-------- 401 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH----HHHHTTCCCC--------
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCCC--------
Confidence 1223456789999999999999999999999999999999 99998643221 111 1111211100
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM 676 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~ 676 (717)
.+......+.+++.+||+.+|++|||+++|+++|+....
T Consensus 402 -~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 402 -CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 111123456789999999999999999999999988753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.03 Aligned_cols=226 Identities=24% Similarity=0.331 Sum_probs=172.4
Q ss_pred hcCcccccccccCCccceEeeeeCCchhhh------------------------------hhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA------------------------------HRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va------------------------------h~niv~l~~~~~~~~~~~lV 472 (717)
.++|++.+.||+|+||.||++....++.+| ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 456999999999999999999876543222 59999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|| +.+++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+||||+ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 6788999999543 36788899999999999999999998 99999999999995 57999999999987654
Q ss_pred CccccccceecccccccCcccccc-----------CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHh
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASD-----------GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLW 621 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 621 (717)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .........
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~ 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHh
Confidence 433333345689999999999865 4689999999999999999999999864221 111112222
Q ss_pred hCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 622 NNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 622 ~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
........ ... ....+.+|+.+||+.||++||++.||++.
T Consensus 282 ~~~~~~~~-----~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 DPNHEIEF-----PDI----PEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CTTSCCCC-----CCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CccccCCC-----Ccc----chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111111 001 12356788999999999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=323.37 Aligned_cols=218 Identities=21% Similarity=0.235 Sum_probs=178.7
Q ss_pred cCcccccccccCCccceEeeeeCC-chhh-----------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEI-----------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-----------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||.||+++... ++.+ .||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 689999999999999999998753 2211 1999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++++|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999543 35899999999999999999999998 999999999999999999999999999875332
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ..+..+... +
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~----~~i~~~~~~-~---- 257 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIY----EKIVSGKVR-F---- 257 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHCCCC-C----
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---HHHH----HHHHcCCCC-C----
Confidence 2356899999999999999999999999999999999999999864321 1111 111111111 0
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPC-----MPSVIL 669 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----~~evl~ 669 (717)
.. .....+.+++.+||+.||++||+ ++||++
T Consensus 258 -p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 258 -PS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CC----CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 01 11235678899999999999998 888876
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=321.55 Aligned_cols=226 Identities=22% Similarity=0.290 Sum_probs=179.2
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hh--------------------------------hhhhhhhhhcceeecCcee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QE--------------------------------IAHRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~--------------------------------vah~niv~l~~~~~~~~~~ 469 (717)
.++|.+.+.||+|+||.||+|+.... +. +.||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 35799999999999999999986431 11 1299999999999999999
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC----Cceecccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM----NPKISDFG 545 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~Dfg 545 (717)
++||||+++++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999943 456899999999999999999999998 99999999999999887 79999999
Q ss_pred ccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM 625 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 625 (717)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ........ ..
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~----~~ 233 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVSA----VN 233 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHH----TC
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHHh----cC
Confidence 998764322 223467999999999999999999999999999999999999998643221 11111111 10
Q ss_pred CccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 626 PSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 626 ~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
. ...+.. ... ....+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~-~~~~~~-~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 Y-EFEDEY-FSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp C-CCCHHH-HTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C-CcCccc-ccc----CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 000110 011 12356788999999999999999999984
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=322.52 Aligned_cols=230 Identities=22% Similarity=0.333 Sum_probs=180.2
Q ss_pred HhcCcccccccccCCccceEeeeeCCc-hhh-----------------------hhhhhhhhcceeecCceeeEEEeccC
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADG-QEI-----------------------AHRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v-----------------------ah~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
..++|++.+.||+|+||.||+++.+.. +.+ .||||+++++++.+.+..++||||++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 356899999999999999999987642 211 29999999999999999999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC----CCceeccccccccccCC
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE----MNPKISDFGLARTFVGD 553 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~----~~~kl~Dfgla~~~~~~ 553 (717)
+|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||+..+ +.+||+|||+++.....
T Consensus 100 gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 100 GGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp SCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 9999999954 346899999999999999999999998 9999999999998543 34999999999875433
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....+....+... +..+... +...
T Consensus 174 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~----i~~~~~~-~~~~- 245 (342)
T 2qr7_A 174 N--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR----IGSGKFS-LSGG- 245 (342)
T ss_dssp T--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH----HHHCCCC-CCST-
T ss_pred C--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH----HccCCcc-cCcc-
Confidence 2 123356789999999999988899999999999999999999999975433322222211 1111111 0000
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.. ......+.+|+.+||+.||++||++.++++
T Consensus 246 ~~----~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 246 YW----NSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TT----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 011235678899999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=321.36 Aligned_cols=228 Identities=23% Similarity=0.306 Sum_probs=178.6
Q ss_pred cCcccccccccCCccceEeeeeC----Cchh------------------------------h-hhhhhhhhcceeecCce
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLA----DGQE------------------------------I-AHRNLVKLLGCCIQGEE 468 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~------------------------------v-ah~niv~l~~~~~~~~~ 468 (717)
++|++.++||+|+||.||+++.. .++. + .||||+++++++.+.+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 67999999999999999999863 2211 1 18999999999999999
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
.++||||+++++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999543 35889999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCccccccceecccccccCcccccc--CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYASD--GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (717)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.. ........
T Consensus 208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~~~~~~ 284 (355)
T 1vzo_A 208 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--RILKSEPP 284 (355)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--HHHHCCCC
T ss_pred ecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH--HHhccCCC
Confidence 6543322 12234679999999999986 3478999999999999999999999975543333222211 11111100
Q ss_pred ccccchhhhccCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHHh
Q 039318 627 SQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP-----CMPSVILML 671 (717)
Q Consensus 627 ~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~~L 671 (717)
.+......+.+|+.+||+.||++|| ++.|+++..
T Consensus 285 -----------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 285 -----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -----------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0111123467889999999999999 899998854
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=317.53 Aligned_cols=238 Identities=24% Similarity=0.326 Sum_probs=165.2
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hhh---------------------------hhhhhhhhcceeecCceeeEEEe
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QEI---------------------------AHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v---------------------------ah~niv~l~~~~~~~~~~~lV~E 474 (717)
.++|++.++||+|+||.||+|+.... +.+ .||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46899999999999999999976532 211 29999999999999999999999
Q ss_pred ccCCCChhhHhhhcc---ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 475 FMPNRSLDSFIFDQT---KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
|++ ++|.+++.... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999885432 1235889999999999999999999998 9999999999999999999999999998754
Q ss_pred CCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC---Cc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM---PS 627 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 627 (717)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+........... ..
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhh
Confidence 321 11234578999999999876 468999999999999999999999987543322 2222222111100 00
Q ss_pred cc-----------------cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 628 QL-----------------IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 628 ~l-----------------~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.. +...+...........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00 0000000000011235778999999999999999999876
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.34 Aligned_cols=220 Identities=25% Similarity=0.355 Sum_probs=177.3
Q ss_pred cCcccccccccCCccceEeeeeCCc-hhh-----------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QEI-----------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v-----------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
++|.+.+.||+|+||.||+|+.... +.+ .||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6899999999999999999987432 211 1999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+ +|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 6889888854 345899999999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccceecccccccCccccccCCC-CccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+ ....
T Consensus 162 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-------~~~~------- 224 (336)
T 3h4j_B 162 N---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-------NSCV------- 224 (336)
T ss_dssp B---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-------CSSC-------
T ss_pred c---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-------HcCC-------
Confidence 2 2335689999999999988876 78999999999999999999998653322211100 0000
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
. ..+......+.+++.+||+.||.+|||++|+++.
T Consensus 225 -~--~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 -Y--VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -C--CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -C--CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0 0011112356789999999999999999999873
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.49 Aligned_cols=243 Identities=28% Similarity=0.441 Sum_probs=188.4
Q ss_pred ccHHHHHHHhcCcccccccccCCccceEeeeeC------Cchhh----------------------------hhhhhhhh
Q 039318 414 FELATIANATDNFSINKKLGEGGFGPVYKGTLA------DGQEI----------------------------AHRNLVKL 459 (717)
Q Consensus 414 ~~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~v----------------------------ah~niv~l 459 (717)
+.........++|++.+.||+|+||.||+|+.. .++.+ .||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 344455556789999999999999999999742 11111 18999999
Q ss_pred cceeecCc-eeeEEEeccCCCChhhHhhhccc-------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEecc
Q 039318 460 LGCCIQGE-EKLLIYEFMPNRSLDSFIFDQTK-------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRD 525 (717)
Q Consensus 460 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrD 525 (717)
++++...+ ..++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99987654 58999999999999999965332 123788999999999999999999998 99999
Q ss_pred CCCCceEEcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCC
Q 039318 526 LKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGF 604 (717)
Q Consensus 526 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~ 604 (717)
|||+||||+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987654433333344678899999999999999999999999999999998 9999865
Q ss_pred CCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 605 YHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
...... .. ............ ......+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 254 ~~~~~~--~~----~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKIDEE--FC----RRLKEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCCSHH--HH----HHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhHH--HH----HHhccCccCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 433221 11 111111111110 01123567889999999999999999999999754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=326.16 Aligned_cols=244 Identities=19% Similarity=0.238 Sum_probs=179.9
Q ss_pred hcCcccccccccC--CccceEeeeeCC-chhh----------------------------hhhhhhhhcceeecCceeeE
Q 039318 423 TDNFSINKKLGEG--GFGPVYKGTLAD-GQEI----------------------------AHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 423 ~~~~~~~~~lG~G--~fg~Vy~~~~~~-~~~v----------------------------ah~niv~l~~~~~~~~~~~l 471 (717)
.++|++.++||+| +||.||+|+... ++.+ .|||||++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 999999999763 2222 19999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
|||||++++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999999653 2345899999999999999999999998 9999999999999999999999999987543
Q ss_pred CCcc-----ccccceecccccccCcccccc--CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHH-HHHHHHhhC
Q 039318 552 GDEI-----EGSTKRVVGTYGYMAPEYASD--GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLI-GHAWKLWNN 623 (717)
Q Consensus 552 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~ 623 (717)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ ......+..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 2211 111223578999999999987 67999999999999999999999999754333211110 000000000
Q ss_pred C-------------------CCccccch---h------hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 624 G-------------------MPSQLIDA---Y------YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 624 ~-------------------~~~~l~d~---~------~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
. ........ . ............+.+|+.+||+.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 00000000 0 0000011112457889999999999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.77 Aligned_cols=227 Identities=22% Similarity=0.333 Sum_probs=178.9
Q ss_pred HhcCcccccccccCCccceEeeeeCCc-hh----------------------------hhhhhhhhhcceeecCceeeEE
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADG-QE----------------------------IAHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~----------------------------vah~niv~l~~~~~~~~~~~lV 472 (717)
..++|++.+.||+|+||.||+|+.+.. +. +.||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 356899999999999999999986532 11 1299999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC---Cceecccccccc
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM---NPKISDFGLART 549 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~Dfgla~~ 549 (717)
|||+++++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+||||+.++ .+||+|||+++.
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999999843 456899999999999999999999998 99999999999998654 599999999987
Q ss_pred ccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 550 FVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 550 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...... ...+... .
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~~----i~~~~~~-~ 249 (362)
T 2bdw_A 181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQ----IKAGAYD-Y 249 (362)
T ss_dssp CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH----HHHTCCC-C
T ss_pred ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHH----HHhCCCC-C
Confidence 64322 22346799999999999999999999999999999999999999864321 111111 1111110 0
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
..+.. ... ...+.+|+.+||+.||++||++.++++.
T Consensus 250 ~~~~~-~~~----~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PSPEW-DTV----TPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CTTGG-GGS----CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Ccccc-cCC----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 111 2356788999999999999999998864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=312.03 Aligned_cols=230 Identities=28% Similarity=0.449 Sum_probs=184.3
Q ss_pred hcCcccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCceeeEEEeccC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.++|++.+.||+|+||.||+|+..+++.++ ||||+++++++.+.+..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 367999999999999999999886554332 9999999999999999999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++... ...+++..+..++.|+++||.|||+++ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 160 (267)
T 3t9t_A 87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 160 (267)
T ss_dssp TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-c
Confidence 99999999543 346889999999999999999999998 99999999999999999999999999986543221 1
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ... .......... .
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~----~~i~~~~~~~-~------ 226 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVV----EDISTGFRLY-K------ 226 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH----HHHHTTCCCC-C------
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHH----HHHhcCCcCC-C------
Confidence 1223467789999999998999999999999999999999 89998643211 111 1111111100 0
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
+......+.+++.+||+.+|++||++.+++++|+..
T Consensus 227 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 227 --PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011123567889999999999999999999999754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=332.45 Aligned_cols=226 Identities=27% Similarity=0.370 Sum_probs=180.2
Q ss_pred hcCcccccccccCCccceEeeeeCCchhh------------------------hhhhhhhhcceeecCc-eeeEEEeccC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEI------------------------AHRNLVKLLGCCIQGE-EKLLIYEFMP 477 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~v------------------------ah~niv~l~~~~~~~~-~~~lV~E~~~ 477 (717)
.++|++.++||+|+||.||+|++.. +.+ .|||||++++++.+.+ ..++||||++
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~~-~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~ 270 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYRG-NKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-EEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred hHHeEEEeeecCcCCeeEEEEEecC-CeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence 4678999999999999999998753 222 2999999999987665 7899999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 271 ~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 342 (450)
T 1k9a_A 271 KGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 342 (450)
T ss_dssp TCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc----
Confidence 99999999653 2334789999999999999999999998 999999999999999999999999999854321
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+... ....+....
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~-------~i~~~~~~~-------- 406 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-------RVEKGYKMD-------- 406 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH-------HHHTTCCCC--------
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCCCCC--------
Confidence 123467889999999999999999999999999999998 999987544332211 111111111
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.+......+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 407 -~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 407 -APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111224567889999999999999999999999754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.16 Aligned_cols=238 Identities=18% Similarity=0.259 Sum_probs=182.1
Q ss_pred hcCcccccccccCCccceEeeeeC-Cchhhh------------------------hhhhhhhccee-ecCceeeEEEecc
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLA-DGQEIA------------------------HRNLVKLLGCC-IQGEEKLLIYEFM 476 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~va------------------------h~niv~l~~~~-~~~~~~~lV~E~~ 476 (717)
.++|++.+.||+|+||.||+|+.. .++.++ |++++..+..+ .+.+..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 578999999999999999999863 232222 66655555544 6677889999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE---cCCCCceeccccccccccCC
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL---DHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~Dfgla~~~~~~ 553 (717)
+++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 88 -~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 88 -GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp -CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred -CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 9999999953 2346899999999999999999999998 9999999999999 58899999999999876543
Q ss_pred cccc-----ccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 554 EIEG-----STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 554 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........................
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 239 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-- 239 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH--
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch--
Confidence 2211 123567999999999999999999999999999999999999999865544333333222211100000
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
....... ...+.+++.+||+.||++||++.+|++.|+...
T Consensus 240 ---~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 240 ---EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp ---HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred ---HHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 0001111 235778899999999999999999999997653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=333.38 Aligned_cols=222 Identities=21% Similarity=0.281 Sum_probs=178.1
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hhh-----------------------------hhhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QEI-----------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v-----------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
.++|++.++||+|+||.||+|+.... +.+ .||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46899999999999999999986532 111 299999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhh-cCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHH-DSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
|||+++++|.+++.. ...+++..+..++.||++||+|||+ ++ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999854 3468999999999999999999998 77 9999999999999999999999999998643
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ....... . +
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~---~i~~~~~-~-~-- 368 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE---LILMEEI-R-F-- 368 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHCCC-C-C--
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHH---HHHhCCC-C-C--
Confidence 222 2233578999999999999999999999999999999999999998643221 1111 1111111 0 0
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHH
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRP-----CMPSVIL 669 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~ 669 (717)
... ....+.+|+.+||+.||++|| +++|+++
T Consensus 369 ---p~~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 ---PRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---CTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---Ccc----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 011 123567889999999999999 9999987
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=325.37 Aligned_cols=227 Identities=22% Similarity=0.269 Sum_probs=179.9
Q ss_pred hcCcccccccccCCccceEeeeeCCch-hh--------------------------hhhhhhhhcceeecCceeeEEEec
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ-EI--------------------------AHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~v--------------------------ah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
.++|++.+.||+|+||.||+|...... .+ .||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999875422 11 199999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC--CCCceeccccccccccCC
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH--EMNPKISDFGLARTFVGD 553 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~--~~~~kl~Dfgla~~~~~~ 553 (717)
+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999843 2345899999999999999999999998 999999999999974 467999999999876443
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+.... ..... . +..
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~---~~~~~--~-~~~ 272 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVK---RCDWE--F-DED 272 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHH---HCCCC--C-CSS
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHHHHH---hCCCC--C-Ccc
Confidence 2 22345799999999999999999999999999999999999999864322 11111111 11100 0 000
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
... .....+.+++.+||+.||++|||+.|+++.
T Consensus 273 ~~~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 AFS----SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 001 112356789999999999999999999984
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=313.18 Aligned_cols=232 Identities=28% Similarity=0.426 Sum_probs=186.1
Q ss_pred HhcCcccccccccCCccceEeeeeCCch-h-------------------------hhhhhhhhhcceeecCceeeEEEec
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQ-E-------------------------IAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~-------------------------vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
..++|++.++||+|+||.||+|++.... . +.||||+++++++.+.+..++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 4578999999999999999999876421 1 1299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 91 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 91 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred CCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 9999999999553 3456899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
. ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||........ .. .........
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~~----~~~~~~~~~------ 232 (288)
T 3kfa_A 167 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YE----LLEKDYRME------ 232 (288)
T ss_dssp E-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HH----HHHTTCCCC------
T ss_pred c-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHhccCCCC------
Confidence 2 2233567889999999999999999999999999999999 9999865432221 11 111111100
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.+......+.+++.+||+.||.+||++.+|+++|+..
T Consensus 233 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 233 ---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 0111124567889999999999999999999998653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=320.26 Aligned_cols=239 Identities=21% Similarity=0.288 Sum_probs=182.6
Q ss_pred CcccHHHHHHHhcCcccc-cccccCCccceEeeeeCC-chhhh-----------------------------hhhhhhhc
Q 039318 412 PLFELATIANATDNFSIN-KKLGEGGFGPVYKGTLAD-GQEIA-----------------------------HRNLVKLL 460 (717)
Q Consensus 412 ~~~~~~~i~~~~~~~~~~-~~lG~G~fg~Vy~~~~~~-~~~va-----------------------------h~niv~l~ 460 (717)
+.+.+.......++|.+. +.||+|+||.||+|+... ++.+| ||||++++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 334445556667788887 899999999999998753 22211 79999999
Q ss_pred ceeecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC---CC
Q 039318 461 GCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH---EM 537 (717)
Q Consensus 461 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~---~~ 537 (717)
+++.+.+..++||||+++++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||||+. ++
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBC
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCC
Confidence 9999999999999999999999998442 3356899999999999999999999998 999999999999987 78
Q ss_pred CceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHH
Q 039318 538 NPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHA 617 (717)
Q Consensus 538 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~ 617 (717)
.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .....
T Consensus 172 ~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i 245 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE---TYLNI 245 (327)
T ss_dssp CEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH
T ss_pred cEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHHHH
Confidence 99999999998764322 1234679999999999999999999999999999999999999986433221 11111
Q ss_pred HHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 618 WKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 618 ~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.. ......... .......+.+++.+||+.||++|||++++++.
T Consensus 246 ~~-~~~~~~~~~---------~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 246 SQ-VNVDYSEET---------FSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HH-TCCCCCTTT---------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred Hh-cccccCchh---------hcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11 111111100 00112346788999999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=317.44 Aligned_cols=228 Identities=23% Similarity=0.305 Sum_probs=172.3
Q ss_pred HhcCcccccccccCCccceEeeeeCCch-hh------------------------hhhhhhhhcceeecCceeeEEEecc
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQ-EI------------------------AHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~v------------------------ah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
..++|++.+.||+|+||.||+|+..... .+ .||||+++++++.+.+..++||||+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 3578999999999999999999876432 12 2999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC---CCCceeccccccccccCC
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH---EMNPKISDFGLARTFVGD 553 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~Dfgla~~~~~~ 553 (717)
++++|.+++.. .+.+++..+..++.||++||.|||+++ |+||||||+||||+. ++.+||+|||+++.....
T Consensus 131 ~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 131 TGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999943 345899999999999999999999998 999999999999975 889999999999865432
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ......... ...+.
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~----~~i~~~~~~-~~~~~ 274 (349)
T 2w4o_A 205 V---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMF----RRILNCEYY-FISPW 274 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHH----HHHHTTCCC-CCTTT
T ss_pred c---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHH----HHHHhCCCc-cCCch
Confidence 1 2234679999999999999999999999999999999999999986432221 111 111111110 11110
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
. ......+.+++.+||+.||++|||+.++++.
T Consensus 275 ~-----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 275 W-----DEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp T-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred h-----hhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 1122356789999999999999999999884
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=327.71 Aligned_cols=239 Identities=23% Similarity=0.353 Sum_probs=169.0
Q ss_pred HHhcCcccccccccCCccceEeeeeCCc-hhh----------------------------h-hhhhhhhcceeecCc--e
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADG-QEI----------------------------A-HRNLVKLLGCCIQGE--E 468 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v----------------------------a-h~niv~l~~~~~~~~--~ 468 (717)
...++|++.++||+|+||.||+|.+... +.+ . ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457899999999999999999986432 111 1 999999999997544 6
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
.++|||||+ ++|..++.. ..+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999998 589888843 35889999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCc-------------------cccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCC
Q 039318 549 TFVGDE-------------------IEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSD 608 (717)
Q Consensus 549 ~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~ 608 (717)
...... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 653210 0111234689999999999876 67899999999999999999999998754322
Q ss_pred CchhHHHHHHHHhhCCCCc-----------------------------cccchhh----hccCCHHHHHHHHHHHhhccc
Q 039318 609 KNLNLIGHAWKLWNNGMPS-----------------------------QLIDAYY----QESCNLAEVIRCIHVGLLCVQ 655 (717)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~-----------------------------~l~d~~~----~~~~~~~~~~~~~~l~~~Cl~ 655 (717)
..+............. .+..... ...........+.+|+.+||+
T Consensus 238 ---~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 238 ---NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp ---HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred ---HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 2222222221111000 0000000 000000112357789999999
Q ss_pred cCCCCCCChHHHHHH
Q 039318 656 HHPEDRPCMPSVILM 670 (717)
Q Consensus 656 ~dp~~RPs~~evl~~ 670 (717)
.||++|||++|+++.
T Consensus 315 ~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 315 FNPNKRISANDALKH 329 (388)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred cCcccCCCHHHHhCC
Confidence 999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.71 Aligned_cols=228 Identities=29% Similarity=0.514 Sum_probs=177.5
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hh---------------------------------hhhhhhhhhcceeecCce
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QE---------------------------------IAHRNLVKLLGCCIQGEE 468 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~---------------------------------vah~niv~l~~~~~~~~~ 468 (717)
.++|++.+.||+|+||.||+|++... +. +.||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36899999999999999999986421 11 12999999999986654
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC-----ceecc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN-----PKISD 543 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~-----~kl~D 543 (717)
++||||+++++|.+++.. ....+++..++.++.|+++||+|||+++ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999998854 3446899999999999999999999875 34999999999999988776 99999
Q ss_pred ccccccccCCccccccceecccccccCcccc--ccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHh
Q 039318 544 FGLARTFVGDEIEGSTKRVVGTYGYMAPEYA--SDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLW 621 (717)
Q Consensus 544 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 621 (717)
||+++.... ......||+.|+|||++ ....++.++||||||+++|||++|+.||......... .. ....
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~---~~~~ 243 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-FI---NMIR 243 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-HH---HHHH
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-HH---HHHh
Confidence 999985432 22346799999999998 4556789999999999999999999999754433211 11 1111
Q ss_pred hCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 622 NNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 622 ~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
.......+ +......+.+++.+||+.||++||++.+|++.|+.
T Consensus 244 ~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 EEGLRPTI---------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HSCCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccCCCCCC---------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11111111 11112456789999999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=319.33 Aligned_cols=238 Identities=26% Similarity=0.378 Sum_probs=182.6
Q ss_pred cCcccccccccCCccceEeeeeC-----Cchhh--------------------------hhhhhhhhcceee--cCceee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLA-----DGQEI--------------------------AHRNLVKLLGCCI--QGEEKL 470 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~v--------------------------ah~niv~l~~~~~--~~~~~~ 470 (717)
++|++.+.||+|+||.||+|++. .++.+ .||||+++++++. +.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 68999999999999999999842 22211 2999999999886 456689
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
+||||+++++|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 999999999999999543 235899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcc-ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCC--------CchhHHHHHHHHh
Q 039318 551 VGDEI-EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSD--------KNLNLIGHAWKLW 621 (717)
Q Consensus 551 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~--------~~~~~~~~~~~~~ 621 (717)
..... ........+|+.|+|||++.+..++.++||||||+++|+|++|+.||...... .............
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 43322 11223456888899999999999999999999999999999999997532111 0001111111111
Q ss_pred hCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 622 NNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 622 ~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
..+... ..+......+.+++.+||+.||++|||+.+|++.|+...
T Consensus 258 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 258 EEGQRL---------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred hcccCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111 111122345778999999999999999999999998765
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=316.04 Aligned_cols=243 Identities=21% Similarity=0.263 Sum_probs=185.7
Q ss_pred HHHHhcCcccccccccCCccceEeeeeCCchhh-------------------------hhhhhhhhcceeecCc----ee
Q 039318 419 IANATDNFSINKKLGEGGFGPVYKGTLADGQEI-------------------------AHRNLVKLLGCCIQGE----EK 469 (717)
Q Consensus 419 i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~v-------------------------ah~niv~l~~~~~~~~----~~ 469 (717)
.....++|.+.+.||+|+||.||+|+.. ++.+ .||||+++++++...+ ..
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 3455679999999999999999999874 3222 2999999999998876 78
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHh--------hcCCCcEEeccCCCCceEEcCCCCcee
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH--------HDSRLRIIHRDLKASNVLLDHEMNPKI 541 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivHrDlkp~NIll~~~~~~kl 541 (717)
++||||+++++|.+++.. ..+++..++.++.||++||+||| +.+ |+||||||+||||+.++.+||
T Consensus 116 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEE
T ss_pred EEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEE
Confidence 999999999999999943 25889999999999999999999 666 999999999999999999999
Q ss_pred ccccccccccCCcccc--ccceecccccccCccccccC------CCCccccchhHhHHHHHhhcC----------CCCCC
Q 039318 542 SDFGLARTFVGDEIEG--STKRVVGTYGYMAPEYASDG------LFSVKSDVFSFGILLLEIVSG----------KKNRG 603 (717)
Q Consensus 542 ~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~il~elltG----------~~p~~ 603 (717)
+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 9999998754432211 22345799999999999775 344789999999999999999 66765
Q ss_pred CCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 604 FYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
........ ................+... .........+.+++.+||+.||++|||+.+|++.|+..
T Consensus 269 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 269 DLVPSDPS--VEEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTSCSSCC--HHHHHHHHTTSCCCCCCCGG---GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCcCccc--HHHHHHHHHHHHhCCCCccc---ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 43322211 11112222222111111111 11234556788999999999999999999999999764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=319.22 Aligned_cols=222 Identities=23% Similarity=0.316 Sum_probs=173.8
Q ss_pred hcCcccccccccCCccceEeeeeC----Cchhh------------------------------hhhhhhhhcceeecCce
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLA----DGQEI------------------------------AHRNLVKLLGCCIQGEE 468 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~v------------------------------ah~niv~l~~~~~~~~~ 468 (717)
.++|++.+.||+|+||.||+++.. .++.+ .||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 368999999999999999998763 22211 29999999999999999
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999954 345888999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .... ...... . .
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~---~i~~~~-~-~ 239 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTID---KILKCK-L-N 239 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH---HHHHTC-C-C
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHHH---HHHhCC-C-C
Confidence 643221 1223467999999999999999999999999999999999999998643221 1111 111111 0 0
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHH
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP-----CMPSVIL 669 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~ 669 (717)
+ +......+.+++.+||+.||++|| ++.|+++
T Consensus 240 ~---------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 240 L---------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp C---------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred C---------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 011123567889999999999999 6778876
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=328.01 Aligned_cols=237 Identities=19% Similarity=0.266 Sum_probs=184.8
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhhh-------------------------hhhhhhhcceeecCceeeEEEecc
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
.++|++.++||+|+||.||+|+... ++.+| |++|+.+..++.+.+..+|||||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 4789999999999999999998643 32222 466667777778888999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE---cCCCCceeccccccccccCC
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL---DHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~Dfgla~~~~~~ 553 (717)
+++|.+++... ...+++..++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++.....
T Consensus 86 -g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 86 -GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred -CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999999532 346899999999999999999999998 9999999999999 68899999999999876543
Q ss_pred cccc-----ccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 554 EIEG-----STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 554 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
.... ......||+.|+|||++.+..++.++||||||||+|||++|+.||...........+...........+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 2211 12256899999999999999999999999999999999999999986655443333332222111111111
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
+ .... ..++.+|+.+||+.+|++||++.+|+++|+..
T Consensus 240 l-----~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 240 L-----CRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp H-----HTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred H-----hcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0 0111 23577899999999999999999999988643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=315.43 Aligned_cols=237 Identities=23% Similarity=0.319 Sum_probs=174.9
Q ss_pred cCcccccccccCCccceEeeeeCC-chhh----------------------------hhhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEI----------------------------AHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v----------------------------ah~niv~l~~~~~~~~~~~lV~E 474 (717)
++|++.++||+|+||.||+|+... ++.+ .||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 689999999999999999998754 2211 19999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++++|.+++.. ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999988743 345899999999999999999999998 9999999999999999999999999998754322
Q ss_pred cccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHH--------HHhhCCC
Q 039318 555 IEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAW--------KLWNNGM 625 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 625 (717)
. ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+.... ..+....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 1 2234578999999999876 668999999999999999999999987544332222211110 0000000
Q ss_pred C---ccccchhhhccCC-----HHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 626 P---SQLIDAYYQESCN-----LAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 626 ~---~~l~d~~~~~~~~-----~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
. ..+.++ ..... ......+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDP--EDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCC--SSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCc--cccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 000000 00000 0122346789999999999999999999974
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.44 Aligned_cols=236 Identities=25% Similarity=0.378 Sum_probs=180.8
Q ss_pred cCcccccccccCCccceEeeeeC-----Cchhh---------------------------hhhhhhhhcceeecC--cee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLA-----DGQEI---------------------------AHRNLVKLLGCCIQG--EEK 469 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~v---------------------------ah~niv~l~~~~~~~--~~~ 469 (717)
++|++.++||+|+||.||+|++. .++.+ .||||+++++++.+. +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 56899999999999999999831 22211 299999999999876 668
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 9999999999999999543 345899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccc-cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCC--------CCCchhHHHHHHHH
Q 039318 550 FVGDEIE-GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYH--------SDKNLNLIGHAWKL 620 (717)
Q Consensus 550 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~--------~~~~~~~~~~~~~~ 620 (717)
....... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+.... ..............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 6443221 22334568889999999999999999999999999999999999854211 00011111111111
Q ss_pred hhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 621 WNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 621 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
........ .+......+.+++.+||+.||.+|||+.+++++|+.
T Consensus 256 ~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 256 LKEGKRLP---------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHTTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HhccCCCC---------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 21211111 111222457789999999999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.41 Aligned_cols=224 Identities=23% Similarity=0.431 Sum_probs=177.2
Q ss_pred hcCcccccccccCCccceEeeeeCCchh--------h--------------------------hhhhhhhhcceeecCce
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQE--------I--------------------------AHRNLVKLLGCCIQGEE 468 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~--------v--------------------------ah~niv~l~~~~~~~~~ 468 (717)
.++|.+.+.||+|+||.||+|+.....+ + .||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4689999999999999999997653221 1 19999999999999999
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC--------ce
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN--------PK 540 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~--------~k 540 (717)
.++||||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+||||+.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999543 334889999999999999999999998 999999999999998887 99
Q ss_pred eccccccccccCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCC-CCCCCCCCchhHHHHHH
Q 039318 541 ISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKN-RGFYHSDKNLNLIGHAW 618 (717)
Q Consensus 541 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p-~~~~~~~~~~~~~~~~~ 618 (717)
|+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|||++|..| +.... .....
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~---- 228 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD---SQRKL---- 228 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHH----
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc---hHHHH----
Confidence 9999999764321 23568899999999987 7799999999999999999996554 33211 11111
Q ss_pred HHhhCC-CCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCC
Q 039318 619 KLWNNG-MPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM 676 (717)
Q Consensus 619 ~~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~ 676 (717)
...... ..... ....+.+++.+||+.||++|||+.++++.|+....
T Consensus 229 ~~~~~~~~~~~~------------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 229 QFYEDRHQLPAP------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHTTCCCCCC------------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHhhccCCCCCC------------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111111 11110 01235678889999999999999999999987753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=310.05 Aligned_cols=222 Identities=25% Similarity=0.363 Sum_probs=176.7
Q ss_pred HhcCcccccccccCCccceEeeeeCCchh-h-----------------------------hhhhhhhhcceeecCceeeE
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQE-I-----------------------------AHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-v-----------------------------ah~niv~l~~~~~~~~~~~l 471 (717)
+.++|++.+.||+|+||.||+|+...... + .||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 34689999999999999999998764321 1 19999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999999543 45889999999999999999999998 9999999999999999999999999987543
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+. ... ...... .
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~----~~~~~~-~--- 225 (279)
T 3fdn_A 161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YKR----ISRVEF-T--- 225 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHH----HHHTCC-C---
T ss_pred ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH---HHH----HHhCCC-C---
Confidence 221 2346789999999999999999999999999999999999999874322111 111 111100 0
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+......+.+++.+||+.||++||++.||++.
T Consensus 226 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 226 ------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 001112346688999999999999999999984
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=333.32 Aligned_cols=228 Identities=24% Similarity=0.317 Sum_probs=182.7
Q ss_pred HhcCcccccccccCCccceEeeeeCC-chhh-----------------------------hhhhhhhhcceeecCceeeE
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLAD-GQEI-----------------------------AHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-----------------------------ah~niv~l~~~~~~~~~~~l 471 (717)
..++|++.+.||+|+||.||+|+.+. ++.+ .|||||++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 34689999999999999999998753 2221 19999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++|+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 262 VmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999543 2335899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.......... +
T Consensus 338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~----~-- 408 (576)
T 2acx_A 338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE----Y-- 408 (576)
T ss_dssp TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC----C--
T ss_pred cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc----C--
Confidence 332 1234689999999999999999999999999999999999999997654333222222211111100 0
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHH
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRP-----CMPSVIL 669 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~ 669 (717)
+......+.+|+.+||+.||.+|| +++||++
T Consensus 409 -------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 409 -------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 011123567889999999999999 6788876
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=304.03 Aligned_cols=229 Identities=25% Similarity=0.344 Sum_probs=180.6
Q ss_pred HhcCcccccccccCCccceEeeeeCC-chhh---------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLAD-GQEI---------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v---------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
..++|++.+.||+|+||.||+|+... ++.+ .||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 34689999999999999999998652 2211 2999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++++|.+++. ....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999983 3346899999999999999999999998 999999999999999999999999999865433
Q ss_pred ccccccceecccccccCccccccCCC-CccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
..........|++.|+|||++.+..+ +.++||||||+++|||++|+.||......... . ..+...... ...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~----~~~~~~~~~--~~~ 230 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--Y----SDWKEKKTY--LNP 230 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH--H----HHHHTTCTT--STT
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--H----HHhhhcccc--cCc
Confidence 32223345679999999999987775 78999999999999999999998754332211 1 111111110 000
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
... ....+.+++.+||+.||++|||+.|+++.
T Consensus 231 --~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 231 --WKK----IDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp --GGG----SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --hhh----cCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 001 12346688999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.23 Aligned_cols=242 Identities=15% Similarity=0.195 Sum_probs=183.6
Q ss_pred hcCcccccccccCCccceEeeeeCC---------chhhh---------------------hhhhhhh-------------
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD---------GQEIA---------------------HRNLVKL------------- 459 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~va---------------------h~niv~l------------- 459 (717)
.++|++.+.||+|+||.||+|+... ++.+| ||||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 4689999999999999999998764 33322 9999984
Q ss_pred --cceeec-CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC
Q 039318 460 --LGCCIQ-GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE 536 (717)
Q Consensus 460 --~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~ 536 (717)
++++.. .+..++||||+ +++|.+++... ....+++..++.++.||++||.|||+++ |+||||||+|||++.+
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPE 195 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETT
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCC
Confidence 555554 67889999999 99999999643 2356899999999999999999999998 9999999999999999
Q ss_pred C--CceeccccccccccCCccc-----cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCC
Q 039318 537 M--NPKISDFGLARTFVGDEIE-----GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDK 609 (717)
Q Consensus 537 ~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~ 609 (717)
+ .+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 275 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT 275 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence 8 8999999999876432211 11123579999999999999999999999999999999999999987543221
Q ss_pred chhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 610 NLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
..+......+... ...+.+....... ....+.+++.+||+.||++||++++|+++|+...
T Consensus 276 --~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 276 --EDIMKQKQKFVDK-PGPFVGPCGHWIR---PSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp --HHHHHHHHHHHHS-CCCEECTTSCEEC---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred --HHHHHHHHhccCC-hhhhhhhccccCC---CcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 1121222211111 1122221111000 1245678889999999999999999999997653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=316.22 Aligned_cols=236 Identities=25% Similarity=0.422 Sum_probs=174.9
Q ss_pred HHhcCcccccccccCCccceEeeeeCCc----hhh----------------------------hhhhhhhhcceeecCce
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADG----QEI----------------------------AHRNLVKLLGCCIQGEE 468 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~v----------------------------ah~niv~l~~~~~~~~~ 468 (717)
...++|.+.+.||+|+||.||+|+.... ..+ .||||+++++++.+.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 3457899999999999999999975421 111 19999999999987653
Q ss_pred -----eeEEEeccCCCChhhHhhhc---cccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCce
Q 039318 469 -----KLLIYEFMPNRSLDSFIFDQ---TKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPK 540 (717)
Q Consensus 469 -----~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~k 540 (717)
.++||||+++++|.+++... .....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 49999999999999998543 23456899999999999999999999998 99999999999999999999
Q ss_pred eccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHH
Q 039318 541 ISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWK 619 (717)
Q Consensus 541 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~ 619 (717)
|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~--- 261 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYDY--- 261 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH---
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHH---
Confidence 999999987644332223334567889999999999999999999999999999999 888986543222 1111
Q ss_pred HhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 620 LWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 620 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
...+...... ......+.+++.+||+.+|++||++.++++.|+...
T Consensus 262 -~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 262 -LLHGHRLKQP---------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp -HHTTCCCCCB---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHcCCCCCCC---------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111111110 111235778899999999999999999999997653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=310.61 Aligned_cols=230 Identities=30% Similarity=0.455 Sum_probs=182.3
Q ss_pred hcCcccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCceeeEEEeccC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.++|++.+.||+|+||.||+|+...++.++ ||||+++++++. .+..++||||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 468999999999999999999876553332 999999999986 456899999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+++|.+++... ....+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.........
T Consensus 91 ~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 91 NGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp TCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 99999999542 1235889999999999999999999998 9999999999999999999999999998765433221
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ... ...........
T Consensus 167 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~----~~~~~~~~~~~------- 231 (279)
T 1qpc_A 167 -REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVI----QNLERGYRMVR------- 231 (279)
T ss_dssp -CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH----HHHHTTCCCCC-------
T ss_pred -ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHH----HHHhcccCCCC-------
Confidence 223456789999999998899999999999999999999 99998643221 111 11111111100
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
+......+.+++.+||+.+|++|||+.+++++|+..
T Consensus 232 --~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 232 --PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 011124567889999999999999999999999765
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=325.23 Aligned_cols=238 Identities=21% Similarity=0.262 Sum_probs=177.6
Q ss_pred cCcccccccccCCccceEeeeeCCchhhh----------------------hhhhhhhcceeecCce------eeEEEec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA----------------------HRNLVKLLGCCIQGEE------KLLIYEF 475 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~va----------------------h~niv~l~~~~~~~~~------~~lV~E~ 475 (717)
.+|++.+.||+|+||.||+|+...+..++ ||||+++++++...+. .++||||
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~ 119 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence 57999999999999999999986554333 9999999999865433 7899999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc-CCCCceeccccccccccCCc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD-HEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~Dfgla~~~~~~~ 554 (717)
++++.+............+++..+..++.||++||+|||+++ |+||||||+||||+ .++.+||+|||+++......
T Consensus 120 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~ 196 (394)
T 4e7w_A 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196 (394)
T ss_dssp CSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred cCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence 988655544433334567899999999999999999999998 99999999999999 79999999999998764332
Q ss_pred cccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCC---------
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG--------- 624 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 624 (717)
. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+....+.....
T Consensus 197 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 197 P---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID---QLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp C---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHC
T ss_pred C---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHhhC
Confidence 1 2346789999999998765 58999999999999999999999987543222 222222211111
Q ss_pred ------CCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 625 ------MPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 625 ------~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.....................+.+|+.+||+.||++|||+.|+++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000000111111122467889999999999999999999984
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=329.38 Aligned_cols=220 Identities=27% Similarity=0.405 Sum_probs=179.1
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh-----------------------------hhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA-----------------------------HRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va-----------------------------h~niv~l~~~~~~~~~~~lV~ 473 (717)
++|.+.+.||+|+||.||+|+... ++.+| ||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 579999999999999999998752 22221 999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++++|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999943 456899999999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccceecccccccCccccccCCC-CccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
. .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ... .....+... .
T Consensus 170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~----~~i~~~~~~-~--- 235 (476)
T 2y94_A 170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLF----KKICDGIFY-T--- 235 (476)
T ss_dssp C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHH----HHHHTTCCC-C---
T ss_pred c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHH----HHHhcCCcC-C---
Confidence 2 2335689999999999988775 78999999999999999999998743221 111 111111110 0
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
... ....+.+++.+||+.||++|||+.|+++
T Consensus 236 --p~~----~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 --PQY----LNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --CTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --Ccc----CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 001 1235678899999999999999999997
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=305.51 Aligned_cols=227 Identities=26% Similarity=0.396 Sum_probs=182.2
Q ss_pred HhcCcccccccccCCccceEeeeeC-Cchhh----------------------hhhhhhhhcceeec-------------
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLA-DGQEI----------------------AHRNLVKLLGCCIQ------------- 465 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~v----------------------ah~niv~l~~~~~~------------- 465 (717)
..++|++.+.||+|+||.||+|+.. +++.+ .||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence 4568999999999999999999876 33322 29999999998854
Q ss_pred ---CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceec
Q 039318 466 ---GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKIS 542 (717)
Q Consensus 466 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 542 (717)
....++||||+++++|.+++... ....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEEC
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEEC
Confidence 45689999999999999999653 2346889999999999999999999998 9999999999999999999999
Q ss_pred cccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhh
Q 039318 543 DFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWN 622 (717)
Q Consensus 543 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 622 (717)
|||+++...... ......|++.|+|||++.+..++.++||||||+++|||++|..|+.. .........
T Consensus 165 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---------~~~~~~~~~ 232 (284)
T 2a19_B 165 DFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---------TSKFFTDLR 232 (284)
T ss_dssp CCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---------HHHHHHHHH
T ss_pred cchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---------HHHHHHHhh
Confidence 999998764432 12345789999999999999999999999999999999999988531 011112222
Q ss_pred CCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCC
Q 039318 623 NGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM 676 (717)
Q Consensus 623 ~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~ 676 (717)
...... .. ...+.+++.+||+.||++||++.|+++.|+....
T Consensus 233 ~~~~~~--------~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 233 DGIISD--------IF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp TTCCCT--------TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred cccccc--------cC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 222111 11 1245678899999999999999999999976553
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=322.85 Aligned_cols=242 Identities=21% Similarity=0.291 Sum_probs=186.8
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh---------------------------hhhhhhhhcceeecCc--eeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI---------------------------AHRNLVKLLGCCIQGE--EKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v---------------------------ah~niv~l~~~~~~~~--~~~lV 472 (717)
.++|.+.++||+|+||.||+|++.. ++.+ .||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4689999999999999999998764 2222 2999999999988765 77999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE----cCCCCceeccccccc
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL----DHEMNPKISDFGLAR 548 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~Dfgla~ 548 (717)
|||+++++|.+++........+++..++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999966554445899999999999999999999998 9999999999999 777889999999998
Q ss_pred cccCCccccccceecccccccCcccccc--------CCCCccccchhHhHHHHHhhcCCCCCCCCCCCC-chhHHHHHHH
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYASD--------GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDK-NLNLIGHAWK 619 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~-~~~~~~~~~~ 619 (717)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+. .
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~---~ 238 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY---K 238 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH---H
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH---H
Confidence 764332 2234679999999999865 567889999999999999999999997543322 222222 2
Q ss_pred HhhCCCCc---ccc---------ch--hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 620 LWNNGMPS---QLI---------DA--YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 620 ~~~~~~~~---~l~---------d~--~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
........ .+. .. .............+.+++.+||+.||++||++.++++.|+.
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 22211110 000 00 01112334556677899999999999999999999887754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=311.47 Aligned_cols=236 Identities=22% Similarity=0.278 Sum_probs=173.4
Q ss_pred hcCcccc-cccccCCccceEeeeeCC-chhh---------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 423 TDNFSIN-KKLGEGGFGPVYKGTLAD-GQEI---------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 423 ~~~~~~~-~~lG~G~fg~Vy~~~~~~-~~~v---------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
.+.|++. +.||+|+||.||+|+... ++.+ .||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3578885 789999999999997542 2211 1999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC---ceeccccccccc
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN---PKISDFGLARTF 550 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~Dfgla~~~ 550 (717)
||+++++|.+++... ..+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||+++..
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999999543 45889999999999999999999998 999999999999998776 999999999865
Q ss_pred cCCcc-----ccccceecccccccCcccccc-----CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchh--------
Q 039318 551 VGDEI-----EGSTKRVVGTYGYMAPEYASD-----GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLN-------- 612 (717)
Q Consensus 551 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~-------- 612 (717)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32211 111223569999999999875 568899999999999999999999997544322100
Q ss_pred HHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 613 LIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
............... +..... .. ....+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~i~~~~~~-~~~~~~-~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKYE-FPDKDW-AH----ISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCCC-CCHHHH-TT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCcc-cCchhc-cc----CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 001111111111110 100000 00 12357789999999999999999999984
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.95 Aligned_cols=223 Identities=24% Similarity=0.350 Sum_probs=171.9
Q ss_pred hcCcccccccccCCccceEeeeeCCch-----------------------------------------------h-----
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ-----------------------------------------------E----- 450 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-----------------------------------------------~----- 450 (717)
.++|++.+.||+|+||.||+|+..... +
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 368999999999999999999753210 1
Q ss_pred -hhhhhhhhhcceeec--CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCC
Q 039318 451 -IAHRNLVKLLGCCIQ--GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLK 527 (717)
Q Consensus 451 -vah~niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk 527 (717)
+.||||+++++++.+ .+..++||||+++++|.+++ ....+++..+..++.||++||+|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 129999999999986 56889999999999998865 3346899999999999999999999998 9999999
Q ss_pred CCceEEcCCCCceeccccccccccCCccccccceecccccccCccccccCC---CCccccchhHhHHHHHhhcCCCCCCC
Q 039318 528 ASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL---FSVKSDVFSFGILLLEIVSGKKNRGF 604 (717)
Q Consensus 528 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~elltG~~p~~~ 604 (717)
|+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987643321 123467999999999998765 47889999999999999999999864
Q ss_pred CCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 605 YHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
... .... ......... ..+ .......+.+++.+||+.||++||++.|+++
T Consensus 243 ~~~---~~~~----~~~~~~~~~-~~~-------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERI---MCLH----SKIKSQALE-FPD-------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSH---HHHH----HHHHHCCCC-CCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccH---HHHH----HHHhcccCC-CCC-------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 321 1111 111111110 000 0011235678899999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=328.97 Aligned_cols=229 Identities=24% Similarity=0.317 Sum_probs=181.6
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh-----------------------------hhhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI-----------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-----------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
.++|.+.+.||+|+||.||+|+.+. ++.+ .||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 4689999999999999999998754 2221 199999999999999999999
Q ss_pred EeccCCCChhhHhhhccc-cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 473 YEFMPNRSLDSFIFDQTK-RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
|||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999965432 346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ....... ..
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~--~~i~~~~-~~---- 411 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--QRVLEQA-VT---- 411 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH--HHHHHCC-CC----
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH--HHHhhcc-cC----
Confidence 3321 2234689999999999999999999999999999999999999997543322222111 1111111 10
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCCh-----HHHHH
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCM-----PSVIL 669 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~-----~evl~ 669 (717)
.+......+.+++.+||+.||++||++ .+|++
T Consensus 412 ------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 412 ------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 011112356788999999999999975 56654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=319.02 Aligned_cols=236 Identities=18% Similarity=0.196 Sum_probs=176.7
Q ss_pred HHHHhcCcccccccccCCccceEeeeeCCchh--------------------------------hhhhhhhhhcceeecC
Q 039318 419 IANATDNFSINKKLGEGGFGPVYKGTLADGQE--------------------------------IAHRNLVKLLGCCIQG 466 (717)
Q Consensus 419 i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~--------------------------------vah~niv~l~~~~~~~ 466 (717)
+....++|++.+.||+|+||.||+|+...... +.||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 34566889999999999999999997643211 1199999999999999
Q ss_pred ceeeEEEeccCCCChhhHhhhcc-------------------------------------ccccCChhhHHHHHHHHHHH
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQT-------------------------------------KRKLLDWSKRFCIICGTARG 509 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~~ 509 (717)
+..++||||+++++|.+++.... ....+++..+..++.||++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999984211 01224567788899999999
Q ss_pred HHHHhhcCCCcEEeccCCCCceEEcCCC--CceeccccccccccCCcc--ccccceecccccccCcccccc--CCCCccc
Q 039318 510 LLYLHHDSRLRIIHRDLKASNVLLDHEM--NPKISDFGLARTFVGDEI--EGSTKRVVGTYGYMAPEYASD--GLFSVKS 583 (717)
Q Consensus 510 l~yLH~~~~~~ivHrDlkp~NIll~~~~--~~kl~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~s 583 (717)
|+|||+++ |+||||||+||||+.++ .+||+|||+++.+..... ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 899999999986533211 112235679999999999875 6789999
Q ss_pred cchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCC
Q 039318 584 DVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPC 663 (717)
Q Consensus 584 DvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs 663 (717)
||||||+++|||++|+.||......+ . ........... ..+... .....+.+++.+||+.+|.+||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~---~---~~~~~~~~~~~--~~~~~~-----~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDAD---T---ISQVLNKKLCF--ENPNYN-----VLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHHHCCCCT--TSGGGG-----GSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHH---H---HHHHHhccccc--CCcccc-----cCCHHHHHHHHHHcCCChhHCCC
Confidence 99999999999999999986433221 1 11222221111 011110 01235678899999999999999
Q ss_pred hHHHHHH
Q 039318 664 MPSVILM 670 (717)
Q Consensus 664 ~~evl~~ 670 (717)
+.++++.
T Consensus 325 ~~~~l~h 331 (345)
T 3hko_A 325 AMRALQH 331 (345)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999883
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=309.89 Aligned_cols=232 Identities=28% Similarity=0.394 Sum_probs=177.4
Q ss_pred hcCcccccccccCCccceEeeeeCCch-------------------------------hhhhhhhhhhccee-ecCceee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ-------------------------------EIAHRNLVKLLGCC-IQGEEKL 470 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-------------------------------~vah~niv~l~~~~-~~~~~~~ 470 (717)
..+|++.++||+|+||.||+|++.... .+.||||+++++++ ...+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 457899999999999999999864321 01199999999985 4566889
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
+||||+++++|.+++.. ....+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999954 3445789999999999999999999998 999999999999999999999999999876
Q ss_pred cCCccc--cccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 551 VGDEIE--GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 551 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||......+. .... ......
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~~----~~~~~~ 251 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYL----LQGRRL 251 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HHHH----HTTCCC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HHHH----hcCCCC
Confidence 433211 12233567889999999999999999999999999999999 5556554332221 1111 111110
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.. . .. ....+.+++.+||+.+|++||++.|++++|+...
T Consensus 252 ~~-~----~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 252 LQ-P----EY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp CC-C----TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC-C----cc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 0 01 1235678899999999999999999999997653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=340.57 Aligned_cols=233 Identities=28% Similarity=0.454 Sum_probs=185.1
Q ss_pred HhcCcccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCceeeEEEecc
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
..++|++.++||+|+||.||+|++..+..+| |||||++++++.+ +..+|||||+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 3567899999999999999999987643332 9999999999876 7789999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+++........
T Consensus 344 ~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp TTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred cCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 999999999542 2345889999999999999999999998 999999999999999999999999999876432211
Q ss_pred cccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 557 GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..+ ..+..+....
T Consensus 420 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~----~~i~~~~~~~------- 484 (535)
T 2h8h_A 420 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL----DQVERGYRMP------- 484 (535)
T ss_dssp -TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHH----HHHHTTCCCC-------
T ss_pred -cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCCC-------
Confidence 1123456789999999999999999999999999999999 99998643221 111 1111221100
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCC
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM 676 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~ 676 (717)
.+......+.+|+.+||+.||++|||+.+|+++|+....
T Consensus 485 --~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 485 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred --CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 111122456789999999999999999999999988753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=344.16 Aligned_cols=223 Identities=25% Similarity=0.336 Sum_probs=180.4
Q ss_pred HhcCcccccccccCCccceEeeeeCCchh-hh------------------------------hhhhhhhcceeecCceee
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQE-IA------------------------------HRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-va------------------------------h~niv~l~~~~~~~~~~~ 470 (717)
..++|++.+.||+|+||.||+|+.+...+ +| ||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 45789999999999999999998764321 11 899999999999999999
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
|||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999543 45899999999999999999999998 999999999999999999999999999864
Q ss_pred cCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ..+. ..... +
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~~~---~~i~-~~~~~-~- 561 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELF---QSIM-EHNVA-Y- 561 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHH-SSCCC-C-
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---HHH---HHHH-hCCCC-C-
Confidence 3222 2234578999999999999999999999999999999999999998643221 111 1111 11110 0
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCCh-----HHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCM-----PSVIL 669 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~-----~evl~ 669 (717)
+......+.+|+.+||+.||++||++ +||++
T Consensus 562 --------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 562 --------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11122456788999999999999998 67765
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.78 Aligned_cols=231 Identities=28% Similarity=0.450 Sum_probs=176.0
Q ss_pred cCcccccccccCCccceEeeeeCCch-----hh---------------------------hhhhhhhhcceeecCceeeE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-----EI---------------------------AHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-----~v---------------------------ah~niv~l~~~~~~~~~~~l 471 (717)
++|.+.+.||+|+||.||+|+..... .+ .||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 57888899999999999999764221 01 19999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++++|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 99999999999999542 346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccc-cccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 552 GDEIE-GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 552 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .. ......+....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~----~~~~~~~~~~~- 270 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EV----MKAINDGFRLP- 270 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH----HHHHHTTCCCC-
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HH----HHHHHCCCcCC-
Confidence 33211 11222356788999999999999999999999999999999 99998643221 11 11122221100
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.+......+.+++.+||+.+|++||++.+|+++|+...
T Consensus 271 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 271 --------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp --------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01112245678899999999999999999999997654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=313.61 Aligned_cols=217 Identities=22% Similarity=0.271 Sum_probs=177.1
Q ss_pred HhcCcccccccccCCccceEeeeeCCch-----------------------------------hhhhhhhhhhcceeecC
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQ-----------------------------------EIAHRNLVKLLGCCIQG 466 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-----------------------------------~vah~niv~l~~~~~~~ 466 (717)
..++|++.+.||+|+||.||+|+..... .+.||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999753211 11299999999999999
Q ss_pred ceeeEEEeccCCC-ChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 467 EEKLLIYEFMPNR-SLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 467 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
+..++||||+.+| +|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 99999843 345899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCccccccceecccccccCccccccCCC-CccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCC
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG 624 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 624 (717)
+++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....... ...
T Consensus 176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------~~~ 240 (335)
T 3dls_A 176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------EAA 240 (335)
T ss_dssp TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------TTC
T ss_pred cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------hhc
Confidence 998764332 2234679999999999988876 889999999999999999999986321100 000
Q ss_pred CCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 625 MPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 625 ~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
... +......+.+++.+||+.||++|||+.++++.
T Consensus 241 ---------~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 241 ---------IHP--PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---------CCC--SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---------cCC--CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00012346788999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=304.66 Aligned_cols=223 Identities=26% Similarity=0.431 Sum_probs=158.4
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh-----------------------------hhhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI-----------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-----------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
.++|++.+.||+|+||.||+|+... ++.+ .||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 4689999999999999999998642 2221 199999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++++|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999954 2356899999999999999999999998 99999999999999999999999999986543
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ... ....
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~----~~~~--- 229 (278)
T 3cok_A 165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KVV----LADY--- 229 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC----SSCC---
T ss_pred CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------HHh----hccc---
Confidence 221 1224678999999999999999999999999999999999999987543322110 000 0000
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.... .....+.+++.+||+.||++||++.++++
T Consensus 230 ~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EMPS----FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCcc----ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0011 11235678999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=318.11 Aligned_cols=238 Identities=25% Similarity=0.344 Sum_probs=175.0
Q ss_pred cCcccccccccCCccceEeeeeCCc-hhh----------------------------hhhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QEI----------------------------AHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v----------------------------ah~niv~l~~~~~~~~~~~lV~E 474 (717)
++|++.+.||+|+||.||+|+.... +.+ .||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 5799999999999999999987542 211 19999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 105 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999888732 345899999999999999999999998 9999999999999999999999999998654322
Q ss_pred cccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHH--------HHHhh---
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHA--------WKLWN--- 622 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~--- 622 (717)
.......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+....+... ...+.
T Consensus 179 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 179 --EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred --cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 122345789999999999875 7899999999999999999999998754332211111100 00000
Q ss_pred ---CCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 623 ---NGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 623 ---~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
......+................+.+|+.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00111111000000000112346788999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=301.84 Aligned_cols=227 Identities=22% Similarity=0.340 Sum_probs=178.0
Q ss_pred cCcccccccccCCccceEeeeeCCch---------------------------hhhhhhhhhhcceeecC--ceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ---------------------------EIAHRNLVKLLGCCIQG--EEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~---------------------------~vah~niv~l~~~~~~~--~~~~lV~E 474 (717)
++|++.+.||+|+||.||+|++.... .+.||||+++++++.+. +..++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 57999999999999999999875321 01199999999999887 78899999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++++|.+++... ....+++..++.++.||++||+|||+++ ..|+||||||+|||++.++.++|.|||++....
T Consensus 90 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--- 164 (271)
T 3kmu_A 90 WMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--- 164 (271)
T ss_dssp CCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS---
T ss_pred ccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec---
Confidence 99999999999542 2335899999999999999999999875 349999999999999999999999988876432
Q ss_pred cccccceecccccccCccccccCCCCc---cccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSV---KSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
.....||+.|+|||.+.+..++. ++||||||+++|||++|+.||....... . ............+.
T Consensus 165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~---~~~~~~~~~~~~~~- 233 (271)
T 3kmu_A 165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME---I---GMKVALEGLRPTIP- 233 (271)
T ss_dssp ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH---H---HHHHHHSCCCCCCC-
T ss_pred ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH---H---HHHHHhcCCCCCCC-
Confidence 12357899999999998765544 8999999999999999999986432211 1 11222222111111
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
. .....+.+++.+||+.||++|||+.++++.|+..
T Consensus 234 ----~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 234 ----P----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp ----T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1 1123567889999999999999999999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=314.79 Aligned_cols=222 Identities=26% Similarity=0.371 Sum_probs=179.4
Q ss_pred hcCcccccccccCCccceEeeeeCCchh------------------------------hhhhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQE------------------------------IAHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~------------------------------vah~niv~l~~~~~~~~~~~lV 472 (717)
.++|.+.+.||+|+||.||+++.....+ +.||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4689999999999999999998754211 1299999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++++|.+++.. ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999998844 346899999999999999999999998 99999999999999999999999999987543
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .. .. ...... .+
T Consensus 194 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~-~~~~~~-~~--- 260 (335)
T 2owb_A 194 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TY---LR-IKKNEY-SI--- 260 (335)
T ss_dssp TT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HH-HHHTCC-CC---
T ss_pred Cc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---HH---HH-HhcCCC-CC---
Confidence 22 12234679999999999999999999999999999999999999986432211 11 11 111110 00
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.... ...+.+++.+||+.||++||++.|+++
T Consensus 261 --~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 261 --PKHI----NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp --CTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --CccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111 134667899999999999999999997
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.72 Aligned_cols=231 Identities=28% Similarity=0.417 Sum_probs=169.5
Q ss_pred cCcccccccccCCccceEeeeeCCch-------------------------------hhhhhhhhhhcceeec-CceeeE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-------------------------------EIAHRNLVKLLGCCIQ-GEEKLL 471 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-------------------------------~vah~niv~l~~~~~~-~~~~~l 471 (717)
..|.+.+.||+|+||.||+|++.+.. .+.||||+++++++.+ .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35778899999999999999753210 0129999999998654 567899
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++++|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999953 3345788999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcccc--ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 552 GDEIEG--STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 552 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |.+||......+... . ...+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~---~----~~~~~~~~ 316 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---Y----LLQGRRLL 316 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH---H----HHTTCCCC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH---H----HHcCCCCC
Confidence 332111 1223467889999999999999999999999999999999 677776543332111 1 11111100
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
. .. .....+.+++.+||+.+|++||++.|+++.|+...
T Consensus 317 --~---p~----~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 317 --Q---PE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp --C---CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --C---CC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 01 11235678899999999999999999999997653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=308.50 Aligned_cols=229 Identities=28% Similarity=0.404 Sum_probs=179.9
Q ss_pred cCccccc-ccccCCccceEeeeeC---Cchhh---------------------------hhhhhhhhcceeecCceeeEE
Q 039318 424 DNFSINK-KLGEGGFGPVYKGTLA---DGQEI---------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 424 ~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~v---------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
++|.+.+ .||+|+||.||+|++. .+..+ .||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 5677776 9999999999999753 22111 199999999999 55679999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++++|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999953 3446899999999999999999999998 99999999999999999999999999987643
Q ss_pred Cccc-cccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 553 DEIE-GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 553 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
.... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+ .. .....+.....
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~----~~i~~~~~~~~- 234 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQGKRMEC- 234 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HH----HHHHTTCCCCC-
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HH----HHHhcCCcCCC-
Confidence 3221 11223456889999999998899999999999999999998 999986543221 11 11112211111
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 235 --------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 235 --------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp --------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111224577889999999999999999999999765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.73 Aligned_cols=230 Identities=27% Similarity=0.415 Sum_probs=181.0
Q ss_pred cCcccccccccCCccceEeeeeCCch------------------------------hh-hhhhhhhhcceeecCceeeEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ------------------------------EI-AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~------------------------------~v-ah~niv~l~~~~~~~~~~~lV 472 (717)
++|++.+.||+|+||.||+|+..... .+ .||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57999999999999999999764321 01 299999999999999999999
Q ss_pred EeccCCCChhhHhhhcc-------------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCc
Q 039318 473 YEFMPNRSLDSFIFDQT-------------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP 539 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~ 539 (717)
|||+++++|.+++.... ....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996532 2346899999999999999999999998 9999999999999999999
Q ss_pred eeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHH
Q 039318 540 KISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAW 618 (717)
Q Consensus 540 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~ 618 (717)
||+|||+++.... ........+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ..
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LY 251 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HH
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------HH
Confidence 9999999974321 112223567889999999998899999999999999999998 999986432211 11
Q ss_pred HHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 619 KLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 619 ~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.....+.... .+......+.+++.+||+.+|++||++.++++.|+...
T Consensus 252 ~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 252 EKLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp HHGGGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhcCCCCC---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1121211110 01111245778999999999999999999999987543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=315.83 Aligned_cols=242 Identities=21% Similarity=0.297 Sum_probs=176.5
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh----------------------------hhhhhhhhcceeec--------
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI----------------------------AHRNLVKLLGCCIQ-------- 465 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v----------------------------ah~niv~l~~~~~~-------- 465 (717)
.++|++.++||+|+||.||+|+... ++.+ .||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 3689999999999999999998742 2222 29999999999887
Q ss_pred CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 466 GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 466 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
.+..++||||+++ +|.+.+.. ....+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 4568999999986 77676643 2345899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCcc--ccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhh
Q 039318 546 LARTFVGDEI--EGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWN 622 (717)
Q Consensus 546 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 622 (717)
+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9986542211 122234678999999998876 4589999999999999999999999875433222222211111111
Q ss_pred CCCCccccchh--------hhccCCHHH-------HHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 623 NGMPSQLIDAY--------YQESCNLAE-------VIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 623 ~~~~~~l~d~~--------~~~~~~~~~-------~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
........... ......... ...+.+|+.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11111100000 000011111 1347789999999999999999999884
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=304.33 Aligned_cols=221 Identities=20% Similarity=0.313 Sum_probs=174.7
Q ss_pred HhcCcccccccccCCccceEeeeeCC-chhh-----------------------------hhhhhhhhcceeecCceeeE
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLAD-GQEI-----------------------------AHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-----------------------------ah~niv~l~~~~~~~~~~~l 471 (717)
..++|++.+.||+|+||.||+|+... ++.+ .||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 35789999999999999999998752 2211 29999999999999999999
Q ss_pred EEeccCCCChhhHhhhccc-cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC--------------
Q 039318 472 IYEFMPNRSLDSFIFDQTK-RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE-------------- 536 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~-------------- 536 (717)
||||+++++|.+++..... ...+++..+..++.||++||.|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999965422 256899999999999999999999998 9999999999999844
Q ss_pred -----CCceeccccccccccCCccccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCc
Q 039318 537 -----MNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKN 610 (717)
Q Consensus 537 -----~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~ 610 (717)
..+||+|||++....... ...||+.|+|||++.+. .++.++||||||+++|||++|.+++...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----- 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----- 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----
Confidence 479999999998754322 34589999999999776 5678999999999999999998875321
Q ss_pred hhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 611 LNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.. ...........+. .. ....+.+++.+||+.||++|||+.++++.
T Consensus 235 -~~----~~~~~~~~~~~~~-----~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 235 -DQ----WHEIRQGRLPRIP-----QV----LSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -HH----HHHHHTTCCCCCS-----SC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -hH----HHHHHcCCCCCCC-----cc----cCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11 1112222221111 11 12356788999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=307.49 Aligned_cols=229 Identities=24% Similarity=0.367 Sum_probs=177.4
Q ss_pred hcCcccccccccCCccceEeeeeCCch-------------------------------hhhhhhhhhhcceeecCceeeE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ-------------------------------EIAHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-------------------------------~vah~niv~l~~~~~~~~~~~l 471 (717)
.++|.+.+.||+|+||.||+|+..... .+.||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 468999999999999999999753211 1129999999999865 56789
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 99999999999999543 345889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
..... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+. ...... .... ..
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~~~~~---~~~~-~~- 235 (281)
T 3cc6_A 165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGVLEK---GDRL-PK- 235 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HHHHHH---TCCC-CC-
T ss_pred ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HHHHhc---CCCC-CC-
Confidence 33211 1223567889999999999999999999999999999998 9999864433221 111111 1110 00
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
+......+.+++.+||+.+|++||++.|+++.|+..
T Consensus 236 --------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 236 --------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 001123467889999999999999999999998753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.91 Aligned_cols=234 Identities=27% Similarity=0.436 Sum_probs=178.6
Q ss_pred hcCcccccccccCCccceEeeeeCC------chh---------------------------hhhhhhhhhcceeecCcee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD------GQE---------------------------IAHRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~---------------------------vah~niv~l~~~~~~~~~~ 469 (717)
.++|++.+.||+|+||.||+|++.. ++. +.||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 4689999999999999999998431 111 1299999999999999999
Q ss_pred eEEEeccCCCChhhHhhhccc----cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC---CCCceec
Q 039318 470 LLIYEFMPNRSLDSFIFDQTK----RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH---EMNPKIS 542 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~ 542 (717)
++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+||||+. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999965432 145888999999999999999999998 999999999999984 4469999
Q ss_pred cccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHh
Q 039318 543 DFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLW 621 (717)
Q Consensus 543 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 621 (717)
|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ... ...
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~----~~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVL----EFV 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH----HHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHH----HHH
Confidence 9999986543333233334578899999999999999999999999999999998 99998643211 111 111
Q ss_pred hCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 622 NNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 622 ~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
........ +......+.+++.+||+.||++||++.+|++.|+...
T Consensus 259 ~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 259 TSGGRMDP---------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCCCC---------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 11111111 0111235678899999999999999999999987553
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.20 Aligned_cols=236 Identities=23% Similarity=0.305 Sum_probs=178.1
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh--------------------------hhhhhhhhcceee----cCceeeE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI--------------------------AHRNLVKLLGCCI----QGEEKLL 471 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v--------------------------ah~niv~l~~~~~----~~~~~~l 471 (717)
.++|++.+.||+|+||.||+++... ++.+ .||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 4689999999999999999998632 2222 1999999999987 3457899
Q ss_pred EEeccCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
||||+++++|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999996532 3456899999999999999999999998 999999999999999999999999998764
Q ss_pred cCCccc-------cccceecccccccCccccccCC---CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHH
Q 039318 551 VGDEIE-------GSTKRVVGTYGYMAPEYASDGL---FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKL 620 (717)
Q Consensus 551 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 620 (717)
...... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||......... ... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~---~ 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS--VAL---A 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC--HHH---H
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch--hhH---H
Confidence 321110 0112346799999999987654 689999999999999999999998532111110 000 0
Q ss_pred hhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 621 WNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 621 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
...... ..........+.+++.+||+.||.+||++.+|++.|+...
T Consensus 260 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 260 VQNQLS---------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hhccCC---------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 111000 0001112245778999999999999999999999998765
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=318.86 Aligned_cols=232 Identities=24% Similarity=0.284 Sum_probs=163.5
Q ss_pred hcCcccccccccCCccceEeeeeCC-chh--------------------------hh-hhhhhhhcceee--------cC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQE--------------------------IA-HRNLVKLLGCCI--------QG 466 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~--------------------------va-h~niv~l~~~~~--------~~ 466 (717)
..+|++.++||+|+||.||+|+... ++. +. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 4589999999999999999998643 211 11 999999999983 44
Q ss_pred ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccc
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGL 546 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgl 546 (717)
...++||||++ |+|.+++........+++..++.++.||+.||.|||+++ .+|+||||||+||||+.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 56799999996 699999866555667999999999999999999999875 3499999999999999999999999999
Q ss_pred cccccCCcccc----------ccceecccccccCcccc---ccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhH
Q 039318 547 ARTFVGDEIEG----------STKRVVGTYGYMAPEYA---SDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNL 613 (717)
Q Consensus 547 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~ 613 (717)
++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||....... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~ 261 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---I 261 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---h
Confidence 98764322110 11235689999999998 56778999999999999999999999986422111 0
Q ss_pred HHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 614 IGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
......... .. .....+.+|+.+||+.||++||++.|+++.|+...
T Consensus 262 -------~~~~~~~~~-----~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 262 -------VNGKYSIPP-----HD----TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp -----------CCCCT-----TC----CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------hcCcccCCc-----cc----ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000000000 00 01123567888999999999999999999997664
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=305.17 Aligned_cols=226 Identities=22% Similarity=0.334 Sum_probs=178.4
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hhh----------------------------hhhhhhhhcceeecCceeeEEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QEI----------------------------AHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v----------------------------ah~niv~l~~~~~~~~~~~lV~ 473 (717)
.++|++.+.||+|+||.||+|..... +.+ .||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999986532 111 2999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC---ceeccccccccc
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN---PKISDFGLARTF 550 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~Dfgla~~~ 550 (717)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999998854 345899999999999999999999998 999999999999986655 999999999865
Q ss_pred cCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ..... ........ .
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~----~~~~~~~~-~ 227 (284)
T 3kk8_A 159 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQ----IKAGAYDY-P 227 (284)
T ss_dssp CSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHTCCCC-C
T ss_pred ccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHH----HHhccccC-C
Confidence 4332 123467999999999999999999999999999999999999998643211 11111 11111100 0
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+.. . .....+.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~~-~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 228 SPEW-D----TVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTTT-T----TSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred chhh-c----ccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000 0 112346788999999999999999999883
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=323.28 Aligned_cols=216 Identities=15% Similarity=0.152 Sum_probs=165.7
Q ss_pred hcCcccccccccCCccceEeeeeCC-chh-----------------------h---------hhhhhhhhc-------ce
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQE-----------------------I---------AHRNLVKLL-------GC 462 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~-----------------------v---------ah~niv~l~-------~~ 462 (717)
.++|++.+.||+|+||.||+|+... ++. + .|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4689999999999999999998642 221 1 299999999 55
Q ss_pred eecCc-----------------eeeEEEeccCCCChhhHhhhccc----cccCChhhHHHHHHHHHHHHHHHhhcCCCcE
Q 039318 463 CIQGE-----------------EKLLIYEFMPNRSLDSFIFDQTK----RKLLDWSKRFCIICGTARGLLYLHHDSRLRI 521 (717)
Q Consensus 463 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i 521 (717)
+.+.+ ..+|||||+ +|+|.+++..... ...+++..++.++.||++||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 44443 278999999 6799999965321 122445888899999999999999998 9
Q ss_pred EeccCCCCceEEcCCCCceeccccccccccCCccccccceecccccccCccccccC-----------CCCccccchhHhH
Q 039318 522 IHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDG-----------LFSVKSDVFSFGI 590 (717)
Q Consensus 522 vHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlG~ 590 (717)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986322 2234567 999999999887 8999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 591 LLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 591 il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
++|||++|+.||........... +.... ... ...+.+|+.+||+.||++||++.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~---------------~~~~~--~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEW---------------IFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSGG---------------GGSSC--CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchhh---------------hhhhc--cCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999864332221111 10000 111 235678899999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.88 Aligned_cols=236 Identities=22% Similarity=0.276 Sum_probs=179.9
Q ss_pred hcCcccccccccCCccceEeeeeCCch-hh-------------------------h--------hhhhhhhcceee----
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ-EI-------------------------A--------HRNLVKLLGCCI---- 464 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~v-------------------------a--------h~niv~l~~~~~---- 464 (717)
.++|++.++||+|+||.||+|+...+. .+ . |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 478999999999999999999764321 11 1 788999999987
Q ss_pred cCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhc-CCCcEEeccCCCCceEEcCCC------
Q 039318 465 QGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD-SRLRIIHRDLKASNVLLDHEM------ 537 (717)
Q Consensus 465 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrDlkp~NIll~~~~------ 537 (717)
.....++||||+ +++|.+++... ....+++..+..++.||++||.|||++ + |+||||||+||||+.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhh
Confidence 667899999999 55666666432 234689999999999999999999998 7 99999999999998775
Q ss_pred -------------------------------------------CceeccccccccccCCccccccceecccccccCcccc
Q 039318 538 -------------------------------------------NPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYA 574 (717)
Q Consensus 538 -------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 574 (717)
.+||+|||+++..... .....||+.|+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence 7999999999875332 2345789999999999
Q ss_pred ccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCch---hHHHHHHHHhhCCCCcccc----------c----------
Q 039318 575 SDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNL---NLIGHAWKLWNNGMPSQLI----------D---------- 631 (717)
Q Consensus 575 ~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~----------d---------- 631 (717)
.+..++.++|||||||++|||++|+.||......+.. ..+......... .+..++ .
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK-VPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCS-CCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCC-CChHHhhcccccccccCCccccccccc
Confidence 9999999999999999999999999999765544322 122222221111 110000 0
Q ss_pred --------hh-hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 632 --------AY-YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 632 --------~~-~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.. .....+......+.+|+.+||+.||++|||+.||++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 001234556677899999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=307.59 Aligned_cols=230 Identities=25% Similarity=0.354 Sum_probs=177.5
Q ss_pred CcccccccccCCccceEeeeeCCch----h---------------------------hhhhhhhhhcceeecCcee-eEE
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADGQ----E---------------------------IAHRNLVKLLGCCIQGEEK-LLI 472 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~~----~---------------------------vah~niv~l~~~~~~~~~~-~lV 472 (717)
.|.+.++||+|+||.||+|++.+.. . +.||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 5667789999999999999753211 0 1299999999999876665 999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+.+++|.+++.. ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999954 3456789999999999999999999998 99999999999999999999999999986543
Q ss_pred Ccc--ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCC-CCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 553 DEI--EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKN-RGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 553 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
... ........+++.|+|||.+.+..++.++||||||+++|||++|..| |...... ...... ........
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~---~~~~~~----~~~~~~~~ 249 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF---DLTHFL----AQGRRLPQ 249 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG---GHHHHH----HTTCCCCC
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH---HHHHHh----hcCCCCCC
Confidence 321 1222345788999999999999999999999999999999996555 3322211 111111 11111000
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
+......+.+++.+||+.||.+|||+.+++++|+...
T Consensus 250 ---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 250 ---------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0111235678899999999999999999999997653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=319.30 Aligned_cols=221 Identities=23% Similarity=0.287 Sum_probs=169.4
Q ss_pred cccccccCCccceEeeeeCC-chhh--------------------------hhhhhhhhcceeecCceeeEEEeccCCCC
Q 039318 428 INKKLGEGGFGPVYKGTLAD-GQEI--------------------------AHRNLVKLLGCCIQGEEKLLIYEFMPNRS 480 (717)
Q Consensus 428 ~~~~lG~G~fg~Vy~~~~~~-~~~v--------------------------ah~niv~l~~~~~~~~~~~lV~E~~~~gs 480 (717)
..+.||+|+||.||+|+... ++.+ .||||+++++++.+.+..+|||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 35789999999999998643 2222 29999999999999999999999999999
Q ss_pred hhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE--cCCCCceeccccccccccCCccccc
Q 039318 481 LDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL--DHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 481 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||| +.++.+||+|||+++...... .
T Consensus 173 L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~ 244 (373)
T 2x4f_A 173 LFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K 244 (373)
T ss_dssp EHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence 99988542 345889999999999999999999998 9999999999999 567789999999998764332 1
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.. ....... +..... ..
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~---i~~~~~~--~~~~~~-~~- 314 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---ETLNN---ILACRWD--LEDEEF-QD- 314 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHH---HHHTCCC--SCSGGG-TT-
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---HHhccCC--CChhhh-cc-
Confidence 23457999999999999999999999999999999999999998643221 11111 1111110 000000 01
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 639 NLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 639 ~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
....+.+|+.+||+.||.+||++.|+++
T Consensus 315 ---~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ---ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ---SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1235678999999999999999999998
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=303.98 Aligned_cols=225 Identities=18% Similarity=0.275 Sum_probs=177.9
Q ss_pred HhcCcccccccccCCccceEeeeeCCchh---------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQE---------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~---------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
..++|++.++||+|+||.||+|+...... +.||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 35689999999999999999998754321 129999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE---cCCCCceecccccccccc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL---DHEMNPKISDFGLARTFV 551 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~Dfgla~~~~ 551 (717)
|+++++|.+++.. ...+++..+..++.|+++||.|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999999854 345899999999999999999999998 9999999999999 788999999999998754
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
... ......||+.|+|||++.+. ++.++||||||+++|||++|+.||...... ... .......... ..
T Consensus 161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~----~~~~~~~~~~-~~ 228 (277)
T 3f3z_A 161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---EVM----LKIREGTFTF-PE 228 (277)
T ss_dssp TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHCCCCC-CH
T ss_pred Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHhCCCCC-Cc
Confidence 332 22346799999999998764 899999999999999999999998643221 111 1111111110 00
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
... .. ....+.+++.+||+.||++||++.++++
T Consensus 229 ~~~-~~----~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KDW-LN----VSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHH-TT----SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhh-hc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00 1235678899999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=306.59 Aligned_cols=223 Identities=26% Similarity=0.363 Sum_probs=179.8
Q ss_pred hcCcccccccccCCccceEeeeeCCchh------------------------------hhhhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQE------------------------------IAHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~------------------------------vah~niv~l~~~~~~~~~~~lV 472 (717)
.++|.+.+.||+|+||.||+++.....+ +.||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 4689999999999999999998754211 1199999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999998844 346899999999999999999999998 99999999999999999999999999987543
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ......... .+
T Consensus 168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~-~~--- 234 (294)
T 2rku_A 168 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-------YLRIKKNEY-SI--- 234 (294)
T ss_dssp TT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTCC-CC---
T ss_pred Cc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhhccC-CC---
Confidence 22 122346789999999999999999999999999999999999999864332111 111111111 00
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
... ....+.+++.+||+.||++||+++++++.
T Consensus 235 --~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 --PKH----INPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --CTT----SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --ccc----cCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 011 11346688999999999999999999973
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=313.89 Aligned_cols=240 Identities=26% Similarity=0.321 Sum_probs=177.3
Q ss_pred HHHhcCcccccccccCCccceEeeeeCC-chhh-------------------------------hhhhhhhhcceeecCc
Q 039318 420 ANATDNFSINKKLGEGGFGPVYKGTLAD-GQEI-------------------------------AHRNLVKLLGCCIQGE 467 (717)
Q Consensus 420 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-------------------------------ah~niv~l~~~~~~~~ 467 (717)
....++|++.+.||+|+||.||+|+... ++.+ .||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 3445789999999999999999998653 2111 1999999999999999
Q ss_pred eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla 547 (717)
..++||||+++ +|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ceEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 99999999986 88888843 3346889999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC
Q 039318 548 RTFVGDEIEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (717)
+...... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||.... ....+............
T Consensus 160 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~---~~~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 160 KSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS---DLDQLTRIFETLGTPTE 234 (346)
T ss_dssp STTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCT
T ss_pred eeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHHHcCCCCh
Confidence 8764322 122346789999999998764 58999999999999999999999986433 22222222222211111
Q ss_pred cccc------chh---hhccCCHH-----HHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 627 SQLI------DAY---YQESCNLA-----EVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 627 ~~l~------d~~---~~~~~~~~-----~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.... +.. .....+.. ....+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 1000 000 00001111 12467889999999999999999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=308.35 Aligned_cols=236 Identities=25% Similarity=0.359 Sum_probs=179.2
Q ss_pred cCc-ccccccccCCccceEeeeeC-----Cchh---------------------------hhhhhhhhhcceeec--Cce
Q 039318 424 DNF-SINKKLGEGGFGPVYKGTLA-----DGQE---------------------------IAHRNLVKLLGCCIQ--GEE 468 (717)
Q Consensus 424 ~~~-~~~~~lG~G~fg~Vy~~~~~-----~~~~---------------------------vah~niv~l~~~~~~--~~~ 468 (717)
++| ++.++||+|+||.||++.+. .++. +.||||+++++++.+ ...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344 89999999999999887542 1111 129999999999987 467
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
.++||||+++++|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 8999999999999999943 23899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCccc-cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCC--------CchhHHHHHHH
Q 039318 549 TFVGDEIE-GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSD--------KNLNLIGHAWK 619 (717)
Q Consensus 549 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~--------~~~~~~~~~~~ 619 (717)
........ .......+|+.|+|||++.+..++.++||||||+++|||++|+.||...... ...........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 76443221 1223456888999999999999999999999999999999999997632111 00000111111
Q ss_pred HhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 620 LWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 620 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
....... ...+......+.+|+.+||+.||++|||+.||+++|+...
T Consensus 263 ~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 263 LLERGER---------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcccC---------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111111 1111122346778999999999999999999999998654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=320.44 Aligned_cols=174 Identities=24% Similarity=0.282 Sum_probs=150.5
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hhhh-------------------------------hhhhhhhcceeecCceee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QEIA-------------------------------HRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~va-------------------------------h~niv~l~~~~~~~~~~~ 470 (717)
..+|++.++||+|+||.||+|+.... +.+| |+||+++++++...+..+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 46799999999999999999976542 2221 679999999999999999
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC--ceeccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN--PKISDFGLAR 548 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~--~kl~Dfgla~ 548 (717)
+||||+. ++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+||||+.++. +||+|||+++
T Consensus 176 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 9999996 5899888553 2335899999999999999999999998 999999999999999987 9999999997
Q ss_pred cccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCC
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYH 606 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~ 606 (717)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 251 YEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp ETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 64322 234678999999999999999999999999999999999999987543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.52 Aligned_cols=238 Identities=21% Similarity=0.260 Sum_probs=171.7
Q ss_pred HHHhcCcccccccccCCccceEeeeeCCc-hh----------------------------hhhhhhhhhcceeecCceee
Q 039318 420 ANATDNFSINKKLGEGGFGPVYKGTLADG-QE----------------------------IAHRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 420 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~----------------------------vah~niv~l~~~~~~~~~~~ 470 (717)
....++|++.++||+|+||.||+|+.... +. +.||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 34557899999999999999999975422 11 12999999999999999999
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc-----CCCCceecccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD-----HEMNPKISDFG 545 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~-----~~~~~kl~Dfg 545 (717)
+||||+++ +|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+||||+ .++.+||+|||
T Consensus 110 lv~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99999985 99999844 335899999999999999999999998 99999999999994 45559999999
Q ss_pred ccccccCCccccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCC
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG 624 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 624 (717)
+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..........
T Consensus 183 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 183 LARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---DQLFKIFEVLGLP 257 (329)
T ss_dssp HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCC
T ss_pred CccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH---HHHHHHHHHhCCC
Confidence 998654221 122345789999999999874 4899999999999999999999998643322 2222222221111
Q ss_pred CCccc---cc-----hhhh--ccCCHH------HHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 625 MPSQL---ID-----AYYQ--ESCNLA------EVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 625 ~~~~l---~d-----~~~~--~~~~~~------~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
..... .. .... ...... ....+.+|+.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 00 0000 000111 1245678999999999999999999987
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=313.93 Aligned_cols=221 Identities=28% Similarity=0.412 Sum_probs=174.7
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh-----------------------------hhhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI-----------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-----------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
.+.|++.+.||+|+||.||+|+... ++.+ .||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 3569999999999999999998632 2211 199999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||++ |+|.+++... ...+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 5787777432 346899999999999999999999998 99999999999999999999999999986532
Q ss_pred CccccccceecccccccCccccc---cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYAS---DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...... .. .......... .+
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~---~~---~~~~~~~~~~-~~ 273 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SA---LYHIAQNESP-AL 273 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HH---HHHHHHSCCC-CC
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HH---HHHHHhcCCC-CC
Confidence 22467999999999884 567899999999999999999999998643211 11 1122222211 11
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.. .. ....+.+++.+||+.||++|||+.++++.
T Consensus 274 ~~----~~----~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 274 QS----GH----WSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CC----TT----SCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CC----CC----CCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11 11 12346688899999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=312.29 Aligned_cols=226 Identities=22% Similarity=0.283 Sum_probs=179.6
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hh--------------------------------hhhhhhhhhcceeecCcee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QE--------------------------------IAHRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~--------------------------------vah~niv~l~~~~~~~~~~ 469 (717)
.++|++.+.||+|+||.||+|+.... +. +.||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 46799999999999999999986531 11 1299999999999999999
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC----Cceecccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM----NPKISDFG 545 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~Dfg 545 (717)
++||||+++++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999943 346889999999999999999999998 99999999999999888 79999999
Q ss_pred ccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM 625 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 625 (717)
+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .... ......
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~----~i~~~~ 234 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLA----NITSVS 234 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH----HHHTTC
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HHHH----HHHhcc
Confidence 998764322 123467999999999999999999999999999999999999998643211 1111 111111
Q ss_pred CccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 626 PSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 626 ~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
. . .+....... ...+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~-~-~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 Y-D-FDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp C-C-CCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred c-c-cChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 0 011111111 1346789999999999999999999984
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=315.75 Aligned_cols=173 Identities=28% Similarity=0.406 Sum_probs=150.4
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hh---------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QE---------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~---------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
.++|++.++||+|+||.||+|+.... +. +.||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 46899999999999999999987632 11 129999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhc-CCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD-SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
|+++++|.+++... ..+++..+..++.|++.||.|||++ + |+||||||+||||+.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999543 3588999999999999999999996 7 999999999999999999999999999754321
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCC
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFY 605 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~ 605 (717)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 223467999999999999999999999999999999999999998653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.66 Aligned_cols=228 Identities=22% Similarity=0.294 Sum_probs=169.8
Q ss_pred HHhcCcccccccccCCccceEeeeeCCc-h----------------------------h------hhhhhhhhhcceeec
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADG-Q----------------------------E------IAHRNLVKLLGCCIQ 465 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~----------------------------~------vah~niv~l~~~~~~ 465 (717)
...++|.+.+.||+|+||.||+|..... + + +.||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4467999999999999999999976432 1 1 12999999999975
Q ss_pred CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC---Cceec
Q 039318 466 GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM---NPKIS 542 (717)
Q Consensus 466 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~ 542 (717)
.+..++||||+++++|.+++. ..+.+++..+..++.||++||+|||+++ |+||||||+||||+.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 455899999999999999884 3456899999999999999999999998 99999999999997544 59999
Q ss_pred cccccccccCCccccccceecccccccCcccccc---CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHH
Q 039318 543 DFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASD---GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWK 619 (717)
Q Consensus 543 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 619 (717)
|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... .
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~------~ 355 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK------D 355 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH------H
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH------H
Confidence 999998764322 2335689999999999853 668899999999999999999999997543322211 1
Q ss_pred HhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 620 LWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 620 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
....+..... ... ... ....+.+++.+||+.||++||++.|+++.
T Consensus 356 ~i~~~~~~~~-~~~-~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 356 QITSGKYNFI-PEV-WAE----VSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHTTCCCCC-HHH-HTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCCCC-chh-hcc----cCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1111111110 000 001 12356789999999999999999999873
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=308.07 Aligned_cols=240 Identities=26% Similarity=0.373 Sum_probs=173.6
Q ss_pred HHhcCcccccccccCCccceEeeeeCC-chhh---------------------------hhhhhhhhcceeecCceeeEE
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLAD-GQEI---------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v---------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
...++|++.+.||+|+||.||+|.... ++.+ .||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 345789999999999999999997542 2111 299999999999999999999
Q ss_pred EeccCCCChhhHhhhc-----cccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccc
Q 039318 473 YEFMPNRSLDSFIFDQ-----TKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla 547 (717)
|||+++++|.+++... .....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999999542 12445899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCcc---ccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhC
Q 039318 548 RTFVGDEI---EGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNN 623 (717)
Q Consensus 548 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 623 (717)
........ ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ .. .....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~---~~~~~ 242 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---LM---LTLQN 242 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HH---HHHTS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---HH---HHhcc
Confidence 86543211 111234579999999999876 5689999999999999999999999875433221 11 11111
Q ss_pred CCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 624 GMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 624 ~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
. ...+................+.+++.+||+.||++||++.++++.
T Consensus 243 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 D-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp S-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred C-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1 111110000000000112356788999999999999999999873
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=319.35 Aligned_cols=228 Identities=8% Similarity=0.009 Sum_probs=160.9
Q ss_pred hcCcccccccccCCccceEeeeeCC-ch-----------------------------hhh--hhhhhhhc-------cee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQ-----------------------------EIA--HRNLVKLL-------GCC 463 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~-----------------------------~va--h~niv~l~-------~~~ 463 (717)
..+|.+.++||+|+||.||+|++.. ++ .+. ||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3468999999999999999998642 21 112 99988855 333
Q ss_pred ecC-----------------ceeeEEEeccCCCChhhHhhhccccccCChhhH------HHHHHHHHHHHHHHhhcCCCc
Q 039318 464 IQG-----------------EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKR------FCIICGTARGLLYLHHDSRLR 520 (717)
Q Consensus 464 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~yLH~~~~~~ 520 (717)
... ...+|||||++ ++|.+++... ...+++..+ +.++.||++||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 322 34799999999 8999999654 224566666 788899999999999998
Q ss_pred EEeccCCCCceEEcCCCCceeccccccccccCCccccccceecccccccCcccccc--CCCCccccchhHhHHHHHhhcC
Q 039318 521 IIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASD--GLFSVKSDVFSFGILLLEIVSG 598 (717)
Q Consensus 521 ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG 598 (717)
|+||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999865321 113567799999999987 7799999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 599 KKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 599 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+.||.......... +........................+.+|+.+||+.||++|||+.++++
T Consensus 290 ~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99997553322110 0000000000000000000112345678899999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.30 Aligned_cols=234 Identities=27% Similarity=0.373 Sum_probs=177.2
Q ss_pred HhcCcccccccccCCccceEeeeeCCch--------------------------hhhhhhhhhhcceeecCceeeEEEec
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQ--------------------------EIAHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~--------------------------~vah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
..++|++.+.||+|+||.||+|+..... .+.||||+++++++.+.+..++||||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 110 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL 110 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence 3578999999999999999999764320 12299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc-
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE- 554 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~- 554 (717)
+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++ ++.+||+|||+++......
T Consensus 111 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 111 CKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred ccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 999999999943 2346899999999999999999999998 99999999999998 6799999999987643211
Q ss_pred --cccccceecccccccCcccccc---------CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhC
Q 039318 555 --IEGSTKRVVGTYGYMAPEYASD---------GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNN 623 (717)
Q Consensus 555 --~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 623 (717)
.........|++.|+|||++.+ ..++.++||||||+++|||++|+.||....... .. .....
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~----~~~~~ 257 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---II----WQMGT 257 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH---HH----HHHHT
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHhcc
Confidence 1112233568999999999874 457899999999999999999999986432211 11 11111
Q ss_pred CCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCC
Q 039318 624 GMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM 676 (717)
Q Consensus 624 ~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~ 676 (717)
.......... ....+.+++.+||+.||++|||+.+|+++|+....
T Consensus 258 ~~~~~~~~~~--------~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 258 GMKPNLSQIG--------MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp TCCCCCCCSS--------CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred CCCCCCCcCC--------CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1111111100 11246678899999999999999999999988763
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=319.18 Aligned_cols=240 Identities=20% Similarity=0.280 Sum_probs=176.3
Q ss_pred HHHhcCcccccccccCCccceEeeeeCC-chhhh----------------------hhhhhhhcceeec-----------
Q 039318 420 ANATDNFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------HRNLVKLLGCCIQ----------- 465 (717)
Q Consensus 420 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va----------------------h~niv~l~~~~~~----------- 465 (717)
....++|++.+.||+|+||.||+|+... ++.+| |||||++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 4556899999999999999999998643 33222 9999999999843
Q ss_pred ---------------------------CceeeEEEeccCCCChhhHhhhc-cccccCChhhHHHHHHHHHHHHHHHhhcC
Q 039318 466 ---------------------------GEEKLLIYEFMPNRSLDSFIFDQ-TKRKLLDWSKRFCIICGTARGLLYLHHDS 517 (717)
Q Consensus 466 ---------------------------~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~ 517 (717)
....++||||+++ +|.+.+... .....+++..+..++.||++||+|||+++
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp ---------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 3347899999984 887777542 23456899999999999999999999998
Q ss_pred CCcEEeccCCCCceEEc-CCCCceeccccccccccCCccccccceecccccccCccccccC-CCCccccchhHhHHHHHh
Q 039318 518 RLRIIHRDLKASNVLLD-HEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEI 595 (717)
Q Consensus 518 ~~~ivHrDlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~el 595 (717)
|+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||
T Consensus 162 ---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 162 ---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp ---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred ---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 99999999999998 68899999999998764332 22346789999999998775 489999999999999999
Q ss_pred hcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc---------------cccchhhhccCCHHHHHHHHHHHhhccccCCCC
Q 039318 596 VSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS---------------QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPED 660 (717)
Q Consensus 596 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~ 660 (717)
++|+.||...... ..+....+........ .+.........+......+.+|+.+||+.||++
T Consensus 236 l~g~~pf~~~~~~---~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 236 ILGKPLFSGETSI---DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HhCCCCCCCCChH---HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999998754322 2222222221111100 000000111111112245788999999999999
Q ss_pred CCChHHHHH
Q 039318 661 RPCMPSVIL 669 (717)
Q Consensus 661 RPs~~evl~ 669 (717)
|||+.|+++
T Consensus 313 R~t~~e~l~ 321 (383)
T 3eb0_A 313 RINPYEAMA 321 (383)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=325.25 Aligned_cols=233 Identities=24% Similarity=0.255 Sum_probs=170.1
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hhh----------------------------hhhhhhhhcceeecC------c
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QEI----------------------------AHRNLVKLLGCCIQG------E 467 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v----------------------------ah~niv~l~~~~~~~------~ 467 (717)
.++|++.++||+|+||.||+|+.... +.+ .|||||++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46899999999999999999976532 111 199999999998654 4
Q ss_pred eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla 547 (717)
..+|||||++++ |.+.+. ..+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 579999999875 555552 23889999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC-
Q 039318 548 RTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP- 626 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 626 (717)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+......+.....
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~---~~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTPCPE 285 (464)
T ss_dssp -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSCCHH
T ss_pred eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCHH
Confidence 875432 1234578999999999999999999999999999999999999998654322 222222221111000
Q ss_pred -------------------ccc-cchhhh-----ccC--CHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 627 -------------------SQL-IDAYYQ-----ESC--NLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 627 -------------------~~l-~d~~~~-----~~~--~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
... ...... ... .......+.+|+.+||+.||++|||++|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000000 000 00113567899999999999999999999984
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=306.61 Aligned_cols=226 Identities=24% Similarity=0.328 Sum_probs=172.5
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hh---------------------------hhhhhhhhhcceeecCceeeEEEe
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QE---------------------------IAHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~---------------------------vah~niv~l~~~~~~~~~~~lV~E 474 (717)
.++|.+.++||+|+||.||+++.... .. +.||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 36799999999999999999986532 11 129999999999999999999999
Q ss_pred ccCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE---cCCCCceeccccccccc
Q 039318 475 FMPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL---DHEMNPKISDFGLARTF 550 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~Dfgla~~~ 550 (717)
|+++++|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999986532 3456899999999999999999999998 9999999999999 45678999999999865
Q ss_pred cCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
.... ......||+.|+|||++. ..++.++||||||+++|||++|+.||......+ .... . .........
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~---~~~~-~-~~~~~~~~~-- 246 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE---VQQK-A-TYKEPNYAV-- 246 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH-H-HHCCCCCCC--
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH---HHhh-h-ccCCccccc--
Confidence 4322 223467999999999886 568999999999999999999999986432211 1111 1 111111000
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
. ... ....+.+++.+||+.||++|||+.||++
T Consensus 247 ~---~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 E---CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c---cCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000 1235668899999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=307.45 Aligned_cols=229 Identities=27% Similarity=0.401 Sum_probs=178.3
Q ss_pred hcCccccc-ccccCCccceEeeeeC--C-chh----------------------------hhhhhhhhhcceeecCceee
Q 039318 423 TDNFSINK-KLGEGGFGPVYKGTLA--D-GQE----------------------------IAHRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 423 ~~~~~~~~-~lG~G~fg~Vy~~~~~--~-~~~----------------------------vah~niv~l~~~~~~~~~~~ 470 (717)
.++|.+.+ .||+|+||.||+|.+. . ++. +.||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45788888 9999999999999542 1 111 1299999999999 667889
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
+||||+++++|.+++.. ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999954 345889999999999999999999998 999999999999999999999999999876
Q ss_pred cCCccc-cccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 551 VGDEIE-GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 551 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
...... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ............
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~ 240 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMG 240 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCCC
Confidence 443221 11223456788999999998899999999999999999999 999986433211 111122221111
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
. +......+.+++.+||+.||++||++.+|++.|+..
T Consensus 241 ~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 241 C---------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp C---------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 111224577899999999999999999999999754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.37 Aligned_cols=233 Identities=18% Similarity=0.239 Sum_probs=173.6
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh-----------------------------hhhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI-----------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-----------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
.++|++.+.||+|+||.||+|+... ++.+ .||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 4789999999999999999998653 2111 199999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999999543 45899999999999999999999998 99999999999999999999999999986543
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
... .......|++.|+|||++.+..++.++||||||+++|||++|+.||...... . ........... ..
T Consensus 187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~---~~~~~~~~~~~-~~-- 255 (309)
T 2h34_A 187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----V---MGAHINQAIPR-PS-- 255 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----H---HHHHHHSCCCC-GG--
T ss_pred ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----H---HHHHhccCCCC-cc--
Confidence 321 1223467899999999999999999999999999999999999998643211 1 11111111110 00
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCC-ChHHHHHHhcCCCC
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRP-CMPSVILMLGSEIM 676 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-s~~evl~~L~~~~~ 676 (717)
... ......+.+++.+||+.||++|| +++++++.|+....
T Consensus 256 ~~~----~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 256 TVR----PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp GTS----TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred ccC----CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 001 11123466788999999999999 99999999987653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.83 Aligned_cols=232 Identities=20% Similarity=0.352 Sum_probs=181.8
Q ss_pred HHHHHHHhcCcccccccccCCccceEeeeeCC-chh----------------------------------h-hhhhhhhh
Q 039318 416 LATIANATDNFSINKKLGEGGFGPVYKGTLAD-GQE----------------------------------I-AHRNLVKL 459 (717)
Q Consensus 416 ~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~----------------------------------v-ah~niv~l 459 (717)
........++|++.+.||+|+||.||+|++.. ++. + .||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 33445566789999999999999999998752 221 1 29999999
Q ss_pred cceeecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCc
Q 039318 460 LGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP 539 (717)
Q Consensus 460 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~ 539 (717)
++++...+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999954 345899999999999999999999998 9999999999999999999
Q ss_pred eeccccccccccCCccccccceecccccccCcccccc------CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhH
Q 039318 540 KISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASD------GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNL 613 (717)
Q Consensus 540 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~ 613 (717)
||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...
T Consensus 240 kl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~ 313 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---ILM 313 (365)
T ss_dssp EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHH
T ss_pred EEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HHH
Confidence 999999998764332 2234679999999999863 3588999999999999999999999864221 111
Q ss_pred HHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 614 IGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.. ......... ..+.. .. ....+.+++.+||+.||++||++.++++
T Consensus 314 ~~----~i~~~~~~~-~~~~~-~~----~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 314 LR----MIMEGQYQF-SSPEW-DD----RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HH----HHHHTCCCC-CHHHH-SS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HH----HHHhCCCCC-CCccc-cc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 111111110 00000 01 1234678899999999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=305.82 Aligned_cols=227 Identities=26% Similarity=0.370 Sum_probs=173.8
Q ss_pred hcCcccccccccCCccceEeeeeCCch-----------------------hhhhhhhhhhcceeecC-ceeeEEEeccCC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ-----------------------EIAHRNLVKLLGCCIQG-EEKLLIYEFMPN 478 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-----------------------~vah~niv~l~~~~~~~-~~~~lV~E~~~~ 478 (717)
.++|++.+.||+|+||.||+++..... .+.||||+++++++.+. +..++||||+++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 99 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 99 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCC
Confidence 368999999999999999999865321 11299999999987554 578999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
++|.+++... ....+++..+..++.|+++||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 170 (278)
T 1byg_A 100 GSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----- 170 (278)
T ss_dssp EEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc-----
Confidence 9999999543 2234788999999999999999999998 999999999999999999999999999864322
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhcc
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 637 (717)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ .. .....+.....
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~----~~~~~~~~~~~-------- 235 (278)
T 1byg_A 171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKGYKMDA-------- 235 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH----HHHTTTCCCCC--------
T ss_pred ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHhcCCCCCC--------
Confidence 223467889999999999999999999999999999998 999987543222 11 11111111111
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
+......+.+++.+||+.||++||++.++++.|+..
T Consensus 236 -~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 236 -PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 111124567889999999999999999999999754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=304.29 Aligned_cols=235 Identities=25% Similarity=0.354 Sum_probs=173.0
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh-----------------------------hhhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI-----------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-----------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
.++|++.+.||+|+||.||+|+... ++.+ .||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 3579999999999999999998632 2211 199999999999999999999
Q ss_pred EeccCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 473 YEFMPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
|||+++++|.+++.... ....+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999995432 3456889999999999999999999998 9999999999999999999999999998654
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
.... ......|++.|+|||++.+..++.++||||||+++|||++|+.||...... ... ............+..
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~~~~~~~ 260 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-LCKKIEQCDYPPLPS 260 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHH-HHHHHHTTCSCCCCT
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHH-HHHHhhcccCCCCcc
Confidence 3221 123457899999999999999999999999999999999999998643211 111 111122221111110
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
. .....+.+++.+||+.||++||++.+|+++|+...
T Consensus 261 ----~----~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 261 ----D----HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp ----T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----c----ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1 11235678899999999999999999999998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=336.84 Aligned_cols=229 Identities=28% Similarity=0.407 Sum_probs=174.8
Q ss_pred cCccccc-ccccCCccceEeeeeC---Cchhh---------------------------hhhhhhhhcceeecCceeeEE
Q 039318 424 DNFSINK-KLGEGGFGPVYKGTLA---DGQEI---------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 424 ~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~v---------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
+++.+.+ +||+|+||.||+|.++ .+..+ .|||||++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444445 7999999999999763 12111 19999999999976 568999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
||||++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999954 3456899999999999999999999998 99999999999999999999999999987643
Q ss_pred Ccccc-ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 553 DEIEG-STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 553 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
..... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ .. ..+..+....
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~----~~i~~~~~~~-- 559 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQGKRME-- 559 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HH----HHHHTTCCCC--
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCCCCC--
Confidence 32111 1122345689999999999999999999999999999998 999987543322 11 1122221111
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.+......+.+|+.+||+.+|++||++.+|++.|+..
T Consensus 560 -------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 560 -------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp -------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111224577899999999999999999999999754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=303.72 Aligned_cols=227 Identities=26% Similarity=0.367 Sum_probs=168.6
Q ss_pred HhcCcccccccccCCccceEeeeeCC-chhhh----------------------------hhhhhhhcceeecCceeeEE
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------------HRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va----------------------------h~niv~l~~~~~~~~~~~lV 472 (717)
..++|++.+.||+|+||.||+|+... ++.+| ||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 34789999999999999999998743 22221 99999999999999999999
Q ss_pred EeccCCCChhhHhhhc-cccccCChhhHHHHHHHHHHHHHHHhhc-CCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 473 YEFMPNRSLDSFIFDQ-TKRKLLDWSKRFCIICGTARGLLYLHHD-SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
|||+++ +|.+++... .....+++..+..++.||+.||+|||++ + |+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999985 888877542 2345789999999999999999999998 7 999999999999999999999999999875
Q ss_pred cCCccccccceecccccccCcccc----ccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYA----SDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (717)
.... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||...... ... ..........
T Consensus 161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~---~~~~~~~~~~ 232 (290)
T 3fme_A 161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--FQQ---LKQVVEEPSP 232 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH--HHH---HHHHHHSCCC
T ss_pred cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch--HHH---HHHHhccCCC
Confidence 4332 12235799999999996 5667899999999999999999999998643211 111 1122222211
Q ss_pred ccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 627 SQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 627 ~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
... . . .....+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~-~----~----~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 QLP-A----D----KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCC-T----T----TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred Ccc-c----c----cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111 0 0 11235678899999999999999999987
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=303.69 Aligned_cols=220 Identities=23% Similarity=0.326 Sum_probs=178.5
Q ss_pred hcCcccccccccCCccceEeeeeCCch-hh-----------------------------hhhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ-EI-----------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~v-----------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
.++|++.+.||+|+||.||+|+..... .+ .||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 368999999999999999999875321 11 199999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999999543 35889999999999999999999998 99999999999999999999999999976532
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
. ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+ .. .... .....
T Consensus 167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~~~-~~~~~----- 230 (284)
T 2vgo_A 167 L----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---TH---RRIV-NVDLK----- 230 (284)
T ss_dssp S----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHH-TTCCC-----
T ss_pred c----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---HH---HHHh-ccccC-----
Confidence 2 1234678999999999999999999999999999999999999986432211 11 1111 11110
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
... .....+.+++.+||+.||.+||++.++++
T Consensus 231 -~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 -FPP----FLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -CCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCC----cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 001 11235678899999999999999999987
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=304.65 Aligned_cols=225 Identities=22% Similarity=0.320 Sum_probs=175.9
Q ss_pred hcCcccccccccCCccceEeeeeCC-chh--------------------------------hhhhhhhhhcceeecCcee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQE--------------------------------IAHRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~--------------------------------vah~niv~l~~~~~~~~~~ 469 (717)
.++|++.+.||+|+||.||+|+... ++. +.||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 3679999999999999999998652 211 1299999999999999999
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC----Cceecccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM----NPKISDFG 545 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~Dfg 545 (717)
++||||+++++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999954 345899999999999999999999998 99999999999998877 79999999
Q ss_pred ccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM 625 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 625 (717)
++....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ... ..+....
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~ 227 (283)
T 3bhy_A 158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---ETL----TNISAVN 227 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH----HHHHTTC
T ss_pred cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---HHH----HHhHhcc
Confidence 998654322 123457899999999999999999999999999999999999998643221 111 1111111
Q ss_pred CccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 626 PSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 626 ~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.. . ....... ....+.+++.+||+.||++||++.++++
T Consensus 228 ~~-~-~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 YD-F-DEEYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CC-C-CHHHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cC-C-cchhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 10 0 0011111 1235678999999999999999999997
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=310.60 Aligned_cols=177 Identities=23% Similarity=0.302 Sum_probs=148.6
Q ss_pred HhcCcccccccccCCccceEeeeeCCc-hhhh-------------------------------hhhhhhhcceeecCcee
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADG-QEIA-------------------------------HRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~va-------------------------------h~niv~l~~~~~~~~~~ 469 (717)
..++|++.++||+|+||.||+|+.... +.+| |++|+++++++...+..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 457899999999999999999986532 2121 44699999999999999
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc--CCCCceecccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD--HEMNPKISDFGLA 547 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~--~~~~~kl~Dfgla 547 (717)
++||||+++ +|.+++.... ...+++..+..++.||+.||.|||.+. .+|+||||||+||||+ .++.+||+|||++
T Consensus 132 ~lv~e~~~~-~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 132 CLVFEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEECCCC-BHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEecCCC-CHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999965 9999986532 345899999999999999999999531 2399999999999994 5778999999999
Q ss_pred ccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCC
Q 039318 548 RTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYH 606 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~ 606 (717)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 875322 234678999999999999999999999999999999999999987543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-35 Score=324.17 Aligned_cols=169 Identities=27% Similarity=0.386 Sum_probs=130.8
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hhh----------------------------hhhhhhhhcceeec-----Cce
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QEI----------------------------AHRNLVKLLGCCIQ-----GEE 468 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v----------------------------ah~niv~l~~~~~~-----~~~ 468 (717)
.++|++.++||+|+||.||+|+.... +.+ .|||||++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36899999999999999999976532 111 29999999999844 357
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
.++||||+. ++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 689888843 346899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCccc-------------------------cccceecccccccCcccc-ccCCCCccccchhHhHHHHHhhcC
Q 039318 549 TFVGDEIE-------------------------GSTKRVVGTYGYMAPEYA-SDGLFSVKSDVFSFGILLLEIVSG 598 (717)
Q Consensus 549 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~elltG 598 (717)
........ ......+||+.|+|||++ .+..++.++||||||||+|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 76422110 122346789999999976 566799999999999999999994
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=305.92 Aligned_cols=223 Identities=26% Similarity=0.420 Sum_probs=179.5
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh---------------------------hhhhhhhhcceeecCceeeEEEe
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI---------------------------AHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v---------------------------ah~niv~l~~~~~~~~~~~lV~E 474 (717)
.+.|++.+.||+|+||.||+|+... ++.+ .||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 3579999999999999999997643 2211 19999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++++|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999983 246899999999999999999999998 9999999999999999999999999998764432
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
. ......|++.|+|||++.+..++.++||||||+++|||++|+.||...... ..... ........+
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~----~~~~~~~~~----- 239 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLFL----IPKNNPPTL----- 239 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH----HHHSCCCCC-----
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHHH----hhcCCCCCC-----
Confidence 2 223467899999999999999999999999999999999999998643221 11111 111111111
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.... ...+.+++.+||+.+|++|||+.++++.
T Consensus 240 ~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNY----SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cccc----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111 2346788999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=310.94 Aligned_cols=230 Identities=21% Similarity=0.244 Sum_probs=156.1
Q ss_pred hcCccccc-ccccCCccceEeeeeCC-chhhh----------------------hhhhhhhcceeec----CceeeEEEe
Q 039318 423 TDNFSINK-KLGEGGFGPVYKGTLAD-GQEIA----------------------HRNLVKLLGCCIQ----GEEKLLIYE 474 (717)
Q Consensus 423 ~~~~~~~~-~lG~G~fg~Vy~~~~~~-~~~va----------------------h~niv~l~~~~~~----~~~~~lV~E 474 (717)
.++|.+.+ .||+|+||.||+|+... ++.+| ||||+++++++.. ....++|||
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 106 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME 106 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEe
Confidence 46899855 69999999999998763 33332 8999999999876 556899999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC---CCCceecccccccccc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH---EMNPKISDFGLARTFV 551 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~Dfgla~~~~ 551 (717)
|+++++|.+++... ....+++..+..++.||++||.|||+++ |+||||||+||||+. ++.+||+|||+++...
T Consensus 107 ~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 107 CMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp CCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred ccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 99999999999653 2346899999999999999999999998 999999999999976 4559999999998654
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||............. ........ .+..
T Consensus 183 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~-~~~~ 254 (336)
T 3fhr_A 183 QN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRIRLGQY-GFPN 254 (336)
T ss_dssp -------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CCCT
T ss_pred cc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhhhcccc-ccCc
Confidence 32 2234678999999999998899999999999999999999999986443222111000 00000000 0000
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+ ........+.+++.+||+.||++|||+.|+++
T Consensus 255 ~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 255 P-----EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp T-----TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred h-----hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00112235678899999999999999999998
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=322.81 Aligned_cols=236 Identities=22% Similarity=0.271 Sum_probs=173.3
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh----------------------hhhhhhhcceeecC------ceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------HRNLVKLLGCCIQG------EEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va----------------------h~niv~l~~~~~~~------~~~~lV~E 474 (717)
.+|++.+.||+|+||.||+|++.. ++.+| |||||++++++... ...++|||
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence 468999999999999999999854 33222 99999999988542 23679999
Q ss_pred ccCCCChhhHhhhc-cccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC-CCceeccccccccccC
Q 039318 475 FMPNRSLDSFIFDQ-TKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE-MNPKISDFGLARTFVG 552 (717)
Q Consensus 475 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~Dfgla~~~~~ 552 (717)
|+++ +|.+.+... .....+++..+..++.||++||+|||+++ |+||||||+||||+.+ +.+||+|||+++....
T Consensus 134 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp CCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred cccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 9986 565555332 23456899999999999999999999998 9999999999999965 5689999999987543
Q ss_pred CccccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC------
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM------ 625 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 625 (717)
... .....||+.|+|||++.+. .++.++||||||||+|||++|+.||...... ..+....+.+....
T Consensus 210 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 210 GEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp TCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSCCHHHHHH
T ss_pred CCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHHHh
Confidence 321 2346789999999998765 7999999999999999999999998753322 22222222211110
Q ss_pred ----Cccccchh-----hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 626 ----PSQLIDAY-----YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 626 ----~~~l~d~~-----~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
..++.-+. ............+.+|+.+||+.||++||++.|+++
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00000000 000011112246789999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=308.48 Aligned_cols=241 Identities=20% Similarity=0.272 Sum_probs=179.1
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hh-------------------------h-----------hhhhhhhhcceeec
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QE-------------------------I-----------AHRNLVKLLGCCIQ 465 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~-------------------------v-----------ah~niv~l~~~~~~ 465 (717)
.++|++.+.||+|+||.||+|+.... +. + .||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 36899999999999999999986422 11 1 17899999999886
Q ss_pred Cc----eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhc-CCCcEEeccCCCCceEEc------
Q 039318 466 GE----EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD-SRLRIIHRDLKASNVLLD------ 534 (717)
Q Consensus 466 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrDlkp~NIll~------ 534 (717)
.+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ + |+||||||+||||+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 54 789999999 889999996532 34588999999999999999999998 7 99999999999995
Q ss_pred CCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCC---ch
Q 039318 535 HEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDK---NL 611 (717)
Q Consensus 535 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~---~~ 611 (717)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 3447999999999865322 234578999999999999999999999999999999999999997544322 11
Q ss_pred hHHHHHHHHhhCCCCcccc---------------------------chhh--hccCCHHHHHHHHHHHhhccccCCCCCC
Q 039318 612 NLIGHAWKLWNNGMPSQLI---------------------------DAYY--QESCNLAEVIRCIHVGLLCVQHHPEDRP 662 (717)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~---------------------------d~~~--~~~~~~~~~~~~~~l~~~Cl~~dp~~RP 662 (717)
..+......... .+..+. ...+ ....+......+.+|+.+||+.||++||
T Consensus 248 ~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 248 DHIAQIIELLGE-LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHCS-CCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHhcCC-CCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 122222221111 000000 0000 1123445667888999999999999999
Q ss_pred ChHHHHH--HhcCC
Q 039318 663 CMPSVIL--MLGSE 674 (717)
Q Consensus 663 s~~evl~--~L~~~ 674 (717)
|+.||++ .+...
T Consensus 327 t~~ell~hp~f~~~ 340 (373)
T 1q8y_A 327 DAGGLVNHPWLKDT 340 (373)
T ss_dssp CHHHHHTCGGGTTC
T ss_pred CHHHHhhChhhhcc
Confidence 9999998 34443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=301.68 Aligned_cols=233 Identities=24% Similarity=0.315 Sum_probs=178.8
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hh----------------------------hhhhhhhhhcceee--cCceeeE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QE----------------------------IAHRNLVKLLGCCI--QGEEKLL 471 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~----------------------------vah~niv~l~~~~~--~~~~~~l 471 (717)
.++|++.+.||+|+||.||+++.... +. +.||||+++++++. ..+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46899999999999999999987532 11 12999999999874 4668899
Q ss_pred EEeccCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcC--CCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDS--RLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999996543 2345899999999999999999999976 2349999999999999999999999999998
Q ss_pred cccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||...... ... ..+..+....
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~----~~i~~~~~~~ 235 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELA----GKIREGKFRR 235 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHTCCCC
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHH----HHHhhccccc
Confidence 6543221 122457899999999999999999999999999999999999998754211 111 1111222111
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
+. ......+.+++.+||+.||++||++.||++.+..
T Consensus 236 ~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 236 IP---------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CC---------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11 1122456788999999999999999999997744
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=316.04 Aligned_cols=234 Identities=23% Similarity=0.330 Sum_probs=172.2
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhhh----------------------------hhhhhhhcceeecCc------
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------------HRNLVKLLGCCIQGE------ 467 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va----------------------------h~niv~l~~~~~~~~------ 467 (717)
.++|++.+.||+|+||.||+|+... ++.+| ||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 3689999999999999999998643 22221 999999999997663
Q ss_pred eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla 547 (717)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899999843 35889999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC
Q 039318 548 RTFVGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (717)
+..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+......... ..
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~-~~ 246 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTGT-PP 246 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCC-CC
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCC-CC
Confidence 875322 234678999999999877 67999999999999999999999998743322 222222211110 00
Q ss_pred ccccc-------------------hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH--hcCC
Q 039318 627 SQLID-------------------AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM--LGSE 674 (717)
Q Consensus 627 ~~l~d-------------------~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~--L~~~ 674 (717)
.+++. .... .........+.+|+.+||+.||++|||+.|+++. ++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 00000 0000 0001112457789999999999999999999983 5443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=306.45 Aligned_cols=238 Identities=26% Similarity=0.387 Sum_probs=179.9
Q ss_pred hcCcccccccccCCccceEeeeeC-----Cchhh--------------------------hhhhhhhhcceeecCc--ee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLA-----DGQEI--------------------------AHRNLVKLLGCCIQGE--EK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~v--------------------------ah~niv~l~~~~~~~~--~~ 469 (717)
.++|++.+.||+|+||.||++++. .++.+ .||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 357999999999999999999842 22222 1999999999987654 78
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||+++++|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999999543 345899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccc-cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCC--------C-CchhHHHHHHH
Q 039318 550 FVGDEIE-GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHS--------D-KNLNLIGHAWK 619 (717)
Q Consensus 550 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~--------~-~~~~~~~~~~~ 619 (717)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+..... . ...........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 6443221 112234577889999999998999999999999999999999998753210 0 00011111112
Q ss_pred HhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 620 LWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 620 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
......... .+......+.+++.+||+.||++||++.||++.|+..
T Consensus 275 ~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNGRLP---------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTCCCC---------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCCCCC---------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 221111110 1111224577899999999999999999999998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=297.95 Aligned_cols=224 Identities=23% Similarity=0.395 Sum_probs=173.9
Q ss_pred hcCcccccccccCCccceEeeeeCCch-h----------------------------hhhhhhhhhcceeec----Ccee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ-E----------------------------IAHRNLVKLLGCCIQ----GEEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~----------------------------vah~niv~l~~~~~~----~~~~ 469 (717)
.+.|.+.+.||+|+||.||+|...... . +.||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 345888899999999999999865322 1 129999999998865 4568
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc-CCCCceeccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD-HEMNPKISDFGLAR 548 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~Dfgla~ 548 (717)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ .+|+||||||+||||+ .++.+||+|||++.
T Consensus 105 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999999954 245889999999999999999999875 3499999999999997 78999999999997
Q ss_pred cccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||....... .............
T Consensus 181 ~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~ 249 (290)
T 1t4h_A 181 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPA 249 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCG
T ss_pred ccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH------HHHHHHhccCCcc
Confidence 64332 2234679999999998864 58999999999999999999999986432211 1112222221111
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.. .... ...+.+++.+||+.||.+|||+.+|++
T Consensus 250 ~~----~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 SF----DKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG----GGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc----CCCC----CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 1111 134678899999999999999999987
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.57 Aligned_cols=234 Identities=18% Similarity=0.272 Sum_probs=175.7
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hh-----------------------hh-hhhhhhhcceeec--CceeeEEEec
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QE-----------------------IA-HRNLVKLLGCCIQ--GEEKLLIYEF 475 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~-----------------------va-h~niv~l~~~~~~--~~~~~lV~E~ 475 (717)
.++|++.++||+|+||.||+|+.... +. +. ||||+++++++.+ ....++||||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 36899999999999999999976432 21 12 9999999999987 6678999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC-CceeccccccccccCCc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM-NPKISDFGLARTFVGDE 554 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~Dfgla~~~~~~~ 554 (717)
+++++|.+++. .+++..+..++.||++||+|||+++ |+||||||+||||+.++ .+||+|||+++......
T Consensus 115 ~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 115 VNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp CCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred cCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999998883 2788899999999999999999998 99999999999999776 89999999998654332
Q ss_pred cccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHh---------hCC
Q 039318 555 IEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLW---------NNG 624 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~---------~~~ 624 (717)
......|++.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+....... ...
T Consensus 186 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 186 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHHHT
T ss_pred ---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch--HHHHHHHHHhcCCchhhhHHHHh
Confidence 2234678999999999877 67999999999999999999999998533221 11111111110 000
Q ss_pred C--------------CccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 625 M--------------PSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 625 ~--------------~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
. .....+..............+.+|+.+||+.||++|||++|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 000000000101111123467889999999999999999999973
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=325.16 Aligned_cols=226 Identities=26% Similarity=0.340 Sum_probs=176.7
Q ss_pred HhcCcccccccccCCccceEeeeeCC-chhh----------------------------hhhhhhhhcceeecCceeeEE
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLAD-GQEI----------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v----------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
..++|++.++||+|+||.||+|+... ++.+ .||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 34689999999999999999998753 2222 199999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc---CCCCceecccccccc
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD---HEMNPKISDFGLART 549 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~Dfgla~~ 549 (717)
|||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999988543 45899999999999999999999998 99999999999995 456799999999986
Q ss_pred ccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 550 FVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 550 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ..+.. ...+.....
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~----i~~~~~~~~ 242 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKR----VETGKYAFD 242 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHTCCCSC
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhCCCCCC
Confidence 54332 2234679999999999876 5999999999999999999999998643221 11111 111111110
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
... . .. ....+.+++.+||+.||.+|||+.++++.
T Consensus 243 ~~~-~-~~----~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 LPQ-W-RT----ISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SGG-G-GG----SCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred Ccc-c-CC----CCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0 01 12356789999999999999999999984
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=309.01 Aligned_cols=242 Identities=21% Similarity=0.289 Sum_probs=168.3
Q ss_pred HHHHHhcCcccccccccCCccceEeeeeCC-chhh-------------------------hhhhhhhhcceeecCce---
Q 039318 418 TIANATDNFSINKKLGEGGFGPVYKGTLAD-GQEI-------------------------AHRNLVKLLGCCIQGEE--- 468 (717)
Q Consensus 418 ~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-------------------------ah~niv~l~~~~~~~~~--- 468 (717)
......++|++.+.||+|+||.||+|+... ++.+ .||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 345667899999999999999999998753 2222 29999999999876443
Q ss_pred ----eeEEEeccCCCChhhHhhh-ccccccCChhhHHHHHHHHHHHHHHHh--hcCCCcEEeccCCCCceEEcC-CCCce
Q 039318 469 ----KLLIYEFMPNRSLDSFIFD-QTKRKLLDWSKRFCIICGTARGLLYLH--HDSRLRIIHRDLKASNVLLDH-EMNPK 540 (717)
Q Consensus 469 ----~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH--~~~~~~ivHrDlkp~NIll~~-~~~~k 540 (717)
.++||||++++ |...+.. ......+++..+..++.||+.||.||| +++ |+||||||+||||+. ++.+|
T Consensus 97 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred cceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 78999999874 4444322 234556888999999999999999999 777 999999999999997 89999
Q ss_pred eccccccccccCCccccccceecccccccCccccccCC-CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHH
Q 039318 541 ISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWK 619 (717)
Q Consensus 541 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 619 (717)
|+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... .+.....
T Consensus 173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~~~ 246 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEIVR 246 (360)
T ss_dssp ECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH
T ss_pred EeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHHHH
Confidence 99999998764332 122457899999999986654 8999999999999999999999987543222 2222211
Q ss_pred HhhCCCCcccc----------chhhhc---------cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 620 LWNNGMPSQLI----------DAYYQE---------SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 620 ~~~~~~~~~l~----------d~~~~~---------~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
..... ..+.+ +..... .........+.+|+.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 247 VLGCP-SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHCCC-CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HcCCC-CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11100 00000 000000 1111234568899999999999999999999873
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.21 Aligned_cols=231 Identities=21% Similarity=0.297 Sum_probs=181.6
Q ss_pred HhcCcccccccccCCccceEeeeeCC-chhh--------------------------hhhhhhhhcceeecCceeeEEEe
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLAD-GQEI--------------------------AHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v--------------------------ah~niv~l~~~~~~~~~~~lV~E 474 (717)
..++|.+.+.||+|+||.||+++... ++.+ .||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 34689999999999999999998652 2211 29999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE---cCCCCceecccccccccc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL---DHEMNPKISDFGLARTFV 551 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~Dfgla~~~~ 551 (717)
|+++++|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+||++ +.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999999854 345889999999999999999999998 9999999999999 788999999999998643
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... ..+.++... ...
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~----~~i~~~~~~-~~~ 228 (304)
T 2jam_A 161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLF----EKIKEGYYE-FES 228 (304)
T ss_dssp CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH----HHHHHCCCC-CCT
T ss_pred CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHcCCCC-CCc
Confidence 22 123457899999999999999999999999999999999999998643211 111 111111110 000
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH--HhcCCC
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL--MLGSEI 675 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~--~L~~~~ 675 (717)
.... .....+.+++.+||+.||++||++.++++ .+.+..
T Consensus 229 -~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 229 -PFWD----DISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp -TTTT----TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred -cccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 0001 11245678999999999999999999997 454443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=300.31 Aligned_cols=228 Identities=29% Similarity=0.445 Sum_probs=175.5
Q ss_pred HHhcCcccccccccCCccceEeeeeCC-chhh------------------------hhhhhhhhcceeecCceeeEEEec
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLAD-GQEI------------------------AHRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v------------------------ah~niv~l~~~~~~~~~~~lV~E~ 475 (717)
...++|++.+.||+|+||.||+|+... ++.+ .||||+++++++.+.+..++||||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 345789999999999999999998764 3222 299999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++........
T Consensus 106 ~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 106 CGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999999853 2346899999999999999999999998 99999999999999999999999999986543221
Q ss_pred ccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhh
Q 039318 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~ 635 (717)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... .. ....... ...+.. .
T Consensus 181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~---~~~~~~~-~~~~~~---~ 248 (314)
T 3com_A 181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR---AI---FMIPTNP-PPTFRK---P 248 (314)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH---HHHHHSC-CCCCSS---G
T ss_pred --ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---HH---HHHhcCC-CcccCC---c
Confidence 2234678999999999999999999999999999999999999986432211 11 1111111 111100 0
Q ss_pred ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 636 ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 636 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.. ....+.+++.+||+.||.+||++.++++
T Consensus 249 ~~----~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 EL----WSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GG----SCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cc----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00 1235678899999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.99 Aligned_cols=234 Identities=22% Similarity=0.279 Sum_probs=179.5
Q ss_pred hcCcccccccccCCccceEeeeeC--Cchhhh-------------------------hh------hhhhhcceeecCcee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLA--DGQEIA-------------------------HR------NLVKLLGCCIQGEEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~va-------------------------h~------niv~l~~~~~~~~~~ 469 (717)
.++|++.+.||+|+||.||+|... .++.+| |+ +++++++++.+.+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 468999999999999999999862 222221 54 489999999999999
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC--------------
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH-------------- 535 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~-------------- 535 (717)
++||||+ +++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+||||+.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence 9999999 88999998553 2345889999999999999999999998 999999999999987
Q ss_pred -----CCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCc
Q 039318 536 -----EMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKN 610 (717)
Q Consensus 536 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~ 610 (717)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 678999999999864322 2346789999999999999999999999999999999999999875433222
Q ss_pred hhHHHHHHHHhhCCCCccccchh-------------------------------hhccCCHHHHHHHHHHHhhccccCCC
Q 039318 611 LNLIGHAWKLWNNGMPSQLIDAY-------------------------------YQESCNLAEVIRCIHVGLLCVQHHPE 659 (717)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~d~~-------------------------------~~~~~~~~~~~~~~~l~~~Cl~~dp~ 659 (717)
...+.. .. ...+..+.... ............+.+++.+||+.||+
T Consensus 243 ~~~~~~---~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 243 LAMMER---IL-GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHH---HH-CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHH---Hh-CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 221111 11 11111000000 00011223456788999999999999
Q ss_pred CCCChHHHHHH
Q 039318 660 DRPCMPSVILM 670 (717)
Q Consensus 660 ~RPs~~evl~~ 670 (717)
+|||+.||++.
T Consensus 319 ~Rpt~~ell~h 329 (339)
T 1z57_A 319 KRITLREALKH 329 (339)
T ss_dssp TSCCHHHHTTS
T ss_pred cccCHHHHhcC
Confidence 99999999863
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=318.43 Aligned_cols=173 Identities=26% Similarity=0.413 Sum_probs=142.5
Q ss_pred hcCcccccccccCCccceEeeeeCCch-hh----------------------------hhhhhhhhcceeecC-----ce
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ-EI----------------------------AHRNLVKLLGCCIQG-----EE 468 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~v----------------------------ah~niv~l~~~~~~~-----~~ 468 (717)
.++|++.+.||+|+||.||+|+..... .+ .||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999865421 11 199999999999776 57
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
.++||||++ ++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999987 599999843 446899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCccc--------------------cccceecccccccCcccc-ccCCCCccccchhHhHHHHHhhcCCCCC
Q 039318 549 TFVGDEIE--------------------GSTKRVVGTYGYMAPEYA-SDGLFSVKSDVFSFGILLLEIVSGKKNR 602 (717)
Q Consensus 549 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~elltG~~p~ 602 (717)
........ ......+||+.|+|||++ ....++.++||||||||+|||++|..||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76433211 122457899999999986 5667999999999999999999865554
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=325.26 Aligned_cols=224 Identities=25% Similarity=0.354 Sum_probs=173.0
Q ss_pred hcCcccccccccCCccceEeeeeCCch-h----------------------------hhhhhhhhhcceeecCceeeEEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ-E----------------------------IAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~----------------------------vah~niv~l~~~~~~~~~~~lV~ 473 (717)
.++|++.++||+|+||.||+|+..... . +.|||||++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999875321 1 11999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC---CCceeccccccccc
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE---MNPKISDFGLARTF 550 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~---~~~kl~Dfgla~~~ 550 (717)
|||++|+|.+++... ..+++..+..++.||++||.|||+++ |+||||||+||||+.. +.+||+|||+++..
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999988543 45889999999999999999999998 9999999999999764 45999999999876
Q ss_pred cCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||...... ... .....+... ..
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~i~~~~~~-~~ 257 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EIL----RKVEKGKYT-FD 257 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHTCCC-CC
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCCC-CC
Confidence 4332 233467999999999986 56999999999999999999999998743321 111 111111111 00
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.+.. .. ....+.+++.+||+.+|.+|||+.++++
T Consensus 258 ~~~~-~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 SPEW-KN----VSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp SGGG-TT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhc-cc----CCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1111 01 1235678899999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=299.42 Aligned_cols=226 Identities=19% Similarity=0.273 Sum_probs=173.0
Q ss_pred hcCcccccccccCCccceEeeeeCCch-h------------------------------hhhhhhhhhccee--ecCcee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ-E------------------------------IAHRNLVKLLGCC--IQGEEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~------------------------------vah~niv~l~~~~--~~~~~~ 469 (717)
.++|++.+.||+|+||.||++...... . +.||||+++++++ .+.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999875321 1 1199999999998 455688
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||++++ |.+++... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999987 66666442 3456899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccccccceecccccccCccccccCC--CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 550 FVGDEIEGSTKRVVGTYGYMAPEYASDGL--FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 550 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
..............||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... .. ...+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~----~~~i~~~~~~ 231 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KL----FENIGKGSYA 231 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH----HHHHHHCCCC
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HH----HHHHhcCCCC
Confidence 64333233334567999999999987654 478999999999999999999998743211 11 1111111110
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.... ....+.+++.+||+.||++||++.|+++.
T Consensus 232 ------~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 232 ------IPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ------CCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------CCCc----cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0011 12356688999999999999999999974
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.60 Aligned_cols=233 Identities=24% Similarity=0.329 Sum_probs=173.7
Q ss_pred HHHHHHHhcCcccccccccCCccceEeeeeCCchhhh------------------------------hhhhhhhcceeec
Q 039318 416 LATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA------------------------------HRNLVKLLGCCIQ 465 (717)
Q Consensus 416 ~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va------------------------------h~niv~l~~~~~~ 465 (717)
+..+....++|++.+.||+|+||.||+++..+++.++ ||||+++++++.+
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 3334445678999999999999999999876543322 4999999999999
Q ss_pred CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 466 GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 466 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
.+..++||| +.+++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||+++ +.+||+|||
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred CCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 999999999 678899999954 346889999999999999999999998 999999999999964 899999999
Q ss_pred ccccccCCccccccceecccccccCcccccc-----------CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHH
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASD-----------GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLI 614 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~ 614 (717)
+++...............||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~ 246 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I 246 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----H
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----H
Confidence 9987654433223345679999999999875 46889999999999999999999998643211 1
Q ss_pred HHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 615 GHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 615 ~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
..............+. .. ....+.+++.+||+.||++||++.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~-----~~----~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 247 SKLHAIIDPNHEIEFP-----DI----PEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHHHCTTSCCCCC-----CC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHhcccccCCc-----cc----chHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1111112111111110 01 12356788899999999999999999873
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.02 Aligned_cols=222 Identities=25% Similarity=0.385 Sum_probs=170.5
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh-----------------------------hhhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI-----------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-----------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
.++|.+.+.||+|+||.||+|+... ++.+ .||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 3689999999999999999998752 2221 199999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++++|.+++... ..+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999999543 35889999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccceecccccccCccccccCCC-CccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
.. ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...... ... ......... +
T Consensus 164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~----~~~~~~~~~-~-- 230 (276)
T 2h6d_A 164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLF----KKIRGGVFY-I-- 230 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHCCCC-C--
T ss_pred Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHH----HHhhcCccc-C--
Confidence 32 1234578999999999988765 68999999999999999999998643211 111 111111110 0
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
... ....+.+++.+||+.||++|||+.++++.
T Consensus 231 ---~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 ---PEY----LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---chh----cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011 12346788999999999999999999984
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=306.19 Aligned_cols=237 Identities=23% Similarity=0.329 Sum_probs=179.6
Q ss_pred HhcCcccccccccCCccceEeeeeC--Cchhh-------------------------------hhhhhhhhcceee----
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLA--DGQEI-------------------------------AHRNLVKLLGCCI---- 464 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~v-------------------------------ah~niv~l~~~~~---- 464 (717)
..++|++.+.||+|+||.||+|+.. +++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999873 22211 2999999999987
Q ss_pred -cCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecc
Q 039318 465 -QGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISD 543 (717)
Q Consensus 465 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 543 (717)
.....++||||++ ++|.+++... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 5678899999998 5999998543 2345889999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhC
Q 039318 544 FGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNN 623 (717)
Q Consensus 544 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 623 (717)
||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+.........
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~ 237 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGL 237 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCC
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCC
Confidence 99998654322 233467899999999999999999999999999999999999998743322 222222221111
Q ss_pred CCCcccc------chhh-------hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 624 GMPSQLI------DAYY-------QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 624 ~~~~~l~------d~~~-------~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
....... .... ...........+.+++.+||+.||++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 0000 00001112245678999999999999999999996
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=304.84 Aligned_cols=232 Identities=27% Similarity=0.380 Sum_probs=175.3
Q ss_pred hcCcccccccccCCccceEeeeeCC--ch--h-----------------------------hhhhhhhhhcceeecCcee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD--GQ--E-----------------------------IAHRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~~--~-----------------------------vah~niv~l~~~~~~~~~~ 469 (717)
.++|++.+.||+|+||.||+|++.. ++ . +.||||+++++++.+.+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3689999999999999999997521 11 0 11999999999998765 8
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 9999999999999999653 345889999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccc-cccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 550 FVGDEIE-GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 550 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ... ..........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~---~~~~~~~~~~ 244 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QIL---HKIDKEGERL 244 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH---HHHHTSCCCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHH---HHHHccCCCC
Confidence 6433221 12233567889999999998899999999999999999999 99998643221 111 1111111111
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
. .+......+.+++.+||+.+|++||++.++++.|+...
T Consensus 245 ~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 245 P---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C---------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 0 01112245778999999999999999999999997654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=313.93 Aligned_cols=243 Identities=19% Similarity=0.266 Sum_probs=175.2
Q ss_pred cHHHHHHHhcCcccccccccCCccceEeeeeCCchhh-------------------------------------hhhhhh
Q 039318 415 ELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEI-------------------------------------AHRNLV 457 (717)
Q Consensus 415 ~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~v-------------------------------------ah~niv 457 (717)
...++....++|++.+.||+|+||.||+|....++.+ .||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4567778889999999999999999999976543211 199999
Q ss_pred hhcceeec-----CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceE
Q 039318 458 KLLGCCIQ-----GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVL 532 (717)
Q Consensus 458 ~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIl 532 (717)
++++++.. ....++||||++ ++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 99999843 346799999998 588888743 3446899999999999999999999998 999999999999
Q ss_pred EcCCCCceeccccccccccCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCch
Q 039318 533 LDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNL 611 (717)
Q Consensus 533 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~ 611 (717)
|+.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-- 241 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-- 241 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH--
Confidence 9999999999999998543322 2234678999999999877 679999999999999999999999987543222
Q ss_pred hHHHHHHHHhhCCCCc-------------------cccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 612 NLIGHAWKLWNNGMPS-------------------QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 612 ~~~~~~~~~~~~~~~~-------------------~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
............... ....... ..........+.+|+.+||+.||++|||+.|+++.
T Consensus 242 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 -QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW-TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp -HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCH-HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhH-HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 222221111111100 0000000 00001112357789999999999999999999984
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=300.22 Aligned_cols=226 Identities=25% Similarity=0.395 Sum_probs=173.4
Q ss_pred CcccccccccCCccceEeeeeCCc-hhh--------------------------hhhhhhhhcceeecCceeeEEEeccC
Q 039318 425 NFSINKKLGEGGFGPVYKGTLADG-QEI--------------------------AHRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~~-~~v--------------------------ah~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
+|.....||+|+||.||+|+.... +.+ .||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 445556899999999999986432 111 19999999999999999999999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC-CCCceeccccccccccCCccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH-EMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~ 556 (717)
+++|.+++........+++..+..++.||++||.|||+++ |+|+||||+||+++. ++.+||+|||+++......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 9999999966544445678888999999999999999998 999999999999987 8999999999998654321
Q ss_pred cccceecccccccCccccccCC--CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 557 GSTKRVVGTYGYMAPEYASDGL--FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
.......|++.|+|||++.+.. ++.++||||||+++|||++|+.||........ .. ...... .....+
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~-~~~~~~--~~~~~~----- 247 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--AM-FKVGMF--KVHPEI----- 247 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--HH-HHHHHH--CCCCCC-----
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--HH-Hhhccc--cccccc-----
Confidence 1223467899999999987654 88999999999999999999999863221111 11 000110 100010
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+......+.+++.+||+.||++||++.++++
T Consensus 248 ----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 ----PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111235678899999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=301.26 Aligned_cols=227 Identities=26% Similarity=0.421 Sum_probs=174.8
Q ss_pred HhcCcccccccccCCccceEeeeeCCc-hhh--------------------------hhhhhhhhcceeecCceeeEEEe
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADG-QEI--------------------------AHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v--------------------------ah~niv~l~~~~~~~~~~~lV~E 474 (717)
..++|++.+.||+|+||.||+|+.... +.+ .||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 346899999999999999999987642 211 29999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999998543 345899999999999999999999998 999999999999999999999999998643211
Q ss_pred cccccceecccccccCcccc-----ccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 555 IEGSTKRVVGTYGYMAPEYA-----SDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
........||+.|+|||++ .+..++.++||||||+++|||++|+.||...... .. .............
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~---~~~~~~~~~~~~~ 243 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RV---LLKIAKSDPPTLL 243 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HH---HHHHHHSCCCCCS
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH---HH---HHHHhccCCcccC
Confidence 1112345789999999988 4677899999999999999999999998743321 11 1111111111111
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
... .....+.+++.+||+.||++|||+.++++
T Consensus 244 ~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 TPS--------KWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SGG--------GSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred Ccc--------ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111 11235678899999999999999999886
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=285.75 Aligned_cols=206 Identities=14% Similarity=0.191 Sum_probs=152.3
Q ss_pred CCCCCCEEEeCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEEe
Q 039318 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSA 80 (717)
Q Consensus 1 ~l~~~~~l~S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst 80 (717)
+|++|++| ++|.|+|||+.+++ +.+ |.. +||||+|||+.| ..++|+|+.||+|||.|++|.+||+|
T Consensus 16 ~L~~g~~l--~~g~f~l~f~~~gn-----l~l-y~~---~~~vW~an~~~~---~~~~l~l~~dGnLvl~d~~~~~vW~s 81 (236)
T 1dlp_A 16 TLHAAQSL--ELSSFRFTMQSDCN-----LVL-FDS---DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSS 81 (236)
T ss_dssp CCCTTCEE--CSTTEEEEECTTSC-----EEE-EES---SSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred EECCCCEE--EcCCEEEEECCCCc-----EEE-EEC---CEEEEECCCCCC---CCeEEEEcCCCcEEEEcCCCcEEEeC
Confidence 47889998 59999999997664 334 433 799999999998 45789999999999999999999999
Q ss_pred ccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCccc-cccCeeceee-ccCC-----ceEEEEecCCCCCC
Q 039318 81 NLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTL-LPGMKLGWDF-KTGL-----ERRITSWKSSDDPS 153 (717)
Q Consensus 81 ~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTl-Lpgq~l~~~~-~~~~-----~~~l~S~~s~~dps 153 (717)
++.... ...+|+|+|+|||||++. ++||||||||||+ |||| +.|. .+|. .++|++ .+||+
T Consensus 82 ~~~~~~-~~~~~~l~d~Gnlvl~~~-------~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~s---~~d~s 148 (236)
T 1dlp_A 82 GTKGSI-GNYVLVLQPDRTVTIYGP-------GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLHA---TQSLQ 148 (236)
T ss_dssp CCCCCS-SCCEEEECSSSCEEEECS-------EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEECS---SCCCB
T ss_pred CccccC-CcEEEEEeCCCCEEEecC-------CEEECCCCCCcccccCCc--cceEEecCCcCCCccceEEc---CcEee
Confidence 986432 233599999999999942 8999999999887 6665 5554 4454 457774 78999
Q ss_pred CceeEEeeccCCCcEEEEEcCCeeEEecCCCCCceeecc-ccccccceeeEEeecCCeEEEEEEecCCceEEEEEEeecc
Q 039318 154 PGDFIWKIERQFYPELVMWKGSRKFYRTGPWNGLIFSAS-SLRLNPIFKYRFVFNEDELYYTFYLTDKDVISRTVMNQTV 232 (717)
Q Consensus 154 ~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~g~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G 232 (717)
+|.|++.++++| +++++++..+||++++|++. +... .+..... .+.+..+.++++.+|.... ....|++|+.+|
T Consensus 149 ~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gn-l~ly~~~~~~vw~s~~~~~-~~~~rl~Ld~dG 223 (236)
T 1dlp_A 149 LSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGR-MDVLTNQNIAVWTSGNSRS-AGRYVFVLQPDR 223 (236)
T ss_dssp CSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTE-EEEEETTTEEEEECCCCCS-SSCCEEEECSSS
T ss_pred cCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCc-EEEEeCCCcEEEEeCCCCC-CCCEEEEEcCCC
Confidence 999999999998 67888888899999999753 3322 3322221 1122223334444443333 346899999999
Q ss_pred ceEEEEE
Q 039318 233 SLRQRFI 239 (717)
Q Consensus 233 ~~~~~~~ 239 (717)
++++|.
T Consensus 224 -~l~ly~ 229 (236)
T 1dlp_A 224 -NLAIYG 229 (236)
T ss_dssp -CEEEEC
T ss_pred -cEEEeC
Confidence 888773
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=335.97 Aligned_cols=221 Identities=29% Similarity=0.407 Sum_probs=169.8
Q ss_pred cccccCCccceEeeeeCC---chh----------------------------hhhhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLAD---GQE----------------------------IAHRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~---~~~----------------------------vah~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
++||+|+||.||+|.+.. ++. +.|||||++++++. .+..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 479999999999995421 111 12999999999986 4568999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc-c
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE-G 557 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 557 (717)
|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999943 346899999999999999999999998 999999999999999999999999999876443221 1
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ . ...+..+.....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~----~~~i~~~~~~~~------- 593 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---V----TAMLEKGERMGC------- 593 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H----HHHHHTTCCCCC-------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCCCCC-------
Confidence 1223456789999999999999999999999999999998 999986433221 1 112222211111
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
+......+.+|+.+||+.||++||++.+|+++|+.
T Consensus 594 --p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 594 --PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp --CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11122457788999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=306.46 Aligned_cols=235 Identities=28% Similarity=0.438 Sum_probs=174.6
Q ss_pred ccHHHHHHHhcCcccccccccCCccceEeeeeCC-chhh--------------------------hhhhhhhhcceeec-
Q 039318 414 FELATIANATDNFSINKKLGEGGFGPVYKGTLAD-GQEI--------------------------AHRNLVKLLGCCIQ- 465 (717)
Q Consensus 414 ~~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v--------------------------ah~niv~l~~~~~~- 465 (717)
+++.++....++|++.+.||+|+||.||+|+... ++.+ .||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3344444567899999999999999999998742 2211 29999999999987
Q ss_pred -----CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCce
Q 039318 466 -----GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPK 540 (717)
Q Consensus 466 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~k 540 (717)
.+..++||||+++++|.+++... ....+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 46789999999999999999653 2346889999999999999999999998 99999999999999999999
Q ss_pred eccccccccccCCccccccceecccccccCccccc-----cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHH
Q 039318 541 ISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYAS-----DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIG 615 (717)
Q Consensus 541 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~ 615 (717)
|+|||++....... .......||+.|+|||++. +..++.++||||||+++|+|++|+.||....... .
T Consensus 170 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~-- 242 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---A-- 242 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---H--
T ss_pred EeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---H--
Confidence 99999998653321 1223467999999999987 5678999999999999999999999986432211 1
Q ss_pred HHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 616 HAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 616 ~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.......... .+.. .. ....+.+++.+||+.||++||++.++++
T Consensus 243 -~~~~~~~~~~-~~~~----~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 243 -LFLIPRNPAP-RLKS----KK----WSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -HHHHHHSCCC-CCSC----SC----SCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHHhhcCccc-cCCc----cc----cCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111111111 1111 01 1235678899999999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=314.13 Aligned_cols=244 Identities=22% Similarity=0.340 Sum_probs=163.4
Q ss_pred hcCccc-ccccccCCccceEeeeeCC---chhhh------------------------hhhhhhhcceee--cCceeeEE
Q 039318 423 TDNFSI-NKKLGEGGFGPVYKGTLAD---GQEIA------------------------HRNLVKLLGCCI--QGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~-~~~lG~G~fg~Vy~~~~~~---~~~va------------------------h~niv~l~~~~~--~~~~~~lV 472 (717)
.+.|++ .++||+|+||.||+|+.++ ++.+| |||||++++++. .....++|
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 345766 4589999999999999653 22222 999999999995 46789999
Q ss_pred EeccCCCChhhHhhhcc------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE----cCCCCceec
Q 039318 473 YEFMPNRSLDSFIFDQT------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL----DHEMNPKIS 542 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~ 542 (717)
|||+++ +|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999975 7777774322 1224889999999999999999999998 9999999999999 778899999
Q ss_pred cccccccccCCcc-ccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCC------chhHH
Q 039318 543 DFGLARTFVGDEI-EGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDK------NLNLI 614 (717)
Q Consensus 543 Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~------~~~~~ 614 (717)
|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.....+. ....+
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987643211 1223346899999999999874 58999999999999999999999996543321 12222
Q ss_pred HHHHHHhhCCCCccccch------------h---hhccCCHH---------HHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 615 GHAWKLWNNGMPSQLIDA------------Y---YQESCNLA---------EVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 615 ~~~~~~~~~~~~~~l~d~------------~---~~~~~~~~---------~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
......+.........+. . ........ ....+.+|+.+||+.||.+|||++|+++.
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 223222221111000000 0 00000110 02356789999999999999999999984
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=327.00 Aligned_cols=224 Identities=26% Similarity=0.334 Sum_probs=177.4
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh-----------------------------hhhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI-----------------------------AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-----------------------------ah~niv~l~~~~~~~~~~~lV 472 (717)
.++|++.++||+|+||.||+|+... ++.+ .||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 4689999999999999999998752 2211 299999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE---cCCCCceecccccccc
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL---DHEMNPKISDFGLART 549 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~Dfgla~~ 549 (717)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999999843 345899999999999999999999998 9999999999999 5678999999999987
Q ss_pred ccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 550 FVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 550 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ..+. .+..+.....
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~----~i~~~~~~~~ 247 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILK----KVEKGKYTFE 247 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCCCCC
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHH----HHHcCCCCCC
Confidence 54332 2234679999999999876 6999999999999999999999998643221 1111 1111111100
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.. .. . .....+.+++.+||+.+|.+|||+.|+++
T Consensus 248 ~~-~~-~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 LP-QW-K----KVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp SG-GG-G----GSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Cc-cc-c----cCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00 00 0 11235678999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=310.72 Aligned_cols=236 Identities=22% Similarity=0.303 Sum_probs=176.7
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hhh---------------------------hhhhhhhhcceeecC-----cee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QEI---------------------------AHRNLVKLLGCCIQG-----EEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~v---------------------------ah~niv~l~~~~~~~-----~~~ 469 (717)
.++|++.+.||+|+||.||+|+.... +.+ .||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 46899999999999999999976532 111 299999999998755 368
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||+++ +|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 106 ~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 999999984 89888843 34899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccc-cccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 550 FVGDEIE-GSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 550 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+... ...........
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~~~~- 253 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN---HILGILGSPSQ- 253 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH---HHHHHHCSCCH-
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH---HHHHHhCCCCH-
Confidence 6433221 11234689999999998654 458999999999999999999999987544333222 22221111100
Q ss_pred cccchh-------------hhccCCHH-----HHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 628 QLIDAY-------------YQESCNLA-----EVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 628 ~l~d~~-------------~~~~~~~~-----~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+.+... .....+.. ....+.+|+.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00001111 12457789999999999999999999983
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=299.65 Aligned_cols=226 Identities=22% Similarity=0.293 Sum_probs=174.4
Q ss_pred HhcCcccccccccCCccceEeeeeCCc-hh----------------------------------hhhhhhhhhcceeecC
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADG-QE----------------------------------IAHRNLVKLLGCCIQG 466 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~----------------------------------vah~niv~l~~~~~~~ 466 (717)
..++|.+.+.||+|+||.||+|+.... +. +.||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 346899999999999999999976432 10 1299999999998765
Q ss_pred ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC---ceecc
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN---PKISD 543 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~D 543 (717)
+ .++||||+++++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 8999999999999999843 446899999999999999999999998 999999999999987665 99999
Q ss_pred ccccccccCCccccccceecccccccCccccc---cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHH
Q 039318 544 FGLARTFVGDEIEGSTKRVVGTYGYMAPEYAS---DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKL 620 (717)
Q Consensus 544 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 620 (717)
||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||......... ...
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~---- 231 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQ---- 231 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHH----
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHH----
Confidence 99998764322 122457899999999874 567899999999999999999999998754333221 111
Q ss_pred hhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 621 WNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 621 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
...+.... . +..... ....+.+++.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~-~-~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 232 ITSGKYNF-I-PEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHTCCCC-C-HHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhCcccc-C-chhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11111110 0 000011 1245678999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=310.13 Aligned_cols=231 Identities=23% Similarity=0.342 Sum_probs=159.6
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh----------------------------hhhhhhhhcceeecC------c
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI----------------------------AHRNLVKLLGCCIQG------E 467 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v----------------------------ah~niv~l~~~~~~~------~ 467 (717)
.++|++.+.||+|+||.||+|.... ++.+ .||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 3689999999999999999997543 2211 199999999998654 5
Q ss_pred eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla 547 (717)
..++||||+ +++|.+++.. ..+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 6899988843 45899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC
Q 039318 548 RTFVGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (717)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+....+..... .
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p-~ 250 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTP-G 250 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSC-C
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCC-C
Confidence 865322 234689999999999877 67999999999999999999999998754322 2222222221111 0
Q ss_pred ccccch--------hh-----hccCCHHH-----HHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 627 SQLIDA--------YY-----QESCNLAE-----VIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 627 ~~l~d~--------~~-----~~~~~~~~-----~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+.+.. .. .....+.. ...+.+|+.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000 00 00111111 2357789999999999999999999984
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=320.37 Aligned_cols=226 Identities=26% Similarity=0.365 Sum_probs=176.2
Q ss_pred HhcCcccccccccCCccceEeeeeCCch----------------------------------h------hhhhhhhhhcc
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLADGQ----------------------------------E------IAHRNLVKLLG 461 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----------------------------------~------vah~niv~l~~ 461 (717)
..++|.+.++||+|+||.||+|+...+. + +.||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999864321 0 12999999999
Q ss_pred eeecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC---C
Q 039318 462 CCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM---N 538 (717)
Q Consensus 462 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~---~ 538 (717)
++.+.+..++|||||++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999999854 345899999999999999999999998 99999999999998776 6
Q ss_pred ceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHH
Q 039318 539 PKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAW 618 (717)
Q Consensus 539 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~ 618 (717)
+||+|||+++...... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||...... ..+
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---- 256 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DII---- 256 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHH----
Confidence 9999999998764332 223467999999999987 46999999999999999999999998743322 111
Q ss_pred HHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 619 KLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 619 ~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.....+....... ..... ...+.+++.+||+.||.+|||+.|+++.
T Consensus 257 ~~i~~~~~~~~~~--~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 257 KKVEKGKYYFDFN--DWKNI----SDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHHCCCCCCHH--HHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCCCCCcc--ccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111111110000 00111 2356789999999999999999999873
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=308.56 Aligned_cols=233 Identities=22% Similarity=0.239 Sum_probs=166.6
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh----------------------------hhhhhhhhcceeecCc------
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI----------------------------AHRNLVKLLGCCIQGE------ 467 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v----------------------------ah~niv~l~~~~~~~~------ 467 (717)
.++|++.+.||+|+||.||+|.... ++.+ .||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 3689999999999999999997643 2111 1999999999987665
Q ss_pred eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla 547 (717)
..++||||+++ +|.+++. ..+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999985 7777773 24788999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCC---
Q 039318 548 RTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG--- 624 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 624 (717)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .............
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGTPCPE 248 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHC-CCCCCHH
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHH
Confidence 8653321 223467999999999999999999999999999999999999998653321 1111111100000
Q ss_pred ---------------CC-------ccccchhhhccC---CHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 625 ---------------MP-------SQLIDAYYQESC---NLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 625 ---------------~~-------~~l~d~~~~~~~---~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.. ..+......... .......+.+|+.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00 000000000000 01124567899999999999999999999983
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=331.58 Aligned_cols=231 Identities=25% Similarity=0.357 Sum_probs=178.0
Q ss_pred HHhcCcccccccccCCccceEeeeeCCch----h---------------------------hhhhhhhhhcceeecCcee
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADGQ----E---------------------------IAHRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~---------------------------vah~niv~l~~~~~~~~~~ 469 (717)
...++|++.+.||+|+||.||+|++.... . +.||||+++++++. .+..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 34578999999999999999999864211 0 12999999999985 4678
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||+++|+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999999542 335889999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 550 FVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 550 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ..+... ..+....
T Consensus 541 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i----~~~~~~~ 612 (656)
T 2j0j_A 541 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI----ENGERLP 612 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH----HHTCCCC
T ss_pred cCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH----HcCCCCC
Confidence 643322 12223567789999999999999999999999999999997 99998643221 111111 1111111
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
+ +......+.+++.+||+.||++||++.+|+++|+..
T Consensus 613 ~---------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 613 M---------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp C---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 111124567899999999999999999999998753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=313.30 Aligned_cols=230 Identities=23% Similarity=0.293 Sum_probs=164.7
Q ss_pred cCcccccccccCCccceEeeeeCCchhhh------------------------hhhhhhhcceeecCceeeEEEeccCCC
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA------------------------HRNLVKLLGCCIQGEEKLLIYEFMPNR 479 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~va------------------------h~niv~l~~~~~~~~~~~lV~E~~~~g 479 (717)
+.|.+.+.||+|+||+||.+...+++.+| |||||++++++.+.+..++|||||+ |
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 34566788999999999765544443322 9999999999999999999999996 6
Q ss_pred ChhhHhhhccccc----cCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC-------------CCceec
Q 039318 480 SLDSFIFDQTKRK----LLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE-------------MNPKIS 542 (717)
Q Consensus 480 sL~~~l~~~~~~~----~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~-------------~~~kl~ 542 (717)
+|.+++....... ...+..++.++.||+.||+|||+++ |+||||||+||||+.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 9999996532211 1234456789999999999999998 9999999999999754 479999
Q ss_pred cccccccccCCcccc--ccceecccccccCcccccc-------CCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchh
Q 039318 543 DFGLARTFVGDEIEG--STKRVVGTYGYMAPEYASD-------GLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLN 612 (717)
Q Consensus 543 Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~ 612 (717)
|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--- 247 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--- 247 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH---
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH---
Confidence 999999765432211 1234679999999999976 668999999999999999999 999986432211
Q ss_pred HHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 613 LIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
. .......... ......+......+.+++.+||+.||++|||+.+|++
T Consensus 248 -~----~i~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 -S----NIIRGIFSLD----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -H----HHHHTCCCCC----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -H----HHhcCCCCcc----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 1111110000 0011123344567889999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.80 Aligned_cols=232 Identities=25% Similarity=0.356 Sum_probs=178.7
Q ss_pred hcCcccccccccCCccceEeeeeCCch---------------------------------h----------hhhhhhhhh
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ---------------------------------E----------IAHRNLVKL 459 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~---------------------------------~----------vah~niv~l 459 (717)
.++|++.+.||+|+||.||+|+. +++ . +.||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999976 221 1 129999999
Q ss_pred cceeecCceeeEEEeccCCCChhhH------hhhccccccCChhhHHHHHHHHHHHHHHHhh-cCCCcEEeccCCCCceE
Q 039318 460 LGCCIQGEEKLLIYEFMPNRSLDSF------IFDQTKRKLLDWSKRFCIICGTARGLLYLHH-DSRLRIIHRDLKASNVL 532 (717)
Q Consensus 460 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlkp~NIl 532 (717)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||.|||+ ++ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 422 224678999999999999999999999 87 999999999999
Q ss_pred EcCCCCceeccccccccccCCccccccceecccccccCccccccC-CCCc-cccchhHhHHHHHhhcCCCCCCCCCCCCc
Q 039318 533 LDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDG-LFSV-KSDVFSFGILLLEIVSGKKNRGFYHSDKN 610 (717)
Q Consensus 533 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlG~il~elltG~~p~~~~~~~~~ 610 (717)
++.++.+||+|||++...... ......|++.|+|||++.+. .++. ++||||||+++|||++|+.||......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 999999999999999875433 23346799999999999887 6666 999999999999999999998754331
Q ss_pred hhHHHHHHHHhhCCCCccccc------hhhh---ccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 611 LNLIGHAWKLWNNGMPSQLID------AYYQ---ESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~d------~~~~---~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
... ...+.........+ .... ..........+.+++.+||+.||++||++.|+++
T Consensus 259 ~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 VEL----FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHH----HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH----HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 11122211110000 0000 0000112245678999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=297.18 Aligned_cols=227 Identities=20% Similarity=0.288 Sum_probs=178.4
Q ss_pred HHhcCcccccccccCCccceEeeeeCCc-h-----------------------------------hh-hhhhhhhhccee
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADG-Q-----------------------------------EI-AHRNLVKLLGCC 463 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~-----------------------------------~v-ah~niv~l~~~~ 463 (717)
...++|++.+.||+|+||.||+|+.... + .+ .||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 3457899999999999999999986431 1 01 199999999999
Q ss_pred ecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecc
Q 039318 464 IQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISD 543 (717)
Q Consensus 464 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 543 (717)
.+.+..++||||+++++|.+++.. ...+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999954 345899999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCccccccceecccccccCccccc------cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHH
Q 039318 544 FGLARTFVGDEIEGSTKRVVGTYGYMAPEYAS------DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHA 617 (717)
Q Consensus 544 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~ 617 (717)
||++....... ......|++.|+|||++. ...++.++||||||+++|||++|+.||...... ...
T Consensus 168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~--- 238 (298)
T 1phk_A 168 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LML--- 238 (298)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---
T ss_pred ccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HHH---
Confidence 99998754332 223467899999999885 456889999999999999999999998643211 111
Q ss_pred HHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 618 WKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 618 ~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.......... ..+.. ......+.+++.+||+.||++||++.|+++
T Consensus 239 -~~~~~~~~~~-~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 -RMIMSGNYQF-GSPEW-----DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -HHHHHTCCCC-CTTTG-----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -HHHhcCCccc-Ccccc-----cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111111110 00000 011235678899999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=298.20 Aligned_cols=236 Identities=21% Similarity=0.273 Sum_probs=167.2
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh--------------------------hhhhhhhhcceee-----------
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI--------------------------AHRNLVKLLGCCI----------- 464 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v--------------------------ah~niv~l~~~~~----------- 464 (717)
.++|++.+.||+|+||.||+|+... ++.+ .||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999998764 2222 1999999998873
Q ss_pred ---cCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc-CCCCce
Q 039318 465 ---QGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD-HEMNPK 540 (717)
Q Consensus 465 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~-~~~~~k 540 (717)
+.+..++||||++ ++|.+++. ...+++..+..++.||++||+|||+++ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 4467899999998 59999883 245889999999999999999999998 99999999999997 567999
Q ss_pred eccccccccccCCcc-ccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHH
Q 039318 541 ISDFGLARTFVGDEI-EGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAW 618 (717)
Q Consensus 541 l~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~ 618 (717)
|+|||+++....... ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. .....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ---MQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence 999999987543211 112234567999999998865 6789999999999999999999999875432211 11111
Q ss_pred HHhhC----------CCCccccchhhh-ccCCHH-----HHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 619 KLWNN----------GMPSQLIDAYYQ-ESCNLA-----EVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 619 ~~~~~----------~~~~~l~d~~~~-~~~~~~-----~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
..... ......+..... ...+.. ....+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 11000 000000000000 001111 1245788999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=304.76 Aligned_cols=228 Identities=29% Similarity=0.384 Sum_probs=156.6
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh----------------------------hhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------------HRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va----------------------------h~niv~l~~~~~~~~~~~lV~E 474 (717)
++|++.+.||+|+||.||+|.... ++.++ ||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 678999999999999999998753 22221 9999999999999999999999
Q ss_pred ccCCCChhhHhhhc--cccccCChhhHHHHHHHHHHHHHHHhhc-CCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 475 FMPNRSLDSFIFDQ--TKRKLLDWSKRFCIICGTARGLLYLHHD-SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 475 ~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
|+++ +|.+++... .....+++..+..++.|+++||.|||++ + |+||||||+||||+.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9986 787777432 2245689999999999999999999998 8 9999999999999999999999999998754
Q ss_pred CCccccccceecccccccCcccc----ccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYA----SDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||........ .. .....+...
T Consensus 178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~-~~~~~~~~~ 248 (327)
T 3aln_A 178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QL-TQVVKGDPP 248 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCCC
T ss_pred ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HH-HHHhcCCCC
Confidence 322 12234799999999998 466789999999999999999999999864321110 00 000011111
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.+.. .........+.+++.+||+.||++||++.+|++
T Consensus 249 ~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 249 QLSN-----SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCC-----CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC-----cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 1110 000112235778899999999999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.36 Aligned_cols=233 Identities=20% Similarity=0.283 Sum_probs=176.7
Q ss_pred hcCcccccccccCCccceEeeeeCCc--hhhh-------------------------hhh------hhhhcceeecCcee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG--QEIA-------------------------HRN------LVKLLGCCIQGEEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~--~~va-------------------------h~n------iv~l~~~~~~~~~~ 469 (717)
.++|++.+.||+|+||.||+|+.... +.+| |++ ++++++++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 46899999999999999999986432 1221 555 88889999999999
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE----------------
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL---------------- 533 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll---------------- 533 (717)
++||||+ +++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+||||
T Consensus 98 ~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence 9999999 56666666442 2346899999999999999999999998 9999999999999
Q ss_pred ---cCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCc
Q 039318 534 ---DHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKN 610 (717)
Q Consensus 534 ---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~ 610 (717)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 67889999999999864322 2346799999999999999999999999999999999999999875433222
Q ss_pred hhHHHHHHHHhhCCCCccccchh-------------------------------hhccCCHHHHHHHHHHHhhccccCCC
Q 039318 611 LNLIGHAWKLWNNGMPSQLIDAY-------------------------------YQESCNLAEVIRCIHVGLLCVQHHPE 659 (717)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~l~d~~-------------------------------~~~~~~~~~~~~~~~l~~~Cl~~dp~ 659 (717)
...+ .... ...+..+.... ........+...+.+|+.+||+.||+
T Consensus 248 ~~~~---~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 248 LVMM---EKIL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HHHH---HHHH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHH---HHHc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 1111 1111 11111100000 00011223345788999999999999
Q ss_pred CCCChHHHHH
Q 039318 660 DRPCMPSVIL 669 (717)
Q Consensus 660 ~RPs~~evl~ 669 (717)
+|||+.|+++
T Consensus 324 ~Rpt~~e~l~ 333 (355)
T 2eu9_A 324 QRITLAEALL 333 (355)
T ss_dssp TSCCHHHHTT
T ss_pred hCcCHHHHhc
Confidence 9999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=305.96 Aligned_cols=237 Identities=24% Similarity=0.311 Sum_probs=174.3
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh---------------------------hhhhhhhhcceeecC-----cee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI---------------------------AHRNLVKLLGCCIQG-----EEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v---------------------------ah~niv~l~~~~~~~-----~~~ 469 (717)
.++|++.+.||+|+||.||+|+... ++.+ .||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 4689999999999999999998753 2211 199999999987654 678
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
++||||++ ++|.+++.. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 589888843 35899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCcccc--------ccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHH
Q 039318 550 FVGDEIEG--------STKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKL 620 (717)
Q Consensus 550 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~ 620 (717)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~ 238 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGI 238 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHH
Confidence 64322111 1223578999999998754 778999999999999999999999987543221 11111111
Q ss_pred hhCCCCc----cccchhh----h-----ccCCH-----HHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 621 WNNGMPS----QLIDAYY----Q-----ESCNL-----AEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 621 ~~~~~~~----~l~d~~~----~-----~~~~~-----~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
....... ....... . ..... .....+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 1111000 0000000 0 00001 112456789999999999999999999983
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=308.74 Aligned_cols=230 Identities=21% Similarity=0.316 Sum_probs=171.2
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh----------------------------hhhhhhhhcceeecCcee----
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI----------------------------AHRNLVKLLGCCIQGEEK---- 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v----------------------------ah~niv~l~~~~~~~~~~---- 469 (717)
.++|.+.+.||+|+||.||+|+... ++.+ .||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 3689999999999999999998653 2211 299999999999887765
Q ss_pred --eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccc
Q 039318 470 --LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547 (717)
Q Consensus 470 --~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla 547 (717)
++||||++ ++|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 58877772 23899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC
Q 039318 548 RTFVGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (717)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+.......... .
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~-~ 262 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVP-G 262 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC-C
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCC-c
Confidence 865322 234678999999999887 779999999999999999999999987533222 221111111100 0
Q ss_pred ccccch--------hh----h-ccCCH-----HHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 627 SQLIDA--------YY----Q-ESCNL-----AEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 627 ~~l~d~--------~~----~-~~~~~-----~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+.... .. . ..... .....+.+|+.+||+.||++|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000 00 0 00011 112467889999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=301.57 Aligned_cols=218 Identities=23% Similarity=0.387 Sum_probs=175.4
Q ss_pred HHHhcCcccccccccCCccceEeeeeCCc-hh--------------------------------h--hhhhhhhhcceee
Q 039318 420 ANATDNFSINKKLGEGGFGPVYKGTLADG-QE--------------------------------I--AHRNLVKLLGCCI 464 (717)
Q Consensus 420 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~--------------------------------v--ah~niv~l~~~~~ 464 (717)
....++|++.+.||+|+||.||+|+.... +. + .||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34457899999999999999999975321 11 1 1699999999999
Q ss_pred cCceeeEEEeccCC-CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc-CCCCceec
Q 039318 465 QGEEKLLIYEFMPN-RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD-HEMNPKIS 542 (717)
Q Consensus 465 ~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~ 542 (717)
+.+..++||||+.+ ++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+||||+ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999986 899999954 346889999999999999999999998 99999999999999 78899999
Q ss_pred cccccccccCCccccccceecccccccCccccccCCC-CccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHh
Q 039318 543 DFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLW 621 (717)
Q Consensus 543 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~ 621 (717)
|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ...
T Consensus 193 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~ 256 (320)
T 3a99_A 193 DFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EII 256 (320)
T ss_dssp CCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHH
T ss_pred eCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhh
Confidence 999998764322 234679999999999987765 688999999999999999999986321 011
Q ss_pred hCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 622 NNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 622 ~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
..... ..... ...+.+++.+||+.||++||++++|++.
T Consensus 257 ~~~~~-------~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 257 RGQVF-------FRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HCCCC-------CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccccc-------ccccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11100 00111 2356788999999999999999999884
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=291.99 Aligned_cols=229 Identities=23% Similarity=0.345 Sum_probs=167.7
Q ss_pred HhcCcccccccccCCccceEeeeeCC-chhh-------------------------hhhhhhhhcceeec----------
Q 039318 422 ATDNFSINKKLGEGGFGPVYKGTLAD-GQEI-------------------------AHRNLVKLLGCCIQ---------- 465 (717)
Q Consensus 422 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v-------------------------ah~niv~l~~~~~~---------- 465 (717)
..++|++.+.||+|+||.||+|+... ++.+ .||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 35689999999999999999998653 3222 29999999998765
Q ss_pred ---CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceec
Q 039318 466 ---GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKIS 542 (717)
Q Consensus 466 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~ 542 (717)
.+..++||||+++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 46789999999999999999542 345778899999999999999999998 9999999999999999999999
Q ss_pred cccccccccCCcc------------ccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCC
Q 039318 543 DFGLARTFVGDEI------------EGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDK 609 (717)
Q Consensus 543 Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~ 609 (717)
|||+++....... ........||+.|+|||++.+. .++.++||||||+++|||++ ||... .+
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~ 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--ME 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hh
Confidence 9999986542210 1122346789999999999764 68999999999999999998 43211 11
Q ss_pred chhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 610 NLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
... ....+..... . .....+......+.+++.+||+.||++|||+.++++.
T Consensus 234 ~~~----~~~~~~~~~~-~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 RVN----ILKKLRSVSI-E-----FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHH----HHHHHHSTTC-C-----CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHH----HHHhcccccc-c-----cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111 1111111111 0 0111112223456788999999999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.4e-33 Score=307.03 Aligned_cols=227 Identities=22% Similarity=0.309 Sum_probs=164.3
Q ss_pred hcCcccccccccCCccceEeeeeCCchhhh------------------------hhhhhhhcceeecCceeeEEEeccCC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA------------------------HRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va------------------------h~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
..+|.+.+.||+|+||.||.....+++.|| |||||++++++.+.+..+||||||+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 457999999999999996544333343332 9999999999999999999999997
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC---C--CCceeccccccccccCC
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH---E--MNPKISDFGLARTFVGD 553 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~---~--~~~kl~Dfgla~~~~~~ 553 (717)
|+|.+++... ...+.+..+..++.||++||.|||+++ |+||||||+||||+. + ..+||+|||+++.....
T Consensus 102 g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 102 ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 5999999543 223555677889999999999999998 999999999999953 2 35779999999876433
Q ss_pred ccc-cccceecccccccCccccc---cCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 554 EIE-GSTKRVVGTYGYMAPEYAS---DGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 554 ~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||....... . ......... .
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~---~~~~~~~~~-~ 248 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----A---NILLGACSL-D 248 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----H---HHHTTCCCC-T
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----H---HHHhccCCc-c
Confidence 211 2233467999999999997 4567889999999999999999 999985322111 1 111111111 1
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
... ........+.+|+.+||+.||++|||+.+|++
T Consensus 249 ~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 CLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111 11123345678999999999999999999995
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-33 Score=297.97 Aligned_cols=224 Identities=24% Similarity=0.390 Sum_probs=157.7
Q ss_pred cCcccccccccCCccceEeeeeCC-chhh----------------------------hhhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEI----------------------------AHRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v----------------------------ah~niv~l~~~~~~~~~~~lV~E 474 (717)
++|++.+.||+|+||.||+|+... ++.+ .||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 578999999999999999998753 2222 19999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhc-CCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD-SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
|+ ++.+..+... ....+++..+..++.||++||.|||++ + |+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 105 LM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 99 4455554432 234689999999999999999999995 7 999999999999999999999999999765432
Q ss_pred ccccccceecccccccCccccc-----cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 554 EIEGSTKRVVGTYGYMAPEYAS-----DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
. ......||+.|+|||++. ...++.++||||||+++|||++|+.||...... ..... ........ .
T Consensus 179 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~---~~~~~~~~-~ 249 (318)
T 2dyl_A 179 K---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLT---KVLQEEPP-L 249 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHH---HHHHSCCC-C
T ss_pred c---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHH---HHhccCCC-C
Confidence 2 123457999999999984 556889999999999999999999998643221 11111 11111111 1
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+.. . ......+.+++.+||+.||.+||++.++++
T Consensus 250 ~~~-----~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 LPG-----H--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCS-----S--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCc-----c--CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 100 0 011234668899999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-33 Score=296.33 Aligned_cols=219 Identities=23% Similarity=0.423 Sum_probs=168.4
Q ss_pred HHHHhcCcccccccccCCccceEeeeeCCch---------------------------------hh----hhhhhhhhcc
Q 039318 419 IANATDNFSINKKLGEGGFGPVYKGTLADGQ---------------------------------EI----AHRNLVKLLG 461 (717)
Q Consensus 419 i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~---------------------------------~v----ah~niv~l~~ 461 (717)
.....++|++.+.||+|+||.||+|+..... .+ .||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445678999999999999999999753211 11 3999999999
Q ss_pred eeecCceeeEEEec-cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc-CCCCc
Q 039318 462 CCIQGEEKLLIYEF-MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD-HEMNP 539 (717)
Q Consensus 462 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~-~~~~~ 539 (717)
++.+.+..++|||| +++++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 789999999954 335899999999999999999999998 99999999999999 88999
Q ss_pred eeccccccccccCCccccccceecccccccCccccccCCCC-ccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHH
Q 039318 540 KISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFS-VKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAW 618 (717)
Q Consensus 540 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~ 618 (717)
||+|||+++...... .....|++.|+|||++.+..+. .++||||||+++|||++|+.||....
T Consensus 180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------ 243 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------ 243 (312)
T ss_dssp EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------
T ss_pred EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------
Confidence 999999998764432 2346789999999998877664 58999999999999999999986311
Q ss_pred HHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 619 KLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 619 ~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
...... . .+ +......+.+++.+||+.+|++||++.|+++.
T Consensus 244 ~~~~~~-~-~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 EILEAE-L-HF---------PAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHHHTC-C-CC---------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHhhhc-c-CC---------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001110 0 00 01112356788999999999999999999984
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.6e-33 Score=288.92 Aligned_cols=227 Identities=26% Similarity=0.331 Sum_probs=176.7
Q ss_pred HHHhcCcccccccccCCccceEeeeeCC-chhh----------------------------hhhhhhhhcceeecCceee
Q 039318 420 ANATDNFSINKKLGEGGFGPVYKGTLAD-GQEI----------------------------AHRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 420 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v----------------------------ah~niv~l~~~~~~~~~~~ 470 (717)
....++|++.+.||+|+||.||+|+... ++.+ .||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 3445789999999999999999998752 2211 1999999999999999999
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC---CCceecccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE---MNPKISDFGLA 547 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~---~~~kl~Dfgla 547 (717)
+||||+++++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999999988543 35899999999999999999999998 9999999999999754 46999999999
Q ss_pred ccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 548 RTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
....... ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||...... ... ..+..+...
T Consensus 172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~----~~~~~~~~~ 240 (287)
T 2wei_A 172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DIL----KRVETGKYA 240 (287)
T ss_dssp GTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHCCCC
T ss_pred eeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHcCCCC
Confidence 8654322 1223568999999999875 4899999999999999999999998643211 111 111111111
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
..... ... ....+.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~~--~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FDLPQ--WRT----ISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCSGG--GTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchh--hhh----cCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00000 001 1235678899999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-33 Score=301.91 Aligned_cols=229 Identities=20% Similarity=0.295 Sum_probs=170.7
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh----------------------------hhhhhhhhcceeecCce-----
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI----------------------------AHRNLVKLLGCCIQGEE----- 468 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v----------------------------ah~niv~l~~~~~~~~~----- 468 (717)
.++|.+.+.||+|+||.||+|+... ++.+ .||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 3679999999999999999998653 2211 19999999999987654
Q ss_pred -eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccc
Q 039318 469 -KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547 (717)
Q Consensus 469 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla 547 (717)
.++||||++ ++|.+++. ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999998 58887772 24889999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC
Q 039318 548 RTFVGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (717)
+..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ..+.......... .
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~-~ 244 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVP-G 244 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHHHCBC-C
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCC-C
Confidence 864322 234678999999999877 67899999999999999999999998653322 1222211111000 0
Q ss_pred cccc-------------------chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 627 SQLI-------------------DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 627 ~~l~-------------------d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.+.. ..... .........+.+++.+||+.||++|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 00000 0011223467789999999999999999999873
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=313.16 Aligned_cols=238 Identities=23% Similarity=0.308 Sum_probs=171.7
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh---------------------------hhhhhhhhcceeec------Cce
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI---------------------------AHRNLVKLLGCCIQ------GEE 468 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v---------------------------ah~niv~l~~~~~~------~~~ 468 (717)
.++|++.++||+|+||.||+|.... ++.+ .||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 3689999999999999999998643 2221 29999999998765 678
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCC---ceecccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMN---PKISDFG 545 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~Dfg 545 (717)
.++||||+++++|.+++........+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976555556899999999999999999999998 999999999999997765 8999999
Q ss_pred ccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCch-h-HHHHHHH--Hh
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNL-N-LIGHAWK--LW 621 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~-~-~~~~~~~--~~ 621 (717)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... . ....... ..
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 998764332 223467999999999999999999999999999999999999998642110000 0 0000000 00
Q ss_pred hCCCCccc-cchh--hhccCCHHHHHHHHHHHhhccccCCCCCCChHH
Q 039318 622 NNGMPSQL-IDAY--YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPS 666 (717)
Q Consensus 622 ~~~~~~~l-~d~~--~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~e 666 (717)
.+.....+ .... ............+.+++.+||+.||++|||+.+
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 00000000 0000 011122234466788999999999999999966
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=319.82 Aligned_cols=211 Identities=20% Similarity=0.314 Sum_probs=166.3
Q ss_pred hcCcccccccccCCccceEeeeeCC--chhhh---------------------------hhhhhhhcceeecCce-----
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD--GQEIA---------------------------HRNLVKLLGCCIQGEE----- 468 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~va---------------------------h~niv~l~~~~~~~~~----- 468 (717)
.++|++.++||+|+||.||+|++.. ++.|+ |||||++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 3689999999999999999998753 32222 9999999999987765
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
.+|||||+++++|.+++.. .+++..++.++.||++||.|||+++ |+||||||+||||+.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999987732 5899999999999999999999998 9999999999999986 89999999998
Q ss_pred cccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..|+....... ..
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------~~-- 285 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------LP-- 285 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------CC--
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------------cc--
Confidence 75332 3467999999999987654 899999999999999999988865321110 00
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCC-hHHHHHHhc
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPC-MPSVILMLG 672 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-~~evl~~L~ 672 (717)
...........+.+|+.+||+.||++||+ ++++.+.|.
T Consensus 286 ------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 286 ------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp ------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 00000112245778999999999999995 555555554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=281.17 Aligned_cols=206 Identities=19% Similarity=0.252 Sum_probs=157.9
Q ss_pred cCcccc-cccccCCccceEeeeeCC-chhhh----------------------hhhhhhhcceeec----CceeeEEEec
Q 039318 424 DNFSIN-KKLGEGGFGPVYKGTLAD-GQEIA----------------------HRNLVKLLGCCIQ----GEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~-~~lG~G~fg~Vy~~~~~~-~~~va----------------------h~niv~l~~~~~~----~~~~~lV~E~ 475 (717)
++|.+. +.||+|+||.||++.... ++.+| ||||+++++++.. ....++||||
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 96 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 96 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEee
Confidence 567777 789999999999998753 22222 9999999999877 7788999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC---CCCceeccccccccccC
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH---EMNPKISDFGLARTFVG 552 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~Dfgla~~~~~ 552 (717)
+++++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||||+. ++.+||+|||++....
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 97 LDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp CCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred cCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 9999999999653 2346899999999999999999999998 999999999999998 7889999999987532
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
+..++.++|||||||++|||++|+.||......... ......+...
T Consensus 172 -----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~~~~~~ 217 (299)
T 3m2w_A 172 -----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKTRIRMG 217 (299)
T ss_dssp -----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCTT
T ss_pred -----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHHHHhhc
Confidence 235678999999999999999999998643322110 0000000000
Q ss_pred hhhccCCH----HHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 633 YYQESCNL----AEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 633 ~~~~~~~~----~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.. ..+. .....+.+++.+||+.||++|||+.|+++.
T Consensus 218 ~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 218 QY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00 0011 112457789999999999999999999983
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=273.94 Aligned_cols=205 Identities=11% Similarity=0.028 Sum_probs=156.8
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhhh-----------------------------hhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEIA-----------------------------HRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va-----------------------------h~niv~l~~~~~~~~~~~lV 472 (717)
.++|++.+.||+|+||.||+|+... ++.+| ||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3689999999999999999998754 22221 99999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
|||+++++|.+++.. + .....+..++.||++||.|||+++ |+||||||+||||+.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999832 1 345567889999999999999998 9999999999999999999997443
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
|++ +++.++|||||||++|||++|+.||......+..... .+... ..... ..
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~~-~~~~~--~~ 226 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDTA-GQPIE--PA 226 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCTT-SCBCC--HH
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHhc-cCCCC--hh
Confidence 333 3688999999999999999999999754433211000 00000 00000 00
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
..... ....+.+++.+||+.||++| |+.|+++.|+...
T Consensus 227 ~~~~~----~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 227 DIDRD----IPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HHCTT----SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred hcccC----CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 00111 12346789999999999999 9999999997653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=293.44 Aligned_cols=170 Identities=16% Similarity=0.173 Sum_probs=131.2
Q ss_pred eeEEEeccCCCChhhHhhh----ccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccc
Q 039318 469 KLLIYEFMPNRSLDSFIFD----QTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDF 544 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 544 (717)
.+++|+++ +++|.+++.. ......+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 180 ~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DF 255 (413)
T 3dzo_A 180 RFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGF 255 (413)
T ss_dssp EEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCG
T ss_pred eEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEec
Confidence 46677765 6799988842 123456788899999999999999999998 999999999999999999999999
Q ss_pred cccccccCCccccccceecccccccCcccc----------ccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHH
Q 039318 545 GLARTFVGDEIEGSTKRVVGTYGYMAPEYA----------SDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLI 614 (717)
Q Consensus 545 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~ 614 (717)
|+++..... .....| +.|+|||++ .+..++.++|||||||++|||++|+.||...........
T Consensus 256 G~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~- 328 (413)
T 3dzo_A 256 EHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW- 328 (413)
T ss_dssp GGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGG-
T ss_pred cceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHH-
Confidence 999864322 334577 999999999 556688999999999999999999999875432221111
Q ss_pred HHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 615 GHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 615 ~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
++... ... ...+.+|+.+||+.||++||++.++++
T Consensus 329 --------------~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 329 --------------IFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp --------------GGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------------HHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11100 011 145778899999999999999777654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-30 Score=274.90 Aligned_cols=216 Identities=16% Similarity=0.083 Sum_probs=162.6
Q ss_pred hcCcccccccccCCccceEeeeeCCc---------------------------------hhhh-----------------
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG---------------------------------QEIA----------------- 452 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~---------------------------------~~va----------------- 452 (717)
.++|++.++||+|+||.||+|+.... +++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 46799999999999999999975310 1122
Q ss_pred ---------hhhhhhhcceeec-------------CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHH
Q 039318 453 ---------HRNLVKLLGCCIQ-------------GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGL 510 (717)
Q Consensus 453 ---------h~niv~l~~~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l 510 (717)
||||+++++++.+ .+..+|||||+++|++.+.+.+ ..+++..+..++.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 6999999998876 7899999999999977666622 4589999999999999999
Q ss_pred HHHh-hcCCCcEEeccCCCCceEEcCCC--------------------CceeccccccccccCCccccccceeccccccc
Q 039318 511 LYLH-HDSRLRIIHRDLKASNVLLDHEM--------------------NPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569 (717)
Q Consensus 511 ~yLH-~~~~~~ivHrDlkp~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~ 569 (717)
+||| +++ |+||||||+||||+.++ .+||+|||+|+.... ....||+.|+
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~ 244 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSM 244 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTT
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeeccc
Confidence 9999 888 99999999999999887 899999999986532 2458999999
Q ss_pred CccccccCCCCccccchhHhHH-HHHhhcCCCCCCCCCCCCchhHHHHHH-HHhhCCCCccccchhhhccCCHHHHHHHH
Q 039318 570 APEYASDGLFSVKSDVFSFGIL-LLEIVSGKKNRGFYHSDKNLNLIGHAW-KLWNNGMPSQLIDAYYQESCNLAEVIRCI 647 (717)
Q Consensus 570 aPE~~~~~~~~~~sDvwSlG~i-l~elltG~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 647 (717)
|||++.+.. +.++|||||+++ .++++.|..||... ....... ............ ...........+.
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTFKTKC----NTPAMKQIKRKIQ 313 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCCSSCC----CSHHHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhccCccc----chhhhhhcCHHHH
Confidence 999998776 899999998776 88899999986310 0000011 111111110000 0001123445788
Q ss_pred HHHhhccccCCCCCCChHHHH
Q 039318 648 HVGLLCVQHHPEDRPCMPSVI 668 (717)
Q Consensus 648 ~l~~~Cl~~dp~~RPs~~evl 668 (717)
+|+.+||+.| |+.|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999966 898888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-26 Score=260.90 Aligned_cols=137 Identities=19% Similarity=0.184 Sum_probs=103.0
Q ss_pred hhhhhhhcceeecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceE
Q 039318 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVL 532 (717)
Q Consensus 453 h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIl 532 (717)
|+||+++++++++++..||||||++|++|.++|.+ .+.++.. .|+.||+.||+|||+++ ||||||||+|||
T Consensus 301 ~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNIL 371 (569)
T 4azs_A 301 GFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVM 371 (569)
T ss_dssp TCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEE
T ss_pred CCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEE
Confidence 99999999999999999999999999999999954 3445544 48899999999999999 999999999999
Q ss_pred EcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCC
Q 039318 533 LDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKN 601 (717)
Q Consensus 533 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p 601 (717)
|++++.+||+|||+|+...... ......+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 372 L~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 372 VDARQHARLIDFGSIVTTPQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ECCCCCEEEeecccCeeCCCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 9999999999999998764432 22345789999999999976 467789999999999999876554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.7e-23 Score=233.30 Aligned_cols=160 Identities=19% Similarity=0.188 Sum_probs=124.4
Q ss_pred ccccccccCCccceEeeeeCCc---------------------------------hhhhhhhhhhhcceeecCceeeEEE
Q 039318 427 SINKKLGEGGFGPVYKGTLADG---------------------------------QEIAHRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 427 ~~~~~lG~G~fg~Vy~~~~~~~---------------------------------~~vah~niv~l~~~~~~~~~~~lV~ 473 (717)
...++||+|+||.||+|+.... +.+.||||+++..++...+..+|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 3457899999999998753221 0123999997777777888889999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+++++|.+++.. +..++.||++||.|||+++ |+||||||+|||++. .+||+|||+++.....
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999843 5579999999999999998 999999999999999 9999999999986543
Q ss_pred cccc-----ccceecccccccCcccccc--CCCCccccchhHhHHHHHhhcCCCCC
Q 039318 554 EIEG-----STKRVVGTYGYMAPEYASD--GLFSVKSDVFSFGILLLEIVSGKKNR 602 (717)
Q Consensus 554 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~elltG~~p~ 602 (717)
.... ......||+.|||||++.. ..|+..+|+|+..+-.++.+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2211 1235789999999999987 56888899999999988888877765
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.7e-18 Score=150.62 Aligned_cols=96 Identities=19% Similarity=0.377 Sum_probs=80.7
Q ss_pred CCCCCEEEeCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEEec
Q 039318 2 LSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSAN 81 (717)
Q Consensus 2 l~~~~~l~S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~ 81 (717)
|..|++|+| |.|.|.|...++ |.|+. ..++||+|||+.|... .++|+|+.||+|||.|+++.+||+|+
T Consensus 10 L~~g~~L~s--g~y~l~~q~DgN-----Lvly~----~~~~vW~ant~~~~~~-~~~L~l~~dGnLvL~d~~~~~vWss~ 77 (105)
T 4h3o_A 10 LYAGQSLDV--EPYHFIMQDDCN-----LVLYD----HSTSTWASNTEIGGKS-GCSAVLQSDGNFVVYDSSGRSLWASH 77 (105)
T ss_dssp ECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-SCEEEECTTSCEEEECTTCCEEEECC
T ss_pred EcCCCEEEE--CCEEEEECCCCe-----EEEEE----CCEEEEEecCCCCCCc-cEEEEEeCCccEEEECCCcEEEEEec
Confidence 677899988 789999987765 77764 3589999999999755 56899999999999999999999999
Q ss_pred cccCcCCcEEEEEccCCCeEEEeccCCCCcceeeee
Q 039318 82 LSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQS 117 (717)
Q Consensus 82 ~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQS 117 (717)
++... ...+|+|+|+|||||++. .||||
T Consensus 78 t~~~~-~~~~l~L~ddGNlVly~~-------~~W~S 105 (105)
T 4h3o_A 78 STRGS-GNYILILQDDGNVIIYGS-------DIWST 105 (105)
T ss_dssp CCCCS-SCEEEEECTTSCEEEEES-------EEEEC
T ss_pred CCCCC-CCEEEEEeCCCeEEEECC-------cEecC
Confidence 87543 345699999999999952 69998
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.76 E-value=3.8e-18 Score=151.94 Aligned_cols=97 Identities=21% Similarity=0.382 Sum_probs=82.4
Q ss_pred CCCCCEEE--eCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEE
Q 039318 2 LSDGRTLV--SKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWS 79 (717)
Q Consensus 2 l~~~~~l~--S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWs 79 (717)
|.+|++|+ |++|.|+|+|+.+|+ | +||++ +++||+||++.| +.++.|+|..||||||.|.++.++|+
T Consensus 17 L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~---~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~d~~~~~lW~ 85 (119)
T 1b2p_A 17 LHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN---NNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQ 85 (119)
T ss_dssp EETTCEEEEEETTEEEEEEECTTSC-----E-EEEET---TEEEEECCCTTS--CSSCEEEECTTSCEEEECTTCCEEEE
T ss_pred EcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC---CEEEEeCCCccC--CCceEEEEccCCEEEEEeCCCcEEEc
Confidence 67899999 999999999998775 2 57875 799999999877 33578999999999999999999999
Q ss_pred eccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeee
Q 039318 80 ANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQS 117 (717)
Q Consensus 80 t~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQS 117 (717)
|++... .+...++|+|+|||||++. ++|||
T Consensus 86 S~~~~~-~g~~~l~l~~~Gnlvl~~~-------~~W~S 115 (119)
T 1b2p_A 86 SPVAGK-AGHYVLVLQPDRNVVIYGD-------ALWAT 115 (119)
T ss_dssp CSCCCC-SSCEEEEECTTSCEEEEES-------EEEEC
T ss_pred CCCCCC-CCCEEEEEECCCcEEEECc-------cEeCC
Confidence 997643 2345699999999999961 79998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=6e-18 Score=148.70 Aligned_cols=100 Identities=26% Similarity=0.407 Sum_probs=84.4
Q ss_pred CCCCCEEEeCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEEec
Q 039318 2 LSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSAN 81 (717)
Q Consensus 2 l~~~~~l~S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~ 81 (717)
|.+|++|+ ++|.|+|+|+..|+ | |+|+ ..++||.||++.|. .++.++|..||||||.|.++.++|+|+
T Consensus 10 L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~---~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~~~~~~W~S~ 77 (110)
T 3a0c_A 10 LFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD---SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQSNRVIWQTK 77 (110)
T ss_dssp ECTTCEEE-ETTTEEEEECTTSC-----E-EEEE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTTCCEEEECC
T ss_pred ECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE---CCEEEEECCCCCCC--CcEEEEEeCCCCEEEECCCCcEEEecC
Confidence 67899999 99999999988775 3 5676 37999999998763 346899999999999999999999999
Q ss_pred cccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCC
Q 039318 82 LSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYP 121 (717)
Q Consensus 82 ~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~P 121 (717)
+... .+...++|+|+|||||++. ++||||+||
T Consensus 78 t~~~-~g~~~l~l~~dGnlvl~~~-------~~W~S~~~~ 109 (110)
T 3a0c_A 78 TNGK-EDHYVLVLQQDRNVVIYGP-------VVWATGSGP 109 (110)
T ss_dssp CCCS-SSCCEEEECTTSCEEEECS-------EEEECSCCC
T ss_pred CCCC-CCCEEEEEeCCccEEEECC-------CEecCCCcC
Confidence 8653 2344599999999999852 799999998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=3e-19 Score=185.30 Aligned_cols=130 Identities=18% Similarity=0.142 Sum_probs=103.7
Q ss_pred cHHHHHHHhcCcccccccccCCccceEeeeeCCchhhh------------------------------------------
Q 039318 415 ELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA------------------------------------------ 452 (717)
Q Consensus 415 ~~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va------------------------------------------ 452 (717)
.+..+......|.+.+.||+|+||.||+|+..+++.+|
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 34455566677888899999999999999875443322
Q ss_pred -hhhhhhhcceeecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCce
Q 039318 453 -HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNV 531 (717)
Q Consensus 453 -h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NI 531 (717)
+ | +++.+++. .+..++||||+++++|.+ + .......++.||++||.|||+++ |+||||||+||
T Consensus 161 l~-~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l---------~~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 161 LQ-G-LAVPKVYA-WEGNAVLMELIDAKELYR-V---------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp TT-T-SSSCCEEE-EETTEEEEECCCCEEGGG-C---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred cc-C-CCcCeEEe-ccceEEEEEecCCCcHHH-c---------chhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 2 5 67777654 467799999999999987 4 11334569999999999999998 99999999999
Q ss_pred EEcCCCCceeccccccccccCCccccccceecccccccCcccccc
Q 039318 532 LLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASD 576 (717)
Q Consensus 532 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 576 (717)
||+ ++.+||+|||+++. +..++|||++..
T Consensus 225 Ll~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp EEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 999 99999999999873 345789998753
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=4.5e-17 Score=144.49 Aligned_cols=101 Identities=23% Similarity=0.341 Sum_probs=82.5
Q ss_pred CCCCCEEEeCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEEec
Q 039318 2 LSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSAN 81 (717)
Q Consensus 2 l~~~~~l~S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~ 81 (717)
|.+|++|+ +|.|+|+|+..++ |- +|. ..++||+||++.|. .+++|+|..+|||||.|.++.++|+++
T Consensus 11 L~~g~~L~--~g~~~L~~~~dgn-----lv-ly~---~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~~~~~vW~S~ 77 (115)
T 2dpf_A 11 LHADHSLQ--AGAYTLTIQNKCN-----LV-KYQ---NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDHNNNDVWGSA 77 (115)
T ss_dssp EETTEEEE--ETTEEEEECTTSC-----EE-EEE---TTEEEEECSCTTSC--SSCEEEECTTSCEEEECTTCCEEEECC
T ss_pred ECCCCEEE--CCCEEEEEcCCCc-----EE-EEe---CCEEEEeCCCCCCC--CceEEEECCCCcEEEECCCceEEEEcC
Confidence 66788998 8999999987664 22 355 37999999999883 357899999999999999899999999
Q ss_pred cccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCc
Q 039318 82 LSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSD 123 (717)
Q Consensus 82 ~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTD 123 (717)
+... .+...|+|+|+|||||++. ++||||.++..
T Consensus 78 ~~~~-~g~~~l~l~~dGnlvl~~~-------~~W~S~~~~~~ 111 (115)
T 2dpf_A 78 CWGD-NGKYALVLQKDGRFVIYGP-------VLWSLGPNGCR 111 (115)
T ss_dssp CCCS-SSCCEEEECTTSCEEEECS-------EEECSSTTCBC
T ss_pred CCCC-CCCEEEEEeCCCeEEEECC-------CEEECCCCCCc
Confidence 8643 2334599999999999842 79999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.67 E-value=3.4e-16 Score=138.19 Aligned_cols=101 Identities=24% Similarity=0.450 Sum_probs=81.6
Q ss_pred CCCCCEEEeCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEEec
Q 039318 2 LSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSAN 81 (717)
Q Consensus 2 l~~~~~l~S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~ 81 (717)
|.+|++| ++|.|+|+|+.+|+ | ++|.+ .++||+||++.+ +.+++|+|..+|||||.| ++.++|++.
T Consensus 10 L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~---~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~~~~~W~S~ 75 (112)
T 1xd5_A 10 LDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN---NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-GSRAIWASN 75 (112)
T ss_dssp ECTTCEE--EETTEEEEECTTSC-----E-EEEET---TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-TTEEEEECC
T ss_pred ECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC---CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-CCEEEEECC
Confidence 6788999 58999999998875 3 35764 689999999764 345789999999999999 888999999
Q ss_pred cccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCC
Q 039318 82 LSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYP 121 (717)
Q Consensus 82 ~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~P 121 (717)
+.... +...++|+++|||||++.. +.++||||+|.
T Consensus 76 ~~~~~-g~~~l~l~~dGnlvl~~~~----~~~~W~S~~~~ 110 (112)
T 1xd5_A 76 TNRQN-GNYYLILQRDRNVVIYDNS----NNAIWATHTNV 110 (112)
T ss_dssp CCCSC-CCCEEEECTTSCEEEECTT----SCEEEECCCCC
T ss_pred ccCCC-CCEEEEEeCCCcEEEECCC----CceEEECCCcc
Confidence 76432 3345999999999999642 24899999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=8.7e-16 Score=134.69 Aligned_cols=95 Identities=25% Similarity=0.403 Sum_probs=77.8
Q ss_pred CCCCCEEEeCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEEec
Q 039318 2 LSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSAN 81 (717)
Q Consensus 2 l~~~~~l~S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~ 81 (717)
|.+|++|+ +|.|+|+|+..|+ |-+ |.. .++||.||++.+ +.++.|+|..||||||.|.++.++|+++
T Consensus 10 L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~---~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~~~~~W~S~ 76 (109)
T 3dzw_A 10 LSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV---DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPRNNPIWASN 76 (109)
T ss_dssp ECTTCEEE--ETTEEEEECTTSC-----EEE-EET---TEEEEECCCTTS--SSSCEEEECTTSCEEEECTTSCEEEECC
T ss_pred eCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC---CEEEEECCcccC--CCCEEEEEeCCCCEEEECCCCCEEEECC
Confidence 67788886 7999999988775 333 554 589999999876 3457899999999999999999999999
Q ss_pred cccCcCCcEEEEEccCCCeEEEeccCCCCcceeeee
Q 039318 82 LSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQS 117 (717)
Q Consensus 82 ~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQS 117 (717)
+.... ...+|+|+|+|||||++. ++|||
T Consensus 77 t~~~~-~~~~~~L~ddGNlvly~~-------~~W~s 104 (109)
T 3dzw_A 77 TGGEN-GNYVCVLQKDRNVVIYGT-------ARWAT 104 (109)
T ss_dssp CCCSS-SCEEEEECTTSCEEEEES-------CCCCC
T ss_pred CCCCC-CCEEEEEeCCCEEEEECC-------CEEeC
Confidence 86533 345699999999999963 68998
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-15 Score=134.76 Aligned_cols=98 Identities=19% Similarity=0.424 Sum_probs=78.2
Q ss_pred CCCCcCCcceEEEecCCCEEEEcCCCcEEEEeccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCcccccc
Q 039318 49 INPINDSSGVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTLLPG 128 (717)
Q Consensus 49 ~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpg 128 (717)
+.|+.+...+|.|..||+|+|.+. +++||++++.... ....|+|+++|||||++ + + .++||||+
T Consensus 13 g~~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~-~~~~l~l~~~GNLvl~d-~-~---~~~W~S~~--------- 76 (112)
T 1xd5_A 13 GGSLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKA-SGCVLKMQNDGNLVIYS-G-S---RAIWASNT--------- 76 (112)
T ss_dssp TCEEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSC-SSEEEEECTTSCEEEEE-T-T---EEEEECCC---------
T ss_pred CCEEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCC-CCEEEEEeCCCCEEEEc-C-C---EEEEECCc---------
Confidence 344545567899999999999987 7899999986533 23459999999999997 3 2 49999994
Q ss_pred CeeceeeccCCceEEEEecCCCCCCCceeEEeeccCCCcEEEEEc-CCeeEEecCCCCC
Q 039318 129 MKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWK-GSRKFYRTGPWNG 186 (717)
Q Consensus 129 q~l~~~~~~~~~~~l~S~~s~~dps~G~~~~~~~~~~~~~~~~~~-~~~~y~~~~~~~g 186 (717)
+|++|.|++.++++|. ++++. ...+||++++|+|
T Consensus 77 ----------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ----------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp ----------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred ----------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 3467889999999997 45565 5789999999986
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=3.7e-15 Score=130.80 Aligned_cols=90 Identities=21% Similarity=0.359 Sum_probs=72.3
Q ss_pred CCcceEEEecCCCEEEEcCCCcEEEEeccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCccccccCeece
Q 039318 54 DSSGVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTLLPGMKLGW 133 (717)
Q Consensus 54 ~~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~ 133 (717)
+...+|.|..||+|||.+ .+++||++++..... ...|+|+|+|||||++.+ + .+|||||.
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~-~~~l~l~~dGNLVl~~~~-~---~~~W~S~t-------------- 78 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGS-GCRLTLHNNGNLVIYDQS-N---RVIWQTKT-------------- 78 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCS-SCEEEECTTSCEEEECTT-C---CEEEECCC--------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCC-cEEEEEeCCCCEEEECCC-C---cEEEecCC--------------
Confidence 335789999999999998 589999999875433 335999999999999753 2 49999993
Q ss_pred eeccCCceEEEEecCCCCCCCceeEEeeccCCCcEEEEEcCCeeEEecCCC
Q 039318 134 DFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYRTGPW 184 (717)
Q Consensus 134 ~~~~~~~~~l~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~~ 184 (717)
++++|.|++.++++|. ++++++ +||+++++
T Consensus 79 -----------------~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 79 -----------------NGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp -----------------CCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred -----------------CCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 4567899999999997 556665 89999875
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.55 E-value=3.1e-15 Score=159.60 Aligned_cols=122 Identities=16% Similarity=0.216 Sum_probs=94.9
Q ss_pred HHHHHHHhcCcccccccccCCccceEeeeeCCchhhh----------------------------------------hhh
Q 039318 416 LATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA----------------------------------------HRN 455 (717)
Q Consensus 416 ~~~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va----------------------------------------h~n 455 (717)
+..+.....-|++.++||+|+||.||+|...+|+.+| |+|
T Consensus 87 L~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~n 166 (397)
T 4gyi_A 87 LHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAF 166 (397)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHH
Confidence 3444444556999999999999999999877665443 788
Q ss_pred hhhhcceeecCc------eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCC
Q 039318 456 LVKLLGCCIQGE------EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKAS 529 (717)
Q Consensus 456 iv~l~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~ 529 (717)
|++++.....-. ..+|||||++++.|..+. .......++.||+.+|.|||+.+ ||||||||.
T Consensus 167 L~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~ 234 (397)
T 4gyi_A 167 MKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKHG---LIHGDFNEF 234 (397)
T ss_dssp HHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred HHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHH
Confidence 888876543322 336999999998885543 12334568899999999999998 999999999
Q ss_pred ceEEcCCCC----------ceecccccccc
Q 039318 530 NVLLDHEMN----------PKISDFGLART 549 (717)
Q Consensus 530 NIll~~~~~----------~kl~Dfgla~~ 549 (717)
||||++++. +.|+||+-+..
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HEEEeCCCCcccccccccceEEEEeCCccc
Confidence 999988773 88999998764
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.54 E-value=3.6e-14 Score=126.17 Aligned_cols=86 Identities=19% Similarity=0.305 Sum_probs=69.9
Q ss_pred ceEEEecCCCEEEEcCCCcEEEEeccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCccccccCeeceeec
Q 039318 57 GVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTLLPGMKLGWDFK 136 (717)
Q Consensus 57 ~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~ 136 (717)
.+|.|..||+|+|.+. +++||++++.....+ ..|+|+|+|||||++.+ +.+|||||
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~-~~l~l~~dGNLVl~d~~----~~~lW~S~------------------ 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNG-CRAVLQPDGVLVVITNE----NVTVWQSP------------------ 87 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSS-CEEEECTTSCEEEECTT----CCEEEECS------------------
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCc-eEEEEccCCEEEEEeCC----CcEEEcCC------------------
Confidence 4799999999999987 899999998654333 45999999999999753 24999999
Q ss_pred cCCceEEEEecCCCCCCCceeEEeeccCCCcEEEEEcCCeeEEecCC
Q 039318 137 TGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYRTGP 183 (717)
Q Consensus 137 ~~~~~~l~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 183 (717)
++|++|.|++.++++|. ++++. .+||++|+
T Consensus 88 -------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 -------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp -------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred -------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 34568899999999997 45565 38999886
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=7.4e-14 Score=123.68 Aligned_cols=91 Identities=22% Similarity=0.383 Sum_probs=73.6
Q ss_pred cceEEEecCCCEEEEcCCCcEEEEeccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCccccccCeeceee
Q 039318 56 SGVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTLLPGMKLGWDF 135 (717)
Q Consensus 56 ~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~ 135 (717)
..+|.|..||+|+|.+ .+++||++++..... ...|+|+++|||||++.+ + .++||||++|
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~-~~~l~l~~~GnLvl~d~~-~---~~vW~S~~~~-------------- 80 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGS-GCRLTLLSDGNLVIYDHN-N---NDVWGSACWG-------------- 80 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCS-SCEEEECTTSCEEEECTT-C---CEEEECCCCC--------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCC-ceEEEECCCCcEEEECCC-c---eEEEEcCCCC--------------
Confidence 4689999999999987 588999999865433 335999999999999753 2 3999999983
Q ss_pred ccCCceEEEEecCCCCCCCceeEEeeccCCCcEEEEEcCCeeEEecCCCCCc
Q 039318 136 KTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYRTGPWNGL 187 (717)
Q Consensus 136 ~~~~~~~l~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~g~ 187 (717)
++|.|++.++++|. +++++. +||++++|...
T Consensus 81 -----------------~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 81 -----------------DNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp -----------------SSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred -----------------CCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 46789999999997 556655 89999999743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=1.3e-14 Score=148.34 Aligned_cols=119 Identities=19% Similarity=0.187 Sum_probs=84.9
Q ss_pred HHhcCcccccccccCCccceEeeee-CCchh--hhh------------------------------------------hh
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTL-ADGQE--IAH------------------------------------------RN 455 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~--vah------------------------------------------~n 455 (717)
....-|++.+.||+|+||.||+|.. .+++. +|- .+
T Consensus 44 ~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 123 (258)
T 1zth_A 44 AKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRN 123 (258)
T ss_dssp HTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHH
T ss_pred hCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHH
Confidence 3334467889999999999999987 44444 330 01
Q ss_pred hhhhcce------eecCceeeEEEeccCC-C----ChhhHhhhccccccCChhhHHHHHHHHHHHHHHHh-hcCCCcEEe
Q 039318 456 LVKLLGC------CIQGEEKLLIYEFMPN-R----SLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH-HDSRLRIIH 523 (717)
Q Consensus 456 iv~l~~~------~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~ivH 523 (717)
+.++... ....+..+|||||+.+ | +|.++... .++..+..++.||+.+|.||| +.+ |+|
T Consensus 124 l~~l~~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 124 LERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHHHHHTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HHHHHhCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 1111100 0112456899999942 4 56555421 235577889999999999999 887 999
Q ss_pred ccCCCCceEEcCCCCceeccccccccc
Q 039318 524 RDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 524 rDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.50 E-value=6.4e-14 Score=122.76 Aligned_cols=94 Identities=21% Similarity=0.346 Sum_probs=72.5
Q ss_pred CCCCCEEEeCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEEec
Q 039318 2 LSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSAN 81 (717)
Q Consensus 2 l~~~~~l~S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~ 81 (717)
|..|+.|+| |.|.|-|...|+ |.| |.. .+||.+|+... +.++.|+|..+|||||.|.++.++|+++
T Consensus 15 L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~dGNLvl~d~~~~~iW~S~ 80 (110)
T 3r0e_B 15 LYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG----KYGWQSNTHGN--GEHCFLRLNHKGELIIKDDDFKTIWSSR 80 (110)
T ss_dssp EETTEEEEC--SSCEEEECTTSC-----EEE-ECS----SSCEECCCTTS--SSSCEEEECTTSCEEEECTTCCEEEECC
T ss_pred ecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC----eEEEECCCcCC--CcCEEEEEeCCCcEEEEeCCCCEEEEcC
Confidence 556778887 458886655443 565 544 48999999863 3346899999999999999999999999
Q ss_pred cccCcCCcEEEEEccCCCeEEEeccCCCCcceeeee
Q 039318 82 LSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQS 117 (717)
Q Consensus 82 ~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQS 117 (717)
+.... +..+|+|+|+|||||++. .+|+|
T Consensus 81 t~~~~-~~~~~~L~~dGNlvly~~-------~~W~t 108 (110)
T 3r0e_B 81 SSSKQ-GEYVLILQDDGFGVIYGP-------AIFET 108 (110)
T ss_dssp CCCSS-SCCEEEECTTSCEEEECS-------EEEES
T ss_pred CcCCC-CCEEEEEcCCccEEEecC-------CEecC
Confidence 86432 334599999999999962 79987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.47 E-value=3.2e-13 Score=118.95 Aligned_cols=97 Identities=18% Similarity=0.271 Sum_probs=75.1
Q ss_pred CCCCCEEEeCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEEec
Q 039318 2 LSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSAN 81 (717)
Q Consensus 2 l~~~~~l~S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~ 81 (717)
|..|+.|. +|.|.|-|...|+ |.++..+ ..++||.+|+..+- .++.|+|..+|||||.|.++.++|+++
T Consensus 15 L~~g~~L~--~g~~~L~~q~dGN-----LvL~~~~--~~~~vWssnt~~~~--~~~~l~l~~dGNLVl~d~~~~~iW~S~ 83 (113)
T 3mez_B 15 MYDNAQLA--TRDYSLVMRDDCN-----LVLTKGS--KTNIVWESGTSGRG--QHCFMRLGHSGELDITDDRLNTVFVSN 83 (113)
T ss_dssp EETTCEEE--ETTEEEEECTTSC-----EEEEETT--TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTTSCEEEECS
T ss_pred ECCCCEeE--cCCEEEEEcCCCE-----EEEEECC--CCEEEEECCcccCC--cCEEEEEeCCCcEEEECCCCCEEEECC
Confidence 34556665 4889999976664 6765321 36899999998762 346899999999999999999999999
Q ss_pred cccCcCCcEEEEEccCCCeEEEeccCCCCcceeeee
Q 039318 82 LSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQS 117 (717)
Q Consensus 82 ~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQS 117 (717)
+.... +..+|+|+|+|||||++ ..||+|
T Consensus 84 t~~~~-~~~~~~L~~dGnlvly~-------~~~W~s 111 (113)
T 3mez_B 84 TVGQE-GDYVLILQINGQAVVYG-------PAVWST 111 (113)
T ss_dssp CCCSS-SCCEEEECTTSCEEEEC-------SEEEES
T ss_pred CcCCC-CCEEEEEcCCceEEEec-------CCEecC
Confidence 86532 33459999999999995 179987
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.7e-12 Score=112.14 Aligned_cols=98 Identities=23% Similarity=0.419 Sum_probs=74.8
Q ss_pred CCCCCEEEeCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEEec
Q 039318 2 LSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSAN 81 (717)
Q Consensus 2 l~~~~~l~S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~ 81 (717)
|..|+.| .+|.|.|.|...|+ |-+ |.. +|.+|+..+ +.+..|+|..||+|||.|.++.++|+++
T Consensus 12 L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~~------~Wssnt~~~--~~~~~l~l~~dGnLvl~d~~~~~vWss~ 75 (109)
T 3r0e_A 12 LDTEGHL--KNGDFDLVMQDDCN-----LVL-YNG------NWQSNTANN--GRDCKLTLTDYGELVIKNGDGSTVWKSG 75 (109)
T ss_dssp ECTTCEE--EETTEEEEECTTSC-----EEE-ETT------TEECCCTTS--CSSCEEEECTTSCEEEECTTSCEEEECC
T ss_pred cCCCCEe--ECCCEEEEEecCCe-----EEE-EeC------eEEcCCCCC--CCcEEEEEcCCCeEEEEeCCCCEEEcCC
Confidence 4556666 57999999977664 443 331 699998865 3357899999999999999999999999
Q ss_pred cccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCcccccc
Q 039318 82 LSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTLLPG 128 (717)
Q Consensus 82 ~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpg 128 (717)
+... ....+|+|+|+|||||++. .+|+| .|.+||
T Consensus 76 t~~~-~~~~~~~L~~dGNlvly~~-------~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 76 AQSV-KGNYAAVVHPDGRLVVFGP-------SVFKI-----DPWVRG 109 (109)
T ss_dssp CCCS-SSCCEEEEETTTEEEEECS-------EEEEE-----CTTSCC
T ss_pred CcCC-CcCEEEEEcCCCeEEEEec-------CEECC-----CCccCC
Confidence 8653 2344599999999999962 79997 555554
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.23 E-value=3.5e-11 Score=105.47 Aligned_cols=95 Identities=19% Similarity=0.261 Sum_probs=71.8
Q ss_pred CCCCCEEEeCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCc-EEEEe
Q 039318 2 LSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKS-VVWSA 80 (717)
Q Consensus 2 l~~~~~l~S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~-~vWst 80 (717)
|..|+.| .+|.|.|-|...|+ |.+ |.. .. ||.+|+..+ +....|+|..+|||||.|.++. ++|++
T Consensus 11 L~~g~~L--~~g~~~L~~q~dGn-----Lvl-~~~---~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~~~~~~vW~S 76 (111)
T 3mez_A 11 IHTDNQL--SYESAAFVMQGDCN-----LVL-YNE---AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSANSNTPVWVY 76 (111)
T ss_dssp ECTTCEE--EETTEEEEECTTSC-----EEE-ECS---SC-CEECCCTTS--CSSCEEEECTTSCEEEECSSCSSCSEEE
T ss_pred eCCCCEE--ecCCEEEEEccCCe-----EEE-ECC---CC-EEECCcccC--CcCEEEEEcCCCcEEEEeCCCCEEEEEe
Confidence 5567777 47899999976664 554 443 23 999999876 2346899999999999998876 59999
Q ss_pred cccc-CcCCcEEEEEccCCCeEEEeccCCCCcceeeee
Q 039318 81 NLSK-EVRTPVVLQLLDSGNLVLRGERDGDSETYLWQS 117 (717)
Q Consensus 81 ~~~~-~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQS 117 (717)
++.. ...+..+|.|+++|||||++ ..+|+|
T Consensus 77 ~t~~~~~~~~~~l~Lq~dGNlvly~-------~~~W~s 107 (111)
T 3mez_A 77 PRSVNTVRGNYAATLGPDQHVTIYG-------PAIWST 107 (111)
T ss_dssp SSSCCCCSSCCEEEECTTSCEEEEC-------SEEEEC
T ss_pred ccccCCCCcCEEEEECCCCeEEEec-------cCEEcc
Confidence 9642 22344569999999999996 279987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.19 E-value=8.2e-11 Score=103.47 Aligned_cols=96 Identities=20% Similarity=0.286 Sum_probs=71.9
Q ss_pred CCCCCcCCcceEEEecCCCEEEEcC-CCcEEEEeccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCcccc
Q 039318 48 RINPINDSSGVLVVNKTGNLVLTSQ-NKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTLL 126 (717)
Q Consensus 48 r~~p~~~~~~~l~l~~~G~Lvl~~~-~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlL 126 (717)
.+.|+.+...+|.+..||+|||.+. .++++|++++..... ...|+|+++|||||++.++ .++|||=.+-
T Consensus 17 ~g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~-~~~l~l~~dGNLVl~d~~~----~~iW~S~t~~----- 86 (113)
T 3mez_B 17 DNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQ-HCFMRLGHSGELDITDDRL----NTVFVSNTVG----- 86 (113)
T ss_dssp TTCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCS-SCEEEECTTSCEEEECTTS----CEEEECSCCC-----
T ss_pred CCCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCc-CEEEEEeCCCcEEEECCCC----CEEEECCCcC-----
Confidence 4566766677999999999999988 589999999875433 3459999999999997542 3899873210
Q ss_pred ccCeeceeeccCCceEEEEecCCCCCCCceeEEeeccCCCcEEEEEcCCeeEEecCC
Q 039318 127 PGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYRTGP 183 (717)
Q Consensus 127 pgq~l~~~~~~~~~~~l~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 183 (717)
..|.|.+.++++|...+ +. .+.|.+++
T Consensus 87 --------------------------~~~~~~~~L~~dGnlvl--y~--~~~W~s~~ 113 (113)
T 3mez_B 87 --------------------------QEGDYVLILQINGQAVV--YG--PAVWSTAA 113 (113)
T ss_dssp --------------------------SSSCCEEEECTTSCEEE--EC--SEEEESCC
T ss_pred --------------------------CCCCEEEEEcCCceEEE--ec--CCEecCCC
Confidence 12458889999997554 44 58898875
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.17 E-value=1e-10 Score=102.51 Aligned_cols=96 Identities=17% Similarity=0.217 Sum_probs=70.5
Q ss_pred CCCCcCCcceEEEecCCCEEEEcCCCcEEEEeccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCcccccc
Q 039318 49 INPINDSSGVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTLLPG 128 (717)
Q Consensus 49 ~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpg 128 (717)
+.++.+...+|.+..||||||.+.++ +|++++..... .+.|+|+++|||||++.++. .++|||.-+
T Consensus 14 g~~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~-~~~l~l~~dGNLVl~~~~~~---~~vW~S~t~-------- 79 (111)
T 3mez_A 14 DNQLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGV-DCTLRLNNRGQLEIHSANSN---TPVWVYPRS-------- 79 (111)
T ss_dssp TCEEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCS-SCEEEECTTSCEEEECSSCS---SCSEEESSS--------
T ss_pred CCEEecCCEEEEEccCCeEEEECCCC--EEECCcccCCc-CEEEEEcCCCcEEEEeCCCC---EEEEEeccc--------
Confidence 44454555689999999999998877 99999875433 34599999999999976432 259998731
Q ss_pred CeeceeeccCCceEEEEecCCCCCCCceeEEeeccCCCcEEEEEcCCeeEEecCC
Q 039318 129 MKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYRTGP 183 (717)
Q Consensus 129 q~l~~~~~~~~~~~l~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 183 (717)
.....|.|.+.++++|...+ +. .++|.+++
T Consensus 80 ---------------------~~~~~~~~~l~Lq~dGNlvl--y~--~~~W~s~t 109 (111)
T 3mez_A 80 ---------------------VNTVRGNYAATLGPDQHVTI--YG--PAIWSTPA 109 (111)
T ss_dssp ---------------------CCCCSSCCEEEECTTSCEEE--EC--SEEEECCC
T ss_pred ---------------------cCCCCcCEEEEECCCCeEEE--ec--cCEEccCC
Confidence 01134679999999997554 44 68898875
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=1.9e-09 Score=94.05 Aligned_cols=87 Identities=22% Similarity=0.383 Sum_probs=64.4
Q ss_pred cceEEEecCCCEEEEcCCCcEEEEeccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCccccccCeeceee
Q 039318 56 SGVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTLLPGMKLGWDF 135 (717)
Q Consensus 56 ~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~ 135 (717)
..+|.|..||+|||.+. ++++|++++..... ...|.|+++|||||++.++ .++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~-~~~l~l~~dGNLvl~~~~~----~~~W~S~t~~-------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDR-RCHLSMQSDGNLVVYSPRN----NPIWASNTGG-------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSS-SCEEEECTTSCEEEECTTS----CEEEECCCCC--------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCC-CEEEEEeCCCCEEEECCCC----CEEEECCCCC--------------
Confidence 46899999999999887 78999999865432 3459999999999997542 3899885321
Q ss_pred ccCCceEEEEecCCCCCCCceeEEeeccCCCcEEEEEcCCeeEEecCC
Q 039318 136 KTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYRTGP 183 (717)
Q Consensus 136 ~~~~~~~l~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 183 (717)
..+.|.+.++++|...+ +.. +.|.++.
T Consensus 80 -----------------~~~~~~~~L~ddGNlvl--y~~--~~W~s~t 106 (109)
T 3dzw_A 80 -----------------ENGNYVCVLQKDRNVVI--YGT--ARWATGT 106 (109)
T ss_dssp -----------------SSSCEEEEECTTSCEEE--EES--CCCCCCC
T ss_pred -----------------CCCCEEEEEeCCCEEEE--ECC--CEEeCCC
Confidence 12457889999987554 442 6777664
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.6e-09 Score=94.71 Aligned_cols=87 Identities=18% Similarity=0.363 Sum_probs=64.2
Q ss_pred CCcceEEEecCCCEEEEcCCCcEEEEeccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCccccccCeece
Q 039318 54 DSSGVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTLLPGMKLGW 133 (717)
Q Consensus 54 ~~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~ 133 (717)
..+.+|.+..||+|||.+. .++|++++..... ...|+|+++|||||++.+ + .++|||-.+-
T Consensus 23 sg~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~-~~~l~l~~dGNLvl~d~~-~---~~iW~S~t~~------------ 83 (110)
T 3r0e_B 23 AKNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGE-HCFLRLNHKGELIIKDDD-F---KTIWSSRSSS------------ 83 (110)
T ss_dssp CSSCEEEECTTSCEEEECS--SSCEECCCTTSSS-SCEEEECTTSCEEEECTT-C---CEEEECCCCC------------
T ss_pred eCCEEEEEcCCCeEEEECC--eEEEECCCcCCCc-CEEEEEeCCCcEEEEeCC-C---CEEEEcCCcC------------
Confidence 3456899999999999876 5899999875433 235999999999999754 2 3899985321
Q ss_pred eeccCCceEEEEecCCCCCCCceeEEeeccCCCcEEEEEcCCeeEEecC
Q 039318 134 DFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYRTG 182 (717)
Q Consensus 134 ~~~~~~~~~l~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~ 182 (717)
..|.|.+.++++|...+ +. ...|.++
T Consensus 84 -------------------~~~~~~~~L~~dGNlvl--y~--~~~W~t~ 109 (110)
T 3r0e_B 84 -------------------KQGEYVLILQDDGFGVI--YG--PAIFETS 109 (110)
T ss_dssp -------------------SSSCCEEEECTTSCEEE--EC--SEEEESC
T ss_pred -------------------CCCCEEEEEcCCccEEE--ec--CCEecCC
Confidence 12458889999987554 44 3788876
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=1e-09 Score=112.21 Aligned_cols=102 Identities=23% Similarity=0.372 Sum_probs=75.6
Q ss_pred CCCCCEEEeCCCeEEEEeeCCC--CCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEE
Q 039318 2 LSDGRTLVSKEGSFELGFFSPG--SSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWS 79 (717)
Q Consensus 2 l~~~~~l~S~~g~F~~GFf~~~--~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWs 79 (717)
|..|+.|+| ...++-|+|... ...+.+ + |.+ ..+++|.+++..+- . ..|.+..+|+|++.|.++.++|+
T Consensus 149 l~~g~~L~S-~~dps~G~fsl~l~~dGnlv--L-y~~--~~~~yW~Sgt~~~~--~-~~l~l~~dGnLvl~d~~~~~vWs 219 (276)
T 3m7h_A 149 LAPGSELVQ-GVVYGAGASKLVFQGDGNLV--A-YGP--NGAATWNAGTQGKG--A-VRAVFQGDGNLVVYGAGNAVLWH 219 (276)
T ss_dssp ECSSEEECT-TCEEEETTEEEEECTTSCEE--E-ECT--TSSEEEECCCTTTT--C-CEEEECTTSCEEEECTTSCEEEE
T ss_pred cccCccccc-CCCCCCceEEEeecCCceEE--E-EeC--CCeEEEECCCCCCc--c-EEEEEcCCCeEEEEeCCCcEEEE
Confidence 455677755 457777777542 222333 3 332 25899999998762 2 68999999999999998899999
Q ss_pred eccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCC
Q 039318 80 ANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDY 120 (717)
Q Consensus 80 t~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~ 120 (717)
+++... ...+|+|+++|||||++. .++||||||
T Consensus 220 S~t~~~--~~~rl~Ld~dGnLvly~~------~~~Wqsf~~ 252 (276)
T 3m7h_A 220 SHTGGH--ASAVLRLQANGSIAILDE------KPVWARFGF 252 (276)
T ss_dssp CSCTTC--TTCEEEECTTSCEEEEEE------EEEEESSSC
T ss_pred ecCCCC--CCEEEEEcCCccEEEEcC------CCeEEccCc
Confidence 998643 234599999999999974 289999998
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.91 E-value=5.7e-09 Score=90.97 Aligned_cols=93 Identities=22% Similarity=0.384 Sum_probs=67.8
Q ss_pred CCCCCcCCcceEEEecCCCEEEEcCCCcEEEEeccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCccccc
Q 039318 48 RINPINDSSGVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTLLP 127 (717)
Q Consensus 48 r~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLp 127 (717)
.+.|+.+....|.+..||||||.++ +|++++..... ...++|.++|||||++.++ .++|+|-..
T Consensus 14 ~g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~-~~~l~l~~dGnLvl~d~~~----~~vWss~t~------- 77 (109)
T 3r0e_A 14 TEGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGR-DCKLTLTDYGELVIKNGDG----STVWKSGAQ------- 77 (109)
T ss_dssp TTCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCS-SCEEEECTTSCEEEECTTS----CEEEECCCC-------
T ss_pred CCCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCC-cEEEEEcCCCeEEEEeCCC----CEEEcCCCc-------
Confidence 4455555567899999999999985 79999875433 3459999999999997542 389965210
Q ss_pred cCeeceeeccCCceEEEEecCCCCCCCceeEEeeccCCCcEEEEEcCCeeEEecCCC
Q 039318 128 GMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYRTGPW 184 (717)
Q Consensus 128 gq~l~~~~~~~~~~~l~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~~ 184 (717)
...+.|.+.++++|... ++. .+.|.+++|
T Consensus 78 ------------------------~~~~~~~~~L~~dGNlv--ly~--~~~W~s~t~ 106 (109)
T 3r0e_A 78 ------------------------SVKGNYAAVVHPDGRLV--VFG--PSVFKIDPW 106 (109)
T ss_dssp ------------------------CSSSCCEEEEETTTEEE--EEC--SEEEEECTT
T ss_pred ------------------------CCCcCEEEEEcCCCeEE--EEe--cCEECCCCc
Confidence 02356888999998654 444 688999886
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=9.4e-09 Score=104.67 Aligned_cols=121 Identities=17% Similarity=0.052 Sum_probs=90.4
Q ss_pred HHhcCcccccccccCCccceEeeeeCCchh---------------hh-----------hhhhhhhcceeecCceeeEEEe
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADGQE---------------IA-----------HRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~---------------va-----------h~niv~l~~~~~~~~~~~lV~E 474 (717)
.....|++...++.|+.+.||+....++.. +. |..+.++++++.+.+..++|||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 344678888889999999999986432110 10 4456678888888889999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhc--------------------------------------
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD-------------------------------------- 516 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-------------------------------------- 516 (717)
|++|.+|.+.+ .+......++.+++++|+.||+.
T Consensus 91 ~i~G~~l~~~~--------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 91 EADGVLCSEEY--------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CCSSEEHHHHC--------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred ecCCeehhhcc--------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 99999987653 12233456888999999999981
Q ss_pred ------------------CCCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 517 ------------------SRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 517 ------------------~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
....++|+|++|.|||++++..+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 113499999999999998765567999998753
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.72 E-value=7.1e-08 Score=83.30 Aligned_cols=77 Identities=19% Similarity=0.335 Sum_probs=58.5
Q ss_pred ceEEEecCCCEEEEcCCCcEEEEeccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCccccccCeeceeec
Q 039318 57 GVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTLLPGMKLGWDFK 136 (717)
Q Consensus 57 ~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~ 136 (717)
-+|.+..||||||.+. +++||++++.......+.+.|.++|||||++.++ +++|+|=.
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~----~~vWss~t----------------- 78 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSG----RSLWASHS----------------- 78 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTC----CEEEECCC-----------------
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCCc----EEEEEecC-----------------
Confidence 4799999999999874 6899999987654444569999999999997652 38897621
Q ss_pred cCCceEEEEecCCCCCCCceeEEeeccCCCcEE
Q 039318 137 TGLERRITSWKSSDDPSPGDFIWKIERQFYPEL 169 (717)
Q Consensus 137 ~~~~~~l~S~~s~~dps~G~~~~~~~~~~~~~~ 169 (717)
....+.|.+.++++|...+
T Consensus 79 --------------~~~~~~~~l~L~ddGNlVl 97 (105)
T 4h3o_A 79 --------------TRGSGNYILILQDDGNVII 97 (105)
T ss_dssp --------------CCCSSCEEEEECTTSCEEE
T ss_pred --------------CCCCCCEEEEEeCCCeEEE
Confidence 1134568899999987554
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.52 E-value=6.7e-08 Score=97.81 Aligned_cols=115 Identities=13% Similarity=0.101 Sum_probs=77.8
Q ss_pred cCcccccccccCCccceEeeeeCCchhhh-----------------------hhh--hhhhcceeecCceeeEEEeccCC
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-----------------------HRN--LVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-----------------------h~n--iv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
..+.+....+.|..+.||++...+++.++ +.+ +.+++.+...++..++||||++|
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G 99 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 99 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence 34555333345566899988754432111 222 45677887777788999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS----------------------------------------- 517 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~----------------------------------------- 517 (717)
.+|. .. . . ....++.++++.|+.||+..
T Consensus 100 ~~l~--~~---~---~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 100 QDLL--SS---H---L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp EETT--TS---C---C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred cccC--cC---c---C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 8884 21 0 1 12246677777777777642
Q ss_pred --------------CCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 518 --------------RLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 518 --------------~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
+..++|+|++|.|||++.+..+.|+||+.+..
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776667999999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.44 E-value=2.2e-07 Score=99.25 Aligned_cols=117 Identities=18% Similarity=0.217 Sum_probs=85.7
Q ss_pred cccccccCCccceEeeeeCCchh------------------hh------------hhhhhhhcceeecC---ceeeEEEe
Q 039318 428 INKKLGEGGFGPVYKGTLADGQE------------------IA------------HRNLVKLLGCCIQG---EEKLLIYE 474 (717)
Q Consensus 428 ~~~~lG~G~fg~Vy~~~~~~~~~------------------va------------h~niv~l~~~~~~~---~~~~lV~E 474 (717)
..+.|+.|.++.||+....++.. +. +..+.+++.++.+. +..++|||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 45789999999999886432210 00 23366777777665 44899999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS------------------------------------- 517 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------- 517 (717)
|++|..+.+.. ...++...+..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99998875422 123667788889999999999999731
Q ss_pred ------------------CCcEEeccCCCCceEEcCCCC--ceecccccccc
Q 039318 518 ------------------RLRIIHRDLKASNVLLDHEMN--PKISDFGLART 549 (717)
Q Consensus 518 ------------------~~~ivHrDlkp~NIll~~~~~--~kl~Dfgla~~ 549 (717)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999999875
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.36 E-value=6.5e-07 Score=89.53 Aligned_cols=86 Identities=20% Similarity=0.310 Sum_probs=64.1
Q ss_pred cceEEEecCCCEEEEcCCCcEEEEeccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCccccccCeeceee
Q 039318 56 SGVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTLLPGMKLGWDF 135 (717)
Q Consensus 56 ~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~ 135 (717)
.-+|.++.+|+|+|.+.+ .++|++++.+... ...++|.++||||+++.+ +.++||||.+.
T Consensus 151 ~~~l~l~~dG~LvL~~~~-~~~W~s~~~~~~~-~~~~~L~~~Gnl~ly~~~----~~~vw~s~~~~-------------- 210 (236)
T 1dlp_A 151 PYRLSMETDCNLVLFDRD-DRVWSTNTAGKGT-GCRAVLQPNGRMDVLTNQ----NIAVWTSGNSR-------------- 210 (236)
T ss_dssp SCEEEEETTTEEEEEBTT-BCCSCCCCCSSCS-SCEEEEETTTEEEEEETT----TEEEEECCCCC--------------
T ss_pred cEEEEECCCCcEEEEcCC-EeEEeCCCcCCCC-ceEEEECCCCcEEEEeCC----CcEEEEeCCCC--------------
Confidence 358999999999998765 6899999764332 234899999999999743 24899999431
Q ss_pred ccCCceEEEEecCCCCCCCceeEEeeccCCCcEEEEEcCCeeEEecC
Q 039318 136 KTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYRTG 182 (717)
Q Consensus 136 ~~~~~~~l~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~ 182 (717)
++|.|++.++++|..+++ . ..||.+|
T Consensus 211 -----------------~~~~~rl~Ld~dG~l~ly--~--~~~W~sg 236 (236)
T 1dlp_A 211 -----------------SAGRYVFVLQPDRNLAIY--G--GALWTTG 236 (236)
T ss_dssp -----------------SSSCCEEEECSSSCEEEE--C--CCCCBC-
T ss_pred -----------------CCCCEEEEEcCCCcEEEe--C--CCCccCC
Confidence 236789999999976654 3 3788764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.03 E-value=1.3e-06 Score=90.88 Aligned_cols=128 Identities=20% Similarity=0.178 Sum_probs=82.0
Q ss_pred eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhc-------------------------------
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD------------------------------- 516 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~------------------------------- 516 (717)
..|+|||+++|..|..... ..++..++..++.++++.|+.||+.
T Consensus 90 ~~~~vm~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (304)
T 3sg8_A 90 MSFAGFTKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRE 164 (304)
T ss_dssp CSCEEEECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTT
T ss_pred cceEEEcccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhccc
Confidence 3489999999998875432 2356667777788888888888751
Q ss_pred ------------------------CCCcEEeccCCCCceEEcC--CCCceeccccccccccCCcccccc-----------
Q 039318 517 ------------------------SRLRIIHRDLKASNVLLDH--EMNPKISDFGLARTFVGDEIEGST----------- 559 (717)
Q Consensus 517 ------------------------~~~~ivHrDlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~----------- 559 (717)
....++|+|++|.||++++ ...+.|+||+.+..-.....-...
T Consensus 165 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 165 LKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEF 244 (304)
T ss_dssp SCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHH
T ss_pred CCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHH
Confidence 1235899999999999998 456789999998753221100000
Q ss_pred -ceecccccccC-ccccccCCCCccccchhHhHHHHHhhcCCCCC
Q 039318 560 -KRVVGTYGYMA-PEYASDGLFSVKSDVFSFGILLLEIVSGKKNR 602 (717)
Q Consensus 560 -~~~~gt~~y~a-PE~~~~~~~~~~sDvwSlG~il~elltG~~p~ 602 (717)
.......+... |+.... .....+.|+++.+++.+.+|+.+|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00011111122 222211 122368999999999999998774
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00032 Score=71.03 Aligned_cols=87 Identities=16% Similarity=0.097 Sum_probs=62.5
Q ss_pred hhhhcceeecCceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcC------------------
Q 039318 456 LVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS------------------ 517 (717)
Q Consensus 456 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------ 517 (717)
+.+++.++.+.+..++|||++++.++.+.... .......+..++++.|+-||...
T Consensus 82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~ 154 (272)
T 4gkh_A 82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQ 154 (272)
T ss_dssp CCCEEEEEEETTEEEEEEECCCSEEHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHH
T ss_pred cCeEEEEEEECCeEEEEEEeeCCccccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHH
Confidence 45677888888899999999999888765521 11223345556666666666421
Q ss_pred -------------------------------------CCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 518 -------------------------------------RLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 518 -------------------------------------~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 155 SRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999877677999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0018 Score=67.09 Aligned_cols=31 Identities=35% Similarity=0.459 Sum_probs=25.7
Q ss_pred CcEEeccCCCCceEEcC---CCCc-eecccccccc
Q 039318 519 LRIIHRDLKASNVLLDH---EMNP-KISDFGLART 549 (717)
Q Consensus 519 ~~ivHrDlkp~NIll~~---~~~~-kl~Dfgla~~ 549 (717)
..++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 190 ~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 190 PRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred CeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 35799999999999987 4554 7999998764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0027 Score=66.36 Aligned_cols=32 Identities=19% Similarity=0.230 Sum_probs=28.0
Q ss_pred CCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 518 ~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 34699999999999998888899999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0026 Score=67.12 Aligned_cols=32 Identities=16% Similarity=0.204 Sum_probs=26.6
Q ss_pred CCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 518 ~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 34699999999999999644578999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=95.58 E-value=0.016 Score=62.01 Aligned_cols=30 Identities=23% Similarity=0.336 Sum_probs=25.8
Q ss_pred CcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 519 LRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 519 ~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
..++|+|+.|.|||++.+ .++|+||..+..
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 459999999999999876 489999988764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.55 E-value=0.067 Score=51.57 Aligned_cols=102 Identities=11% Similarity=0.057 Sum_probs=65.4
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
.-+|.+.|.. ...++++++++.++.|.+++|.-+-... .+ ..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 32 ~vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 32 ALSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc---------
Confidence 3478888843 4568999999999999999887662111 11 1233457999999999988763 1110
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhcCC
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~ 599 (717)
.....+.+||... ...+.+.=|||||+++|.-+-=.
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1223566888763 35568889999999999988633
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.39 E-value=0.022 Score=58.92 Aligned_cols=54 Identities=13% Similarity=0.079 Sum_probs=37.8
Q ss_pred cccccccCCccceEeeeeCCchhhh---------------------h----hhhhhhcceeecCceeeEEEeccCCCCh
Q 039318 428 INKKLGEGGFGPVYKGTLADGQEIA---------------------H----RNLVKLLGCCIQGEEKLLIYEFMPNRSL 481 (717)
Q Consensus 428 ~~~~lG~G~fg~Vy~~~~~~~~~va---------------------h----~niv~l~~~~~~~~~~~lV~E~~~~gsL 481 (717)
..+.|+.|....+|+.....+.-+. + ..+.+++.+....+..++||||+++..+
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 3467899999999988653321110 1 2356667777777889999999999765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=93.25 E-value=0.1 Score=52.93 Aligned_cols=29 Identities=21% Similarity=0.265 Sum_probs=23.3
Q ss_pred hcCcccccccccCCccceEeeeeCCchhh
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEI 451 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~v 451 (717)
.......+.+|.|..+.||+.++.+|+.+
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~ 42 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPL 42 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEE
Confidence 34566678899999999999998887643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=92.22 E-value=0.15 Score=52.18 Aligned_cols=31 Identities=26% Similarity=0.209 Sum_probs=26.0
Q ss_pred CCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 518 ~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
...++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 345899999999999 5667789999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=89.89 E-value=0.22 Score=53.54 Aligned_cols=79 Identities=11% Similarity=0.011 Sum_probs=46.4
Q ss_pred CcEEeccCCCCceEEcCCCCceeccccccccccCCccccccceecccccccCccccccC---CCCccccchhHhHHHHHh
Q 039318 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDG---LFSVKSDVFSFGILLLEI 595 (717)
Q Consensus 519 ~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~el 595 (717)
..++|+|++|.|||++.++ ++|+||+.+..-.....-... ...-...|++|+..... .-....++......+++.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAY-LGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHH-HHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHH-HHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4599999999999998876 999999998753211000000 00012345666554311 111234555777777777
Q ss_pred hcCC
Q 039318 596 VSGK 599 (717)
Q Consensus 596 ltG~ 599 (717)
+.++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.80 E-value=0.27 Score=52.61 Aligned_cols=30 Identities=23% Similarity=0.371 Sum_probs=25.2
Q ss_pred cEEeccCCCCceEE------cCCCCceecccccccc
Q 039318 520 RIIHRDLKASNVLL------DHEMNPKISDFGLART 549 (717)
Q Consensus 520 ~ivHrDlkp~NIll------~~~~~~kl~Dfgla~~ 549 (717)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4456799999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=86.25 E-value=0.66 Score=47.88 Aligned_cols=32 Identities=31% Similarity=0.429 Sum_probs=27.4
Q ss_pred CCcEEeccCCCCceEEcCC----CCceecccccccc
Q 039318 518 RLRIIHRDLKASNVLLDHE----MNPKISDFGLART 549 (717)
Q Consensus 518 ~~~ivHrDlkp~NIll~~~----~~~kl~Dfgla~~ 549 (717)
...++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3469999999999999874 6789999998875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=84.42 E-value=0.45 Score=48.84 Aligned_cols=31 Identities=29% Similarity=0.326 Sum_probs=26.2
Q ss_pred CcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 519 LRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 519 ~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
..++|+|+++.|||++.+..+.|+||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 4599999999999998876567999988753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=82.92 E-value=0.97 Score=46.38 Aligned_cols=29 Identities=31% Similarity=0.475 Sum_probs=25.2
Q ss_pred CcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 519 LRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 519 ~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 4589999999999999 4 889999988764
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=82.66 E-value=39 Score=33.25 Aligned_cols=74 Identities=15% Similarity=0.238 Sum_probs=44.6
Q ss_pred EEEEEeeeCCCCeEEEeeCCCCC--Cc----CCcceEEEecCCCEEEEcCCCcEEEEeccccCcCCcEEEEEccCCCeEE
Q 039318 29 YVGIWYKNMPVKTVVWVANRINP--IN----DSSGVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVL 102 (717)
Q Consensus 29 ~lgIw~~~~~~~tvvW~ANr~~p--~~----~~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl 102 (717)
.+.|| ....-+++|......+ +. .+++.+-++.++.+...|.+|..+|....... .....+..+.+||+++
T Consensus 16 ~v~~~--d~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~-~~~~~~~~~~dG~~lv 92 (276)
T 3no2_A 16 KIAII--NKDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAG-CEMQTARILPDGNALV 92 (276)
T ss_dssp EEEEE--ETTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTT-CEEEEEEECTTSCEEE
T ss_pred EEEEE--ECCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCC-ccccccEECCCCCEEE
Confidence 35665 2335678899887652 11 12334444545555556778999999986421 1122366788899988
Q ss_pred Eec
Q 039318 103 RGE 105 (717)
Q Consensus 103 ~~~ 105 (717)
.+.
T Consensus 93 ~~~ 95 (276)
T 3no2_A 93 AWC 95 (276)
T ss_dssp EEE
T ss_pred Eec
Confidence 754
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=81.40 E-value=0.81 Score=36.54 Aligned_cols=35 Identities=29% Similarity=0.584 Sum_probs=28.3
Q ss_pred cccChhhHHHhhcCCCCccccccccccCCCceeEEEec
Q 039318 330 KSMNLKECREKCLENSSCMAYTNSDITRGGSGCVMWFG 367 (717)
Q Consensus 330 ~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~g~gc~~~~g 367 (717)
..+++++|++.|+.+=.|.||.|. .....|.+..+
T Consensus 28 ~~~sl~~Cq~aC~a~~~C~aFTyN---~~s~~CflKs~ 62 (82)
T 2ll3_A 28 RASSLSECRARCQAEKECSHYTYN---VKSGLCYPKRG 62 (82)
T ss_dssp ECSSHHHHHHHHHHCTTEEEEEEE---TTTTEEEEEES
T ss_pred cCCCHHHHHHHhhccCCCCeEEec---cCCCceEcccC
Confidence 356899999999999999999984 23455988765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=80.33 E-value=1.2 Score=46.56 Aligned_cols=30 Identities=20% Similarity=0.407 Sum_probs=25.0
Q ss_pred CcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 519 LRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 519 ~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
..++|+|+++.|||++.+. +.|+||..+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 4599999999999998654 89999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 717 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-52 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-45 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-41 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-37 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-31 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-31 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-28 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-19 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-19 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 6e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-16 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 4e-13 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 5e-11 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 5e-11 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 8e-11 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 5e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-57
Identities = 62/277 (22%), Positives = 114/277 (41%), Gaps = 46/277 (16%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADG--------------------QEIA------HRNLV 457
++ +++G G FG VYKG E+ H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS 517
+G + ++ ++ SL + + K I TA+G+ YLH S
Sbjct: 68 LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYA--- 574
IIHRDLK++N+ L ++ KI DFGLA +++ G+ +MAPE
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 575 SDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634
+S +SDV++FGI+L E+++G+ Y + N + I + + + L
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQI--IFMVGRGYLSPDLSKVRS 236
Query: 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
+ ++ C++ ++RP P ++ +
Sbjct: 237 NCPKAMKRLMA------ECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 5e-54
Identities = 75/291 (25%), Positives = 121/291 (41%), Gaps = 56/291 (19%)
Query: 406 NEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA------------- 452
++ E+P + + ++LG G FG V+ G ++A
Sbjct: 5 EDEWEVPR----------ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA 54
Query: 453 ------------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRF 500
H+ LV+L Q E +I E+M N SL F+ + KL +K
Sbjct: 55 FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKL-TINKLL 112
Query: 501 CIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTK 560
+ A G+ ++ + IHRDL+A+N+L+ ++ KI+DFGLAR +E
Sbjct: 113 DMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE- 168
Query: 561 RVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKL 620
+ APE + G F++KSDV+SFGILL EIV+ + Y N +I + +
Sbjct: 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNLERG 226
Query: 621 WNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
+ P + + LC + PEDRP + +L
Sbjct: 227 YRMVRPDNCPE-------------ELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 5e-53
Identities = 57/295 (19%), Positives = 106/295 (35%), Gaps = 52/295 (17%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVK 458
+ + +G+G FG V++G G+E+A H N++
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 459 LLGCCIQGEEKL----LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH 514
+ + L+ ++ + SL ++ R + + TA GL +LH
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLH 117
Query: 515 HD-----SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF--VGDEIEGSTKRVVGTYG 567
+ + I HRDLK+ N+L+ I+D GLA D I+ + VGT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 568 YMAPEYASDGL------FSVKSDVFSFGILLLEIVSGKKNRGFYHSDK----NLNLIGHA 617
YMAPE D + ++D+++ G++ EI G + + +L +
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 618 WKLWNNGMPSQLIDAYYQESCNLAEVIRCIH-VGLLCVQHHPEDRPCMPSVILML 671
+ + Q + E +R + + C + R + L
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 8e-53
Identities = 64/274 (23%), Positives = 107/274 (39%), Gaps = 48/274 (17%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVK 458
+ +++G G FG V+ G + ++A H LV+
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
L G C++ L++EFM + L ++ Q + G+ +
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGM---AYLEE 119
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL 578
+IHRDL A N L+ K+SDFG+ R FV D+ S+ + +PE S
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 579 FSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637
+S KSDV+SFG+L+ E+ S GK + + + I ++L+ + S
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST--------- 229
Query: 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
+ C + PEDRP ++ L
Sbjct: 230 -------HVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 4e-52
Identities = 70/287 (24%), Positives = 118/287 (41%), Gaps = 47/287 (16%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVK 458
++ + KLG+G FG V+ GT +A H LV+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
L + E ++ E+M SL F+ + K L + + A G+ Y+
Sbjct: 77 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER--- 131
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL 578
+ +HRDL+A+N+L+ + K++DFGLAR + D + + + APE A G
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 579 FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638
F++KSDV+SFGILL E+ + + Y N ++ + + P + +
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQVERGYRMPCPPECPE------- 241
Query: 639 NLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPK-QPG 684
+ C + PE+RP + L +P+ QPG
Sbjct: 242 ------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-51
Identities = 52/206 (25%), Positives = 83/206 (40%), Gaps = 37/206 (17%)
Query: 422 ATDNFSINKKLGEGGFGPVYKGT-LADGQEIA---------------------------H 453
D+F +LG G G V+K + G +A
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 454 RNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYL 513
+V G E + E M SLD + K + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEY 573
+ +I+HRD+K SN+L++ K+ DFG++ I+ VGT YM+PE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 574 ASDGLFSVKSDVFSFGILLLEIVSGK 599
+SV+SD++S G+ L+E+ G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 6e-51
Identities = 59/273 (21%), Positives = 102/273 (37%), Gaps = 46/273 (16%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVK 458
+ + K+LG G FG V G ++A H LV+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
L G C + +I E+M N L +++ + R + + + YL
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK-- 119
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL 578
+ +HRDL A N L++ + K+SDFGL+R + DE S + PE
Sbjct: 120 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSK 177
Query: 579 FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638
FS KSD+++FG+L+ EI S K ++ + N ++ I +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLYR 222
Query: 639 NLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
+ + C ++RP ++ +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-50
Identities = 72/306 (23%), Positives = 108/306 (35%), Gaps = 71/306 (23%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA------------------------------- 452
+N K LG G FG V T +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 453 ---HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKR------------------ 491
H N+V LLG C LI+E+ L +++ + ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 492 --KLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549
+L + C A+G+ +L +HRDL A NVL+ H KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 550 FVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDK 609
+ D +MAPE +G++++KSDV+S+GILL EI S +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYPGIPV 272
Query: 610 NLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669
+ N +KL NG +E + C RP P++
Sbjct: 273 DANF----YKLIQNGFKMDQPFYATEEIYIIM---------QSCWAFDSRKRPSFPNLTS 319
Query: 670 MLGSEI 675
LG ++
Sbjct: 320 FLGCQL 325
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (445), Expect = 2e-50
Identities = 65/311 (20%), Positives = 114/311 (36%), Gaps = 72/311 (23%)
Query: 415 ELATIANATDNFSINKKLGEGGFGPVYKGTL------ADGQEIA---------------- 452
+L ++ +N + +GEG FG V++ +A
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 453 -----------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKL-------- 493
+ N+VKLLG C G+ L++E+M L+ F+ + +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 494 -------------LDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPK 540
L +++ CI A G+ YL + +HRDL N L+ M K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 541 ISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKK 600
I+DFGL+R + + +M PE ++ +SDV+++G++L EI S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 601 NRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPED 660
Y+ + +I + +C + ++ LC P D
Sbjct: 241 Q--PYYGMAHEEVI-------------YYVRDGNILACPENCPLELYNLMRLCWSKLPAD 285
Query: 661 RPCMPSVILML 671
RP S+ +L
Sbjct: 286 RPSFCSIHRIL 296
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 9e-50
Identities = 65/273 (23%), Positives = 97/273 (35%), Gaps = 50/273 (18%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA------------------------HRNLVKL 459
+ + +G+G FG V G G ++A H NLV+L
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 460 LGCCIQGEEKL-LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
LG ++ + L ++ E+M SL ++ + R +L + YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---G 121
Query: 519 LRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGL 578
+HRDL A NVL+ + K+SDFGL + E + + APE +
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKK 176
Query: 579 FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638
FS KSDV+SFGILL EI S + Y +++ G D
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVV----PRVEKGYKMDAPDGCPPA-- 228
Query: 639 NLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
V C RP + L
Sbjct: 229 -------VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-48
Identities = 68/301 (22%), Positives = 103/301 (34%), Gaps = 66/301 (21%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLA------DGQEIA------------------------- 452
+ S K LG G FG V + T +A
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 453 ---HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKL---------------L 494
H N+V LLG C G L+I E+ L +F+ + + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 495 DWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554
D A+G+ +L IHRDL A N+LL H KI DFGLAR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLI 614
+MAPE + +++ +SDV+S+GI L E+ S + + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-----YPGMPVD 254
Query: 615 GHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674
+K+ G + E + C P RP ++ ++ +
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAE---------MYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
Query: 675 I 675
I
Sbjct: 306 I 306
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 3e-48
Identities = 65/279 (23%), Positives = 105/279 (37%), Gaps = 52/279 (18%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------HR 454
+++ + +G G +G K +DG+ + H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 455 NLVKLLGCCIQGEEKLL--IYEFMPNRSLDSFIFDQTK-RKLLDWSKRFCIICGTARGLL 511
N+V+ I L + E+ L S I TK R+ LD ++ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 512 YLH--HDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYM 569
H D ++HRDLK +NV LD + N K+ DFGLAR + K VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYM 181
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629
+PE + ++ KSD++S G LL E+ + + + L G + +P +
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELAGKIREGKFRRIPYRY 238
Query: 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVI 668
S L E+I + RP + ++
Sbjct: 239 -------SDELNEIITR------MLNLKDYHRPSVEEIL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (429), Expect = 4e-48
Identities = 71/310 (22%), Positives = 116/310 (37%), Gaps = 65/310 (20%)
Query: 414 FELATIANATDNFS---------INKKLGEGGFGPVYKGTLADG---------------- 448
F A F+ I + +G G FG V G L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 449 ---------------QEIAHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKL 493
+ H N++ L G + ++I EFM N SLDSF+ +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 494 LDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553
+ ++ G A G+ YL + +HRDL A N+L++ + K+SDFGL+R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 554 EIEGSTKRVVG---TYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKN 610
+ + +G + APE F+ SDV+S+GI++ E++S + Y N
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--PYWDMTN 239
Query: 611 LNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670
++I I+ Y+ + + L C Q RP ++
Sbjct: 240 QDVI-------------NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 671 LGSEIMLPQP 680
L + M+ P
Sbjct: 287 L--DKMIRNP 294
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (427), Expect = 5e-48
Identities = 65/274 (23%), Positives = 105/274 (38%), Gaps = 46/274 (16%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA-------------------------HRNLV 457
+ ++ KLG G +G VY+G +A H NLV
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS 517
+LLG C + +I EFM +L ++ + R+ + + + + YL
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE--- 132
Query: 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDG 577
+ IHRDL A N L+ K++DFGL+R GD + APE +
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYN 191
Query: 578 LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637
FS+KSDV++FG+LL EI + + Y + +L++ Y+
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQVY-------------ELLEKDYRME 236
Query: 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
+ + C Q +P DRP +
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 8e-48
Identities = 67/283 (23%), Positives = 106/283 (37%), Gaps = 60/283 (21%)
Query: 415 ELATIANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA--------------------- 452
EL + FS +++G G FG VY + + + +A
Sbjct: 6 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 453 --------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIIC 504
H N ++ GC ++ L+ E+ + D +K L + +
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTH 122
Query: 505 GTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVG 564
G +GL YLH +IHRD+KA N+LL K+ DFG A VG
Sbjct: 123 GALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVG 173
Query: 565 TYGYMAPEYA---SDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLW 621
T +MAPE +G + K DV+S GI +E+ K N+N + + +
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSALYHIA 227
Query: 622 NNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCM 664
N P+ + + N + C+Q P+DRP
Sbjct: 228 QNESPALQSGHWSEYFRNFVD---------SCLQKIPQDRPTS 261
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-47
Identities = 64/277 (23%), Positives = 106/277 (38%), Gaps = 54/277 (19%)
Query: 429 NKKLGEGGFGPVYKGTLADG-------------------------------QEIAHRNLV 457
N+ +G G FG VY GTL D ++ +H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 458 KLLGCCIQGEEK-LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD 516
LLG C++ E L++ +M + L +FI ++T + F + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFL 146
Query: 517 SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR--VVGTYGYMAPEYA 574
+ + +HRDL A N +LD + K++DFGLAR E + + +MA E
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 575 SDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634
F+ KSDV+SFG+LL E+++ Y ++ + + P D
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPD--- 261
Query: 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
V L C E RP ++ +
Sbjct: 262 ----------PLYEVMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-47
Identities = 61/273 (22%), Positives = 101/273 (36%), Gaps = 49/273 (17%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA---------------------------HRN 455
+++ + + LGEG +G V + +A H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 456 LVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHH 515
+VK G +G + L E+ L I + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 516 DSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYAS 575
+ I HRD+K N+LLD N KISDFGLA F + E ++ GT Y+APE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 576 DGLF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634
F + DV+S GI+L +++G+ + + + P + ID+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWKEKKTYLNPWKKIDS-- 234
Query: 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSV 667
++ + +P R +P +
Sbjct: 235 ----APLALLHK------ILVENPSARITIPDI 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-47
Identities = 67/282 (23%), Positives = 107/282 (37%), Gaps = 53/282 (18%)
Query: 422 ATDNFSI-NKKLGEGGFGPVYKGTLA---DGQEIA------------------------- 452
DN I + +LG G FG V +G ++A
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 453 --HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGL 510
+ +V+L+G C Q E +L+ E L F+ KR+ + S ++ + G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKR-VVGTYGYM 569
YL +HRDL A NVLL + KISDFGL++ D+ + + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629
APE + FS +SDV+S+G+ + E +S + Y K ++ G +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVM----AFIEQGKRMEC 233
Query: 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
E L C + EDRP +V +
Sbjct: 234 PPECPPELYALM---------SDCWIYKWEDRPDFLTVEQRM 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-46
Identities = 65/322 (20%), Positives = 120/322 (37%), Gaps = 55/322 (17%)
Query: 419 IANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA------------------------- 452
I T+ F K LG G FG VYKG + +G+++
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 453 ------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGT 506
+ ++ +LLG C+ LI + MP L ++ + + +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQI 120
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
A+G+ YL R++HRDL A NVL+ + KI+DFGLA+ +E E +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 567 GYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626
+MA E +++ +SDV+S+G+ + E+++ +
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEI 222
Query: 627 SQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQPGFL 686
S +++ + I + + C + RP +I+ PQ +
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ-RYLVIQ 281
Query: 687 ADRKSTGPNSSSSMLESSSTNT 708
D + P+ + S + +
Sbjct: 282 GDERMHLPSPTDSNFYRALMDE 303
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-46
Identities = 64/288 (22%), Positives = 115/288 (39%), Gaps = 53/288 (18%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQE--------------------------------I 451
+ K +G G FG VYKG L
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 452 AHRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLL 511
+H N+++L G + + ++I E+M N +LD F+ + K + ++ G A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGM- 123
Query: 512 YLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD-EIEGSTKRVVGTYGYMA 570
+ + + +HRDL A N+L++ + K+SDFGL+R D E +T + A
Sbjct: 124 --KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 571 PEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630
PE S F+ SDV+SFGI++ E+++ + + S+ + + I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---------------MKAI 226
Query: 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLP 678
+ ++ + + + C Q RP ++ +L I P
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-46
Identities = 65/275 (23%), Positives = 105/275 (38%), Gaps = 54/275 (19%)
Query: 429 NKKLGEGGFGPVYKGTLAD---GQEIA----------------------------HRNLV 457
+K+LG G FG V KG + +A + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS 517
+++G C + E +L+ E L+ ++ + + + ++ + G+ YL
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES- 126
Query: 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTK-RVVGTYGYMAPEYASD 576
+HRDL A NVLL + KISDFGL++ DE + + APE +
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 577 GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636
FS KSDV+SFG+L+ E S + Y K + + G +E
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVT----AMLEKGERMGCPAGCPRE 238
Query: 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
+ LC + E+RP +V L L
Sbjct: 239 ---------MYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 3e-46
Identities = 71/333 (21%), Positives = 113/333 (33%), Gaps = 79/333 (23%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADG------------------------QEIA------- 452
++ +GEG FG V K + E+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFI-------------FDQTKRKLLDWSKR 499
H N++ LLG C L E+ P+ +L F+ + L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 500 FCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559
ARG+ YL + IHRDL A N+L+ KI+DFGL+R G E+
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183
Query: 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWK 619
+MA E + +++ SDV+S+G+LL EIVS Y L +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEKLPQ 241
Query: 620 LWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQ 679
+ P D + C + P +RP +++ L ML +
Sbjct: 242 GYRLEKPLNCDD-------------EVYDLMRQCWREKPYERPSFAQILVSL--NRMLEE 286
Query: 680 PKQPGFLADRKSTGPNSSSSMLESSSTNTITIS 712
K ++++ E + I S
Sbjct: 287 RK------------TYVNTTLYEKFTYAGIDCS 307
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-46
Identities = 64/276 (23%), Positives = 113/276 (40%), Gaps = 53/276 (19%)
Query: 421 NATDNFSINKKLGEGGFGPVYKGTLADGQEIA---------------------------H 453
N D + I +LG+G FG VYK + +A H
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 454 RNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYL 513
N+VKLL ++ EF ++D+ + + + L S+ + T L YL
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYL 126
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEY 573
H +IIHRDLKA N+L + + K++DFG++ + +GT +MAPE
Sbjct: 127 H---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEV 181
Query: 574 A-----SDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628
D + K+DV+S GI L+E+ + +H + ++ K+ + P+
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVL---LKIAKSEPPTL 235
Query: 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCM 664
+ + S N + ++ C++ + + R
Sbjct: 236 AQPSRW--SSNFKDFLKK------CLEKNVDARWTT 263
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-45
Identities = 68/302 (22%), Positives = 119/302 (39%), Gaps = 59/302 (19%)
Query: 424 DNFSINKKLGEGGFGPVYKGTL------ADGQEIA------------------------- 452
+ +++++LG+G FG VY+G +A
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 453 --HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIF-------DQTKRKLLDWSKRFCII 503
++V+LLG QG+ L+I E M L S++ + SK +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 504 CGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVV 563
A G+ YL+ + + +HRDL A N ++ + KI DFG+ R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 564 GTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNN 623
+M+PE DG+F+ SDV+SFG++L EI + + Y N ++ +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVLRFVMEGGLL 254
Query: 624 GMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQP 683
P D + +C Q++P+ RP +I + E M P ++
Sbjct: 255 DKPDNCPD-------------MLFELMRMCWQYNPKMRPSFLEIISSI-KEEMEPGFREV 300
Query: 684 GF 685
F
Sbjct: 301 SF 302
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-45
Identities = 70/298 (23%), Positives = 105/298 (35%), Gaps = 65/298 (21%)
Query: 424 DNFSINKKLGEGGFGPVYKGT------LADGQEIA------------------------- 452
D + K LG G FG V + A + +A
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 453 ---HRNLVKLLGCCIQGEEKLLI-YEFMPNRSLDSFIFDQ-------------TKRKLLD 495
H N+V LLG C + L++ EF +L +++ + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 496 WSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555
C A+G+ +L + IHRDL A N+LL + KI DFGLAR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 556 EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIG 615
+MAPE D +++++SDV+SFG+LL EI S + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDE 244
Query: 616 HAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673
+ G + D E L C P RP ++ LG+
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 5e-45
Identities = 69/282 (24%), Positives = 102/282 (36%), Gaps = 54/282 (19%)
Query: 424 DNFSINKKLGEGGFGPVYKGTL----ADGQEIA--------------------------- 452
+ + +KLG+G FG V +G +A
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 453 --HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGL 510
HRNL++L G + K+ + E P SL + LL R+ + A G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGM 124
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS-TKRVVGTYGYM 569
YL R IHRDL A N+LL KI DFGL R ++ + + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 570 APEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629
APE FS SD + FG+ L E+ + + LN K+ G
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERLPR 236
Query: 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
+ Q+ +V + C H PEDRP ++ L
Sbjct: 237 PEDCPQD---------IYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 5e-45
Identities = 58/277 (20%), Positives = 108/277 (38%), Gaps = 57/277 (20%)
Query: 426 FSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------------HRNL 456
+ ++G G F VYKG + E+A H N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 457 VKLLGCCIQGEEK----LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLY 512
V+ + +L+ E M + +L +++ + K++ +GL +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQF 127
Query: 513 LHHDSRLRIIHRDLKASNVLLDHE-MNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAP 571
LH + IIHRDLK N+ + + KI D GLA K V+GT +MAP
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAP 182
Query: 572 EYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631
E + + DV++FG+ +LE+ + + Y +N I ++ +G+ D
Sbjct: 183 EMYEEK-YDESVDVYAFGMCMLEMATSEYP---YSECQNAAQI---YRRVTSGVKPASFD 235
Query: 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVI 668
+ E+I C++ + ++R + ++
Sbjct: 236 KVA--IPEVKEIIEG------CIRQNKDERYSIKDLL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 6e-45
Identities = 60/275 (21%), Positives = 96/275 (34%), Gaps = 57/275 (20%)
Query: 424 DNFSINKKLGEGGFGPVYKGTL-ADGQEIA-----------------------------H 453
++F I + LG+G FG VY +A H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 454 RNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYL 513
N+++L G LI E+ P ++ + +K D + I A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEY 573
H R+IHRD+K N+LL KI+DFG + + GT Y+ PE
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 574 ASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633
+ K D++S G+L E + GK + I + + + D
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-- 233
Query: 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVI 668
+I ++H+P RP + V+
Sbjct: 234 ---------LISR------LLKHNPSQRPMLREVL 253
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-43
Identities = 63/285 (22%), Positives = 117/285 (41%), Gaps = 51/285 (17%)
Query: 407 EDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA------------- 452
E LE L + ++ + ++ +K+G+G G VY +A GQE+A
Sbjct: 4 EILE-KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 62
Query: 453 -------------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKR 499
+ N+V L + G+E ++ E++ SL D +D +
Sbjct: 63 LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL----TDVVTETCMDEGQI 118
Query: 500 FCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST 559
+ + L +LH ++IHRD+K+ N+LL + + K++DFG ++
Sbjct: 119 AAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR 173
Query: 560 KRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWK 619
+VGT +MAPE + + K D++S GI+ +E++ G+ Y ++ L + +
Sbjct: 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRAL---YL 227
Query: 620 LWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCM 664
+ NG P S + + C+ E R
Sbjct: 228 IATNGTPELQNPEKL--SAIFRDFLNR------CLDMDVEKRGSA 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-41
Identities = 57/279 (20%), Positives = 95/279 (34%), Gaps = 53/279 (18%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQE-------------------------------IA 452
+ + + +GEG FG V++G +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLY 512
H ++VKL+G + +I E L SF+ + LD + + L Y
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE 572
L R +HRD+ A NVL+ K+ DFGL+R ++ D + +MAPE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPE 179
Query: 573 YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632
+ F+ SDV+ FG+ + EI+ + ++ NG +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGERLPMPPN 233
Query: 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
+L C + P RP + L
Sbjct: 234 CPPTLYSLM---------TKCWAYDPSRRPRFTELKAQL 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 7e-41
Identities = 69/297 (23%), Positives = 102/297 (34%), Gaps = 67/297 (22%)
Query: 424 DNFSINKKLGEGGFGPVYKGTL--------ADGQEIA----------------------- 452
D + K LGEG FG V ++A
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 453 -----HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQ-------------TKRKLL 494
H+N++ LLG C Q +I E+ +L ++ + + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 495 DWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554
ARG+ YL + IHRDL A NVL+ + KI+DFGLAR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLI 614
T +MAPE D +++ +SDV+SFG+LL EI + + + L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--- 246
Query: 615 GHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
+KL G E + C P RP ++ L
Sbjct: 247 ---FKLLKEGHRMDKPSNCTNE---------LYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 5e-40
Identities = 53/206 (25%), Positives = 83/206 (40%), Gaps = 36/206 (17%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA-----------------------------H 453
++F K LGEG F V LA +E A H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 454 RNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYL 513
VKL E+ + N L +I K D + C TA + L
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDET---CTRFYTAEIVSAL 121
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEY 573
+ IIHRDLK N+LL+ +M+ +I+DFG A+ + + VGT Y++PE
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 574 ASDGLFSVKSDVFSFGILLLEIVSGK 599
++ SD+++ G ++ ++V+G
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 145 bits (368), Expect = 4e-39
Identities = 60/268 (22%), Positives = 101/268 (37%), Gaps = 50/268 (18%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA--------------------------HRNL 456
D++ I+++LG G FG V++ T A G A H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 457 VKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD 516
V L E ++IYEFM L + D+ + + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 517 SRLRIIHRDLKASNVLLDHEMNP--KISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYA 574
+H DLK N++ + + K+ DFGL + S K GT + APE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197
Query: 575 SDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634
+D++S G+L ++SG G + D+ L + ++ S +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI----- 252
Query: 635 QESCNLAEVIRCIHVGLLCVQHHPEDRP 662
S + + IR + P R
Sbjct: 253 --SEDGKDFIRK------LLLADPNTRM 272
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 141 bits (356), Expect = 2e-37
Identities = 56/268 (20%), Positives = 96/268 (35%), Gaps = 50/268 (18%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA--------------------------HRNL 456
D + I ++LG G FG V++ A G+ H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 457 VKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD 516
+ L E +LI EF+ L I + + + ++ + GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMH-- 144
Query: 517 SRLRIIHRDLKASNVLLDHEMNP--KISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYA 574
I+H D+K N++ + + KI DFGLA DEI K T + APE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 575 SDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634
+D+++ G+L ++SG + + +L + + DA+
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS---PFAGEDDLETL----QNVKRCDWEFDEDAFS 253
Query: 635 QESCNLAEVIRCIHVGLLCVQHHPEDRP 662
S + I+ +Q P R
Sbjct: 254 SVSPEAKDFIKN------LLQKEPRKRL 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-36
Identities = 47/267 (17%), Positives = 94/267 (35%), Gaps = 49/267 (18%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA-------------------------HRNLV 457
+ + I + LG G FG V++ + + HRN++
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS 517
L EE ++I+EF+ + I T L+ + + L +LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLH--- 119
Query: 518 RLRIIHRDLKASNVLLDHEMNP--KISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYAS 575
I H D++ N++ + KI +FG AR + + + + Y APE
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEVHQ 176
Query: 576 DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQ 635
+ S +D++S G L+ ++SG + + + I +A ++ ++
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI------ 230
Query: 636 ESCNLAEVIRCIHVGLLCVQHHPEDRP 662
S + + + + R
Sbjct: 231 -SIEAMDFVDR------LLVKERKSRM 250
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (347), Expect = 3e-36
Identities = 59/273 (21%), Positives = 100/273 (36%), Gaps = 58/273 (21%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA------------------------------ 452
++FS+++ +G GGFG VY AD G+ A
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 453 --HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGL 510
+V + ++ I + M L + + + + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMA 570
++H+ +++RDLK +N+LLD + +ISD GLA F + VGT+GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 571 PEYASDGL-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629
PE G+ + +D FS G +L +++ G H K+ + I +P
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
S L ++ +Q R
Sbjct: 233 -------SPELRSLLEG------LLQRDVNRRL 252
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-36
Identities = 60/277 (21%), Positives = 103/277 (37%), Gaps = 56/277 (20%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA------------------------------ 452
++F ++K LG+G FG V+ Q A
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLY 512
H L + E + E++ L I D S+ GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE 572
LH I++RDLK N+LLD + + KI+DFG+ + + + + +T GT Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 573 YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632
++ D +SFG+LL E++ G+ F+ ++ + H+ ++ N P L
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFH--GQDEEELFHSIRMDNPFYPRWL--- 226
Query: 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669
+++ PE R + I
Sbjct: 227 ----EKEAKDLLVK------LFVREPEKRLGVRGDIR 253
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 135 bits (341), Expect = 4e-36
Identities = 55/282 (19%), Positives = 105/282 (37%), Gaps = 65/282 (23%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA------------------------------ 452
+N+ + LG G V + +E A
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 453 ------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGT 506
H N+++L L+++ M L ++ T++ L + I+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTY 566
+ LH +L I+HRDLK N+LLD +MN K++DFG + E + V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 567 GYMAPEYASDGL------FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKL 620
Y+APE + + + D++S G+++ +++G F+H + L L ++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS--PPFWHRKQMLML-----RM 226
Query: 621 WNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
+G + S + +++ + P+ R
Sbjct: 227 IMSGNYQFGSPEWDDYSDTVKDLVSR------FLVVQPQKRY 262
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 131 bits (331), Expect = 6e-35
Identities = 53/275 (19%), Positives = 105/275 (38%), Gaps = 54/275 (19%)
Query: 423 TDNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------- 452
+D + + + LG GG V+ L +++A
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 453 HRNLVKLLGCCI----QGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTAR 508
H +V + G ++ E++ +L + + + + +I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV-GDEIEGSTKRVVGTYG 567
L + H + IIHRD+K +N+++ K+ DFG+AR T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627
Y++PE A +SDV+S G +L E+++G+ + D +++ + + +P
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVSVA--YQHVREDPIPP 234
Query: 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
S +L V+ + +PE+R
Sbjct: 235 SARHEGL--SADLDAVVLK------ALAKNPENRY 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 131 bits (331), Expect = 2e-34
Identities = 54/238 (22%), Positives = 93/238 (39%), Gaps = 41/238 (17%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA-----------------------------H 453
+F I + LG G FG V+ +G+ A H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 454 RNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYL 513
++++ G ++ +I +++ L S + + +C L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LAL 117
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEY 573
+ II+RDLK N+LLD + KI+DFG A+ + T + GT Y+APE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 172
Query: 574 ASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631
S ++ D +SFGIL+ E+++G ++ K I +A + + D
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 230
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (326), Expect = 5e-34
Identities = 47/281 (16%), Positives = 86/281 (30%), Gaps = 47/281 (16%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA------------------------HRNLVK 458
+ + + +K+G G FG +Y GT +A G+E+A +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 459 LLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSR 518
+ C + ++ + SL+ +++ + + Y+H
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH---S 121
Query: 519 LRIIHRDLKASNVL---LDHEMNPKISDFGLARTFVGDEIEG-----STKRVVGTYGYMA 570
IHRD+K N L I DFGLA+ + K + GT Y +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 571 PEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630
S + D+ S G +L+ G + + + L
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
Y E A + C +D+P + +
Sbjct: 242 KGYPSE---FATYLNF------CRSLRFDDKPDYSYLRQLF 273
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 1e-33
Identities = 56/289 (19%), Positives = 98/289 (33%), Gaps = 47/289 (16%)
Query: 418 TIANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA------------------------ 452
+ + ++ +GEG +G V + +A
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 453 ---HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARG 509
H N++ + + + ++ + + ++ K + L + RG
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 510 LLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGST-KRVVGTYGY 568
L Y+H ++HRDLK SN+LL+ + KI DFGLAR D V T Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 569 MAPEYASDGLFSVKS-DVFSFGILLLEIVSGKKNRGFYHSDKNLNLI---------GHAW 618
APE + KS D++S G +L E++S + H LN I
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 619 KLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLL-----CVQHHPEDRP 662
+ N + L+ ++ + L + +P R
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (322), Expect = 2e-33
Identities = 50/270 (18%), Positives = 81/270 (30%), Gaps = 47/270 (17%)
Query: 421 NATDNFSINKKLGEGGFGPVYKGT-LADGQEIA--------------------------- 452
+ D + LG G F V + +A
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 453 HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLY 512
H N+V L G LI + + L I ++ +I + Y
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKY 122
Query: 513 LHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE 572
LH + + LD + ISDFGL++ + GT GY+APE
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPE 179
Query: 573 YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632
+ +S D +S G++ ++ G D+N + S D
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGY----PPFYDENDAKLFEQILKAEYEFDSPYWDD 235
Query: 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
S + + IR ++ PE R
Sbjct: 236 I---SDSAKDFIRH------LMEKDPEKRF 256
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 4e-33
Identities = 57/287 (19%), Positives = 101/287 (35%), Gaps = 52/287 (18%)
Query: 422 ATDNFSINKKLGEGGFGPVYKGT--LADGQEIA--------------------------- 452
A + ++GEG +G V+K G+ +A
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 453 ----HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDS---FIFDQTKRKLLDWSKRFCIICG 505
H N+V+L C + +D D+ + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 506 TARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGT 565
RGL +LH R++HRDLK N+L+ K++DFGLAR + + + VV T
Sbjct: 125 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 566 YGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK----KNRGFYHSDKNLNLIGHAWKL- 620
Y APE ++ D++S G + E+ K + K L++IG +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 621 WNNGMPSQLIDAYYQESCNLAEVIRCIHVGLL-----CVQHHPEDRP 662
W + + + + + + + I C+ +P R
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 285
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 125 bits (314), Expect = 2e-32
Identities = 34/284 (11%), Positives = 86/284 (30%), Gaps = 51/284 (17%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA-------------------------HRNLV 457
++ + +++GEG FG +++GT L + Q++A +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS 517
+ +G +L+ + + + + +H
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGP---SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE-- 119
Query: 518 RLRIIHRDLKASNVLLDHEMNP-----KISDFGLARTFVGDEIEG-----STKRVVGTYG 567
+++RD+K N L+ + + DFG+ + + + K + GT
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627
YM+ S + D+ + G + + + G + N + +
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILML 671
+L + +E + + + P + +
Sbjct: 239 ELCAGFPEE---FYKYMHY------ARNLAFDATPDYDYLQGLF 273
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 3e-32
Identities = 48/270 (17%), Positives = 95/270 (35%), Gaps = 47/270 (17%)
Query: 424 DNFSI-NKKLGEGGFGPVYKGT-LADGQEIA----------------------HRNLVKL 459
D++ + ++ LG G G V + ++ A ++V++
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRI 70
Query: 460 LGCCIQGEEK----LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHH 515
+ L++ E + L S I D+ + + I+ + YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLH- 128
Query: 516 DSRLRIIHRDLKASNVLLDHEMNP---KISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE 572
+ I HRD+K N+L + K++DFG A+ S T Y+APE
Sbjct: 129 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPE 183
Query: 573 YASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632
+ D++S G+++ ++ G ++S+ L + G
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
+ + S + +IR ++ P R
Sbjct: 241 WSEVSEEVKMLIRN------LLKTEPTQRM 264
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 4e-31
Identities = 57/281 (20%), Positives = 102/281 (36%), Gaps = 47/281 (16%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------HRNLVKLL 460
+++ K +G G FG VY+ L D G+ +A H N+V+L
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 461 GCCIQGEEK------LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH 514
EK L+ +++P ++ L + R L Y+H
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 515 HDSRLRIIHRDLKASNVLLDHE-MNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEY 573
I HRD+K N+LLD + K+ DFG A+ V E S + Y
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--ICSRYYRAPELI 194
Query: 574 ASDGLFSVKSDVFSFGILLLEIVSGKK----NRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629
++ DV+S G +L E++ G+ + G + + ++G + M
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 630 IDAYYQE--SCNLAEVIR------CIHVGLLCVQHHPEDRP 662
+ + + + +V R I + +++ P R
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 4e-31
Identities = 60/281 (21%), Positives = 100/281 (35%), Gaps = 49/281 (17%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------HR 454
+NF +K+GEG +G VYK G+ +A H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 455 NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH 514
N+VKLL + L++EF+ D + + + +GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 515 HDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYA 574
R++HRDLK N+L++ E K++DFGLAR F G + T VV +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILL 175
Query: 575 SDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHA--------WKLWNNGMP 626
+S D++S G + E+V+ + L I W + MP
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS-MP 234
Query: 627 SQLIDAYYQESCNLAEVIRCIHVGLL-----CVQHHPEDRP 662
+ ++V+ + + + P R
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI 275
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 5e-31
Identities = 58/294 (19%), Positives = 96/294 (32%), Gaps = 70/294 (23%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA------------------------------ 452
+ + LG GGFG VY G ++D +A
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 453 ----HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTAR 508
+++LL + + +LI E T+R L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHE-MNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
+ + H+ ++HRD+K N+L+D K+ DFG + GT
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 174
Query: 568 YMAPEY-ASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626
Y PE+ + V+S GILL ++V G F H ++ I + +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHDEE----IIRGQVFFRQRVS 228
Query: 627 SQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM-LGSEIMLPQ 679
S+ +IR C+ P DRP + +++LPQ
Sbjct: 229 SECQH-----------LIRW------CLALRPSDRPTFEEIQNHPWMQDVLLPQ 265
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 6e-31
Identities = 54/279 (19%), Positives = 97/279 (34%), Gaps = 59/279 (21%)
Query: 421 NATDNFSINKKLGEGGFGPVYKGT-LADGQEIA--------------------------- 452
N D + ++LG G F V K + G + A
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 453 -----HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTA 507
H N++ L + +LI E + L F+ +++ L + +
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQIL 123
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP----KISDFGLARTFVGDEIEGSTKRVV 563
G+ ++ L+I H DLK N++L P KI DFGLA + K +
Sbjct: 124 NGV---YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIF 177
Query: 564 GTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNN 623
GT ++APE + +++D++S G++ ++SG + L + + +
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237
Query: 624 GMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
S S + IR + P+ R
Sbjct: 238 EYFSNT-------SALAKDFIRR------LLVKDPKKRM 263
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 119 bits (298), Expect = 2e-30
Identities = 59/282 (20%), Positives = 96/282 (34%), Gaps = 49/282 (17%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA----------------------------HRN 455
+ + +K+GEG +G VYK G+ A H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 456 LVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHH 515
+VKL + +L++E + L+ + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH- 117
Query: 516 DSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE-YA 574
R++HRDLK N+L++ E KI+DFGLAR F + T Y AP+
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLM 173
Query: 575 SDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHA-----WKLWNNG--MPS 627
+S D++S G + E+V+G L I K W N +P
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 628 QLIDAYYQESCNLAEVIRCIHVGLL-----CVQHHPEDRPCM 664
+ E ++ + + ++ P R
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 8e-29
Identities = 61/280 (21%), Positives = 96/280 (34%), Gaps = 58/280 (20%)
Query: 430 KKLGEGGFGPVYKGT-LADGQEIA-------------------------------HRNLV 457
LGEG F VYK Q +A H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 458 KLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS 517
LL L+++FM + +L S + T +GL YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASD- 576
I+HRDLK +N+LLD K++DFGLA++F + V T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 577 GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636
++ V D+++ G +L E++ F D +L+ + ++ Q D
Sbjct: 176 RMYGVGVDMWAVGCILAELLLR---VPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 637 SCNLAEVIRCIHVGLL--------------CVQHHPEDRP 662
+ I + + +P R
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 272
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 2e-28
Identities = 45/238 (18%), Positives = 86/238 (36%), Gaps = 38/238 (15%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA-----------------------------H 453
++F K LG+G FG V A G+ A H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 454 RNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYL 513
L L + + E+ L + ++ ++ + A + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG---AEIVSAL 118
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEY 573
+ +++RD+K N++LD + + KI+DFGL + + D + K GT Y+APE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176
Query: 574 ASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631
D + D + G+++ E++ G+ ++ LI + + +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 234
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 9e-28
Identities = 48/216 (22%), Positives = 82/216 (37%), Gaps = 46/216 (21%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------HR 454
+ K+G+G FG V+K GQ++A H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 455 NLVKLLGCCIQGEEK--------LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGT 506
N+V L+ C L+++F + + + L KR +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQML-- 126
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF--VGDEIEGSTKRVVG 564
L L++ R +I+HRD+KA+NVL+ + K++DFGLAR F + V
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 565 TYGYMAPE-YASDGLFSVKSDVFSFGILLLEIVSGK 599
T Y PE + + D++ G ++ E+ +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (274), Expect = 3e-27
Identities = 49/283 (17%), Positives = 96/283 (33%), Gaps = 53/283 (18%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------HR 454
+ +K+GEG +G V+K + +A H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 455 NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH 514
N+V+L ++ L++EF F + + L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 515 HDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYA 574
++HRDLK N+L++ K+++FGLAR F G + + VV +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 575 SDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY- 633
L+S D++S G + E+ + R + + + + ++L Q
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAG--RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 634 ---------YQESCNLAEVIRCIHVGLL-----CVQHHPEDRP 662
Y + +L V+ ++ ++ +P R
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 107 bits (267), Expect = 7e-26
Identities = 57/290 (19%), Positives = 98/290 (33%), Gaps = 46/290 (15%)
Query: 400 QENEDQNEDLELPLFELATIANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA------ 452
+ ED + E P A + D F K LG G FG V G A
Sbjct: 21 KAKEDFLKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 453 -----------------------HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQT 489
LVKL ++ E++ + S +
Sbjct: 77 QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--- 133
Query: 490 KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLART 549
+ YLH L +I+RDLK N+L+D + +++DFG A+
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK- 189
Query: 550 FVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDK 609
++G T + GT +APE ++ D ++ G+L+ E+ +G +
Sbjct: 190 ----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
Query: 610 NLNLIGHAWKLWNNGMPSQLIDAYYQE-SCNLAEVIRCIHVGLLCVQHHP 658
I + + S L D +L + + G+ +++H
Sbjct: 246 IYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 104 bits (261), Expect = 3e-25
Identities = 48/289 (16%), Positives = 104/289 (35%), Gaps = 44/289 (15%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA------------------------HRNLVK 458
D++ + +KLG G + V++ + + +++ N++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 94
Query: 459 LLGCCIQGEEKL--LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD 516
L + L++E + N + L + + L Y H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS- 147
Query: 517 SRLRIIHRDLKASNVLLDHE-MNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYAS 575
+ I+HRD+K NV++DHE ++ D+GLA + + V + + PE
Sbjct: 148 --MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLV 202
Query: 576 D-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY- 633
D ++ D++S G +L ++ K+ F+H N + + K+ ID Y
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIMLPQPKQ 682
+ +++ H E++ + L +++ +
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 309
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 4e-24
Identities = 46/207 (22%), Positives = 79/207 (38%), Gaps = 39/207 (18%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------HR 454
+ + +G G +G V G ++A H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 455 NLVKLLGCCIQGEEKLLIYEFMPNRSL-DSFIFDQTKRKLLDWSKRFCIICGTARGLLYL 513
N++ LL E +F + + K + L + ++ +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 514 HHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPE- 572
H IIHRDLK N+ ++ + KI DFGLAR + + V T Y APE
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 189
Query: 573 YASDGLFSVKSDVFSFGILLLEIVSGK 599
+ ++ D++S G ++ E+++GK
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 9e-24
Identities = 58/276 (21%), Positives = 97/276 (35%), Gaps = 57/276 (20%)
Query: 424 DNFSINKKLGEGGFGPVYKGTLA----DGQEIA--------------------------- 452
+NF + K LG G +G V+ G+ A
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 453 ----HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTAR 508
LV L + LI +++ L + + + + + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI----- 138
Query: 509 GLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGY 568
+L L H +L II+RD+K N+LLD + ++DFGL++ FV DE E GT Y
Sbjct: 139 -VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 569 MAPEYASDGL--FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626
MAP+ G D +S G+L+ E+++G + I P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256
Query: 627 SQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP 662
++ S ++I+ + P+ R
Sbjct: 257 QEM-------SALAKDLIQR------LLMKDPKKRL 279
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.2 bits (225), Expect = 2e-20
Identities = 47/205 (22%), Positives = 72/205 (35%), Gaps = 35/205 (17%)
Query: 424 DNFSINKKLGEGGFGPVYKGT-LADGQEIA----------------------------HR 454
+ K +G G G V + +A H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 455 NLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLH 514
N++ LL + + L Q + LD + ++ G+ +LH
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 515 HDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYA 574
IIHRDLK SN+++ + KI DFGLART V T Y APE
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVI 190
Query: 575 SDGLFSVKSDVFSFGILLLEIVSGK 599
+ D++S G ++ E+V K
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.4 bits (218), Expect = 1e-19
Identities = 44/212 (20%), Positives = 78/212 (36%), Gaps = 37/212 (17%)
Query: 418 TIANATDNFSINKKLGEGGFGPVYKGT-LADGQEIA------------------------ 452
TI + + +G G +G V G +A
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 453 ----HRNLVKLLGCCIQGEE-KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTA 507
H N++ LL + ++ + + + + K + L +I
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 508 RGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYG 567
RGL Y+H IIHRDLK SN+ ++ + KI DFGLAR + T V +
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWY 184
Query: 568 YMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
+ ++ D++S G ++ E+++G+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 87.4 bits (215), Expect = 4e-19
Identities = 36/214 (16%), Positives = 67/214 (31%), Gaps = 42/214 (19%)
Query: 426 FSINKKLGEGGFGPVYKGT-LADGQEIA-------------------------HRNLVKL 459
+ + +KLG G F V+ + + +A + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 460 LGCCIQGEEKLLIY-------------EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGT 506
KLL + F + + + + + I
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 507 ARGLLYLHHDSRLRIIHRDLKASNVLLDHE-MNPKISDFGLARTFVGDEIEGSTKRVVGT 565
GL Y+H R IIH D+K NVL++ + +A + + T
Sbjct: 135 LLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 566 YGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK 599
Y +PE + +D++S L+ E+++G
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 80.4 bits (198), Expect = 6e-19
Identities = 22/119 (18%), Positives = 47/119 (39%), Gaps = 14/119 (11%)
Query: 2 LSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVV 61
L++G L + S ++ + ++ + ++ + T VW +N V+
Sbjct: 4 LTNGEGLYA-GQSLDVEPYHFIMQEDCNLVLYDHS----TSVWASNTGILGKKGCK-AVL 57
Query: 62 NKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDY 120
GN V+ +W+++ + VL L + GN+V+ G +W + Y
Sbjct: 58 QSDGNFVVYDAEGRSLWASHSVRG-NGNYVLVLQEDGNVVIYGSD-------IWSTGTY 108
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.4 bits (187), Expect = 2e-16
Identities = 28/160 (17%), Positives = 45/160 (28%), Gaps = 46/160 (28%)
Query: 427 SINKKLGEGGFGPVYKGTLADGQEIA---------------------------------- 452
+I K +GEG V+ E
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 453 --HRNLVKLLGCCIQGEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGL 510
R L KL G + +Y + N L I + ++ + ++ +
Sbjct: 63 NEFRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEV 116
Query: 511 LYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550
+H I+H DL NVL+ E I DF +
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLV-SEEGIWIIDFPQSVEV 152
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 64.6 bits (157), Expect = 4e-13
Identities = 15/97 (15%), Positives = 28/97 (28%), Gaps = 8/97 (8%)
Query: 32 IWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVV 91
I Y + + S L + NLVL ++ V + K T
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGK--GTGCR 69
Query: 92 LQLLDSGNLVLRGERDGDSETYLWQSFD--YPSDTLL 126
L +G + + + +W S + +
Sbjct: 70 AVLQPNGRMDVL----TNQNIAVWTSGNSRSAGRYVF 102
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 58.1 bits (140), Expect = 5e-11
Identities = 25/120 (20%), Positives = 44/120 (36%), Gaps = 21/120 (17%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
+LS G L GSF + + ++ + P+ W N S L
Sbjct: 9 TLSTGEFLNY--GSFVFIMQEDCN-----LVLYDVDKPI----WATNTGGL--SRSCFLS 55
Query: 61 VNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDY 120
+ GNLV+ + + +W++N + V L N+V+ G T W + +
Sbjct: 56 MQTDGNLVVYNPSNKPIWASNTGGQNGNYV-CILQKDRNVVIYG-------TDRWATGTH 107
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 58.0 bits (140), Expect = 5e-11
Identities = 18/87 (20%), Positives = 28/87 (32%), Gaps = 7/87 (8%)
Query: 32 IWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVV 91
I + + + + SS + NLVL + VW++N + T
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVR-VWASNTAG--ATGCR 59
Query: 92 LQLLDSGNLVLRGERDGDSETYLWQSF 118
L G LV+ T W S
Sbjct: 60 AVLQSDGLLVIL----TAQNTIRWSSG 82
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 57.5 bits (138), Expect = 8e-11
Identities = 22/123 (17%), Positives = 42/123 (34%), Gaps = 19/123 (15%)
Query: 1 SLSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLV 60
L G +L G + + + + Y N VW + + VL
Sbjct: 9 QLDTGGSLAE--GGYLFIIQNDCNL------VLYDNNRA---VWASGTNGKASGC--VLK 55
Query: 61 VNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDY 120
+ GNLV+ S ++++ S + L L N+V+ +S +W +
Sbjct: 56 MQNDGNLVIYSGSRAIWASNTNRQ--NGNYYLILQRDRNVVIY----DNSNNAIWATHTN 109
Query: 121 PSD 123
+
Sbjct: 110 VGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 52.7 bits (126), Expect = 5e-09
Identities = 19/114 (16%), Positives = 36/114 (31%), Gaps = 19/114 (16%)
Query: 7 TLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGN 66
++ + + + + Y N +W N N V+ G
Sbjct: 24 EILFGTHVYRFIMQTDCNL------VLYDN---NNPIWATNTGGLGNGCR--AVLQPDGV 72
Query: 67 LVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDY 120
LV+ + VW + ++ + V L L N+V+ G LW +
Sbjct: 73 LVVITNENVTVWQSPVAGKAGHYV-LVLQPDRNVVIYG-------DALWATQTV 118
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 717 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.76 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.73 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.73 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.72 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.66 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.51 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.49 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.19 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.87 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.77 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.76 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.74 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.4 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.61 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.63 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.76 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 93.23 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 91.58 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 88.38 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 88.1 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 85.76 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 81.55 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.59 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.53 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-45 Score=374.95 Aligned_cols=227 Identities=26% Similarity=0.343 Sum_probs=182.4
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhhh---------------------------hhhhhhhcceeecCceeeEEEe
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEIA---------------------------HRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va---------------------------h~niv~l~~~~~~~~~~~lV~E 474 (717)
.++|++.+.||+|+||+||+|+.+. ++.+| |||||++++++.+++..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 3579999999999999999998753 33332 9999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
||++|+|.+++. ....+++..+..++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999993 3456899999999999999999999998 9999999999999999999999999999765444
Q ss_pred cccccceecccccccCccccccCCC-CccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
........+||+.|||||++.+..+ +.++|||||||++|||++|+.||......... .. ...........
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~~----~~~~~~~~~~~--- 228 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YS----DWKEKKTYLNP--- 228 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--HH----HHHTTCTTSTT---
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--HH----HHhcCCCCCCc---
Confidence 3334456789999999999988876 67899999999999999999999654322211 11 11111111000
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.... ...+.+|+.+||+.||++|||++|+++
T Consensus 229 -~~~~----s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 -WKKI----DSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -GGGS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0011 135568899999999999999999865
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=387.92 Aligned_cols=231 Identities=32% Similarity=0.520 Sum_probs=185.6
Q ss_pred cCcccccccccCCccceEeeeeCCch------hh----------------------------hhhhhhhhcceeecCcee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ------EI----------------------------AHRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~------~v----------------------------ah~niv~l~~~~~~~~~~ 469 (717)
++|++.++||+|+||+||+|++.... .| .|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 57999999999999999999764211 11 199999999999999999
Q ss_pred eEEEeccCCCChhhHhhhccc--------------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCC
Q 039318 470 LLIYEFMPNRSLDSFIFDQTK--------------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKAS 529 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~ 529 (717)
++|||||++|+|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999965321 235889999999999999999999998 999999999
Q ss_pred ceEEcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCC
Q 039318 530 NVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSD 608 (717)
Q Consensus 530 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~ 608 (717)
|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++ |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654443333345678999999999999999999999999999999998 89998754433
Q ss_pred CchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhc
Q 039318 609 KNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLG 672 (717)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~ 672 (717)
... .+....+.... .+......+.+|+.+||+.||++|||++||+++|.
T Consensus 274 ~~~------~~~~~~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANF------YKLIQNGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHH------HHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH------HHHHhcCCCCC---------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 211 12222221111 11111245778999999999999999999999984
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=375.82 Aligned_cols=229 Identities=28% Similarity=0.453 Sum_probs=175.3
Q ss_pred cCcccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCceeeEEEeccCC
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
++|++.+.||+|+||.||+|++.+++.|| |||||++++++.+.+..++|||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 57899999999999999999988766554 99999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
|+|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+||||++++.+||+|||+++........ .
T Consensus 85 g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~ 158 (263)
T d1sm2a_ 85 GCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-S 158 (263)
T ss_dssp CBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-e
Confidence 999999854 3456889999999999999999999998 999999999999999999999999999876443322 2
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcC-CCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhcc
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSG-KKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 637 (717)
.....||+.|+|||++.+..++.++|||||||++|||+++ ++|+.... ......... .+.... .
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~~~i~----~~~~~~--~------ 223 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDIS----TGFRLY--K------ 223 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHHHHHH----HTCCCC--C------
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---HHHHHHHHH----hcCCCC--C------
Confidence 2346789999999999999999999999999999999995 55544221 112221111 111100 0
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
+.....++.+|+.+||+.||++||||+||++.|+..
T Consensus 224 -p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 224 -PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 011124567899999999999999999999999753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-45 Score=374.36 Aligned_cols=236 Identities=25% Similarity=0.408 Sum_probs=178.4
Q ss_pred hcCcccccccccCCccceEeeeeCCch--------------------------hhhhhhhhhhcceeecCceeeEEEecc
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ--------------------------EIAHRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~--------------------------~vah~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
.++|++.++||+|+||.||+|+++..- .+.|||||++++++.+ +..+||||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~ 85 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC 85 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecC
Confidence 367999999999999999999865421 1119999999998754 5689999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
++|+|.+++... ...+++..++.++.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+........
T Consensus 86 ~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 86 EGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 999999999542 345899999999999999999999998 999999999999999999999999999876544433
Q ss_pred cccceecccccccCcccccc---CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 557 GSTKRVVGTYGYMAPEYASD---GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
.......||+.|||||++.+ ..|+.++|||||||++|||++|+.||....... .+ ......+........
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~---~~~~~~~~~~p~~~~- 233 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QI---IFMVGRGYLSPDLSK- 233 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HH---HHHHHHTSCCCCGGG-
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HH---HHHHhcCCCCCcchh-
Confidence 34456789999999999864 358999999999999999999999987433221 11 111111111111110
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
. +......+.+|+.+||+.||++|||+.||++.|+...
T Consensus 234 ~----~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 234 V----RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp S----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c----cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1 1112245778999999999999999999999997653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=372.85 Aligned_cols=219 Identities=26% Similarity=0.383 Sum_probs=180.6
Q ss_pred cCcccccccccCCccceEeeeeCCc-hhhh-----------------------------hhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QEIA-----------------------------HRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~va-----------------------------h~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||.||+|+.+.. +.+| |||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999988643 2222 999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
|||++|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999954 345899999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
......||+.|||||++.+..++.++|||||||++|||++|+.||...... ... ......... +
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~----~~i~~~~~~-~---- 223 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETY----KRISRVEFT-F---- 223 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH----HHHHTTCCC-C----
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---HHH----HHHHcCCCC-C----
Confidence 233568999999999999999999999999999999999999998643221 111 111111110 0
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
... ....+.+|+.+||+.||++|||++|+++
T Consensus 224 -p~~----~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 -PDF----VTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -Ccc----CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 011 1235678899999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-44 Score=369.14 Aligned_cols=223 Identities=25% Similarity=0.436 Sum_probs=180.7
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh--------------------------hhhhhhhcceeecCceeeEEEecc
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA--------------------------HRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va--------------------------h~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
++|++.++||+|+||.||+|+... ++.+| |||||++++++.+.+..+||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 579999999999999999998653 33332 999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
++|+|.+++.+ ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 99999998743 35899999999999999999999998 99999999999999999999999999987644322
Q ss_pred cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 557 GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+ .......... +.. ..
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~---~~~~~~~~~~-~~~---~~ 240 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RAL---YLIATNGTPE-LQN---PE 240 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH---HHHHHHCSCC-CSS---GG
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH---HHH---HHHHhCCCCC-CCC---cc
Confidence 234568999999999999999999999999999999999999998643221 111 1111111111 100 01
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
. ....+.+|+.+||+.||++|||+.|+++
T Consensus 241 ~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 K----LSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp G----SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred c----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1235678899999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-44 Score=377.70 Aligned_cols=230 Identities=27% Similarity=0.402 Sum_probs=173.3
Q ss_pred cCcccccccccCCccceEeeeeCCchh----hh---------------------------hhhhhhhcceeecCceeeEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQE----IA---------------------------HRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~----va---------------------------h~niv~l~~~~~~~~~~~lV 472 (717)
++|++.++||+|+||.||+|+++.... +| |||||++++++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 467788999999999999998753211 11 99999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
||||++|+|.+++.. ..+.+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998854 3446899999999999999999999998 99999999999999999999999999987654
Q ss_pred Cccccc---cceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 553 DEIEGS---TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 553 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
...... .....||+.|||||.+.+..++.++|||||||++|||++ |+.||...... .++ .....+...
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~----~~i~~~~~~- 252 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVI----NAIEQDYRL- 252 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH----HHHHTTCCC-
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCC-
Confidence 322211 122467899999999999999999999999999999998 89998643321 111 111121111
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
..+......+.+|+.+||+.||++|||+.||++.|+..
T Consensus 253 --------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 253 --------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 01112234577899999999999999999999999754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-45 Score=376.68 Aligned_cols=222 Identities=24% Similarity=0.314 Sum_probs=177.8
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh-----------------------------hhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA-----------------------------HRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va-----------------------------h~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||.||+|+.+. ++.+| |||||++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 579999999999999999998753 33332 999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
|||++|+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999999843 346899999999999999999999998 999999999999999999999999999977544
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
..........||+.|||||++.+..++.++|||||||++|||++|+.||..... ..... ... .... .+
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~---~i~-~~~~-~~---- 229 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQ---KII-KLEY-DF---- 229 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHH-TTCC-CC----
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---HHHHH---HHH-cCCC-CC----
Confidence 433344457899999999999999999999999999999999999999874321 11111 111 1111 11
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVI 668 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl 668 (717)
.... ..++.+|+.+||+.||++|||++|++
T Consensus 230 -p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 230 -PEKF----FPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp -CTTC----CHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred -CccC----CHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 1111 23567899999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=370.12 Aligned_cols=230 Identities=31% Similarity=0.458 Sum_probs=182.5
Q ss_pred hcCcccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCceeeEEEeccC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFMP 477 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~~ 477 (717)
.++|++.++||+|+||.||+|++++++.|| |||||++++++.+ +..++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 357899999999999999999988766554 9999999998754 56799999999
Q ss_pred CCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcccc
Q 039318 478 NRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEG 557 (717)
Q Consensus 478 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 557 (717)
+|+|.+++... ....+++..++.|+.||++||.|||+++ |+||||||+||||++++.+||+|||+|+.........
T Consensus 91 ~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 91 NGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 99999988443 2335899999999999999999999998 9999999999999999999999999999765443222
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhcc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 637 (717)
.....||+.|||||++.+..++.++|||||||++|||++|..|+... ....... ..+..+..... ...
T Consensus 167 -~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~--~~~~~~~----~~i~~~~~~~~-----p~~ 234 (272)
T d1qpca_ 167 -REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--MTNPEVI----QNLERGYRMVR-----PDN 234 (272)
T ss_dssp -CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHH----HHHHTTCCCCC-----CTT
T ss_pred -ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC--CCHHHHH----HHHHhcCCCCC-----ccc
Confidence 23467899999999999999999999999999999999966554321 1111121 12222211111 011
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
....+.+|+.+||+.||++||||++|+++|+.
T Consensus 235 ----~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 235 ----CPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 12356789999999999999999999999863
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-45 Score=376.21 Aligned_cols=233 Identities=27% Similarity=0.416 Sum_probs=186.7
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhhh-------------------------hhhhhhhcceeecCceeeEEEecc
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
.++|++.++||+|+||.||+|+++. ++.+| |||||++++++.+++..++|||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 4679999999999999999998764 33333 999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+........
T Consensus 96 ~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 96 TYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp TTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred cCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 999999999653 3456899999999999999999999998 999999999999999999999999999976544322
Q ss_pred cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 557 GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
. .....|++.|+|||++.+..++.++|||||||++|||++|..|+.... .... .......+.....
T Consensus 172 ~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--~~~~----~~~~i~~~~~~~~------- 237 (287)
T d1opja_ 172 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQ----VYELLEKDYRMER------- 237 (287)
T ss_dssp E-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHH----HHHHHHTTCCCCC-------
T ss_pred e-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--hHHH----HHHHHhcCCCCCC-------
Confidence 2 223568999999999999999999999999999999999777653221 1111 1222222221111
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
+.....++.+|+.+||+.||++|||++||+++|+...
T Consensus 238 --~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 238 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111245778999999999999999999999997643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=378.49 Aligned_cols=173 Identities=28% Similarity=0.418 Sum_probs=152.6
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hhhh---------------------------hhhhhhhcceeecCceeeEEEe
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QEIA---------------------------HRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~va---------------------------h~niv~l~~~~~~~~~~~lV~E 474 (717)
.++|++.++||+|+||.||+|+.... +.+| |||||++++++.+.++.+||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57899999999999999999987532 2222 9999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhc-CCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHD-SRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||++|+|.+++.+. +.+++..+..++.||++||.|||++ + |+||||||+||||+.++.+||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 99999999999543 4589999999999999999999974 7 999999999999999999999999999865322
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCC
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFY 605 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~ 605 (717)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||...
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 234578999999999999999999999999999999999999999654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=368.21 Aligned_cols=228 Identities=25% Similarity=0.347 Sum_probs=170.1
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh----------------------------hhhhhhhcceeec--CceeeEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------------HRNLVKLLGCCIQ--GEEKLLI 472 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va----------------------------h~niv~l~~~~~~--~~~~~lV 472 (717)
++|++.+.||+|+||.||+|+.+. ++.+| |||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 679999999999999999998754 33232 9999999999865 4568999
Q ss_pred EeccCCCChhhHhhhcc-ccccCChhhHHHHHHHHHHHHHHHhhcC--CCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 473 YEFMPNRSLDSFIFDQT-KRKLLDWSKRFCIICGTARGLLYLHHDS--RLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
||||++|+|.+++.+.. ....+++..++.++.||++||.|||+++ ..+|+||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999996432 3457999999999999999999999865 23599999999999999999999999999997
Q ss_pred ccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 550 FVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 550 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
..... .......||+.|||||++.+..++.++|||||||++|||++|+.||...... .+. ..+..+....+
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~----~~i~~~~~~~~ 234 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELA----GKIREGKFRRI 234 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH----HHHHHTCCCCC
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHH----HHHHcCCCCCC
Confidence 64332 2234578999999999999999999999999999999999999998643221 111 11112222111
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
. .. ...++.+|+.+||+.||++|||++|+++
T Consensus 235 ~-----~~----~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 P-----YR----YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp C-----TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-----cc----cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 11 1235678899999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-44 Score=364.14 Aligned_cols=228 Identities=26% Similarity=0.423 Sum_probs=187.6
Q ss_pred cCcccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCceeeEEEeccCC
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
++|++.++||+|+||.||+|++++++.|| |||||++++++.+++..++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 68999999999999999999998765554 99999999999999999999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
|+|.+++... ...+++..+++++.||++||+|||+++ |+||||||+||||++++.+||+|||+++........ .
T Consensus 84 g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~ 157 (258)
T d1k2pa_ 84 GCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-S 157 (258)
T ss_dssp EEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-C
T ss_pred CcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-e
Confidence 9999998543 446889999999999999999999998 999999999999999999999999999876544322 2
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhcc
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 637 (717)
.....||+.|+|||.+.+..++.++|||||||++|||++ |+.||+.....+ .. ..+.++.... .+ .
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~----~~i~~~~~~~--~p---~- 224 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TA----EHIAQGLRLY--RP---H- 224 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HH----HHHHTTCCCC--CC---T-
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HH----HHHHhCCCCC--Cc---c-
Confidence 234678999999999999999999999999999999998 899987543222 11 1122221111 11 1
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
.....+.+|+.+||+.||++|||++||++.|..
T Consensus 225 ---~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 ---LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ---cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 112457789999999999999999999999854
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=368.25 Aligned_cols=225 Identities=27% Similarity=0.379 Sum_probs=179.7
Q ss_pred cCcccccccccCCccceEeeeeCCc-hhhh--------------------------hhhhhhhcceeecCceeeEEEecc
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QEIA--------------------------HRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~va--------------------------h~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
+.|++.+.||+|+||.||+|+.... +.+| |||||++++++.+.+..+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5689999999999999999987542 2222 999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
++|+|.+++.+. .+.+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 999999998543 346899999999999999999999998 9999999999999999999999999998653221
Q ss_pred cccceecccccccCccccc-----cCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 557 GSTKRVVGTYGYMAPEYAS-----DGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 557 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
.......||+.|||||++. +..|+.++|||||||++|||++|+.||......+ .+. ....... ..+..
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~---~i~~~~~-~~~~~ 237 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLL---KIAKSEP-PTLAQ 237 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH---HHHHSCC-CCCSS
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHH---HHHcCCC-CCCCc
Confidence 1233578999999999984 5568999999999999999999999987543322 111 1112211 11111
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+ ......+.+|+.+||+.||++|||++|+++
T Consensus 238 ~-------~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 238 P-------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp G-------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c-------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 011235678899999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-44 Score=368.64 Aligned_cols=231 Identities=29% Similarity=0.434 Sum_probs=179.5
Q ss_pred cCcccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCceeeEEEeccCC
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
++|++.+.||+|+||.||+|++++++.|| |||||++++++.+ +..++|||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 57999999999999999999998776555 9999999999854 568999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
|+|.+++.... ...+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++........ .
T Consensus 96 g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-~ 170 (285)
T d1fmka3 96 GSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-A 170 (285)
T ss_dssp CBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred Cchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-e
Confidence 99999985532 345899999999999999999999998 999999999999999999999999999876433322 2
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhccC
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESC 638 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~ 638 (717)
.....||+.|+|||++....++.++|||||||++|||++|..|+..... ....+.. +..+..... ..
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~----i~~~~~~~~-----~~-- 237 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQ----VERGYRMPC-----PP-- 237 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHH----HHTTCCCCC-----CT--
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHH----HHhcCCCCC-----Cc--
Confidence 2346789999999999999999999999999999999997666433221 1112211 112211111 11
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 639 NLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 639 ~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
....++.+++.+||+.||++||++++|+++|+...
T Consensus 238 --~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 238 --ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred --ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 11235778999999999999999999999998765
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=364.79 Aligned_cols=228 Identities=28% Similarity=0.401 Sum_probs=180.3
Q ss_pred cCccccc-ccccCCccceEeeeeCCc---hhhh---------------------------hhhhhhhcceeecCceeeEE
Q 039318 424 DNFSINK-KLGEGGFGPVYKGTLADG---QEIA---------------------------HRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 424 ~~~~~~~-~lG~G~fg~Vy~~~~~~~---~~va---------------------------h~niv~l~~~~~~~~~~~lV 472 (717)
++|.+.+ +||+|+||.||+|.++.. ..|| |||||++++++.+ +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 5677777 499999999999976422 1122 9999999999864 568999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
||||++|+|.+++.. .+..+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999843 3456899999999999999999999998 99999999999999999999999999997654
Q ss_pred Ccc-ccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 553 DEI-EGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 553 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
... ........||+.|||||++.+..++.++|||||||++|||++ |+.||...... .+. ..+..+......
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~----~~i~~~~~~~~p 234 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM----AFIEQGKRMECP 234 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHH----HHHHTTCCCCCC
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCCCCC
Confidence 332 222334578999999999999999999999999999999998 99998754322 111 222222211111
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
. .....+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 235 -----~----~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 235 -----P----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp -----T----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -----C----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 112456789999999999999999999998864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-43 Score=367.72 Aligned_cols=229 Identities=23% Similarity=0.298 Sum_probs=171.5
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhhh---------------------------hhhhhhhcceeecCceeeEEEe
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEIA---------------------------HRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va---------------------------h~niv~l~~~~~~~~~~~lV~E 474 (717)
.+.|++.+.||+|+||.||+|+.+. ++.+| |||||++++++.+++..+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4679999999999999999998764 33222 9999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc---CCCCceecccccccccc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD---HEMNPKISDFGLARTFV 551 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~Dfgla~~~~ 551 (717)
||++|+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999943 456899999999999999999999998 99999999999994 57899999999998754
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
... .....+||+.|||||++.+..++.++|||||||++|||++|+.||...... .... ........ . .
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~---~i~~~~~~--~-~ 229 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFE---QILKAEYE--F-D 229 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH---HHHTTCCC--C-C
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHH---HHhccCCC--C-C
Confidence 332 233568999999999999999999999999999999999999998643211 1111 11111110 0 0
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH--hcC
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM--LGS 673 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~--L~~ 673 (717)
...... -...+.+|+.+||+.||++|||++|+++. +.+
T Consensus 230 ~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 230 SPYWDD----ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp TTTTTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred CccccC----CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 000111 12356789999999999999999999983 544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=355.55 Aligned_cols=220 Identities=24% Similarity=0.397 Sum_probs=171.9
Q ss_pred ccccccccCCccceEeeeeCCc-hhhh----------------------------hhhhhhhcceeec----CceeeEEE
Q 039318 427 SINKKLGEGGFGPVYKGTLADG-QEIA----------------------------HRNLVKLLGCCIQ----GEEKLLIY 473 (717)
Q Consensus 427 ~~~~~lG~G~fg~Vy~~~~~~~-~~va----------------------------h~niv~l~~~~~~----~~~~~lV~ 473 (717)
++.++||+|+||+||+|++... +.+| |||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 5667899999999999987542 2222 9999999999865 45679999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc-CCCCceeccccccccccC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD-HEMNPKISDFGLARTFVG 552 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~Dfgla~~~~~ 552 (717)
|||++|+|.+++.+ ...+++..+..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999954 346899999999999999999999875 3599999999999996 578999999999986433
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
. ......||+.|||||++.+ .++.++|||||||++|||++|+.||...... .. ..+....+......
T Consensus 168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~----~~~~i~~~~~~~~~-- 234 (270)
T d1t4ha_ 168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQ----IYRRVTSGVKPASF-- 234 (270)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HH----HHHHHTTTCCCGGG--
T ss_pred C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HH----HHHHHHcCCCCccc--
Confidence 2 2335789999999999875 5999999999999999999999998633211 11 11222222211111
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
....+ .++.+|+.+||+.||++|||++|+++
T Consensus 235 --~~~~~----~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 --DKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --GGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CccCC----HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11112 24678899999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=364.84 Aligned_cols=232 Identities=29% Similarity=0.443 Sum_probs=176.2
Q ss_pred cCcccccccccCCccceEeeeeCCch-----hhh---------------------------hhhhhhhcceeecCceeeE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQ-----EIA---------------------------HRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-----~va---------------------------h~niv~l~~~~~~~~~~~l 471 (717)
..|++.+.||+|+||.||+|+++... .|| |||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 46888899999999999999865321 111 9999999999999999999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
|||||.+++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999988854 3346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccc-cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 552 GDEIE-GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 552 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
..... .......||+.|||||++.+..++.++|||||||++|||++|..|+..... .... ...+.++....
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~----~~~i~~~~~~~-- 233 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEV----MKAINDGFRLP-- 233 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHH----HHHHHTTCCCC--
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHH----HHHHhccCCCC--
Confidence 43221 122335689999999999999999999999999999999997666432211 1111 12222222111
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.+.....++.+|+.+||+.||++|||+.||+++|+...
T Consensus 234 -------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 234 -------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp -------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 11112245778999999999999999999999997654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=363.60 Aligned_cols=236 Identities=29% Similarity=0.437 Sum_probs=179.3
Q ss_pred HHhcCcccccccccCCccceEeeeeCCc------hhhh----------------------------hhhhhhhcceeecC
Q 039318 421 NATDNFSINKKLGEGGFGPVYKGTLADG------QEIA----------------------------HRNLVKLLGCCIQG 466 (717)
Q Consensus 421 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~va----------------------------h~niv~l~~~~~~~ 466 (717)
...++|++.++||+|+||.||+|++... +.|| |+|||++++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 3347899999999999999999975321 1222 89999999987654
Q ss_pred -ceeeEEEeccCCCChhhHhhhccc-------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceE
Q 039318 467 -EEKLLIYEFMPNRSLDSFIFDQTK-------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVL 532 (717)
Q Consensus 467 -~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIl 532 (717)
+..++|||||++|+|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcccee
Confidence 568999999999999999965322 345889999999999999999999998 999999999999
Q ss_pred EcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCC-CCCCCCCCCCch
Q 039318 533 LDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK-KNRGFYHSDKNL 611 (717)
Q Consensus 533 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~-~p~~~~~~~~~~ 611 (717)
|++++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++|. +||........
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~- 245 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 245 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 9999999999999998765544444445678999999999999999999999999999999999865 56654332221
Q ss_pred hHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 612 NLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 612 ~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
....+.++......+ ....++.+++.+||+.||++|||++||+++|+..
T Consensus 246 -----~~~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 246 -----FCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp -----HHHHHHHTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHHhcCCCCCCCc---------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111222222111111 1123567899999999999999999999999754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=362.20 Aligned_cols=221 Identities=29% Similarity=0.413 Sum_probs=173.8
Q ss_pred cccccCCccceEeeeeCCc---hhhh----------------------------hhhhhhhcceeecCceeeEEEeccCC
Q 039318 430 KKLGEGGFGPVYKGTLADG---QEIA----------------------------HRNLVKLLGCCIQGEEKLLIYEFMPN 478 (717)
Q Consensus 430 ~~lG~G~fg~Vy~~~~~~~---~~va----------------------------h~niv~l~~~~~~~~~~~lV~E~~~~ 478 (717)
++||+|+||.||+|.++.. +.|| |||||++++++.. +..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 4799999999999976432 1222 9999999999864 567899999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc-c
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE-G 557 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 557 (717)
|+|.+++.. ...+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++........ .
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999853 345899999999999999999999998 999999999999999999999999999876543222 2
Q ss_pred ccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhc
Q 039318 558 STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQE 636 (717)
Q Consensus 558 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~ 636 (717)
......||+.|||||.+.+..++.++|||||||++|||++ |+.||...... .+ ...+..+...... .
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~----~~~i~~~~~~~~p-----~ 233 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EV----TAMLEKGERMGCP-----A 233 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH----HHHHHTTCCCCCC-----T
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HH----HHHHHcCCCCCCC-----c
Confidence 2234578999999999999999999999999999999998 89998743321 11 1222222211111 1
Q ss_pred cCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 637 SCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 637 ~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
. ....+.+|+.+||+.||++|||+++|+++|+.
T Consensus 234 ~----~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 234 G----CPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp T----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred c----cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 1 12456789999999999999999999998853
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-42 Score=362.80 Aligned_cols=219 Identities=29% Similarity=0.431 Sum_probs=176.8
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh-----------------------------hhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA-----------------------------HRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va-----------------------------h~niv~l~~~~~~~~~~~lV~ 473 (717)
+.|+++++||+|+||.||+|+... ++.+| |||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 459999999999999999998653 32222 999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
|||++|+|..++.. .+.+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 99999999876633 346899999999999999999999998 99999999999999999999999999986532
Q ss_pred ccccccceecccccccCcccccc---CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASD---GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||..... ... .......... .+.
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~---~~~---~~~i~~~~~~-~~~ 235 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSA---LYHIAQNESP-ALQ 235 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH---HHHHHHSCCC-CCS
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH---HHH---HHHHHhCCCC-CCC
Confidence 234689999999999864 4589999999999999999999999864321 111 1222222211 111
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.. . ....+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~----~----~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 SG----H----WSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CT----T----SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC----C----CCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11 1 1235678899999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.4e-43 Score=364.18 Aligned_cols=237 Identities=27% Similarity=0.456 Sum_probs=186.6
Q ss_pred HHHhcCcccccccccCCccceEeeeeCC------chhhh---------------------------hhhhhhhcceeecC
Q 039318 420 ANATDNFSINKKLGEGGFGPVYKGTLAD------GQEIA---------------------------HRNLVKLLGCCIQG 466 (717)
Q Consensus 420 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~va---------------------------h~niv~l~~~~~~~ 466 (717)
+...++|++.+.||+|+||.||+|+.+. ++.|| ||||+++++++.+.
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 3345789999999999999999997532 11121 99999999999999
Q ss_pred ceeeEEEeccCCCChhhHhhhcc---------------------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEecc
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQT---------------------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRD 525 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrD 525 (717)
+..++||||+++|+|.+++.... ....+++..++.++.||++||+|||+++ |||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrD 165 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 165 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeE
Confidence 99999999999999999995422 1234788999999999999999999998 99999
Q ss_pred CCCCceEEcCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCC-CCCCC
Q 039318 526 LKASNVLLDHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK-KNRGF 604 (717)
Q Consensus 526 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~-~p~~~ 604 (717)
|||+||||+.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|. +||..
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999999999999999999998765444334444577899999999999999999999999999999999986 56653
Q ss_pred CCCCCchhHHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 605 YHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.... ..+ ..+..+...... ... ..++.+|+.+||+.+|++||||.||+++|+...
T Consensus 246 ~~~~---e~~----~~v~~~~~~~~p-----~~~----~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 246 MAHE---EVI----YYVRDGNILACP-----ENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp SCHH---HHH----HHHHTTCCCCCC-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCHH---HHH----HHHHcCCCCCCC-----ccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 3222 111 122223222111 111 235778999999999999999999999998754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-42 Score=369.59 Aligned_cols=225 Identities=24% Similarity=0.326 Sum_probs=181.3
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh--------------------------hhhhhhhcceeecCceeeEEEecc
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA--------------------------HRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va--------------------------h~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
++|++.+.||+|+||.||+|+.+. ++.+| |||||++++++.+.+..+||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 589999999999999999998753 33332 999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc--CCCCceeccccccccccCCc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD--HEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~--~~~~~kl~Dfgla~~~~~~~ 554 (717)
++|+|.+++.+ ....+++..+..++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999843 2346899999999999999999999998 99999999999995 46789999999998764432
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCC-CCccccchh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG-MPSQLIDAY 633 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~d~~ 633 (717)
......||+.|||||++.+..++.++|||||||++|||++|+.||...... ..+... .... .... .
T Consensus 181 ---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i---~~~~~~~~~----~ 247 (350)
T d1koaa2 181 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNV---KSCDWNMDD----S 247 (350)
T ss_dssp ---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHTCCCSCC----G
T ss_pred ---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHH---HhCCCCCCc----c
Confidence 234578999999999999999999999999999999999999998643222 111111 1111 1110 0
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
.... ....+.+|+.+||+.||++|||++|+++.
T Consensus 248 ~~~~----~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 AFSG----ISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGG----CCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001 11356788999999999999999999984
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.6e-42 Score=367.54 Aligned_cols=230 Identities=23% Similarity=0.288 Sum_probs=183.4
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh--------------------------hhhhhhhcceeecCceeeEEEecc
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA--------------------------HRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va--------------------------h~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
++|++.+.||+|+||.||+|+... ++.+| |||||++++++.+++..+||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 579999999999999999998753 33332 999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc--CCCCceeccccccccccCCc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD--HEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~--~~~~~kl~Dfgla~~~~~~~ 554 (717)
++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+||||+ .++.+||+|||+|+......
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999988743 3345899999999999999999999998 99999999999998 67899999999999765432
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+... .... .. . .
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i---~~~~-~~-~-~--- 248 (352)
T d1koba_ 184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNV---KRCD-WE-F-D--- 248 (352)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHH---HHCC-CC-C-C---
T ss_pred ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---HhCC-CC-C-C---
Confidence 234578999999999999999999999999999999999999998643222 111111 1111 10 0 0
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH--hcCC
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM--LGSE 674 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~--L~~~ 674 (717)
..........+.+|+.+||+.||.+|||+.|+++. +.+.
T Consensus 249 -~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 249 -EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 00001112356789999999999999999999884 5443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=359.76 Aligned_cols=225 Identities=22% Similarity=0.298 Sum_probs=180.0
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh--------------------------------hhhhhhhhcceeecCcee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI--------------------------------AHRNLVKLLGCCIQGEEK 469 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v--------------------------------ah~niv~l~~~~~~~~~~ 469 (717)
.++|++.+.||+|+||+||+|+.+. ++.+ .|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4689999999999999999998753 2222 299999999999999999
Q ss_pred eEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC----Cceecccc
Q 039318 470 LLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM----NPKISDFG 545 (717)
Q Consensus 470 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~Dfg 545 (717)
+||||||++|+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999954 346899999999999999999999998 99999999999998776 49999999
Q ss_pred ccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM 625 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 625 (717)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .... .....
T Consensus 163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~----i~~~~ 232 (293)
T d1jksa_ 163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLAN----VSAVN 232 (293)
T ss_dssp TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----HHTTC
T ss_pred hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HHHH----HHhcC
Confidence 998764332 2334679999999999999999999999999999999999999987432211 1111 11111
Q ss_pred CccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 626 PSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 626 ~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.. .... .... ....+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~-~~~~-~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 YE-FEDE-YFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CC-CCHH-HHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC-CCch-hcCC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 0000 0011 1235678999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=360.13 Aligned_cols=233 Identities=29% Similarity=0.414 Sum_probs=184.3
Q ss_pred hcCcccccccccCCccceEeeeeCCch--------hhh----------------------------hhhhhhhcceeecC
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ--------EIA----------------------------HRNLVKLLGCCIQG 466 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~--------~va----------------------------h~niv~l~~~~~~~ 466 (717)
.++|++.+.||+|+||.||+|+..... .+| |||||++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 368999999999999999999753211 111 99999999999999
Q ss_pred ceeeEEEeccCCCChhhHhhhccc-------------cccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE
Q 039318 467 EEKLLIYEFMPNRSLDSFIFDQTK-------------RKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL 533 (717)
Q Consensus 467 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll 533 (717)
+..++|||||++|+|.+++..... ...+++..++.++.||+.||+|||+++ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999965431 245899999999999999999999998 9999999999999
Q ss_pred cCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchh
Q 039318 534 DHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLN 612 (717)
Q Consensus 534 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~ 612 (717)
+.++.+||+|||+++...............||+.|+|||.+.+..|+.++|||||||++|||++ |++||......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---- 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----
Confidence 9999999999999997765544444555789999999999999999999999999999999998 78887643322
Q ss_pred HHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 613 LIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.....+..+...... .. ...++.+|+.+||+.||++|||+.||+++|+.+
T Consensus 245 ---~~~~~i~~~~~~~~p-----~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 245 ---ELFKLLKEGHRMDKP-----SN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ---HHHHHHHTTCCCCCC-----SS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHcCCCCCCC-----cc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 122233333221111 11 123577899999999999999999999999764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=363.11 Aligned_cols=229 Identities=25% Similarity=0.403 Sum_probs=178.8
Q ss_pred cCcccccccccCCccceEeeeeCCc-hh----h---------------------------hhhhhhhhcceeecCceeeE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QE----I---------------------------AHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~----v---------------------------ah~niv~l~~~~~~~~~~~l 471 (717)
.+|+++++||+|+||.||+|++... +. | .|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 4699999999999999999986432 11 1 199999999999864 5678
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
+|||+.+++|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999998854 3456899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
............||+.|||||++.+..++.++|||||||++|||++ |++||......+-.. .+..+....
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~-------~i~~~~~~~-- 233 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKGERLP-- 233 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH-------HHHHTCCCC--
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH-------HHHcCCCCC--
Confidence 5544444445678999999999999999999999999999999998 888887544332111 111111100
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.+......+.+|+.+||+.||++|||+.||++.|+..
T Consensus 234 -------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 234 -------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 1111224567899999999999999999999987643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.7e-42 Score=365.77 Aligned_cols=222 Identities=25% Similarity=0.330 Sum_probs=179.4
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh--------------------------------hhhhhhhcceeecCceee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA--------------------------------HRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va--------------------------------h~niv~l~~~~~~~~~~~ 470 (717)
++|++.+.||+|+||.||+|+... ++.+| |||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 689999999999999999998764 33222 999999999999999999
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
+|||||++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999954 345788999999999999999999998 999999999999999999999999999876
Q ss_pred cCCccccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccc
Q 039318 551 VGDEIEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL 629 (717)
Q Consensus 551 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 629 (717)
.... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||......+..... ....... ..+
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~~~~-~~~ 228 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTMA-VEL 228 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHSSSCC-CCC
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhcccCC-CCC
Confidence 4432 335689999999999864 56899999999999999999999999765443322111 1111111 011
Q ss_pred cchhhhccCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHH
Q 039318 630 IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPC-----MPSVIL 669 (717)
Q Consensus 630 ~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----~~evl~ 669 (717)
.... ...+.+|+.+||+.||++||| ++|+++
T Consensus 229 -----~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 229 -----PDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -----CSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -----CCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1111 234678999999999999999 578875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=355.78 Aligned_cols=228 Identities=25% Similarity=0.370 Sum_probs=171.7
Q ss_pred hcCcccccccccCCccceEeeeeCCch----hh---------------------------hhhhhhhhcceeecCceeeE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADGQ----EI---------------------------AHRNLVKLLGCCIQGEEKLL 471 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~v---------------------------ah~niv~l~~~~~~~~~~~l 471 (717)
.++|++.+.||+|+||.||+|++.... .+ .|||||++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 367999999999999999999865321 11 1999999999986 567899
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccccccc
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFV 551 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~ 551 (717)
||||+++|+|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999998744 3446899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI 630 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 630 (717)
.... .......||+.|+|||++.+..++.++|||||||++|||++ |++||......+ +... ...+....+.
T Consensus 160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~----i~~~~~~~~~ 231 (273)
T d1mp8a_ 160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR----IENGERLPMP 231 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTCCCCCC
T ss_pred CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHH----HHcCCCCCCC
Confidence 3322 22334678999999999999999999999999999999998 899987544332 2211 1122211111
Q ss_pred chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 631 DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 631 d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
......+.+|+.+||+.||++|||+.||++.|+.
T Consensus 232 ---------~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 232 ---------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1112457789999999999999999999998864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.4e-42 Score=359.47 Aligned_cols=218 Identities=25% Similarity=0.326 Sum_probs=178.8
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh-----------------------------hhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA-----------------------------HRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va-----------------------------h~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++.+.||+|+||+||+|+.+. ++.+| |||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 579999999999999999999754 33332 999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
|||++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999998843 445788888899999999999999998 999999999999999999999999999876432
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
....+||+.|||||++.+..++.++|||||||++|||++|+.||...... ... .+...... .+
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~---~~i~~~~~--~~---- 220 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTY---EKILNAEL--RF---- 220 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH---HHHHHCCC--CC----
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH---HHH---HHHHcCCC--CC----
Confidence 23578999999999999999999999999999999999999998643221 111 11111111 00
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRP-----CMPSVIL 669 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~ 669 (717)
.... ...+.+++.+||+.||.+|| |++++++
T Consensus 221 -p~~~----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 221 -PPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCC----CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 0111 23467889999999999996 8999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-41 Score=361.96 Aligned_cols=218 Identities=22% Similarity=0.239 Sum_probs=179.8
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh-----------------------------hhhhhhhcceeecCceeeEEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA-----------------------------HRNLVKLLGCCIQGEEKLLIY 473 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va-----------------------------h~niv~l~~~~~~~~~~~lV~ 473 (717)
++|++++.||+|+||.||+|+++. ++.+| |||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 589999999999999999998753 33322 999999999999999999999
Q ss_pred eccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCC
Q 039318 474 EFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 474 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~ 553 (717)
||+.+|+|.+++... +.+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999999543 45899999999999999999999998 999999999999999999999999999976432
Q ss_pred ccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchh
Q 039318 554 EIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAY 633 (717)
Q Consensus 554 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 633 (717)
.....||+.|||||++.+..++.++|||||||++|||++|+.||.... ...... ...... .. .
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~---~i~~~~-~~-~---- 257 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYE---KIVSGK-VR-F---- 257 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHHCC-CC-C----
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC---HHHHHH---HHhcCC-CC-C----
Confidence 235789999999999999999999999999999999999999986432 111111 111111 10 0
Q ss_pred hhccCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHH
Q 039318 634 YQESCNLAEVIRCIHVGLLCVQHHPEDRP-----CMPSVIL 669 (717)
Q Consensus 634 ~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----s~~evl~ 669 (717)
.. .....+.+++.+||+.||.+|+ |++++++
T Consensus 258 -p~----~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 -PS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -Cc----cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 01 1123567889999999999994 8999987
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-42 Score=362.06 Aligned_cols=222 Identities=22% Similarity=0.295 Sum_probs=180.4
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhhh-----------------------------hhhhhhhcceeecCceeeEE
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEIA-----------------------------HRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va-----------------------------h~niv~l~~~~~~~~~~~lV 472 (717)
.++|++++.||+|+||.||+|+.+. ++.+| |||||++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 3679999999999999999998753 32222 99999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
||||++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999854 345888999999999999999999998 99999999999999999999999999986543
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
.. ......+||+.|||||++.+..|+.++|||||||++|||++|++||...... .+. +......+. +
T Consensus 158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~----~~i~~~~~~-~--- 224 (337)
T d1o6la_ 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLF----ELILMEEIR-F--- 224 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHCCCC-C---
T ss_pred CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HHH----HHHhcCCCC-C---
Confidence 22 2234578999999999999999999999999999999999999998753321 111 111111111 1
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPC-----MPSVIL 669 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----~~evl~ 669 (717)
.... ..++.+|+.+||+.||++||+ ++|+++
T Consensus 225 --p~~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 225 --PRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CccC----CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1111 235678999999999999995 778776
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=356.14 Aligned_cols=243 Identities=21% Similarity=0.287 Sum_probs=182.6
Q ss_pred cCcccccccccCCccceEeeeeCCchhhh-------------------------hhhhhhhcceeecCc----eeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA-------------------------HRNLVKLLGCCIQGE----EKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~va-------------------------h~niv~l~~~~~~~~----~~~lV~E 474 (717)
++|.+.++||+|+||.||+|++. ++.|| |||||++++++.+.+ ..++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 56888899999999999999975 33333 999999999998654 5799999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcC-----CCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS-----RLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
||++|+|.+++.+ ..+++..++.++.|++.||+|||+.. +.+|+||||||+||||+.++.+||+|||+++.
T Consensus 82 y~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 9999999999954 25899999999999999999999741 23599999999999999999999999999987
Q ss_pred ccCCcc--ccccceecccccccCccccccCC------CCccccchhHhHHHHHhhcCCCCCCCCCCCCc--------hhH
Q 039318 550 FVGDEI--EGSTKRVVGTYGYMAPEYASDGL------FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKN--------LNL 613 (717)
Q Consensus 550 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG~il~elltG~~p~~~~~~~~~--------~~~ 613 (717)
...... ........||+.|+|||++.+.. ++.++|||||||++|||++|..|+........ ...
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 654322 22234578999999999987643 67899999999999999999988754322211 011
Q ss_pred HHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 614 IGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 614 ~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
..........+....-+.. ...+.+....+.+|+.+||+.||++|||+.||+++|+..
T Consensus 238 ~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCG---GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCc---ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1122222222221111111 111223455688899999999999999999999999754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=360.89 Aligned_cols=231 Identities=19% Similarity=0.204 Sum_probs=178.3
Q ss_pred hcCccccc-ccccCCccceEeeeeCC-chhhh----------------------hhhhhhhcceeec----CceeeEEEe
Q 039318 423 TDNFSINK-KLGEGGFGPVYKGTLAD-GQEIA----------------------HRNLVKLLGCCIQ----GEEKLLIYE 474 (717)
Q Consensus 423 ~~~~~~~~-~lG~G~fg~Vy~~~~~~-~~~va----------------------h~niv~l~~~~~~----~~~~~lV~E 474 (717)
.++|.+.. .||+|+||.||+|+... ++.+| |||||++++++.+ ....+||||
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE 89 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 89 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence 36898875 59999999999998754 33333 9999999999865 467899999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC---CCCceecccccccccc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH---EMNPKISDFGLARTFV 551 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~Dfgla~~~~ 551 (717)
||++|+|.+++.+. ....+++..+..++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||+|+...
T Consensus 90 y~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 90 CLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp CCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred CCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceeeecc
Confidence 99999999999543 2346899999999999999999999998 999999999999985 5679999999998764
Q ss_pred CCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccc
Q 039318 552 GDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLID 631 (717)
Q Consensus 552 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 631 (717)
... ......||+.|||||++.+..|+.++|||||||++|||++|+.||...........+ ......... .+..
T Consensus 166 ~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i~~~~~-~~~~ 238 (335)
T d2ozaa1 166 SHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQY-EFPN 238 (335)
T ss_dssp CCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS-SCCT
T ss_pred CCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHHhcCCC-CCCC
Confidence 432 233578999999999999999999999999999999999999999654332211111 010000100 0000
Q ss_pred hhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 632 AYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 632 ~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
+. ......++.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~-----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 239 PE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp TH-----HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cc-----cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00 0112346788999999999999999999998
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-42 Score=360.56 Aligned_cols=234 Identities=29% Similarity=0.449 Sum_probs=186.0
Q ss_pred hcCcccccccccCCccceEeeeeCC------chhh----------------------------hhhhhhhhcceeecCce
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD------GQEI----------------------------AHRNLVKLLGCCIQGEE 468 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~v----------------------------ah~niv~l~~~~~~~~~ 468 (717)
.++|++.++||+|+||.||+|++.. ++.+ .|||||++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 3688999999999999999997531 1111 19999999999999999
Q ss_pred eeEEEeccCCCChhhHhhhcc---------------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEE
Q 039318 469 KLLIYEFMPNRSLDSFIFDQT---------------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLL 533 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll 533 (717)
.++|||||++|+|.++++... ....+++..++.++.||++||+|||+++ |+||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999996532 2235889999999999999999999998 9999999999999
Q ss_pred cCCCCceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchh
Q 039318 534 DHEMNPKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLN 612 (717)
Q Consensus 534 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~ 612 (717)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |++|+......+..
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~- 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF- 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence 9999999999999997765444444455789999999999999999999999999999999999 55555443332211
Q ss_pred HHHHHHHHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 613 LIGHAWKLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 613 ~~~~~~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.+....+..... +......+.+|+.+||+.||++|||+++|+++|+..
T Consensus 258 -----~~~i~~~~~~~~---------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 258 -----YKMIKEGFRMLS---------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp -----HHHHHHTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHhcCCCCCC---------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 112222211110 111224578899999999999999999999999753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-42 Score=349.63 Aligned_cols=225 Identities=28% Similarity=0.389 Sum_probs=174.3
Q ss_pred cCcccccccccCCccceEeeeeCCchhhh------------------------hhhhhhhcceeec-CceeeEEEeccCC
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA------------------------HRNLVKLLGCCIQ-GEEKLLIYEFMPN 478 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~va------------------------h~niv~l~~~~~~-~~~~~lV~E~~~~ 478 (717)
++|++.+.||+|+||.||+|++++ ..|| |||||++++++.+ .+..++||||+++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRG-NKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-EEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred HHeEEeEEEecCCCeEEEEEEECC-eEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 578899999999999999999863 3333 9999999999865 4568999999999
Q ss_pred CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccccc
Q 039318 479 RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIEGS 558 (717)
Q Consensus 479 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 558 (717)
|+|.+++... ....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----- 156 (262)
T d1byga_ 86 GSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----- 156 (262)
T ss_dssp EEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC-----
Confidence 9999999653 2335899999999999999999999998 999999999999999999999999999865322
Q ss_pred cceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhhhcc
Q 039318 559 TKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYYQES 637 (717)
Q Consensus 559 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~~~~ 637 (717)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||......+ .... ...+...++.+
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~----i~~~~~~~~~~------ 223 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYKMDAPD------ 223 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH----HTTTCCCCCCT------
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCCCCCCCc------
Confidence 234578999999999999999999999999999999998 677776433222 2211 12222111111
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 638 CNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 638 ~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
....++.+|+.+||+.||++|||+.+|+++|+..
T Consensus 224 ---~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 224 ---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1123567899999999999999999999999753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-41 Score=347.03 Aligned_cols=229 Identities=28% Similarity=0.412 Sum_probs=175.2
Q ss_pred cCcccccccccCCccceEeeeeCCc--h--hhh-----------------------------hhhhhhhcceeecCceee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG--Q--EIA-----------------------------HRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~--~--~va-----------------------------h~niv~l~~~~~~~~~~~ 470 (717)
++|++.+.||+|+||.||+|++... + .|| |||||++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5799999999999999999975321 1 111 9999999999975 5678
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
+|||||++|+|.+++..+ ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999988543 346899999999999999999999998 999999999999999999999999999976
Q ss_pred cCCccc-cccceecccccccCccccccCCCCccccchhHhHHHHHhhc-CCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 551 VGDEIE-GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVS-GKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 551 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
...... .......|+..|+|||.+.+..++.++|||||||++|||++ |+.||......+ .. .....++....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~---~~i~~~~~~~~ 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---IL---HKIDKEGERLP 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---HHHHTSCCCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HH---HHHHhCCCCCC
Confidence 544322 22334568889999999999999999999999999999998 899986432221 11 22222222111
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
.. ... ...+.+|+.+||+.||++|||++||+++|++
T Consensus 236 ~~-----~~~----~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 236 RP-----EDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CC-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Cc-----ccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11 111 1356789999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.2e-41 Score=348.59 Aligned_cols=225 Identities=20% Similarity=0.283 Sum_probs=179.2
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhh------------------------------------hhhhhhhhcceeec
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEI------------------------------------AHRNLVKLLGCCIQ 465 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~v------------------------------------ah~niv~l~~~~~~ 465 (717)
.++|++.+.||+|+||+||+|+... ++.+ .|||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 3689999999999999999998643 2211 19999999999999
Q ss_pred CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 466 GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 466 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
++..+||||||++|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999954 346899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCccccccceecccccccCcccccc------CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHH
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASD------GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWK 619 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~ 619 (717)
+++.+.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .... .
T Consensus 156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~---~~~~---~ 226 (277)
T d1phka_ 156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLR---M 226 (277)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---H
T ss_pred heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH---HHHH---H
Confidence 998765432 2234689999999998853 34788999999999999999999998743321 1111 1
Q ss_pred HhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 620 LWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 620 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
..... .. ...+. .. ....++.+|+.+||+.||++|||++||++
T Consensus 227 i~~~~-~~-~~~~~-~~----~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 227 IMSGN-YQ-FGSPE-WD----DYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHTC-CC-CCTTT-GG----GSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhCC-CC-CCCcc-cc----cCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111 11 00000 01 11235778999999999999999999976
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-41 Score=351.59 Aligned_cols=231 Identities=22% Similarity=0.331 Sum_probs=174.5
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhhh-----------------------------hhhhhhhcceeecCc----e
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEIA-----------------------------HRNLVKLLGCCIQGE----E 468 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va-----------------------------h~niv~l~~~~~~~~----~ 468 (717)
.++|++.+.||+|+||.||+|+... ++.+| |||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4689999999999999999998643 33322 999999999987654 3
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
.+|||||+++++|.+++.. .+.+++..+..++.||++||+|||+++ |+||||||+||||+.++.++|+|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 7899999999999998844 346899999999999999999999998 9999999999999999999999999987
Q ss_pred cccCCc-cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 549 TFVGDE-IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 549 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
...... .........||+.|||||++.+..++.++|||||||++|||++|+.||...... . ...+........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~---~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---S---VAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---H---HHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH---H---HHHHHHhcCCCC
Confidence 653322 122334568999999999999999999999999999999999999998643221 1 122222222211
Q ss_pred cccchhhhccCCHHHHHHHHHHHhhccccCCCCCC-ChHHHHHHhc
Q 039318 628 QLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRP-CMPSVILMLG 672 (717)
Q Consensus 628 ~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-s~~evl~~L~ 672 (717)
. ...... ....+.+++.+||+.||++|| |++++++.|.
T Consensus 234 ~---~~~~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 234 P---SARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp G---GGTSSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred C---chhccC----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 0 001111 123567889999999999999 8999988775
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=358.23 Aligned_cols=221 Identities=25% Similarity=0.371 Sum_probs=179.8
Q ss_pred cCcccccccccCCccceEeeeeCCc-hhhh------------------------------hhhhhhhcceeecCceeeEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QEIA------------------------------HRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~va------------------------------h~niv~l~~~~~~~~~~~lV 472 (717)
++|++.+.||+|+||+||+|+.+.. +.+| |||||++++++.+++..+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999987642 2222 99999999999999999999
Q ss_pred EeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccC
Q 039318 473 YEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVG 552 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~ 552 (717)
||||++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999954 345788999999999999999999998 99999999999999999999999999986543
Q ss_pred CccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch
Q 039318 553 DEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA 632 (717)
Q Consensus 553 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 632 (717)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.... ....+. +
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i----~~~~~~-~--- 222 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSI----RMDNPF-Y--- 222 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH----HHCCCC-C---
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHH----HcCCCC-C---
Confidence 32 2233468999999999999999999999999999999999999999743222 111111 111110 0
Q ss_pred hhhccCCHHHHHHHHHHHhhccccCCCCCCChH-HHHH
Q 039318 633 YYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMP-SVIL 669 (717)
Q Consensus 633 ~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~-evl~ 669 (717)
.... ..++.+|+.+||+.||++||++. ++++
T Consensus 223 --p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 --PRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0111 23467899999999999999995 6764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-41 Score=352.44 Aligned_cols=230 Identities=27% Similarity=0.393 Sum_probs=181.9
Q ss_pred cCcccccccccCCccceEeeeeCCchh------------------------------h-hhhhhhhhcceeecCceeeEE
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQE------------------------------I-AHRNLVKLLGCCIQGEEKLLI 472 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~------------------------------v-ah~niv~l~~~~~~~~~~~lV 472 (717)
++|++.++||+|+||.||+|+++++.. + .|||||++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678999999999999999998754311 1 199999999999999999999
Q ss_pred EeccCCCChhhHhhhc-------------cccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCc
Q 039318 473 YEFMPNRSLDSFIFDQ-------------TKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNP 539 (717)
Q Consensus 473 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~ 539 (717)
|||+++|+|.+++... .....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999643 23456899999999999999999999998 9999999999999999999
Q ss_pred eeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCC-CCCCCCCCCchhHHHHHH
Q 039318 540 KISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKK-NRGFYHSDKNLNLIGHAW 618 (717)
Q Consensus 540 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~-p~~~~~~~~~~~~~~~~~ 618 (717)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||.... ...+.
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---~~~~~---- 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELY---- 236 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHH----
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC---HHHHH----
Confidence 999999998643221 2234578999999999999999999999999999999999765 554322 11111
Q ss_pred HHhhCCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 619 KLWNNGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 619 ~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
..+.++..... +.....++.+|+.+||+.||++||||+||++.|+...
T Consensus 237 ~~i~~~~~~~~---------~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 237 EKLPQGYRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HHGGGTCCCCC---------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCCCCC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11222211111 1112246778999999999999999999999987654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-41 Score=351.27 Aligned_cols=231 Identities=26% Similarity=0.280 Sum_probs=176.0
Q ss_pred cccccccCCccceEeeeeCC-chhhh-------------------------------hhhhhhhcceeecCceeeEEEec
Q 039318 428 INKKLGEGGFGPVYKGTLAD-GQEIA-------------------------------HRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 428 ~~~~lG~G~fg~Vy~~~~~~-~~~va-------------------------------h~niv~l~~~~~~~~~~~lV~E~ 475 (717)
.+++||+|+||+||+|+++. ++.+| |||||++++++.+++..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 35789999999999998754 22222 99999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
++++++..++ .....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9998777665 34456899999999999999999999998 99999999999999999999999999987644322
Q ss_pred ccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccch--
Q 039318 556 EGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDA-- 632 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~-- 632 (717)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+....+...........+.
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---HHHHHHHHHhcCCCChhhccchhc
Confidence 2234679999999998865 4589999999999999999999999864432 2223222222211110000000
Q ss_pred -------hhhccCCHHH-----HHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 633 -------YYQESCNLAE-----VIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 633 -------~~~~~~~~~~-----~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
......+..+ ...+++|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000111111 246788999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-41 Score=353.14 Aligned_cols=234 Identities=27% Similarity=0.447 Sum_probs=187.2
Q ss_pred cCcccccccccCCccceEeeeeCC------chhhh---------------------------hhhhhhhcceeecCceee
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD------GQEIA---------------------------HRNLVKLLGCCIQGEEKL 470 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~va---------------------------h~niv~l~~~~~~~~~~~ 470 (717)
++|++.++||+|+||.||+|+++. +..|| |||||++++++...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 688999999999999999997631 12222 999999999999999999
Q ss_pred EEEeccCCCChhhHhhhcc-------ccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecc
Q 039318 471 LIYEFMPNRSLDSFIFDQT-------KRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISD 543 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D 543 (717)
+|||||++|+|.+++.... ....+++..++.++.|+++||.|||+++ |+||||||+||||++++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 9999999999999986432 2234688899999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCC-CCCCCCCCCCchhHHHHHHHHhh
Q 039318 544 FGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGK-KNRGFYHSDKNLNLIGHAWKLWN 622 (717)
Q Consensus 544 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~-~p~~~~~~~~~~~~~~~~~~~~~ 622 (717)
||+++...............||+.|+|||.+.+..++.++||||||+++|||++|. +||...... ... ....
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~---~~~----~~i~ 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVL----RFVM 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHH----HHHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHH
Confidence 99999775554444445567999999999999999999999999999999999985 666432211 111 1122
Q ss_pred CCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCCC
Q 039318 623 NGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEIM 676 (717)
Q Consensus 623 ~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~ 676 (717)
.+......+ . ....+.+++.+||+.+|++||||++|+++|+...+
T Consensus 250 ~~~~~~~p~-----~----~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGGLLDKPD-----N----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTCCCCCCT-----T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCCCCCCcc-----c----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 222111111 1 12357889999999999999999999999987653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-41 Score=352.21 Aligned_cols=226 Identities=21% Similarity=0.300 Sum_probs=180.7
Q ss_pred hcCcccccccccCCccceEeeeeCCc-hhhh-------------------------hhhhhhhcceeecCceeeEEEecc
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLADG-QEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
-++|++.+.||+|+||+||+|+.+.+ +.+| |||||++++++.+.+..+||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 36899999999999999999987643 2222 999999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC--CCceeccccccccccCCc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE--MNPKISDFGLARTFVGDE 554 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~--~~~kl~Dfgla~~~~~~~ 554 (717)
++|+|.+++.. ....+++.++..++.||++||.|||+++ |+||||||+||||+.+ ..+||+|||+++......
T Consensus 84 ~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 84 SGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999943 2335899999999999999999999998 9999999999999854 479999999998764332
Q ss_pred cccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...... .... ........ + +...
T Consensus 159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~~~---~i~~~~~~--~-~~~~ 226 (321)
T d1tkia_ 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIE---NIMNAEYT--F-DEEA 226 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH---HHHHTCCC--C-CHHH
T ss_pred ---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHhCCCC--C-Chhh
Confidence 234568999999999999999999999999999999999999998753322 1111 11111110 0 0000
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.... ..++.+|+.+||+.||++|||+.|+++
T Consensus 227 ~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 FKEI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111 235678999999999999999999998
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-40 Score=345.94 Aligned_cols=237 Identities=24% Similarity=0.293 Sum_probs=178.2
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh----------------------------hhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------------HRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va----------------------------h~niv~l~~~~~~~~~~~lV~E 474 (717)
++|+++++||+|+||.||+|++.. ++.+| |||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 689999999999999999998753 33333 9999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
|+.++.+. ++.. .....+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~-~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKK-FMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHH-HHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhh-hhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99765444 4422 23456899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccceecccccccCccccccCC-CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCC---Ccccc
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGL-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGM---PSQLI 630 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~l~ 630 (717)
.......||+.|+|||++.... ++.++|||||||++|+|++|+.||...... ..+........... .....
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGG
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH---HHHHHHHHhcCCCchhhccccc
Confidence 2233468999999999877665 578999999999999999999998743322 22222222111100 00000
Q ss_pred ---chh----hhccCCHH-----HHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 631 ---DAY----YQESCNLA-----EVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 631 ---d~~----~~~~~~~~-----~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
+.. .....+.. ....+.+|+.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 00001111 11467889999999999999999999984
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=346.74 Aligned_cols=227 Identities=28% Similarity=0.428 Sum_probs=175.8
Q ss_pred ccccccCCccceEeeeeCCch----hhh---------------------------hhhhhhhcceeec-CceeeEEEecc
Q 039318 429 NKKLGEGGFGPVYKGTLADGQ----EIA---------------------------HRNLVKLLGCCIQ-GEEKLLIYEFM 476 (717)
Q Consensus 429 ~~~lG~G~fg~Vy~~~~~~~~----~va---------------------------h~niv~l~~~~~~-~~~~~lV~E~~ 476 (717)
.++||+|+||+||+|++.+.. .+| |||||++++++.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 468999999999999875431 111 9999999999875 46889999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEIE 556 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 556 (717)
++|+|.+++.. ....+++..++.++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999853 3445778889999999999999999998 999999999999999999999999999976543322
Q ss_pred c--ccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccccchhh
Q 039318 557 G--STKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLIDAYY 634 (717)
Q Consensus 557 ~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~~ 634 (717)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ...... ...+.... .+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~----i~~g~~~~--~p-- 256 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVY----LLQGRRLL--QP-- 256 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH----HHTTCCCC--CC--
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHH----HHcCCCCC--Cc--
Confidence 1 223357899999999999999999999999999999999988886532211 111111 11121111 00
Q ss_pred hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCCC
Q 039318 635 QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSEI 675 (717)
Q Consensus 635 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~~ 675 (717)
.. ....+.+|+.+||+.||++||+|.||++.|+...
T Consensus 257 -~~----~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 257 -EY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp -TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -cc----CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11 1235678999999999999999999999997653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-40 Score=345.54 Aligned_cols=237 Identities=22% Similarity=0.293 Sum_probs=178.6
Q ss_pred hcCcccccccccCCccceEeeeeC-C-chhhh-------------------------------hhhhhhhcceeec----
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLA-D-GQEIA-------------------------------HRNLVKLLGCCIQ---- 465 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~-~-~~~va-------------------------------h~niv~l~~~~~~---- 465 (717)
.++|+++++||+|+||+||+|++. . ++.|| ||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999874 2 22222 9999999999853
Q ss_pred -CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccc
Q 039318 466 -GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDF 544 (717)
Q Consensus 466 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Df 544 (717)
....+++|||++++.+..... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 357899999999987765442 34456889999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCC
Q 039318 545 GLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG 624 (717)
Q Consensus 545 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 624 (717)
|+++..... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||......+ .+..........
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~ 234 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLP 234 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCC
Confidence 999865332 23346789999999999999999999999999999999999999997543222 222222221110
Q ss_pred CCccc------cchhh-------hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 625 MPSQL------IDAYY-------QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 625 ~~~~l------~d~~~-------~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
..... ..... ...........+.+|+.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 00000 000001112356788999999999999999999873
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=340.66 Aligned_cols=214 Identities=24% Similarity=0.409 Sum_probs=172.9
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhhh----------------------------------hhhhhhhcceeecCc
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------------------HRNLVKLLGCCIQGE 467 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va----------------------------------h~niv~l~~~~~~~~ 467 (717)
.++|++.++||+|+||.||+|+... ++.+| |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 4689999999999999999998653 22221 899999999999999
Q ss_pred eeeEEEeccCC-CChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCC-CCceecccc
Q 039318 468 EKLLIYEFMPN-RSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHE-MNPKISDFG 545 (717)
Q Consensus 468 ~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~Dfg 545 (717)
..++||||+.+ +++.+++.. ...+++..+..++.||++||+|||+++ |+||||||+||||+.+ +.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 677777743 346899999999999999999999998 9999999999999854 789999999
Q ss_pred ccccccCCccccccceecccccccCccccccCCC-CccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCC
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLF-SVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNG 624 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 624 (717)
+|+..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ......
T Consensus 157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~ 220 (273)
T d1xwsa_ 157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQ 220 (273)
T ss_dssp TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCC
T ss_pred cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhcc
Confidence 99865432 2235789999999999987765 577999999999999999999986321 011111
Q ss_pred CCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 625 MPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 625 ~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
. . ..... ..++.+|+.+||+.||++|||++|+++
T Consensus 221 ~---~----~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 V---F----FRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp C---C----CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c---C----CCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 0 01111 135678899999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.1e-40 Score=340.96 Aligned_cols=235 Identities=23% Similarity=0.297 Sum_probs=177.6
Q ss_pred cCcccccccccCCccceEeeeeCCchhhh----------------------------hhhhhhhcceeecCceeeEEEec
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADGQEIA----------------------------HRNLVKLLGCCIQGEEKLLIYEF 475 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~va----------------------------h~niv~l~~~~~~~~~~~lV~E~ 475 (717)
++|+++++||+|+||.||+|++++++.+| |||||++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999988766554 99999999999999999999999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCcc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDEI 555 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 555 (717)
+.++.+..+. ...+.+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9988777666 33456999999999999999999999998 99999999999999999999999999987643321
Q ss_pred ccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcccc----
Q 039318 556 EGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQLI---- 630 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---- 630 (717)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... ..+................
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCChhhccchhh
Confidence 23345789999999998754 5799999999999999999999998643322 2222222211111000000
Q ss_pred -----------chhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 631 -----------DAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 631 -----------d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.+.............+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000001111235778999999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-38 Score=332.61 Aligned_cols=236 Identities=19% Similarity=0.257 Sum_probs=174.5
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhhh------------------------hhh-hhhhcceeecCceeeEEEecc
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEIA------------------------HRN-LVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va------------------------h~n-iv~l~~~~~~~~~~~lV~E~~ 476 (717)
.++|++.+.||+|+||.||+|++.. ++.|| |+| |+.+..+..+.+..++||||+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 3679999999999999999998753 44443 555 555566667888899999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEc---CCCCceeccccccccccCC
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLD---HEMNPKISDFGLARTFVGD 553 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~Dfgla~~~~~~ 553 (717)
.+ +|...+.. ..+.+++..++.++.|+++||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+...
T Consensus 86 ~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 86 GP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred CC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 54 56555533 3446899999999999999999999998 99999999999985 4567999999999976543
Q ss_pred ccc-----cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 554 EIE-----GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 554 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
... .......||+.|||||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-- 237 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-- 237 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH--
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh--
Confidence 221 1234568999999999999999999999999999999999999999765544433322221111000000
Q ss_pred ccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcC
Q 039318 629 LIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGS 673 (717)
Q Consensus 629 l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~ 673 (717)
+...... ..++.+++.+|++.+|++||+++++.+.|+.
T Consensus 238 ---~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 238 ---EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp ---HHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred ---hHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0011111 1346788899999999999999999888864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.7e-38 Score=328.74 Aligned_cols=237 Identities=14% Similarity=0.174 Sum_probs=184.5
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhhh-------------------------hhhhhhhcceeecCceeeEEEecc
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEIA-------------------------HRNLVKLLGCCIQGEEKLLIYEFM 476 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va-------------------------h~niv~l~~~~~~~~~~~lV~E~~ 476 (717)
.++|++.++||+|+||.||+|++.. ++.+| |+|++++++++.++...++||||+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 4689999999999999999998753 33333 589999999999999999999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcC-----CCCceecccccccccc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDH-----EMNPKISDFGLARTFV 551 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~-----~~~~kl~Dfgla~~~~ 551 (717)
+++|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+||||+. ++.+||+|||+|+...
T Consensus 84 -~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 84 -GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp -CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred -CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 6899988844 3346899999999999999999999998 999999999999974 5779999999998764
Q ss_pred CCccc-----cccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC
Q 039318 552 GDEIE-----GSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626 (717)
Q Consensus 552 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (717)
..... .......||+.|||||++.+..++.++|||||||++|||++|+.||..................-....+
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 32211 1233468999999999999999999999999999999999999999865554443333222111111111
Q ss_pred ccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHhcCC
Q 039318 627 SQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILMLGSE 674 (717)
Q Consensus 627 ~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~L~~~ 674 (717)
.+ +....+ .++.+++..|++.+|++||+++.+.+.|+..
T Consensus 238 ~~-----l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 238 RE-----LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HH-----HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HH-----hcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11 111122 3466788889999999999999888877643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=339.59 Aligned_cols=239 Identities=23% Similarity=0.261 Sum_probs=174.4
Q ss_pred CcccccccccCCccceEeeeeCC-chhhh----------------------hhhhhhhcceeecC------ceeeEEEec
Q 039318 425 NFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------HRNLVKLLGCCIQG------EEKLLIYEF 475 (717)
Q Consensus 425 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~va----------------------h~niv~l~~~~~~~------~~~~lV~E~ 475 (717)
+|+..++||+|+||+||+|++.. ++.+| |||||++++++... .+.+|||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 58888999999999999999864 33333 99999999998543 347899999
Q ss_pred cCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC-CceeccccccccccCCc
Q 039318 476 MPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM-NPKISDFGLARTFVGDE 554 (717)
Q Consensus 476 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~Dfgla~~~~~~~ 554 (717)
|+++.+..+.........+++..+..++.||++||+|||+++ |+||||||+||||+.++ .+||+|||+++......
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 987755544433344557899999999999999999999998 99999999999999775 89999999998764432
Q ss_pred cccccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHH--------HHHHhh---
Q 039318 555 IEGSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGH--------AWKLWN--- 622 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~--- 622 (717)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.. .+....
T Consensus 178 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 254 (350)
T d1q5ka_ 178 ---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254 (350)
T ss_dssp ---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred ---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence 2234689999999998765 5689999999999999999999999875433222111110 000000
Q ss_pred -CCCCccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 623 -NGMPSQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 623 -~~~~~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
.......................+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00101100000001111112235778899999999999999999997
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-38 Score=333.36 Aligned_cols=242 Identities=21% Similarity=0.296 Sum_probs=176.3
Q ss_pred hcCcccccccccCCccceEeeeeC-Cchhhh----------------------------hhhhhhhcceeec--------
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLA-DGQEIA----------------------------HRNLVKLLGCCIQ-------- 465 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~va----------------------------h~niv~l~~~~~~-------- 465 (717)
.++|+++++||+|+||+||+|+.. +++.+| ||||+++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 368999999999999999999875 343333 9999999998755
Q ss_pred CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 466 GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 466 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
.+..++||||++++.+..+. .....+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34679999999988776554 33456888999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCccc--cccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhh
Q 039318 546 LARTFVGDEIE--GSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWN 622 (717)
Q Consensus 546 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 622 (717)
+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99865433221 122335799999999998765 689999999999999999999999865433222222222111111
Q ss_pred CCCCccc--------cchhhhccCCHHH-------HHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 623 NGMPSQL--------IDAYYQESCNLAE-------VIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 623 ~~~~~~l--------~d~~~~~~~~~~~-------~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
....... ............+ ...+++|+.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 1100000 0000011111111 2356789999999999999999999974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-37 Score=326.60 Aligned_cols=226 Identities=24% Similarity=0.306 Sum_probs=178.6
Q ss_pred cCcccccccccCCccceEeeeeCC----chhhh------------------------------h-hhhhhhcceeecCce
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD----GQEIA------------------------------H-RNLVKLLGCCIQGEE 468 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~va------------------------------h-~niv~l~~~~~~~~~ 468 (717)
++|++.++||+|+||.||+|+... ++.+| | |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 679999999999999999997522 22222 5 899999999999999
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
.++||||+.+|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999999543 34678888999999999999999998 9999999999999999999999999998
Q ss_pred cccCCccccccceecccccccCccccccC--CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYASDG--LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (717)
.+...... ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+....+...... . ..
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~--~-~~ 253 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--S-EP 253 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--C-CC
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc--C-CC
Confidence 76443322 23356899999999998764 4688999999999999999999999766555444333222111 1 11
Q ss_pred ccccchhhhccCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHH
Q 039318 627 SQLIDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPC-----MPSVIL 669 (717)
Q Consensus 627 ~~l~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----~~evl~ 669 (717)
. .+.....++.+++.+||+.||++||| ++|+++
T Consensus 254 ~----------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 P----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp C----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred C----------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0 01112346778899999999999995 788876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-37 Score=329.04 Aligned_cols=235 Identities=23% Similarity=0.320 Sum_probs=170.5
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhhh----------------------------hhhhhhhcceeecCc------
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------------HRNLVKLLGCCIQGE------ 467 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va----------------------------h~niv~l~~~~~~~~------ 467 (717)
.++|+++++||+|+||+||+|+... ++.+| |||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 3689999999999999999998753 33332 999999999997655
Q ss_pred eeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccccc
Q 039318 468 EKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLA 547 (717)
Q Consensus 468 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla 547 (717)
+.++||||+ +.+|..++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 569999999 557777663 235899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCC
Q 039318 548 RTFVGDEIEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMP 626 (717)
Q Consensus 548 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (717)
+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... ....... ...
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~---~~~~~~~-~~~ 239 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK---EIMKVTG-TPP 239 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHC-CCC
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHH---HHHhccC-CCc
Confidence 875432 2356799999999998764 57899999999999999999999986543222111 1111100 000
Q ss_pred ccc-------------------cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH--hcCCC
Q 039318 627 SQL-------------------IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM--LGSEI 675 (717)
Q Consensus 627 ~~l-------------------~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~--L~~~~ 675 (717)
.+. ....+. .........+++|+.+||+.||++|||+.|+++. |++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 000 000000 0000112356789999999999999999999984 65543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-37 Score=327.76 Aligned_cols=238 Identities=21% Similarity=0.281 Sum_probs=172.1
Q ss_pred hcCcccccccccCCccceEeeeeC-Cchhhh---------------------------hhhhhhhcceeecCc----eee
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLA-DGQEIA---------------------------HRNLVKLLGCCIQGE----EKL 470 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~va---------------------------h~niv~l~~~~~~~~----~~~ 470 (717)
+++|+++++||+|+||+||+|+.+ .++.+| ||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 467999999999999999999864 333332 999999999987653 235
Q ss_pred EEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccc
Q 039318 471 LIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTF 550 (717)
Q Consensus 471 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~ 550 (717)
++++|+.+|+|.+++.. ..+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55667779999999943 25899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCccc-cccceecccccccCcccccc-CCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCcc
Q 039318 551 VGDEIE-GSTKRVVGTYGYMAPEYASD-GLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQ 628 (717)
Q Consensus 551 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (717)
...... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||......+. ...............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---HHHHhhhccCCChhh
Confidence 443222 22345679999999999854 5678999999999999999999999865432221 111111111100000
Q ss_pred --------ccc----hhhhccCCHHH-----HHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 629 --------LID----AYYQESCNLAE-----VIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 629 --------l~d----~~~~~~~~~~~-----~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
... .......+... ..++++|+.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00000011111 1357789999999999999999999984
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.2e-37 Score=324.01 Aligned_cols=232 Identities=18% Similarity=0.291 Sum_probs=173.1
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh------------------------hhhhhhhcceeec--CceeeEEEecc
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA------------------------HRNLVKLLGCCIQ--GEEKLLIYEFM 476 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va------------------------h~niv~l~~~~~~--~~~~~lV~E~~ 476 (717)
++|+++++||+|+||+||+|+... ++.+| ||||+++++++.. ....++|||||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 689999999999999999998753 33222 9999999999874 45689999999
Q ss_pred CCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCC-CceeccccccccccCCcc
Q 039318 477 PNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEM-NPKISDFGLARTFVGDEI 555 (717)
Q Consensus 477 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~ 555 (717)
++++|..+. +.+++..+..++.||++||.|||+++ |+||||||+||||+.++ .+||+|||+|+......
T Consensus 115 ~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~- 184 (328)
T d3bqca1 115 NNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 184 (328)
T ss_dssp CSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred CCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence 999997654 24889999999999999999999998 99999999999998655 58999999998764332
Q ss_pred ccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHh------------h
Q 039318 556 EGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLW------------N 622 (717)
Q Consensus 556 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~------------~ 622 (717)
......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........ ......... .
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~--~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHHHHTT
T ss_pred --cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH--HHHHHHHHHCCchhhhhhhhcc
Confidence 23356789999999998765 479999999999999999999999865433211 111111100 0
Q ss_pred CCCCccc-----------cchhhhccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 623 NGMPSQL-----------IDAYYQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 623 ~~~~~~l-----------~d~~~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
....... ...............++++|+.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 0000000000111235678999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-37 Score=317.66 Aligned_cols=236 Identities=21% Similarity=0.259 Sum_probs=178.6
Q ss_pred cCcccccccccCCccceEeeeeCCc-hhhh----------------------------hhhhhhhcceeecCceeeEEEe
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLADG-QEIA----------------------------HRNLVKLLGCCIQGEEKLLIYE 474 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~va----------------------------h~niv~l~~~~~~~~~~~lV~E 474 (717)
++|+++++||+|+||+||+|++..+ +.+| |||||++++++.+.+..++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999987533 2222 9999999999999999999999
Q ss_pred ccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccccccCCc
Q 039318 475 FMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLARTFVGDE 554 (717)
Q Consensus 475 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 554 (717)
++.+++|..++. ..+.+++..+..++.|+++||+|||+++ |+||||||+||||+.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988774 3456789999999999999999999998 9999999999999999999999999998764432
Q ss_pred cccccceecccccccCccccccCC-CCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCccc----
Q 039318 555 IEGSTKRVVGTYGYMAPEYASDGL-FSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPSQL---- 629 (717)
Q Consensus 555 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l---- 629 (717)
. ......+++.|+|||.+.... ++.++|||||||++|||++|+.||.. ..+....................
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC--CCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 2 222356788999999887665 68999999999999999999999642 22222222222222211110000
Q ss_pred ----------cchhh-hccCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 039318 630 ----------IDAYY-QESCNLAEVIRCIHVGLLCVQHHPEDRPCMPSVIL 669 (717)
Q Consensus 630 ----------~d~~~-~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~ 669 (717)
..... ...........+.+|+.+||+.||.+|||++||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00011111235678899999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-36 Score=322.96 Aligned_cols=235 Identities=23% Similarity=0.225 Sum_probs=165.6
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh----------------------------hhhhhhhcceeec------Cce
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------------HRNLVKLLGCCIQ------GEE 468 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va----------------------------h~niv~l~~~~~~------~~~ 468 (717)
++|+++++||+|+||+||+|++.. ++.+| |||||++++++.. .+.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 679999999999999999998763 33332 9999999999863 468
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
.|+|||||.++.+..+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999776554332 24789999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHH-----------
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHA----------- 617 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~----------- 617 (717)
...... ......+|+.|+|||++.+..++.++||||+||++|||++|+.||...+.......+...
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 654322 234568999999999999999999999999999999999999998644322111111000
Q ss_pred -----HHHhhCCC-C-----ccccchhhhccC---CHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 039318 618 -----WKLWNNGM-P-----SQLIDAYYQESC---NLAEVIRCIHVGLLCVQHHPEDRPCMPSVILM 670 (717)
Q Consensus 618 -----~~~~~~~~-~-----~~l~d~~~~~~~---~~~~~~~~~~l~~~Cl~~dp~~RPs~~evl~~ 670 (717)
........ . ............ .......+.+|+.+||+.||++|||++||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 0 000000000001 11234567899999999999999999999874
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-36 Score=322.39 Aligned_cols=235 Identities=23% Similarity=0.336 Sum_probs=171.8
Q ss_pred hcCcccccccccCCccceEeeeeCC-chhhh----------------------------hhhhhhhcceeecC-----ce
Q 039318 423 TDNFSINKKLGEGGFGPVYKGTLAD-GQEIA----------------------------HRNLVKLLGCCIQG-----EE 468 (717)
Q Consensus 423 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va----------------------------h~niv~l~~~~~~~-----~~ 468 (717)
.++|+++++||+|+||+||+|+... ++.+| |||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4689999999999999999998653 33332 99999999998643 34
Q ss_pred eeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceeccccccc
Q 039318 469 KLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFGLAR 548 (717)
Q Consensus 469 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~ 548 (717)
.+++|||+.+|+|.+++.. +.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5777888899999999832 35899999999999999999999998 9999999999999999999999999997
Q ss_pred cccCCccccccceecccccccCccccccC-CCCccccchhHhHHHHHhhcCCCCCCCCCCCCchhHHHHHHHHhhCCCCc
Q 039318 549 TFVGDEIEGSTKRVVGTYGYMAPEYASDG-LFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKNLNLIGHAWKLWNNGMPS 627 (717)
Q Consensus 549 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (717)
.... ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+ ...... ...
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i---~~~~~~-~~~ 240 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGT-PGA 240 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCC-CCH
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCC-CCh
Confidence 6432 23356799999999987665 4689999999999999999999998644322221111 111100 000
Q ss_pred ccc--------chhh-----hccCCHH-----HHHHHHHHHhhccccCCCCCCChHHHHH--HhcC
Q 039318 628 QLI--------DAYY-----QESCNLA-----EVIRCIHVGLLCVQHHPEDRPCMPSVIL--MLGS 673 (717)
Q Consensus 628 ~l~--------d~~~-----~~~~~~~-----~~~~~~~l~~~Cl~~dp~~RPs~~evl~--~L~~ 673 (717)
+.. .... ....... ....+++|+.+||+.||++|||+.|+++ .+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 000 0000 0000111 1235678999999999999999999998 3543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-33 Score=300.01 Aligned_cols=254 Identities=18% Similarity=0.186 Sum_probs=179.9
Q ss_pred cCcccccccccCCccceEeeeeCC-chhhh------------------------------------hhhhhhhcceeecC
Q 039318 424 DNFSINKKLGEGGFGPVYKGTLAD-GQEIA------------------------------------HRNLVKLLGCCIQG 466 (717)
Q Consensus 424 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~va------------------------------------h~niv~l~~~~~~~ 466 (717)
.+|+++++||+|+||+||+|+... ++.+| |+|||++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 359999999999999999998753 33222 78999999988653
Q ss_pred --ceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhh-cCCCcEEeccCCCCceEEcCCCC-----
Q 039318 467 --EEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHH-DSRLRIIHRDLKASNVLLDHEMN----- 538 (717)
Q Consensus 467 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlkp~NIll~~~~~----- 538 (717)
...+++|+++..+..............+++..+..++.||++||+|||+ .+ |+||||||+||||+.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence 4567777777666555444444556678889999999999999999998 66 999999999999987654
Q ss_pred -ceeccccccccccCCccccccceecccccccCccccccCCCCccccchhHhHHHHHhhcCCCCCCCCCCCCc---hhHH
Q 039318 539 -PKISDFGLARTFVGDEIEGSTKRVVGTYGYMAPEYASDGLFSVKSDVFSFGILLLEIVSGKKNRGFYHSDKN---LNLI 614 (717)
Q Consensus 539 -~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~elltG~~p~~~~~~~~~---~~~~ 614 (717)
+||+|||.+..... ......||+.|+|||++.+..++.++||||+||+++||++|+.||........ ...+
T Consensus 170 ~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 89999999986432 22356799999999999999999999999999999999999999875432211 1111
Q ss_pred HHHHHHhhCC-------------------CCccc-------cchh--hhccCCHHHHHHHHHHHhhccccCCCCCCChHH
Q 039318 615 GHAWKLWNNG-------------------MPSQL-------IDAY--YQESCNLAEVIRCIHVGLLCVQHHPEDRPCMPS 666 (717)
Q Consensus 615 ~~~~~~~~~~-------------------~~~~l-------~d~~--~~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs~~e 666 (717)
......+... ....+ .... ............+.+|+.+||+.||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 1111111100 00000 0000 011223455667899999999999999999999
Q ss_pred HHHH--hcCC---CCCCCCCCCCc
Q 039318 667 VILM--LGSE---IMLPQPKQPGF 685 (717)
Q Consensus 667 vl~~--L~~~---~~~~~p~~p~~ 685 (717)
+++. +... .++..|+.|..
T Consensus 325 ~L~Hp~f~~~~~~~~~~~p~~~~~ 348 (362)
T d1q8ya_ 325 LVNHPWLKDTLGMEEIRVPDRELY 348 (362)
T ss_dssp HHTCGGGTTCTTCTTCCCTTSCTT
T ss_pred HhcCcccCCCCCcccCCCCCcccC
Confidence 9984 5433 24555555554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.76 E-value=1.3e-19 Score=174.63 Aligned_cols=142 Identities=21% Similarity=0.202 Sum_probs=100.9
Q ss_pred cccccccccCCccceEeeeeCCchhhh------------------------------------hhhhhhhcceeec----
Q 039318 426 FSINKKLGEGGFGPVYKGTLADGQEIA------------------------------------HRNLVKLLGCCIQ---- 465 (717)
Q Consensus 426 ~~~~~~lG~G~fg~Vy~~~~~~~~~va------------------------------------h~niv~l~~~~~~---- 465 (717)
+.+.++||+|+||.||+|++.+++.+| |+++.++.+....
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 346789999999999999987766543 4455555443221
Q ss_pred CceeeEEEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcCCCcEEeccCCCCceEEcCCCCceecccc
Q 039318 466 GEEKLLIYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDSRLRIIHRDLKASNVLLDHEMNPKISDFG 545 (717)
Q Consensus 466 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~Dfg 545 (717)
....+++|||+++..+. .++......++.|++++|+|||+++ |+||||||+|||++++ .++|+|||
T Consensus 82 ~~~~~lvme~~~~~~~~----------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 82 WEGNAVLMELIDAKELY----------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp EETTEEEEECCCCEEGG----------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCT
T ss_pred ecCCEEEEEeecccccc----------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECC
Confidence 12347999999886542 2455666789999999999999998 9999999999999966 48999999
Q ss_pred ccccccCCccccccceecccccccC------ccccccCCCCccccchhHhHHH
Q 039318 546 LARTFVGDEIEGSTKRVVGTYGYMA------PEYASDGLFSVKSDVFSFGILL 592 (717)
Q Consensus 546 la~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDvwSlG~il 592 (717)
+|+........ .|.. .|.+ ...|+.++|+||+.--+
T Consensus 148 ~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99765322111 1111 1111 35678899999976433
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.73 E-value=5.9e-18 Score=145.84 Aligned_cols=98 Identities=23% Similarity=0.327 Sum_probs=82.0
Q ss_pred CCCCCEEEeCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEEec
Q 039318 2 LSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSAN 81 (717)
Q Consensus 2 l~~~~~l~S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~ 81 (717)
|..|++|. +|.|+|.|...|+ |.|+.. .++||.||++.|- +.+.|.|..+|+|+|.+++|.+||+++
T Consensus 10 L~~G~~l~--ng~~~l~~q~DGN-----Lvly~~----~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~~g~~vWsS~ 76 (108)
T d1jpca_ 10 LSTGEFLN--YGSFVFIMQEDCN-----LVLYDV----DKPIWATNTGGLS--RSCFLSMQTDGNLVVYNPSNKPIWASN 76 (108)
T ss_dssp ECTTCEEE--ETTEEEEECTTSC-----EEEEET----TEEEEECCCTTSC--SSCEEEECTTSCEEEECTTCCEEEECC
T ss_pred ecCCCEEE--cCCEEEEECCCCe-----EEEEeC----CceeeEeCCCCCC--CccEEEEeccceEEEECCCccceEEcc
Confidence 67888884 6999999998886 778653 5899999999884 346899999999999999999999999
Q ss_pred cccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCC
Q 039318 82 LSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDY 120 (717)
Q Consensus 82 ~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~ 120 (717)
+.... ...+|+|+|+|||||++. .+||||+|
T Consensus 77 t~~~~-~~~~l~L~ddGNlVly~~-------~~W~S~t~ 107 (108)
T d1jpca_ 77 TGGQN-GNYVCILQKDRNVVIYGT-------DRWATGTH 107 (108)
T ss_dssp CCCSC-SCEEEEECTTSCEEEEEC-------CCCCCCCC
T ss_pred ccCCC-CcEEEEEcCCCCEEEeCC-------CcccCCCC
Confidence 76543 344589999999999953 58999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.73 E-value=1.4e-17 Score=143.59 Aligned_cols=99 Identities=21% Similarity=0.354 Sum_probs=80.3
Q ss_pred CCCCCEEEeCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEEec
Q 039318 2 LSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSAN 81 (717)
Q Consensus 2 l~~~~~l~S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~ 81 (717)
|..|++|. +|.|.|+|...++ |.|+. ..++||+||++.|... .++|.|+.||+|||.|++|.+||+|+
T Consensus 10 L~~g~~l~--~g~~~l~~q~dgn-----Lvl~~----~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~s~ 77 (109)
T d1kj1a_ 10 LYAGQSLD--VEPYHFIMQEDCN-----LVLYD----HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDAEGRSLWASH 77 (109)
T ss_dssp EETTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECSSSCEEEECC
T ss_pred EeCCCEEE--eCCEEEEecCCCe-----EEEEe----CCEEEEEeCCCCCCce-eEEEEEcCCceEEEEeCCCcEEEEEe
Confidence 55677775 5889999987665 66654 3589999999999854 56899999999999999999999999
Q ss_pred cccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCC
Q 039318 82 LSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDY 120 (717)
Q Consensus 82 ~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~ 120 (717)
++... +..+|.|+|+|||||++. .+|||+-|
T Consensus 78 t~~~~-~~~~l~L~ddGNlvly~~-------~~W~S~t~ 108 (109)
T d1kj1a_ 78 SVRGN-GNYVLVLQEDGNVVIYGS-------DIWSTGTY 108 (109)
T ss_dssp CCCCS-SCCEEEECTTSCEEEECC-------EEEECCCC
T ss_pred eECCC-CCEEEEEeCCCcEEEECC-------CEecCCCc
Confidence 87532 344599999999999952 69999865
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.72 E-value=2.1e-17 Score=143.69 Aligned_cols=103 Identities=19% Similarity=0.393 Sum_probs=82.8
Q ss_pred CCCCCEEEeCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEEec
Q 039318 2 LSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSAN 81 (717)
Q Consensus 2 l~~~~~l~S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~ 81 (717)
|..|++|+| |.|+|.|...|+ |.|+.. .++||.||++.|.. .+.|.|+.||+|+|.+. +.++|+++
T Consensus 10 L~~g~~l~~--g~~~l~~q~DGN-----Lvly~~----~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~-~~~~w~s~ 75 (112)
T d1xd5a_ 10 LDTGGSLAE--GGYLFIIQNDCN-----LVLYDN----NRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG-SRAIWASN 75 (112)
T ss_dssp ECTTCEEEE--TTEEEEECTTSC-----EEEEET----TEEEEECCCTTSCS--SEEEEECTTSCEEEEET-TEEEEECC
T ss_pred ecCCCEEEE--CCEEEEEcCCCC-----EEEEcC----CcEEEEccCccCCC--CcEEEEeccccEEEEec-CCeEEEEe
Confidence 678899974 999999998775 677653 58999999998853 36899999999999986 56778777
Q ss_pred cccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCc
Q 039318 82 LSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSD 123 (717)
Q Consensus 82 ~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTD 123 (717)
+.... +..+|+|+|+|||||++.++ .++|||+.+|+|
T Consensus 76 t~~~~-~~~~l~L~ddGNlvly~~~~----~~~W~S~t~~~n 112 (112)
T d1xd5a_ 76 TNRQN-GNYYLILQRDRNVVIYDNSN----NAIWATHTNVGN 112 (112)
T ss_dssp CCCSC-CCCEEEECTTSCEEEECTTS----CEEEECCCCCCC
T ss_pred eccCC-CceEEEEcCCCCEEEECCCC----cEEecCCCccCC
Confidence 65432 34459999999999997542 389999999986
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.66 E-value=6.5e-17 Score=141.60 Aligned_cols=102 Identities=18% Similarity=0.239 Sum_probs=83.8
Q ss_pred EEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEEeccccCcCCcEEEEEccCCCeEEEeccCCCC
Q 039318 31 GIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDS 110 (717)
Q Consensus 31 gIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~ 110 (717)
.|||.++++++.+|++|++.|+.....+|.+..||||+|.+. +.++|++++...... ..|.|+++|||||++.+
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~-~~~~l~~~GnLvl~d~~---- 84 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTG-CRAVLQPNGRMDVLTNQ---- 84 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSS-CEEEEETTTEEEEEETT----
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCc-EEEEEeCCeeEEEEcCC----
Confidence 689999999999999999999988777999999999999876 678999998765443 44999999999999864
Q ss_pred cceeeeecCCCCccccccCeeceeeccCCceEEEEecCCCCCCCceeEEeeccCCCcEE
Q 039318 111 ETYLWQSFDYPSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPEL 169 (717)
Q Consensus 111 ~~~lWQSFd~PTDTlLpgq~l~~~~~~~~~~~l~S~~s~~dps~G~~~~~~~~~~~~~~ 169 (717)
+.+|||||. +.++|.|.+.|+++|...+
T Consensus 85 ~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvl 112 (120)
T d1dlpa2 85 NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAI 112 (120)
T ss_dssp TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEE
T ss_pred CCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEE
Confidence 248999984 2356789999999997654
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.51 E-value=4.2e-15 Score=128.52 Aligned_cols=111 Identities=18% Similarity=0.240 Sum_probs=89.8
Q ss_pred EEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEEeccccCcCCcEEEEEccCCCeEEEeccCCCC
Q 039318 31 GIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDS 110 (717)
Q Consensus 31 gIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~ 110 (717)
.|||.-.++.+..|+.+.+.++.+...+|.+..||||||.+ ++.++|++++.+.. ...|.|+++|||||++..+
T Consensus 2 ~~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~--~~~l~l~~dGNLvl~d~~~--- 75 (115)
T d1dlpa1 2 NILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGAT--GCRAVLQSDGLLVILTAQN--- 75 (115)
T ss_dssp CCCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSCS--CCBCCBCSSSCBCCBCTTT---
T ss_pred cEEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCCC--ceEEEEeccCCEEEEccCC---
Confidence 37888778888889999999998877799999999999987 46789999986532 3348999999999997643
Q ss_pred cceeeeecCCCCccccccCeeceeeccCCceEEEEecCCCCCCCceeEEeeccCCCcEEEEEcCCeeEEecCC
Q 039318 111 ETYLWQSFDYPSDTLLPGMKLGWDFKTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYRTGP 183 (717)
Q Consensus 111 ~~~lWQSFd~PTDTlLpgq~l~~~~~~~~~~~l~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 183 (717)
.+||||+- +.+.|.|.+.|+++|... ++ ..++|.+|.
T Consensus 76 -~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlv--lY--~~~~Wssgt 112 (115)
T d1dlpa1 76 -TIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVT--IY--GPGLWDSGT 112 (115)
T ss_dssp -CCSCCCCC-------------------------------CCCSSCCEEEECSSSCEE--EE--CSEEEECSC
T ss_pred -CEEEEcCC-------------------------------CCCCCCEEEEECCCCcEE--Ee--CCCeecCCC
Confidence 38999873 236789999999999754 44 347898875
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.49 E-value=1e-13 Score=120.60 Aligned_cols=99 Identities=20% Similarity=0.345 Sum_probs=79.6
Q ss_pred CCCCCEE--EeCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEE
Q 039318 2 LSDGRTL--VSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWS 79 (717)
Q Consensus 2 l~~~~~l--~S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWs 79 (717)
|.++|.| .+..|.|.|.|...|+ |.+ |. ..++||.||+..+.. ...|.|..||+|+|.|++|.+||+
T Consensus 17 l~~~q~l~~~~~~~~y~l~mQ~DGN-----LVL-y~---~~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~~g~~vWs 85 (119)
T d1b2pa_ 17 LHATESLEILFGTHVYRFIMQTDCN-----LVL-YD---NNNPIWATNTGGLGN--GCRAVLQPDGVLVVITNENVTVWQ 85 (119)
T ss_dssp EETTCEEEEEETTEEEEEEECTTSC-----EEE-EE---TTEEEEECCCTTSCS--SCEEEECTTSCEEEECTTCCEEEE
T ss_pred EeCCCeEEEecCCceEEEEECCCCc-----EEE-EE---CCeEEEEecCCCCCc--ceEEEEEeCCCEEEECCCCcEEEE
Confidence 4567766 5679999999998886 655 33 358999999987743 368999999999999999999999
Q ss_pred eccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecC
Q 039318 80 ANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFD 119 (717)
Q Consensus 80 t~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd 119 (717)
+++.... ...+|+|+|+|||||++. .+|||-.
T Consensus 86 S~t~~~~-~~~~l~Lq~DGNlvlYg~-------~~W~S~T 117 (119)
T d1b2pa_ 86 SPVAGKA-GHYVLVLQPDRNVVIYGD-------ALWATQT 117 (119)
T ss_dssp CSCCCCS-SCEEEEECTTSCEEEEES-------EEEECCC
T ss_pred CCCcCCC-CceEEEEcCCCCEEEECC-------CEeccCC
Confidence 9987543 344589999999999952 7999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.19 E-value=1.3e-11 Score=106.32 Aligned_cols=96 Identities=22% Similarity=0.375 Sum_probs=76.9
Q ss_pred CCCCCEEEeCCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEEec
Q 039318 2 LSDGRTLVSKEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSAN 81 (717)
Q Consensus 2 l~~~~~l~S~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~ 81 (717)
|..++.| .+|.|.|.|...|+ |.|+.. .++||.+|...+ ..+++.|..+|+|||.|.++.+||++.
T Consensus 17 l~~~~~l--~~g~~~l~~q~DGN-----LvL~~~----~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~vWsS~ 82 (115)
T d1dlpa1 17 LHAAQSL--ELSSFRFTMQSDCN-----LVLFDS----DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSG 82 (115)
T ss_dssp CCTTCEE--CSTTEEEEECTTSC-----EEEEES----SSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCCCC
T ss_pred ecCCCcE--EcCCEEEEECCCCe-----EEEEcC----CeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEEEEcC
Confidence 6778888 68999999998886 777542 478999997543 346899999999999999999999999
Q ss_pred cccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecC
Q 039318 82 LSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFD 119 (717)
Q Consensus 82 ~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd 119 (717)
+.... +..+|+|+++|||||++. .+|+|-.
T Consensus 83 t~~~~-g~y~l~Lq~DGNlvlY~~-------~~Wssgt 112 (115)
T d1dlpa1 83 TKGSI-GNYVLVLQPDRTVTIYGP-------GLWDSGT 112 (115)
T ss_dssp CCCCS-SCCEEEECSSSCEEEECS-------EEEECSC
T ss_pred CCCCC-CCEEEEECCCCcEEEeCC-------CeecCCC
Confidence 86543 344599999999999942 6999853
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.87 E-value=1.9e-09 Score=93.35 Aligned_cols=88 Identities=18% Similarity=0.345 Sum_probs=66.2
Q ss_pred CCCeEEEEeeCCCCCCCeEEEEEeeeCCCCeEEEeeCCCCCCcCCcceEEEecCCCEEEEcCCCcEEEEeccccCcCCcE
Q 039318 11 KEGSFELGFFSPGSSKNRYVGIWYKNMPVKTVVWVANRINPINDSSGVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPV 90 (717)
Q Consensus 11 ~~g~F~~GFf~~~~~~~~~lgIw~~~~~~~tvvW~ANr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~ 90 (717)
..|.|.|.|-..|+ |.|+- ...+||.+|-. -.+....+.|..+|+|||.|.++.++|++++.... +..
T Consensus 33 ~~g~y~L~~q~DGN-----LvL~~----~~~~vW~s~t~--~~~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~~~~-~~~ 100 (120)
T d1dlpa2 33 QLSPYRLSMETDCN-----LVLFD----RDDRVWSTNTA--GKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSA-GRY 100 (120)
T ss_dssp BCSSCEEEEETTTE-----EEEEB----TTBCCSCCCCC--SSCSSCEEEEETTTEEEEEETTTEEEEECCCCCSS-SCC
T ss_pred EcCCEEEEEcCCCc-----EEEec----CCcEEEEEccc--cCCCcEEEEEeCCeeEEEEcCCCCEEEEeCCCCCC-CcE
Confidence 35778887766554 66653 24678998843 33445689999999999999999999999986543 334
Q ss_pred EEEEccCCCeEEEeccCCCCcceeeee
Q 039318 91 VLQLLDSGNLVLRGERDGDSETYLWQS 117 (717)
Q Consensus 91 ~~~LldsGNlVl~~~~~~~~~~~lWQS 117 (717)
++.|.++|||||++. .+|.|
T Consensus 101 ~l~Lq~DGnlvlY~~-------~~W~t 120 (120)
T d1dlpa2 101 VFVLQPDRNLAIYGG-------ALWTT 120 (120)
T ss_dssp EEEECSSSCEEEECC-------CCCBC
T ss_pred EEEECCCCcEEEeCC-------CcccC
Confidence 589999999999942 58876
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.77 E-value=2.4e-08 Score=84.73 Aligned_cols=87 Identities=20% Similarity=0.352 Sum_probs=64.5
Q ss_pred ceEEEecCCCEEEEcCCCcEEEEeccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCccccccCeeceeec
Q 039318 57 GVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTLLPGMKLGWDFK 136 (717)
Q Consensus 57 ~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~ 136 (717)
-+|.+..||||||.+ .+.+||++++.........+.|.++|||||++.++ .++|+|=
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g----~~vW~s~------------------ 77 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEG----RSLWASH------------------ 77 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSS----CEEEECC------------------
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCC----cEEEEEe------------------
Confidence 478889999999976 56899999987654444559999999999997642 3889761
Q ss_pred cCCceEEEEecCCCCCCCceeEEeeccCCCcEEEEEcCCeeEEecCC
Q 039318 137 TGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYRTGP 183 (717)
Q Consensus 137 ~~~~~~l~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 183 (717)
+..+.|.|.+.|+++|... +++ .+.|.++.
T Consensus 78 -------------t~~~~~~~~l~L~ddGNlv--ly~--~~~W~S~t 107 (109)
T d1kj1a_ 78 -------------SVRGNGNYVLVLQEDGNVV--IYG--SDIWSTGT 107 (109)
T ss_dssp -------------CCCCSSCCEEEECTTSCEE--EEC--CEEEECCC
T ss_pred -------------eECCCCCEEEEEeCCCcEE--EEC--CCEecCCC
Confidence 1113567889999998755 443 46888765
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.76 E-value=2.5e-08 Score=85.86 Aligned_cols=85 Identities=18% Similarity=0.295 Sum_probs=63.5
Q ss_pred eEEEecCCCEEEEcCCCcEEEEeccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCccccccCeeceeecc
Q 039318 58 VLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTLLPGMKLGWDFKT 137 (717)
Q Consensus 58 ~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~~ 137 (717)
+|.+..||||||.++ +.++|++++.+.... ..|.|.++|||||++.++ .+||+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~-~~l~l~~dGnLvL~d~~g----~~vWsS~t------------------ 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNG-CRAVLQPDGVLVVITNEN----VTVWQSPV------------------ 88 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSS-CEEEECTTSCEEEECTTC----CEEEECSC------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcc-eEEEEEeCCCEEEECCCC----cEEEECCC------------------
Confidence 688889999999865 568999998765433 349999999999997652 38997531
Q ss_pred CCceEEEEecCCCCCCCceeEEeeccCCCcEEEEEcCCeeEEecCC
Q 039318 138 GLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYRTGP 183 (717)
Q Consensus 138 ~~~~~l~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 183 (717)
.-+.|.|.+.|+++|...+ +. .+.|.++.
T Consensus 89 -------------~~~~~~~~l~Lq~DGNlvl--Yg--~~~W~S~T 117 (119)
T d1b2pa_ 89 -------------AGKAGHYVLVLQPDRNVVI--YG--DALWATQT 117 (119)
T ss_dssp -------------CCCSSCEEEEECTTSCEEE--EE--SEEEECCC
T ss_pred -------------cCCCCceEEEEcCCCCEEE--EC--CCEeccCC
Confidence 1135678899999997654 43 46888774
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.74 E-value=2.2e-08 Score=84.88 Aligned_cols=85 Identities=21% Similarity=0.412 Sum_probs=62.5
Q ss_pred ceEEEecCCCEEEEcCCCcEEEEeccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCccccccCeeceeec
Q 039318 57 GVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTLLPGMKLGWDFK 136 (717)
Q Consensus 57 ~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~ 136 (717)
-+|.+..||||||.+ .+.+||++++.+..... .+.|.++|||||++.++ .+||+|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~-~l~l~~~Gnlvl~~~~g----~~vWsS------------------- 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSC-FLSMQTDGNLVVYNPSN----KPIWAS------------------- 75 (108)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSC-EEEECTTSCEEEECTTC----CEEEEC-------------------
T ss_pred EEEEECCCCeEEEEe-CCceeeEeCCCCCCCcc-EEEEeccceEEEECCCc----cceEEc-------------------
Confidence 479999999999986 56799999987654434 49999999999997652 489976
Q ss_pred cCCceEEEEecCCCCCCCceeEEeeccCCCcEEEEEcCCeeEEecC
Q 039318 137 TGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKGSRKFYRTG 182 (717)
Q Consensus 137 ~~~~~~l~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~ 182 (717)
.+....+.|.+.|+++|...+ +. .+.|.++
T Consensus 76 ------------~t~~~~~~~~l~L~ddGNlVl--y~--~~~W~S~ 105 (108)
T d1jpca_ 76 ------------NTGGQNGNYVCILQKDRNVVI--YG--TDRWATG 105 (108)
T ss_dssp ------------CCCCSCSCEEEEECTTSCEEE--EE--CCCCCCC
T ss_pred ------------cccCCCCcEEEEEcCCCCEEE--eC--CCcccCC
Confidence 111245678889999997554 43 3467655
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.40 E-value=8.2e-07 Score=75.57 Aligned_cols=88 Identities=20% Similarity=0.450 Sum_probs=63.6
Q ss_pred cceEEEecCCCEEEEcCCCcEEEEeccccCcCCcEEEEEccCCCeEEEeccCCCCcceeeeecCCCCccccccCeeceee
Q 039318 56 SGVLVVNKTGNLVLTSQNKSVVWSANLSKEVRTPVVLQLLDSGNLVLRGERDGDSETYLWQSFDYPSDTLLPGMKLGWDF 135 (717)
Q Consensus 56 ~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~LldsGNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~ 135 (717)
.-.|.+..||||||.+ .+.+||++++.....+ ..+.|..+|||||++.. ..+|.|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~-~~l~l~~dGnLvl~~~~-----~~~w~s------------------ 74 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASG-CVLKMQNDGNLVIYSGS-----RAIWAS------------------ 74 (112)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSS-EEEEECTTSCEEEEETT-----EEEEEC------------------
T ss_pred CEEEEEcCCCCEEEEc-CCcEEEEccCccCCCC-cEEEEeccccEEEEecC-----CeEEEE------------------
Confidence 3579999999999986 5689999998764433 34999999999999742 256643
Q ss_pred ccCCceEEEEecCCCCCCCceeEEeeccCCCcEEEEEcC-CeeEEecCC
Q 039318 136 KTGLERRITSWKSSDDPSPGDFIWKIERQFYPELVMWKG-SRKFYRTGP 183 (717)
Q Consensus 136 ~~~~~~~l~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~-~~~y~~~~~ 183 (717)
...-..|.|.+.|+++|...+ ++. ..+.|.++.
T Consensus 75 -------------~t~~~~~~~~l~L~ddGNlvl--y~~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 -------------NTNRQNGNYYLILQRDRNVVI--YDNSNNAIWATHT 108 (112)
T ss_dssp -------------CCCCSCCCCEEEECTTSCEEE--ECTTSCEEEECCC
T ss_pred -------------eeccCCCceEEEEcCCCCEEE--ECCCCcEEecCCC
Confidence 122234678899999997654 443 467898774
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.61 E-value=4.8e-05 Score=74.39 Aligned_cols=124 Identities=16% Similarity=0.048 Sum_probs=77.5
Q ss_pred HHHHHhcCcccccccccCCccceEeeeeCCchhhh------------------------hhh--hhhhcceeecCceeeE
Q 039318 418 TIANATDNFSINKKLGEGGFGPVYKGTLADGQEIA------------------------HRN--LVKLLGCCIQGEEKLL 471 (717)
Q Consensus 418 ~i~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~va------------------------h~n--iv~l~~~~~~~~~~~l 471 (717)
++...-..|++.+..+.++...||+....+++.+. +.. +.+++.+...++..++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 34444567776665544455678887643322110 211 3556667777888999
Q ss_pred EEeccCCCChhhHhhhccccccCChhhHHHHHHHHHHHHHHHhhcC----------------------------------
Q 039318 472 IYEFMPNRSLDSFIFDQTKRKLLDWSKRFCIICGTARGLLYLHHDS---------------------------------- 517 (717)
Q Consensus 472 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~---------------------------------- 517 (717)
|||++++..+.+... +......++.++++.++.||+..
T Consensus 88 v~~~l~G~~~~~~~~--------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 88 LMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHTT--------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEeccccccccccc--------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 999999988765441 11122234445555555555321
Q ss_pred ----------------------CCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 518 ----------------------RLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 518 ----------------------~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999876667999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.63 E-value=0.00074 Score=65.14 Aligned_cols=30 Identities=17% Similarity=0.222 Sum_probs=26.0
Q ss_pred cEEeccCCCCceEEcCCCCceecccccccc
Q 039318 520 RIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 520 ~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 489999999999999876678999988764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.76 E-value=0.0066 Score=62.57 Aligned_cols=30 Identities=23% Similarity=0.304 Sum_probs=26.0
Q ss_pred CcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 519 LRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 519 ~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
..++|+|+.|.|||++++. ++|+||..+..
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 3599999999999998764 89999988764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=93.23 E-value=0.044 Score=56.08 Aligned_cols=16 Identities=38% Similarity=0.655 Sum_probs=13.8
Q ss_pred cEEeccCCCCceEEcC
Q 039318 520 RIIHRDLKASNVLLDH 535 (717)
Q Consensus 520 ~ivHrDlkp~NIll~~ 535 (717)
.++|.|+.+.|||+.+
T Consensus 219 v~CHnDL~~~NiL~~~ 234 (395)
T d1nw1a_ 219 TFCHNDLQEGNILLPK 234 (395)
T ss_dssp EEECSCCCGGGEEEEC
T ss_pred eEEecCCCcccEeecc
Confidence 3689999999999854
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.58 E-value=0.036 Score=34.24 Aligned_cols=32 Identities=38% Similarity=0.816 Sum_probs=26.0
Q ss_pred CCcccccccCCccccccC-CCCcccccCCcccCC
Q 039318 256 DQCDTYGLCGAYGICIIS-QSPICQCLEGFHPKS 288 (717)
Q Consensus 256 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~~~ 288 (717)
|+|.+-..|| ||.|+.- ..-.|.|-.||+|..
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 6899999998 7889754 345699999999864
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.38 E-value=0.078 Score=35.03 Aligned_cols=30 Identities=40% Similarity=0.847 Sum_probs=24.1
Q ss_pred CCccc-ccccCCccccccCC-CCcccccCCcc
Q 039318 256 DQCDT-YGLCGAYGICIISQ-SPICQCLEGFH 285 (717)
Q Consensus 256 ~~C~~-~~~CG~~g~C~~~~-~~~C~C~~gf~ 285 (717)
|+|.. ...|..+|.|.... .-.|.|++||+
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 56875 56799999998653 46899999996
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=88.10 E-value=0.18 Score=49.23 Aligned_cols=32 Identities=28% Similarity=0.307 Sum_probs=27.7
Q ss_pred CCcEEeccCCCCceEEcCCCCceecccccccc
Q 039318 518 RLRIIHRDLKASNVLLDHEMNPKISDFGLART 549 (717)
Q Consensus 518 ~~~ivHrDlkp~NIll~~~~~~kl~Dfgla~~ 549 (717)
+.++||+|+.++||+++.+...-|+||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCcchhhhhcccccceeEeccccccc
Confidence 44599999999999999887778999998863
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.76 E-value=0.19 Score=32.42 Aligned_cols=29 Identities=41% Similarity=0.883 Sum_probs=22.5
Q ss_pred CCcccccccCCccccccC-CCCcccccCCcc
Q 039318 256 DQCDTYGLCGAYGICIIS-QSPICQCLEGFH 285 (717)
Q Consensus 256 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~ 285 (717)
|+|. ...|...|.|... ..-.|.|++||.
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~ 30 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFE 30 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEE
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCC
Confidence 4565 4778999999765 357899999997
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.55 E-value=0.26 Score=31.80 Aligned_cols=29 Identities=21% Similarity=0.641 Sum_probs=22.2
Q ss_pred CCcccccccCCccccccC-CCCcccccCCcc
Q 039318 256 DQCDTYGLCGAYGICIIS-QSPICQCLEGFH 285 (717)
Q Consensus 256 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~ 285 (717)
|+|. ...|...|.|... ..-.|.|++||.
T Consensus 2 d~C~-~~PC~n~g~C~~~~~~y~C~C~~G~~ 31 (39)
T d2vj3a2 2 NECV-SNPCQNDATCLDQIGEFQCICMPGYE 31 (39)
T ss_dssp CTTT-TCCCCSSCEEEECSSCEEEECCTTEE
T ss_pred cCCc-CCCCCCCCEEECCCCCEEEeCCCCCc
Confidence 4563 4679999999765 346799999997
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.59 E-value=0.18 Score=33.20 Aligned_cols=31 Identities=32% Similarity=0.700 Sum_probs=22.6
Q ss_pred CCccc-ccccCCccccccCC-CCcccccCCcccC
Q 039318 256 DQCDT-YGLCGAYGICIISQ-SPICQCLEGFHPK 287 (717)
Q Consensus 256 ~~C~~-~~~CG~~g~C~~~~-~~~C~C~~gf~~~ 287 (717)
|+|.. ++.|. +++|.... +-.|.|++||...
T Consensus 3 dEC~~~~~~C~-~~~C~Nt~Gsy~C~C~~Gy~l~ 35 (42)
T d1lmja2 3 DECQRDPLLCR-GGVCHNTEGSYRCECPPGHQLS 35 (42)
T ss_dssp CHHHHCSSTTT-TSEEEEETTEEEEESCTTSCCC
T ss_pred cccCCCCCCCC-CCEeECCCCCeEEeCCCCCeEC
Confidence 45654 56674 78998664 4679999999864
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.53 E-value=0.48 Score=31.16 Aligned_cols=31 Identities=29% Similarity=0.554 Sum_probs=23.7
Q ss_pred CCCcccccccCCccccccCC-CCcccccCCccc
Q 039318 255 KDQCDTYGLCGAYGICIISQ-SPICQCLEGFHP 286 (717)
Q Consensus 255 ~~~C~~~~~CG~~g~C~~~~-~~~C~C~~gf~~ 286 (717)
-|+|..+. |+.++.|.... +-.|.|++||..
T Consensus 5 idEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEPD-VCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCCcC-CCCCCEeECCCCCeEeECCCCccc
Confidence 47897654 55789998664 568999999975
|